Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.726067631084103,-2.871218244623796,0.0,0.0,0.0,58/87,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6949208043643444,-2.7648316082759026,0.0,0.0,0.0,58/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,protein targeting to ER (GO:0045047),-0.6787846795913564,-2.733109047411276,0.0,0.0,0.0,60/99,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;CHMP4B;CHMP4A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;SRP19;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL21;SEC61A1;RPL34;RPL10A;RPL12;RPL35;RPL14;SRP14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,cytoplasmic translation (GO:0002181),-0.6721663139187402,-2.690110300316496,0.0,0.0,0.0,59/91,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;EIF3M;RPS17;RPS16;RPL39;RPS27A;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;RPL22L1;TMA7;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5993449590099497,-2.471821172721106,0.0,0.0,0.0,59/110,16.20%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;RPS13;RPS15A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.7119759652461757,-2.307166621660238,0.0,0.00021031417437196974,0.001,19/32,14.47%,RHOJ;RHOA;MEOX2;THBS1;NOTCH1;JCAD;AKT3;KDR;STARD13;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;KLF4;VEGFA;SRPX2
prerank,peptide biosynthetic process (GO:0043043),-0.5309207630422986,-2.2660135163858803,0.0,0.00036053858463766243,0.002,74/153,20.60%,RPLP1;PCSK5;RPS15;RPL38;RPL18A;RPL41;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;GGTA1;RPL6;RPL18;RPS25;AGO2;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;RPL21;MRPL10;RPL34;RPL10A;RPL12;RPL35;RPL14;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;MRPS12;MRPL55;MRPL43;MRPL36;DMD;MRPL35;GGT7;RPL3
prerank,epithelial tube morphogenesis (GO:0060562),-0.6788138751769248,-2.204324792435201,0.0,0.00047320689233693193,0.003,14/32,7.55%,MEF2C;PODXL;COL4A1;SLIT2;ACVR1;ACVRL1;PKD1;BMP4;MTSS1;RASIP1;SOX17;MET;HES1;PRKX
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6559279189142283,-2.190670618405278,0.0,0.000841256697487879,0.006,19/39,13.82%,NRP1;COL4A1;SLIT2;LRP6;TIE1;ENG;LRP5;PKD1;BMP4;RASIP1;SIX1;TGFBR2;KDR;MET;FGF2;NOTCH4;SEMA3E;BMP2;VEGFA
prerank,extracellular matrix organization (GO:0030198),-0.4579800446340492,-2.1449679424188206,0.0,0.001766639064724546,0.013,97/276,14.58%,COL8A1;SH3PXD2A;ELN;COL12A1;ADAMTSL3;VWF;FLRT2;PECAM1;SPARC;LAMA2;TLL1;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;COL25A1;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;DST;GSN;COL6A1;TGFB2;LAMC3;COL4A2;NDNF;THBS1;GAS6;ITGA5;CYP1B1;VCAM1;PLOD2;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;CREB3L1;ICAM1;P4HA1;CAPN2;ADAMTS6;RECK;SH3PXD2B;ADAM10;LOX;LUM;ITGB5;ADAMTS1;PLOD3;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;CRTAP;MMP11;CAPG;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;P4HA2;ICAM2;TNC;HAS1;ADAM15;AGRN
prerank,regulation of ossification (GO:0030278),-0.64545141459305,-2.1380538208873685,0.0,0.001950185980540083,0.016,18/36,13.74%,MEF2C;BMPR2;ZBTB16;PTN;SGMS2;LRP6;ACVR1;TGFB2;NOTCH1;BMP4;S1PR1;WNT5A;MDK;NBR1;TWIST1;BMP2;ECM1;ENPP1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8310166484598858,2.127994254768871,0.0,0.042564070296363055,0.05,5/14,4.28%,ACTN2;ATP1B3;ANK2;LRRC38;ATP1B2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.538978440831894,-2.125129276794605,0.0,0.002313455918091667,0.021,29/88,12.61%,PTPRM;NRP1;TEK;CAV1;SPARC;NRP2;BMPR2;ACVRL1;TIE1;VEGFC;THBS1;CDH13;F3;BMP4;AKT3;KDR;XDH;PRKD1;WNT5A;PPP1R16B;FLT4;FGF2;APOE;AGGF1;CAV2;PIK3CD;NRAS;BMP2;ECM1
prerank,external encapsulating structure organization (GO:0045229),-0.46269069332044316,-2.1021763773605895,0.0,0.0036885870582160844,0.037,78/205,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;HRNR;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,extracellular structure organization (GO:0043062),-0.4591640547415185,-2.0758351899130965,0.0,0.004867270892608442,0.048,77/204,14.58%,COL8A1;SH3PXD2A;ELN;ADAMTSL3;VWF;PECAM1;SPARC;LAMA2;SPOCK2;LAMA1;DCN;COL6A3;COL4A1;BSG;ITGA6;MFAP5;ADAMTSL1;COL15A1;COL6A2;COL8A2;VIT;COL6A1;LAMC3;COL4A2;NDNF;THBS1;ITGA5;VCAM1;COL23A1;CDH1;CD44;ADAMTS5;KDR;APP;ITGA1;FN1;COL5A2;ITGB4;ITGA8;F11R;LAMA3;FBN1;ADAMTS17;SLC39A8;COL4A6;ITGB1;ICAM1;ADAMTS6;RECK;LOX;LUM;ITGB5;ADAMTS1;ADAM19;ADAMTS14;TGFBI;LAMB2;COL27A1;ECM2;VCAN;FGF2;SERPINE1;COL14A1;MMP11;POSTN;JAM3;ITGA7;COL1A1;COMP;ITGA4;ADAMTS20;BGN;ITGB8;ICAM2;TNC;ADAM15;AGRN
prerank,negative regulation of vascular permeability (GO:0043116),-0.8222457112578536,-2.0688863619181186,0.0,0.005384042863922425,0.057,11/12,15.34%,PDE3A;CLDN5;SLIT2;RAMP2;PTPRJ;PDE2A;CEACAM1;DDAH1;SH3GL2;VEGFA;FERMT2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.73527931964638,-2.0680032787837903,0.0,0.005126408000316763,0.058,13/18,14.47%,RHOJ;JCAD;AKT3;KDR;PTGS2;PIK3C2A;ANXA1;HDAC7;HDAC9;GATA2;FGF2;VEGFA;SRPX2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.5369572424278436,-2.0650104848745507,0.0,0.005270225781321124,0.063,28/75,13.82%,NRP1;TEK;NRP2;BMPR2;VEGFC;CDH13;F3;PLCG1;JCAD;BMP4;AKT3;KDR;PRKD1;WNT5A;AGTR1;PPP1R16B;MDK;GATA2;FLT4;IGF2;FGF2;AGGF1;PIK3CD;NRAS;BMP2;ITGA4;ECM1;VEGFA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.47619545093617976,-2.060330708342731,0.0,0.005678482708043183,0.071,68/168,16.39%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPS12;RPS20;AGO1;RPL32;RPL5;TENT2;RPS10;RPL10;RPS23;RPS24;EIF3E;RPL7;RPL37A;CNOT6L;DCP1B;RPS17;RPS16;RPL39;RPS27A;PABPC1;RPL13;CNOT11;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;TENT4B;RPL36;RPL28;RPL27;RPL24;RPS29;RPL23;RPL17;RPS9;RPS27;NCBP2;PAN3;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;NCBP1;RPL19;RPL37;RPS18;NBAS;RPS13;RPS15A;TNKS1BP1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6100801722968926,-2.049880169968023,0.0,0.006774330248191867,0.085,13/35,9.64%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;GUCY1B1;PDE9A;CAP2;PDE2A;ADCY2;CAP1;AHR;APOE
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5806999157806476,-2.0479778383216507,0.0,0.006687990745028637,0.087,22/48,14.47%,RHOJ;NOS3;TMSB4X;ETS1;THBS1;PLCG1;JCAD;AKT3;KDR;PTGS2;PIK3C2A;PRKD1;ANXA1;HDAC7;HDAC9;GATA2;ATP5F1B;FGF2;HSPB1;CD40;VEGFA;SRPX2
prerank,positive regulation of chemotaxis (GO:0050921),-0.6009760090124395,-2.0421389112442743,0.0,0.007090592164540694,0.096,18/43,13.91%,NRP1;NTRK3;PTN;TMSB4X;THBS1;CDH13;F3;KDR;STX3;PRKD1;MET;IL6R;MDK;FGF2;HSPB1;EDN3;VEGFA;RARRES2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.6204375785918064,-2.037940999570489,0.0,0.00734187663262149,0.105,18/34,11.50%,NRP1;SEMA6A;DAB2IP;GAB1;VEGFC;RAMP2;NOTCH1;KDR;PRKD1;ERN1;ANXA1;FLT1;SPRY2;PIK3CA;FLT4;MT1G;MAPKAPK2;HSPB1
prerank,regulation of endothelial cell migration (GO:0010594),-0.5185208294678896,-2.037233366025031,0.0,0.007077529172343677,0.106,30/85,10.62%,PTPRM;NRP1;FOXP1;TEK;RHOJ;SPARC;NRP2;DCN;BMPR2;DAB2IP;PTN;SLIT2;ETS1;ACVRL1;SCARB1;BMPER;THBS1;BMP4;KDR;PRKD1;WNT5A;PRCP;EMP2;CEACAM1;FLT4;FGF2;BCAR1;APOE;EDN1;PIK3CD
prerank,maintenance of blood-brain barrier (GO:0035633),-0.642249199767046,-2.033562160937767,0.0,0.007150681928646971,0.111,17/30,12.49%,ACTB;PECAM1;LAMA2;SLC12A2;CLDN5;VCL;TJP1;ESAM;ACTG1;LSR;F11R;ITGB1;TJP2;OCLN;JAM3;MFSD2A;SLC1A1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5671557112186859,-2.0326248661144324,0.0,0.006915130053350366,0.112,22/54,10.47%,NRP1;TEK;LIMS1;VCL;RHOA;ACVRL1;THBS1;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;PTPRJ;KDR;PHLDB2;APOD;MYOC;EFNA5;SRC;MAP4K4;DUSP3;FAM107A
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.625489904983815,-2.02739425141203,0.0,0.0071830379554734276,0.121,8/33,2.97%,PTPRM;PTPRG;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;CORO1C
prerank,endothelial cell migration (GO:0043542),-0.6038751742614419,-2.0158707739876105,0.0,0.008599512907653874,0.151,18/37,13.82%,NRP1;NOS3;RHOA;FAP;MYH9;CDH13;CYP1B1;ID1;STARD13;CCN3;ADGRA2;PXN;PRKX;EMP2;PIK3CA;PTP4A3;SOX18;VEGFA
prerank,translation (GO:0006412),-0.44732498493877704,-2.0103067381438464,0.0,0.008878262646702436,0.162,82/208,17.86%,RPLP1;GATB;RPS15;RPL38;WARS2;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;LARS2;AGO2;RPL36;RPL28;FTSJ1;RPL27;RPL24;RPS29;RPL23;MRPL23;RPL17;YARS2;NDUFA7;RPS9;RPS27;ASMT;ABCE1;RPL22L1;TMA7;RPL21;MRPL10;EEF1E1;RPL34;GARS1;RPL10A;RPL12;RPL35;RPL14;GFM2;RPL19;RPL37;RPS18;RPS13;RPS15A;RRBP1;PTCD3;EEF1G;MRPS12;MRPL55;MRPL43
prerank,blood vessel morphogenesis (GO:0048514),-0.55628113066501,-2.0079738789303194,0.0,0.00892022187853527,0.165,28/54,14.36%,NRP1;CAV1;LAMA1;COL4A1;ENG;RAMP2;LRP5;CYP1B1;ID1;RASIP1;TGFBR2;KDR;TBX1;SOX17;HES1;LOX;FLT1;STRA6;CCBE1;HEY2;FLT4;AGGF1;ADM;SOX18;SLC1A1;ITGB8;VEGFA;CDH2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5730202746042186,-2.0047388825357464,0.0,0.009001446663120305,0.17,17/46,12.40%,NRP1;TMEFF2;TEK;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;VAMP3;NTN4;PXN;LAMB2;PARVA;MICALL2;ITGA4
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7010821197380865,-2.0000355460583648,0.0,0.009158843077489005,0.176,11/22,13.07%,SLIT2;TMSB4X;GSN;KANK1;SSH2;KANK3;KANK4;PRKCD;TMSB10;HIP1R;PFN1
prerank,circulatory system development (GO:0072359),-0.48335989230714166,-1.9789055819980947,0.0,0.012816020000791907,0.246,36/118,13.73%,TEK;MEF2C;NTRK3;HEG1;PDLIM5;PLCE1;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;RAMP2;NOTCH1;PKD1;TGFBR2;FN1;TBX1;FBN1;SOX17;CRIP1;SH3PXD2B;STRA6;HDAC9;CXADR;PIK3CA;HEY2;ZFPM2;FLT4;NOTCH4;WDR11;LDB3;SOX18;BMP2;FBXW7;NCOA6
prerank,regulation of cell junction assembly (GO:1901888),-0.630672305378207,-1.978030264086877,0.0,0.012771806225497798,0.254,11/27,7.71%,PRKCH;MEF2C;PDLIM5;RAPGEF2;CLDN5;TJP1;RAP1A;RUNX1;F11R;CBFB;OCLN
prerank,sodium ion export across plasma membrane (GO:0036376),0.8013487672628713,1.9771495049576355,0.0,0.31226549753786353,0.475,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,cAMP-mediated signaling (GO:0019933),-0.6417090283261315,-1.9731244068895752,0.0,0.013212678719368452,0.268,10/24,9.63%,PDE3A;PDE4D;PDE7B;RAPGEF2;ADGRG6;CAP2;PDE2A;ADCY2;CAP1;AHR
prerank,regulation of angiogenesis (GO:0045765),-0.4456540408334838,-1.971411206581877,0.0,0.013303873773129743,0.279,62/192,13.82%,PTPRM;TEK;RHOJ;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;GAB1;NOS3;HIPK1;ETS1;TIE1;TGFB2;COL4A2;VEGFC;BMPER;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;AGO1;KDR;SERPINF1;ITGB1;PIK3R6;ADGRA2;PRKD1;WNT5A;ISM1;PPP1R16B;ADAMTS1;FLT1;SPRY2;ECSCR;EMP2;CEACAM1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;PIK3CD;SEMA3E;HGS;HSPB1;TWIST1;HHEX;THBS2;ECM1;TSPAN12;ITGB8;STAB1;CD40;AMOT;VEGFA
prerank,regulation of epithelial cell migration (GO:0010632),-0.5528500677867565,-1.9703728779307423,0.0,0.013109583535852782,0.283,15/51,8.77%,PTPRG;RHOJ;DOCK1;BMPR2;DAB2IP;PTN;TGFB2;BMPER;CORO1C;PLCG1;MACF1;PLCG2;EMP2;CEACAM1;SRC
prerank,positive regulation of cell migration (GO:0030335),-0.42736370132446794,-1.9585307626078856,0.0,0.015040305551033297,0.328,82/253,13.82%,NRP1;LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK1;RAPGEF2;BMPR2;DAB2IP;GAB1;SEMA3C;ITGA6;TJP1;SEMA7A;ACVR1;TGFB2;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;PLCG1;STAT3;KDR;FN1;MGAT5;PLCG2;CPNE3;ITGB1;ARHGEF2;NIPBL;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;AGO2;BCAR1;NEDD9;S100A11;EPHB2;RIPOR1;EDN1;FAM107A;NSMF;PIK3CD;SEMA3E;FBXO5;CCN4;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;HDAC6;PFN1;SHTN1;AKT2;PTPRC;VEGFA
prerank,positive regulation of neuron migration (GO:2001224),-0.7972312717350012,-1.9573801846475583,0.0,0.014976583048698686,0.335,8/11,13.40%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;SHTN1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.7059966564168867,-1.9546119414682774,0.0,0.015207332608434734,0.345,8/18,12.51%,MTUS1;PTN;SLIT2;LYN;IL6R;MDK;EDN3;PTK2B
prerank,artery morphogenesis (GO:0048844),-0.616683318755944,-1.9465079842108002,0.0,0.01653069410563682,0.376,14/30,13.83%,NRP1;BMPR2;JAG1;TGFB2;ENG;NOTCH1;BMP4;TBX1;HES1;STRA6;HEY2;TBX2;VEGFA;LRP1
prerank,retinoic acid metabolic process (GO:0042573),0.7800110046331761,1.9460408494400434,0.0,0.33483735299805606,0.638,4/14,2.49%,ALDH1A2;ALDH8A1;ADH7;CYP26B1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6556569259957772,-1.9369873577053913,0.0,0.018989831061586145,0.422,12/24,15.34%,NRP1;TEK;LIMS1;PIK3R1;PTPRJ;KDR;MYOC;MAP4K4;DUSP3;VEGFA;S100A10;FERMT2
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.6368584373763511,-1.93406117208971,0.0,0.01946908357043377,0.433,9/25,13.79%,SPTBN1;PDE4D;RUNX1;PLCG2;ANXA1;RPS3;MALT1;PTPRC;CD86
prerank,sodium ion transport (GO:0006814),0.5334190106942354,1.9323947454164507,0.0017331022530329288,0.3041396295721942,0.71,11/85,2.73%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC5A5;SLC24A3;ATP1B3;SLC6A9;SLC5A10;SLC23A1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7890661668480718,-1.928420489104277,0.0,0.0209238148363555,0.465,5/12,7.11%,PDE4D;CAV1;GJD3;CAMK2D;CALM3
prerank,smooth muscle cell differentiation (GO:0051145),-0.7811053917095827,-1.9260711515587405,0.0,0.021452045785940916,0.48,9/12,17.19%,MEF2C;MRTFB;TMEM204;BMP4;TBX18;HEY2;MYOCD;APLNR;HEY1
prerank,positive regulation of angiogenesis (GO:0045766),-0.4731348735701016,-1.92600460213254,0.0,0.021003375547280708,0.48,41/108,13.82%,TEK;GAB1;TJP1;NOS3;HIPK1;ETS1;TIE1;VEGFC;BMPER;RAMP2;THBS1;F3;ITGA5;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;SMAD1;PRKD1;WNT5A;FLT1;MDK;GATA2;FGF2;SERPINE1;AGO2;AGGF1;KLF4;JAK1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4985636879338075,-1.9225027984147727,0.0,0.02169893633846453,0.5,22/70,12.40%,NRP1;TMEFF2;TEK;MEF2C;RHOA;PARVB;LAMC3;PIK3R1;PEAK1;FN1;ITGA8;ACTN1;TBCD;VAMP3;SIPA1L3;NTN4;PXN;ARL13B;LAMB2;PARVA;MICALL2;ITGA4
prerank,heme catabolic process (GO:0042167),-0.7459673420547251,-1.9209083658673523,0.0,0.021294310155161936,0.508,3/14,3.05%,ABCG2;ABCC1;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.7459673420547251,-1.9209083658673523,0.0,0.021294310155161936,0.508,3/14,3.05%,ABCG2;ABCC1;SLCO2B1
prerank,cardiac myofibril assembly (GO:0055003),0.7302948509174361,1.9206916612666567,0.0,0.28386365426738125,0.757,4/15,3.95%,NEBL;PDGFRA;OBSL1;CSRP3
prerank,regulation of vasculogenesis (GO:2001212),-0.7546565907303414,-1.9082870879246376,0.0,0.024954420608135346,0.573,9/14,8.50%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;XDH;EMP2;CEACAM1;HEY2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4887693907169844,-1.9079711776158104,0.0,0.024631996102445094,0.574,25/79,15.07%,BMPR2;DAB2IP;SLIT2;HTRA3;BMPER;THBS1;NOTCH1;CRIM1;SMURF1;CASK;CREB3L1;SMAD5;SMAD1;UBE2D3;EPN2;SPRY2;PTPN1;FGF2;HGS;LEMD3;HHEX;BMP2;SPRY1;GPC1;SKIL
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5728014562710997,-1.9075905757759524,0.002188183807439825,0.024297472850973445,0.575,11/36,9.64%,PTPRM;MEF2C;DCN;DAB2IP;SLIT2;ACVRL1;THBS1;NOTCH1;ANGPT2;FGF2;APOE
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.666996965238128,-1.9016466567930184,0.0,0.025917177487991962,0.597,8/18,7.50%,HEG1;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC
prerank,endothelial cell development (GO:0001885),-0.6292402487035885,-1.8970145396186984,0.0041841004184100415,0.027047196462629163,0.616,10/25,6.89%,PDE4D;PECAM1;RAPGEF2;COL15A1;RAP1A;ICAM1;MET;PDE2A;PPP1R16B;ROBO4
prerank,regulation of T cell migration (GO:2000404),-0.6671962118832679,-1.8849676427793278,0.0021691973969631237,0.03178080857176432,0.677,7/18,9.84%,LRCH1;RHOA;CD200;APP;CXCL12;APOD;DOCK8
prerank,cell-cell junction assembly (GO:0007043),-0.5058453043496527,-1.883756329564781,0.0,0.031615956249226286,0.68,15/63,5.72%,CDH11;ACTB;CLDN5;VCL;TJP1;RHOA;GJC1;GJD3;RAMP2;CD9;ACTG1;WDR1;CTNNA1;TBCD;PAK2
prerank,carboxylic acid transport (GO:0046942),0.5492127346818118,1.8819870431922505,0.0,0.3937821412569588,0.9,11/55,3.99%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC16A12;SLC38A1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4959304924591766,-1.8781475896667468,0.0,0.033530088371302606,0.704,16/67,9.72%,UTRN;NRP1;LIMS1;LIMS2;DOCK1;VIT;NDNF;CDH13;FN1;FLNA;MDK;MYOC;FBLN2;EMP2;ECM2;NEDD9
prerank,regulation of potassium ion transport (GO:0043266),0.6343962561599458,1.8758761545884084,0.0,0.3641715520940776,0.916,11/31,11.94%,CACNA1D;KCNIP3;ACTN2;ANK2;ADRA2A;DLG1;KCNH2;DRD3;VIP;DPP10;KCNIP4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5710411593250766,-1.874377077038511,0.0,0.03519995128962441,0.725,11/33,9.91%,MEF2C;RHOA;ACVRL1;MEOX2;THBS1;NOTCH1;STARD13;ANGPT2;FGF2;APOE;KLF4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7389512034230247,-1.8738038501944794,0.0021008403361344537,0.03481062196501568,0.728,8/13,13.82%,NRP1;COL4A1;ENG;TGFBR2;KDR;NOTCH4;SEMA3E;VEGFA
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6634095529890957,-1.8733714481543235,0.0,0.03447726600891002,0.733,10/19,15.34%,NRP1;TEK;LIMS1;PTPRJ;KDR;MYOC;MAP4K4;VEGFA;S100A10;FERMT2
prerank,regulation of cation transmembrane transport (GO:1904062),0.6288683399867654,1.867679744449177,0.0018484288354898336,0.3552165139278299,0.934,10/29,11.94%,CACNA1D;KCNIP3;WNK3;SNTA1;DLG1;FGF12;KCNH2;PDZK1;DPP10;KCNIP4
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.6500443991820728,-1.8663017550438163,0.0021413276231263384,0.03730973453358743,0.763,7/21,13.72%,CAV1;LRP6;CSNK1A1;APC;PPP1CA;AMER1;FZD1
prerank,sodium ion transmembrane transport (GO:0035725),0.5159428373411107,1.864915020118278,0.0,0.32623855091798265,0.94,10/84,5.43%,ATP1A2;SLC6A13;SLC6A1;SLC6A12;SLC8A3;SLC24A3;ATP1B3;SLC6A9;ATP1B2;NALCN
prerank,regulation of mononuclear cell migration (GO:0071675),-0.6312991258694867,-1.863078271146696,0.002079002079002079,0.03816685098848697,0.778,14/23,25.81%,BMP5;SLIT2;THBS1;LYN;IL34;MAPK1;MDK;STK10;RARRES2;CSF1R;MAPK3;MSN;CMKLR1;AIF1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.696541041231632,-1.8625497683790826,0.002070393374741201,0.03789725735618784,0.788,6/15,6.52%,NTRK3;VEGFC;CDH13;F3;KDR;CXCL12
prerank,cellular zinc ion homeostasis (GO:0006882),-0.610975234274382,-1.860296346096199,0.0,0.03839735926391105,0.796,15/26,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC39A7;SLC30A5;MT3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7070309564343354,-1.8601263060187179,0.004166666666666667,0.03783683443310718,0.796,7/14,12.75%,ECE1;NOS3;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,cation transmembrane transport (GO:0098655),0.5735956882555309,1.8582383335269224,0.0037593984962406013,0.3163671261300585,0.953,4/44,2.09%,TRPM3;ATP1A2;TRPM6;SLC6A9
prerank,negative regulation of angiogenesis (GO:0016525),-0.47608503215628056,-1.858115681055696,0.002421307506053269,0.03845837348592665,0.803,28/84,13.94%,PTPRM;TEK;SPARC;SEMA6A;SLC12A2;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;CREB3L1;ISM1;ADAMTS1;EPN2;SPRY2;ECSCR;SERPINE1;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT;KLF2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.5456793801340929,-1.854393608787094,0.002242152466367713,0.039692020545109924,0.817,19/39,14.55%,ACTN4;GCNT2;JAG1;RHOA;ACER2;THBS1;NOTCH1;CORO1C;KANK1;TBCD;CASK;AJAP1;MYOC;EFNA5;MAP4K4;SEMA3E;FZD4;AP1AR;ADAM15
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7195448518428141,-1.8526683561195854,0.0040650406504065045,0.03989063474505957,0.823,6/14,9.91%,RHOA;MEOX2;THBS1;NOTCH1;STARD13;KLF4
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.6131792752275835,-1.8525435673740447,0.0,0.0393225648965474,0.823,14/25,23.21%,NRP1;ITGA6;THBS1;EGFR;APP;AR;PTGES3;SRC;NCKAP1L;PTH1R;KCTD20;GLMN;EGF;BCL10
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5019146855737138,-1.8481848803778644,0.0047169811320754715,0.04092896715169289,0.837,19/54,13.82%,MEF2C;NOS3;TMSB4X;ETS1;ACVRL1;THBS1;PLCG1;AKT3;KDR;ANGPT2;PRKD1;PRCP;GATA2;ATP5F1B;FGF2;APOE;HSPB1;CD40;VEGFA
prerank,zinc ion homeostasis (GO:0055069),-0.5918616464801051,-1.8440192135927487,0.0,0.04263368763340358,0.856,15/28,14.78%,SLC39A10;SLC30A1;SLC39A8;SLC30A9;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC39A7;SLC30A5;MT3
prerank,epiboly involved in wound healing (GO:0090505),-0.684232690772253,-1.8402404312423533,0.0,0.04414820358929347,0.865,7/16,8.02%,TMEFF2;RHOA;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,endoderm formation (GO:0001706),-0.5638362513507919,-1.8368483214932227,0.0021645021645021645,0.04560312347632211,0.874,12/35,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;SOX17;ITGB5;SOX7;ITGA7;ITGA4
prerank,actin cytoskeleton reorganization (GO:0031532),-0.48057087623041644,-1.8360511000537716,0.0022727272727272726,0.04542786166434546,0.875,23/63,13.24%,NRP1;GAB1;RHOA;GSN;PARVB;MYH9;THSD7A;MKLN1;TNIK;FLNA;RAP2A;S1PR1;CDC42BPA;ANXA1;CXADR;PTPN1;BCAR1;NEDD9;FGF7;WHAMM;PARVA;MICALL2;TRPV4
prerank,cellular response to copper ion (GO:0071280),-0.6896175505142526,-1.832509089940854,0.0,0.0465362742049545,0.882,10/16,19.01%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;MT2A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.49181027193215937,-1.8323310602988792,0.0,0.04599991621863722,0.883,25/67,12.51%,NRP1;ABI1;NRP2;DOCK1;DAB2IP;RHOA;WASF2;VEGFC;PIK3R1;KDR;CLEC14A;PAK2;PRKD1;NCK1;PXN;FLT1;PIK3CA;SRC;FLT4;VAV2;MAPKAPK2;BCAR1;NCF2;HSPB1;PTK2B
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.665611721879313,-1.8307354942031657,0.0,0.04645729420206089,0.888,9/17,15.78%,PTN;NOTCH1;TNFRSF1B;HES1;IL34;MDK;PTPRZ1;BMP2;ID2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.5666621297214445,-1.8303494848839694,0.002197802197802198,0.04603422201123608,0.888,15/32,10.64%,JAG1;ACER2;ACVRL1;THBS1;CORO1C;PHLDB2;CASK;AJAP1;APOD;MYOC;SRC;MAP4K4;SERPINE1;FAM107A;SEMA3E
prerank,gliogenesis (GO:0042063),-0.6826925620478104,-1.8298256677533167,0.0021413276231263384,0.04576759994602326,0.89,8/15,26.61%,TGFB2;CD9;ANXA1;CDH2;CDK6;METTL3;METRN;METTL14
prerank,cardiac ventricle development (GO:0003231),-0.6275797818053971,-1.8288118296719074,0.002,0.04574732623301175,0.893,12/20,25.43%,ENG;NOTCH1;HES1;PDE2A;HEYL;STRA6;HEY2;HEY1;DLL4;SALL1;GJA5;MATR3
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6384231498679335,-1.8210982793187938,0.004201680672268907,0.049292384618430406,0.911,9/19,14.75%,LIFR;RUNX1;WNT5A;CBFB;KLF4;TLE5;CD24;IFIH1;IRAK2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5406757791534788,-1.8157459737136532,0.0,0.052173494071979756,0.926,14/38,16.35%,BMP5;NOS3;TNFSF10;THBS1;BCL2L1;FAS;ICAM1;ARHGEF2;FEM1B;SERPINE1;GPX1;MADD;TMBIM1;SP100
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6566161895037618,-1.8155580409154932,0.002079002079002079,0.05164495384334125,0.927,11/18,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;BMP2;TBX2
prerank,endothelial cell proliferation (GO:0001935),-0.6561751950683454,-1.8150493071047846,0.002036659877800407,0.05144842164395751,0.927,8/17,7.55%,TEK;BMPR2;ACVRL1;BMPER;CD34;BMP4;ERN1;PRKX
prerank,histone lysine demethylation (GO:0070076),0.6237255436601068,1.8094435358800782,0.005870841487279843,0.5047887675643056,0.99,10/25,19.44%,KDM7A;PHF8;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A;KDM1A;KDM3B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5264492483163299,-1.8078497001117626,0.00228310502283105,0.0554328073880406,0.94,18/42,21.29%,UTRN;NRP1;TEK;LIMS1;CDH13;PTPRJ;KDR;MYOC;EMP2;MAP4K4;PTK2B;VEGFA;S100A10;FERMT2;CCL25;CDK6;JUP;ROCK1
prerank,collagen fibril organization (GO:0030199),-0.4536211661019961,-1.805658378930209,0.0,0.05604254175911899,0.943,29/88,9.90%,COL8A1;COL12A1;TLL1;COL6A3;COL4A1;ITGA6;COL25A1;COL15A1;COL6A2;COL8A2;DST;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;COL23A1;COL5A2;ITGB4;LAMA3;COL4A6;P4HA1;LOX;LUM;PLOD3;ADAMTS14;COL27A1;COL14A1;CRTAP
prerank,regulation of vasoconstriction (GO:0019229),-0.5749686501152483,-1.8030182207691967,0.0,0.05726903878421846,0.948,9/27,12.75%,CAV1;BMPR2;ECE1;ADRA1B;ATP2B1;AGTR1;KCNMB2;ADM;ACE2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5416071837564871,-1.7982512336757004,0.004166666666666667,0.05987426977982697,0.957,16/39,17.68%,TEK;RAMP2;NDNF;THBS1;GAS6;PLCG1;KDR;ICAM1;ECSCR;GATA2;SERPINE1;PDCD4;ITGA4;CD40;SEMA5A;GPER1
prerank,regulation of fatty acid oxidation (GO:0046320),0.6947661563482629,1.798114255275267,0.009541984732824428,0.52405399277007,0.992,7/16,11.97%,PRKAG2;APPL2;PPARA;LONP2;PPARGC1A;ABCD1;SOX9
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.46910140227710756,-1.7978776839558355,0.0,0.05953803081766489,0.958,24/72,11.03%,NRP1;HEG1;ARHGEF28;NET1;ARHGEF3;STARD8;BCR;ABCA1;KANK1;RASIP1;STMN1;STARD13;F11R;ARHGEF2;EPS8;MET;ARHGDIB;KCTD10;ARHGAP35;MYOC;EPS8L2;APOE;LPAR6;ADGRG1
prerank,epithelial cell migration (GO:0010631),-0.5424964765854712,-1.795206927536132,0.004434589800443459,0.06108090763108622,0.965,15/37,14.76%,NRP1;NOS3;RHOA;FAP;CDH13;CYP1B1;KANK1;STARD13;ADGRA2;PXN;PRKX;PIK3CA;PTP4A3;FAT2;PKN3
prerank,cell-matrix adhesion (GO:0007160),-0.447678372606548,-1.7941476820777593,0.0,0.06110327812753627,0.966,31/95,15.59%,ITGBL1;THSD1;VCL;PKD1;PEAK1;CD34;VCAM1;BCR;CD44;ITGA1;FN1;ITGB4;ITGA8;MKLN1;PTPRK;ACTN1;MSLN;ITGB1;ITGB5;EMP2;SRC;ECM2;TIAM1;WHAMM;BCAM;ITGA7;ITGA4;ITGB8;ADAM15;FERMT2;VTN
prerank,aggrephagy (GO:0035973),-0.5778695011588563,-1.7901499895745394,0.006342494714587738,0.06319132039207029,0.971,13/27,17.93%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;DYNC1I1;SQSTM1;HDAC6;DYNLL1;CFTR;ATG5;ACBD5;DYNC1H1
prerank,positive regulation of cell motility (GO:2000147),-0.3994593651462627,-1.788722512164566,0.0,0.06378005940193429,0.972,64/205,13.82%,LEF1;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;SPOCK2;SEMA3C;ITGA6;TJP1;NTN1;SEMA7A;ACVR1;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;EGFR;STAT3;KDR;MGAT5;CPNE3;ITGB1;NUMB;RACK1;ADAM10;TWIST2;CXCL12;FLT1;CCN1;PPP3CA;MDK;MYOC;APC;SPRY2;PDGFC;TIAM1;SEMA5B;MAP4K4;BCAR1;NEDD9;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;TWIST1;CCDC25;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SMO;ROR2;AKT2;VEGFA
prerank,lipid translocation (GO:0034204),-0.638136797733701,-1.7867089808729573,0.006355932203389831,0.06462751048604463,0.973,8/21,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;TMEM30A;ATP11B;ATP11C
prerank,endocardial cushion development (GO:0003197),-0.6077219637888738,-1.7847474527218965,0.002044989775051125,0.06533611191500277,0.976,11/21,12.91%,BMPR2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;BMP4;HEYL;BMP2;TBX2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.5370498948233847,-1.7842746851027866,0.004434589800443459,0.06504685338312857,0.976,12/35,10.32%,HEG1;DAB2IP;TGFB2;KANK1;RASIP1;STMN1;MET;KCTD10;ARHGAP35;MYOC;SPRY2;EPHB2
prerank,regulation of neuron migration (GO:2001222),-0.5785710760154439,-1.7835503014586103,0.008247422680412371,0.06507909233222639,0.978,10/26,13.45%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL;MDK;NSMF;ADGRG1;SHTN1;IGSF10
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6869099753589425,-1.7823525476461777,0.0042643923240938165,0.06529279429935564,0.98,8/14,13.82%,NRP1;GAB1;VEGFC;KDR;PIK3CA;FLT4;PIK3CD;VEGFA
prerank,phospholipid translocation (GO:0045332),-0.5731944878065592,-1.7770548670066633,0.0041753653444676405,0.06861821848336082,0.983,10/28,7.48%,ATP10A;ATP8B1;ATP8A1;ABCC1;ABCA1;PLSCR1;PLSCR4;TMEM30A;ATP11B;ATP11C
prerank,monosaccharide transmembrane transport (GO:0015749),0.6908036200946626,1.7751444811220687,0.011363636363636364,0.6173278447178809,0.995,6/16,8.55%,SLC2A12;SLC5A3;SLC5A10;SLC23A2;SLC23A1;SLC45A3
prerank,membrane repolarization (GO:0086009),0.6907387811184782,1.7749934093974107,0.012121212121212121,0.5740068908538103,0.995,5/15,8.02%,ATP1A2;KCND3;ATP1B3;ATP1B2;KCNH2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6937559795018887,-1.7743388693186635,0.003976143141153081,0.0702449342402379,0.985,8/13,18.96%,LTBP1;GREM2;FBN1;BMP2;NRROS;CD46;CHRDL1;GREM1
prerank,endothelial cell differentiation (GO:0045446),-0.7218079470911793,-1.7714449237229488,0.0,0.07194006648567597,0.985,5/12,3.61%,BMPR2;JAG1;ACVRL1;TIE1;KDR
prerank,regulation of dopamine secretion (GO:0014059),0.6129722909753137,1.7707164055703977,0.00390625,0.5589565304130877,0.995,9/25,11.43%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;DTNBP1
prerank,regulation of interleukin-1 production (GO:0032652),-0.6776046447908362,-1.767389969448792,0.004032258064516129,0.07453867510711909,0.988,5/15,8.02%,FOXP1;GAS6;TMED10;ANXA1;CEACAM1
prerank,positive regulation of vasculature development (GO:1904018),-0.44295974768249813,-1.7671468760015832,0.0,0.07398110369084583,0.988,34/94,13.82%,TEK;GAB1;NOS3;HIPK1;ETS1;TIE1;VEGFC;RAMP2;THBS1;F3;CYP1B1;PTGIS;CD34;PLCG1;RUNX1;BTG1;KDR;ITGB1;PIK3R6;PRKD1;WNT5A;FLT1;GATA2;FGF2;SERPINE1;AGO2;AGGF1;PIK3CD;HSPB1;TWIST1;ECM1;ITGB8;CD40;VEGFA
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.49257261539956654,-1.763048343486673,0.004728132387706856,0.0763011657080754,0.989,16/50,13.79%,LIMS1;ACTN4;RHOA;EGFR;APP;NOD1;NR3C2;RPS3;NFAT5;IFI35;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6175639190453168,-1.7608745427717607,0.004319654427645789,0.07743606120241793,0.989,13/20,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7192182393230615,-1.7597585352105787,0.00816326530612245,0.07764799317813123,0.989,6/11,10.14%,MECOM;CD34;RUNX1;WNT5A;ARIH2;ETV6
prerank,motor neuron axon guidance (GO:0008045),-0.6634352253769586,-1.753310926850988,0.005825242718446602,0.08273680255953904,0.991,4/15,2.63%,SLIT2;NTN1;TMEFF1;CHN1
prerank,phospholipid transport (GO:0015914),-0.48680979328654383,-1.7521273376223498,0.0022026431718061676,0.08290702686924938,0.993,16/52,7.63%,ATP10A;ATP8B1;PITPNC1;ATP8A1;SCARB1;ABCC1;ABCA1;SCARB2;PLTP;TMEM30A;ATP11B;TNFAIP8L3;NPC2;MTTP;ATP11C;ABCA3
prerank,positive regulation of cellular component movement (GO:0051272),-0.5757385256262527,-1.7521171572961813,0.006224066390041493,0.08213936921305262,0.993,11/24,15.76%,ACTN4;SPOCK2;NTN1;ETS1;LYN;TWIST1;CCDC25;AKT2;VEGFA;CAVIN1;CSF1R
prerank,morphogenesis of an epithelium (GO:0002009),-0.5755743033785815,-1.749738610167683,0.006134969325153374,0.08352752851892267,0.994,14/25,24.50%,ACTB;VCL;LRP6;ACTG1;TBX18;LAMA3;PRKX;LIN7C;TIMELESS;TRAF3IP1;SOX8;KDM2B;ARHGAP12;LHX1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7243621011193941,-1.7457188568503683,0.00816326530612245,0.0863817672556872,0.996,8/11,16.60%,NDNF;CD34;KDR;ADIPOR2;PRCP;GATA2;VEGFA;MCAM
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7287247230653611,-1.7446271239966507,0.00411522633744856,0.08649028316875382,0.996,4/10,8.02%,PRKG1;CD9;PRKCD;CEACAM1
prerank,establishment of endothelial barrier (GO:0061028),-0.5535312175113999,-1.743877290740756,0.006134969325153374,0.08643912566687957,0.996,12/29,7.33%,PDE4D;PECAM1;RAPGEF2;TJP1;RAP1A;F11R;ICAM1;TJP2;PDE2A;PPP1R16B;ROBO4;RAPGEF6
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5901245121830322,-1.741822323248737,0.008281573498964804,0.08758375590793054,0.996,12/21,28.79%,MTUS1;THBS1;IL34;MAPK1;MDK;PTK2B;RARRES2;CSF1R;MAPK3;CMKLR1;DDT;MIF
prerank,sodium-independent organic anion transport (GO:0043252),-0.7394033049137732,-1.7415310378752253,0.007782101167315175,0.08715862152657315,0.996,5/10,8.49%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1;SLC16A2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5562945086714248,-1.7384758219971599,0.006772009029345372,0.08981329655136898,0.996,9/30,9.75%,BMP5;NOS3;TNFSF10;BCL2L1;FAS;ICAM1;ARHGEF2;SERPINE1;GPX1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.7378386924980194,-1.7384717607879052,0.0038461538461538464,0.08904992231425574,0.996,4/10,5.88%,FAP;NOTCH1;TNFRSF1B;CST3
prerank,response to copper ion (GO:0046688),-0.6104936294005141,-1.7370881170407437,0.006237006237006237,0.08961540896701008,0.997,11/20,19.01%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;ATP5F1D;MT2A
prerank,presynapse assembly (GO:0099054),0.6786088281498649,1.736980143843504,0.011516314779270634,0.7357296287249755,0.999,8/16,10.84%,CEL;IL1RAPL1;NLGN2;WNT7A;NLGN3;LRP4;PTPRD;BSN
prerank,microvillus organization (GO:0032528),-0.6848654833712263,-1.735799450000927,0.0,0.09000020804311003,0.998,9/13,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,xenobiotic transport (GO:0042908),-0.6311816659808078,-1.7353990996412845,0.006122448979591836,0.08966806681459039,0.998,6/17,9.11%,ABCG2;SLC47A1;ABCC1;SLC7A5;ABCA3;SLC22A18
prerank,cellular response to drug (GO:0035690),-0.5846769894498439,-1.7344879044315824,0.0020242914979757085,0.08983569958298687,0.998,7/25,7.09%,MEF2C;ACER2;GAS6;RAP2A;TFRC;AIM2;KCNQ1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.5777095197560549,-1.7338379553373535,0.010940919037199124,0.08966683989670392,0.998,12/24,22.00%,NRP1;SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;VEGFA;SEMA5A;SEMA6D;SEMA3F;SEMA4C
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7631438251007782,-1.7328835961694466,0.004210526315789474,0.08985242128373612,0.998,6/10,8.02%,RAPGEF2;RAP1A;CD34;KDR;TMEM100;CEACAM1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5956645415371926,-1.7302689193078966,0.002109704641350211,0.0916046469740155,0.998,6/21,7.25%,FOXP1;PRKCH;SLC39A10;RUNX1;LYN;CBFB
prerank,embryonic eye morphogenesis (GO:0048048),-0.7067633429010767,-1.7293885302503016,0.009689922480620155,0.09152737182104012,0.998,8/11,22.99%,MFAP5;LRP6;FBN1;RARG;TBX2;ALDH1A3;EFEMP1;KDM2B
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5261440366366467,-1.7290364472967368,0.0022222222222222222,0.09110810033793729,0.998,17/35,22.00%,NRP1;SEMA6A;NRP2;SEMA3C;SEMA7A;FLNA;MET;SEMA5B;SEMA3E;SEMA3G;ARHGDIA;SEMA5A;SEMA6D;PLXNA4;PLXND1;SEMA3F;SEMA4C
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4429763211953899,-1.729031386297677,0.0,0.09038502017652508,0.998,29/84,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;BMPR2;NOS3;TMSB4X;ETS1;SCARB1;THBS1;PLCG1;BMP4;AKT3;KDR;PRKD1;WNT5A;MET;GATA2;FLT4;ATP5F1B;FGF2;BCAR1;EDN1;PIK3CD;HSPB1;PTK2B;CD40;VEGFA
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6525649813319986,-1.7280790370414356,0.006160164271047228,0.09043840701418907,0.998,5/16,7.92%,ST3GAL4;RHOA;ETS1;MDK;NFAT5
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.47122173416964414,-1.7274342122390876,0.0,0.09041209186712507,0.998,20/64,10.64%,UTRN;JAG1;VCL;RHOA;ACER2;THBS1;ACTG1;CDH13;PEAK1;LIMCH1;CORO1C;MACF1;CASK;AJAP1;MYOC;EMP2;EFNA5;MAP4K4;DUSP3;SEMA3E
prerank,positive regulation of transporter activity (GO:0032411),0.7109713617574691,1.7267036840295775,0.008818342151675485,0.7630576965857087,1.0,7/13,9.58%,WNK3;PON1;STK39;KMT2A;NR1H3;RXRA;PDZK1
prerank,heart development (GO:0007507),-0.4073548129796839,-1.7223858502453748,0.0,0.09445551942956928,0.999,41/150,13.82%,TEK;MEF2C;FLRT2;NTRK3;BMP5;HEG1;PDLIM5;PLCE1;BMPR2;ECE1;MICAL2;ACVR1;PCSK5;ACVRL1;TGFB2;INSR;RAMP2;NOTCH1;PKD1;BMP4;TGFBR2;FN1;TBX1;FBN1;SGCD;SOX17;CRIP1;NIPBL;SH3PXD2B;STRA6;HDAC9;CXADR;ZFPM2;WDR11;MYOCD;LDB3;SOX18;BMP2;TBX2;NCOA6;VEGFA
prerank,limb morphogenesis (GO:0035108),-0.598554672604714,-1.7201492930389313,0.004273504273504274,0.0960585724423852,1.0,7/20,5.55%,MBNL1;LRP6;PCSK5;TGFB2;TBX3;GLI3;NIPBL
prerank,cellular response to fluid shear stress (GO:0071498),-0.6839022855327241,-1.7193364406885878,0.011976047904191617,0.09614408127053267,1.0,7/12,22.49%,MEF2C;MTSS1;KLF4;SREBF2;KLF2;ASS1;HAS2
prerank,regulation of striated muscle contraction (GO:0006942),0.5868445568824678,1.7162776529543737,0.007782101167315175,0.7877792525659195,1.0,3/27,1.72%,ATP1A2;SLC8A3;ANK2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5774402120168542,-1.7143950808943784,0.005836575875486381,0.10015734567705123,1.0,8/24,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;ICAM1;GATA2;SERPINE1
prerank,cellular protein metabolic process (GO:0044267),-0.3585399384768934,-1.7129865186719317,0.0,0.100675655831322,1.0,127/396,17.44%,MSRB3;DAB2IP;ST8SIA4;LTBP1;RPLP1;PCSK5;ST3GAL6;GAS6;RPS15;RPL38;PLOD2;RPL18A;ATG3;RPL41;BMP4;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;APP;FN1;RPS10;RPL10;RPS23;RPS24;FBN1;RPL7;RPL37A;PDIA6;MSLN;IGFBP6;RPS17;RPS16;RPL39;RPS27A;ST3GAL1;UBE2D3;CST3;MSRB2;RPL13;ADAM10;MRPL52;LOX;RPLP0;RPL30;RPS5;RPL35A;PAPPA;RPS8;CCN1;RPS7;RPL22;CSNK1G3;ABCA3;RPS3;SPPL3;LAMB2;RPS28;KTN1;MFGE8;RPL29;RPL7A;RPS26;MGAT4A;RPL6;VCAN;RPL18;IGF2;RPS25;AGO2;RPL36;APOE;RPL28;YES1;RPL27;CPE;RPL24;RPS29;SFTPA2;SFTPA1;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;PNPLA2;UBE2L3;RPL21;MRPL10;FBXW2;STK38;EVA1A;RPL34;AKT2;RPL10A;UBL5;RPL12;LMCD1;HM13;TNC;RPL35;CDH2;RPL14;D2HGDH;PPP4R2;ST8SIA2;GOLM1;ICMT;PHKA2;RPL19;RPL37;RPS18;RPS13;ZDHHC2;RPS15A;PHEX;CHRDL1;RRBP1;MRPS12;IGFBP4;UBE2G1;MMP2;MRPL55
prerank,receptor metabolic process (GO:0043112),-0.47532675879604197,-1.7125743906813489,0.004347826086956522,0.10036694643834866,1.0,30/53,31.60%,CAV1;CALCRL;DNM3;RAMP2;CD9;SMURF1;RAB31;ITGB1;TFRC;SNX1;ACKR3;ADM;LRP1;RAB11B;PIK3R4;LDLRAP1;ARRB2;NEDD4;SYK;AP2M1;PHETA1;GRB2;PHETA2;DNM1;NSG1;DNM2;CD36;LMTK2;SH3GLB1;GRK2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.4321579019599165,-1.7122144741778895,0.002364066193853428,0.09995064295819878,1.0,32/100,12.90%,ROR1;TEK;NTRK3;DCN;DAB2IP;GAB1;PIP5K1B;TGFB2;PIP4K2A;INSR;PIK3R1;EGFR;KDR;FN1;PIK3IP1;LYN;PPP1R16B;MAPK1;FLT1;MYOC;PPP2R5C;CEACAM1;PIK3CA;SRC;PDGFC;IER3;FGF2;PIK3CD;UNC5B;TWIST1;PDGFD;ROR2
prerank,regulation of protein localization to membrane (GO:1905475),-0.5478106005350727,-1.7115325602950193,0.0021231422505307855,0.10010645414555212,1.0,14/28,19.96%,SPTBN1;GPC6;ACTB;GSN;AR;CDK5;STX7;ZDHHC7;STX8;GPC1;ZDHHC2;LDLRAP1;CRIPT;GPC4
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.41144781593871665,-1.7101252929226778,0.0,0.10104291209608064,1.0,29/118,10.57%,FMNL2;MEF2C;SHANK3;SPARC;PDLIM5;PID1;NEDD4L;ETS1;BMPER;PHLDB1;CHN1;HECW2;TBX1;PHLDB2;TNIK;RAP2A;PAK2;ADGRA2;ARHGAP35;EMP2;CEACAM1;EFNA5;CDK5;FLT4;MYO19;FGF2;ABI3;CFL1;NSMF
prerank,secretion (GO:0046903),0.6819282680413817,1.7073455592716764,0.01383399209486166,0.8072917447597279,1.0,6/14,12.82%,SLC22A6;RIMS1;PRKCI;DRD3;VIP;SLC22A2
prerank,lamellipodium assembly (GO:0030032),-0.5615980881895299,-1.7068717481527362,0.006423982869379015,0.1040963722195871,1.0,11/26,13.00%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;GOLPH3;WHAMM;ABLIM2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6696760123166379,-1.7064925839161014,0.006198347107438017,0.10377415801061811,1.0,7/14,8.94%,GHR;PIK3R1;SOCS2;STAT3;LYN;PXN;PTPN1
prerank,sprouting angiogenesis (GO:0002040),-0.4815418839827595,-1.706441705559231,0.002257336343115124,0.10315910252945115,1.0,21/51,10.80%,NRP1;TEK;RSPO3;SLIT2;ACVRL1;ENG;VEGFC;BMPER;RAMP2;THBS1;CDH13;BMP4;KDR;ADGRA2;RECK;CCBE1;FLT4;FGF2;PARVA;SEMA3E;ESM1
prerank,protein localization to cell-cell junction (GO:0150105),-0.6590862424234781,-1.7062042548501517,0.007751937984496124,0.10268701432953109,1.0,8/15,10.02%,ACTB;TJP1;ACTG1;LSR;F11R;TJP2;PAK2;JAK1
prerank,amide transport (GO:0042886),-0.5721054804280148,-1.7048014557502762,0.006342494714587738,0.10309245367137553,1.0,9/26,6.72%,ABCG2;DISP1;CERT1;SLC5A6;PLTP;PLEKHA8;AQP11;SLC38A5;TAP2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6200754396921324,-1.7026119409904577,0.014256619144602852,0.10452467393437685,1.0,7/17,17.68%,PRKG1;MEF2C;TAFA5;TGFB3;PDCD4;PTEN;GPER1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.6821045407065314,-1.7020217357881962,0.010309278350515464,0.10441222448508415,1.0,4/13,7.11%,PDE4D;CAV1;CAMK2D;CALM3
prerank,regulation of regulated secretory pathway (GO:1903305),0.5552572209622993,1.7001042825871058,0.017543859649122806,0.8169979820340088,1.0,11/34,11.43%,SYT11;SYT12;UNC13D;SYT9;SYT1;SNAPIN;SYT13;RIMS1;LRRK2;SYT10;DTNBP1
prerank,regulation of interleukin-2 production (GO:0032663),-0.4953839204975298,-1.6969891279157232,0.0022727272727272726,0.1088789228510778,1.0,11/43,13.79%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;ANXA1;RPS3;HDAC7;MALT1;PTPRC;CD86
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.6428408114451958,1.6968373848553382,0.005802707930367505,0.8023787900975868,1.0,3/17,1.31%,ATP1A2;BMP7;TFPI
prerank,positive regulation of heart rate (GO:0010460),-0.6269252582588821,-1.6968273576903312,0.0,0.10836653910722287,1.0,6/17,11.67%,PDE4D;ADRA1B;KCNQ1;EDN1;ADM;EDN3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7182483910854829,-1.69592138361074,0.005836575875486381,0.10849636121989083,1.0,4/10,6.52%,RAPGEF2;GAS6;LYN;CXCL12
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.684578151343675,-1.6955932775116833,0.01160541586073501,0.10818959021375368,1.0,3/11,9.62%,NRP1;STMN1;BCAR1
prerank,regulation of platelet aggregation (GO:0090330),-0.6119653990299558,-1.6955604974800298,0.008368200836820083,0.10749736169007029,1.0,6/17,8.02%,PRKG1;CD9;F11R;LYN;PRKCD;CEACAM1
prerank,carnitine shuttle (GO:0006853),0.7378683406880351,1.6926126544155495,0.02321083172147002,0.7943299763323752,1.0,2/11,1.77%,PRKAG2;PRKAA2
prerank,lamellipodium organization (GO:0097581),-0.539077288138689,-1.690696154352113,0.004301075268817204,0.11179460252916423,1.0,13/29,14.74%,ABLIM1;VCL;PARVB;CDH13;SPATA13;ITGB1;S1PR1;ABLIM3;SNX1;GOLPH3;WHAMM;ABLIM2;SNX2
prerank,microvillus assembly (GO:0030033),-0.6549733800319026,-1.6901133756299602,0.007952286282306162,0.11173114614648617,1.0,9/14,18.43%,RAPGEF2;FXYD5;RAP1A;TNIK;RAP2A;RAPGEF6;MAP4K4;RAP2B;STK26
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.47300596073765644,-1.685671710084966,0.004662004662004662,0.11582776424359428,1.0,16/47,16.70%,NRP1;LIMS1;ACTN4;LIMS2;DOCK1;CORO1C;KANK1;FLNA;MDK;MYOC;EFNA5;NEDD9;AP1AR;S100A10;FERMT2;RREB1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.35950047401600105,-1.6851797031011997,0.0,0.11558207214308956,1.0,125/306,25.43%,ST3GAL4;RPLP1;PTMA;EXT1;RPA1;KAT7;RPS15;RPL38;RPL18A;RPL41;EEF2K;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;RPS27A;RPL13;EEF2;MRPL52;RPLP0;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;TIPIN;RPL29;RPL7A;RPS26;RPL6;RPL18;RPS25;AGO2;RPL36;APOE;RPL28;GOLPH3;RPL27;B4GALT5;RPL24;RPS29;GCNT1;RPL23;MRPL23;RPL17;YARS2;RPS9;RPS27;ASMT;BLM;KIN;RPL21;MRPL10;ORC1;RPL34;RPL10A;RPL12;RPL35;RPL14;NR4A2;TIMELESS;RPL19;RPL37;RPS18;RPS13;RPS15A;ING4;RRBP1;EEF1G;MRPS12;MRPL55;ORC2;ST3GAL2;RHNO1;MRPL43;NBN;BARD1;RPA2;EPC1;RMI1;CDC45;MRPL36;ORC5;PCLAF;POLA1;POLR3A;MRPL35;DUT;SET;RPL3;POLR2I;RFC4;CHEK1;POLA2;THAP1;TOP1;BCL3;MCM3;RPL15;RPS21;POLR2F;RPS19;RPL8;RPL13A;EXT2;RPL23A;RBMS1;SRBD1;MRPL11;POLE3;TYMS
prerank,positive regulation of locomotion (GO:0040017),-0.5469492354937774,-1.6845635267357066,0.012711864406779662,0.11549525796517845,1.0,10/27,15.76%,SPOCK2;NTN1;THBS1;STX3;TWIST1;CCDC25;AKT2;RARRES2;CAVIN1;CSF1R
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6844393117674681,-1.6842796686201529,0.005859375,0.11505135144095521,1.0,8/11,20.85%,LIMD1;STAT3;PUM2;PUM1;FMR1;FXR1;XPO5;AJUBA
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5730420629111466,1.6836814540371092,0.009940357852882704,0.8187779340645838,1.0,8/27,10.21%,SYT11;SYT12;SYT9;VAMP7;SYT1;SYT13;RIMS1;SYT10
prerank,modified amino acid transport (GO:0072337),0.6557552424074721,1.6806304977740796,0.01195219123505976,0.8043964375856612,1.0,4/15,7.83%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,cellular glucan metabolic process (GO:0006073),0.7221309814558128,1.679951426585932,0.023668639053254437,0.7769568002679391,1.0,5/11,13.55%,PRKAG2;PHKG2;PHKB;PYGL;PYGM
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5854795572543942,-1.679306341503251,0.014705882352941176,0.11981436733836984,1.0,9/20,13.32%,GSN;THBS1;PLCG1;SFRP4;PLA2R1;ECSCR;PDCD4;ITGA4;CD40
prerank,vasoconstriction (GO:0042310),-0.6984944589880202,-1.6786839953692811,0.009487666034155597,0.11975047964208832,1.0,5/11,11.67%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,potassium ion transport (GO:0006813),0.43392435927496265,1.678322488505917,0.0035714285714285713,0.7571939750134123,1.0,21/120,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;KCNH7;KCNK4;SLC9A9
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.42416026540850715,-1.6774472963623828,0.0,0.12052599514357198,1.0,29/92,13.82%,NRP1;FOXP1;TEK;SPARC;NRP2;DOCK1;BMPR2;ETS1;SCARB1;TGFB2;THBS1;PLCG1;BMP4;KDR;PLCG2;PRKD1;WNT5A;SRC;FLT4;MAP4K4;FGF2;BCAR1;FGF7;EDN1;PIK3CD;PTK2B;HDAC6;PFN1;VEGFA
prerank,regulation of cell migration (GO:0030334),-0.35273311422768633,-1.6754005346204928,0.0,0.12217269435026801,1.0,106/382,13.82%,LEF1;TMEFF2;FRMD5;ACTN4;NTRK3;PODXL;CAV1;GCNT2;PECAM1;SEMA6A;DOCK10;CLDN5;JAG1;SEMA3C;ITGA6;VCL;SLIT2;TJP1;SRGAP1;RHOA;TMSB4X;CLIC4;SEMA7A;ACVR1;ACVRL1;ENG;INSR;THBS1;NOTCH1;ACTG1;CDH13;F3;LIMCH1;EGFR;CYP1B1;FOXO3;PRR5L;CORO1C;CDH1;MACF1;STAT3;SPATA13;PTPRJ;KANK1;KDR;ADARB1;MGAT5;PTPRK;DACH1;FLNA;CPNE3;RAP2A;ITGB1;NUMB;RECK;RACK1;ADAM10;TWIST2;CXCL12;ANXA1;ROBO4;FLT1;CCN1;PPP3CA;MDK;MYOC;PRKX;APC;SPRY2;CEACAM1;STK24;SRC;PDGFC;TIAM1;SEMA5B;MAP4K4;FGF2;SERPINE1;ABI3;BCAR1;NEDD9;FGF7;DUSP3;TMSB10;EPHB2;RIPOR1;EDN1;FAM107A;PIK3CD;SEMA3E;PLXNC1;CD74;CEMIP;COL1A1;RET;BMP2;SEMA3G;PTK2B;PDGFD;SST;SMO;ROR2;IGSF10;AKT2;AMOT;VEGFA
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5847391904230744,1.6734108508520105,0.009633911368015413,0.761108634780892,1.0,7/26,11.59%,ATP1A2;CRHR1;ADRA2A;GNB5;GSTM2;DRD3;GSTO1
prerank,cGMP-mediated signaling (GO:0019934),-0.6544172705700131,-1.671766370636374,0.013779527559055118,0.12574684485700072,1.0,5/13,9.64%,PDE3A;GUCY1B1;PDE9A;PDE2A;APOE
prerank,myelination in peripheral nervous system (GO:0022011),-0.6559501675620943,-1.6682443638004916,0.026915113871635612,0.1293628117270569,1.0,6/13,10.76%,ADGRG6;PARD3;LGI4;MYOC;SOD1;PRX
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.6351506159241398,-1.6681642498819924,0.012145748987854251,0.12866553823245172,1.0,8/13,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;SPI1;CDCA4;ZMIZ1;CHEK1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6306080554666386,1.6665880103621804,0.018072289156626505,0.7752741375408984,1.0,6/18,7.82%,UNC13C;NAPB;GRID2;GRIK5;GRIK2;NAPA
prerank,ribosomal small subunit assembly (GO:0000028),-0.6128788636019575,-1.6660225408676375,0.00847457627118644,0.13039994919465492,1.0,8/16,23.34%,RPS15;XRCC5;RPS5;RPS28;RPS27;RRP7A;PWP2;RPS19
prerank,rRNA metabolic process (GO:0016072),-0.39305755912519746,-1.665451430305569,0.0,0.13018960355025833,1.0,74/160,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;TRIR;RPL19;DDX49;RPL37;RRP12;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4665612217535269,-1.6653610062819946,0.0,0.1295382358368154,1.0,11/51,5.76%,BMPR2;HTRA3;GREM2;BMPER;NOTCH1;CRIM1;SMURF1;FBN1;SMAD5;SMAD1;UBE2D3
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5557956188084953,-1.6646936435065725,0.01059322033898305,0.12956366703599465,1.0,10/24,18.44%,NCKAP5;STMN1;MAP7D3;TPPP3;FGF13;TRPV4;NCKAP5L;KATNB1;KIF24;STMN4
prerank,sulfation (GO:0051923),0.7052763177759263,1.6645870726218122,0.030425963488843813,0.7607627059615786,1.0,2/11,1.22%,UST;CHST4
prerank,negative regulation of calcium ion transport (GO:0051926),0.6488331232324384,1.6636775330216762,0.024074074074074074,0.7408469908128792,1.0,2/15,4.37%,ATP1A2;ADRA2A
prerank,cilium-dependent cell motility (GO:0060285),0.5834797314877275,1.6632989455820777,0.022132796780684104,0.7191705202918632,1.0,6/22,13.59%,CFAP44;DNAH1;TEKT2;TEKT5;DRC1;DNAAF2
prerank,substantia nigra development (GO:0021762),-0.4939504256285755,-1.6627067845876995,0.004219409282700422,0.1312889381932805,1.0,11/37,15.36%,ACTB;RHOA;YWHAE;GNB4;CALM3;MAOB;YWHAQ;NDRG2;CNP;DYNLL1;GLUD1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.6454705636898075,-1.6613974885209915,0.019011406844106463,0.13226508201842913,1.0,3/14,3.88%,IL6ST;OSMR;PTGS2
prerank,heart morphogenesis (GO:0003007),-0.47883500110159105,-1.6601991775876819,0.002232142857142857,0.13293100282878736,1.0,18/50,13.82%,FLRT2;NOS3;ACVR1;ACVRL1;TGFB2;ENG;INSR;TBX3;NOTCH1;TBX1;SOX17;NIPBL;HES1;HEYL;HEY2;BMP2;TBX2;VEGFA
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4329688219055707,-1.6595100668388951,0.0048543689320388345,0.13313629523066997,1.0,23/75,13.69%,PTPRM;TEK;SPARC;SEMA6A;DCN;CLDN5;DAB2IP;TGFB2;COL4A2;THBS1;AGO1;SERPINF1;ISM1;ADAMTS1;SPRY2;ECSCR;KLF4;SEMA3E;HGS;HHEX;THBS2;STAB1;AMOT
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4403351850633275,-1.6579653921210287,0.006160164271047228,0.13433541158832762,1.0,32/70,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5787190546428078,1.6567699376727891,0.009541984732824428,0.7364551526504817,1.0,9/25,9.58%,ACTN2;ATP1B3;ANK2;SLC6A9;WNK3;STK39;ATP1B2;WNK4;PDZK1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.6769069547189728,1.654482989331429,0.018518518518518517,0.7277400713150073,1.0,6/14,19.63%,MOXD1;DAGLA;SLC6A4;SLC22A2;ALDH9A1;ACHE
prerank,intestinal lipid absorption (GO:0098856),0.7004793146162718,1.6541326124864728,0.014,0.7081796358987934,1.0,3/11,2.07%,CEL;ABCG5;SOAT2
prerank,response to progesterone (GO:0032570),-0.602696809533821,-1.6539901543349333,0.018367346938775512,0.13844786457814331,1.0,6/18,9.46%,CAV1;ABHD2;TGFB2;THBS1;SRC;TGFB3
prerank,positive regulation of response to wounding (GO:1903036),-0.5528108275973797,-1.653662625945274,0.017167381974248927,0.13801958869825703,1.0,8/24,7.71%,PTN;ACTG1;KANK1;SCARF1;ITGB1;ANXA1;MDK;OCLN
prerank,regulation of wound healing (GO:0061041),-0.4846851111533911,-1.6517109508886025,0.015021459227467811,0.14006924013173183,1.0,12/42,10.32%,CAV1;ACTG1;KANK1;CD109;CASK;ITGB1;AJAP1;ANXA1;OCLN;FGF2;SERPINE1;EPHB2
prerank,negative regulation of anoikis (GO:2000811),-0.6358151200836157,-1.651590974295318,0.012121212121212121,0.13940584913599854,1.0,6/14,8.77%,CAV1;NOTCH1;ITGA5;ITGB1;PIK3CA;SRC
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5696062278643433,1.6499812575158812,0.018518518518518517,0.7126220371851869,1.0,6/25,2.89%,ERRFI1;SNX6;SLC6A9;CHMP6;GPRC5A;PPARA
prerank,histone H3-K9 demethylation (GO:0033169),0.6978078147158285,1.6491420193173592,0.022494887525562373,0.6973628486939482,1.0,5/11,19.44%,KDM7A;PHF8;KDM4A;KDM1A;KDM3B
prerank,cellular response to cadmium ion (GO:0071276),-0.5433702023330071,-1.6489436451913513,0.004008016032064128,0.1418186716730987,1.0,14/24,19.05%,EGFR;JUN;MAPK1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;MT2A;MAPK3
prerank,neuron cell-cell adhesion (GO:0007158),0.644230269625366,1.6483966090735007,0.026515151515151516,0.6823010010504467,1.0,4/14,7.03%,CEL;NLGN2;NRXN3;NLGN3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.43699772490841216,-1.6479271038052639,0.006211180124223602,0.14248607081349787,1.0,32/71,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,neurotransmitter uptake (GO:0001504),0.6941244191612014,1.6475394146796747,0.01782178217821782,0.6689279679207372,1.0,6/12,15.94%,ATP1A2;SLC29A2;SLC38A1;SNAP25;SLC22A2;GLUL
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4472333215992353,-1.6426320301458377,0.0024096385542168677,0.1487252044095355,1.0,26/58,20.23%,SGMS1;ST3GAL4;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ST8SIA6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;ST3GAL2;SGPP1;SPTSSA;PPM1L;ACER3
prerank,regulation of catecholamine secretion (GO:0050433),0.5493785960468588,1.638359222691415,0.013157894736842105,0.7012653819456738,1.0,10/29,11.43%,SYT11;SYT12;SYT9;SYT1;SYT13;CHRNB2;DRD3;SYT10;CHGA;DTNBP1
prerank,supramolecular fiber organization (GO:0097435),-0.34725885049913596,-1.6375543726165906,0.0,0.15465493935326052,1.0,83/333,13.75%,HIP1;COL8A1;COL12A1;MYO1D;PGM5;TLL1;COL6A3;MYO1B;COL4A1;RHOBTB1;ITGA6;COL25A1;SHROOM4;RHOA;COL15A1;COL6A2;COL8A2;B2M;DST;GSN;COL6A1;TGFB2;COL4A2;CYP1B1;PLOD2;NCKAP5;CORO1C;COL23A1;H3-3A;APP;COL5A2;STMN1;ITGB4;UBC;LAMA3;ACTN1;COL4A6;ARHGEF2;P4HA1;RPS27A;UBB;CST3;TPM4;TNXB;ADAM10;LOX;LUM;IAPP;PLOD3;CLIP4;MAP7D3;ALDOA;MFAP4;ADAMTS14;EMP2;TGFBI;MFGE8;TPM2;MYH11;COL27A1;TMOD3;MYO19;TPPP3;TPM3;BCAR1;COL14A1;MYO1F;CRTAP;CD2AP;WHAMM;FGF13;CDC42EP2;GFAP;CLIP2;COL1A1;HIP1R;ITM2B;RND3;TRPV4;P4HA2;MARCKS;NCKAP5L;AVIL
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.5740103565820915,-1.637260275053468,0.026530612244897958,0.15425142595688165,1.0,9/19,19.05%,THBS1;IL34;MPP1;MAPK1;MDK;JAM3;RARRES2;CSF1R;MAPK3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6098270858590259,1.6369072750497204,0.02531645569620253,0.6911437650895351,1.0,6/19,15.79%,DDO;ALDH7A1;ASPA;GCDH;GOT1;GOT2
prerank,monocyte differentiation (GO:0030224),-0.6932591341300225,-1.6367948263968797,0.017509727626459144,0.15404060826791177,1.0,5/10,15.76%,MYH9;BMP4;MT1G;VEGFA;CSF1R
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.45912640520348325,-1.6357994407314989,0.004597701149425287,0.15451851725451818,1.0,21/51,25.81%,PTN;VEGFC;THBS1;GAS6;CXCL12;IL6R;IL34;MAPK1;MDK;SERPINE1;EDN3;VEGFA;RARRES2;CSF1R;MAPK3;HMGB1;PLA2G7;CCR2;ANO6;CMKLR1;AIF1
prerank,intraciliary retrograde transport (GO:0035721),0.6731986826755936,1.6357488626103562,0.02952755905511811,0.6806287409386056,1.0,7/12,10.31%,TTC21B;DYNLT2B;WDR19;WDR35;DYNC2LI1;DYNC2I2;IFT122
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5978185712483678,1.6347185303274947,0.017110266159695818,0.6696010019782828,1.0,5/23,5.38%,PRKAG2;BMP7;SPHK1;WNK3;PLK1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.4406270338708262,-1.6331344256131108,0.004651162790697674,0.15727362915002904,1.0,28/67,22.08%,TEK;GHR;ABI1;INSR;EGFR;KDR;BMX;TEC;LYN;FLT1;SRC;FLT4;ABI3;IL15;EPHB2;DYRK1A;PIBF1;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;MAPK3;BTK;JAK3;HCK;SYK;FYN
prerank,heterocycle biosynthetic process (GO:0018130),-0.6346406959026636,-1.63299599610434,0.01160541586073501,0.1566040490799107,1.0,7/14,21.80%,GPHN;GCH1;LIAS;NFS1;MOCS1;NOXRED1;PYCR3
prerank,mesenchyme morphogenesis (GO:0072132),-0.6047634708105217,-1.6323536506390097,0.01652892561983471,0.15672612274199185,1.0,9/17,12.91%,NOS3;ACVR1;ACVRL1;TGFB2;ENG;NOTCH1;HEYL;BMP2;TBX2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5789140175346781,-1.6321044891759486,0.02390438247011952,0.1562159412609347,1.0,13/19,24.99%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;HEY2;BMP2;HEY1;SLIT3;ZFPM1;SMAD6;OLFM1
prerank,regulation of glucose import (GO:0046324),0.5503957887968142,1.6314301006562468,0.0223463687150838,0.6717024235098782,1.0,8/30,9.68%,PRKAG2;OSBPL8;IGF1;APPL2;PRKCI;SORBS1;RHOQ;CREBL2
prerank,regulation of microtubule-based movement (GO:0060632),0.7001100607389263,1.6309916575123018,0.03536345776031434,0.6586526051480179,1.0,4/11,8.39%,MAP2;TTC21B;DYNLT2B;DRC1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5405372703649407,-1.6294095542961913,0.02386117136659436,0.1591932092281007,1.0,12/24,27.26%,PECAM1;VCAM1;F11R;ITGB1;ICAM1;ITGA4;NT5E;SYK;MSN;ROCK1;SEMA4D;SELP
prerank,mesonephros development (GO:0001823),0.7012336471617403,1.6292316767997759,0.029411764705882353,0.6527522635025277,1.0,3/11,1.12%,BMP7;FGF1;OSR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5262620978226562,-1.6280743889107,0.017204301075268817,0.16015871855392244,1.0,12/29,13.07%,SHANK3;SLIT2;TJP1;KANK1;SSH2;KANK3;KANK4;PRKCD;PIK3CA;LIMA1;HIP1R;PFN1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.5895000701675389,-1.6269043287437064,0.014583333333333334,0.16091371163615373,1.0,9/18,16.63%,SPTBN1;ACTB;AR;CDK5;STX7;ZDHHC7;STX8;ZDHHC2;LDLRAP1
prerank,activation of protein kinase B activity (GO:0032148),0.5423636782956424,1.6250874219816238,0.025,0.6602478018896316,1.0,8/29,6.82%,FGF1;OSBPL8;IGF1;IL18;RICTOR;ADRA2A;PDPK1;NRG1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.542688899681562,-1.6241681176071445,0.01882845188284519,0.16372626399845677,1.0,10/24,4.34%,NRP1;NRP2;BMPR2;SEMA3C;ACVR1;TGFB2;ENG;BMP4;TGFBR2;TBX1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7057917139839833,1.6240492660271355,0.02676864244741874,0.6508433294407515,1.0,2/10,4.37%,ATP1A2;ADRA2A
prerank,regulation of muscle contraction (GO:0006937),0.5492765919321283,1.6229089514237887,0.01727447216890595,0.6428141979984829,1.0,5/26,7.44%,ATP1A2;ANXA6;ENO1;CHRM2;TNNI1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.5087031210939483,-1.6227766127348928,0.00909090909090909,0.16493035756089588,1.0,17/33,15.20%,RHOJ;SEMA6A;TJP1;BMPER;THBS1;ITGA5;CREB3L1;SMAD1;PPP1R16B;EPN2;CEACAM1;FGF2;KLF4;JAK1;VEGFA;KLF2;CEMIP2
prerank,regulation of anoikis (GO:2000209),-0.5762914735757052,-1.6226998636744125,0.02178649237472767,0.164183074687068,1.0,8/19,11.20%,CAV1;NOTCH1;ITGA5;ITGB1;MYBBP1A;PIK3CA;SRC;TLE5
prerank,regulation of sequestering of triglyceride (GO:0010889),0.641100133037262,1.6225940107589292,0.025193798449612403,0.6314644373243739,1.0,4/15,5.08%,OSBPL8;FITM2;PPARA;ABHD5
prerank,cellular potassium ion homeostasis (GO:0030007),0.654942869249298,1.6223008832440073,0.03275529865125241,0.6203519772648113,1.0,3/13,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,histone H3-K36 demethylation (GO:0070544),0.7054037426408424,1.6219609647054551,0.03711340206185567,0.6099332640150849,1.0,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,platelet degranulation (GO:0002576),-0.3909407924931566,-1.6215520694693357,0.005249343832020997,0.1648819538646321,1.0,34/118,13.91%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;TAGLN2;APP;WDR1;FN1;CD109;ACTN1;FLNA;LYN;ALDOA;CHID1;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;ECM1;VEGFA;TMX3;RARRES2
prerank,metal ion export (GO:0070839),0.5340874501788302,1.6196173105892717,0.011472275334608031,0.6093210370887049,1.0,4/31,4.28%,ATP1A2;KCND3;ATP1B3;ATP1B2
prerank,protein localization to synapse (GO:0035418),0.6870439411046443,1.618272815325857,0.03621730382293763,0.6039717460269176,1.0,5/12,10.84%,NLGN2;ZDHHC12;SHANK1;DLG4;BSN
prerank,positive regulation of hemostasis (GO:1900048),-0.6858904185221301,-1.6176616227682172,0.03319502074688797,0.16875609351606852,1.0,7/10,25.72%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,positive regulation of coagulation (GO:0050820),-0.6858904185221301,-1.6176616227682172,0.03319502074688797,0.16875609351606852,1.0,7/10,25.72%,ST3GAL4;THBS1;SERPINE1;ENPP4;HPSE;F2R;DMTN
prerank,regulation of blood coagulation (GO:0030193),-0.5242966719048292,-1.6174433797091279,0.013186813186813187,0.16821056430050366,1.0,10/27,11.56%,ST3GAL4;CAV1;FAP;THBS1;CD34;SERPINE1;APOE;EPHB2;EDN1;ENPP4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.683822794168713,-1.614307561193026,0.00980392156862745,0.17184055906223855,1.0,5/10,16.62%,PDE3A;PDE4D;PDE2A;RNF157;APLNR
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.48502340597060994,-1.6135113032531907,0.015765765765765764,0.1723110403786347,1.0,11/34,16.70%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;MDK;MYOC;NEDD9;S100A10;FERMT2;RREB1
prerank,filopodium assembly (GO:0046847),-0.5894819847712762,-1.6118226252919925,0.035196687370600416,0.17391819679899542,1.0,4/16,3.19%,FGD5;DNM3;FGD6;SPATA13
prerank,positive regulation of vasoconstriction (GO:0045907),-0.6324986346523066,-1.6115478417377065,0.01593625498007968,0.17350288443164388,1.0,2/13,1.51%,CAV1;ADRA1B
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5335591693631816,-1.610699838630354,0.023655913978494623,0.1740020196087616,1.0,12/27,7.50%,TMEFF2;SHANK3;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,triglyceride biosynthetic process (GO:0019432),0.597601563804801,1.610604180060911,0.036585365853658534,0.62841478734856,1.0,5/18,12.75%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2
prerank,response to hydroxyurea (GO:0072710),-0.6533035616705595,-1.6099726645626635,0.036072144288577156,0.1741963589810607,1.0,7/11,21.67%,KAT7;DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6713283344593151,-1.609959384401201,0.033203125,0.1733817621157531,1.0,5/10,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,regulation of osteoblast differentiation (GO:0045667),0.4426123242891952,1.6090921663912947,0.01155115511551155,0.6239259520930017,1.0,15/82,6.95%,RANBP3L;SMOC1;BMP7;BMP6;WNT4;TMEM64;IGF1;DDX5;SUFU;BMPR1A;LRP3;WWTR1;NPNT;CITED1;FGFR2
prerank,triglyceride homeostasis (GO:0070328),0.5566307615898246,1.6085398635241734,0.015151515151515152,0.6154654008827353,1.0,7/26,9.09%,RORA;IL18;FITM2;ACSM2A;PNPLA8;C1QTNF3;NR1H3
prerank,clathrin coat assembly (GO:0048268),-0.6237738855636913,-1.6083330439122103,0.023952095808383235,0.17504943589859917,1.0,5/15,5.93%,HIP1;PIK3C2A;FCHO2;SGIP1;CLTB
prerank,acylglycerol homeostasis (GO:0055090),0.5827391630499498,1.6075919624493586,0.04452690166975881,0.609039574275679,1.0,5/20,9.09%,RORA;IL18;ACSM2A;PNPLA8;NR1H3
prerank,inorganic cation transmembrane transport (GO:0098662),0.37731311855759214,1.6075210537679596,0.0,0.5988190943042249,1.0,25/268,6.47%,TRPM3;ATP1A2;KCNK2;SLC6A13;SLC6A1;CACNA1D;SLC6A12;SLC8A3;SLC41A1;SLC24A3;TRPM6;KCND3;ATP1B3;TRPV1;KCNA3;SLC30A6;LRRC38;SLC6A9;TMEM175;KCNJ10;SLC30A10;ATP6V1H;NALCN;SLC39A13;KCNC3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5800558540543324,1.60694090651754,0.022267206477732792,0.5911749301254492,1.0,3/23,1.72%,ATP1A2;CACNB1;ANK2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.6507048243325728,-1.6065912759478596,0.02448210922787194,0.17670699523013078,1.0,5/12,17.64%,TMEFF2;AR;EDN1;AP2A1;HDAC2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.42901629929905527,-1.6061766771014057,0.01276595744680851,0.176437257216578,1.0,32/73,22.73%,ACTB;MYO10;ABI1;DOCK1;WASF2;ACTG1;PIK3R1;PLCG1;PLCG2;WIPF1;LYN;PRKCD;NCK1;MAPK1;PIK3CA;SRC;VAV2;YES1;WIPF3;PLA2G6;LIMK1;ARPC2;NCKAP1L;MAPK3;HCK;CDC42;ARPC3;SYK;FCGR1A;FYN;FCGR2B;MYO1C
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.37666691692498905,-1.6029793294383994,0.0,0.18046784980022584,1.0,42/151,15.76%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;MFHAS1;TNFRSF11A;ICAM1;TNFAIP8L3;GAREM1;SPRY2;CCL13;PDGFC;FLT4;FGF2;APOE;ACKR3;CD74;PHB2;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;P2RY6;MTURN;MT3;FERMT2;CSF1R
prerank,regulation of neuroinflammatory response (GO:0150077),0.5882307281422108,1.602622088660152,0.029296875,0.6002049839911995,1.0,5/19,3.39%,IGF1;IL18;NUPR1;SPHK1;DAGLA
prerank,cell-substrate junction assembly (GO:0007044),-0.49862797309611273,-1.602540602178768,0.014084507042253521,0.18036462704073056,1.0,12/33,10.16%,THSD1;ITGA6;DST;PEAK1;BCR;FN1;ITGB4;PTPRK;LAMA3;ACTN1;SRC;WHAMM
prerank,endodermal cell differentiation (GO:0035987),-0.5104950444927603,-1.6022716491797246,0.015350877192982455,0.17983371340676896,1.0,12/31,12.40%,COL8A1;COL12A1;COL6A1;COL4A2;ITGA5;FN1;LAMA3;ITGB5;RTF1;PAF1;ITGA7;ITGA4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5496005469825223,1.600401746493093,0.022598870056497175,0.5997156980564465,1.0,6/26,11.40%,PRKAG2;LPGAT1;PRKAA2;SLC45A3;NR1H3;WDTC1
prerank,organic anion transport (GO:0015711),-0.41830054253519794,-1.5994195272141691,0.006993006993006993,0.18359225627390832,1.0,14/76,8.49%,ABCG2;ABCC4;SLC4A10;SLC26A7;SLCO3A1;LRRC8D;SLCO1C1;SLCO2A1;LRRC8C;SLCO2B1;SLC39A8;CA4;LRRC8A;SLC16A2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6152083721964682,-1.5989474868307962,0.020618556701030927,0.18353549850146103,1.0,7/14,19.05%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6687534465182138,-1.5988975651573225,0.02119460500963391,0.18274119247341064,1.0,6/10,19.05%,FAS;LYN;MAPK1;NBR1;GREM1;MAPK3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.522278145679985,-1.597953475324169,0.022774327122153208,0.18328732187943664,1.0,9/26,10.10%,PDE8A;DAB2IP;PTPN12;IQGAP1;EGFR;PLCG1;EEF1A1;GAREM1;DUSP3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6121939888521163,-1.5975482085337236,0.03725490196078431,0.18299102168089731,1.0,9/14,24.61%,THBS1;PLCG1;ECSCR;PDCD4;ITGA4;CD40;GPER1;RGCC;ANO6
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5440751478918636,-1.5959650531264038,0.023454157782515993,0.18454628608682355,1.0,9/24,15.59%,DAB2IP;ITGA5;TMEM204;EPN2;PTPN1;HGS;HHEX;MT3;VTN
prerank,ncRNA processing (GO:0034470),-0.35812288850482965,-1.5957489176877404,0.0,0.18399569227347742,1.0,86/200,24.47%,RPLP1;RPS15;RPL38;RPL18A;RPL41;AGO1;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;SMAD1;RPL39;HELQ;INTS11;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;RPL6;RPL18;RPS25;PELP1;AGO2;RPL36;DDX54;RPL28;RPL27;DROSHA;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;INTS10;DDX49;RPL37;RRP12;RPP21;ADAT1;PWP2;AGO4;RCL1;MRPL44;INTS9;MRTO4;NOP58;EBNA1BP2;METTL3;RPL3;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;TARBP2;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6063851021244305,1.594846268426378,0.03275529865125241,0.6141208969445932,1.0,5/16,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.6639009795985963,-1.593996564635428,0.02529182879377432,0.18580530413455787,1.0,6/10,23.95%,RUNX1;CBFB;NCKAP1L;SH3RF1;HMGB1;SOCS1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5914057880171562,-1.593144727649316,0.026422764227642278,0.18618014049082665,1.0,9/16,20.36%,THBS1;JCAD;AGTR1;PPP1R16B;GATA2;FGF2;VEGFA;APLNR;DLL4
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6207158207581146,-1.5927334583348325,0.021912350597609563,0.1858658718552501,1.0,7/13,11.83%,SEMA7A;TGFB2;IRAK3;PLCG2;WNT5A;TGFB3;CD74
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4189606201713311,-1.5921689153363623,0.0,0.1859158181977815,1.0,28/73,15.34%,NRP1;ITGBL1;DOCK1;PTN;SEMA7A;DST;MYH9;ITGA5;FN1;ITGB4;LAMA3;ITGB1;TEC;PRKD1;ADAM10;ITGB5;ADAMTS1;CEACAM1;SRC;BCAR1;NEDD9;ISG15;PTK2B;ITGB8;NME2;ADAM15;PLPP3;FERMT2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.46128514342083937,-1.59200598249462,0.006550218340611353,0.18532580518346667,1.0,16/44,14.78%,YWHAE;THBS1;GAS6;NGF;CD44;CAST;RPS6KA3;CARD16;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4918998147848684,-1.5917590424056849,0.028017241379310345,0.18478658093671252,1.0,9/35,10.48%,PTPRM;MEF2C;CAV1;SPARC;THBS1;XDH;FLT1;APOE;CAV2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6705862758776953,1.5900700154275778,0.036072144288577156,0.6253048872629337,1.0,3/12,3.76%,IL18;NUPR1;TAFA3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5767426394252151,-1.5898609815076876,0.025974025974025976,0.18710416615988823,1.0,9/18,11.68%,PTN;DAAM2;NOTCH1;TNFRSF1B;HES1;IL34;TNFRSF21;MDK;PTPRZ1
prerank,histone H3-K4 trimethylation (GO:0080182),0.6752201593480416,1.5896088736673224,0.03275529865125241,0.6173966764749161,1.0,5/11,19.43%,CTR9;KMT2A;BEND3;TET2;SETD1B
prerank,platelet aggregation (GO:0070527),-0.49728306977462566,-1.5895525031160995,0.015521064301552107,0.18683785465769862,1.0,12/33,11.50%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;UBASH3B;PPIA;CLIC1;MYL9;HSPB1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6611738523425614,1.589540905995447,0.031315240083507306,0.6082078229424924,1.0,4/12,6.71%,ATP1B3;WNK3;ATP1B2;WNK4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.61071264719636,1.5894931353736195,0.046,0.5991684374859108,1.0,3/17,1.72%,ATP1A2;CACNA1D;ANK2
prerank,receptor internalization (GO:0031623),-0.4688218666125906,-1.5891051614290133,0.010775862068965518,0.18666925279457708,1.0,14/44,13.83%,CAV1;CALCRL;DNM3;RAMP2;CD9;RAB31;ITGB1;TFRC;LMBRD1;SNX1;CEACAM1;ACKR3;ADM;LRP1
prerank,vasculogenesis (GO:0001570),-0.49767496412724394,-1.5883613647844557,0.017817371937639197,0.18691532658255022,1.0,14/32,13.82%,CAV1;ENG;RAMP2;NOTCH1;RASIP1;TGFBR2;KDR;SOX17;HEY2;AGGF1;ADM;SOX18;ITGB8;VEGFA
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6838572217387187,1.5878373148554463,0.047325102880658436,0.5970866990040421,1.0,5/10,16.53%,KMT5A;SETD4;SETD7;SMYD2;METTL18
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.42396212829389285,-1.5872836155806824,0.0049382716049382715,0.18759839055147656,1.0,22/65,17.80%,HIP1;DAB2IP;PTPN12;BCAR3;CDH13;EGFR;AFAP1L2;PTPRJ;ITGA1;ARAP1;SPRY2;CEACAM1;MVB12B;DUSP3;HGS;SH3GL2;HIP1R;SPRY1;CBL;PLAUR;GPER1;PDE6H
prerank,cardiac muscle cell action potential (GO:0086001),0.5204320792167209,1.5871279976152037,0.03984819734345351,0.5909691118393701,1.0,6/30,8.02%,ATP1A2;CACNA1D;KCND3;ANK2;FGF12;KCNH2
prerank,positive regulation of protein modification process (GO:0031401),-0.35729972690861356,-1.5854428577584516,0.0,0.18951520944328917,1.0,66/203,18.58%,TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;NIBAN1;ENG;INSR;VEGFC;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;NOS1AP;CARD14;TBX1;RALB;FAM161A;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;NPTN;PPIA;LYN;PPP1R16B;IL34;PRKCD;NNMT;CALM3;CCN1;RB1CC1;SPPL3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;NSMF;TERF2IP;DYRK1A;CD74;KRAS;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PLAUR;FMR1;CSF1R;RAB3GAP2;ALG10B;FXR1;CEP295;GPER1;TAOK1;C3;CCND1
prerank,hemopoiesis (GO:0030097),-0.4037467022674002,-1.5844014747210597,0.0024509803921568627,0.19045096492517077,1.0,24/87,10.14%,MECOM;KITLG;TEK;SNRK;ZBTB16;JAG1;MFAP5;HIPK1;TGFB2;RUNX2;CD34;RUNX1;BMP4;TGFBR2;KDR;KAT6A;WNT5A;FLT1;PRKX;ARIH2;FLT4;NOTCH4;TAL1;ETV6
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6257671135224223,-1.5843997997146624,0.039603960396039604,0.18962291725158306,1.0,5/13,12.09%,DAB2IP;EPN2;PTPN1;HGS;HHEX
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5816215674448248,-1.584097314243985,0.042283298097251586,0.18935377211053472,1.0,6/17,9.74%,MAML2;PBX1;NOTCH3;NOTCH1;HEYL;NOTCH4
prerank,cellular sodium ion homeostasis (GO:0006883),0.6272486170113505,1.5840165854914714,0.03346456692913386,0.5954147035106787,1.0,3/15,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,positive regulation of GTPase activity (GO:0043547),-0.35994886517771957,-1.583461956574522,0.0,0.18957103239792056,1.0,54/188,15.77%,DOCK9;LIMS1;TBC1D4;NTRK3;RABGAP1L;DOCK10;RAPGEF2;ARHGAP42;ITGA6;NET1;BCAR3;SIPA1L2;RAP1A;TBC1D8;CORO1C;BCR;F11R;TBC1D12;SNX18;SNX13;TIAM2;USP6NL;TBC1D5;ARAP1;ITGB1;TBC1D2B;SIPA1L3;ARHGEF15;RACK1;TBC1D1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;ABR;TIAM1;MAP4K4;TBC1D13;DOCK8;CAV2;RGS10;SIPA1;RALGAPA1;TAX1BP3;CD40;TBC1D7;TBC1D10A;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP;TBC1D25
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.46835065605490867,-1.5821894325540178,0.004291845493562232,0.19062587921574053,1.0,14/43,16.62%,MEF2C;MICAL2;ACVR1;ENG;TBX3;NOTCH1;TGFBR2;SOX17;HES1;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of glycolytic process (GO:0006110),0.44527804107145236,1.5803469281083877,0.016129032258064516,0.6020328436333636,1.0,8/68,3.98%,PRKAG2;IGF1;NUPR1;GCK;PRKAA2;PPARA;POM121;NUP155
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.6380112702851268,-1.5801233976983144,0.03112033195020747,0.19309537542915695,1.0,7/11,21.00%,ARID1B;ARID1A;SERTAD1;ZMIZ2;CDCA4;ZMIZ1;CHEK1
prerank,cell junction assembly (GO:0034329),-0.3872681548926903,-1.5796544545589652,0.002544529262086514,0.19307378179706922,1.0,17/100,4.67%,CDH11;ACTB;LIMS1;SHANK3;FARP1;LIMS2;DNM3;SPOCK2;CLDN5;ITGA6;TJP1;RHOA;GJC1;ACTG1;CDH1;FN1;FLNA
prerank,regulation of spindle organization (GO:0090224),-0.5664060505653481,-1.5767617330049886,0.021526418786692758,0.19660810656755917,1.0,9/18,23.88%,SENP6;MAP9;DYNC1H1;DCTN1;GPSM2;TPX2;FSD1;PARP3;NUP62
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5604198629275673,-1.5762252796030058,0.026859504132231406,0.1967049837467861,1.0,7/19,7.71%,PRKCH;CLDN5;TJP1;RUNX1;F11R;CBFB;OCLN
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6062463635519953,1.572213330223519,0.04563492063492063,0.6290435495194387,1.0,7/16,18.41%,NUPR1;PPIF;COX7A1;COX7A2L;ABCD1;ATP7A;MLXIPL
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6388142685684484,-1.5719127167487295,0.018218623481781375,0.2024583213880756,1.0,6/12,14.93%,CBLB;F3;PTPRJ;APOD;HGS;CBL
prerank,mesenchymal cell differentiation (GO:0048762),0.4736923094591938,1.5706195172719488,0.00865051903114187,0.6272503662335501,1.0,11/51,7.14%,RANBP3L;BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;FGFR2;DDX17
prerank,amino sugar metabolic process (GO:0006040),-0.6569463504984083,-1.5679837119378384,0.043478260869565216,0.20807903628450194,1.0,3/10,10.72%,CSGALNACT1;ST3GAL1;GFPT2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5440957424223317,1.567574793068622,0.030303030303030304,0.6314112146578789,1.0,10/26,18.35%,EYA1;HSPA1A;EYA4;EYA2;HTRA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,B cell receptor signaling pathway (GO:0050853),-0.49746885771154425,-1.5672221522369045,0.016194331983805668,0.20837402611338832,1.0,15/32,21.23%,MEF2C;RFTN1;PLCG2;BMX;TEC;CD38;BCAR1;PIK3CD;NFATC2;SH2B2;PTPRC;NCKAP1L;LAT2;BTK;SYK
prerank,sterol metabolic process (GO:0016125),0.45374953263284706,1.5666421022040335,0.015570934256055362,0.6270409156828834,1.0,22/60,18.60%,PRKAG2;LIPA;SOAT2;CYP26B1;CYP11B1;INSIG2;APOF;SOAT1;CLN8;SC5D;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;FDX2;MSMO1;ABCA5;HMGCR
prerank,heart looping (GO:0001947),-0.46973347377946584,-1.5631757149212915,0.010660980810234541,0.21420105956969904,1.0,12/39,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,positive regulation of wound healing (GO:0090303),-0.4765982257113735,-1.562529790000364,0.02336448598130841,0.2144265986410944,1.0,18/36,25.72%,ST3GAL4;THBS1;ACTG1;KANK1;ITGB1;ANXA1;OCLN;SERPINE1;ENPP4;PLPP3;FERMT2;VTN;RREB1;MYLK;HPSE;PRKCE;F2R;DMTN
prerank,regulation of monooxygenase activity (GO:0032768),-0.5194870507882393,-1.5622734120254136,0.041407867494824016,0.2139907777165464,1.0,8/23,15.52%,CAV1;NOS3;NOSTRIN;EGFR;NOS1AP;DDAH1;CYGB;POR
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6480879462074698,1.5621260306348366,0.024761904761904763,0.638368187382981,1.0,4/13,2.43%,ERRFI1;SNX6;CHMP6;GPRC5A
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.45805150232792163,-1.5619191912850134,0.017817371937639197,0.21368782059529715,1.0,11/42,8.79%,LIMS1;GCNT2;RHOA;VIT;NDNF;NOTCH1;CORO1C;TBCD;FBLN2;EMP2;ECM2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5015951979905543,-1.5591392344137518,0.031185031185031187,0.2174511214973924,1.0,6/25,7.36%,BMPR2;ACVRL1;ENG;NOTCH1;BMP4;CCN1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.36844406988161826,-1.5590879992314195,0.002688172043010753,0.21664411805916511,1.0,44/151,10.10%,NRP1;PDE3A;LIMS1;MEF2C;NTRK3;SEMA6A;RAPGEF2;PDE8A;BMPR2;DAB2IP;PTPN12;ACVR1;ACVRL1;RAMP2;NDNF;NOTCH1;RAP1A;IQGAP1;EGFR;RUNX2;PLCG1;CD44;BMP4;EEF1A1;TGFBR2;KDR;TBX1;CPNE3;TMEM100;PRKD1;WNT5A;ERN1;RACK1;PDE2A;ANXA1;FLT1;GAREM1;SPRY2;FLT4;MT1G;MAPKAPK2;BCAR1;KLF4;DUSP3
prerank,positive regulation of hydrolase activity (GO:0051345),-0.370692839692556,-1.5589801178924854,0.0025,0.2159815879129407,1.0,37/137,15.39%,DOCK9;LIMS1;DOCK10;RAPGEF2;ITGA6;RHOA;CD200;NET1;BCAR3;RAP1A;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;CALM3;RAPGEF6;RGS6;TGM2;EVI5L;RPS3;CCL13;MAP4K4;DOCK8;CAV2;RGS10;PSAP;BMP2;CD40;TBC1D7;AGRN;ARHGAP27;S100A10;FERMT2;RAP1GAP
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3286758545860325,-1.557701785267501,0.0,0.21726811078265582,1.0,75/348,9.88%,NRP1;TEK;GHR;NTRK3;CAV1;BMP5;PECAM1;SLCO3A1;RAPGEF2;PDE8A;BMPR2;NIBAN1;BCAR3;ACVR1;ACVRL1;TGFB2;ENG;INSR;VEGFC;RPS6KA5;RBPMS;GAS6;RASSF2;RAP1A;LIMCH1;IQGAP1;EGFR;ITGA5;LIMK2;NGF;CD44;BMP4;PTPRJ;CSPG4;KDR;APP;CARD14;CACUL1;FNIP2;TBX1;PLCG2;RALB;FAS;TNIK;CAB39;RAP2A;TFRC;ARHGEF2;PAK2;TEC;PRKD1;AXIN2;RACK1;XRCC5;NPTN;PPIA;LYN;IL6R;IL34;MAPK1;CALM3;CCN1;RB1CC1;SPRY2;EFNA5;TMEM119;SRC;PDGFC;FLT4;IGF2;FGF2;TGFB3;IL15;RPTOR;FGF7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.5095562945904584,-1.5575990890493765,0.03112033195020747,0.21658305711168363,1.0,10/25,17.80%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;CBL;PLAUR;RTN4;GPER1;PDE6H
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.5793017768199273,-1.5574092955470138,0.02079002079002079,0.2151338043759043,1.0,7/16,10.47%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.5793017768199273,-1.5574092955470138,0.02079002079002079,0.2151338043759043,1.0,7/16,10.47%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5256573438594125,-1.5570228345514125,0.03347280334728033,0.21491604880644213,1.0,11/24,7.50%,TMEFF2;TJP1;WASF2;PIK3R1;STMN1;F11R;PHLDB2;ARAP1;PAK2;MET;MYOC
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6158675231465146,-1.557019102085458,0.032,0.21407156594572985,1.0,5/12,7.77%,SEMA6A;DCN;DAB2IP;XDH;SPRY2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5667815188058984,-1.556791330992489,0.013565891472868217,0.21363614471677422,1.0,6/18,3.88%,LTBP1;CD200;TGFB2;CD34;FN1;PTGS2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6751179754251573,1.556449613541752,0.05928853754940711,0.6546415108332259,1.0,5/10,15.22%,USH1C;WHRN;ADGRV1;PDZD7;TSKU
prerank,mesoderm formation (GO:0001707),-0.5626902787190968,-1.5562601823045652,0.04184100418410042,0.21375342969405253,1.0,4/17,5.13%,BMPR2;ITGB4;ITGA8;ITGB1
prerank,regulation of protein phosphorylation (GO:0001932),-0.3380863280190966,-1.5561286217844161,0.0,0.2132240681439444,1.0,72/256,15.94%,TEK;NTRK3;PECAM1;SLCO3A1;PLCE1;PID1;PDE8A;DAB2IP;SLIT2;NIBAN1;LRP6;ENG;INSR;VEGFC;BMPER;GAS6;LIMCH1;EGFR;PRR5L;LIMK2;CORO1C;BMP4;KDR;APP;FN1;CARD14;FNIP2;TBX1;RALB;FAS;TNIK;BRD4;RAP2A;TFRC;XDH;AXIN2;RACK1;NPTN;PPIA;LYN;IL34;CCN1;RB1CC1;OCLN;PPP2R5C;EFNA5;TMEM119;SOD1;FLT4;EIF2AK3;IGF2;FGF2;FGF7;EPHB2;TERF2IP;HSPB1;CD74;KRAS;SH3GL2;BMP2;CD40;AKT2;VEGFA;RARRES2;MT3;PAQR3;PLPP3;PLAUR;FMR1;CSF1R;ATF4;FKBP8
prerank,regulation of BMP signaling pathway (GO:0030510),-0.40416306762380205,-1.5560099694102811,0.0023584905660377358,0.2125564344411495,1.0,15/73,8.78%,BMPR2;HTRA3;ACVRL1;ENG;BMPER;NOTCH1;CRIM1;SMURF1;BMP4;SFRP4;SMAD5;SMAD1;UBE2D3;CCN1;XIAP
prerank,maturation of 5.8S rRNA (GO:0000460),0.6072908356611785,1.555815978918625,0.028790786948176585,0.6490342308213075,1.0,2/17,0.34%,NSA2;MPHOSPH6
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5620881009904086,1.5550637160888552,0.03213610586011342,0.6438981431453076,1.0,5/20,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,sterol biosynthetic process (GO:0016126),0.5187257636384454,1.554696164567628,0.0311284046692607,0.6371189882473787,1.0,11/33,20.27%,PRKAG2;ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.3704878996107556,-1.5543445445180983,0.0,0.21460360532369574,1.0,31/140,10.13%,ARHGAP31;ARHGAP10;RHOJ;CHN2;PLCE1;ARAP2;SLIT2;SRGAP1;RHOA;NET1;ARHGEF3;MCF2L;STARD8;CHN1;BCR;RASGRF2;ARAP3;STARD13;TIAM2;ARAP1;ARHGEF2;ARHGAP32;ARHGDIB;ARHGAP35;TGM2;ABR;SRC;TIAM1;VAV2;ARHGEF12;CD2AP
prerank,atrioventricular valve development (GO:0003171),-0.5956766680661789,-1.5513703904744747,0.043478260869565216,0.2186520351536353,1.0,11/14,25.01%,BMPR2;ACVR1;TGFB2;NOTCH1;TGFBR2;HEYL;BMP2;APLNR;SLIT3;ZFPM1;GJA5
prerank,regulation of integrin activation (GO:0033623),-0.5972502784333895,-1.5512955807483257,0.03838383838383838,0.21793240088825902,1.0,12/15,32.06%,PIEZO1;RASIP1;SRC;JAM3;FERMT2;KIF14;SELP;FARP2;PTGER4;FBLIM1;RAP1B;SKAP1
prerank,negative regulation of cell adhesion (GO:0007162),-0.41129992801552206,-1.5510710593771617,0.008988764044943821,0.2174165082145542,1.0,24/72,13.79%,PODXL;GCNT2;SEMA6A;JAG1;RHOA;ACER2;ACVRL1;NOTCH1;CDH13;CYP1B1;CDH1;TBCD;ARHGDIB;ADAM10;MDK;TGFBI;SERPINE1;EPHB2;PLXNC1;JAM3;FZD4;SIPA1;PTPRC;ARHGDIA
prerank,regulation of water loss via skin (GO:0033561),-0.585374930234045,-1.5500769630162905,0.027777777777777776,0.21762479103397941,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,establishment of skin barrier (GO:0061436),-0.585374930234045,-1.5500769630162905,0.027777777777777776,0.21762479103397941,1.0,5/15,12.12%,LSR;STMN1;MET;HRNR;UGCG
prerank,ceramide biosynthetic process (GO:0046513),-0.4626192257997513,-1.5497222425001238,0.013856812933025405,0.21750309524141162,1.0,11/40,9.26%,SGMS1;ST6GALNAC3;ST8SIA4;SGMS2;DEGS2;AGK;ST6GALNAC5;CERS5;CERS6;ST8SIA6;SAMD8
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4387781636038322,1.5470058166994896,0.01232394366197183,0.6634384247875389,1.0,10/65,7.57%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;LMNA;PGK1;KCND2;CPEB4
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4204886396408828,-1.5469461434936498,0.0066518847006651885,0.22135368443051354,1.0,18/56,15.90%,NRP1;TEK;LIMS1;CAV1;CLDN5;PTPRJ;KDR;CLSTN2;MYOC;IL1RAP;MAP4K4;EPHB2;ACE2;VEGFA;SRPX2;S100A10;FERMT2;NPHP1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.6026162277201204,-1.5467091642644304,0.029644268774703556,0.22094848130919903,1.0,5/13,11.49%,CD9;CDH13;ABCA1;ITGB1;SREBF2
prerank,cyclooxygenase pathway (GO:0019371),0.6802760959452453,1.5460980409817981,0.03614457831325301,0.6590695167640216,1.0,2/10,0.31%,PTGDS;PTGS1
prerank,regulation of cellular component organization (GO:0051128),-0.36230617558616207,-1.5454830932477712,0.002717391304347826,0.2222004698449024,1.0,31/135,12.45%,HIP1;LTBP4;PLCE1;RAPGEF2;DAB2IP;TJP1;MLLT3;NET1;STON2;HJURP;STK38L;RAP1A;CDH13;SOCS2;IRAK3;TFRC;CAMK2D;WNT5A;AGTR1;ANKRA2;CEACAM1;PTPN1;ZFYVE16;BCAR1;APOE;RPTOR;FAM107A;BAG5;GFAP;DCUN1D5;HIP1R
prerank,regulation of MAPK cascade (GO:0043408),-0.358578711352278,-1.5454621981894234,0.0,0.2213901977193055,1.0,45/157,13.67%,ROR1;TEK;NTRK3;CAV1;DAB2IP;ADRA1B;BCAR3;INSR;STK3;IQGAP1;EGFR;JCAD;PTPRJ;KDR;FN1;TBX1;PLCG2;FAS;TNIK;DHX33;PAK2;LYN;IAPP;MAPK1;FLT1;CCN1;MYOC;NBR1;CEACAM1;FLT4;ATP6AP2;MAP4K4;IGF2;FGF2;DUSP3;YWHAZ;CAV2;PHLPP1;CD74;RET;BMP2;ROR2;PEBP1;PTPRC;CD24
prerank,substrate-dependent cell migration (GO:0006929),-0.5939367451422616,-1.5453417208547215,0.037698412698412696,0.22075951775341776,1.0,7/14,13.63%,NRP1;NTN1;VEGFC;ANKS1A;CD2AP;SHTN1;PTPRC
prerank,response to cadmium ion (GO:0046686),-0.49941338541787117,-1.5448876765604251,0.02620967741935484,0.22059152702628002,1.0,14/26,19.05%,EGFR;JUN;MAPK1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;MT2A;MAPK3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5442508472996483,1.544170695489606,0.040293040293040296,0.6597902781416277,1.0,6/23,4.22%,ERRFI1;SNX6;SH3BP5L;CHMP6;GPRC5A;SH3BP5
prerank,autophagy of peroxisome (GO:0030242),-0.6235979127141336,-1.5430471279236717,0.03435114503816794,0.2229951101994162,1.0,7/12,17.12%,MAP1LC3B;RB1CC1;NBR1;PIK3C3;SQSTM1;PIK3R4;ACBD5
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5585281046442513,1.5430202233224548,0.050505050505050504,0.6490283680017074,1.0,9/21,18.35%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5585281046442513,1.5430202233224548,0.050505050505050504,0.6490283680017074,1.0,9/21,18.35%,EYA1;HSPA1A;EYA4;EYA2;BCL2;TERT;HSPA1B;IL1A;AKT1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.42008086472365835,-1.5424392622046061,0.009302325581395349,0.22319127826899468,1.0,28/56,34.79%,ALPK1;UBC;RPS6KA3;NOD1;PLCG2;RPS27A;UBB;MAPKAPK2;CTSB;SFTPA2;SFTPA1;IRAK2;TAB1;CTSS;NOD2;HMGB1;MYD88;BCL10;TLR4;CD36;TLR6;MAPKAPK3;TLR1;CD14;TLR3;S100A9;IRAK4;TLR2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5885290724771677,-1.5422189605855465,0.02880658436213992,0.22277586698970225,1.0,8/15,23.54%,EGFR;KDR;BMX;TEC;DYRK1A;PTK2B;MAPK3;IGF1R
prerank,regulation of cardiac conduction (GO:1903779),0.4597117700036714,1.5415729973430266,0.024013722126929673,0.6476020868684509,1.0,11/54,11.04%,ATP1A2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2;CORIN;FXYD4;ITPR2;RYR2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4333893690789884,-1.540044391346345,0.008869179600886918,0.225734655259316,1.0,17/50,15.24%,YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;CARD16;PAK2;SRC;XIAP;GPX1;KLF4;USP47;CSNK2A1;VEGFA;MT3;PLAUR
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.6140354962355882,-1.5391692895515598,0.039337474120082816,0.22636841127530205,1.0,8/11,32.80%,LRP6;WNT5A;FZD1;NR4A2;RYK;LMX1A;WNT2;CTNNB1
prerank,energy reserve metabolic process (GO:0006112),0.5815097716869048,1.5389733609747127,0.04924242424242424,0.6508883231725657,1.0,7/19,13.55%,PRKAG2;LEPR;PHKG2;MRAP2;PHKB;PYGL;PYGM
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3671052432072958,-1.538643990309639,0.0,0.22636663233327375,1.0,33/121,13.82%,NRP1;GHR;PECAM1;IL6ST;ACVR1;GAS6;ITGA5;STAT3;CD44;PTPRJ;CSPG4;PLCG2;ARHGEF2;PAK2;TEC;HES1;LYN;IL6R;IL34;EFNA5;SRC;PTPN1;IGF2;IL15;NEDD9;FGF7;PIBF1;CD74;ARL2BP;PTK2B;CD40;PTPRC;VEGFA
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6303675516744411,-1.5386113287382377,0.05394990366088632,0.22560409077450666,1.0,5/11,8.96%,CD200;THBS1;CD34;PTGS2;ATP6AP2
prerank,glycerolipid catabolic process (GO:0046503),-0.5316158783219977,-1.5383843102558117,0.03556485355648536,0.22520108920395399,1.0,6/19,12.54%,PLA2G4A;ABHD2;GPCPD1;MGLL;PRDX6;ABHD6
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5291082845434709,1.53780974229794,0.04431599229287091,0.6486817685040709,1.0,7/26,4.79%,CACNA1D;ACTN2;ATP1B3;ANK2;STK39;ATP1B2;DLG1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6066354051278025,1.5369590016245387,0.04024144869215292,0.6448984303663008,1.0,2/15,4.00%,MOXD1;SAT1
prerank,cellular response to zinc ion (GO:0071294),-0.5773414359053297,-1.5350565921827874,0.0498960498960499,0.23007013810652382,1.0,11/15,19.01%,MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;MT3;GLRA2;MT2A
prerank,negative regulation of platelet activation (GO:0010544),-0.5609322974943507,-1.5350077158770983,0.046460176991150445,0.22933408695570912,1.0,6/16,9.64%,PRKG1;NOS3;CD9;PRKCD;CEACAM1;APOE
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.5065129506194025,-1.5346185732584732,0.03619909502262444,0.22920053692037645,1.0,12/24,25.81%,SLIT2;CCN3;LYN;CXCL12;SERPINE1;GREM1;HMGB1;DUSP1;PLA2G7;CCR2;ANO6;AIF1
prerank,regulation of membrane repolarization (GO:0060306),-0.6109872849091396,-1.5345667531161467,0.024096385542168676,0.22848173922197393,1.0,6/13,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;CACNA2D1;KCNQ1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.5036693533702317,-1.5337665581485571,0.02631578947368421,0.22900315266563154,1.0,8/27,16.03%,PTN;ICAM1;IL6R;MDK;JAM3;EDN3;VEGFA;NCKAP1L
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4287628887806648,-1.5334379574626578,0.023965141612200435,0.22872555114392715,1.0,24/56,22.08%,TEK;ABI1;INSR;EGFR;KDR;TEC;LYN;FLT1;SRC;FLT4;ABI3;EPHB2;DYRK1A;TPST2;PTK2B;CSF1R;FGFR3;PTPN6;EFEMP1;BTK;JAK3;HCK;SYK;FYN
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5755072741036203,-1.5333622306872157,0.038696537678207736,0.22807797368945062,1.0,8/15,16.30%,TMSB4X;KDR;PRKD1;MET;FGF2;HSPB1;VEGFA;SEMA5A
prerank,membrane depolarization during action potential (GO:0086010),0.5256298037098309,1.532789375885504,0.06302521008403361,0.6557562405168382,1.0,2/26,0.44%,ATP1A2;CACNA1D
prerank,response to lipid (GO:0033993),-0.37590382227133484,-1.5321540888442395,0.004784688995215311,0.22939834728561087,1.0,19/105,9.38%,FOXP1;NOS3;ACER2;PPARD;FOXO1;FOXO3;SOCS2;STAT3;ALPL;IRAK3;RPS6KA3;ESR1;TNFRSF11A;GCH1;STRN3;ANXA1;SRR;TRIM16;MAPKAPK2
prerank,positive regulation of cell development (GO:0010720),-0.48040705893584,-1.5309225854855613,0.027896995708154508,0.2307402973560962,1.0,12/31,22.64%,PDE3A;BMP4;SERPINF1;NUMB;TGM2;SPEN;GPER1;NKX6-1;LIG4;NUMBL;SNW1;SOX11
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5646362178455301,-1.530794751673942,0.043824701195219126,0.2301669561236238,1.0,6/15,9.04%,RSPO3;DAAM2;SFRP4;CSNK1E;ZNRF3;TIAM1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3218513081411275,-1.5307729628574336,0.0,0.22940982812809602,1.0,104/390,16.25%,NRP1;PTPRG;ACTB;ROR1;TEK;GHR;FLRT2;ABI1;NTRK3;NRP2;ARHGEF28;DOCK1;RAPGEF2;GAB1;RHOA;BCAR3;TIE1;WASF2;COL4A2;INSR;MERTK;VEGFC;FOXO1;RAB14;ACTG1;ANKS1A;PIK3R1;CHN1;EGFR;NGF;GRB14;SOCS2;STAT3;ATP6V0A4;PTPRJ;MTSS1;KDR;STMN1;AP2B1;PIK3C2A;COL4A6;ANGPT2;SPRED2;UBASH3B;PAK2;PRKD1;MET;LYN;NCK1;PXN;MAPK1;FLT1;SHOC2;APC;GRIN2B;ATP6V0D1;EFNA5;PIK3CA;SRC;PDGFC;FLT4;ATP6V0A1;TIAM1;EIF2AK3;VAV2;IGF2;FGF2;MAPKAPK2;BCAR1;NEDD9;SORT1;FGF7;GTF2F1;NCF2;YES1;EPHB2;CAV2;MPZL1;NCBP2;COL1A1;RET;SH2B2;PTK2B;PDGFD;ROR2;ATP6V1D;FGFRL1;AKT2;IRS1;VEGFA;RARRES2;AP2A1;RBFOX2;POLR1G;ALK;CBL;ARPC2;NCBP1;GIT1;FOXO4;CSF1R;NCKAP1L;DDIT4;SHC4
prerank,sodium ion homeostasis (GO:0055078),0.5626985670012717,1.530751962720058,0.043151969981238276,0.6573956166257673,1.0,3/21,4.28%,ATP1A2;ATP1B3;ATP1B2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5724049471681948,-1.530575458282356,0.04121475054229935,0.22896686597489066,1.0,7/15,26.95%,LEF1;JUN;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.5164916608387826,-1.5271694612727609,0.03205128205128205,0.23413821713484811,1.0,16/22,44.28%,RUNX1;CBFB;MDK;NFATC2;SOX12;CD46;LAG3;SOCS1;IL2RA;IL4I1;VSIR;FANCA;BCL6;CTLA4;TNFRSF18;FOXP3
prerank,aortic valve development (GO:0003176),-0.46307776774117065,-1.526832099697544,0.012987012987012988,0.23395867340033627,1.0,14/34,12.38%,ELN;BMPR2;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;HEY2;TWIST1;BMP2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.588279990322504,1.5243416094217754,0.056338028169014086,0.6776404094614986,1.0,7/16,15.98%,UPB1;DPYD;CRMP1;NT5C3A;UPP2;DPYSL2;TET2
prerank,regulation of biomineral tissue development (GO:0070167),-0.500588791979496,-1.5240134845561684,0.02188183807439825,0.23822494691899931,1.0,11/26,13.74%,SGMS2;NOS3;NOTCH1;GAS6;S1PR1;NBR1;HEY2;FBXO5;TWIST1;ECM1;ENPP1
prerank,regulation of macrophage migration (GO:1905521),-0.6449716304657912,-1.5234404984986967,0.04285714285714286,0.23845335247773775,1.0,3/10,12.51%,MTUS1;CD200;PTK2B
prerank,SNARE complex assembly (GO:0035493),-0.6396718002584054,-1.5226325296755603,0.04950495049504951,0.2390609138262971,1.0,2/10,5.49%,STXBP6;VAMP3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5389905210697832,-1.522374765016214,0.0430327868852459,0.23862416749249935,1.0,6/19,10.11%,CYTH3;PARD3;RHOA;RAP2A;SIPA1L3;GOLPH3
prerank,response to laminar fluid shear stress (GO:0034616),-0.6405217413328366,-1.5222045454643385,0.041916167664670656,0.23805440153307258,1.0,7/10,29.20%,ABCA1;KLF4;SREBF2;KLF2;ASS1;SMAD6;SMAD7
prerank,sensory perception (GO:0007600),0.45903610847547427,1.5204951231084112,0.03806228373702422,0.6868040805310581,1.0,15/45,20.11%,USH1C;RETREG1;WHRN;PCDH15;PTGES;NTSR2;CHRNB2;ADGRV1;TTC8;KCNK4;OPRM1;PENK;P2RX4;SCN9A;OPRL1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3549128596895806,-1.5204229587457867,0.0026455026455026454,0.24030017652202426,1.0,32/149,8.37%,PRKCH;ROR1;CAV1;SLCO3A1;TRAF5;RPS6KA5;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;MID2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5982042636593522,-1.5201992885743956,0.03529411764705882,0.23987210826982566,1.0,4/13,7.92%,RHOA;ETS1;MDK;NFAT5
prerank,genitalia development (GO:0048806),-0.6112341887098073,-1.5200279010546198,0.046747967479674794,0.23936276813622617,1.0,5/12,12.24%,TBX3;PKD1;WNT5A;STRA6;FOXF2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.5059002531567962,-1.5195765418835734,0.04025423728813559,0.23922992783446007,1.0,9/24,8.02%,TMEFF2;RHOA;ACVRL1;ITGA5;CD44;FLNA;ARHGAP35;CCN1;CEACAM1
prerank,cardiac cell development (GO:0055006),-0.6297431174783946,-1.5171723369625747,0.043478260869565216,0.2426955931797441,1.0,5/11,13.82%,JAG1;NOTCH1;MYH11;CXADR;VEGFA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.36302878250117426,-1.5168745519876317,0.0,0.24234439843325326,1.0,29/138,12.90%,PTPRG;ROR1;TEK;ABI1;NTRK3;BMPR2;IL6ST;PTN;LIFR;TIE1;INSR;MERTK;EGFR;NGF;MTSS1;KDR;MET;LYN;FLT1;SRC;FLT4;BCAR1;NEDD9;YES1;EPHB2;MPZL1;RET;PTK2B;ROR2
prerank,potassium ion transmembrane transport (GO:0071805),0.3879725449268744,1.516651539754431,0.0052173913043478265,0.6962200401594352,1.0,24/135,12.63%,ATP1A2;KCNK2;SLC24A3;KCND3;ATP1B3;KCNA3;KCNJ13;LRRC38;KCNJ5;ATP1B2;TMEM175;KCNJ10;NALCN;KCNC3;KCND2;KCNH2;KCNC2;KCNN4;KCNJ16;SLC12A5;KCNH7;SLC12A1;KCNK4;SLC9A9
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.621286123131628,-1.5166210805402,0.054878048780487805,0.24200796699147195,1.0,5/11,8.57%,JAG1;TGFB2;BMP4;HEY2;ZFPM2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3892469572834943,-1.5158563536230791,0.009302325581395349,0.24261291511814376,1.0,25/86,13.82%,NRP1;GHR;PECAM1;ACVR1;EGFR;ITGA5;CD44;PTPRJ;CSPG4;APP;PLCG2;ARHGEF2;PAK2;TEC;IL6R;PRKCD;EFNA5;SRC;IGF2;IL15;FGF7;CD74;PTK2B;PTPRC;VEGFA
prerank,entry into host (GO:0044409),-0.6069021806745735,-1.5156056925305914,0.04480651731160896,0.24228605268384978,1.0,10/13,32.80%,CDH1;MET;PPIA;SRC;CBL;CXCR4;GRB2;CBLL1;ITGAV;CTNNB1
prerank,protein depolymerization (GO:0051261),-0.4976622790270162,-1.5154898294727293,0.03146067415730337,0.24171469716191632,1.0,10/27,18.44%,MICAL2;GSN;NCKAP5;WDR1;STMN1;CFL1;NCKAP5L;KATNB1;KIF24;STMN4
prerank,negative regulation of leukocyte migration (GO:0002686),-0.646604614875869,-1.5141670061383572,0.04384133611691023,0.24337993274790568,1.0,3/10,1.54%,BMP5;SLIT2;CD200
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6275353499939241,1.5141116073812153,0.07283464566929133,0.7000019491195878,1.0,7/13,15.94%,DDO;ASPA;MTHFS;GAD1;GOT1;GOT2;GLUL
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.662722849243054,1.5140023679207952,0.06504065040650407,0.6931385740299796,1.0,5/10,12.39%,KMT2A;CAMK1;PIH1D1;SPHK2;RAPGEF3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.45327171834068386,1.513157528866845,0.033210332103321034,0.6895621229319316,1.0,5/48,3.98%,PRKAG2;GCGR;GCK;POM121;NUP155
prerank,vascular transport (GO:0010232),0.4205024610674138,1.5124284482395685,0.01618705035971223,0.6856445430551349,1.0,16/81,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,organic hydroxy compound transport (GO:0015850),-0.46415107034260145,-1.5119615266668671,0.028634361233480177,0.2467332385865178,1.0,9/36,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;NPC2;OSBP;STRA6;CEACAM1
prerank,skeletal muscle organ development (GO:0060538),-0.4887959156727555,-1.5098757379658923,0.028513238289205704,0.24963749751696362,1.0,7/26,7.63%,MEF2C;CAV1;DISP1;SVIL;SIX1;MYL6;STRA6
prerank,negative regulation of wound healing (GO:0061045),-0.49026385104418,-1.50976297081962,0.03543307086614173,0.24901739246732849,1.0,10/28,10.45%,SLC12A2;CD34;CD109;PHLDB2;CASK;AJAP1;FGF2;SERPINE1;APOE;EDN1
prerank,hippo signaling (GO:0035329),-0.49461778413639873,-1.508565057351116,0.034274193548387094,0.25026173399258406,1.0,11/26,20.13%,TJP1;YWHAE;STK3;TEAD4;YWHAB;TJP2;TEAD1;AMOT;LATS1;AMOTL1;TEAD3
prerank,ganglion development (GO:0061548),-0.6271847678709404,-1.50844354597624,0.044444444444444446,0.24969197588920589,1.0,2/11,0.78%,NRP1;NRP2
prerank,apical junction assembly (GO:0043297),-0.4215209262873547,-1.508273073685683,0.008948545861297539,0.2492464090838969,1.0,15/53,7.76%,PECAM1;CLDN5;VCL;ESAM;PARD3;RHOA;RAMP2;WDR1;F11R;CTNNA1;TBCD;PAK2;CLDN14;OCLN;APC
prerank,ERBB signaling pathway (GO:0038127),-0.4001511223458241,-1.5081337120990452,0.015659955257270694,0.24877162339998707,1.0,15/64,9.62%,PLCE1;GAB1;PTPN12;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;CPNE3;MAPK1;GAREM1;PIK3CA;SRC;BCAR1
prerank,striated muscle tissue development (GO:0014706),-0.4786698809528609,-1.507073673992558,0.018,0.2499011588392,1.0,9/29,5.91%,MEF2C;PGM5;CAV1;BMP5;BMPR2;SVIL;SIX1;SGCD;MYL6
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5990138998283174,-1.5059160003884513,0.038910505836575876,0.25107531710088166,1.0,4/12,13.15%,WAPL;CTCF;AXIN2;RAD21
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6171765449611543,-1.5044115940399136,0.049484536082474224,0.25304763368917244,1.0,7/11,18.85%,MAP3K5;CYP1B1;PRKCD;STK24;GSKIP;DIABLO;PRODH
prerank,positive regulation of neuron projection development (GO:0010976),-0.38321060193471973,-1.5034490245122698,0.011876484560570071,0.25401469077971783,1.0,25/85,13.75%,ROR1;NTRK3;BMP5;RAPGEF2;DAB2IP;PTN;ITGA6;NDNF;RAP1A;SCARF1;SCARB2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;RETREG3;APOE;VLDLR;RET;PTK2B;ROR2;FZD1;AVIL
prerank,transport across blood-brain barrier (GO:0150104),0.4169518182428277,1.5030188185151583,0.017825311942959002,0.720217236222486,1.0,16/83,4.55%,ATP1A2;SLC6A13;SLC6A1;SLC13A3;SLC22A8;LEPR;SLC5A5;SLC24A3;SLC38A3;SLC6A9;SLC5A3;SLC16A12;SLC29A2;SLC38A1;ATP1B2;LRP3
prerank,endochondral bone morphogenesis (GO:0060350),-0.5993028229546823,-1.5026479307183636,0.05811623246492986,0.25467994945573674,1.0,6/11,17.34%,MEF2C;BMPR2;BMP4;TMEM119;TRPV4;FGFR3
prerank,negative regulation of heart contraction (GO:0045822),0.6187101957373042,1.501582181438034,0.08364312267657993,0.7197119170093389,1.0,1/11,0.03%,ATP1A2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6219698709114295,-1.5010968394261919,0.04222648752399232,0.256720881446009,1.0,5/10,17.31%,IRAK3;KLF4;TLE5;PTPRC;SIGIRR
prerank,positive chemotaxis (GO:0050918),-0.5411371980608911,-1.5010298970730571,0.05918367346938776,0.25604117855762687,1.0,6/17,16.30%,NRP1;PTPRJ;MET;FGF7;VEGFA;SEMA5A
prerank,anion transmembrane transport (GO:0098656),0.43312366906648725,1.500168571272145,0.02664298401420959,0.7188529748524675,1.0,11/67,6.01%,SLC6A13;SLC13A4;SLC13A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC25A5;SFXN2;SLC25A11
prerank,positive regulation of developmental growth (GO:0048639),-0.42333196657109806,-1.499881446462069,0.010964912280701754,0.2572643720724814,1.0,9/49,3.36%,GHR;NEDD4L;NTN1;SEMA7A;INSR;NGF;SMURF1;MACF1;ITSN2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5334663375358436,-1.4992775241507679,0.02510460251046025,0.2575258118115441,1.0,9/21,10.10%,VCL;RHOA;ACTG1;PEAK1;LIMCH1;CORO1C;MACF1;EFNA5;DUSP3
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6345795889817277,-1.4990205240515422,0.06868686868686869,0.25715275880594873,1.0,5/10,13.83%,PTPN12;PTPRJ;APOD;HGS;LRP1
prerank,bile acid and bile salt transport (GO:0015721),-0.5096785388234046,-1.498714783421089,0.042826552462526764,0.2569019896728821,1.0,5/24,8.02%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5527451667876242,1.497895279686508,0.05056179775280899,0.7143783605747521,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5527451667876242,1.497895279686508,0.05056179775280899,0.7143783605747521,1.0,8/20,10.76%,IVD;SLC25A44;DBT;ACAT1;ACADSB;ECHS1;BCAT2;BCKDHB
prerank,carbohydrate homeostasis (GO:0033500),0.4282195272734288,1.4975698162862046,0.029259896729776247,0.7088777299648659,1.0,18/67,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;USF1;PYGL;HECTD4;IL6;BACE2;RBP4
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6157387858251764,-1.4972118208237086,0.0398406374501992,0.25885622940729097,1.0,4/10,15.99%,ABCA1;ZDHHC8;APOE;PRKACA
prerank,thyroid hormone generation (GO:0006590),0.6449709270323503,1.497055428018705,0.07961165048543689,0.7043237443393461,1.0,2/10,2.36%,SLC5A5;CPQ
prerank,rRNA processing (GO:0006364),-0.3440529236793343,-1.4968900116074222,0.0,0.2586171846884003,1.0,86/172,27.87%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;THUMPD1;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;RRP15;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;MRPL1;PWP2;RCL1;MRTO4;NOP58;EBNA1BP2;RPL3;NHP2;RPL15;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;RIOK1;MDN1;WDR55;WDR18;EXOSC3;TEX10;XRN2;ERI1;LYAR
prerank,negative regulation of ion transport (GO:0043271),0.5366285126081215,1.496466421821509,0.052941176470588235,0.7002545029934472,1.0,6/24,10.46%,SYT11;ACTN2;WNK3;ADRA2A;WNK4;VIP
prerank,determination of heart left/right asymmetry (GO:0061371),-0.44248699167092836,-1.496047205120222,0.0262582056892779,0.2593998406130824,1.0,12/42,16.62%,MEF2C;MICAL2;ENG;TBX3;NOTCH1;TGFBR2;SOX17;SOX18;SMO;TBX2;STIL;APLNR
prerank,regulation of lipid biosynthetic process (GO:0046890),0.4891062816443123,1.495897586690214,0.054249547920433995,0.696086818913575,1.0,11/32,18.41%,PRKAG2;PRKAA2;FITM2;PPARA;SORBS1;CREBL2;STAR;CREB1;AKT1;MID1IP1;MLXIPL
prerank,regulation of defense response (GO:0031347),-0.3902192178664588,-1.4958456623778909,0.017857142857142856,0.2589196920163717,1.0,37/76,27.07%,FOXP1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;WNT5A;AGTR1;ANXA1;PSMA6;XIAP;APOE;SPATA2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;CCR2;AREL1;CASP8;LRP8;AKNA;TREM2
prerank,nuclear migration (GO:0007097),0.6080952060279771,1.4954222131231272,0.06614785992217899,0.6917004973429017,1.0,5/13,11.14%,SYNE3;SYNE2;CLMN;PCM1;DOCK7
prerank,transepithelial transport (GO:0070633),-0.5689014027528925,-1.494970768942037,0.034482758620689655,0.25976151478881393,1.0,7/15,12.76%,ABCG2;SLC12A2;ABCC1;SLC1A3;CXADR;SLC1A1;SLC26A6
prerank,protein export from nucleus (GO:0006611),0.512176582527878,1.4946157441437775,0.0531496062992126,0.6890793360234775,1.0,1/27,0.01%,RANBP3L
prerank,regulation of GTPase activity (GO:0043087),-0.33899320089769136,-1.4941960209824259,0.002577319587628866,0.2604576345725349,1.0,37/177,11.07%,PRKG1;DOCK9;LIMS1;LRCH1;CHN2;FGD5;DOCK10;RAPGEF2;DAB2IP;ITGA6;FGD6;NET1;BCAR3;RAP1A;SH3BP4;CHN1;RASIP1;F11R;SNX18;SNX13;USP6NL;ARAP1;ITGB1;RACK1;RAPGEF6;RGS6;TGM2;EVI5L;CCL13;EFNA5;SOD1;MAP4K4;VAV2;DOCK8;CAV2;RGS10;PLXNC1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5367115972031996,-1.4930092222929323,0.04056795131845842,0.26172556903331234,1.0,5/17,9.34%,BTG1;BMP4;SFRP4;TMEM100;FGF2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5730420559242168,1.4928282742573726,0.073558648111332,0.6906100279778539,1.0,5/15,14.83%,DAB2;PIK3CB;TNK2;WASL;DGKD
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5344562564698156,-1.4903965566259954,0.04216867469879518,0.26547190017522443,1.0,8/18,12.40%,MEF2C;PLCG1;AKT3;FLT1;MDK;IGF2;FGF2;ITGA4
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3971142611309026,-1.4902649630105684,0.0136986301369863,0.2649544246773131,1.0,21/72,12.90%,ROR1;TEK;NTRK3;DCN;GAB1;TGFB2;INSR;PIK3R1;KDR;FN1;LYN;FLT1;MYOC;PIK3CA;SRC;PDGFC;FGF2;PIK3CD;UNC5B;PDGFD;ROR2
prerank,regulation of microglial cell activation (GO:1903978),0.5887491721152059,1.4887759560238858,0.062381852551984876,0.701800612276546,1.0,3/15,3.76%,SYT11;SPHK1;TAFA3
prerank,regulation of glycogen metabolic process (GO:0070873),0.6155883110094171,1.4876529131632126,0.07272727272727272,0.700309681406795,1.0,6/12,20.59%,GCGR;PPP1R3F;RUBCNL;AKT1;KHK;INPP5K
prerank,smooth muscle tissue development (GO:0048745),-0.6123137589931744,-1.4874918211299202,0.08498023715415019,0.2692284324679178,1.0,5/10,12.66%,ENG;BMP4;STRA6;PTCH1;SMO
prerank,purine ribonucleotide transport (GO:0015868),-0.5491595047207372,-1.4863503322466831,0.0640495867768595,0.27065000338764345,1.0,4/16,6.87%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.545706049411117,1.4861153455982183,0.05947955390334572,0.7003655196703024,1.0,4/20,6.84%,ATP1A2;ATP1B3;ATP1B2;LACC1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5079698130921886,1.48572728371077,0.06839186691312385,0.6956742874713213,1.0,10/26,12.52%,SLC8A3;PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;LRRK2;DLG4;MTMR2
prerank,endothelial tube morphogenesis (GO:0061154),-0.6224360717107532,-1.485374034715729,0.05970149253731343,0.27163008967067576,1.0,4/10,3.79%,RHOA;ACVRL1;BMP4;STARD13
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6491621361982033,1.4852664103820807,0.07021276595744681,0.6915066119088877,1.0,4/10,16.36%,IL18;PRKCZ;SPHK2;RARA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.41501777018294456,-1.4849301185520114,0.03837471783295711,0.2716365762941614,1.0,19/47,19.05%,DAB2IP;TGFB2;FOXO1;EGFR;MID1;FAS;RAP2A;PPIA;MAPK1;NBR1;MAP4K4;PER1;PHLPP1;TAOK3;KLHDC10;NOD2;TAOK1;GREM1;MAPK3
prerank,cellular response to interleukin-7 (GO:0098761),-0.547294634575268,-1.4847340957911324,0.05894308943089431,0.2703246411355846,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.547294634575268,-1.4847340957911324,0.05894308943089431,0.2703246411355846,1.0,12/17,34.14%,SOCS2;STAT3;BRWD1;JAK1;IRS1;CISH;SMARCA4;JAK3;SOCS1;IL2RG;TSLP;IL7R
prerank,skeletal system morphogenesis (GO:0048705),0.4592828382297447,1.4845789140092105,0.04595588235294118,0.6885217847117927,1.0,11/42,10.07%,WWOX;PDGFRA;RFLNA;CYP26B1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,macrophage activation (GO:0042116),-0.45912305418096655,-1.484112914220361,0.030864197530864196,0.27079610325451936,1.0,15/34,29.40%,FOXP1;CD93;APP;PLCG2;IFI35;DYSF;CRTC3;SYK;NMI;SBNO2;TLR4;AIF1;TREM2;MAPT;TMEM106A
prerank,regulation of acrosome reaction (GO:0060046),0.644793564622896,1.4840149035997767,0.06097560975609756,0.6847744989591373,1.0,3/10,10.18%,SERPINA10;GLRA1;PLCB1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5531938626107982,-1.4835154371357218,0.06458333333333334,0.2710882259960285,1.0,7/16,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,cytoskeleton organization (GO:0007010),-0.3615923088601311,-1.4821187679136263,0.0055248618784530384,0.2729450018458457,1.0,28/114,12.96%,FMNL2;ARHGAP10;FGD5;SEMA6A;PLCE1;RHOBTB1;MICAL2;MARK1;RHOA;FGD6;DST;LIMD1;ARAP3;PALLD;TNIK;SIPA1L3;MAST4;MDK;CCL13;CNN2;BRWD1;APOE;NEDD9;CFL1;RANBP9;NECTIN2;SIPA1;RND3
prerank,ERBB2 signaling pathway (GO:0038128),-0.4607451373878418,-1.4811088345781587,0.042643923240938165,0.27401193692306286,1.0,8/31,8.77%,GAB1;PTPN12;PIK3R1;EGFR;CPNE3;MYOC;PIK3CA;SRC
prerank,meiosis I (GO:0007127),0.5252860087597353,1.4803664782291954,0.062146892655367235,0.6943664968921995,1.0,4/23,6.97%,MEI1;DNMT3L;TDRD9;MEIOB
prerank,selective autophagy (GO:0061912),-0.40541128583916075,-1.479744522719003,0.023809523809523808,0.2758750593991718,1.0,29/56,30.21%,UBC;DYNC1I2;RPS27A;UBB;ARL13B;MAP1LC3B;RB1CC1;UFC1;NBR1;DYNC1I1;SQSTM1;PHB2;HDAC6;DYNLL1;AUP1;KLHL3;CFTR;ATG5;ACBD5;DYNC1H1;ULK2;ULK1;UBQLN1;TEX264;WDFY3;ATG14;STBD1;PARK7;USP30
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5407029110160974,1.4796164524408366,0.052830188679245285,0.6917612392372088,1.0,7/21,10.07%,BMP6;DAB2;OVOL2;BMPR1A;WWTR1;VEPH1;TGFBR1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6473802167960125,1.4792057630513442,0.09803921568627451,0.6875544336153839,1.0,3/10,4.13%,ATP1A2;OSR1;STK39
prerank,glycogen metabolic process (GO:0005977),0.5119807876346307,1.478102377853266,0.058823529411764705,0.6865971484896964,1.0,8/27,15.02%,PRKAG2;PHKG2;PGM1;PHKB;GYG1;PYGL;PYGM;PER2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3797242494984286,-1.4772595744164598,0.011547344110854504,0.27969118383497227,1.0,24/78,14.30%,SPTBN1;PRKCH;ACTB;PID1;PIK3R1;EGFR;BCL2L1;NKD2;ITGB1;STX3;NUMB;TMEM59;ZDHHC8;AR;CDK5;ABI3;STAC;EPHB2;SQSTM1;STX7;ZDHHC7;LRP1;TMBIM1;STX8
prerank,macrophage activation involved in immune response (GO:0002281),-0.5872664166109842,-1.4770172574697502,0.060665362035225046,0.2793189802047039,1.0,9/13,33.08%,PLCG2;IFI35;DYSF;SYK;NMI;SBNO2;TREM2;GRN;TYROBP
prerank,axon guidance (GO:0007411),-0.32836418956579916,-1.4766623877494631,0.0,0.27928517117775964,1.0,47/201,12.66%,PTPRM;NRP1;SPTBN1;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;NTN1;SEMA7A;NOTCH3;TMEFF1;RPS6KA5;NOTCH1;PIK3R1;CHN1;PLCG1;PALLD;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;SRC;SEMA5B;EPHB2;PIK3CD;SEMA3E;DSCAML1;PLXNC1;UNC5B;VLDLR;RANBP9;RET;SEMA3G;SMO
prerank,regulation of multicellular organismal development (GO:2000026),-0.4881793055046072,-1.4766180954318888,0.034482758620689655,0.2785557158769043,1.0,9/25,17.73%,PTN;INSR;RAB14;SOX17;NIPBL;SPAAR;CD24;TDG;DUSP6
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5662569560715244,1.475866167601661,0.06883365200764818,0.6901199568922864,1.0,4/17,6.99%,PRKAG2;PRKAA2;PPARA;PANK2
prerank,ribosome biogenesis (GO:0042254),-0.33766183845757264,-1.4758441201209531,0.002898550724637681,0.2791642043445782,1.0,87/187,26.25%,RPLP1;RPS15;RPL38;RPL18A;RPL41;RPL32;RPL5;RPL10;RPS24;RPL7;RPL37A;RPS17;RPS16;RPL39;HELQ;EXOSC1;FCF1;RPL13;RPLP0;RPL30;RPL35A;RPF1;RPS7;RPL22;RPS28;RPL29;BMS1;RPL7A;SURF6;RPL6;RPL18;RPS25;PELP1;RPL36;DDX54;RPL28;RPL27;RPL24;RPL23;RPL17;RPS9;RPS27;ABCE1;RRP7A;DCAF13;RPL21;RPL34;RPL10A;RPL12;RPL35;RPL14;DDX27;ESF1;RPL19;DDX49;RPL37;RRP12;GTF3A;PWP2;URB2;RCL1;MRPL36;LTV1;MRTO4;NOP58;EBNA1BP2;RPL3;SDAD1;RRS1;RPL15;NOP16;EXOSC4;DKC1;EXOSC5;IMP4;RPS19;RPL8;NOP56;RPL13A;UTP14A;RPL23A;WDR46;CUL4A;RIOK1;MDN1;WDR55;WDR18
prerank,regulation of axon guidance (GO:1902667),-0.6256885391654741,-1.4754692253622934,0.06437768240343347,0.2790594251529075,1.0,1/10,0.06%,NRP1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6085445160996767,1.4750686471869952,0.07326732673267326,0.6873114129182166,1.0,5/13,13.27%,IGF1;SOAT1;GOLGA2;PLCB1;ABCA2
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6384493991436286,1.47475158664905,0.07630522088353414,0.6829567093066253,1.0,5/11,17.36%,DAB2;RAB21;MTMR2;EIPR1;PTPN23
prerank,protein localization to vacuole (GO:0072665),-0.5764003206274148,-1.4746801850763382,0.06786427145708583,0.27973453405886256,1.0,6/13,17.84%,SH3BP4;LMBRD1;KPTN;MFSD1;RTN4;RNF128
prerank,positive regulation of telomerase activity (GO:0051973),-0.45060314300711635,-1.4732364987956996,0.035789473684210524,0.28153582189657916,1.0,14/33,22.79%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.36996033138948536,-1.4724136889437698,0.012106537530266344,0.28231034438528807,1.0,26/93,17.70%,PDE4D;NTRK3;CAV1;BCAR3;GAS6;RASSF2;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;RACK1;NCK1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;PAQR3;MAD2L2;DDIT4;TNKS1BP1;PTEN;LATS1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.40541737788057863,1.4719883532692346,0.023529411764705882,0.6883084487939871,1.0,14/75,11.47%,ATP1A2;SLC6A1;SLC8A3;ATP1B3;TRPV1;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1;TRPM2
prerank,lipid transport (GO:0006869),-0.3675535414579655,-1.469914968209321,0.01179245283018868,0.2864620839782883,1.0,22/97,8.27%,ABCC4;ATP8B1;PITPNC1;SLCO3A1;SLCO1C1;ATP8A1;SCARB1;PPARD;SLCO2A1;CERT1;SLCO2B1;ABCA1;PLTP;PLEKHA8;TNFAIP8L3;NPC2;SPNS2;OSBP;MTTP;ABCA3;CEACAM1;ABCD2
prerank,neutrophil migration (GO:1990266),-0.408210668358698,-1.4679243344061734,0.017582417582417582,0.2894488590079304,1.0,29/58,40.70%,PECAM1;BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;PRTN3;S100A9;IRAK4;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3653620803601031,-1.4678780170559873,0.013054830287206266,0.288753136836063,1.0,33/98,20.03%,PID1;ECE1;SLCO1C1;PPARD;INSR;THBS1;NFKBIA;SFRP4;TGFBR2;TBC1D5;VAMP3;XDH;AGTR1;ACACB;APOE;KLF4;FASN;GHITM;STARD4;ACE2;AGPAT1;VEGFA;ROMO1;MT3;RAB1B;FMR1;IFNAR1;DHRS4;GREM1;ZC3H12A;CBR1;RIPK1;ARRB2
prerank,pulmonary valve development (GO:0003177),-0.5112376425374213,-1.4666457146100773,0.0653061224489796,0.29032143563653773,1.0,12/18,8.50%,BMPR2;JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;TNFRSF1B;HEYL;STRA6;HEY2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6063365498214883,1.4659253338725216,0.08782435129740519,0.708074204469054,1.0,2/12,3.69%,IL18;IL17D
prerank,ethanol metabolic process (GO:0006067),0.6121448602282086,1.464950282015105,0.0821917808219178,0.7065205729092263,1.0,5/12,10.60%,ADH7;ADH4;ALDH1A1;ACSS2;ALDH2
prerank,purine nucleotide catabolic process (GO:0006195),-0.5809557376132313,-1.463986558549084,0.062,0.2948254201071062,1.0,7/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;HINT1;GDA
prerank,positive regulation of T cell activation (GO:0050870),-0.3887944679430036,-1.4639542280426185,0.02386634844868735,0.2940576665628961,1.0,17/62,20.27%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;MDK;ZBTB1;IL15;DOCK8;PTPRC;CD86;NCKAP1L;CD46;NOD2;JAK3;ZMIZ1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4740024762903907,-1.4636528476702182,0.05019305019305019,0.2938030918138193,1.0,8/27,12.38%,PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;SRC;NSMF;BMP2
prerank,negative regulation of cell motility (GO:2000146),-0.35832798239620656,-1.4635155415700563,0.019464720194647202,0.29328224709487555,1.0,21/108,5.90%,TMEFF2;FRMD5;CLDN5;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;RAP2A;RECK
prerank,striated muscle contraction (GO:0006941),0.4363423826953698,1.4620926285305587,0.026119402985074626,0.7130776672985547,1.0,8/53,11.04%,ATP1A2;DTNA;CSRP3;TNNI1;ARHGEF11;KCNH2;MYH14;RYR2
prerank,positive regulation of developmental process (GO:0051094),-0.33446932997650614,-1.4620104814359915,0.0,0.29547177026204424,1.0,41/164,16.70%,SLC6A6;SHANK3;BMP5;DCN;BMPR2;DAB2IP;ZBTB16;PTN;ACVR1;INSR;PHLDB1;CORO1C;BMP4;KDR;RPS6KA3;MFF;PHLDB2;TFRC;WNT5A;AR;MDK;SHLD1;TMEM119;SRC;VHL;AGO2;APOE;B4GALT5;CFL1;FBXO5;EDN3;VLDLR;FZD4;BMP2;VEGFA;ALK;MAD2L2;FMR1;PA2G4;RTN4;RREB1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.537440451476837,-1.4611453466955209,0.04081632653061224,0.2965084136714299,1.0,7/17,21.23%,PODXL;TGFB2;PIEZO1;RET;NCKAP1L;RAC3;SYK
prerank,ceramide metabolic process (GO:0006672),-0.41146400824883617,-1.4604779051474135,0.024719101123595506,0.29704980854698027,1.0,11/49,9.26%,SGMS1;ST6GALNAC3;SGMS2;ACER2;DEGS2;AGK;CERS5;CERS6;ORMDL3;PLPP1;SAMD8
prerank,response to zinc ion (GO:0010043),-0.4839367349653791,-1.4598842400619554,0.05664488017429194,0.297354443278403,1.0,13/25,14.92%,CRIP1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC30A5;D2HGDH;MT3;GLRA2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.48212344399138957,-1.4586344511855118,0.053811659192825115,0.2989673139288412,1.0,13/25,20.99%,CD200;ITGA5;VCAM1;ITGB1;CXADR;CTNNA3;PARVA;JAM3;ITGA7;ITGA4;DSG2;DSP;JUP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6248498507113948,1.4585772241654966,0.07894736842105263,0.7225250932807629,1.0,4/10,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5431777970975021,-1.457467040499184,0.07302231237322515,0.30045517148206324,1.0,5/15,13.60%,PRKCH;BMP4;SFRP4;TRIM16;NME2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5761881722541204,-1.4574275518369566,0.09071729957805907,0.2997113404805567,1.0,5/12,16.62%,NIPBL;PRKD1;SAP30BP;VEGFA;APLNR
prerank,cation transport (GO:0006812),0.3632701349630481,1.457066223772999,0.011532125205930808,0.7237091783230102,1.0,14/167,3.16%,TRPM3;ATP1A2;SLC8A3;SLC5A5;SLC41A1;TRPM6;KCND3;KCNA3;KCNJ13;NDFIP1;SLC6A9;SLC5A10;SLC23A1;KCNJ5
prerank,long-chain fatty acid transport (GO:0015909),0.49700170533761673,1.4564713120793342,0.06321839080459771,0.7207972301474035,1.0,3/30,1.77%,PRKAG2;ACSL1;PRKAA2
prerank,regulation of stress fiber assembly (GO:0051492),-0.38550517247948257,-1.4563947532715258,0.022675736961451247,0.30100209986881676,1.0,17/74,7.50%,NRP1;TMEFF2;TJP1;RHOA;WASF2;ACTG1;PIK3R1;LIMCH1;STMN1;F11R;PHLDB2;ARAP1;PAK2;ARHGEF15;MET;PXN;MYOC
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.5671528336835903,-1.4563122968254107,0.058823529411764705,0.30039648428522825,1.0,5/14,7.96%,LIMS1;LIMS2;FLNA;PRKD1;EMP2
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.4201648509967334,-1.4557189702835913,0.04054054054054054,0.30078535543009316,1.0,20/49,24.31%,MEF2C;THBS1;KMT2E;RUNX1;H3-3A;AGO1;CBFB;DPY30;MYL9;PITHD1;KMT2C;MTURN;PRMT6;AGO4;L3MBTL1;ZFPM1;TESC;KMT2B;PRMT1;ASH2L
prerank,cellular response to hydroxyurea (GO:0072711),-0.6102486055434607,-1.4551489270029832,0.09202453987730061,0.30111816266311464,1.0,6/10,21.67%,DDI2;BLM;TIMELESS;FMR1;SPIDR;NSMCE3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5408343494318182,-1.4549993817404372,0.06438631790744467,0.3006113032535287,1.0,3/17,0.51%,NRP1;TEK;NTRK3
prerank,UV protection (GO:0009650),-0.6178364392004442,-1.454871043700632,0.055445544554455446,0.30002995012786793,1.0,6/10,20.32%,MFAP4;CAT;GPX1;ERCC2;SCARA3;XPA
prerank,potassium ion import across plasma membrane (GO:1990573),0.45159160694848627,1.4544610585810684,0.04659498207885305,0.7236069177600164,1.0,10/41,11.41%,ATP1A2;ATP1B3;KCNJ13;KCNJ5;ATP1B2;KCNJ10;KCNH2;KCNJ16;SLC12A5;SLC12A1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3675009314506498,-1.4542289574675569,0.023195876288659795,0.30051608281375364,1.0,22/87,6.74%,GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5040721131204359,-1.453610559670212,0.06726457399103139,0.30081603575647925,1.0,8/20,15.85%,NOTCH1;RUNX2;SMAD5;SMAD1;BMP2;VEGFA;MT3;ATF4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3804600592020399,-1.4526408780551925,0.020737327188940093,0.30199006748884477,1.0,24/71,18.30%,FAP;UBC;CAPN2;RPS27A;UBB;ZYG11B;PSMA6;CHMP4B;OTUD7B;DDI2;CTSO;MALT1;CTSB;ISG15;FBXO44;HDAC6;RNF123;HM13;RHBDD1;CTSF;ADAMTS12;CTSS;RSPRY1;ATE1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3816624131452463,-1.4521673136559865,0.017777777777777778,0.3021251668189923,1.0,26/76,25.56%,NRP1;TEK;NTRK3;WDR1;CDC42EP5;CDC42EP3;NCK1;SYNPO2;CDK5;EDN1;CDC42EP2;PTK2B;PFN1;LIMK1;NCKAP1L;SEMA5A;DYNC1H1;FCHSD1;HCK;CDC42;GPSM2;HCLS1;NUP62;FES;PRKCE;CARMIL1
prerank,positive regulation of phosphorylation (GO:0042327),-0.31856840578683887,-1.451851390019605,0.0,0.30187204895998127,1.0,63/240,16.03%,NRP1;ROR1;TEK;NTRK3;PECAM1;SLCO3A1;PDE8A;ITGA6;NIBAN1;TIE1;ENG;INSR;MERTK;VEGFC;THBS1;GAS6;LIMCH1;EGFR;LIMK2;BMP4;KDR;APP;CARD14;TBX1;RALB;FAS;TNIK;RAP2A;TFRC;AXIN2;RACK1;MET;NPTN;PPIA;LYN;IL34;AR;FLT1;CCN1;RB1CC1;PTGES3;EFNA5;TMEM119;FLT4;IGF2;FGF2;FGF7;EPHB2;CD74;KRAS;RET;BMP2;ROR2;CD40;AKT2;VEGFA;RARRES2;MT3;ALK;PLAUR;FMR1;CSF1R;NCKAP1L
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4811794893830201,1.4511105480414022,0.06476190476190476,0.7325299949282482,1.0,9/31,11.28%,SYT11;SYT12;SYT9;RAB3GAP1;ADRA2A;SYT1;SYT13;SYT10;SCAMP5
prerank,arachidonic acid metabolic process (GO:0019369),0.47293484197972546,1.4509667519758027,0.05410122164048865,0.7276739492894428,1.0,6/35,7.75%,PTGDS;PTGS1;DAGLA;PLA2G4C;PNPLA8;PTGES
prerank,regulation of ATP metabolic process (GO:1903578),0.4333399766056578,1.4508366462124003,0.03910614525139665,0.7228153028509653,1.0,17/54,21.55%,PRKAG2;GCK;POM121;NUP155;COX7A1;COX7A2L;ABCD1;NUP98;BEND3;SPHK2;NUP37;ATP7A;NUP88;NDC1;EIF6;ATP5IF1;JMJD8
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5703412357132037,-1.4496575632602282,0.08203125,0.305366271096114,1.0,8/13,23.63%,PLCG1;AKT3;MDK;IGF2;FGF2;ITGA4;HMGB1;SIRT6
prerank,muscle tissue development (GO:0060537),-0.5706880961883148,-1.4492857016249616,0.07083333333333333,0.3053564127539555,1.0,7/13,12.66%,PGM5;ENG;BMP4;STRA6;CSRP2;PTCH1;SMO
prerank,intracellular cholesterol transport (GO:0032367),-0.5467910806057351,-1.4489178554301971,0.06557377049180328,0.30532031648553254,1.0,6/15,16.63%,LRP6;ABCA1;NPC2;OSBP;STARD4;LDLRAP1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.4162604451462526,-1.4482353887833623,0.040948275862068964,0.30585471421861915,1.0,12/45,9.62%,PLCE1;GAB1;RPS6KA5;PIK3R1;IQGAP1;EGFR;PLCG1;PIK3C2A;GAREM1;PIK3CA;SRC;BCAR1
prerank,sympathetic nervous system development (GO:0048485),-0.5567261645141574,-1.4466505902323525,0.04722792607802875,0.308357629794741,1.0,2/15,0.78%,NRP1;NRP2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4262016869139981,-1.4450292139580094,0.03982300884955752,0.31074978986042573,1.0,11/39,11.21%,RAPGEF2;DAB2IP;TJP1;HJURP;TIE1;NOTCH1;RAP1A;ANKRA2;APOE;BAG5;GFAP
prerank,negative regulation of blood pressure (GO:0045776),-0.5752268593137511,-1.4442589731668398,0.05578512396694215,0.31149372183748675,1.0,3/13,6.88%,BMPR2;NOS3;PRCP
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4956430674903735,1.4440614727907637,0.07303370786516854,0.7462842999948455,1.0,12/26,24.96%,CTR9;EEF2KMT;KMT2A;ANTKMT;SETD4;KMT5C;BEND3;TET2;SETD1B;VCPKMT;SETD2;SETD5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.4839216310018259,-1.443247429182503,0.05194805194805195,0.3127723197624151,1.0,11/24,21.46%,PKD1;UBB;APOE;GPX1;TMF1;PTK2B;PRKACA;LATS1;PSMD14;UCHL5;PSME1
prerank,thymus development (GO:0048538),-0.5615570715206911,-1.4428571384703242,0.0736196319018405,0.3127080568669752,1.0,5/13,8.86%,SIX1;TBX1;HES1;ZBTB1;SOD1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4531769421671717,1.4427660432414349,0.04933586337760911,0.7462653742000712,1.0,5/41,6.84%,PRKAG2;GCK;POM121;NUP155;LACC1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.6061811169235394,-1.4425617653054554,0.06680584551148225,0.3125505301849628,1.0,7/10,32.80%,LRP6;WNT5A;FZD1;RYK;WNT2;WNT3;CTNNB1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5480638733382,-1.4422616355876667,0.06570841889117043,0.3124388745335914,1.0,5/15,9.83%,PTPN12;CDH13;EGFR;CEACAM1;MVB12B
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.294346214576781,-1.4418606410494204,0.0,0.31251401950304497,1.0,111/509,13.82%,HIP1;ROR1;KITLG;VWF;TEK;LIMS1;ACTN4;NTRK3;CAV1;GCNT2;DCN;RAPGEF2;DAB2IP;GAB1;RHOA;ADRA1B;TRAF5;BCAR3;TNFSF10;TGFB2;ENG;INSR;THBS1;GAS6;RPS15;PIK3R1;CDH13;F3;IQGAP1;EGFR;BCL2L1;JCAD;PTPRJ;RPS20;ALPK1;KDR;APP;MIER1;FN1;NOS1AP;MFHAS1;REL;NOD1;ESR1;MID2;TBX1;PLCG2;FLNA;DHX33;BRD4;CARD16;ITGB1;TFRC;TNFAIP8L3;PRKD1;WNT5A;S100A13;RACK1;MET;SLC44A2;NR3C2;LYN;TRIM14;PLK2;IAPP;TRIM25;FLT1;PUM2;MYOC;TGM2;SPRY2;RPS3;BCAP31;NFAT5;IFI35;SCHIP1;PIK3CA;SRC;PDGFC;FLT4;IGF2;FGF2;RPTOR;FGF7;GOLPH3;CAV2;MALT1;PIK3CD;TERF2IP;RPL23;PTP4A3;EDA2R;UNC5B;PDCD4;CD74;PHB2;RET;BMP2;BIRC3;TNFRSF19;PDGFD;ECM1;RRAGA;ROR2;TCIM;CD40;AKT2;PTPRC;IRS1;CD86;VEGFA
prerank,negative regulation of ATPase activity (GO:0032780),0.5576320029815993,1.4403584675483478,0.08366533864541832,0.7511668713735196,1.0,9/16,22.87%,PPIF;IFIT1;PAM16;TSC1;SIRT1;OXA1L;ATP5IF1;VCPKMT;TNNI3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.37916009256742883,-1.4400386959005462,0.027227722772277228,0.31541040923339014,1.0,23/74,15.55%,LEF1;GCNT2;BMP5;DAB2IP;TGFB2;PHLDB1;SDHAF2;TGFBR2;IL17RD;PHLDB2;SPRED2;AXIN2;MDK;SPRY2;VASN;TIAM1;TGFB3;TWIST1;COL1A1;BMP2;SPRY1;FERMT2;MAD2L2
prerank,plasma membrane invagination (GO:0099024),-0.46703805714916163,-1.4398826374409535,0.060267857142857144,0.31492497714553525,1.0,17/29,30.48%,DOCK1;RHOA;GSN;MYH9;SNX18;GULP1;CDC42;FCGR1A;ALKBH4;FCGR2B;ARHGAP12;AIF1;BIN2;MSR1;CD36;SPIRE2;ARHGAP25
prerank,hexose biosynthetic process (GO:0019319),0.4510082254850317,1.4397352868698339,0.056363636363636366,0.7483986083439835,1.0,19/42,21.46%,CHST15;SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,metanephric mesenchyme development (GO:0072075),0.6206284346590033,1.4395182889095415,0.10934393638170974,0.743938662262921,1.0,2/10,1.12%,WNT4;OSR1
prerank,lymphocyte chemotaxis (GO:0048247),-0.45088485147512536,-1.4393945898464147,0.039045553145336226,0.31513029766920003,1.0,19/34,42.06%,CYP7B1;SLC12A2;GAS6;CCL13;PIK3CD;CCL25;HSD3B7;PIK3CG;CXCL16;CCL5;GPR183;CCL11;CCL4;CH25H;CCL7;CCL8;CCL19;CCL14;MSMP
prerank,regulation of inclusion body assembly (GO:0090083),0.6177332381338793,1.4390877651950587,0.09330628803245436,0.7404876837259617,1.0,3/11,2.94%,HSPA1A;SNCAIP;DNAJB8
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5835678021339483,-1.4390761290744924,0.08092485549132948,0.3150326214159395,1.0,3/12,6.90%,PRKG1;MEF2C;ADAMTS1
prerank,histone H2A acetylation (GO:0043968),0.5460741269082604,1.4387872573393008,0.08431372549019608,0.7364434893817029,1.0,7/16,13.06%,BRD8;RUVBL2;MEAF6;DMAP1;EP400;SPHK2;YEATS4
prerank,regulation of Notch signaling pathway (GO:0008593),-0.36764693817908156,-1.4384446095683592,0.02534562211981567,0.3155219906050393,1.0,32/76,23.11%,MAML2;IL6ST;JAG1;NOS3;NOTCH3;TGFB2;NOTCH1;EGFR;STAT3;CCN3;JAG2;EPN2;SRC;GATA2;NOTCH4;MFNG;SREBF2;TCIM;FBXW7;LFNG;CD46;HEY1;NOD2;PRAG1;YJEFN3;METTL3;ZMIZ1;DLL4;MAML3;SNW1;DLL1;EGF
prerank,regulation of cell killing (GO:0031341),-0.5410336094603765,-1.4367870417098556,0.0653061224489796,0.3182480411834973,1.0,6/16,8.48%,TGFB2;CR1L;ICAM1;WNT5A;CD55;CFH
prerank,prostaglandin metabolic process (GO:0006693),0.4958648596622774,1.4329040621140205,0.060263653483992465,0.7560272675610852,1.0,5/26,7.80%,PTGDS;PTGS1;PNPLA8;PTGES;PTGR1
prerank,regulation of transport (GO:0051049),-0.4363244487806308,-1.4317894890467733,0.04793028322440087,0.3281500515599688,1.0,15/36,24.52%,NRP1;ACTB;ACTG1;ICA1;DNAJA1;CDK5;GAPVD1;REEP5;EPB41;RAB11A;CLDN10;DISP3;POFUT2;MUL1;FES
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5095778145104104,1.4314508762373677,0.07738095238095238,0.7572020927636278,1.0,7/22,16.04%,AEBP1;MAP2;PRUNE1;ARL2;EFEMP2;ABL1;GBA2
prerank,regulation of neuron projection development (GO:0010975),-0.3287336675315695,-1.4310112818565626,0.0,0.32891458554175096,1.0,41/163,14.83%,ROR1;NTRK3;SHANK3;PDLIM5;RAPGEF2;DAB2IP;PTN;ITGA6;MARK1;NDNF;MBOAT1;DISC1;RAP1A;CHN1;KANK1;SCARF1;SCARB2;PAK2;PRKD1;WNT5A;NPTN;LYN;ARHGAP35;MDK;NCS1;RETREG3;CDK5;ABI3;APOE;CFL1;BAG5;MFSD2A;RET;PTK2B;ROR2;TRPV4;FZD1;AVIL;CDH2;MT3;PAQR3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5973285517595631,-1.4306071583111872,0.06640625,0.32898159299820773,1.0,3/10,6.28%,SHANK3;APP;NPTN
prerank,blood vessel diameter maintenance (GO:0097746),-0.43879180891454794,-1.4295314152409162,0.05230125523012552,0.3303226778712983,1.0,11/34,13.94%,EDNRA;ECE1;NOS3;AGTR1;KCNMB2;GCLC;EDN1;EDN3;ACE2;GCLM;KLF2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5320537953178275,1.4294097859717425,0.098,0.7608381307987896,1.0,4/18,10.64%,MCM3AP;PABPN1;PCID2;DDX19B
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6049451824120553,-1.4293364892734528,0.08641975308641975,0.32985800047613223,1.0,6/10,34.79%,KDR;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,regulation of hydrolase activity (GO:0051336),-0.3796604136759797,-1.4291000765312254,0.030878859857482184,0.32955452182701095,1.0,20/71,17.63%,PRKG1;CAV1;CHN2;FGD5;DAB2IP;FGD6;CHN1;RASIP1;SCARB2;RAPGEF6;EFNA5;SOD1;VAV2;PLXNC1;ARHGAP27;RAP1GAP;PAFAH1B1;RAB3GAP2;PLXNA4;TDG
prerank,activation of GTPase activity (GO:0090630),-0.3569930390819414,-1.4285261180975501,0.0171990171990172,0.32993631822091735,1.0,27/89,15.77%,TBC1D4;NTRK3;RABGAP1L;ARHGAP42;SIPA1L2;TBC1D8;CORO1C;BCR;TBC1D12;TIAM2;USP6NL;TBC1D5;TBC1D2B;SIPA1L3;ARHGEF15;TBC1D1;EVI5L;ABR;TIAM1;TBC1D13;SIPA1;RALGAPA1;TAX1BP3;TBC1D7;TBC1D10A;RAP1GAP;TBC1D25
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5304305833802944,1.4284900838408354,0.08082706766917293,0.7596045362745177,1.0,7/18,9.52%,PRKCZ;NLGN2;WNT7A;NLGN3;SHANK1;RIMS1;DLG4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4488396757414511,-1.4283751025188935,0.07127429805615551,0.3294047047957084,1.0,10/33,11.66%,ETS1;TGFB2;FOXO3;STAT3;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.37403021030245825,-1.4280658604160394,0.03309692671394799,0.3292004471467366,1.0,19/73,17.70%,NTRK3;CAV1;BCAR3;GAS6;EGFR;NGF;CD44;APP;FNIP2;TFRC;PRKD1;SPRY2;RPTOR;TERF2IP;HDAC6;VEGFA;MAD2L2;TNKS1BP1;LATS1
prerank,response to interleukin-6 (GO:0070741),-0.6014906304638155,-1.4266227794535407,0.08617234468937876,0.3313913760776519,1.0,3/10,2.73%,PID1;ST3GAL6;PTGIS
prerank,T cell migration (GO:0072678),-0.5647401750929497,-1.4261002027295167,0.09591836734693877,0.33162031238131645,1.0,9/13,35.90%,SLC12A2;S1PR1;PIK3CD;MSN;PIK3CG;CXCL16;MYO1G;GPR183;ZAP70
prerank,positive regulation of protein binding (GO:0032092),-0.3958484222575199,-1.4235245671356416,0.04279279279279279,0.33638293807835584,1.0,22/56,21.74%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;BMP4;APP;RALB;SPPL3;TIAM1;APOE;NMD3;BMP2;HIP1R;LRP1;VTN;EPB41;MARK3;PPP2CA;RIPK2;DTX3L
prerank,regulation of T cell differentiation (GO:0045580),-0.4421477291944175,-1.4230023697083098,0.06208425720620843,0.33661396173790176,1.0,23/33,44.28%,RUNX1;CBFB;MDK;ZBTB1;SOD1;NFATC2;PRDM1;METTL3;ZMIZ1;CCR2;TCF7;IL2RA;ZAP70;CLPTM1;PRELID1;FANCA;GATA3;CRTAM;IL4;CTLA4;XBP1;TNFRSF18;FOXP3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5871310827082248,-1.4225452467542359,0.08560311284046693,0.33672470558117135,1.0,3/11,6.52%,MERTK;GAS6;CXCL12
prerank,negative regulation of cell migration (GO:0030336),-0.33592151030199946,-1.4224000341344414,0.008310249307479225,0.33615215537119825,1.0,25/137,6.09%,PTPRG;TMEFF2;CLDN5;DAB2IP;JAG1;VCL;SLIT2;SRGAP1;CLIC4;ACVRL1;ENG;LIMCH1;CYP1B1;FOXO3;CORO1C;CDH1;PTPRJ;KANK1;ADARB1;PTPRK;DACH1;PHLDB2;RAP2A;RECK;ARHGDIB
prerank,regulated exocytosis (GO:0045055),-0.32695437894019624,-1.4217623283764287,0.00847457627118644,0.3367499881929673,1.0,45/173,14.34%,ABCC4;VWF;ACTN4;PECAM1;SPARC;PCDH7;VCL;TMSB4X;TGFB2;VEGFC;CD9;THBS1;GAS6;LHFPL2;MYH9;TAGLN2;APP;WDR1;FN1;STX1A;RAB31;CD109;TMED10;ACTN1;RAB11FIP5;FLNA;LYN;RAB11FIP1;ALDOA;CHID1;CDK5;SYT4;SOD1;IGF2;SERPINE1;TGFB3;ISLR;PSAP;STEAP2;RAB3A;ECM1;VEGFA;TMX3;RARRES2;RAB11B
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4898222851484073,-1.4216958081114035,0.08620689655172414,0.336076995017216,1.0,5/22,6.07%,GHR;NOTCH1;CYP1B1;MGAT5;HES1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.45918088430221793,1.4215053535253424,0.07184466019417475,0.7844563456251129,1.0,9/31,10.07%,PDGFRA;OSR1;HOXB9;HOXB3;FGFR2;HOXA3;HOXB4;MEGF8;TGFBR1
prerank,limb development (GO:0060173),0.4771589008016553,1.4213096044055782,0.08214285714285714,0.7799622395321057,1.0,7/28,10.31%,SMOC1;RSPO2;INTU;LRP4;IQCE;MEGF8;IFT122
prerank,cellular response to glucose starvation (GO:0042149),0.44125294775148743,1.4210402856483892,0.05555555555555555,0.775853062680942,1.0,7/41,8.35%,PRKAG2;PRKAA2;PRKAG3;NIM1K;CPEB4;IMPACT;SESN1
prerank,protein homotrimerization (GO:0070207),-0.5422882193827208,-1.4207859203225488,0.06134969325153374,0.3362833082295388,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,protein trimerization (GO:0070206),-0.5422882193827208,-1.4207859203225488,0.06134969325153374,0.3362833082295388,1.0,3/14,2.82%,SCARA5;DISP1;SLC1A5
prerank,lipid droplet formation (GO:0140042),0.6134543698346598,1.4205900808712,0.09898989898989899,0.7724846383291983,1.0,4/10,14.04%,FITM2;PLA2G4C;CDS1;SQLE
prerank,prostanoid biosynthetic process (GO:0046457),0.5666722162693737,1.4197151927731673,0.07321772639691715,0.77120420167637,1.0,4/15,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,regulation of cellular biosynthetic process (GO:0031326),0.482555221213331,1.419201655296704,0.08052434456928839,0.7683519391644132,1.0,3/28,2.62%,PRKAG2;PRKAA2;FITM2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5279375874861083,-1.4189038063419739,0.08,0.33944105411871606,1.0,4/16,11.60%,BMPR2;PRCP;DDAH1;ADM
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3407733678282032,-1.4188602612159764,0.00997506234413965,0.3387410227081104,1.0,38/113,22.14%,DAB2IP;RPA1;PIEZO1;ABCA1;ICE1;RASIP1;UNC13B;ESR1;FNIP2;DHX33;TFRC;GBP5;RACK1;RPS3;CHD1L;SRC;TPPP3;GTF2H5;TAL1;CAPG;CDC42EP2;GTF2H1;ISG15;ERCC2;VEGFA;PSMC4;FERMT2;BAK1;USP50;SLF2;RPA2;XPA;SPIDR;MYD88;AJUBA;SYK;FAF1;BIK
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3196764425139405,-1.4188023078045013,0.005479452054794521,0.33808328243389957,1.0,61/214,18.33%,NRP1;ROR1;TEK;NTRK3;GCNT2;SEMA6A;RAPGEF2;PDE8A;DAB2IP;SEMA7A;BMPER;NOTCH1;GAS6;RAP1A;EGFR;CD44;KDR;APP;FN1;MFHAS1;SPRED2;ICAM1;TNFAIP8L3;LYN;CCN1;GAREM1;SPRY2;CEACAM1;CCL13;PDGFC;PTPN1;FLT4;FGF2;APOE;DUSP3;YWHAZ;EPHB2;ACKR3;CD74;PHB2;RANBP9;BMP2;PTK2B;PDGFD;ROR2;HTR2A;PTPRC;FBXW7;SPRY1;P2RY6;MTURN;MT3;FERMT2;CSF1R;FGFR3;PTEN;GPER1;DUSP6;NOD2;PTPN6;CCL25
prerank,alpha-amino acid catabolic process (GO:1901606),0.47448895455665263,1.4185497646846044,0.08812949640287769,0.7660870771869449,1.0,6/29,9.06%,DDO;IDO1;ACAT1;HAAO;ACADSB;KMO
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.5607961346653069,-1.41813439783972,0.10721649484536082,0.3386456907245342,1.0,5/12,17.95%,KAT7;TIPIN;BLM;WRNIP1;NBN
prerank,positive regulation of immune system process (GO:0002684),-0.5280949303575164,-1.417897299715642,0.076171875,0.33843876267128503,1.0,7/16,16.03%,TGFB2;ANXA1;IL15;PIK3CD;RSAD2;VEGFA;NCKAP1L
prerank,T-helper cell differentiation (GO:0042093),-0.5404612931145623,-1.4178771327054285,0.07337526205450734,0.33768222405802073,1.0,2/14,0.18%,LEF1;FOXP1
prerank,hepaticobiliary system development (GO:0061008),0.5178378558381582,1.4167887406176654,0.0900562851782364,0.7686823247698508,1.0,4/20,8.14%,TGFBR3;WNT4;CEBPA;PHF2
prerank,response to molecule of bacterial origin (GO:0002237),-0.3823734899838616,-1.4167858324355413,0.037694013303769404,0.3392778363830998,1.0,30/69,33.31%,FOXP1;NOS3;IRAK3;RPS6KA3;TNFRSF11A;GCH1;C4B;SRR;MAPKAPK2;LIAS;CD24;IFNAR1;ERBIN;IRF5;GGT7;FCGR2B;GGT1;SMAD6;TLR4;F2R;PELI1;SELP;TRIB1;LGALS9;NOCT;MAPKAPK3;NOS2;NOS1;CD14;S100A9
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3460136177327519,-1.415325985884791,0.022556390977443608,0.34156503003742905,1.0,21/104,5.76%,CAV1;BMPR2;HTRA3;ACVR1;BMPER;NOTCH1;CRIM1;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;CCN3;ASPN;SPRED2;SMAD5;SMAD1;RPS27A;UBB;UBE2D3
prerank,embryonic organ development (GO:0048568),-0.38758975731519973,-1.415216823002814,0.034229828850855744,0.34102812778702435,1.0,24/61,17.71%,KITLG;PBX1;RARB;PCSK5;TGFB2;TEAD4;PBX3;TGFBR2;KDR;RPL10;GLI3;SOX17;STRA6;HEY2;TAL1;TEAD1;MFSD2A;SOX18;TBX2;RARRES2;ATF4;STIL;HEY1;ALDH1A3
prerank,basement membrane organization (GO:0071711),-0.5460502178008761,-1.4146690633565497,0.09722222222222222,0.341351698323896,1.0,5/14,8.04%,FLRT2;COL4A1;RAMP2;NTN4;LAMB2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.406382046851108,-1.4146458686233152,0.04751131221719457,0.34062071877306427,1.0,25/46,33.02%,PIEZO2;PIEZO1;F11R;FAS;CRADD;PDE2A;CASP8AP2;CNN2;CD40;BAK1;MAPK3;MYD88;CHEK1;CASP1;BCL10;CASP8;TLR4;MAP3K14;PTGER4;FADD;HABP4;AQP1;TMEM150C;TLR3;MAPK8
prerank,hemidesmosome assembly (GO:0031581),-0.5854890186392174,-1.413863131799748,0.0855397148676171,0.3415981512477264,1.0,4/11,4.22%,ITGA6;DST;ITGB4;LAMA3
prerank,cellular response to misfolded protein (GO:0071218),0.5219463282022838,1.4133072956303672,0.09433962264150944,0.7782541249890382,1.0,7/20,14.14%,DERL1;DNAJC18;DNAJB14;RNF126;UBE2W;BAG6;RNF5
prerank,microtubule depolymerization (GO:0007019),-0.5194714971833627,-1.4131905649624519,0.07172995780590717,0.34225191705188135,1.0,8/17,26.55%,NCKAP5;STMN1;NCKAP5L;KATNB1;KIF24;STMN4;KIF14;CCSAP
prerank,positive regulation of protein deacetylation (GO:0090312),-0.5345758567276435,-1.4125703099331826,0.08977035490605428,0.34272739435052196,1.0,5/14,16.62%,NIPBL;NNMT;SAP30BP;DYRK1A;APLNR
prerank,neurotransmitter transport (GO:0006836),0.399193123091382,1.4123814280707248,0.03626943005181347,0.7770326916308136,1.0,17/73,15.94%,ATP1A2;SLC29A2;SLC38A1;SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SLC6A4;GLS2;GAD1;SYN3;SLC22A2;CPLX1;NAAA;SYN1;GLUL
prerank,calcium ion transmembrane transport (GO:0070588),0.3830629938454173,1.4121823441204957,0.04187604690117253,0.7728454484149305,1.0,10/86,5.43%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;TRPV1;CACNB3;AFG3L2;GRIN2D;NALCN
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5183514140399131,-1.4119088930325194,0.08527131782945736,0.343215246870026,1.0,7/16,12.59%,NRP1;PTPRJ;PIK3C2A;PDGFC;PTPN1;BCAR1;PDGFD
prerank,negative regulation of viral life cycle (GO:1903901),-0.5356762937415384,-1.4109981726365997,0.0872210953346856,0.3443812224212794,1.0,5/15,6.36%,GSN;LY6E;MID2;IFITM3;PPIA
prerank,regulation of cell population proliferation (GO:0042127),-0.2813160344632758,-1.4105239395121572,0.0,0.3445787432910352,1.0,144/691,14.08%,LEF1;ELN;KITLG;LIMS1;ABI1;NTRK3;GCNT2;BMP5;ZBTB7C;RAPGEF2;BMPR2;IL6ST;CLDN5;DAB2IP;OSMR;PTN;JAG1;TJP1;LIFR;NOS3;RHOA;CD200;ACER2;ETS1;ACVRL1;TGFB2;ENG;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;CDH13;SH3BP4;TBC1D8;EGFR;CYP1B1;CTCF;NGF;RUNX1;BTG1;STAT3;BMP4;PTPRJ;SFRP4;SIX1;TGFBR2;KDR;APP;ITGA1;ADARB1;FN1;PTPRK;JUN;CACUL1;TBX1;CBFA2T3;GNL3;NUAK1;TNFRSF11A;IGFBP6;STX3;TFRC;CNOT6L;ARHGEF2;JAG2;AQP11;DNAJA2;AGTR1;S100A13;AXIN2;HES1;ADAM10;XRCC5;LYN;IL6R;IL34;AR;ADAMTS1;FLT1;KLF11;NACC2;GAREM1;APC;PPP2R5C;RPS6KA2;EMP2;IFI35;CDC123;TIPIN;RBBP4;PLPP1;XIAP;PDGFC;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;FGF7;KLF4;S100A11;S1PR3;EDN1;BTG3;HGS;ESM1;SERTAD1;RPL23;TES;ADGRG1;PBRM1;MYOCD;SOX7;FBXO5;DDAH1;GRK5;EDN3;RPS9;KRAS;WNT9A;HHEX;BMP2;PTK2B;PDGFD;SST;RARG;ACE2;ROR2;TBX2;NACC1;EEF1E1;CSNK2A1;RERG;AKT2;IRS1;CD86;VEGFA;RBFOX2;COPS9
prerank,positive regulation of heart contraction (GO:0045823),0.5153435024360193,1.4104304533458816,0.09923664122137404,0.7753956083346139,1.0,1/19,0.03%,ATP1A2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.43516219168948134,1.4100772771385066,0.06077348066298342,0.7718888840131358,1.0,13/44,10.67%,ACTN2;ATP1B3;ANK2;WNK3;KCNJ5;ATP1B2;KCNJ10;WNK4;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,wound healing (GO:0042060),0.4079896759527027,1.4098722145840796,0.054844606946983544,0.7679492792784296,1.0,13/62,10.07%,FGF1;SYT11;ANXA6;IGF1;SMAD3;PDGFRA;WNT7A;MYOF;CORO1B;NRG1;FZD7;TGFBR1;CFLAR
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5643475472596966,1.408810779222036,0.094,0.7675075766621465,1.0,2/14,3.69%,IL18;IL17D
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4592786491569782,-1.408458947849186,0.06198347107438017,0.3481702919532002,1.0,9/27,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5808732715958691,-1.407318393187093,0.09052631578947369,0.3498771204271814,1.0,6/11,28.79%,SLIT2;CCN3;GREM1;DUSP1;DDT;MIF
prerank,muscle organ development (GO:0007517),-0.4033580470837427,-1.407203595459884,0.046296296296296294,0.3493462487122782,1.0,10/54,4.50%,UTRN;MEF2C;LAMA2;COL6A3;TCF12;SMTN;TEAD4;FHL1;TBX1;SGCD
prerank,vesicle organization (GO:0016050),-0.40621462235117917,-1.4066242254975978,0.058823529411764705,0.34980085861295823,1.0,14/46,16.55%,CAV1;CD34;WASHC4;CHMP2B;ALS2CL;ZFYVE16;RAB22A;SORT1;CAV2;SQSTM1;SNX10;FNBP1L;SAR1A;USP50
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.44122723656185886,1.4058971472532946,0.0625,0.7745843640696926,1.0,4/41,3.98%,PRKAG2;GCK;POM121;NUP155
prerank,negative regulation of response to stimulus (GO:0048585),-0.3792530719869387,-1.40589103875473,0.04157043879907621,0.350462760305851,1.0,18/60,11.58%,SLIT2;ACVR1;CD34;VPS13C;AKT3;KLF7;CASK;UBASH3B;AQP11;HHIP;LYN;PTPN1;SOCS5;KLF4;TLE5;FBXO5;DDAH1;TWIST1
prerank,actin filament organization (GO:0007015),-0.3277154469060093,-1.4054979541449513,0.011461318051575931,0.35050073261457576,1.0,37/151,14.25%,HIP1;MYO1D;ABI1;MYO1B;RHOBTB1;SHROOM4;RHOA;SVIL;GSN;CORO1C;PLS3;ACTN1;FLNA;ARHGEF2;EPS8;TPM4;ALDOA;EMP2;TPM2;TMOD3;MYO19;TPM3;BCAR1;NEDD9;MYO1F;CD2AP;WHAMM;CAPG;CDC42EP2;HIP1R;RND3;TRPV4;VILL;GAS2L1;MARCKS;AVIL;SHROOM1
prerank,cellular response to inorganic substance (GO:0071241),-0.48880248580742475,-1.4045096498139338,0.07922912205567452,0.3518717917377186,1.0,13/21,31.93%,FOXO1;GUCY1B1;DDI2;BLM;TIMELESS;MT3;FMR1;SPIDR;NSMCE3;ADCY10;CDK2;MMP3;AQP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4845174559423039,-1.4041695189545187,0.09127789046653144,0.35175544151032684,1.0,6/21,13.63%,FOXP1;PRKCH;SLC39A10;RPS3;NECTIN2;PTPRC
prerank,dicarboxylic acid transport (GO:0006835),0.4811755575334279,1.4039353159031087,0.10377358490566038,0.7781294857871704,1.0,6/28,9.70%,SLC22A6;SLC13A3;SLC26A1;PDPN;SLC19A1;SLC25A12
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5251943410163125,1.4037755738141402,0.10224948875255624,0.7740536125708036,1.0,7/18,17.40%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2;RELA
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3085759612677767,-1.4028600062646066,0.008620689655172414,0.35381380921271466,1.0,63/245,14.78%,NRP1;ROR1;TEK;NTRK3;GCNT2;RAPGEF2;PDE8A;DAB2IP;ADRA1B;SEMA7A;BCAR3;TGFB2;INSR;BMPER;NOTCH1;GAS6;RAP1A;IQGAP1;EGFR;JCAD;CD44;PTPRJ;MID1;KDR;APP;MFHAS1;TBX1;PLCG2;DHX33;ICAM1;TNFAIP8L3;PIK3R6;IL34;IAPP;FLT1;GAREM1;SPRY2;CCL13;PDGFC;FLT4;IGF2;FGF2;APOE;EDN1;CAV2;ACKR3;EDN3;CD74;PHB2;RET;BMP2;PTK2B;PDGFD;ROR2;HTR2A;CD40;PTPRC;FBXW7;CD24;VEGFA;P2RY6;MTURN;MT3
prerank,regulation of activated T cell proliferation (GO:0046006),0.4701333203573532,1.4025094388166228,0.09461966604823747,0.7746472039746074,1.0,3/30,1.23%,IGF1;IL18;IDO1
prerank,prostaglandin biosynthetic process (GO:0001516),0.5355490851372853,1.4023060963091905,0.0888468809073724,0.7708341405032149,1.0,4/18,7.75%,PTGDS;PTGS1;PNPLA8;PTGES
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.4443383746650136,-1.4018839459328876,0.07264957264957266,0.35516250873122823,1.0,10/33,9.35%,TEK;RAMP2;NDNF;GAS6;KDR;CAST;ICAM1;MDK;GATA2;SERPINE1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5571273023996541,-1.401494731306502,0.07889546351084813,0.35523195786893164,1.0,3/12,8.27%,FOXP1;LYN;ORMDL3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5450831898285672,1.4014687951835785,0.10112359550561797,0.7696357801769647,1.0,2/16,1.88%,RANBP3L;IGFBP3
prerank,ATP transport (GO:0015867),0.6153652937340393,1.4014233268958924,0.08924949290060852,0.7651847415792884,1.0,2/10,4.92%,SLC25A42;SLC25A5
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3924054548754692,-1.4012522948752797,0.05909090909090909,0.3549397511135856,1.0,21/53,22.10%,DAB2IP;PKD1;GABARAPL2;UBB;ECSCR;PRKCG;APOE;GPX1;TMF1;RAD23B;FOXF2;FBXW7;GNA12;FMR1;PRKACA;PSMD14;PSME3IP1;UCHL5;PSME1;TMTC3;GLMN
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5565091306284722,1.4011378804150418,0.11560693641618497,0.7617448437681259,1.0,4/15,7.09%,CHST4;RENBP;LARGE1;GNPDA1
prerank,ribosomal large subunit assembly (GO:0000027),-0.4667186026777559,-1.400859157520465,0.08057851239669421,0.35499248719116583,1.0,12/24,28.85%,RPL5;RPL10;MRPL20;RPLP0;RPL6;RPL24;RPL3;RRS1;RPL23A;PPAN;MDN1;RSL24D1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5486646270370462,-1.4007523576073064,0.09090909090909091,0.3544154510582538,1.0,6/14,14.97%,THBS1;CREB3L1;SPRY2;FGF2;SPRY1;GPC1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5418386271747833,-1.4002507015013184,0.09325396825396826,0.35462054407004884,1.0,7/13,34.79%,KDR;EDN1;NOD2;IL33;TLR4;NAMPT;TLR2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5783833156373714,1.4000555455688313,0.13018867924528302,0.7616335517915,1.0,3/11,3.73%,LEPROT;ACTN2;PICALM
prerank,regulation of ruffle assembly (GO:1900027),-0.48033929402756503,-1.399151989220485,0.07613168724279835,0.35626288481519114,1.0,6/23,13.07%,CAV1;KANK1;EPS8;ABI3;EPS8L2;PFN1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5278418376235038,1.399059769486207,0.11173184357541899,0.7613551337738541,1.0,2/17,4.28%,ATP1A2;ATP1B2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.4340757848926342,-1.3977643863568314,0.06290672451193059,0.3586182380834253,1.0,16/33,28.95%,HIP1;BCAR3;AFAP1L2;ARAP1;HIP1R;FBXW7;CBL;PLAUR;GPER1;PDE6H;EGF;NUP62;SHKBP1;AGT;BTC;NEU3
prerank,embryonic appendage morphogenesis (GO:0035113),-0.556501067559155,-1.396480784692853,0.094,0.36072920051188034,1.0,3/12,1.96%,MBNL1;LRP6;TGFB2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.37839819258805857,-1.3964573915639105,0.0477326968973747,0.3599707760737507,1.0,17/63,16.58%,MEF2C;IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;CD38;IL15;EPHB2;NFATC2;CD74;CD40;PTPRC;CD86;NCKAP1L;CD46
prerank,neuron migration (GO:0001764),-0.3996494277596825,-1.3959873474104596,0.04672897196261682,0.3602140999114885,1.0,14/48,16.20%,NRP1;MEF2C;RAPGEF2;MARK1;NDNF;DISC1;CEP85L;CDK5;FGF13;VEGFA;NR4A2;MAP1B;PAFAH1B1;DDIT4
prerank,positive regulation of DNA replication (GO:0045740),-0.5243802472495304,-1.3953762740418971,0.08979591836734693,0.36080226801041826,1.0,7/16,24.66%,BCAR3;KAT7;EGFR;BRPF3;FAF1;EGF;CTC1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5883119298726123,-1.3953437127148287,0.10392156862745099,0.36007903600407065,1.0,3/10,6.94%,LRCH1;CD200;APOD
prerank,protein maturation (GO:0051604),0.369305919755486,1.3950845438543797,0.03169014084507042,0.7733445792846595,1.0,10/95,4.65%,AEBP1;NNAT;METAP2;TSPAN5;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2
prerank,T cell mediated immunity (GO:0002456),-0.5602146377800274,-1.3949693129896612,0.08798283261802575,0.3601800140583994,1.0,6/13,20.91%,JAG1;EMP2;CD55;CD46;GNL1;CADM1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.43904566493444175,-1.39464102764657,0.066815144766147,0.3601403426716247,1.0,15/30,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5902839267833171,-1.3945640962051509,0.11064718162839249,0.35954122518342013,1.0,2/10,2.85%,PODXL;PIEZO1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3417567456908279,-1.394453610037577,0.028205128205128206,0.3589802915142556,1.0,27/112,6.74%,PDE3A;LIMS1;MEF2C;GCNT2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;SMURF1;ID1;TGFBR2;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;SMAD1;RPS27A;UBB;WNT5A;PDE2A;ITGB5;PXN
prerank,acute inflammatory response (GO:0002526),-0.4637489405335387,-1.3943473368191341,0.09129511677282377,0.35840266665897563,1.0,11/23,36.32%,F3;PLSCR1;IL6R;SIGIRR;ANO6;CEBPB;AHSG;VNN1;HPR;HP;CRP
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4636284929470389,1.3939270238028416,0.08712121212121213,0.773716711652525,1.0,3/31,1.84%,RANBP3L;TMEM64;SUFU
prerank,neutrophil activation (GO:0042119),-0.5540912164311091,-1.3933284914312234,0.10995850622406639,0.35980076539588224,1.0,5/12,21.23%,KMT2E;PRKCD;IL15;PREX1;SYK
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.32261881880965004,-1.3930854985911723,0.011049723756906077,0.3595529312009968,1.0,48/151,20.23%,SGMS1;ST3GAL4;PLA2G4A;SGMS2;ELOVL7;ACER2;PCSK5;CERT1;CEPT1;DEGS2;PRKD3;GPHN;GCH1;PRKD1;SPNS2;SLC44A2;ELOVL5;AKR1A1;CERS5;CERS6;PLPP1;SAMD8;APOE;GOLPH3;B4GALT5;ELOVL6;GCNT1;MFSD2A;SLC44A1;LPIN3;CSNK2A1;NFS1;ESD;ELOVL1;GSTT1;PLPP3;VAPB;MOCS1;ELOVL4;ST3GAL2;STARD10;SGPP1;ASS1;SPTSSA;LCMT2;DMD;PPM1L;ACER3
prerank,cellular response to oxygen levels (GO:0071453),0.6091723245677072,1.3927874002645726,0.12258064516129032,0.7739950746072123,1.0,4/10,7.57%,ATP6V0A2;CCDC115;TMEM199;CPEB4
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.490538629334669,-1.3927418509536664,0.08281573498964803,0.3595232614622151,1.0,3/20,1.51%,PDE4D;RAPGEF2;ADRA1B
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4201908711367973,-1.3927292960483402,0.07423580786026202,0.3587842472113407,1.0,15/37,17.68%,PRKG1;MEF2C;JUN;ERN1;ADAMTS1;TAFA5;FGF2;TGFB3;PDCD4;P2RY6;HTR1B;LDLRAP1;MMP2;PTEN;GPER1
prerank,cardiac muscle cell differentiation (GO:0055007),-0.46808332851717915,-1.3924146698314885,0.07528957528957529,0.35874554210485515,1.0,7/21,13.82%,MEF2C;ACVR1;MYH11;CXADR;MYOCD;BMP2;VEGFA
prerank,positive regulation of cell adhesion (GO:0045785),-0.36863115067380725,-1.3921522838232991,0.02358490566037736,0.3585452222706753,1.0,14/74,8.79%,LIMS1;FRMD5;ZFHX3;VIT;TGFB2;NDNF;PTPRJ;STX3;CXCL12;PPP3CA;MDK;FBLN2;TGM2;ECM2
prerank,positive regulation of cellular process (GO:0048522),-0.28052982590171627,-1.39206037911686,0.0,0.35796369340260087,1.0,165/565,22.77%,LEF1;SLC6A6;KITLG;FRMD5;ACTN4;NTRK3;CAV1;GCNT2;BMP5;IL6ST;CLDN5;OSMR;ZFHX3;PTN;TJP1;LIFR;PARD3;LRP6;ACER2;ETS1;TGFB2;TRPC3;INSR;MERTK;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;TBC1D8;EGFR;BMP4;PTPRJ;H3-3A;TGFBR2;KDR;TNFRSF1B;FN1;RPS6KA3;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;AXIN2;HES1;ADAM10;LYN;CXCL12;IL6R;IL34;PRKCD;AR;FLT1;PPP3CA;MDK;TGM2;GAREM1;DOCK2;APC;EMP2;CDC123;TIPIN;SMC5;PDGFC;GATA2;FLT4;TIAM1;VHL;IGF2;FGF2;TGFB3;TSPAN31;IL15;ACACB;CDKN2AIP;RPTOR;FGF7;TAL1;FASN;S1PR3;EDN1;ESM1;SERTAD1;RPL23;ADGRG1;PABIR1;FBXO5;GRK5;EDN3;RPS9;KRAS;MFSD2A;PTK2B;PDGFD;RAB27A;USP47;TBX2;AGPAT1;NACC1;CSNK2A1;AKT2;IRS1;CD86;VEGFA;LRP1;COPS9;ROMO1;MT3;NCBP1;PTGFR;KLHL22;DDX49;FMR1;CSF1R;PA2G4;RPS15A;UBE2A;TBRG4;TCIRG1;FXR1;FGFR3;PTEN;HDAC2;GPER1;GRIN1;DYNC1H1;PTPN6;CCND1;KIF20B;PRODH;GREM1;ZC3H12A;CRLF1;PRC1;HCK;CDC42;CCPG1;ACER3;PSMD10;PTHLH;POU3F3;NOXO1;CHEK1;NSMCE4A;POFUT2;CCND2;RIPK2;FAF1;MYRF;RPRD1B;FXN;HAS2;CDKN1B;FCGR2B;CEP131;DLL1;SOX11;CTF1;EXOSC4
prerank,carboxylic acid transmembrane transport (GO:1905039),0.43810932870663477,1.391609196339498,0.07129455909943715,0.7743058192376941,1.0,10/40,9.21%,SLC13A3;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC38A1;SLC7A13;SLC25A11;SLC19A1;SLC38A9
prerank,lipid catabolic process (GO:0016042),0.5307587185368002,1.390630127139655,0.10687022900763359,0.7739452540994379,1.0,6/18,23.27%,CEL;PLA1A;PLAAT3;HSD11B1;LIPC;LIPH
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5901290662456875,-1.3902420814255714,0.10472279260780287,0.36015967466017695,1.0,5/10,20.10%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5901290662456875,-1.3902420814255714,0.10472279260780287,0.36015967466017695,1.0,5/10,20.10%,CDC42EP5;CDC42EP3;APC;CDC42EP2;CDC42
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.4569165445289671,-1.3901954943618529,0.08649789029535865,0.3595035639126962,1.0,6/27,9.67%,UTRN;NEDD4L;FXYD5;CAMK2D;SLMAP;FXYD6
prerank,mucosal immune response (GO:0002385),-0.5170227929004231,-1.3894480934598916,0.11368015414258188,0.36016546912565367,1.0,3/15,7.56%,DEFA6;RPL39;OTUD7B
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5289111074067596,1.3890938301643103,0.11531531531531532,0.7762578349152212,1.0,5/16,7.85%,LEPROT;CHMP6;STAM;VTA1;SNF8
prerank,regulation of peptide hormone secretion (GO:0090276),0.39524700344330504,1.3886075914118166,0.05752961082910321,0.7739315376567979,1.0,22/67,18.38%,CACNA1D;GCK;ITPR1;PASK;CACNA2D2;ADRA2A;SNAP25;KCNC2;CLOCK;ITPR2;GRP;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;HFE;PICK1;DPP4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4583115917149904,1.3883189905254156,0.08043875685557587,0.7708227047112759,1.0,6/37,6.60%,PRKAG2;BMP7;SPHK1;WNK3;PLK1;PPEF2
prerank,actin polymerization or depolymerization (GO:0008154),-0.3910636491460291,-1.3880041933832505,0.06310679611650485,0.3624325531518982,1.0,14/50,13.75%,ABI1;MICAL2;SVIL;GSN;WDR1;MSRB2;WASHC3;FAM107A;CFL1;CAPG;MICALL2;PSTPIP2;VILL;AVIL
prerank,negative regulation of protein polymerization (GO:0032272),-0.4561183476639128,-1.387934706421272,0.06935123042505593,0.3618050238554897,1.0,11/27,13.07%,SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;PRKCD;DYRK1A;HIP1R;PFN1
prerank,protein homotetramerization (GO:0051289),0.4105809797045953,1.3873329391590628,0.07169117647058823,0.7705631537756005,1.0,4/49,1.13%,ALDH1A2;UPB1;APPL2;TRPV1
prerank,stabilization of membrane potential (GO:0030322),0.5329229094607153,1.3871589843170182,0.12648221343873517,0.7670776365581428,1.0,4/16,16.88%,KCNK2;KCNN4;KCNK4;KCNK10
prerank,retina homeostasis (GO:0001895),-0.4643404048086719,-1.3868258135275893,0.08498023715415019,0.3634255443337684,1.0,6/23,11.50%,ACTB;POTEF;B2M;ACTG1;SOD1;HSPB1
prerank,positive regulation of tissue remodeling (GO:0034105),0.6043054483686678,1.3867834344616217,0.1277445109780439,0.7643532177609771,1.0,2/10,0.87%,ROCK2;IL18
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.46686052828251284,-1.3859476229600773,0.10309278350515463,0.3645207597595985,1.0,9/22,18.96%,RASSF2;RAP2A;CALM3;PDGFC;PDGFD;VEGFA;TNKS1BP1;NBN;GREM1
prerank,heart contraction (GO:0060047),0.4298312963800379,1.3856779016665979,0.07635009310986965,0.7647500542258636,1.0,7/41,11.04%,ATP1A2;CSRP3;SGCZ;TNNI1;KCNH2;SGCG;RYR2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.485036303555595,1.3856156176547196,0.08860759493670886,0.7608713454338735,1.0,5/26,4.37%,ERRFI1;SNX6;CHMP6;GPRC5A;ADRA2A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.490904528450326,1.38502405962349,0.10848126232741617,0.7590872931904746,1.0,2/23,1.35%,METAP2;NMT2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.36211906951592904,1.3844930519012761,0.02365930599369085,0.7571133679477595,1.0,32/117,17.36%,ALDH1A2;IGF1;ALDH8A1;ADH7;CYP26B1;PPARA;ME2;PCCA;AASDH;PNPLA8;GLYAT;PANK2;ACADSB;ECHDC3;PTGR1;CPT1C;FA2H;AMACR;MTHFS;CROT;SLC27A4;VDAC1;LDHB;NAAA;PER2;GGT5;GOT2;GBA2;ACOT1;MSMO1;AASDHPPT;ACOT6
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.4063305354265464,-1.3841266034690023,0.04751131221719457,0.3677127744865769,1.0,13/40,12.38%,LEF1;GCNT2;JAG1;TGFB2;NOTCH1;TGFBR2;AXIN2;MDK;TIAM1;TGFB3;TWIST1;COL1A1;BMP2
prerank,fatty acid transmembrane transport (GO:1902001),0.5202066175870821,1.3829948973984563,0.13011152416356878,0.7591133428573652,1.0,2/19,1.77%,PRKAG2;PRKAA2
prerank,extracellular matrix disassembly (GO:0022617),-0.3904533509060888,-1.3824573140033585,0.07017543859649122,0.3706938802199825,1.0,23/53,31.98%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2;HPN
prerank,linoleic acid metabolic process (GO:0043651),0.5274767826000373,1.381685326273027,0.1016949152542373,0.7602807893257321,1.0,4/17,9.07%,ACSL1;PNPLA8;GSTM2;ABCD1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5433689226321312,-1.3816802402686592,0.10693069306930693,0.37156468079013855,1.0,7/13,20.92%,DCN;CSPG4;VCAN;HEXA;BGN;NCAN;BCAN
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4125078544132975,1.3808444741795285,0.07513416815742398,0.7595834146388875,1.0,11/50,10.53%,RORA;DCDC2;SUFU;INTU;TULP3;FGFR2;EVC;ARMC9;MEGF8;IFT122;TEDC2
prerank,Golgi to endosome transport (GO:0006895),-0.507807816596045,-1.3807981183723337,0.10251046025104603,0.3726391140370347,1.0,8/16,13.98%,RAB14;VPS13C;WIPI1;SORT1;VPS13A;AP1AR;SYS1;AP2A1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.49330583744155804,1.3806664780769888,0.11174242424242424,0.7563383469602799,1.0,7/23,10.39%,BMP7;UACA;CPNE1;C1QTNF3;NLRC3;NLRP3;ADGRG3
prerank,nitrogen compound transport (GO:0071705),-0.3255283415830844,-1.3806400495901214,0.015151515151515152,0.37227179675099514,1.0,27/141,9.19%,ABCG2;SLC6A6;CALCRL;SLC12A2;LRRC8D;RAMP2;SEC14L1;CERT1;MYH9;SLC1A5;ABCC1;SLC7A5;LMAN2L;SCARB2;TMEM30A;ATP11B;CHMP2B;SLC38A5;SLC43A2;SLC44A2;SLC7A7;SLC7A1;CMTM6;CUBN;SLC7A14;SLC43A1;TXNIP
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5381160698030301,-1.3797363266297917,0.112,0.37349707289710304,1.0,4/13,7.25%,RUNX1;TGFBR2;GLI3;CBFB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5136954567211817,1.3793284212787993,0.09902912621359224,0.7577667178952804,1.0,6/19,11.47%,IGF1;PICALM;RTN1;FLOT2;NTRK2;CLU
prerank,mitochondrion disassembly (GO:0061726),-0.4217175149354527,-1.3789463800645254,0.058823529411764705,0.37443310106318717,1.0,14/34,25.57%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.47793368224859056,-1.3789071865514269,0.09853249475890985,0.3737339251461384,1.0,11/20,13.85%,ACVRL1;TGFB2;ENG;TBX3;NOTCH1;BMP4;HEYL;HEY2;PDCD4;BMP2;SPRY1
prerank,neutrophil mediated immunity (GO:0002446),-0.28550417760755575,-1.3787979086410498,0.0,0.37320380065870457,1.0,115/432,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;KMT2E;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,regulation of centriole replication (GO:0046599),-0.5037359333446381,-1.378136572705191,0.09127789046653144,0.3739118269228672,1.0,7/17,23.88%,TRIM37;PLK2;CEP76;STIL;CEP295;CDK5RAP2;NUP62
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5691938921490141,-1.3780558879464149,0.1222879684418146,0.3733111072835966,1.0,4/11,5.59%,CACNB2;CACNA2D1;NOS1AP;CAMK2D
prerank,regulation of cartilage development (GO:0061035),-0.4880713698764106,-1.3774483282516385,0.10699588477366255,0.3738998939031097,1.0,5/18,7.43%,BMPR2;ZBTB16;TRPS1;BMP4;MDK
prerank,response to metal ion (GO:0010038),-0.3723134581211305,-1.377292981031617,0.04672897196261682,0.37344844124329524,1.0,19/67,15.61%,CAV1;NEDD4L;TRPC3;THBS1;PLSCR1;GPHN;CRIP1;CALM3;PPP3CA;PPP1CA;MT1A;MT1X;TRPC1;SEC31A;SLC30A5;ITPR3;D2HGDH;MT3;ATP5F1D
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.43038362680474074,-1.3768749520452686,0.08757637474541752,0.37353339386848255,1.0,10/32,16.70%,PLCE1;WASF2;PIK3R1;CORO1C;OCLN;PIK3CA;SRC;AVIL;ARPC2;RREB1
prerank,actin filament depolymerization (GO:0030042),-0.5648899032232029,-1.3768402839948661,0.11316872427983539,0.3728536886704434,1.0,4/11,10.52%,MICAL2;GSN;WDR1;CFL1
prerank,positive regulation of behavior (GO:0048520),-0.5974259046825395,-1.3765205739732551,0.10040160642570281,0.3727936055951992,1.0,3/10,7.63%,MEF2C;SGIP1;STRA6
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.530597435110444,-1.3763530718350323,0.09387755102040816,0.37241446287495805,1.0,7/14,13.85%,CAV1;ZEB1;SPRED2;XDH;SPRY2;NOTCH4;SPRY1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5497134146059268,-1.3756105682721973,0.13385826771653545,0.3733828627604763,1.0,4/12,2.65%,PODXL;JAG1;PROM1;IQGAP1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6106123513176849,1.3753957333180218,0.11041666666666666,0.7694635790358324,1.0,4/10,15.61%,HSPA1A;DNAJB8;HSPA1B;DNAJB2
prerank,regulation of developmental growth (GO:0048638),-0.436203694714451,-1.3753885127145933,0.06638115631691649,0.37319232593075197,1.0,12/29,17.70%,GHR;INSR;SIX1;APP;NIPBL;SPAAR;SOD1;APOE;MFSD2A;SIX4;FGFR3;LATS1
prerank,neutrophil degranulation (GO:0043312),-0.28497462516779976,-1.375292287763254,0.0,0.3726394782600786,1.0,114/425,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,mesoderm development (GO:0007498),-0.4988402756664872,-1.3749409056274036,0.0851528384279476,0.37263364058996984,1.0,8/18,20.01%,TIE1;TBX3;TBX1;BMX;VEGFA;BTK;MEST;HCK
prerank,sensory perception of sound (GO:0007605),0.380033616305934,1.3748284007673939,0.05448717948717949,0.7677050803974232,1.0,16/88,9.16%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;KIT;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,cellular metal ion homeostasis (GO:0006875),0.36375707135989055,1.3747465865277577,0.04297520661157025,0.7640481181931699,1.0,11/102,4.28%,ATP1A2;SLC8A3;SLC41A1;SLC24A3;ATP1B3;ATP13A5;ANK2;DMPK;CSRP3;ATP13A3;ATP1B2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.44779099416893897,-1.3743888804211282,0.08798283261802575,0.3731007171062049,1.0,5/27,7.92%,RHOA;ETS1;CD44;MDK;NFAT5
prerank,positive regulation of cell population proliferation (GO:0008284),-0.28472779570207685,-1.3738139699833978,0.0,0.37359368678739213,1.0,89/423,13.82%,LEF1;FOXP1;PRKCH;KITLG;MEF2C;NTRK3;GCNT2;BMP5;PID1;IL6ST;CLDN5;OSMR;PTN;TJP1;LIFR;ACER2;TGFB2;INSR;VEGFC;TBX3;THBS1;NOTCH1;LRP5;GAS6;CDH13;TBC1D8;EGFR;BMP4;TGFBR2;KDR;FN1;CACUL1;TBX1;TNFRSF11A;STX3;CNOT6L;AQP11;DNAJA2;WNT5A;S100A13;HES1;ADAM10;LYN;IL6R;IL34;AR;FLT1;CCN1;MDK;GAREM1;EMP2;CDC123;TIPIN;ZFPM2;TMEM119;PDGFC;FLT4;TIAM1;IGF2;FGF2;TGFB3;TSPAN31;IL15;S100A6;FGF7;S1PR3;EDN1;ESM1;SERTAD1;RPL23;FBXO5;GRK5;EDN3;RPS9;CD74;CCN4;KRAS;BMP2;PTK2B;PDGFD;TBX2;NACC1;CSNK2A1;AKT2;NME2;PTPRC;IRS1;CD86;VEGFA
prerank,nucleoside catabolic process (GO:0009164),0.5796782666863783,1.3737402686264402,0.12550607287449392,0.7641666761117056,1.0,4/11,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,regulation of leukocyte activation (GO:0002694),-0.5249541091644732,-1.3734170386051954,0.1111111111111111,0.37364894778123314,1.0,6/14,17.68%,CD200;PLSCR1;MFHAS1;LYN;CD74;GPER1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5974439756483622,1.372500522841089,0.11867704280155641,0.7651372837964586,1.0,1/11,0.51%,TAS1R2
prerank,positive regulation of cell projection organization (GO:0031346),-0.3319437792721346,-1.3720572269744988,0.03626943005181347,0.3757602076711497,1.0,32/115,13.79%,ROR1;NTRK3;RAPGEF2;DAB2IP;PTN;ITGA6;SLIT2;RHOA;NDNF;RAP1A;NGF;SCARF1;TIAM2;SCARB2;PRKD1;WNT5A;NPTN;LYN;FBXW8;ARHGAP35;MDK;RETREG3;TIAM1;APOE;PLXNC1;FZD4;RET;PTK2B;ROR2;FZD1;AVIL;ARHGDIA
prerank,ncRNA transcription (GO:0098781),-0.5362855448048626,-1.3720258160296384,0.10821643286573146,0.37509595717185445,1.0,6/13,19.88%,SPIN1;USPL1;POLR1G;CAVIN1;GTF3A;SIRT7
prerank,cellular amide metabolic process (GO:0043603),0.3659359530699275,1.371732123148364,0.04361873990306947,0.7643132971751561,1.0,28/102,17.36%,AEBP1;ALDH1L1;CPN1;ACSM2A;ACSM2B;PLAAT5;PM20D1;PCCA;SMPD3;GLYAT;PANK2;SLC19A1;ORMDL2;CLN8;SMPD2;MTHFS;PLA2G15;ABCA2;NAAA;MTHFD1;MTHFR;CERK;PLAAT3;ACOT1;FPGS;AASDHPPT;MTHFD2;ACOT6
prerank,positive regulation of protein kinase activity (GO:0045860),-0.3197626185527061,-1.3716778123561508,0.016574585635359115,0.37522051700096276,1.0,28/148,9.78%,RAPGEF2;DAB2IP;RHOA;TGFB2;INSR;GAS6;RASSF2;STK3;RAP1A;IQGAP1;TGFBR2;CACUL1;RALB;TNIK;CAB39;PAK2;XRCC5;IL6R;IL34;PRKCD;CALM3;CCN1;EMP2;SRC;PTPN1;MAP4K4;NEDD9;RPTOR
prerank,L-serine metabolic process (GO:0006563),-0.578350073989244,-1.3715735635528523,0.1285444234404537,0.3746899025691385,1.0,6/10,28.59%,SERINC5;SRR;SERINC3;SHMT2;CBS;SHMT1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.35303427754772576,-1.3711536967913835,0.022935779816513763,0.3748870940213402,1.0,22/80,15.68%,NRP1;PLCE1;WASF2;PIK3R1;CDC42EP5;CDC42EP3;ARAP1;EPS8;ARHGAP35;OCLN;APC;PIK3CA;TGFB3;EPS8L2;CDC42EP2;FNBP1L;PFN1;AVIL;CCP110;AGRN;ARPC2;FMR1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4881184523379972,1.3705536591291856,0.11299435028248588,0.7649590357664597,1.0,3/20,6.77%,WNT4;GCK;C1QTNF3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4153826426415327,-1.3704804439238196,0.07174887892376682,0.37556884800038753,1.0,10/37,8.86%,CAV1;BCL2L1;UBB;RACK1;NCK1;RPS7;NACC2;RPS3;BCAP31;SOD1
prerank,positive regulation of binding (GO:0051099),-0.3530829268644563,-1.370407487867868,0.0498812351543943,0.37497361273401164,1.0,33/84,23.31%,CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;NGF;BMP4;APP;STMN1;RALB;MET;HES1;SPPL3;TIAM1;HMBOX1;APOE;NMD3;BMP2;HIP1R;LRP1;NCBP1;PLAUR;VTN;EPB41;DPH3;MARK3;HMGB1;RIPK2;DTX3L;SKI;EGF;TRIB3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5542327409475845,1.369927269708202,0.14231499051233396,0.7636986981953141,1.0,3/13,3.47%,BMP6;DAB2;BMPR1A
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5858983100978941,-1.3695239456430548,0.12373225152129817,0.3762028882328875,1.0,4/10,8.94%,GHR;STAT3;LYN;PTPN1
prerank,positive regulation of axon extension (GO:0045773),-0.4635998397954407,-1.36860771384464,0.09876543209876543,0.3774941487224507,1.0,8/22,16.30%,NRP1;NTN1;SEMA7A;MACF1;SHTN1;VEGFA;LIMK1;SEMA5A
prerank,cellular component disassembly (GO:0022411),-0.38658276669872166,-1.368497642285317,0.06783369803063458,0.3769702541046419,1.0,22/53,31.23%,TLL1;BSG;GSN;CD44;ADAMTS5;CAPN2;SH3PXD2B;ADAM10;MMP11;CAPG;ADAM15;CTSS;MMP2;NOXO1;HTRA1;SCUBE1;TIMP1;SCUBE3;KLKB1;MMP3;TLL2;TIMP2
prerank,adherens junction organization (GO:0034332),-0.3976876962142329,-1.3684348002402125,0.0514018691588785,0.37638432585018,1.0,11/48,6.00%,CDH11;ACTB;VCL;TJP1;RAMP2;CDH13;CDH1;CTNNA1;TBCD;PAK2;NECTIN3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2836402465440351,-1.3673727132403046,0.0,0.37787184606635377,1.0,114/428,19.04%,PTPRB;PECAM1;ATP8A1;VCL;RHOA;B2M;GSN;RAB14;CD93;APAF1;RAP1A;IQGAP1;GNS;CD44;EEF1A1;PTPRJ;TNFRSF1B;FAF2;RAB6A;STOM;RAB31;TMEM30A;PLEKHO2;ATP11B;CAB39;CPNE3;UBR4;ADGRE5;NPC2;CST3;SLC44A2;ADAM10;VAT1;XRCC5;EEF2;SLC2A3;PPIA;PRKCD;PRCP;PSMB7;MAPK1;SPTAN1;OSTF1;ALDOA;DOCK2;CMTM6;CTSD;CEACAM1;CNN2;CD55;ORMDL3;CAP1;ATP6AP2;ATP6V0A1;AGA;PYGB;CAT;CAND1;PFKL;S100A11;FTL;GAA;CTSB;PRDX6;PSAP;CRACR2A;HRNR;ENPP4;STK10;PGM2;RAB3A;NRAS;SCAMP1;CYSTM1;RAB27A;ATP6V1D;ARSA;IST1;CYB5R3;NME2;PTPRC;LRG1;DYNLL1;PGAM1;DERA;CCT2;TMBIM1;SURF4;SRP14;RAB5C;PLAUR;PSMD11;PA2G4;PPIE;RAP2B;NCKAP1L;PDAP1;SNAP23;CDA;TCIRG1;IMPDH1;CTSS;SYNGR1;CD53;CREG1;PDXK;DYNC1H1;PSMD14;PTPN6;C3;DSP;TMEM179B;CKAP4;RAB3D
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5807273236475629,-1.367330574741107,0.10474308300395258,0.3772324329744018,1.0,3/10,2.86%,RAPGEF2;RAP1A;NGF
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5443788545470595,-1.3672519608424352,0.11316872427983539,0.3766616601201822,1.0,4/12,9.84%,RHOA;APP;CXCL12;DOCK8
prerank,innate immune response in mucosa (GO:0002227),-0.5811992117012719,-1.3671920194704972,0.11434108527131782,0.3760613078863258,1.0,2/10,5.46%,DEFA6;RPL39
prerank,regulation of macroautophagy (GO:0016241),0.3623213377257169,1.36702802921206,0.03986710963455149,0.7712593982079131,1.0,26/105,15.49%,PRKAG2;SNX6;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;ATP6V0B;QSOX1;ATP6V1H;CASP3;IKBKG;GPSM1;LRRK2;SESN1;ATP6V1B2;SLC38A9;ATP6V1E1;PAFAH1B2;ATG13;LAMTOR2;ATP6V0E2;TSC1;ATP6V1C1;ATP6V0D2;LAMTOR3;SIRT1
prerank,superoxide metabolic process (GO:0006801),-0.4327785791757975,-1.366512095896163,0.08547008547008547,0.3768667285848698,1.0,8/29,16.67%,SH3PXD2A;NOS3;SH3PXD2B;SOD1;NCF2;MT3;NRROS;PREX1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4191947062264918,1.3663545802513808,0.08021390374331551,0.7699337286690392,1.0,9/46,10.26%,ATP1A2;CACNG7;NLGN2;SYT1;NLGN3;ATAD1;LRRK2;DRD3;DGKI
prerank,neural crest cell migration (GO:0001755),-0.4148210481072607,-1.3659859659981692,0.07709251101321586,0.37716964488983346,1.0,10/36,12.43%,NRP1;SEMA6A;SEMA3C;SEMA7A;CORO1C;FN1;TBX1;SEMA5B;SEMA3E;SEMA3G
prerank,regulation of myelination (GO:0031641),-0.4537669235000647,-1.3625865839766242,0.08425720620842572,0.3837492112078234,1.0,7/25,11.68%,PTN;PARD3;TNFRSF1B;LGI4;TNFRSF21;EIF2AK3;PTPRZ1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.42803246904212694,-1.362508127889074,0.09129511677282377,0.3831908079043876,1.0,10/29,12.95%,RPA1;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5085299042528666,1.3609965036555622,0.12048192771084337,0.7879647043421238,1.0,2/18,4.22%,PRKAG2;CLIP3
prerank,neutrophil chemotaxis (GO:0030593),-0.385078219525528,-1.3606282631750648,0.05530973451327434,0.3864928646494241,1.0,26/53,40.70%,BSG;TGFB2;PPIA;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.4696756823296928,-1.3604651992548353,0.10300429184549356,0.38607155423075207,1.0,7/21,13.85%,DAB2IP;SLIT2;TGFB2;SPRY2;CD2AP;EPHB2;SPRY1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3265772768069671,-1.3601963050683983,0.032432432432432434,0.38593656323137765,1.0,28/128,6.74%,GCNT2;BMP5;BMPR2;CLDN5;PARD3;RHOA;ACVR1;ACVRL1;TGFB2;ENG;RUNX2;SMURF1;ID1;BMP4;TGFBR2;RNF111;UBC;F11R;PTPRK;JUN;ITGB1;SMAD5;TMEM100;SMAD1;RPS27A;UBB;ITGB5;PXN
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.4611689670321775,-1.360156762102199,0.11382113821138211,0.38526988022204434,1.0,9/21,26.39%,MYH9;ADAM10;ADAM19;SPPL3;HM13;PSEN2;PSENEN;ERAP1;PRTN3
prerank,myoblast differentiation (GO:0045445),0.5361625945570117,1.359767365818174,0.11834319526627218,0.7891056816392614,1.0,6/14,8.75%,EPAS1;IGF1;DDX5;NRG1;DDX17;HINFP
prerank,aortic valve morphogenesis (GO:0003180),-0.4287572855217946,-1.35966901048906,0.09190371991247265,0.3855912090888514,1.0,10/30,8.50%,ELN;JAG1;SLIT2;NOS3;TIE1;NOTCH1;BMP4;NFATC1;HEYL;HEY2
prerank,indolalkylamine catabolic process (GO:0046218),0.5875467351240895,1.3590922082843215,0.13682092555331993,0.7877879360852613,1.0,3/10,9.06%,IDO1;HAAO;KMO
prerank,positive regulation of B cell proliferation (GO:0030890),-0.43578755103826516,-1.3590608011324727,0.088659793814433,0.38612482904193424,1.0,9/29,16.03%,MEF2C;TFRC;CD38;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,cardiac conduction system development (GO:0003161),0.4877866893872128,1.358897824852615,0.1141732283464567,0.7848063431997059,1.0,4/24,3.47%,NOTCH2;GJB6;MSX2;BMPR1A
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.460112653061783,-1.3583759259336121,0.11087420042643924,0.38682164221756693,1.0,9/22,12.95%,UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,glucose homeostasis (GO:0042593),0.37395058773130835,1.357999910734877,0.061258278145695365,0.7845718993900521,1.0,22/83,15.93%,LEPR;GCGR;APPL2;GCK;PRKAA2;CYP11B1;ACSM2A;ADRA2A;PAX6;ADCY8;CEBPA;PDK2;HKDC1;PPARGC1A;USF1;PYGL;HECTD4;SIRT1;IL6;BACE2;HK1;RBP4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.47531725853599943,-1.3578518776966637,0.13043478260869565,0.3873341809805768,1.0,8/17,22.00%,TGFB2;MID1;LYN;TAOK3;KLHDC10;NOD2;TAOK1;SEMA4C
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.41049288318355637,-1.3571714232729064,0.07095343680709534,0.3880880944074613,1.0,10/36,11.84%,LEF1;FZD6;NFATC1;AGO1;WNT5A;GNB1;GNG2;PPP3CA;AGO2;FZD4
prerank,tryptophan catabolic process (GO:0006569),0.5760584970239833,1.356349377749586,0.13821138211382114,0.7873301112533875,1.0,3/11,9.06%,IDO1;HAAO;KMO
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.454495939878652,-1.3552441587835178,0.0872210953346856,0.391536739778736,1.0,7/24,14.95%,PLCE1;WASF2;PIK3R1;OCLN;PIK3CA;AVIL;ARPC2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.35135328487153544,-1.3551748655947544,0.04433497536945813,0.39096573264777085,1.0,26/71,20.23%,SGMS1;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;ST6GALNAC5;CERS5;CERS6;PLPP1;SAMD8;ELOVL6;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.417432073320637,-1.3545171216277787,0.09554140127388536,0.3917394039950559,1.0,13/35,13.79%,NRP1;TEK;NTRK3;TJP1;ESAM;F11R;ARHGDIB;MDK;CDK5;ABI3;SEMA3E;PTK2B;ARHGDIA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5755917386271223,-1.3539247185441083,0.11538461538461539,0.3914797494082288,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5755917386271223,-1.3539247185441083,0.11538461538461539,0.3914797494082288,1.0,5/10,23.19%,AP2B1;VLDLR;AP2A1;MYLIP;AP2M1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4164875402409493,-1.3538090844713777,0.08520179372197309,0.3909602912862712,1.0,10/36,12.81%,CAV1;NOS3;NOSTRIN;SCARB1;EGFR;NOS1AP;GCH1;APOE;DDAH1;CYGB
prerank,ribosome assembly (GO:0042255),-0.3912097150044362,-1.3535251528066008,0.053488372093023255,0.3908194535442407,1.0,19/47,26.01%,RPS15;RPL5;RPL10;MRPL20;RPLP0;RPS5;RPS28;RPL6;RPL24;RPS27;RRP7A;MTERF3;PWP2;RPL3;RRS1;RPS19;RPL23A;PPAN;MDN1
prerank,retinoid metabolic process (GO:0001523),0.3822524733048568,1.3526651620111474,0.06688417618270799,0.7984735453268107,1.0,7/71,2.49%,ALDH1A2;ALDH8A1;ADH7;ADH4;ABCA4;RBP1;CYP26B1
prerank,adenine nucleotide transport (GO:0051503),-0.4906213781756936,-1.352404056515151,0.11387163561076605,0.39242745034574944,1.0,4/17,6.87%,ABCC4;LRRC8D;LRRC8C;LRRC8A
prerank,cGMP metabolic process (GO:0046068),-0.5377933804264292,-1.3522410925961497,0.12955465587044535,0.3921249143384417,1.0,5/12,18.89%,GUCY1B1;PDE9A;PDE2A;GUCY1A1;NPPC
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5490536649004072,-1.3521414877028348,0.13,0.391575337991828,1.0,4/11,5.85%,LRP5;TGFBR2;TBX1;WNT5A
prerank,positive regulation of apoptotic process (GO:0043065),-0.2868899548483087,-1.3518753554697642,0.003076923076923077,0.39147179370350543,1.0,85/293,20.44%,DAB2IP;ITGA6;SLIT2;NET1;FAP;TNFSF10;ARHGEF3;TGFB2;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;PTGIS;NGF;BTG1;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;MYBBP1A;RPS3;RPS6KA2;CTSD;CDK5;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TLE5;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;ZC3H12A;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,regulation of exocytosis (GO:0017157),0.4165878518764275,1.3510599809355763,0.08664259927797834,0.8012239757028495,1.0,16/46,16.46%,IL1RAPL1;UNC13D;CHMP6;RAB21;SYT1;CLASP1;RAB3C;STXBP5L;NSF;CPLANE2;RAB2B;RAB13;CPLX1;CADPS2;STX4;CPLX2
prerank,bone morphogenesis (GO:0060349),-0.5195438638469858,-1.3508970886805314,0.12373225152129817,0.39305270060179287,1.0,4/14,3.34%,BMPR2;LRP6;LRP5;SFRP4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3808192383246444,-1.3506986226974371,0.07534246575342465,0.39279780775813433,1.0,22/48,30.26%,ACTB;ARID1B;MYBBP1A;ARID1A;SERTAD1;ATAD2;POLR1F;POLR1G;POLR1A;ZMIZ2;CDCA4;ZMIZ1;CHEK1;POLR1H;MYO1C;POLR2F;POLR1E;POLR2H;DDX21;POLR1C;POLR2E;SMARCA5
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5030270203703471,-1.3497062233101689,0.1069182389937107,0.3942914367200993,1.0,6/16,13.23%,NOS3;NDNF;GUCY1B1;APOE;DDAH1;GUCY1A1
prerank,response to X-ray (GO:0010165),-0.5271598256847324,-1.3495382682224157,0.1443089430894309,0.39395865572027045,1.0,10/14,35.29%,NIPBL;XRCC5;ANXA1;BLM;LIG4;NUCKS1;IKBIP;BRCC3;XRRA1;XRCC4
prerank,artery development (GO:0060840),-0.4577524892398965,-1.3489432783224398,0.11740041928721175,0.39454398855586803,1.0,8/23,7.63%,NRP1;BMPR2;ACVRL1;ENG;TBX1;HES1;PDE2A;STRA6
prerank,positive regulation of chromatin organization (GO:1905269),-0.5411078331662548,-1.3488168645099488,0.11478599221789883,0.3940779175880583,1.0,4/12,10.66%,H3-3A;MIER1;TAL1;TERF2IP
prerank,carbohydrate derivative transport (GO:1901264),-0.4843959466761144,-1.3480207812406757,0.11693548387096774,0.3950369201402863,1.0,6/18,12.19%,SCARB1;SLC10A7;PLTP;NPC2;VLDLR;MFSD2A
prerank,axonogenesis (GO:0007409),-0.29709296462215473,-1.3479394866459355,0.015105740181268883,0.39454171542202066,1.0,48/237,12.43%,NRP1;SPTBN1;ACTB;SHANK3;LAMA2;SEMA6A;NRP2;LAMA1;GAB1;SEMA3C;BSG;SLIT2;PARD3;SEMA7A;NOTCH3;RPS6KA5;NOTCH1;PIK3R1;PLCG1;PALLD;APP;LAMA3;KLF7;WNT5A;NTN4;NPTN;CXCL12;ROBO4;ARHGAP35;MAPK1;SPTAN1;EFNA5;PIK3CA;CDK5;SRC;SEMA5B;S100A6;B4GALT5;EPHB2;PIK3CD;SEMA3E;DSCAML1;UNC5B;VLDLR;RAB3A;RANBP9;RET;SEMA3G
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5538361178522004,1.347717937828438,0.1375968992248062,0.8105761580135665,1.0,3/13,5.71%,CHST4;RENBP;LARGE1
prerank,carboxylic acid catabolic process (GO:0046395),0.5639121106268952,1.3474675900008104,0.1519230769230769,0.8078144614124902,1.0,4/12,11.76%,PON1;RENBP;GNPDA1;NPL
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.45654664242284704,1.3473317507240206,0.11320754716981132,0.8045324494432075,1.0,7/26,9.68%,OSBPL8;IGF1;CLIP3;PRKCI;SORBS1;RHOQ;CREBL2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4861295909781889,1.3471244146252077,0.12403100775193798,0.8015332798553197,1.0,5/21,11.59%,ATP1A2;ANK2;GSTM2;RYR2;GSTO1
prerank,metal ion homeostasis (GO:0055065),-0.39804005706358636,-1.3466619408400884,0.0867579908675799,0.39670999575470767,1.0,17/40,28.39%,TMTC2;CAV1;SLC12A7;SLC12A2;SLC12A6;JPH2;CNNM2;MT3;SLC7A8;GRIN1;SLC12A8;SLC8A1;LETM1;WFS1;SELENON;SLC12A4;TESMIN
prerank,negative regulation of hydrolase activity (GO:0051346),0.4067285028286917,1.3463203845575944,0.10270270270270271,0.8008875813424933,1.0,9/49,8.07%,CPEB2;MAP2;GCHFR;SH3RF2;SH2D4A;GMIP;ARL2;GPSM1;LRRK2
prerank,potassium ion homeostasis (GO:0055075),0.4809943151135146,1.345718977454323,0.11583011583011583,0.7995174210315821,1.0,6/23,11.41%,ATP1A2;ATP1B3;ATP1B2;KCNH2;SLC12A5;SLC12A1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.43728352855331104,-1.3454203624945271,0.12164948453608247,0.3987120822167484,1.0,15/27,22.98%,VPS13C;RAB6A;TMED10;GBP5;GOLPH3;RIPOR1;VPS13D;VPS13A;ARL5A;SYS1;PAQR3;BICD2;COG7;CSNK1D;GAK
prerank,tryptophan metabolic process (GO:0006568),0.5714286815225443,1.345297440991387,0.15139442231075698,0.7975732881351231,1.0,5/11,19.53%,IDO1;HAAO;KMO;ATP7A;KYAT1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4788219045297222,1.3452523536050456,0.11173184357541899,0.7939990527371724,1.0,8/26,15.17%,LGR4;APPL2;NLRP2B;OTUD4;FLOT2;CACTIN;TYRO3;TLR5
prerank,protein phosphorylation (GO:0006468),-0.2752934143829094,-1.34523885588115,0.007326007326007326,0.39836405511214823,1.0,153/478,23.22%,PRKG1;PRKCH;TEK;ABI1;ERG;SNRK;BMPR2;DAB2IP;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;STK38L;PKD1;GAS6;STK3;PEAK1;EGFR;LIMK2;EEF2K;BCR;BMP4;AKT3;TGFBR2;IRAK3;KDR;APP;CRY1;CDK14;RPS6KA3;FNIP2;BMX;TNIK;CAB39;NUAK1;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;TEC;PRKD1;CIT;TNKS;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;FLT1;CSNK1G3;PRKX;PRKCG;RPS6KA2;STK24;CDK5;SRC;FLT4;MAP4K4;EIF2AK3;STK33;MAPKAPK2;ABI3;GTF2H5;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GTF2H1;VRK3;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;INCENP;BMP2;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;PKN3;ALK;LIMK1;CSF1R;PRKACA;MKNK2;TAOK3;CAD;MAST2;FGFR3;COQ8A;LATS1;MASTL;STRADA;TAOK1;HUNK;PTPN6;PRAG1;STK26;MAPK12;CDK16;EFEMP1;CDK6;MAPK3;BTK;CAMK1G;MARK3;STK17B;RIPK1;JAK3;HCK;TRIB2;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;SYK;ROCK1;TOP1;CDKL4;CCNH;FYN;SLK;SIK3;MAP4K3;RYK;CDK11B;PRKAR1B;STK32C;USP15;CDK18
prerank,cellular response to superoxide (GO:0071451),-0.5781443369512357,-1.3450896702506863,0.13654618473895583,0.39798071259716655,1.0,3/10,14.78%,NOS3;SOD1;MT3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5309849150021037,-1.3450071527983192,0.126953125,0.3974276147595133,1.0,8/13,35.75%,RACK1;NCK1;PTPN1;ATF6B;WFS1;HSPA5;ABCA7;DDRGK1
prerank,macrophage differentiation (GO:0030225),-0.5191108386274949,-1.3444624635839466,0.13972055888223553,0.3979333993354466,1.0,7/13,28.71%,BMP4;IL15;VEGFA;CSF1R;CDC42;CASP8;PARP1
prerank,cell projection assembly (GO:0030031),-0.46151858827127823,-1.3433435111984489,0.11066398390342053,0.39962194164099213,1.0,8/22,21.07%,RHOJ;GSN;PARVB;PARVA;CAPG;NCKAP1L;CDC42;RAC3
prerank,cellular response to calcium ion (GO:0071277),0.37944139226334195,1.3419572307501129,0.08885017421602788,0.8035711309021463,1.0,16/67,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SYT10;TRPM2;CPNE6
prerank,nucleotide catabolic process (GO:0009166),-0.5031382123830594,-1.3416091361644555,0.12896825396825398,0.4028840359385634,1.0,7/16,21.88%,XDH;GPX1;NT5C1A;DERA;NT5E;NT5C;GDA
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.39890066875373387,-1.3416050999079283,0.08552631578947369,0.4021675217899101,1.0,12/39,9.74%,MAML2;IL6ST;JAG1;NOS3;TGFB2;NOTCH1;STAT3;CCN3;JAG2;EPN2;SRC;NOTCH4
prerank,dendrite self-avoidance (GO:0070593),-0.4979328039763993,-1.3411407290205994,0.10141987829614604,0.40249610089324644,1.0,6/16,13.17%,BSG;PALLD;NPTN;ROBO4;DSCAML1;EMB
prerank,prostanoid metabolic process (GO:0006692),0.53580171652812,1.3409251814453373,0.14107883817427386,0.8041591816475343,1.0,3/13,7.80%,PTGS1;PTGES;PTGR1
prerank,regulation of cell size (GO:0008361),-0.44533864241448073,-1.340748051328551,0.11182795698924732,0.4026970901561611,1.0,9/23,21.28%,RHOA;VAV2;RPTOR;EDN1;RARG;PRR16;PTEN;AKT1S1;MSN
prerank,positive regulation of synapse assembly (GO:0051965),0.4588795003768548,1.3406572440909497,0.09532710280373832,0.8016215570376978,1.0,10/27,17.49%,IL1RAPL1;NLGN2;WNT7A;VSTM5;GRID2;NLGN3;PTPRD;BDNF;EPHB1;SYNDIG1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4826605527454998,-1.3398098937261804,0.12761506276150628,0.40399700428342467,1.0,9/19,33.02%,SLCO1C1;APP;KLF4;KLF2;EGF;WFS1;TMEM106A;HPN;MAPK8
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3569485856817832,-1.3394571818713636,0.05647058823529412,0.4040438951862439,1.0,12/67,6.60%,MYO10;PODXL;CAV1;ATP8B1;TBC1D8;ATG3;USP6NL;TBC1D5;IFT140;TBC1D2B;TBC1D1;PPP1R16B
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5116675427448744,-1.3390626274592137,0.1437908496732026,0.4042096226115626,1.0,9/15,32.10%,BMP4;SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,T cell activation involved in immune response (GO:0002286),-0.5438156979011812,-1.3380908201018629,0.12629399585921325,0.4055806123815031,1.0,3/12,11.83%,ICAM1;MDK;CD74
prerank,manganese ion transport (GO:0006828),-0.521743657511202,-1.337882316625278,0.11196911196911197,0.40532463648112804,1.0,5/14,9.94%,TRPC3;SLC39A8;TRPC6;TRPC4;TRPC1
prerank,histone H2B ubiquitination (GO:0033523),0.5823945132492878,1.337840350681548,0.1519230769230769,0.8090937286492212,1.0,4/10,11.83%,CTR9;LEO1;RNF20;CDC73
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.52598724411484,-1.3374668728348056,0.14228456913827656,0.40553188563627646,1.0,4/13,14.31%,TMEM30A;SEC16B;INSIG1;SAR1A
prerank,natural killer cell activation (GO:0030101),-0.45203177114743676,-1.3369077153553484,0.1023454157782516,0.4061263317874214,1.0,7/23,16.52%,PBX1;KAT7;ELF4;PIK3CD;NFIL3;PTPRC;ULBP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5557687516445089,1.3362337483867208,0.17670682730923695,0.8120650321511221,1.0,2/12,0.41%,NOTCH2;DOCK11
prerank,regulation of stem cell proliferation (GO:0072091),0.5047622147722041,1.3359461664483765,0.13555992141453832,0.8095818638400297,1.0,6/17,17.54%,FBLN1;HNRNPU;EIF2AK2;AGO3;TERT;KDM1A
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.27351977542339134,-1.3353392015606906,0.0,0.40907108411416554,1.0,153/532,21.87%,LIMS1;GHR;ACTN4;IL6ST;IL1R1;OSMR;ZEB1;LIFR;TMSB4X;TRAF5;B2M;GREM2;FOXO1;RPS6KA5;PIK3R1;F3;FOXO3;VCAM1;BCL2L1;NFKBIA;SOCS2;STAT3;CD44;PTPRJ;MID1;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;NOD1;ADIPOR2;CARD14;IFITM3;MTAP;TNFRSF11A;ITGB1;STX3;ICAM1;RPS27A;IRF9;S1PR1;CAMK2D;UBB;PAK2;TEC;AIM2;PPIA;RPLP0;CXCL12;IL6R;ANXA1;IL34;PRKCD;PSMA6;TNFRSF11B;INPP5D;PSMB7;IL20RB;TRIM25;XAF1;IFI35;CEACAM1;CCL13;CNN2;IL1RAP;PIK3CA;BRWD1;SRC;CNTFR;SOD1;FGF2;SOCS5;IL15;IRF2;PSMB6;JAK1;YWHAZ;IL4R;CFL1;ACKR3;MAOA;PIK3CD;PSMB5;IL1RL2;CEBPD;EDA2R;SQSTM1;TWIST1;ISG15;PTPRZ1;PDCD4;UGCG;BIRC3;PTK2B;POU2F1;CD40;RSAD2;IRS1;CD86;VEGFA;PSMB8;IL17RE;IRAK2;MT3;CBL;TAB1;PSMC4;PSMD11;CSF1R;PRKACA;SP100;IFITM1;BOLA2;CISH;IFNAR1;SOCS3;MMP2;MAP3K8;PSMB4;JUNB;EDAR;PSMD14;NOD2;IL33;PTPN6;CCL25;CCND1;MT2A;MAPK3;MCL1;CRLF1;IRF5;RIPK1;SPI1;SMARCA4;JAK3;HCK;CDC42;PSMD10;CAPZA1;MYD88;TNFSF8;SYK;MSN;PSME1;RIPK2;IFITM2;NUMBL;F13A1;HNRNPF;FCGR1A
prerank,in utero embryonic development (GO:0001701),-0.4459497050739801,-1.335293745841774,0.09611451942740286,0.4084530834592579,1.0,12/25,20.39%,MBNL1;PKD1;FUT8;ADAM10;IGF2;TGFB3;BMP2;VEGFA;STIL;LIG4;SOX8;LMX1B
prerank,regulation of acute inflammatory response (GO:0002673),-0.4778587838185828,-1.3350546077845054,0.1292929292929293,0.4082364453871826,1.0,2/18,1.02%,IL6ST;OSMR
prerank,calcium ion transport (GO:0006816),0.3515432065140366,1.334757124395407,0.05102040816326531,0.8106572716517434,1.0,11/113,3.93%,TRPM3;CACNA1D;SLC8A3;SLC24A3;TRPM6;CACNG7;TRPV1;ANK2;CACNB3;GRIN3A;ITPR1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.33821894399892527,-1.3346182045395338,0.06987951807228916,0.4085452459679162,1.0,33/93,22.51%,DAB2IP;SH3RF3;TRAF5;TGFB2;MAP3K5;RASSF2;MID1;APP;MFHAS1;XDH;FLT4;EDA2R;BMP2;PTK2B;TNFRSF19;ANKRD6;VEGFA;MTURN;TAOK3;KLHDC10;EDAR;RELL1;NOD2;TAOK1;ZC3H12A;SH3RF1;RIPK1;SPI1;HMGB1;TRAF4;MAP3K4;SEMA4C;FCGR2B
prerank,negative regulation of axon extension (GO:0030517),-0.4232564377793924,-1.3340765418450096,0.1137855579868709,0.40903418135185393,1.0,13/30,22.00%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;MT3;SEMA5A;RTN4;SEMA6D;SEMA3F;RTN4R;SEMA4C
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.39420277804253423,-1.3337012821482492,0.09523809523809523,0.4091860810753107,1.0,10/41,10.46%,MEF2C;JAG1;TGFB2;ENG;NOTCH1;BMP4;TGFBR2;HEYL;HEY2;CPE
prerank,organic cation transport (GO:0015695),-0.4694643990361316,-1.3333283960421976,0.125,0.40925816987187164,1.0,5/20,12.51%,SLC47A1;SEC14L1;SLC44A2;SLC22A18;SLC44A1
prerank,tight junction assembly (GO:0120192),-0.3805257659289848,-1.3328453217254956,0.08185840707964602,0.4096531731705284,1.0,13/49,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;ACTG1;LSR;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.33747482093106035,-1.3327535527300522,0.045454545454545456,0.40919530446129765,1.0,24/91,10.04%,ABCG2;SLC39A10;SCARA5;SLC40A1;APP;SLC30A1;SLC39A8;TFRC;SLC30A9;SLC31A1;ATOX1;ATP6V0D1;SOD1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;CAND1;SLC39A7;FTL
prerank,negative regulation of cell cycle (GO:0045786),0.3790918258013255,1.3326338796973816,0.09866220735785954,0.8157341884532936,1.0,14/73,7.55%,BMP7;NUPR1;SMAD3;CDKN2A;GMNC;ANGEL2;TSPYL2;PLK1;NLRP2B;CEBPA;HTRA2;NR2F2;TRIM35;INHA
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5571374840476988,-1.332520169974165,0.1383177570093458,0.40899534597398995,1.0,4/10,16.85%,ETFBKMT;HDAC6;MT3;AOC3
prerank,mononuclear cell differentiation (GO:1903131),-0.44979488111357624,-1.3321437385896908,0.09856262833675565,0.40913506183527926,1.0,8/24,15.76%,GAS6;MYH9;BMP4;LYN;RELB;MT1G;VEGFA;CSF1R
prerank,regulation of B cell proliferation (GO:0030888),-0.3908816019871181,-1.3308788396196731,0.10514541387024609,0.4111933201254876,1.0,12/44,16.03%,MEF2C;TFRC;LYN;TNFRSF21;CD38;AHR;EPHB2;NFATC2;CD74;CD40;PTPRC;NCKAP1L
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5585933443922276,-1.330052158644095,0.13827655310621242,0.4123530853233139,1.0,6/10,22.57%,ACTN4;RARB;TBX1;RARG;SNW1;RXRG
prerank,primary alcohol metabolic process (GO:0034308),0.46392666453349696,1.3293018356127808,0.12710280373831775,0.8257911170410918,1.0,4/25,2.63%,IGF1;ADH7;ADH4;CYP11B1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5064763962582401,-1.3287272195583677,0.14344262295081966,0.4146097372504465,1.0,11/14,47.19%,TYROBP;POU4F1;ATP6AP1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;IL12B
prerank,myofibril assembly (GO:0030239),0.40983979584863695,1.3285254038615237,0.10371819960861056,0.825232742794161,1.0,8/42,10.07%,ACTN2;PDGFRA;OBSL1;CAPN3;CSRP3;CSRP1;TMOD2;CFLAR
prerank,regulation of embryonic development (GO:0045995),-0.4095532623401652,-1.3274935557666585,0.10736842105263159,0.41669789899293974,1.0,8/34,10.52%,INSR;RAB14;PHLDB1;PHLDB2;SOX17;NIPBL;B4GALT5;CFL1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5342106548328198,-1.3273655460350606,0.1375,0.41553246876593186,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5342106548328198,-1.3273655460350606,0.1375,0.41553246876593186,1.0,5/12,13.34%,ACTN4;CORO1C;KANK1;EFNA5;AP1AR
prerank,regulation of kinase activity (GO:0043549),-0.3396264332528852,-1.3254877492832389,0.06265664160401002,0.4190149797350586,1.0,21/89,12.90%,ROR1;TEK;NTRK3;PLCE1;TIE1;INSR;MERTK;EGFR;EEF1A1;KDR;MET;NLRC5;FLT1;EMP2;CDKN1C;SOD1;FLT4;EPHB2;CD74;RET;ROR2
prerank,aorta morphogenesis (GO:0035909),-0.48824934344940507,-1.3253760360731202,0.12601626016260162,0.4185057933841239,1.0,10/17,21.06%,JAG1;ACVRL1;ENG;TBX1;HEY2;TBX2;LRP1;HEY1;DLL4;MYLK
prerank,myeloid leukocyte differentiation (GO:0002573),-0.35066762066379276,-1.3250280363971563,0.06372549019607843,0.41855822560780037,1.0,26/65,28.71%,LEF1;FOXP1;MYH9;RUNX1;BMP4;TGFBR2;CBFA2T3;TNFRSF11A;MT1G;IL15;PIK3CD;SNX10;VEGFA;CSF1R;SPI1;CDC42;SBNO2;OSTM1;CASP8;PRTN3;EFNA2;TREM2;CDK2;BATF2;FARP2;PARP1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.4885393466734399,-1.3248998447437998,0.10408163265306122,0.41815258904221836,1.0,6/16,16.12%,INSR;IRAK3;MTRF1;HDAC6;TBC1D25;CLEC16A
prerank,cholesterol metabolic process (GO:0008203),0.3743153683444107,1.323986375943641,0.08517887563884156,0.8398468931700322,1.0,21/68,18.60%,CEL;ACAT2;SOAT2;CYP11B1;INSIG2;DHCR24;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;CYP51A1;TSKU;GBA2;MSMO1;GGPS1;ABCA5;HMGCR
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5147154654523571,1.323780702427725,0.14951456310679612,0.8370187086876025,1.0,8/15,22.55%,FANCD2;EME2;MDC1;MRE11;CHEK2;RAD17;RAD9B;ATF2
prerank,positive regulation of macrophage migration (GO:1905523),-0.4724343706135041,-1.323592236846397,0.12653061224489795,0.4203987200025333,1.0,9/19,27.07%,THBS1;IL34;MAPK1;MDK;RARRES2;CSF1R;MAPK3;CMKLR1;TREM2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.48289842052347987,1.3234690890273322,0.14285714285714285,0.8346038603208655,1.0,2/22,2.46%,ALDH1A2;RBP1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4226113386931131,-1.3224859284828958,0.11506276150627615,0.4222001704681932,1.0,10/29,17.39%,BMP5;DAB2IP;SDHAF2;IL17RD;SPRED2;SPRY2;VASN;SPRY1;MAD2L2;PTEN
prerank,response to ketone (GO:1901654),-0.44459622288977707,-1.3224348364296206,0.09635974304068523,0.42159793273426455,1.0,5/24,2.26%,CAV1;SLIT2;ABHD2;TGFB2;THBS1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5043833722809823,-1.3214647658956702,0.15217391304347827,0.423218309084175,1.0,5/15,20.12%,TGFB2;IRAK3;TGFB3;JAK3;CUEDC2
prerank,erythrocyte differentiation (GO:0030218),0.41055139867497314,1.3210140359262177,0.11669658886894076,0.8410424758156537,1.0,9/44,8.34%,TGFBR3;KIT;FLVCR1;SLC25A5;IKZF1;ABCB10;CASP3;INHA;MED1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.29025602939716244,-1.3210003696829495,0.01764705882352941,0.423494589890617,1.0,61/259,15.14%,NRP1;ABCC4;FGD5;DNM3;RAPGEF2;ABLIM1;VCL;FGD6;NTN1;FXYD5;GSN;PARVB;NOTCH1;PKD1;DISC1;RAP1A;CDH13;EMP1;SPATA13;MTSS1;EXOC6;EXOC4;FAM161A;TNIK;FLNA;IFT140;RAP2A;ITGB1;S1PR1;ABLIM3;ARL13B;RAPGEF6;BBS9;EMP2;ATP6V0D1;PDE6D;MAP4K4;RP2;GOLPH3;CD2AP;WHAMM;PARVA;EHD2;EXOC1;WDR11;TCTN3;PIBF1;SNX10;FNBP1L;EHD4;ATP6V1D;ABLIM2;HDAC6;SHTN1;DYNLL1;AVIL;CYS1;DZIP1L;BBIP1;TMEM216;CFAP43
prerank,negative regulation of response to wounding (GO:1903035),-0.4741687266158768,-1.3208614942774846,0.14081632653061224,0.4231166527024449,1.0,8/19,16.66%,CD109;CASK;AJAP1;MDK;FGF2;SERPINE1;GIT1;RTN4RL1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5214819257812636,1.3206838077626344,0.15757575757575756,0.8388153763662405,1.0,4/15,11.59%,CPEB2;PPIF;GSTO2;GSTO1
prerank,mitochondrial fission (GO:0000266),-0.486111464853282,-1.320047578693512,0.14314115308151093,0.4242801675898528,1.0,9/16,33.24%,DNM3;MFF;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2;MTFR1L
prerank,regulation of ion transport (GO:0043269),0.366431207942138,1.3197073909652126,0.08188153310104529,0.8391459758537367,1.0,16/76,11.43%,SYT11;SYT12;SNX6;KCNJ13;KCNJ5;SYT9;KCNJ10;SYT1;SYT13;CHRNB2;DRD3;PDZK1;KCNJ16;SYT10;CHRM1;DTNBP1
prerank,cellular response to interleukin-6 (GO:0071354),-0.43761118301065194,-1.3195237558709891,0.1012396694214876,0.4247801979744826,1.0,8/26,10.02%,PID1;IL6ST;ST3GAL6;PTGIS;STAT3;IL6R;SRC;JAK1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4264267160868365,1.31949757457715,0.12213740458015267,0.8363881331056542,1.0,11/37,11.69%,TTC21B;WDR19;IFT74;WDR35;DYNC2LI1;KIF3C;DYNC2I2;IFT122;PCM1;KIF3A;IFT80
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.45125170672413534,-1.319207820979217,0.12422360248447205,0.42486145081737264,1.0,7/21,18.14%,YWHAE;MFHAS1;YWHAB;PPP1R16B;BOD1L1;PPP1R11;MASTL
prerank,regulation of viral entry into host cell (GO:0046596),-0.4186265814548893,-1.3189433918836537,0.11875,0.4247162644548479,1.0,8/30,12.21%,GSN;LY6E;MID2;IFITM3;TRIM14;TRIM25;CD74;NECTIN2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5189564938997684,-1.3189242480513093,0.15415821501014199,0.42405035027678106,1.0,4/12,10.72%,CSGALNACT1;FUT8;PARG;GFPT2
prerank,sphingolipid metabolic process (GO:0006665),-0.3232337792715396,-1.3186781825476896,0.043243243243243246,0.42385854975265763,1.0,38/108,22.64%,SGMS1;ST6GALNAC3;ESYT2;SGMS2;ELOVL7;ACER2;CERT1;DEGS2;AGK;PRKD3;PRKD1;SPNS2;ELOVL5;CERS5;CERS6;ORMDL3;PLPP1;SAMD8;ESYT3;HEXA;ELOVL6;PSAP;UGCG;ARSA;ELOVL1;PLPP3;VAPB;ELOVL4;SGPP1;SPTSSA;ASAH2;PPM1L;ACER3;ARV1;PPP2CA;GLTP;CERS4;PLPP2
prerank,cellular amino acid catabolic process (GO:0009063),0.3623886445052166,1.3186490146458305,0.07378335949764521,0.836147514266332,1.0,18/87,11.65%,DDO;IDO1;ALDH7A1;IVD;SLC25A44;DBT;ACAT1;GLDC;HAAO;ACADSB;ECHS1;BCAT2;ASPA;KMO;GLS2;BCKDHB;GAD1;GCDH
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4359620163593767,-1.3186285856629003,0.13111111111111112,0.42326568849056395,1.0,12/23,24.50%,BMP4;SIX1;MDK;FGF2;PIK3CD;SMO;VEGFA;SIX4;SOX8;EGF;SIRT6;LHX1
prerank,response to muramyl dipeptide (GO:0032495),-0.5325944470746662,-1.3181637821627183,0.15264187866927592,0.42358604491996593,1.0,6/12,21.51%,NOD1;ARHGEF2;NOD2;ERBIN;IRF5;RIPK2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5270564755974814,-1.318125046524327,0.154296875,0.42296206748946236,1.0,3/12,4.28%,BMP5;SLIT2;CCN3
prerank,catecholamine metabolic process (GO:0006584),0.5323732228739511,1.3180447370157338,0.16297786720321933,0.8350988263190345,1.0,5/14,18.63%,SNCAIP;DRD3;COMT;ATP7A;RNF180
prerank,granulocyte chemotaxis (GO:0071621),-0.36995050010831976,-1.3177929258266181,0.07829977628635347,0.42301818742187774,1.0,27/55,40.70%,BSG;TGFB2;PPIA;ANXA1;CCL13;CXADR;EDN1;PIK3CD;EDN3;NCKAP1L;CCL25;SYK;PPIB;PIK3CG;S100A9;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;FCER1G;PPBP;CCL8;CCL19;CCL14
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5322408917776318,-1.3173588303691866,0.13671875,0.42329557817388863,1.0,4/12,4.62%,GSN;LY6E;MID2;IFITM3
prerank,lung development (GO:0030324),0.43666343091112225,1.3171750630838353,0.13686131386861314,0.8351739549799778,1.0,7/33,6.95%,FGF1;ERRFI1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,response to alcohol (GO:0097305),0.4534326311172082,1.3164658930796,0.12678571428571428,0.834507211135361,1.0,9/27,15.79%,TGFBR3;ADH7;GRIN3A;GLRA1;CHRNB2;DRD3;TGFBR1;ABCA2;GOT2
prerank,focal adhesion assembly (GO:0048041),-0.4504690473465986,-1.31485208777683,0.1401673640167364,0.4283818154302079,1.0,7/21,10.16%,THSD1;PEAK1;BCR;PTPRK;ACTN1;SRC;WHAMM
prerank,regulation of histone methylation (GO:0031060),0.5452845992503058,1.3139870194908057,0.15674603174603174,0.841185039367276,1.0,6/13,15.32%,CTR9;TET1;JARID2;NSD1;PIH1D1;MTHFR
prerank,regulation of cell growth (GO:0001558),-0.2948469677257419,-1.313576146562942,0.0221606648199446,0.4306151485487708,1.0,51/204,17.54%,APBB2;LTBP4;PLCE1;BMPR2;SLIT2;NET1;ACVRL1;TGFB2;DCUN1D3;SH3BP4;EGFR;SOCS2;BTG1;PTPRJ;H3-3A;FHL1;RPS6KA3;CCN3;SOX17;CCDC85B;TFRC;CAMK2D;AGTR1;RACK1;ADAM10;CEACAM1;BCAR1;CDKN2AIP;RPTOR;FAM107A;PABIR1;NME6;DCUN1D5;MFSD2A;SIPA1;USP47;CSNK2A1;RERG;ENPP1;PTCH2;ADAM15;MT3;NCBP1;KLHL22;MAD2L2;DDX49;RTN4;CDA;CISH;NUBP1;OSGIN1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.4792425767153705,1.3133476497982253,0.13786764705882354,0.840132825171812,1.0,7/20,19.10%,EPAS1;HSPA1A;TGFBR1;HSPA1B;DNAJB2;HSP90AA1;WASHC1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5478865200557902,-1.3128490870721778,0.15267175572519084,0.43148776695343916,1.0,5/11,18.03%,WIPI1;APOE;PIK3C3;UGCG;WDR45B
prerank,negative regulation of growth (GO:0045926),-0.3115572184292571,-1.312795307924165,0.04030226700251889,0.4309109131310795,1.0,35/121,17.54%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;NOTCH1;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;CDKN2AIP;NME6;SIPA1;RERG;ENPP1;ADAM15;MT3;RTN4;CDA;ING4;FGFR3;OSGIN1
prerank,positive regulation of synaptic transmission (GO:0050806),0.3718268289289485,1.3123462129203562,0.08818635607321132,0.8406145919469301,1.0,14/72,9.52%,SLC8A3;CACNG7;PRKCZ;NLGN2;ZDHHC12;ADCY1;GRIN2D;SYT1;ADCY8;NLGN3;GRIK2;SHISA7;RIMS1;DLG4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3215500015601269,-1.3121575446292975,0.056511056511056514,0.4315750461154382,1.0,29/114,21.46%,LIMS1;ACTN4;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;AIM2;PSMA6;TNFRSF11B;PSMB7;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;PSMB4;EDAR;PSMD14;RIPK1;PSMD10;TNFSF8;PSME1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.33654520613894895,-1.31151706438261,0.06839622641509434,0.43236319011922536,1.0,25/85,14.01%,ARHGEF28;PLCE1;DAB2IP;TGFB2;NOTCH1;STARD8;NGF;BCR;KANK1;STARD13;ARHGEF2;EPS8;ARHGDIB;LYN;SHOC2;SPRY2;EPS8L2;EPHB2;LRRC59;SQSTM1;GABARAP;ARHGDIA;DENND4B;SPRY1;MADD
prerank,gluconeogenesis (GO:0006094),0.4171306369031376,1.3113797741431088,0.10905730129390019,0.8413010867661072,1.0,17/39,21.46%,ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;G6PC3;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;SLC25A13
prerank,ganglioside biosynthetic process (GO:0001574),-0.4975825988410619,-1.3108821402260074,0.1346938775510204,0.43305168619309353,1.0,8/15,17.75%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2;ST3GAL2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.30179416123519,-1.3108547411716425,0.039473684210526314,0.43243893296749486,1.0,44/161,18.06%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;SFRP4;TBX18;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11;IGFBP4;LATS1;PSMB4;PSMD14
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5014690401150069,-1.3105775693137278,0.16317991631799164,0.43240251160869847,1.0,3/15,9.64%,SCARB1;PLTP;APOE
prerank,negative chemotaxis (GO:0050919),-0.40262234180102596,-1.3101079509322402,0.10851063829787234,0.4327340874257867,1.0,6/33,1.72%,SEMA6A;SEMA3C;SLIT2;RHOA;NTN1;SEMA7A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3885043162868522,1.3099643918987511,0.10166358595194085,0.8437183686431967,1.0,18/57,19.03%,CACNG7;ACTN2;NLGN2;NPTX1;DLG1;SHISA7;SHANK1;GSG1L;DLG4;NPTXR;CNIH3;OPRM1;SHISA8;LRRC7;GRIA2;NEFL;MINK1;MAPK8IP2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3834661581318142,-1.3099048412991747,0.1206140350877193,0.43257009015706005,1.0,15/44,14.83%,DAB2IP;BMP4;PTPRJ;IRAK3;DNAJA1;LYN;PRKCD;SPRY2;PTPN1;APOE;AIDA;PDCD4;STK38;SPRY1;PAQR3
prerank,peptidyl-lysine methylation (GO:0018022),0.4482181174702834,1.3097552244864321,0.15225563909774437,0.8411093415406854,1.0,8/26,13.15%,KMT5A;EEF2KMT;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2
prerank,neuromuscular junction development (GO:0007528),0.45990989028503626,1.30942636594763,0.13948919449901767,0.8390006249892941,1.0,6/24,8.27%,UNC13C;CACNB1;CACNB3;PDZRN3;LRRK2;LRP4
prerank,regulation of T cell proliferation (GO:0042129),-0.35739169635084184,-1.3092505294092467,0.08029197080291971,0.433394009425381,1.0,17/61,22.72%,IL6ST;VCAM1;TNFRSF1B;TFRC;ANXA1;NCK1;SLC7A1;TNFRSF21;IL15;PTPRC;CD86;NCKAP1L;CD46;JAK3;TNFSF8;GLMN;CD276
prerank,regulation of actin filament polymerization (GO:0030833),-0.3484670648021346,-1.30774722002624,0.07042253521126761,0.43603957151817846,1.0,25/69,26.41%,SLIT2;ESAM;KANK1;SSH2;KANK3;CDC42EP5;CDC42EP3;KANK4;PRKCD;NCK1;CDC42EP2;HIP1R;PLEKHG2;PTK2B;PFN1;NCKAP1L;LATS1;FCHSD1;HCK;RASA1;HCLS1;SSH1;PRKCE;CARMIL1;TWF2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4001812224528281,-1.3069419228629886,0.10444444444444445,0.43713086483398084,1.0,10/33,24.80%,LEF1;RUNX1;IL34;CD74;ID2;RIPK1;TESC;HCLS1;FES;CASP8
prerank,mismatch repair (GO:0006298),0.4528539637578503,1.3061659428575245,0.14528301886792452,0.8487038711323198,1.0,10/27,15.25%,RNASEH2A;ERCC1;PMS2;POLD2;MSH4;MSH6;MLH3;MSH3;RPA3;ABL1
prerank,keratinocyte differentiation (GO:0030216),-0.42161551867538116,-1.3056759503677833,0.12147505422993492,0.43942547537229953,1.0,8/29,12.12%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.45195932660028226,-1.3055632610707444,0.13859275053304904,0.43899556049481797,1.0,9/21,19.95%,PDE4D;CAV1;RASSF2;RACK1;NCK1;PAQR3;DDIT4;PTEN;DMD
prerank,mRNA splice site selection (GO:0006376),0.4328764462518859,1.305531831160258,0.12962962962962962,0.8479373108256326,1.0,12/30,23.82%,CELF2;SRSF5;SRSF10;PSIP1;YTHDC1;NOL3;SRSF6;CELF6;PUF60;LUC7L;CELF1;SNRPC
prerank,protein tetramerization (GO:0051262),0.37025608441881824,1.3054356148520947,0.08228980322003578,0.844933610092117,1.0,18/67,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;CPSF6;KCNC3;CPSF7;GOLGA2;SSBP1;CUTC;TRPM2;ACACA;CTH;FARSA;OXA1L;ALDH9A1;ACOT13;USP16
prerank,regulation of JUN kinase activity (GO:0043506),-0.40746207895601216,-1.3042433552228407,0.12636165577342048,0.44122084964331676,1.0,8/33,11.79%,DAB2IP;MAP3K5;DNAJA1;TNFRSF11A;RPS3;AIDA;EDN1;PDCD4
prerank,global genome nucleotide-excision repair (GO:0070911),-0.4254315910004326,-1.3041285654699921,0.11659192825112108,0.4407468268390073,1.0,10/26,12.95%,RNF111;UBC;RPS27A;XPC;UBB;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2
prerank,steroid hormone biosynthetic process (GO:0120178),0.43867189029898646,1.3040916886135365,0.14338235294117646,0.8469032981101206,1.0,9/29,23.22%,HSD17B2;CYP11B1;MED1;FDX1;STAR;FDX2;HSD17B11;FDXR;TSPOAP1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5091586258655574,-1.3040194785019439,0.1457905544147844,0.4403047082422455,1.0,5/13,23.99%,PLA2G4A;MGLL;ABHD6;AWAT2;MOGAT3
prerank,positive regulation of histone methylation (GO:0031062),0.4666080664950288,1.303938819014103,0.17073170731707318,0.844157868204058,1.0,6/24,8.14%,CTR9;KMT2A;TET1;AUTS2;JARID2;PHF1
prerank,amyloid fibril formation (GO:1990000),-0.3665825479535157,-1.303807783301449,0.11428571428571428,0.44006420960825676,1.0,12/51,8.14%,B2M;GSN;H3-3A;APP;UBC;RPS27A;UBB;CST3;ADAM10;IAPP;TGFBI;MFGE8
prerank,vasodilation (GO:0042311),-0.5147695947573994,-1.3037347996254707,0.1461864406779661,0.4395599894642067,1.0,4/13,17.68%,NOS3;SOD1;KLF2;GPER1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.34697684351116137,1.3033532729691242,0.07746478873239436,0.8432917429865401,1.0,22/107,12.83%,ATP1A2;SLC8A3;CEL;SNCAIP;NLGN2;NPTX1;GRID2;IQSEC2;SYT1;NLGN3;GRIK5;GRIK2;RIMS1;LRRK2;CHRNB2;DLG4;DGKI;LRRC4C;NPTXR;SYN3;BDNF;CPLX1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3774040614183504,-1.302937964810036,0.10451306413301663,0.44060349179738967,1.0,24/47,30.38%,PID1;THBS1;TGFBR2;PLCG2;XDH;AGTR1;PRKCD;SOD1;ACE2;RAB27A;ROMO1;GRIN1;DHRS4;ZC3H12A;CBR1;RIPK1;SYK;TLR4;GRB2;DCXR;AGT;MAPT;CD36;TLR6
prerank,magnesium ion transport (GO:0015693),0.5321214777402508,1.3022877783074382,0.18290258449304175,0.844119049150843,1.0,5/12,19.09%,SLC41A1;TUSC3;MAGT1;MMGT1;MRS2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3355698182277776,-1.3012224554053824,0.05596107055961071,0.4438112097448076,1.0,37/80,26.85%,TNFSF10;MAP3K5;YWHAE;THBS1;GAS6;NGF;CD44;RPS6KA3;NOD1;CARD16;BCAP31;CTSD;SRC;XIAP;GPX1;KLF4;MALT1;SOX7;USP47;CSNK2A1;VEGFA;ACVR1C;MT3;GPER1;SH3RF1;FOXL2;HMGB1;BEX3;SYK;CASP1;BCL10;TRIAP1;DAPK1;EPHA7;F2R;ARL6IP1;RPS6KA1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4211097237681976,1.3007877872625677,0.1252336448598131,0.846886803864195,1.0,10/33,14.03%,CEL;NLGN2;GRID2;IQSEC2;NLGN3;GRIK5;GRIK2;LRRC4C;BDNF;PSMC5
prerank,blood circulation (GO:0008015),-0.36828624902987744,-1.3004242725314683,0.11283185840707964,0.44503149087473043,1.0,17/49,13.59%,ELN;NOS3;ACVRL1;MEOX2;GUCY1B1;TBC1D8;SGCD;AGTR1;CXCL12;SOD1;GPX1;GCLC;EDN3;ACE2;GCLM;GUCY1A1;CYB5R3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.491618746191531,1.2991481065924921,0.1686046511627907,0.8499477419208497,1.0,4/18,8.02%,ATP1A2;STK39;PPIF;KCNH2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5392144448194736,-1.2988741383805107,0.1680161943319838,0.4480815372987645,1.0,5/11,13.94%,SEMA6A;THBS1;CREB3L1;EPN2;KLF2
prerank,regulation of amyloid-beta formation (GO:1902003),0.4224324304477196,1.298388030875928,0.14095238095238094,0.8495965146692878,1.0,9/34,13.27%,IGF1;ROCK2;PICALM;RTN1;CASP3;NTRK2;CLU;EPHA4;ABCA2
prerank,acidic amino acid transport (GO:0015800),0.4976385085681839,1.298103770062795,0.16822429906542055,0.847387666020649,1.0,2/17,0.21%,SLC6A13;SLC6A1
prerank,negative regulation of cell development (GO:0010721),0.4634364338523567,1.297940007827159,0.15120967741935484,0.844703322336005,1.0,5/25,5.27%,IGF1;APPL2;RFLNA;WNT7A;PAX6
prerank,regulation of lamellipodium assembly (GO:0010591),-0.40905842343486853,-1.2977542412511847,0.11504424778761062,0.4499601655963502,1.0,9/34,14.95%,PLCE1;SLIT2;WASF2;PIK3R1;OCLN;PIK3CA;ABI3;AVIL;ARPC2
prerank,lipid homeostasis (GO:0055088),0.38217605556213574,1.2977480611640797,0.14109347442680775,0.8421362286021775,1.0,22/57,21.69%,PRKAA2;RBP1;FITM2;ABHD5;PNPLA8;CEBPA;ADCK1;ORMDL2;CLN8;ABCD1;NR1H3;USF1;DGAT2;ABCA2;ABCB4;SIRT1;TM6SF2;TLCD3A;MLXIPL;DDX3X;ATP13A2;RCN3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.48119507001988016,-1.2974526480668618,0.177319587628866,0.44999700668468706,1.0,7/15,15.55%,RPL5;RPS7;RPL23;BAG5;FBXO5;LIMK1;MAD2L2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4516411057084108,-1.2965312264850168,0.14498933901918976,0.45153721131358715,1.0,11/21,21.29%,NOS3;NOTCH1;GAS6;ASPN;HEY2;PTK2B;ECM1;ENPP1;HEY1;GREM1;ROCK1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4213592692186073,-1.2961855559618776,0.12317327766179541,0.4517089960674786,1.0,15/27,34.79%,IRAK3;UBC;RPS27A;UBB;IRAK2;TAB1;BTK;MYD88;TLR4;CD36;TLR6;TLR1;CD14;IRAK4;TLR2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5443974710803513,-1.2959991294760247,0.17475728155339806,0.4514423608218768,1.0,5/10,30.42%,TGFBR2;CD55;NCKAP1L;SOCS1;LGALS9
prerank,oogenesis (GO:0048477),-0.4992005226692046,-1.2957228801763438,0.13916500994035785,0.45140112129393706,1.0,12/15,46.82%,PTN;MDK;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;IHO1;MARF1;NANOS2;FMN2;HORMAD1
prerank,positive regulation of programmed cell death (GO:0043068),-0.2779138257893062,-1.2955818161661288,0.006153846153846154,0.45098700140493486,1.0,77/272,20.44%,DAB2IP;ITGA6;SLIT2;NET1;TNFSF10;ARHGEF3;MAP3K5;FOXO1;DCUN1D3;MCF2L;APAF1;RASSF2;STK3;CYP1B1;FOXO3;NGF;BMP4;SFRP4;RASGRF2;UNC13B;UBC;JUN;DNAJA1;TIAM2;FAS;ITGB1;MAP3K20;ARHGEF2;CRADD;RPS27A;UBB;RACK1;IAPP;KLF11;TGM2;APC;RPS6KA2;CTSD;ABR;SOD1;TIAM1;VAV2;ARHGEF12;TGFB3;TCTN3;TNFAIP8;SQSTM1;BMP2;HIP1R;PLEKHG2;SAP18;RARG;HDAC6;EEF1E1;JMY;ACVR1C;BAK1;ATF4;PREX1;ING4;DIABLO;TOP2A;GPER1;LATS1;DUSP6;BARD1;PSEN2;IRF5;RYBP;ARHGEF5;STK17B;RIPK1;FOXL2;TRIO;PSENEN;HMGB1;RHOB
prerank,protein catabolic process (GO:0030163),0.37443864009236427,1.2949413894667094,0.09598603839441536,0.8501565626319026,1.0,18/59,15.07%,MAGEA2;SIAH2;CAPN3;RNF41;SOCS6;HTRA2;CTRL;CLN8;FBXO6;LAMP2;PRPF19;CHEK2;FBXO17;BAG6;CLN5;RNF5;UCHL3;ADAMTS9
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5266645621281623,-1.294641325391587,0.16252390057361377,0.45098665674976385,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5266645621281623,-1.294641325391587,0.16252390057361377,0.45098665674976385,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5266645621281623,-1.294641325391587,0.16252390057361377,0.45098665674976385,1.0,8/12,33.65%,CDC27;ANAPC5;CDC16;CDC23;CUL3;ANAPC11;NSMCE2;ESPL1
prerank,regulation of JNK cascade (GO:0046328),-0.3230177426054081,-1.2939414403886094,0.07090464547677261,0.45186920488330573,1.0,29/101,20.49%,MECOM;DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;EGFR;APP;MFHAS1;RAP2A;FLT4;MAP4K4;AIDA;DUSP3;PER1;EDA2R;PHLPP1;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,regulation of cytoplasmic translation (GO:2000765),0.5137907341828376,1.293768400776572,0.17346938775510204,0.8517266180349591,1.0,3/14,7.57%,CPEB2;UNK;CPEB4
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3102373480398387,1.2921524663547752,0.04468412942989214,0.8549990649342651,1.0,50/224,17.62%,SLC6A1;UNC13C;DTNA;CEL;APBA3;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;DLG1;SYT1;SYN2;HTR7;NLGN3;HRH2;GRIK2;KCND2;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;CPLX1;SPG11;GABRG3;GABRB2;RIT2;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;PTCHD1;MINK1
prerank,negative regulation of protein transport (GO:0051224),0.45251984056654143,1.2918614005307092,0.14785992217898833,0.8529033179058128,1.0,10/25,18.74%,NDFIP1;PKDCC;SERGEF;DRD3;CYP51A1;SNX3;NDFIP2;IL12A;HMGCR;RHBDF1
prerank,chemical synaptic transmission (GO:0007268),0.30239191040014907,1.2918401767100667,0.04105571847507331,0.8497247601919257,1.0,60/284,17.26%,SLC6A1;UNC13C;DTNA;CEL;APBA3;NQO1;CACNB1;CACNB3;NOVA1;NLGN2;PCDHB11;NAPB;GABRG1;NPTX1;GLRA1;CHRM2;CAMK1;GRID2;DLG1;GRIN2D;SYT1;SYN2;SNAPIN;HTR7;NLGN3;HRH2;GRIK5;GRIK2;KCND2;NAPA;RIMS1;CHRNB2;SNAP25;DLG4;SLC12A5;SYT10;HTR1F;GABBR2;BSN;CHRM1;GAD1;PCDHB3;CPNE6;SYN3;CPLX1;SPG11;GABRG3;GABRB2;RIT2;NAAA;SYN1;AMPH;GRIA2;SCN2B;HTR1A;KCNQ3;HRH1;PENK;KIF1B;PTCHD1
prerank,glucose import (GO:0046323),-0.5196757676560307,-1.291799805817995,0.16877637130801687,0.45623739296326843,1.0,4/13,13.54%,SLC2A1;SLC2A3;SORT1;ZDHHC7
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.47861518471537284,-1.2917957944669334,0.14705882352941177,0.45554443279574947,1.0,12/16,47.19%,TNFRSF21;JAK3;TRIB2;FCGR2B;DLL1;VSIR;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,protein K63-linked ubiquitination (GO:0070534),0.403619395601922,1.2914235346554435,0.12411347517730496,0.8482623436304019,1.0,7/41,11.03%,RNF152;UBE2E2;RNF126;TRIM5;PELI3;RNF135;PRPF19
prerank,DNA damage checkpoint signaling (GO:0000077),0.44022487450061404,1.2909993856751654,0.1323251417769376,0.8466878867706219,1.0,10/28,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,negative regulation of chemotaxis (GO:0050922),-0.4110229020837008,-1.2906995306691722,0.10675381263616558,0.4573440356826679,1.0,13/31,16.65%,SEMA6A;SEMA3C;SLIT2;SEMA7A;THBS1;NOTCH1;ANGPT2;SEMA5B;DUSP3;SEMA3E;SEMA3G;SEMA5A;SEMA6D
prerank,homeostasis of number of cells (GO:0048872),-0.5235427935482592,-1.2890889016869935,0.18143459915611815,0.46034702966857877,1.0,3/12,4.28%,NOS3;NOTCH1;CCN3
prerank,regulation of inflammatory response (GO:0050727),-0.29092662075661896,-1.2888560843535288,0.01928374655647383,0.4601791519914161,1.0,38/190,12.75%,FOXP1;TEK;IL1R1;TMSB4X;CD200;SEMA7A;ETS1;PPARD;PTGIS;NFKBIA;ABCC1;APP;TNFRSF1B;MFHAS1;PTGS2;CCN3;BRD4;MGLL;VAMP3;WNT5A;AGTR1;PDE2A;ANXA1;PRKCD;PSMA6;MDK;IFI35;XIAP;SERPINE1;IL15;APOE;KLF4;SPATA2;IL1RL2;PDCD4;CCN4;BIRC3;ACE2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.5533567285524433,-1.2882245341093894,0.16500994035785288,0.460908396592233,1.0,4/10,11.47%,ACER2;CYP1B1;SERPINE1;JAM3
prerank,proton transmembrane transport (GO:1902600),0.4196750399962223,1.2882228187543723,0.15,0.8546193635498162,1.0,2/36,5.32%,ATP1A2;ATP6V1H
prerank,intracellular lipid transport (GO:0032365),0.47183356964414613,1.2880908960679875,0.1647940074906367,0.8519098296582258,1.0,2/21,1.77%,PRKAG2;PRKAA2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.36038410118584835,-1.287785285325489,0.11655011655011654,0.4612063070363687,1.0,13/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;RACK1;ZDHHC8;STAC;EPHB2;ACSL3;SQSTM1
prerank,regulation of fibroblast migration (GO:0010762),-0.44541588909900887,-1.2876622262486286,0.14225941422594143,0.4607886192816537,1.0,7/20,14.60%,THBS1;PRR5L;CORO1C;ITGB1;FGF2;HAS1;GNA12
prerank,gland development (GO:0048732),-0.3512927722276005,-1.287623828293633,0.0896551724137931,0.46017000599643215,1.0,16/59,9.74%,CAV1;IGSF3;TBX3;LSR;SIX1;TBX1;MET;HES1;ANXA1;ARHGAP35;MDK;STRA6;ZBTB1;SOD1;TGFB3;NOTCH4
prerank,regulation of establishment of protein localization (GO:0070201),-0.5164656038914945,-1.2873975272368472,0.16598360655737704,0.4599803956908129,1.0,8/13,27.30%,DNAJA1;CTSD;GAPVD1;PTP4A3;CEP295;SPIDR;TREM2;SCFD1
prerank,reverse cholesterol transport (GO:0043691),-0.5036343644142594,-1.2873623191529795,0.164969450101833,0.45933972548479296,1.0,3/13,9.64%,SCARB1;ABCA1;APOE
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3907296130025313,1.2871814233816734,0.1383177570093458,0.852304566759036,1.0,10/45,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,positive regulation of signal transduction (GO:0009967),-0.28342158728308603,-1.2871479697077801,0.022727272727272728,0.4591074558924552,1.0,57/238,14.23%,NRP1;VWF;TEK;LIMS1;NTRK3;MAML2;SHANK3;LIMS2;IL6ST;DAB2IP;JAG1;RSPO3;NOS3;TGFB2;NOTCH1;GAS6;DISC1;PIK3R1;F3;ITGA5;PTGIS;JCAD;MACF1;STAT3;KANK1;MGAT5;CCN3;FAS;FLNA;CRADD;JAG2;ERN1;NPTN;EPN2;RPS3;EMP2;CCBE1;SPIN1;SRC;ATP6AP2;IGF2;TRIM16;CDKN2AIP;NOTCH4;CAV2;ESM1;CD74;HHEX;BMP2;PTK2B;SMO;AGPAT1;CSNK2A1;PTPRC;IRS1;KLF2;P2RY6
prerank,intestinal absorption (GO:0050892),-0.5049606623141959,-1.2869599371632627,0.16985138004246284,0.4588333839542791,1.0,5/13,12.76%,F11R;TJP2;KCNQ1;UGCG;SLC26A6
prerank,regulation of T cell cytokine production (GO:0002724),-0.4956536202140074,-1.2867837728946812,0.16829745596868884,0.45854857322955717,1.0,4/15,10.52%,B2M;TNFRSF1B;CD55;MALT1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.40325895535541445,-1.2864619494448366,0.12164948453608247,0.45865957327724266,1.0,17/32,26.63%,CDK17;CDK14;BRD4;KLF11;CDK5;FBXO5;ORC1;DHFR;ID2;CDK16;CDC45;POLA1;CDK18;E2F7;TYMS;NPAT;TFDP1
prerank,positive regulation of cartilage development (GO:0061036),-0.4691497871024618,-1.2860894318646345,0.1581196581196581,0.45882794306775077,1.0,5/17,7.43%,BMPR2;ZBTB16;ACVRL1;BMP4;MDK
prerank,transition metal ion transport (GO:0000041),-0.39704301143170984,-1.2860601138048975,0.1348314606741573,0.45819871919955685,1.0,12/35,14.78%,TRPC3;SLC30A1;SLC39A8;TFRC;SLC30A9;TRPC6;SLC31A1;TRPC4;ATOX1;TRPC1;SLC30A5;MT3
prerank,embryonic limb morphogenesis (GO:0030326),-0.4032520914922773,-1.2859673569896517,0.1337579617834395,0.45769797992222566,1.0,12/34,12.91%,MBNL1;ECE1;LRP6;TGFB2;TBX3;GLI3;MAP3K20;NIPBL;TWIST1;PTCH1;RARG;TBX2
prerank,histone monoubiquitination (GO:0010390),0.45585716399719334,1.2858380228187907,0.1657250470809793,0.8546657404175825,1.0,6/24,12.26%,DDB2;CTR9;LEO1;RNF20;CDC73;RING1
prerank,sensory perception of taste (GO:0050909),0.5628205138746556,1.2855527263602438,0.18702290076335878,0.8525760211103203,1.0,1/10,0.51%,TAS1R2
prerank,myelination (GO:0042552),-0.3669109412705758,-1.285217110852602,0.10666666666666667,0.4587880844490327,1.0,20/46,24.61%,ADGRG6;PARD3;CMTM8;LGI4;TNFRSF21;MYOC;EIF2B2;ABCD2;B4GALT5;GPC1;ARHGEF10;PMP22;NFASC;ACER3;MYRF;SKI;MPZ;PLLP;MARVELD1;CXCR4
prerank,gene expression (GO:0010467),-0.2711175159887668,-1.2841446932462133,0.017605633802816902,0.4605172998341431,1.0,119/348,23.88%,RPLP1;PTMA;RBPMS;RPS15;RPL38;RPL18A;RPL41;RBM3;EEF1A1;RPS12;RPS20;DARS1;RPL32;RPL5;ADARB1;RPS10;RPL10;RPS23;RPS24;RPL7;RPL37A;ANGPT2;RPS17;RPS16;RPL39;RPS27A;RPL13;MRPL52;RPLP0;CDC40;RPL30;RPS5;RPL35A;RPS8;RPS7;RPL22;RPS3;RPS28;RPL29;RPL7A;RPS26;NUP107;RPL6;RPL18;RPS25;EIF4E;AGO2;RPL36;DDX54;RPL28;GOLPH3;RPL27;DROSHA;CPSF4;RPL24;RPS29;WDR33;RPL23;MRPL23;RPL17;YARS2;ATXN1;RPS9;RPS27;ASMT;NCBP2;HHEX;SYNCRIP;TPR;RPL21;MRPL10;THOC3;RPL34;CLP1;RPL10A;RBM6;RPL12;RPL35;RPL14;NR4A2;NCBP1;SRSF3;DHX38;RPL19;RPL37;RPS18;SEC13;RPS13;RPS15A;DDX25;RRBP1;MRPS12;MRPL55;MRPL43;EPC1;MRPL44;MRPL36;NUP50;NUFIP1;POLR3A;MRPL35;NUP85;RPL3;POLR2I;THAP1;BCL3;HNRNPF;EIF4A3;AAAS;RPL15;DKC1;TESC;RPS21;POLR2F;RPS19;RPL8;SLU7;RPL13A;NUP62
prerank,receptor-mediated endocytosis (GO:0006898),-0.3063522247156166,-1.2841242922401472,0.05314009661835749,0.45986832831571905,1.0,33/132,14.61%,CAV1;CALCRL;SPARC;DNM3;LRP6;SCARB1;INSR;RAMP2;CD9;SCARF1;AP2B1;RAB31;SCARB2;FCHO2;ITGB1;TFRC;SGIP1;LMBRD1;CLTB;SNX1;CUBN;APOE;GPR107;CAV2;ACKR3;ADM;VLDLR;FNBP1L;HIP1R;STAB1;LRP1;AP2A1;ARHGAP27
prerank,sensory perception of pain (GO:0019233),0.45914915474976803,1.2834432212921472,0.15261044176706828,0.857727641219956,1.0,8/21,20.11%,RETREG1;PTGES;CHRNB2;KCNK4;OPRM1;P2RX4;SCN9A;OPRL1
prerank,steroid biosynthetic process (GO:0006694),0.38438680596945646,1.2832583047780595,0.12641509433962264,0.8552993627811344,1.0,18/56,21.56%,PRKAG2;CYP11B1;INSIG2;PRLR;SC5D;DHRS11;CYP27A1;AMACR;OSBPL9;SQLE;CYP51A1;STAR;MSMO1;HMGCR;HSD17B4;LBR;FDXR;HSD11B1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.4570157031903729,-1.2832430403529043,0.1465863453815261,0.46115608076249454,1.0,6/19,13.74%,SLC26A2;BPNT2;PAPSS2;SLC35B3;TPST2;ENPP1
prerank,melanocyte differentiation (GO:0030318),0.5569906190519526,1.282422604166529,0.18346774193548387,0.8554638379684144,1.0,3/11,6.63%,LRMDA;KIT;CITED1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5105915720438788,1.2821681112447687,0.16412213740458015,0.8533224402671467,1.0,3/14,3.76%,SYT11;IGF1;TAFA3
prerank,bicarbonate transport (GO:0015701),-0.4244254657892383,-1.2815862489199832,0.14705882352941177,0.46437369701330916,1.0,7/25,16.14%,SLC4A10;SLC26A7;SLC39A8;CA4;SLC26A6;CA2;CFTR
prerank,negative regulation of apoptotic process (GO:0043066),-0.26537013096742945,-1.2814485466753098,0.007272727272727273,0.4639841090095779,1.0,150/444,24.15%,LEF1;ARHGAP10;PRKCH;TEK;MEF2C;CAV1;IL6ST;TJP1;PTMA;MERTK;YWHAE;FOXO1;TBX3;NDNF;THBS1;NOTCH1;GAS6;PIK3R1;EGFR;ITGA5;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SIX1;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;TBX1;FAS;FLNA;CARD16;ITGB1;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;ADAM10;ANXA1;PRKCD;TPT1;PLK2;MAPK1;MDK;SPRY2;CD38;PRKCG;FOXQ1;PIK3CA;SRC;XIAP;SOD1;FLT4;VHL;MAP4K4;CAT;TGFB3;APOE;GPX1;KLF4;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;UNC5B;GRK5;PTPRZ1;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;CSNK2A1;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;NR4A2;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157;HDAC2;BARD1;PSEN2;GREM1;MAPK3;ZC3H12A;SH3RF1;MCL1;CRLF1;LIG4;ASAH2;SOX8;RIPK1;HCK;PSMD10;HYPK;AGAP2;MYD88;SET;POU3F3;BEX3;CCND2;RIPK2;BCL3;UBE2Z;FXN;RASA1;DDAH2;DLL1;KDM2B;SMAD6;NFATC4;HCLS1;IGF1R;TAF9;TAX1BP1;PTRH2;NUP62;EGR3;FANK1;NAA15;AATF;TMBIM6;TRIAP1
prerank,protein localization to lysosome (GO:0061462),-0.4135290034588171,-1.2811896365930098,0.14799154334038056,0.4638936114242917,1.0,11/28,20.84%,SH3BP4;SCARB2;LMBRD1;ZFYVE16;KPTN;MFSD1;HGS;RTN4;RNF128;NEDD4;GGA3
prerank,inorganic anion transport (GO:0015698),0.38873610317430696,1.2805451988829875,0.10931899641577061,0.8566845291175028,1.0,11/53,9.87%,SLC13A4;SLC5A5;ENPP3;SLC26A1;GLRA1;CLCN6;SLC25A11;CLCN2;NMUR1;SLC34A3;CLCN4
prerank,positive regulation of cell differentiation (GO:0045597),-0.28184398239705827,-1.2804867031188587,0.034161490683229816,0.46488716675434344,1.0,46/237,9.46%,LEF1;PRKCH;SLC6A6;KITLG;MEF2C;GCNT2;RAPGEF2;BMPR2;IL6ST;ZBTB16;PTN;ZEB1;RHOA;ACVR1;ACVRL1;TGFB2;PPARD;BOC;LRP5;RAP1A;RUNX2;CD34;NGF;ZHX3;BTG1;BMP4;TGFBR2;KDR;RPS6KA3;CTNNA1;ARHGEF2;TMEM100;PRKD1;AGTR1;AXIN2;IL6R;AR;LRRC8A;CCN1;MDK;HEYL;CEACAM1;TMEM119;TIAM1;VHL;TGFB3
prerank,skeletal system development (GO:0001501),-0.30284147885596074,-1.2801396530816362,0.04081632653061224,0.4649734234895542,1.0,35/148,12.38%,CDH11;BMP5;TLL1;ZBTB16;TRPS1;EXT1;PCSK5;TGFB2;TBX3;SLC10A7;PKD1;TEAD4;PLS3;BPNT2;CD44;ALPL;RPS6KA3;KIAA1217;PAPSS2;FBN1;WNT5A;SH3PXD2B;HHIP;RPL13;TNFRSF11B;MYOC;TGM2;VCAN;EIF2AK3;IGF2;XYLT1;ETS2;COL1A1;COMP;BMP2
prerank,response to histamine (GO:0034776),0.5597073847294745,1.280028311938028,0.21138211382113822,0.8555167068063372,1.0,4/10,18.56%,DRD3;GABRB2;HRH1;GABRB3
prerank,Rap protein signal transduction (GO:0032486),-0.542689429358896,-1.2800146441327573,0.18127490039840638,0.4645588238614091,1.0,4/10,6.89%,RAPGEF2;RAP1A;RAP2A;PLK2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.41572315660328973,-1.2796468625862822,0.14663951120162932,0.4646113614614784,1.0,7/27,7.04%,MAP3K5;KAT7;UBC;MAP3K20;RPS27A;UBB;MAPK1
prerank,neuromuscular process controlling balance (GO:0050885),0.5336735237993742,1.2786260468615773,0.21031746031746032,0.8580697863085189,1.0,3/12,7.70%,USH1C;PCDH15;SHANK1
prerank,Wnt signaling pathway (GO:0016055),-0.3220122500212111,-1.278341368448831,0.07560975609756097,0.46704437312608044,1.0,26/92,15.34%,LEF1;LRP6;FZD6;LRP5;SFRP4;UBC;PLCG2;CSNK1E;RPS27A;UBB;CSNK1G1;WNT5A;CSNK1A1;CSNK1G3;APC;VPS26A;CPE;AMER1;FZD4;WNT9A;RARG;CD24;FZD1;NR4A2;PLPP3;FERMT2
prerank,positive regulation of JNK cascade (GO:0046330),-0.3436993150638166,-1.2780528128304016,0.0951276102088167,0.4670121839281575,1.0,21/70,20.49%,DAB2IP;SH3RF3;TRAF5;MAP3K5;RASSF2;APP;MFHAS1;FLT4;EDA2R;PTK2B;TNFRSF19;ANKRD6;MTURN;TAOK3;EDAR;NOD2;TAOK1;SH3RF1;RIPK1;HMGB1;TRAF4
prerank,positive regulation of glucose import (GO:0046326),0.4616205194332711,1.2779911311537144,0.16888045540796964,0.8575815029747372,1.0,6/21,9.68%,OSBPL8;IGF1;PRKCI;SORBS1;RHOQ;CREBL2
prerank,regulation of vasculature development (GO:1901342),-0.41623740112988955,-1.2779359589173729,0.14675052410901468,0.46662894097242297,1.0,14/26,35.45%,ETS1;BMPER;ADGRA2;EMP2;FGF2;TSPAN12;SP100;PLXND1;HMOX1;GPNMB;VASH2;CTNNB1;PROK2;HTATIP2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4456024750468178,1.277711364204173,0.1589648798521257,0.8556575157052781,1.0,6/22,10.67%,CACNA1D;CRHR1;DRD3;ADGRV1;LTB4R2;GABBR2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.39503587103391974,-1.2774951887217305,0.1261061946902655,0.4668899670460626,1.0,16/32,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,heterochromatin organization (GO:0070828),-0.49492580693766225,-1.2774496220863918,0.16898608349900596,0.4662833746797134,1.0,3/14,6.30%,MECOM;PRDM16;EZH1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5222379688510821,-1.2769672888751273,0.1756198347107438,0.46670865171367,1.0,5/12,19.05%,LYN;IL34;MAPK1;CSF1R;MAPK3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.40996294651184934,-1.2766734550162977,0.16122004357298475,0.4666771972308389,1.0,7/28,11.52%,SHANK3;PTN;APP;APOE;EPHB2;FAM107A;SQSTM1
prerank,regulation of heart contraction (GO:0008016),0.3487994404453472,1.2765568101574043,0.1001727115716753,0.8572534126622282,1.0,8/90,4.28%,ATP1A2;CELF2;SLC8A3;ATP1B3;ANK2;DMPK;ITPR1;ATP1B2
prerank,skin development (GO:0043588),-0.3381603533356782,-1.2765494192832565,0.10321100917431193,0.46624508931229997,1.0,17/65,12.26%,JAG1;ITGA6;CLIC4;PKD1;BCR;LSR;COL5A2;STMN1;ITGB4;WNT5A;MET;ANXA1;TXNIP;HRNR;SCEL;UGCG;COL1A1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.48560500950109875,1.2762894236167186,0.18604651162790697,0.8552227282806776,1.0,10/18,22.47%,ASPG;ADI1;ASPA;SLC25A12;GOT1;MTHFD1;MTHFR;GOT2;SLC25A13;MSRA
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.46987425701790064,-1.2762311259845476,0.1784313725490196,0.46631491545463627,1.0,5/17,8.78%,SLIT2;TMEM204;SFRP4;CASK;XIAP
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.5287120779487993,-1.2761769009882367,0.17755102040816326,0.465776823979296,1.0,6/11,29.56%,AGK;TIMM22;ROMO1;TIMM29;TIMM10;TIMM8B
prerank,positive regulation of embryonic development (GO:0040019),0.4725691234186477,1.2758998330020332,0.16216216216216217,0.8537628182428239,1.0,2/19,1.12%,WNT4;OSR1
prerank,anterograde axonal transport (GO:0008089),0.41329868412780446,1.2754043594782687,0.15257352941176472,0.8527056968675456,1.0,16/37,23.72%,TRAK1;KIF5C;RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1;MAP1A;DLG2;SPAST
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.4348376927468564,-1.275364270240735,0.15151515151515152,0.46692530280532196,1.0,11/22,36.30%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMB4;PSMB3;PSMB9;PSMA5;ENC1;PSMA3
prerank,organic acid transport (GO:0015849),0.34202056376293055,1.2753096290716708,0.09914529914529914,0.8500481007101933,1.0,15/94,7.83%,SLC6A13;SLC22A6;SLC13A3;SLC6A12;ACSL1;SLC38A3;SLC7A11;SLC23A2;SLC23A1;SLC26A1;SLC38A1;SLC25A11;STARD5;PDPN;SLC19A1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.554159192845864,1.2750431858404245,0.19008264462809918,0.8479514895442805,1.0,6/10,18.41%,LPGAT1;SLC45A3;ABCD1;NR1H3;MID1IP1;MLXIPL
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4336345279360697,1.274961485054926,0.1564245810055866,0.8423464688567849,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4336345279360697,1.274961485054926,0.1564245810055866,0.8423464688567849,1.0,8/29,19.11%,ACSM2A;ACSM2B;ACAT1;GLYAT;CROT;ACOT1;ACOT6;ACOT13
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.46698574399769455,-1.2747060628839988,0.15306122448979592,0.46776651862806756,1.0,10/18,29.68%,AGTR1;RFK;EDN1;EDN3;POR;NOD2;FXN;PDP1;AGT;PARK7
prerank,regulation of mast cell activation (GO:0033003),-0.5482718254250757,-1.2745562288224201,0.18275154004106775,0.46740999226384644,1.0,7/10,33.12%,PLSCR1;LYN;NECTIN2;MILR1;CD300LF;TSLP;CD84
prerank,lymphocyte migration (GO:0072676),-0.40285418227535486,-1.2741855398461697,0.12396694214876033,0.4676087785886414,1.0,22/32,48.38%,S1PR1;CCL13;RET;CCL25;MSN;MYO1G;CCL5;CCL11;ZAP70;CCL4;GATA3;CRTAM;CCL7;CCL8;CCL19;CCL14;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.34348246650171377,-1.273943643557765,0.09535452322738386,0.4674952021276722,1.0,16/65,8.91%,CAV1;LTBP1;HTRA3;SMURF1;PRDM16;TGFBR2;IL17RD;UBC;CD109;FBN1;ASPN;SPRED2;RPS27A;UBB;SPRY2;VASN
prerank,Notch signaling pathway (GO:0007219),-0.3524873633813791,-1.2729712822202766,0.12240184757505773,0.4690841204632577,1.0,24/59,22.60%,SORBS2;MAML2;PBX1;JAG1;NOTCH3;NOTCH1;JAG2;HES1;ADAM10;MDK;HEYL;HEY2;NOTCH4;BMP2;HEY1;PSEN2;PSENEN;DLL4;PLXND1;MAML3;DTX3L;SNW1;SUSD5;DLL1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.49664933073307094,-1.271705385386787,0.1673913043478261,0.4713526939016526,1.0,3/14,1.27%,PRKG1;MEF2C;SLIT2
prerank,chloride transport (GO:0006821),-0.33244849671609,-1.2714592133588978,0.10120481927710843,0.4712139588941931,1.0,20/74,16.14%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;ANO1;CLIC5;SLC1A3;SLC12A6;LRRC8A;CLIC1;GABRA3;GLRB;SLC1A1;SLC26A6;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,regulation of exosomal secretion (GO:1903541),0.4709184877380507,1.2709749591082515,0.1785063752276867,0.854873128552206,1.0,4/19,7.85%,CHMP6;STAM;SMPD3;SNF8
prerank,electron transport chain (GO:0022900),-0.47945734088983294,-1.2706857975915862,0.17575757575757575,0.4723741949372383,1.0,6/15,15.52%,ENOX2;PDIA5;NDUFA5;ETFA;UQCRFS1;POR
prerank,lipid biosynthetic process (GO:0008610),0.3536539523611742,1.2702988789938179,0.11978221415607986,0.8546349387384896,1.0,23/77,23.27%,ACSL1;PRKAA2;FITM2;ACSM2A;ACSM2B;AGPAT4;PCYT2;PRLR;CLN8;DHRS11;ACSS2;CYP51A1;STAR;ACACA;GGPS1;HMGCR;FDXR;PAM;ALOX5;DOLPP1;CBR4;LIPC;LIPH
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.41458081217477255,-1.2702896107787294,0.13894736842105262,0.4726208209076224,1.0,8/28,19.85%,DAB2IP;NGF;CRADD;CASP8AP2;SORT1;GABARAP;DIABLO;SPI1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.48200874664748744,-1.2702021353807054,0.1748971193415638,0.4721461773705342,1.0,4/15,11.38%,STOX2;TGFB2;RAI2;SCEL
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3199506013028443,-1.270139652819672,0.085995085995086,0.47161994862466644,1.0,25/99,16.14%,PDE3A;ACTB;MEF2C;RAPGEF2;SLIT2;RAP1A;SH3BP4;CDH1;CTNNA1;CAPN2;PDE2A;KCNQ1;SPAAR;AHR;RPTOR;GOLPH3;NSMF;IPO5;SLC26A6;RRAGA;P2RY6;HTR1B;GLRA2;NR1H4;CFTR
prerank,positive regulation of innate immune response (GO:0045089),-0.4023351374009525,-1.2698474141677525,0.14840182648401826,0.4716751243617372,1.0,12/30,23.34%,POLR3F;PLSCR1;GBP5;WNT5A;NLRC5;IFI35;POLR3B;SPI1;ZBP1;POLR3D;NMI;RPS19
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4169851589197245,-1.2695946528185706,0.1422319474835886,0.4715953941177181,1.0,12/26,24.80%,ALPK1;UBC;NOD1;RPS27A;UBB;IFIH1;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,"phagocytosis, engulfment (GO:0006911)",-0.39009854876056227,-1.269346626244292,0.13107822410147993,0.47146316357708135,1.0,5/36,2.53%,DOCK1;RHOBTB1;GSN;THBS1;MYH9
prerank,organic substance transport (GO:0071702),-0.30952307321250083,-1.2693288786018986,0.06601466992665037,0.4708084029181229,1.0,22/121,9.19%,ABCG2;SLC47A1;CALCRL;ATP8A1;DISP1;SLCO2A1;RAMP2;MYH9;SLCO2B1;ABCA1;LMAN2L;PLTP;PLEKHA8;CHMP2B;SPNS2;TAP2;ABCA3;CMTM6;ABCD2;CUBN;SLC22A18;TXNIP
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.49273055837081237,1.2684282348851257,0.1944990176817289,0.8589212481767436,1.0,5/15,9.09%,LPGAT1;PPARA;SLC45A3;PPARGC1A;NR1H3
prerank,regulation of cellular localization (GO:0060341),0.38727932461326064,1.267807063292345,0.13863216266173753,0.8583184876433431,1.0,4/46,2.25%,PARD6G;ADCY5;MAP2;UNC13D
prerank,cellular response to cytokine stimulus (GO:0071345),-0.263644170868346,-1.2678061911449234,0.01858736059479554,0.4735024200129891,1.0,106/416,20.01%,LEF1;GHR;LRCH1;SLC12A2;PID1;IL6ST;DAB2IP;IL1R1;OSMR;ZEB1;LIFR;RHOA;PTPN12;GREM2;ST3GAL6;FOXO1;GAS6;PIK3R1;F3;FOXO3;PTGIS;VCAM1;BCL2L1;SOCS2;STAT3;PTPRJ;IRAK3;TNFRSF1B;FN1;UBC;PTGS2;STX1A;GBP4;ITGB1;STX3;ICAM1;ARHGEF2;RPS27A;S1PR1;UBB;GBP5;TEC;WNT5A;AIM2;YBX3;PDE2A;CXCL12;IL6R;ANXA1;IL34;INPP5D;TNFRSF21;IL20RB;RPS3;NFAT5;CCL13;IL1RAP;PIK3CA;CNTFR;MT1X;FGF2;SOCS5;DOCK8;JAK1;YWHAZ;IL4R;MAOA;PIK3CD;IL1RL2;CEBPD;TWIST1;PTPRZ1;SYNCRIP;TPR;POU2F1;SLC26A6;CD40;CD86;VEGFA;IRAK2;CBL;CSF1R;PRKACA;LDLRAP1;IFNAR1;ADAMTS12;SOCS3;SIGIRR;MMP2;GPER1;GAPDH;JUNB;ERBIN;PTPN6;CCL25;CCND1;USP10;MT2A;ZC3H12A;MCL1;CRLF1;IRF5;ASAH2;RIPK1;JAK3;HCK
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2626792027312786,-1.2677098361762076,0.011320754716981131,0.47303308894462454,1.0,91/417,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;HMBOX1;AHR;CIR1;KLF4;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5119168357018478,-1.267154947895261,0.17849462365591398,0.47364800974564325,1.0,5/13,14.72%,GAS6;WNT5A;CD74;AGPAT1;IFIH1
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2935506949824427,-1.266284870913037,0.0639386189258312,0.47501577476371915,1.0,52/153,21.39%,PRKCH;MARK1;HIPK1;RPS6KA5;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;ERN1;PRKCD;PLK2;CSNK1A1;MAPK1;CSNK1G3;PRKX;PRKCG;RPS6KA2;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;RIPK1;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5109285021043936,1.2659770768318235,0.20159680638722555,0.8625121506233899,1.0,4/14,11.30%,UPB1;DPYD;NT5C3A;UPP2
prerank,regulation of establishment of planar polarity (GO:0090175),-0.32496843965630645,-1.2657268271573507,0.0960591133004926,0.4756170927752346,1.0,29/88,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;AP2M1;PSMB3
prerank,liver development (GO:0001889),0.42639593635606343,1.2656265943411198,0.15985130111524162,0.8610425186857608,1.0,5/32,9.21%,TGFBR3;WNT4;CEBPA;PHF2;E2F8
prerank,histone H3-K4 methylation (GO:0051568),0.4365440334488583,1.264720492658441,0.17790262172284643,0.8615506647117638,1.0,8/26,19.43%,CTR9;KMT2A;DYDC2;SETD4;BEND3;MEN1;TET2;SETD1B
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.3529185753857505,-1.2647017150149622,0.11879049676025918,0.47740297513688396,1.0,17/55,15.32%,GPC6;DCN;GNS;CD44;CSPG4;LUM;VCAN;FGF2;SDC3;HEXA;CEMIP;BGN;NAGLU;AGRN;GPC1;CEMIP2;SGSH
prerank,vesicle transport along actin filament (GO:0030050),-0.4492775181942427,-1.264535762457468,0.17926565874730022,0.4771579227238515,1.0,6/19,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,response to estrogen (GO:0043627),-0.3987156140743003,-1.2642165825505673,0.1413934426229508,0.47723128248437396,1.0,8/31,14.83%,CAV1;ESR1;AR;TRIM25;PELP1;SERPINB9;CD24;ARID5A
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.35894931684869874,-1.2641425832263125,0.12669683257918551,0.47672188747281347,1.0,12/45,16.53%,GCNT2;FOXO3;RBM3;APP;ZC3H7A;RPL10;PUM2;EIF4E;PER1;TDRD7;PUM1;DDX25
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.43662659300483364,-1.2641316788892305,0.15289256198347106,0.4760707449241247,1.0,4/22,2.86%,NTRK3;RAPGEF2;RAP1A;NGF
prerank,anion transport (GO:0006820),0.4213419036098284,1.2640466968383393,0.1640926640926641,0.8612182869024478,1.0,3/33,0.32%,SLC13A4;SLC22A6;SLC13A3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.33016500885408473,-1.2637538457572324,0.09592326139088729,0.4755325446922927,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.33016500885408473,-1.2637538457572324,0.09592326139088729,0.4755325446922927,1.0,33/78,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,peptidyl-serine modification (GO:0018209),-0.29399743301514475,-1.2634355249911424,0.052924791086350974,0.4756148114011398,1.0,56/166,21.39%,PRKCH;MARK1;HIPK1;RPS6KA5;NDNF;STK38L;PKD1;GAS6;AKT3;TGFBR2;RPS6KA3;CAB39;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;TNKS;PRKCD;PLK2;CSNK1A1;MAPK1;GALNT13;CSNK1G3;PRKX;PRKCG;RPS6KA2;HPF1;CDK5;EIF2AK3;MAPKAPK2;VRK3;DYRK1A;MORC3;POGLUT3;STK32A;CSNK2A1;STK38;AKT2;PKN3;PRKACA;MKNK2;NAA10;MAST2;LATS1;MASTL;MAPK12;CAMK1G;MARK3;GALNT4;CSNK1D;DYRK2;ULK2;ROCK1;TOP1
prerank,response to cytokine (GO:0034097),-0.30176374339638906,-1.2630971596637115,0.057534246575342465,0.47581075386392363,1.0,56/141,25.18%,LEF1;PID1;IL6ST;IL1R1;OSMR;LIFR;RHOA;PTPN12;BCL2L1;STAT3;PLSCR1;IRAK3;APP;REL;IFITM3;TNFRSF11A;GCH1;ADAM10;TRIM56;IL6R;ANXA1;RELB;XAF1;NFAT5;SRC;MAPKAPK2;IL1RL2;TLE5;ISG15;CD74;CD40;IRAK2;CSF1R;SP100;IFITM1;LDLRAP1;SIGIRR;PTPN6;MCL1;ASAH2;KYNU;RIPK1;JAK3;GGT7;MYD88;MAP2K7;IFITM2;CASP1;GGT1;MAP4K3;HCLS1;TAF9;CXCR4;CASP8;SHMT2;PTPN11
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5412467672506183,-1.262967097707351,0.17372881355932204,0.47541607981927864,1.0,4/10,8.59%,PARD3;DGKH;PRKD3;PLPP1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3709933610534527,-1.2628583741233657,0.13302752293577982,0.47496217266143714,1.0,11/39,12.41%,RPS15;RPS24;RPS17;RPS16;RPS5;RPS7;RPS28;SURF6;RPS25;RPS27;RRP7A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5353948646476737,1.262847462187956,0.23014256619144602,0.862895035462053,1.0,3/12,8.01%,UNC13C;SYT1;RIMS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5114536348376024,-1.2620649641251425,0.16260162601626016,0.4761648784916523,1.0,8/11,34.02%,CREB3L1;ATF6B;ATF4;ATF3;MBTPS2;CEBPB;HSPA5;TP53
prerank,osteoclast differentiation (GO:0030316),-0.4275470906954526,-1.2619261584272763,0.17735042735042736,0.4758138441926114,1.0,10/22,28.52%,FOXP1;TNFRSF11A;SRC;SNX10;CSF1R;SBNO2;OSTM1;EFNA2;TREM2;FARP2
prerank,amino acid import across plasma membrane (GO:0089718),-0.4115709718573613,-1.2618076761914836,0.14634146341463414,0.47544435237688915,1.0,7/24,8.49%,SLC47A1;SLC6A6;SLC1A5;SLC7A5;SLC1A3;SLC7A1;SLC16A2
prerank,regulation of adaptive immune response (GO:0002819),-0.4590617181010963,-1.2616419153169816,0.17255717255717257,0.47518355143033003,1.0,9/18,33.93%,IL6ST;ADCY7;AHR;FCGR2B;SAMSN1;FADD;IL4I1;SKAP1;SASH3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.43986885535398285,1.2615398384458407,0.1701720841300191,0.8649735457394265,1.0,3/25,2.79%,IGF1;MSX2;DOT1L
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.33454292880982667,-1.2612011771436193,0.10336538461538461,0.4755085988598073,1.0,20/72,13.07%,SHANK3;SLIT2;KANK1;STMN1;SSH2;KANK3;TBCD;KANK4;ARHGEF2;ATXN7;PRKCD;IAPP;APC;PIK3CA;APOE;FGF13;LIMA1;DYRK1A;HIP1R;PFN1
prerank,cellular response to glucagon stimulus (GO:0071377),0.48073599983794113,1.2611104246030052,0.18426103646833014,0.8637496689433675,1.0,4/17,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,regulation of myoblast differentiation (GO:0045661),0.4152736144743076,1.2609146543938654,0.1619217081850534,0.861705577871715,1.0,8/32,11.97%,RANBP3L;IGFBP3;FLOT2;SOSTDC1;PLCB1;MAPK14;SOX9;SRA1
prerank,iron ion transmembrane transport (GO:0034755),-0.5438634303272583,-1.2604310809393042,0.1746987951807229,0.4765719191268834,1.0,3/10,4.90%,SCARA5;SLC40A1;SLC39A8
prerank,carbohydrate catabolic process (GO:0016052),0.4124600279562314,1.2599991632660585,0.15101289134438306,0.8624057825848329,1.0,9/38,7.77%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;NAGA;HKDC1;MAN2C1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3433304623004909,1.2598803151501674,0.1273344651952462,0.8599928523145833,1.0,7/90,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,presynapse organization (GO:0099172),0.5636009082712594,1.2598487942518435,0.1887966804979253,0.8572591445825944,1.0,3/10,7.03%,NLGN2;WNT7A;NLGN3
prerank,negative regulation of viral release from host cell (GO:1902187),0.5151883571641562,1.258361078800084,0.20675944333996024,0.8603118564826122,1.0,9/13,28.71%,TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3;TRIM28;TRIM8;TRIM11
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.44768872848083024,-1.257854515137842,0.18533604887983707,0.48188191265475955,1.0,9/18,27.03%,SEC14L1;RNF125;PUM2;BIRC3;PUM1;ZCCHC3;USP15;UFD1;OASL
prerank,negative regulation of complement activation (GO:0045916),-0.5423161747392564,-1.2577606829342902,0.18003913894324852,0.48144161366783556,1.0,4/10,16.58%,CR1L;CD55;SUSD4;CD46
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5140962259233444,1.2577194840031745,0.18796992481203006,0.8599857774586146,1.0,3/13,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,positive regulation of defense response (GO:0031349),-0.32017240377339595,-1.2574868137925654,0.09462915601023018,0.48143192917299565,1.0,17/89,11.84%,MEF2C;ETS1;NFKBIA;POLR3F;ABCC1;PLSCR1;APP;GBP5;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,regulation of intracellular transport (GO:0032386),0.4070543185036665,1.2572469226080187,0.17680608365019013,0.8589617767456896,1.0,18/38,26.59%,MAP2;TTC21B;DYNLT2B;ANTKMT;LRRK2;GRIPAP1;RINT1;GAS1;SPAG5;RNF139;CAPN10;ATP13A2;WWC1;LAMP1;MLC1;ATP9A;HAP1;RBM4
prerank,signal release from synapse (GO:0099643),0.3875928182910882,1.256831775457761,0.15026833631484796,0.8578683702485342,1.0,22/43,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,rRNA methylation (GO:0031167),0.4453358571089465,1.2564516684518139,0.17358490566037735,0.8565367914338472,1.0,5/22,15.06%,FDXACB1;MRM3;NSUN3;MTERF4;METTL5
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3281467368517436,-1.2563547557543409,0.09624413145539906,0.4834087341323345,1.0,17/73,10.46%,HIP1;ACER2;TNFSF10;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;ATP2A3;EIF2AK3;IFT57
prerank,cilium movement (GO:0003341),0.37667173015187894,1.2560507609858202,0.15601503759398497,0.8553701783300268,1.0,15/47,22.29%,DNAH1;TEKT2;RSPH4A;TEKT5;CFAP61;ROPN1L;CFAP251;DNHD1;DNAH9;DNAAF2;DNAAF5;SPA17;CFAP54;CFAP91;DNAH5
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5453859221784514,1.255949305326962,0.1996124031007752,0.8529925117048186,1.0,3/11,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.40304783344317263,-1.2557304089251482,0.15157894736842106,0.48427722458462213,1.0,11/27,20.85%,EGFR;LIMD1;STAT3;BMP4;PUM2;AGO2;PUM1;FMR1;FXR1;RIPK1;AJUBA
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.3735547322373794,-1.255709962219722,0.13793103448275862,0.48366151395094104,1.0,13/36,25.74%,NRP1;SHANK3;ITGB1;EPHB2;EDN1;HDAC6;FBXW7;HDAC2;GREM1;NCOA3;EGF;CCR2;BUD31
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5078841705769679,-1.2553971814297966,0.18503937007874016,0.48374119236376223,1.0,5/12,15.37%,DAB2IP;PIK3R1;ERN1;PTPN1;BAK1
prerank,epithelial to mesenchymal transition (GO:0001837),0.38643132151712695,1.2552303826449265,0.14840989399293286,0.8531021813968378,1.0,9/47,7.14%,BMP7;TGFBR3;WNT4;ROCK2;DDX5;S100A4;LOXL3;RBPJ;DDX17
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.42716895558524215,-1.2550647501241496,0.16244725738396623,0.48393030443325497,1.0,8/23,21.79%,DAB2IP;MAP3K5;TNFRSF11A;RPS3;EDN1;TAOK3;ARHGEF5;MAP3K4
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4422124140451456,-1.2550396137889603,0.168141592920354,0.48331935404351145,1.0,8/21,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4987644553179532,-1.254826854782501,0.17992424242424243,0.48315269882236284,1.0,4/12,13.63%,RUNX1;LYN;CBFB;PTPRC
prerank,aminoglycan catabolic process (GO:0006026),-0.409221870698108,-1.254646888324805,0.1649269311064718,0.4828998335162291,1.0,9/28,22.25%,GPC6;GNS;SDC3;NAGLU;AGRN;GPC1;SGSH;GPC4;HPSE
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.5215705875660301,-1.2536732315088328,0.205761316872428,0.48450673538467026,1.0,4/11,14.73%,TIPIN;FBXO5;BLM;TIMELESS
prerank,B cell activation (GO:0042113),-0.3359552131890567,-1.2536351811013358,0.12039312039312039,0.48393118662025,1.0,17/68,13.79%,MEF2C;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;EPHB2;MALT1;PIK3CD;PHB2;HHEX;ITGA4;CTPS1;CD40;PTPRC;CD86
prerank,glycerol metabolic process (GO:0006071),0.5369561471484796,1.2535500785633056,0.21703853955375255,0.8569083510561762,1.0,5/10,20.39%,GK;TKFC;GOT1;COQ3;TPI1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3232280108116616,-1.253348403947943,0.08673469387755102,0.4839165159030362,1.0,21/76,13.79%,LIMS1;ACTN4;RHOA;TMSB4X;RASSF2;EGFR;NFKBIA;APP;NOD1;CCN3;NR3C2;RPS3;NFAT5;IFI35;HDAC7;TERF2IP;PTP4A3;PDCD4;PHB2;TCIM;CD86
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.32774649861243565,-1.2527774366346254,0.1024390243902439,0.48448973062598555,1.0,33/79,27.25%,AP2B1;DYNC1I2;SEC24D;CTSD;SEC23A;CAPZA2;DYNC1I1;SEC31A;KIF23;CD74;DCTN3;SH3GL2;DYNLL1;SEC24B;AP2A1;DCTN5;CTSF;DCTN6;SEC13;CTSS;DYNC1H1;CAPZA1;AP1S2;LAG3;DCTN1;SEC24A;FCGR2B;AP2M1;KIF22;KIFAP3;KIF4A;ACTR1A;CTSE
prerank,modulation by symbiont of host process (GO:0044003),-0.5253265906613623,-1.2525898075735533,0.22376237623762377,0.48420405696903135,1.0,5/10,10.78%,B2M;UBC;RPS27A;UBB;HGS
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5448457134065896,-1.251973844295458,0.1947069943289225,0.48504179241630496,1.0,3/10,20.69%,CAV1;KCNE4;KCNAB1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.45127778145329084,1.2517607925839254,0.1907514450867052,0.8612922363746313,1.0,4/22,4.37%,TIMP3;SH3D19;FURIN;ADRA2A
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.47772771434653294,1.251285513174804,0.1883495145631068,0.8603126285350151,1.0,4/16,7.89%,TOP2B;MEIOB;EME2;MSH4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.353386988759134,1.2504488541206848,0.12186978297161936,0.8606694846327674,1.0,18/69,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,regulation of glucose metabolic process (GO:0010906),0.40572852633377327,1.250276794580517,0.17358490566037735,0.8585668368361233,1.0,9/34,19.02%,RORA;GCGR;PDK2;SLC45A3;PDK1;SIRT1;RUBCNL;AKT1;KHK
prerank,cardiac muscle contraction (GO:0060048),0.40466413662296574,1.249829730576684,0.1614100185528757,0.8575609882463089,1.0,5/34,11.04%,ATP1A2;CSRP3;TNNI1;KCNH2;RYR2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4549041657168288,-1.2487096467879437,0.1732283464566929,0.4921420354320214,1.0,6/18,12.40%,VCAM1;SLC39A8;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,autonomic nervous system development (GO:0048483),-0.458548794582574,-1.248036201077413,0.18089430894308944,0.4931295883114071,1.0,2/17,3.71%,NRP1;FN1
prerank,phosphorylation (GO:0016310),-0.26109243992390524,-1.2475433021632605,0.0176678445229682,0.49369154999380777,1.0,74/384,12.51%,PRKG1;PRKCH;ERG;SNRK;BMPR2;MARK1;NEK7;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;MAP3K5;INSR;MERTK;RPS6KA5;DGKH;STK38L;GAS6;STK3;PEAK1;LIMD1;LIMK2;BCR;STAT3;AKT3;DGKZ;TGFBR2;IRAK3;APP;CDK14;AGK;FNIP2;BMX;TNIK;NUAK1;PANK3;MAP3K20;CSNK1E;CAMK2D;PAK2;TEC;PRKD1;ERN1;ADAM10;LYN;CDC42BPA;DCLK1;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;PRKCG;STK24;PIK3CA;CDK5;MAP4K4;EIF2AK3;MAPKAPK2;JAK1;YWHAZ;NEK3;BCKDK;EPHB2;PIK3CD;GRK5;STK10;DYRK1A;MORC3;PRKG2;RET;BMP2;PTK2B
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4663106068640751,1.2475349323179896,0.18371212121212122,0.8640408309125346,1.0,6/18,15.60%,SMAD3;CLASP1;PDPN;IER3IP1;EFEMP2;IL6
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3821070499712105,-1.2471806142507769,0.14847161572052403,0.4938758170508211,1.0,16/33,27.78%,ACER2;TGFB2;CYP1B1;LYN;SERPINE1;JAM3;RET;NCKAP1L;RAC3;SYK;TESC;ADA;PTPN11;PIK3CG;SNAI2;CIB1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.47016228907099367,1.2471416119863443,0.2047970479704797,0.86276528242133,1.0,2/18,0.87%,IGF1;IL18
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3295528426126144,-1.2467938643626904,0.10454545454545454,0.4941859446752325,1.0,29/72,25.18%,LIFR;HIPK1;GAS6;RUNX1;IRAK3;RACK1;CBFB;PTPN1;JAK1;SPATA2;CD74;ABCE1;BIRC3;AGPAT1;PTPRC;CD24;MADD;IRAK2;SOCS3;SIGIRR;PTPN6;RIPK1;ZBP1;SYK;CYLD;TAX1BP1;SOCS1;CASP8;PTPN11
prerank,mitotic spindle assembly (GO:0090307),-0.36119936578500916,-1.2464932956727135,0.16159250585480095,0.4941899943556921,1.0,16/42,23.01%,RHOA;FLNA;SMC1A;STAG1;MAP9;PIBF1;KIF23;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;PRC1;TPX2;AAAS;KIFC1
prerank,detection of mechanical stimulus (GO:0050982),-0.4405936659179959,-1.2463487747350963,0.2079002079002079,0.4938806905302575,1.0,3/19,2.85%,PIEZO2;PKD1;PIEZO1
prerank,pore complex assembly (GO:0046931),0.45756171289608527,1.2462348418655351,0.1875,0.8634714246873801,1.0,3/19,5.72%,AFDN;PLEKHA7;GSDMD
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3905580465852653,1.2462043273589962,0.17689530685920576,0.8608713614633979,1.0,11/45,13.62%,BMP7;SMAD3;ZWINT;ANGEL2;FZD3;TOM1L2;TRIM35;MAD2L1;GAS1;PRCC;FOXC1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4137577568081975,-1.2459859491219138,0.18764302059496568,0.49408751847929616,1.0,9/25,26.05%,TMTC2;CAV1;JPH2;CNNM2;MT3;GRIN1;SLC8A1;WFS1;SELENON
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.49784247226459155,-1.2459197298895868,0.22357723577235772,0.493592365028615,1.0,3/12,6.07%,JAG1;NOTCH1;HES1
prerank,intracellular sterol transport (GO:0032366),-0.4878078868627705,-1.2455142517366078,0.2152917505030181,0.49396354448180424,1.0,4/13,11.36%,ABCA1;NPC2;OSBP;STARD4
prerank,regulation of receptor binding (GO:1900120),-0.5295712598398318,-1.2448006845222541,0.2136279926335175,0.49506206381549456,1.0,4/10,14.55%,B2M;GREM2;ATP2A3;ADAM15
prerank,regulation of interleukin-12 production (GO:0032655),-0.36111351599528646,-1.2440201129784136,0.13043478260869565,0.4962371401981199,1.0,16/47,25.70%,FOXP1;THBS1;IRAK3;PLCG2;MDK;PIBF1;CD40;MAST2;IRF5;JAK3;HMGB1;SYK;RIPK2;MAPK11;CMKLR1;TLR4
prerank,regulation of dendrite development (GO:0050773),-0.37220733808337936,-1.243922059291976,0.1530398322851153,0.49580933131763033,1.0,8/37,5.07%,BMP5;DAB2IP;PTN;NEDD4L;MARK1;HECW2;TNIK;RAP2A
prerank,neurotransmitter secretion (GO:0007269),0.38232602719683595,1.2439007507224593,0.1408199643493761,0.8668874255648992,1.0,22/44,28.87%,SYT1;SYN2;SNAPIN;RIMS1;SNAP25;SYT10;GAD1;SYN3;CPLX1;NAAA;SYN1;CPLX2;STXBP3;SLC32A1;GAD2;SNPH;STXBP2;PPFIA3;NRXN2;DNAJC5;NRXN1;BRSK1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4934025576104366,-1.2436798977203507,0.20464135021097046,0.49573187781458866,1.0,4/13,4.67%,PKD1;NFKBIA;YWHAB;FLNA
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.3651833979873287,-1.2428268356812555,0.1735357917570499,0.4971035245074955,1.0,12/43,11.66%,ETS1;TGFB2;PPARD;FOXO3;STAT3;BMP4;JUN;GNL3;GATA2;FGF2;KLF4;TEAD1
prerank,gas transport (GO:0015669),-0.5336197918303016,-1.242630363192097,0.19477911646586346,0.4969067760185604,1.0,8/10,42.33%,IPCEF1;CYGB;CA2;MYC;AQP1;MB;NGB;RHAG
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3040083737965321,-1.2423414959985823,0.07323232323232323,0.49693570807978915,1.0,31/107,15.04%,CAV1;SLC39A10;STIM2;ATP2B1;SLC10A7;SLC30A1;SLC39A8;SLC30A9;NPTN;CXCL12;TPT1;CCL13;ATP2A3;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;SLC39A7;TMCO1;EDN1;EDN3;HTR2A;SLC30A5;TRPV4;CD40;MT3;VAPB
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5368012341291994,1.2423099896959262,0.22085889570552147,0.8702043958879607,1.0,2/12,1.72%,ANXA6;ANK2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3919098890036251,-1.2422760053694621,0.17410714285714285,0.49640745437044403,1.0,13/30,21.58%,CAV1;NFKBIA;PLTP;ZDHHC8;TTC39B;ABCA3;APOE;SREBF2;PTCH1;LRP1;NAXE;YJEFN3;EEPD1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.272506249148753,-1.2420930538545014,0.06060606060606061,0.49615040916025177,1.0,54/234,15.25%,PRKCH;ROR1;CAV1;SLCO3A1;LRP6;CD200;TRAF5;RPS6KA5;STK3;NFKBIA;STAT3;IRAK3;APP;UBC;NOD1;CARD14;ESR1;MID2;PLCG2;DHX33;TNFRSF11A;CARD16;TFRC;ARHGEF2;RPS27A;TRIM37;UBB;PRKD1;WNT5A;AIM2;PPIA;TRIM14;PSMA6;AR;TRIM25;RPS3;IL1RAP;EDN1;MALT1;TERF2IP;MYOCD;EDA2R;FZD4;PHB2;SMO;CD40;FZD1;VEGFA;JMY;IRAK2;ALK;PLPP3;TAB1;CRTC3
prerank,regulation of lipid metabolic process (GO:0019216),0.33710735218548304,1.2410599568990772,0.13109243697478992,0.8724649020081274,1.0,24/88,19.41%,PRKAG2;RORA;PPARA;NFYB;SMARCD3;NFYC;PANK2;CHD9;MED1;SC5D;RXRA;SQLE;CYP51A1;TBL1XR1;RUBCNL;ACACA;TM6SF2;NCOR2;GGPS1;MID1IP1;HMGCR;NCOR1;SIN3A;OPA3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.2550312091894494,-1.240818852141038,0.012048192771084338,0.4986186463713933,1.0,111/476,17.36%,MECOM;LEF1;MEF2C;ZBTB16;ZFHX3;MLLT3;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PPARD;FLI1;MAP3K5;FOXO1;NOTCH1;LRP5;KMT2E;EGFR;RUNX2;FOXO3;CTCF;AFAP1L2;RUNX1;CDH1;STAT3;BMP4;NFATC1;PRDM16;SIX1;RNF111;GLI3;JUN;NAA16;ESR1;TBX1;KAT6A;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;SMAD5;XPC;NFYA;WNT5A;HES1;TRIM56;SP3;AR;ELF4;CD38;ACTA2;CDKN1C;HEY2;SPIN1;ARID1A;VHL;TRIM16;FGF2;ELK1;TGFB3;AHR;APOE;NOTCH4;FGF7;KLF4;TAL1;ETS2;PITHD1;MYOCD;GTF2H1;NFATC2;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;BMP2;NFIL3;HNRNPAB;NME2;FZD1;NCOA6;CD86;KLF2;ZNF318;YAF2;MRPL12;MT3;MAD2L2;NR1H4;ENY2;BRCA2;ID2;ATF4;SIX4;SP100;RREB1;DNAJC2;HEY1;ZBTB48;ZNF496;MED14
prerank,response to ethanol (GO:0045471),0.4995601457615672,1.2395843101198971,0.21183206106870228,0.8755428061986358,1.0,5/14,8.72%,ADH7;GRIN3A;GLRA1;CHRNB2;DRD3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4532368130124224,-1.239514085320901,0.21085594989561587,0.501061960125673,1.0,7/17,22.36%,ATP5MF;ATP5F1E;ATP5F1B;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,glycolytic process (GO:0006096),0.4282500664697569,1.239410132236385,0.1954459203036053,0.873578577432118,1.0,7/28,7.66%,GCK;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3464809301947722,1.2390920361872828,0.12398042414355628,0.872090771539564,1.0,15/85,9.16%,EYA1;CACNA1D;USH1C;DCDC2;COL4A3;ALDH7A1;WHRN;GSDME;EML2;PCDH15;CCDC50;MYO3A;CHRNB2;ADGRV1;MYH14
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4487969649920588,-1.2387160724710085,0.1875,0.5023036914452825,1.0,10/17,8.50%,JAG1;SLIT2;NOS3;TGFB2;NOTCH1;BMP4;NFATC1;HEYL;STRA6;HEY2
prerank,neutral amino acid transport (GO:0015804),-0.39573437904747377,-1.238614049544174,0.15578947368421053,0.5018801878194068,1.0,9/28,14.08%,SLC6A6;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4435568274042299,1.238124962565631,0.21455938697318008,0.8730548388752946,1.0,2/23,6.95%,TGFBR3;FGFR2
prerank,antibacterial humoral response (GO:0019731),-0.45458431640834573,-1.2380921825316282,0.19189765458422176,0.5023684231480702,1.0,3/16,14.39%,DEFA6;RPL39;PLA2G6
prerank,epithelial cell development (GO:0002064),0.4540140599477395,1.2367474697541587,0.2052313883299799,0.8758353247109567,1.0,6/20,12.70%,WNT5B;WNT7A;RILPL2;RILPL1;DACT2;PDZD7
prerank,positive regulation of transferase activity (GO:0051347),-0.2921158988615357,-1.2366992179405347,0.06199460916442048,0.5051713217161848,1.0,48/142,23.60%,ROR1;TEK;NTRK3;NEK7;CD200;TIE1;INSR;MERTK;DCUN1D3;EGFR;EPM2AIP1;KDR;SERINC5;TNKS;MET;XRCC5;MAPK1;FLT1;PTGES3;FLT4;IGF2;HMBOX1;KLF4;EPHB2;DCUN1D5;CD74;RET;UBE2L3;ROR2;FBXW7;CCT2;ALK;CSF1R;PARM1;FGFR3;NBN;GREM1;MAPK3;MAP2K7;RFC4;EPHB6;DTX3L;MAP3K4;RYK;DKC1;TRIB3;IGF1R;POLG2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.43807965783800884,-1.2365144491470275,0.1934782608695652,0.5049682068755746,1.0,10/20,24.78%,TTC39B;APOE;SREBF2;ACADVL;NR1H4;LDLRAP1;ARV1;SREBF1;LPCAT3;MBTPS2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.45464150660025704,-1.2355528211899702,0.19595959595959597,0.5065680818837623,1.0,6/16,10.56%,BCL2L1;CXCL12;TPT1;NACC2;RPS3;ACKR3
prerank,secondary alcohol metabolic process (GO:1902652),0.3872291278414397,1.2353608742097613,0.17773788150807898,0.8785681838084939,1.0,13/42,16.04%,SOAT2;CYP11B1;APOF;SOAT1;CLN8;OSBPL5;CYP27A1;RXRA;FDX1;SQLE;TSKU;IDH2;GBA2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.42937380578619033,-1.2349069493101836,0.18012422360248448,0.5075593114957677,1.0,5/22,12.96%,B2M;ZBTB1;CD55;MALT1;STX7
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5106728128814186,-1.2341500018544744,0.20118343195266272,0.5086868659893713,1.0,3/11,2.83%,FAP;PTGIS;BCL2L1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5011479391805825,-1.2339311811319789,0.20916334661354583,0.5086040892293325,1.0,3/11,6.22%,PID1;TFRC;VAT1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.31277344464682877,-1.2339125714468484,0.09523809523809523,0.5079771863101613,1.0,28/94,21.51%,IL1R1;RPS6KA5;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;IL1RAP;PSMB6;PSMB5;SQSTM1;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;MAP3K8;PSMB4;PSMD14;NOD2;MAPK3;PSMD10;MYD88;PSME1;RIPK2
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.45303686327583936,-1.233814152058516,0.20204081632653062,0.5075545466632158,1.0,6/17,13.82%,CLDN5;VCL;PPP1R12A;F11R;S1PR3;VEGFA
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.31812571959753544,-1.23342476113321,0.10679611650485436,0.507768064652697,1.0,30/85,23.25%,RHOA;FZD6;PRICKLE2;SMURF1;AP2B1;WNT5A;PSMA6;PSMB7;TIAM1;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10;PSME1;RYK;AP2M1;PSMB3
prerank,insulin receptor signaling pathway (GO:0008286),-0.33076490995548335,-1.2332148213104486,0.13501144164759726,0.5075751859723889,1.0,20/69,13.91%,GAB1;BCAR3;INSR;FOXO1;PIK3R1;GRB14;ATP6V0A4;PIK3C2A;APC;ATP6V0D1;PIK3CA;ATP6V0A1;IGF2;BCAR1;CAV2;SH2B2;ATP6V1D;AKT2;IRS1;RARRES2
prerank,positive regulation of vascular permeability (GO:0043117),-0.4975687929466801,-1.2323273989361019,0.2147239263803681,0.509074620998226,1.0,7/12,13.82%,PDE3A;TJP1;TJP2;PDE2A;OCLN;TRPV4;VEGFA
prerank,copper ion transport (GO:0006825),-0.5113648404560309,-1.2320715386662884,0.22332015810276679,0.509050982896909,1.0,9/11,31.12%,STEAP3;SLC31A1;ATOX1;STEAP2;SLC31A2;ATP7B;STEAP4;SLC11A2;COX17
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4987999154068075,-1.2320685931588453,0.2051792828685259,0.508397281933599,1.0,5/11,18.96%,MEF2C;TGFB2;MYOCD;GPER1;GREM1
prerank,positive regulation of kinase activity (GO:0033674),-0.3070609644565275,-1.2317814242994387,0.09162303664921466,0.5083909281143152,1.0,25/107,13.63%,ROR1;TEK;NTRK3;RAPGEF2;TIE1;INSR;MERTK;GAS6;RASSF2;RAP1A;IQGAP1;EGFR;KDR;CACUL1;MET;XRCC5;FLT1;CCN1;FLT4;EPHB2;CD74;RET;PTK2B;ROR2;PTPRC
prerank,positive regulation of catabolic process (GO:0009896),-0.3252640660577959,-1.231746834951296,0.11214953271028037,0.5078197624989672,1.0,9/65,7.76%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;WNT5A;PLK2;APC
prerank,cardiac muscle cell contraction (GO:0086003),-0.43912996379548336,-1.2317140024205793,0.19230769230769232,0.5072435513940141,1.0,8/19,15.01%,GSN;KCNJ2;CACNA2D1;CACNA1G;CAMK2D;PIK3CA;SCN4B;ATP1A1
prerank,glucose transmembrane transport (GO:1904659),-0.44154772518333685,-1.2316899770511411,0.19172113289760348,0.5066509166589984,1.0,5/18,13.11%,SLC2A1;PPARD;SLC2A3;SORT1;SLC2A9
prerank,response to fatty acid (GO:0070542),-0.45268696824244575,-1.2311336849719212,0.21008403361344538,0.5073184420982784,1.0,6/17,15.58%,PID1;FOXO1;FOXO3;IRS1;SCD;NR1H4
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.44925583030037336,-1.2306261953815525,0.21149897330595482,0.5079322797996458,1.0,8/17,13.74%,CAV1;KLF7;AJAP1;PRKX;CEACAM1;APOLD1;CD24;MAFF
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.43986354158919927,1.2303622962186782,0.20522388059701493,0.8951933188475432,1.0,4/23,6.34%,TGFBR3;SMAD3;DKK3;NREP
prerank,regulation of cholesterol storage (GO:0010885),-0.4700812685192054,-1.2300514487391891,0.2172043010752688,0.5086645645678751,1.0,5/15,11.49%,SCARB1;PPARD;ABCA1;TTC39B;SREBF2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.480228512035219,-1.2297711208182163,0.2192622950819672,0.5087227198576413,1.0,3/13,1.43%,PID1;NOS3;TMSB4X
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.4745491086146373,1.2296600534337372,0.2079002079002079,0.8951704734532355,1.0,3/16,7.14%,DDX5;PQBP1;DDX17
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4431498969260632,-1.2294181641963324,0.20202020202020202,0.5089150035426098,1.0,3/18,4.16%,DCN;KDR;MFF
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4126977250013383,-1.2289756966448466,0.19532908704883228,0.5093055296005827,1.0,8/24,16.06%,B2M;SEC24D;TAP2;BCAP31;SEC23A;SEC31A;SEC24B;SEC13
prerank,DNA methylation or demethylation (GO:0044728),0.46299199910986844,1.228326424529895,0.2310838445807771,0.8949457084897733,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,DNA alkylation (GO:0006305),0.46299199910986844,1.228326424529895,0.2310838445807771,0.8949457084897733,1.0,7/19,12.07%,DNMT3L;DNMT3A;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3689350482850967,-1.2283006261386173,0.15831663326653306,0.5103485906861873,1.0,10/36,14.54%,SGMS1;DAB2IP;FAS;CRADD;PPIA;RPS3;PTPMT1;CSNK2A1;MADD;NR4A2
prerank,positive regulation of secretion (GO:0051047),-0.5076386468690709,-1.2277194200285322,0.20907297830374755,0.511131131044374,1.0,7/11,48.13%,ACSL3;AQP1;SCIN;GPLD1;XBP1;TRH;ABCB11
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.39214303356975194,-1.227690336869989,0.17155756207674944,0.5105532172447341,1.0,8/30,12.65%,DCN;CSGALNACT1;NDNF;CSPG4;VCAN;HEXA;CHSY3;BGN
prerank,Rho protein signal transduction (GO:0007266),-0.3493465838900571,-1.2275607402333006,0.14354066985645933,0.5102355828336834,1.0,21/53,14.86%,RHOJ;RHOA;NTN1;ARHGEF3;CDH13;CDC42EP5;CDC42EP3;EPS8;AGTR1;ARHGDIB;EPS8L2;RIPOR1;CFL1;ADGRG1;CDC42EP2;ARHGAP1;TAX1BP3;SHTN1;ARHGDIA;GNA12;LIMK1
prerank,DNA methylation (GO:0006306),0.44269324851090747,1.2272395919308368,0.19845857418111754,0.8964925128639494,1.0,13/23,24.14%,DNMT3L;DNMT3A;N6AMT1;DMAP1;SPOCD1;PPM1D;GATAD2A;BEND3;PICK1;BAZ2A;HELLS;ATRX;METTL4
prerank,calcium ion import across plasma membrane (GO:0098703),0.4928556329894699,1.2271906677234332,0.21774193548387097,0.8940377907491874,1.0,2/14,1.13%,SLC8A3;TRPV1
prerank,mRNA metabolic process (GO:0016071),0.3353639830923626,1.2266704552580356,0.12433392539964476,0.8933626599038444,1.0,18/90,14.28%,HSPA1A;DDX5;CPSF3;SRSF5;CPSF6;HNRNPA2B1;PRMT9;SON;PTBP1;LSM5;PPARGC1A;SRRM4;SLBP;LSM11;AGO3;USP39;SRSF11;HSPA1B
prerank,organonitrogen compound catabolic process (GO:1901565),0.36258978070790066,1.2264880279104913,0.16062176165803108,0.8914547021452895,1.0,15/57,16.78%,ADAMTS13;CPQ;RENBP;CAPN3;PNPLA8;GNPDA1;CTRL;CLN8;SMPD2;PLA2G15;NPL;CLN5;UCHL3;TRHDE;CTH
prerank,organelle fission (GO:0048285),-0.40771855346987623,-1.2252553846951302,0.20412371134020618,0.5150851002643582,1.0,10/24,29.78%,DNM3;CORO1C;MFF;SEC16B;MTFR2;GDAP1;MIEF1;MUL1;DNM1;DNM2
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.28616510823050334,-1.2242905327317566,0.07859078590785908,0.5167331076673118,1.0,40/175,20.71%,LIMS1;ACTN4;PID1;DAB2IP;TMSB4X;TRAF5;FOXO3;NFKBIA;TNFRSF1B;CARD14;TNFRSF11A;ARHGEF2;AIM2;YBX3;PSMA6;TNFRSF11B;PSMB7;TNFRSF21;RPS3;CCL13;PSMB6;PSMB5;EDA2R;BIRC3;PTK2B;CD40;PSMB8;PSMC4;PSMD11;ADAMTS12;GPER1;PSMB4;EDAR;PSMD14;ERBIN;CCL25;ZC3H12A;RIPK1;PSMD10;TNFSF8
prerank,regulation of apoptotic process (GO:0042981),-0.24426347959700326,-1.22335679933618,0.00847457627118644,0.5183465061480772,1.0,182/676,20.51%,HIP1;LEF1;ARHGAP10;TEK;MEF2C;ACTN4;IL6ST;DAB2IP;ITGA6;SLIT2;TJP1;PTMA;STEAP3;NET1;ACER2;TNFSF10;ARHGEF3;MAP3K5;FOXO1;TBX3;THBS1;DCUN1D3;MCF2L;GAS6;APAF1;RASSF2;STK3;PIK3R1;EGFR;CYP1B1;FOXO3;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;SFRP4;RASGRF2;KDR;UNC13B;UBC;RPS6KA3;RPL10;JUN;CARD14;NAA16;DNAJA1;TIAM2;ACTN1;FAS;FLNA;ITGB1;TFRC;MAP3K20;ARHGEF2;RNF144B;CRADD;RPS27A;UBB;PAK2;WNT5A;RACK1;ADAM10;PERP;PPIA;ANXA1;TPT1;PLK2;IAPP;KLF11;TGM2;APC;SPRY2;CD38;RPS3;RPS6KA2;CTSD;CDK5;ABR;SRC;XIAP;SOD1;FLT4;TIAM1;VHL;MAP4K4;VAV2;ARHGEF12;CAT;TGFB3;BCAR1;GCLC;GOLPH3;YWHAZ;BABAM2;IFT57;CFL1;MALT1;NSMF;CTSB;TCTN3;TNFAIP8;HSPB1;PHLPP1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BMP2;HIP1R;PLEKHG2;BIRC3;PTK2B;SAP18;RARG;USP47;TCIM;EEF1E1;AKT2;NME2;ARHGDIA;VEGFA;MADD;HIGD2A;LANCL1;JMY;ACVR1C;MT3;ALK;CBL;RHBDD1;PLAUR;BAK1;NR1H4;PA2G4;ATF4;BAG1;NCKAP1L;STIL;SIX4;RNF157;RTN4;PREX1;RBM25;ING4;DIABLO;TMEM219;OSGIN1;TOP2A;HDAC2;GPER1;LATS1;DUSP6;BARD1;PTPN6;STK26;PSEN2;GREM1;SH3RF1;MCL1;IRF5;RYBP;SOX8;ARHGEF5;STK17B;RIPK1;JAK3;HCK;AKT1S1;FOXL2;TRIO;PSMD10;PSENEN;HYPK;LCMT1;HMGB1;RHOB;MYD88;POU3F3
prerank,cardiac muscle tissue development (GO:0048738),0.37246172463615634,1.2232078587394908,0.1724137931034483,0.9012743819376102,1.0,9/50,7.98%,NOTCH2;BMP7;GJB6;MSX2;BMPR1A;CSRP3;SGCZ;NRG1;KDM6B
prerank,positive regulation of protein processing (GO:0010954),-0.43715909915773954,-1.2231930688316264,0.20507399577167018,0.5181149661178486,1.0,4/19,7.98%,GSN;MYH9;NKD2;CCBE1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3757473525073348,-1.2224761051329887,0.15711252653927812,0.51924493132743,1.0,14/36,23.57%,EIF3H;GABARAPL2;AQP11;PRKCG;UBXN1;USP7;BAG5;N4BP1;RYBP;PSME3IP1;UCHL5;FHIT;GIPC1;TAF9
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.45265516108412734,1.2222889158032066,0.21361058601134217,0.9021316177191884,1.0,3/19,8.03%,IGF1;NLRP2B;NLRP3
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.38471857902639395,-1.2211676693330997,0.1504237288135593,0.5217216662193034,1.0,14/32,23.40%,FOXO3;RBM3;APP;RPL10;TMED10;PRKCD;SAMD8;EIF4E;PGAM1;NR1H4;DDX25;TIGAR;ROCK1;NANOS3
prerank,modulation by host of symbiont process (GO:0051851),-0.37911829940482966,-1.220481647838273,0.1934782608695652,0.5227406602691301,1.0,15/31,37.10%,LEF1;JUN;SAP30BP;CHD1;SMARCA4;SNW1;NUCKS1;CCNT1;POU2F3;AQP1;HPN;CCL5;HDAC1;SAP30;CCL4
prerank,response to iron ion (GO:0010039),0.5001202143337151,1.2203919606215454,0.22810590631364563,0.9068943486191194,1.0,3/12,10.41%,BMP6;ACO1;BCL2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.29498055621634844,-1.2201182641264094,0.12009803921568628,0.5229741745827077,1.0,31/119,18.23%,PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;TTC7A;SOCS2;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;EFR3B;PLEKHA4;INPP5D;PIK3CA;FGF2;SOCS5;PIGC;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12;PIK3R4;PI4KB;MTMR1;CISH;SOCS3;PTEN;PIGL
prerank,ketone body metabolic process (GO:1902224),0.5341001463645211,1.219719773166819,0.24329896907216494,0.9070061957131199,1.0,3/10,10.55%,OXCT1;ACAT1;BDH1
prerank,bile acid biosynthetic process (GO:0006699),-0.41405327295180694,-1.2196923143374154,0.1953781512605042,0.5233612604590776,1.0,4/24,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,regulation of microtubule nucleation (GO:0010968),0.5249535465255264,1.2191132267516114,0.23588709677419356,0.9067451923294374,1.0,2/10,5.19%,HSPA1A;EML2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5287409375130373,1.2187488887999436,0.24380165289256198,0.9055036415700815,1.0,7/10,29.88%,E2F8;SSBP1;DBF4;CDC7;ATRX;WIZ;STOML2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.48106349773215296,-1.2186370544933736,0.2165991902834008,0.5252536982060405,1.0,7/13,31.47%,TMEM30A;SEC16B;BCAP31;SAR1A;EDEM2;EDEM1;TMEM30B
prerank,error-prone translesion synthesis (GO:0042276),-0.4189503387425271,-1.2182531070224647,0.17857142857142858,0.5255021987503682,1.0,9/21,20.96%,RPA1;UBC;RPS27A;UBB;REV3L;MAD2L2;RPA2;PRIMPOL;RFC4
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25835777378319347,-1.2181483389886822,0.030959752321981424,0.5250660928441804,1.0,72/351,13.33%,ABI1;BMP5;ZBTB7C;RAPGEF2;BMPR2;DAB2IP;NOS3;CD200;B2M;FAP;ETS1;ACVRL1;TGFB2;TBX3;NOTCH1;CDH13;SH3BP4;CYP1B1;CTCF;NGF;BTG1;BMP4;PTPRJ;SFRP4;MTSS1;APP;ITGA1;ADARB1;PTPRK;CCN3;CBFA2T3;IGFBP6;AQP11;WNT5A;AXIN2;HES1;LYN;AR;ADAMTS1;APOD;KLF11;NACC2;APC;PPP2R5C;RPS6KA2;IFI35;RBBP4;CDKN1C;SLC16A2;PLPP1;GATA2;VHL;TGFB3;KLF4;S100A11;BTG3;HGS;TES;ADGRG1;PBRM1;MYOCD;SOX7;DDAH1;MORC3;WNT9A;BMP2;PTK2B;SST;RARG;ROR2;EEF1E1;RERG
prerank,positive regulation of protein secretion (GO:0050714),0.3512443124043715,1.2179960063438497,0.14485165794066318,0.9057652209029609,1.0,7/69,2.86%,BMP6;IGF1;NNAT;FRMD4A;WLS;GCK;NLGN2
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3339657333138959,-1.217876746029746,0.14798206278026907,0.5250501269744133,1.0,24/62,24.52%,MEF2C;ZBTB16;THBS1;KMT2E;RUNX1;H3-3A;AGO1;LYN;CBFB;DPY30;MYL9;PAF1;PTK2B;KMT2C;PRMT6;AGO4;CDK6;SPI1;L3MBTL1;ZFPM1;KMT2B;PRMT1;ASH2L;FES
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.45548094395894567,1.2178691613613162,0.19811320754716982,0.9036113657139261,1.0,8/19,22.39%,OBSL1;IL1RAPL1;PTPRD;CDKL3;CDKL5;CAPRIN2;CUL7;DBNL
prerank,regulation of interleukin-10 production (GO:0032653),-0.3511938194519318,-1.2178040462839566,0.14495798319327732,0.5245777745631927,1.0,20/44,33.08%,CD34;STAT3;PLCG2;TNFRSF21;ISG15;PIBF1;CD46;NOD2;JAK3;HMGB1;TRIB2;SYK;FCGR2B;DLL1;TLR4;LGALS9;VSIR;TSLP;CD47;TYROBP
prerank,response to estradiol (GO:0032355),-0.38712079517113374,-1.2173368230226884,0.18040089086859687,0.524993077277978,1.0,7/31,7.71%,EGFR;SOCS2;STAT3;ESR1;STRN3;ANXA1;NRIP1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4766546471474784,-1.2173334240533296,0.22154471544715448,0.5243423813701885,1.0,6/13,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,positive regulation of biomineral tissue development (GO:0070169),0.386799593195022,1.2170461117568596,0.18850987432675045,0.9041730113827523,1.0,9/40,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;WNT6;PKDCC;ADGRV1
prerank,positive regulation of myelination (GO:0031643),-0.4931868368695326,-1.2167744379847214,0.21141649048625794,0.5250574656705022,1.0,2/11,3.66%,PARD3;TNFRSF1B
prerank,cellular protein modification process (GO:0006464),-0.2376523731988325,-1.2166215947263355,0.005494505494505495,0.5247776041204806,1.0,272/982,22.20%,PRKG1;PTPRM;PTPRB;PTPRG;PRKCH;ST3GAL4;FBXL7;ERG;GCNT2;SNRK;BMPR2;ZBTB16;ST8SIA4;LTBP1;MARK1;NEK7;PTPN12;ACVR1;CDK17;HIPK1;ACVRL1;TGFB2;PTP4A2;ST3GAL6;MAP3K5;INSR;MERTK;RPS6KA5;THBS1;DCUN1D3;STK38L;B3GNT2;GAS6;STK3;PEAK1;PLOD2;SDHAF2;LIMK2;ATG3;SOCS2;BCR;BMP4;PTPRJ;WIPI1;AKT3;PPP1R12A;TGFBR2;IRAK3;APP;FN1;BTBD1;CDK14;SSH2;PTPRK;DCAF6;LMO7;FNIP2;FBN1;BMX;TNIK;NUAK1;PDIA6;MSLN;COP1;MAP3K20;CSNK1E;CAMK2D;ST3GAL1;PAK2;TEC;UBE2D3;PRKD1;CST3;TNKS;ERN1;ART3;ADAM10;LYN;DCAF10;LOX;FBXW8;CDC42BPA;KLHL2;DCLK1;ANXA1;PRKCD;PSMA6;PLK2;CDKL2;CSNK1A1;COG3;PSMB7;MAPK1;CCN1;PPP3CA;CSNK1G3;FBXO31;TGM2;FEM1B;PPP2R5C;FBXO30;PRKCG;LAMB2;PPM1H;KTN1;MFGE8;STK24;ST8SIA6;STT3B;MGAT4A;CDK5;PTPN1;VCAN;PTAR1;VHL;MAP4K4;AGA;EIF2AK3;FBXO4;PPP1CA;MAPKAPK2;CAND1;SOCS5;APOE;PSMB6;FBXO32;JAK1;YWHAZ;YES1;NEK3;BCKDK;B4GALT5;CPE;UBE2F;PIK3CD;MTMR7;PSMB5;SIRT5;OARD1;METAP1D;PIK3C3;GRK5;STK10;ISG15;DYRK1A;MORC3;ILKAP;PTPRZ1;RAB3A;PNPLA2;UGCG;PRKG2;RET;BMP2;DCAF13;PTK2B;DCAF5;UBE2L3;FBXW2;FBXO44;PPP2R3A;CSNK2A1;STK38;EVA1A;AKT2;PTPRC;FBXW7;UBL5;FBXL18;PPP1CC;TNC;RAB11B;CDH2;PSMB8;PIK3R4;ACVR1C;PPP4R2;ST8SIA2;PKN3;MT3;LIMK1;RAB1B;RHBDD1;GOLM1;TAB1;PSMC4;ICMT;KLHL22;KBTBD7;PHKA2;PSMD11;KLHL3;PRKACA;CTTNBP2NL;ALG10B;ASB13;MKNK2;PHEX;TAOK3;GPS1;ST6GALNAC2;PIGK;ATG5;CISH;CHRDL1;MAST2;SOCS3;IGFBP4;PTEN;COQ8A;LATS1;DUSP6;ST3GAL2;PSMB4;WDR45B;PSMD14;KCTD6;STRADA;TAOK1;HUNK;PTPN6;ATE1;CCNF;C3;PRAG1;STK26;CTDNEP1;CDK16;FBXL4;RAB11A;DSP;CDK6;CKAP4;MAPK3;MATN3;BTK;FBXW5;MARK3;STK17B;SIRT7;JAK3;HCK;PPM1L;PSMD10;LCMT1;TRIB2;PPP2R5B;PARP8;ENGASE;COPS6;CALU;COG7;CSNK1D;MAP3K6;DYRK2;PPP2CA;CHEK1;KLHL11;SYK;RCE1;ROCK1;PSME1;CDKL4;PTPRF;F13A1;DUSP1;KLHL25;FYN;CHM;ASB1;JMJD4;CCDC22
prerank,calcium ion import into cytosol (GO:1902656),0.47870346198684566,1.2164668460995414,0.24193548387096775,0.903749506873771,1.0,2/15,1.13%,SLC8A3;TRPV1
prerank,regulation of keratinocyte migration (GO:0051547),-0.495260801386322,-1.216237067870297,0.23214285714285715,0.5251136861789452,1.0,5/12,24.54%,MAP4K4;FGF7;PTEN;MAPRE2;EPB41L4B
prerank,male meiosis I (GO:0007141),0.47544417176354403,1.2157611732082891,0.23076923076923078,0.9039105351310115,1.0,3/16,14.13%,DNMT3L;TDRD9;MYBL1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.48464068086662015,-1.2150748081204106,0.22088353413654618,0.5273347068044906,1.0,8/13,42.29%,CBLB;IPO5;KPNA2;KPNA1;NUP35;NUP54;KPNB1;KPNA7
prerank,skeletal muscle tissue development (GO:0007519),-0.37558415000851947,-1.2149669761403539,0.18777292576419213,0.5269231155828545,1.0,5/32,5.91%,MEF2C;CAV1;SVIL;SIX1;MYL6
prerank,cellular response to interleukin-4 (GO:0071353),-0.5198202823395375,-1.2147779279277655,0.2485089463220676,0.5267173857286285,1.0,1/10,0.18%,LEF1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.33594165626910627,1.2147605767159018,0.1733102253032929,0.905182552000576,1.0,29/77,19.03%,IGF1;HSPA1A;SIAH2;SLC25A5;PPIF;FZD9;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;CSNK2A2;CAAP1;PIH1D1;CLU;QARS1;BDNF;TMEM14A;NOC2L;SCG2;NDUFA13;HGF;NOL3;RELA;TCF7L2;AKT1;CX3CL1;MAPK8IP2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.34495260835978875,-1.214738451215282,0.15296803652968036,0.5261701442835404,1.0,22/51,30.42%,STAT3;APP;TMED10;GBP5;WNT5A;S100A13;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;HMGB1;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.295918938982336,-1.2142950271664057,0.11436170212765957,0.5266209733297161,1.0,28/113,13.82%,NRP1;TEK;BMP5;NRP2;BMPR2;PTN;VEGFC;CDH13;F3;EGFR;BMP4;AKT3;KDR;TBX1;PRKD1;WNT5A;PPP1R16B;MDK;FLT4;FGF2;AGGF1;FGF7;PIK3CD;NRAS;BMP2;ECM1;NME2;VEGFA
prerank,transcription by RNA polymerase I (GO:0006360),-0.36777218412017165,-1.2140949181009022,0.18640350877192982,0.5264303993979984,1.0,16/34,30.12%,GTF2H5;GTF2H1;ERCC2;POLR1F;POLR1G;CAVIN1;MAPK3;POLR1A;UBTF;CCNH;POLR1H;POLR2F;POLR1E;POLR2H;POLR1C;POLR2E
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.49389057171654793,-1.2138396132860736,0.24081632653061225,0.5263927796985792,1.0,8/12,32.10%,SIX1;SMO;VEGFA;SIX4;SOX8;LHX1;AGT;NOG
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3436342036731172,-1.2138367707675508,0.16393442622950818,0.5257538370022478,1.0,9/48,9.72%,NRP1;LIMS1;LIMS2;DOCK1;FLNA;FBXW8;MDK;MYOC;NEDD9
prerank,cellular response to alcohol (GO:0097306),-0.35359922575054425,-1.2131337267431428,0.16519823788546256,0.5267632804306944,1.0,17/42,16.14%,LRP6;CDH1;CTNNA1;GNB1;ADCY7;GNG2;ADCY2;AHR;GOLPH3;GRAMD1A;PTCH1;BLM;SMO;ADAM15;GLRA2;PTGFR;CFTR
prerank,negative regulation of protein modification process (GO:0031400),-0.3168430451909106,-1.2129850190808802,0.14925373134328357,0.5264525504240624,1.0,18/79,10.66%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;MFHAS1;YWHAB;XDH;PPIA;LYN;PPP1R16B;OCLN;CRTAP;EPHB2;TERF2IP
prerank,negative regulation of cation channel activity (GO:2001258),0.40875433104821934,1.2128964222552923,0.2003968253968254,0.9099131632966874,1.0,6/26,11.59%,SLC6A9;CRHR1;GNB5;GSTM2;DRD3;GSTO1
prerank,regulation of histone deacetylation (GO:0031063),-0.47446542312841833,-1.2128052714748325,0.21095334685598377,0.5262354824576602,1.0,5/13,17.53%,NIPBL;CAMK2D;SAP30BP;APLNR;PRMT6
prerank,positive regulation of ion transport (GO:0043270),0.3647621150434228,1.2120732058477122,0.1872791519434629,0.9106190366011935,1.0,7/48,5.33%,CACNA1D;ACTN2;ANK2;WNK3;ADRA2A;DLG1;VAMP7
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.36674529121404,1.2119959379556413,0.18246869409660108,0.9083223312127938,1.0,19/52,19.84%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;HNRNPL;PTBP1;SRRM4;YTHDC1;FXR2;RBM5;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST
prerank,cellular response to hormone stimulus (GO:0032870),0.3446606055128765,1.2115391525531811,0.16457960644007155,0.9074611418922902,1.0,8/69,4.37%,ATP1A2;SLC5A5;TFPI;GCK;THRB;CYP11B1;BRD8;ADRA2A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4463838576749532,1.2112025990790218,0.22178988326848248,0.906161981344663,1.0,7/19,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,mitochondrial transport (GO:0006839),0.3594672570949986,1.210826894080098,0.1711229946524064,0.9049510477236511,1.0,13/53,13.05%,PITRM1;FLVCR1;COX18;SLC25A5;PPIF;ABCB10;TOMM40;TIMM17A;MTX2;TOMM22;BCL2;MFN2;TMEM14A
prerank,regulation of intracellular signal transduction (GO:1902531),-0.25085468068482286,-1.2107747696090654,0.030927835051546393,0.5304541013154316,1.0,63/420,9.36%,ARHGAP31;SGMS1;ARHGAP10;VWF;TEK;NTRK3;RHOJ;CHN2;DAB2IP;PIP5K1B;ARAP2;SRGAP1;RHOA;TMSB4X;TRAF5;NET1;HIPK1;ARHGEF3;RPA1;PIP4K2A;MCF2L;RASSF2;STK3;STARD8;CHN1;EGFR;NFKBIA;BCR;MOB3B;RASGRF2;ARAP3;RPL5;STARD13;TIAM2;PLCG2;KAT6A;TNIK;NUAK1;ARAP1;ARHGEF2;PAK2;WNT5A;ARHGAP32;ARHGDIB;PDE2A;LYN;PPP1R16B;ARHGAP35;MAPK1;MYOC;PPP2R5C;CEACAM1;USP7;RBBP4;CDK5;ABR;XIAP;ATP6AP2;TIAM1;MAP4K4;VAV2;IER3;ARHGEF12
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5115542663824733,-1.2107135637277353,0.2605210420841683,0.529957739648677,1.0,5/11,10.62%,MEF2C;RAPGEF2;LYN;ANXA1;PIK3CD
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4214925129830245,-1.2100962944721738,0.2150313152400835,0.5307692133822792,1.0,9/19,32.80%,LRP6;VEGFA;NR4A2;MANF;LMX1B;RYK;LMX1A;WNT2;CTNNB1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.44442156002284383,1.209952079640029,0.2051792828685259,0.9057263562807396,1.0,2/20,5.27%,IGF1;PAX6
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4298919424373229,-1.2096296816271295,0.19517102615694165,0.53124281912132,1.0,8/18,19.30%,MDFIC;MFHAS1;CTNNA1;APOD;OTUD7B;LATS1;POLR1A;CABP1
prerank,negative regulation of cellular process (GO:0048523),-0.24803950802116345,-1.2095152223258747,0.024390243902439025,0.5308719611813206,1.0,106/521,13.79%,APBB2;ABI1;PODXL;BMP5;ZBTB7C;RAPGEF2;PDE8A;BMPR2;DAB2IP;SLIT2;NOS3;CD200;ETS1;ACVRL1;TGFB2;CD9;NOTCH1;DCUN1D3;MYH9;CDH13;SH3BP4;CYP1B1;CD34;CTCF;VPS13C;NGF;BTG1;BMP4;PTPRJ;SFRP4;PLSCR1;APP;TNFRSF1B;ITGA1;ADARB1;FHL1;PTPRK;CCN3;TBX1;ACTN1;CBFA2T3;CASK;SOX17;IGFBP6;CCDC85B;VAMP3;AQP11;PRKD1;AXIN2;RACK1;ARHGDIB;ADAM10;LYN;NCK1;AR;ADAMTS1;CHMP4B;TNFRSF21;KLF11;CCN1;MDK;NACC2;APC;PPP2R5C;RPS6KA2;TGFBI;IFI35;RBBP4;PLPP1;VHL;EIF2AK3;TXNIP;FGF2;TGFB3;CDKN2AIP;NOTCH4;KLF4;S100A11;EPHB2;BTG3;HGS;TES;ADGRG1;PBRM1;PLXNC1;DYSF;MYOCD;SOX7;FBXO5;DDAH1;NME6;PDCD4;CCN4;WNT9A;BLM;BMP2;PTK2B;SST;RARG;SIPA1;ROR2;EEF1E1;RERG;SUZ12;ENPP1;ARHGDIA
prerank,ureteric bud development (GO:0001657),0.45650847750154916,1.209490874515673,0.22641509433962265,0.9049321339616961,1.0,4/17,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.41574084316739557,-1.2091724742458758,0.2141280353200883,0.5310292010327188,1.0,6/23,12.51%,GHR;NOTCH1;CYP1B1;HES1;PIBF1;PTK2B
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2809517654904859,-1.2090441255000508,0.08533333333333333,0.5306671809992883,1.0,40/150,16.20%,PDE4D;NTRK3;CAV1;PID1;DAB2IP;SLIT2;PARD3;NIBAN1;LRP6;ENG;RASSF2;PRR5L;CORO1C;SPRED2;UBASH3B;XDH;PAK2;RACK1;PPIA;LYN;PRKCD;NCK1;CALM3;OCLN;SPRY2;CEACAM1;EPHB2;TERF2IP;HSPB1;TWIST1;SH3GL2;GSKIP;DBNDD2;PTPRC;ENPP1;PAQR3;PLPP3;TAB1;FKBP8;DDIT4
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4132604625025469,-1.208970823339577,0.20934959349593496,0.5302324435391844,1.0,6/22,17.68%,ASXL3;APOD;CEACAM1;CCDC3;ALK;GPER1
prerank,regulation of small molecule metabolic process (GO:0062012),0.4057999350586814,1.2088019204042537,0.19852941176470587,0.9050506546988929,1.0,8/28,16.53%,RORA;PPARA;PDK2;PANK2;PDK1;EPHX2;SIRT1;NCOR2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5132215055479759,-1.2085694588087788,0.22529644268774704,0.5305445598320357,1.0,3/10,7.43%,BMP4;GLI3;MDK
prerank,postreplication repair (GO:0006301),-0.3507998965774876,-1.2084735516779668,0.16666666666666666,0.5301202022584346,1.0,17/45,22.57%,RPA1;UBC;UBE2V2;RPS27A;UBB;TRIM25;ZBTB1;WDR33;ISG15;USP43;UBE2A;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4
prerank,activation of adenylate cyclase activity (GO:0007190),0.39201013521749345,1.2083515143714796,0.19217081850533807,0.904221684320249,1.0,5/35,6.20%,ADCY5;LGR4;ADCY1;CRHR1;ADCY8
prerank,apoptotic cell clearance (GO:0043277),-0.3867499786192071,-1.2077114207488184,0.2167689161554192,0.5313880425799011,1.0,6/30,7.66%,RHOBTB1;SCARB1;THBS1;GAS6;ANXA1;TGM2
prerank,positive regulation of bone mineralization (GO:0030501),0.39024852899927887,1.207348861819999,0.22018348623853212,0.905637092557942,1.0,8/35,8.79%,BMP7;BMP6;WNT4;OSR1;BMPR1A;FZD9;PKDCC;ADGRV1
prerank,melanosome organization (GO:0032438),0.4190066906718968,1.2071895449567944,0.23440453686200377,0.9037641944229887,1.0,8/26,18.93%,GPR143;SNAPIN;DTNBP1;AP1M1;SHROOM2;HPS1;HPS4;RAB38
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5141145827337963,-1.2070347858611368,0.22393822393822393,0.5324666620352453,1.0,4/10,11.60%,UBC;RPS27A;UBB;ISG15
prerank,pharyngeal system development (GO:0060037),-0.4533554213243746,-1.2069923654368693,0.2200392927308448,0.5319272194278883,1.0,6/15,6.07%,BMP5;BMPR2;TGFB2;BMP4;TBX1;HES1
prerank,nucleic acid-templated transcription (GO:0097659),0.3744209430040928,1.2067658569514756,0.18198874296435272,0.9029392453597194,1.0,16/42,23.53%,THRB;RRAGC;DTX1;E2F1;CREBL2;DRG1;TOPORS;XAB2;TERT;POLR2D;RNPS1;MEF2A;POLR2A;BAZ2A;MMS19;POLR2B
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.35856353906894783,-1.206369178385109,0.16631130063965885,0.5327833927283278,1.0,13/39,17.11%,PIP4K2A;PIK3R1;TTC7A;SOCS2;PIK3C2A;EFR3B;PIK3CA;SOCS5;PIK3CD;PIK3C3;PI4KB;CISH;SOCS3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3837521934358121,1.206233674419247,0.20423892100192678,0.9024544923503671,1.0,13/41,21.26%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,UV-damage excision repair (GO:0070914),0.49481078313411675,1.2062254765996225,0.24904214559386972,0.9000046347052767,1.0,2/12,3.27%,DDB2;ERCC1
prerank,regulation of lipid kinase activity (GO:0043550),0.5089824555794721,1.2060654867945733,0.25609756097560976,0.8981550351891949,1.0,2/11,3.14%,PIK3R3;WDR91
prerank,autophagosome assembly (GO:0000045),-0.33137281632585,-1.206017511843642,0.17011494252873563,0.5329411856700019,1.0,15/52,18.91%,ATG3;SMURF1;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6
prerank,positive regulation of response to stimulus (GO:0048584),-0.3572251761623088,-1.20567718749372,0.15203426124197003,0.533141117234313,1.0,18/40,26.05%,B2M;TGFB2;WNT5A;PRKCD;ABI3;IL15;CDKN2AIP;EEF1E1;RSAD2;IFIH1;FMR1;FXR1;YPEL3;NSMCE4A;FCGR2B;TAF9;IER5;SELENON
prerank,regulation of synapse maturation (GO:0090128),-0.4980664169499339,-1.2047276319526774,0.23809523809523808,0.5347859725797901,1.0,3/10,10.15%,DAB2IP;ARHGEF15;YWHAZ
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4268087268325602,1.2045602229469496,0.21713147410358566,0.901319366524729,1.0,5/24,8.19%,IGF1;PPP1R3F;GCK;PASK;SORBS1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.49228917997302124,1.2045526899661272,0.23847695390781562,0.8988821188190507,1.0,5/13,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,toll-like receptor signaling pathway (GO:0002224),-0.305296650933121,-1.204527450160311,0.14221218961625282,0.5346105519575328,1.0,28/84,21.51%,RFTN1;IRAK3;UBC;RPS6KA3;PLCG2;RPS27A;UBB;UBE2D3;MAPKAPK2;CTSB;SFTPA2;SFTPA1;TRIL;PIK3C3;BIRC3;PIK3R4;IRAK2;SCARA3;TAB1;NR1H4;CTSS;BTK;RIPK1;HMGB1;MYD88;TICAM1;NMI;RIPK2
prerank,spindle assembly (GO:0051225),-0.31732134286633557,-1.203620635521759,0.15914489311163896,0.5361286567645055,1.0,20/67,23.01%,RHOA;NEK7;STARD9;FLNA;SMC1A;TNKS;STAG1;RPS3;MAP9;PIBF1;MZT1;STAG2;TOGARAM1;ARHGEF10;RAB11A;MAPRE2;CSNK1D;TPX2;AAAS;KIFC1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.48440962602726495,1.2034051501844139,0.24948875255623723,0.9008885277366215,1.0,4/13,15.79%,ADHFE1;GOT1;IDH2;GOT2
prerank,translesion synthesis (GO:0019985),-0.3557137596698305,-1.2031522464268898,0.17567567567567569,0.5365761902514141,1.0,22/42,29.64%,RPA1;UBC;RPS27A;UBB;REV3L;TRIM25;ZBTB1;ISG15;MAD2L2;USP43;RPA2;PRIMPOL;USP10;PCLAF;RFC4;POLD4;DTL;UFD1;RFC2;VCP;RCHY1;FAAP20
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4509423884063627,1.202329337021632,0.21052631578947367,0.9026548087567993,1.0,6/18,17.36%,DAB2;RAB21;DENND10;MTMR2;SNX3;PTPN23
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.44772492104738115,1.2023176501976631,0.242914979757085,0.900269410558079,1.0,3/18,6.37%,HSPA1A;SLC25A5;FZD9
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3537901496421935,-1.202113090097824,0.20412844036697247,0.5384505756363628,1.0,6/40,7.43%,MEF2C;ZEB1;RHOA;NGF;ARHGEF2;HEYL
prerank,protein autoubiquitination (GO:0051865),0.3528068300641159,1.201730200890684,0.18806509945750452,0.9000951785354439,1.0,15/61,20.65%,RNF220;DDB2;SH3RF2;RNF41;TRIM71;RNF10;RNFT1;OBI1;RNF213;MDM2;RNF13;TRIM13;BFAR;NFX1;RNF146
prerank,neural tube development (GO:0021915),0.4697578593597388,1.2015071563584172,0.2532347504621072,0.8984825714585575,1.0,2/15,5.66%,ALDH1A2;TRIM71
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.37927518422867285,1.2014765607783542,0.21223709369024857,0.8961754742066117,1.0,13/43,21.26%,SYT11;IGF1;C5AR2;ARG2;NLRC3;CACTIN;DICER1;HAVCR2;RARA;CX3CL1;SIRPA;NFKBIL1;ILRUN
prerank,plasma membrane repair (GO:0001778),0.4858314007137726,1.2012607672161812,0.2702169625246548,0.8946318170787214,1.0,3/13,6.61%,SYT11;ANXA6;MYOF
prerank,negative regulation of cellular component organization (GO:0051129),0.3411081352930051,1.2011392988393181,0.1728395061728395,0.8927115379386263,1.0,15/74,12.52%,BMP6;SYT11;HSPA1A;PRKCZ;PON1;DNAJB8;OPRD1;TFIP11;IMPACT;SCAMP5;CLU;WASL;RTEL1;RAPGEF3;MTMR2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.32814805397195246,-1.2010590993182162,0.16312056737588654,0.5403038982897957,1.0,15/55,20.95%,PID1;THBS1;CYP1B1;TGFBR2;XDH;AGTR1;SIRT5;ACE2;ROMO1;MT3;DHRS4;ZC3H12A;CBR1;RIPK1;NOXO1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3777403003216984,-1.2005972006744396,0.2222222222222222,0.5408276678573211,1.0,8/29,25.41%,RUNX1;ESR1;STRN3;CBFB;LATS1;KCTD6;SRARP;YAP1
prerank,amino sugar biosynthetic process (GO:0046349),0.5133795364312612,1.2005226031936485,0.2638623326959847,0.8926918609365615,1.0,3/12,7.09%,RENBP;GNPNAT1;GNPDA1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4031329615845423,-1.2004780294874844,0.19956616052060738,0.5405034173769754,1.0,7/24,16.62%,PDE3A;PDE4D;RAPGEF2;PDE2A;PRKAR2B;RNF157;APLNR
prerank,negative regulation of cell differentiation (GO:0045596),0.2947849604959487,1.200239251005014,0.12442396313364056,0.8913776657649521,1.0,27/181,10.07%,RANBP3L;BMP7;RORA;COL5A1;TMEM64;SMAD3;OSR1;OVOL2;CTR9;SUFU;DTX1;PPARA;LRP3;MEIS1;LEO1;HNRNPU;WWTR1;E2F1;CITED1;USF3;PTBP1;MED1;ADGRV1;NR1H3;SPRED3;SOSTDC1;TGFBR1
prerank,acylglycerol metabolic process (GO:0006639),-0.3594955501712906,-1.200214252224334,0.1812227074235808,0.5405314640416048,1.0,8/37,12.54%,CAV1;ABHD2;DGKH;DGKZ;MGLL;APOE;PNPLA2;ABHD6
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.41729173543135456,1.1997208130716177,0.24427480916030533,0.8910414000227642,1.0,4/23,6.77%,NUPR1;GCK;PPARA;C1QTNF3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3886146002159094,-1.1995042427119145,0.2028985507246377,0.5416802860168237,1.0,9/28,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IRS1;ENPP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3843321777964714,-1.1992507526048846,0.2299794661190965,0.5416783935153634,1.0,11/27,8.57%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;BMP4;TGFBR2;HES1;HEYL;HEY2;ZFPM2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3531909730948456,1.199146252100644,0.1827956989247312,0.8908195168249698,1.0,14/57,16.58%,ADCY5;ADCY1;ADRA2A;CHRM2;ADCY8;LPAR1;DRD3;GABBR1;GPR37;HTR1F;CHRM1;OPRM1;HTR1A;GRM8
prerank,synapse organization (GO:0050808),0.31014694740747023,1.1987123683713354,0.14100486223662884,0.89006994415464,1.0,12/125,3.51%,SDK1;SLC6A1;UNC13C;SLC8A3;CACNB1;CACNB3;OBSL1;PDZRN3;SDK2;NLGN2;PCDHB11;FLRT3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3623265595808784,-1.1986464091844373,0.2013274336283186,0.5425611722444202,1.0,7/39,8.77%,PTPRG;PODXL;JAG1;CDH1;CEACAM1;EFNA5;SRC
prerank,positive regulation of potassium ion transport (GO:0043268),0.3804931667817043,1.1985694752742695,0.20695970695970695,0.888249013775088,1.0,11/38,10.67%,ACTN2;ANK2;KCNJ5;ADRA2A;DLG1;KCNJ10;KCNH2;GABBR1;KCNN4;KCNJ16;GABBR2
prerank,alcohol catabolic process (GO:0046164),0.5266685357107711,1.1985687549939577,0.24404761904761904,0.8859196827472983,1.0,3/10,9.35%,CEL;ADH4;CYP27A1
prerank,regulation of proteolysis (GO:0030162),-0.3398049864640118,-1.1983838714745787,0.1772428884026258,0.5425537551501122,1.0,13/48,15.37%,CAV1;LTBP4;DNAJC1;SPOPL;CST3;PERP;CDK5;GSAP;HDAC6;IST1;TBC1D10A;PLAUR;BAK1
prerank,positive regulation of protein maturation (GO:1903319),-0.4963731169167679,-1.198200533473785,0.24900398406374502,0.5423611795806043,1.0,3/11,15.00%,NKD2;CCBE1;RHBDD1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.32157435857985134,-1.1981016143119483,0.18072289156626506,0.5419676946374528,1.0,16/66,10.48%,PTPRM;CAV1;SPARC;DAB2IP;B2M;TGFB2;THBS1;MTSS1;PTPRK;CASK;XDH;AQP11;CEACAM1;CDKN1C;APOE;CAV2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.41821362698484443,-1.197705057738114,0.24081632653061225,0.5422440719795957,1.0,3/20,1.53%,CAV1;PLCE1;ATP2B1
prerank,mitochondrion distribution (GO:0048311),0.4896476452113625,1.1976036906599599,0.25157232704402516,0.8871802791139128,1.0,7/12,26.43%,TRAK1;LRRK2;ARMC1;MEF2A;DNM1L;MTM1;HAP1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4244783022562755,1.1974418884476041,0.212406015037594,0.8855205785440127,1.0,6/22,11.06%,NOTCH2;CDH3;FGFR2;MED1;CRNN;STXBP4
prerank,response to prostaglandin E (GO:0034695),0.5227990472502697,1.197373959879753,0.26774847870182555,0.8834523459907481,1.0,1/10,0.29%,TGFBR3
prerank,ephrin receptor signaling pathway (GO:0048013),-0.31165910264006597,-1.1972891991538874,0.13926940639269406,0.5426328909595091,1.0,36/82,27.45%,ACTB;ARHGEF28;RHOA;ACTG1;ANKS1A;CHN1;AP2B1;LYN;GRIN2B;EFNA5;SRC;TIAM1;VAV2;YES1;EPHB2;AP2A1;ARPC2;GIT1;MMP2;GRIN1;PSEN2;CDC42;PSENEN;EPHB6;ARPC3;ROCK1;FYN;RASA1;AP2M1;EPHA7;PTPN11;ACTR3;VAV3;EFNA2;ARPC1B;DNM1
prerank,mitochondrion organization (GO:0007005),0.29688671019177426,1.1971083883014337,0.12096774193548387,0.8821184969504726,1.0,37/165,14.67%,IFIT2;TRAK1;MIGA2;SPATA18;ESRRA;PITRM1;NIPSNAP2;POLRMT;AFG3L2;AIFM1;COX7A1;TOMM40;SUPV3L1;CHCHD3;MIEF2;FMC1;TIMM17A;NDUFS1;ADCK1;LRRK2;MTX2;COX7A2L;WASF1;PPARGC1A;TOMM22;MYH14;AFG1L;MPV17;CYCS;SSBP1;MFN2;GABPA;ATAD3A;TERT;TMEM11;AIFM2;GABPB1
prerank,synapse assembly (GO:0007416),0.34164662987263533,1.1969138723347323,0.18833333333333332,0.8806211423717725,1.0,14/67,12.49%,SDK1;OBSL1;SDK2;NLGN2;PCDHB11;FLRT3;WNT7A;CBLN4;GRID2;NLGN3;GPM6A;FZD5;PCDHB3;BDNF
prerank,cAMP biosynthetic process (GO:0006171),0.5135318432833876,1.1968988633142104,0.25984251968503935,0.8783876296936318,1.0,3/10,6.20%,ADCY5;ADCY1;ADCY8
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.4824082738890263,-1.1967540589013252,0.24949698189134809,0.5433314347176353,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,peptide metabolic process (GO:0006518),0.3348068008414176,1.196714574643514,0.18998272884283246,0.8767999024301509,1.0,6/75,3.24%,AEBP1;ADAMTS13;CPQ;CPN1;ETHE1;FURIN
prerank,cell projection organization (GO:0030030),-0.38219387637748353,-1.1965566112003667,0.1864406779661017,0.5431776758651649,1.0,10/30,21.07%,RHOJ;GSN;PARVB;ITGB1;PARVA;CAPG;NPHP1;NCKAP1L;CDC42;RAC3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3866829798083178,1.1964897212992174,0.21314741035856574,0.8753317469327638,1.0,5/32,4.10%,IGF1;NUPR1;PRKAA2;PPARA;ENO1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4745348367329878,1.196438101838178,0.26556016597510373,0.8732698657386364,1.0,6/15,18.79%,SH3D19;FURIN;ADRA2A;NRDC;SNX33;SNX9
prerank,autophagy of nucleus (GO:0044804),-0.43448319439618904,-1.1961674605127959,0.2489539748953975,0.5435002655644517,1.0,9/16,28.64%,ATG3;WIPI1;RB1CC1;ATG12;ATG5;WDR45B;ULK2;ULK1;WIPI2
prerank,regulation of plasminogen activation (GO:0010755),-0.49015728232383216,-1.1961237975472108,0.23517382413087934,0.5429675115418203,1.0,3/12,9.35%,THBS1;RUNX1;SERPINE1
prerank,muscle contraction (GO:0006936),-0.2911305885221314,-1.195964015731892,0.1240506329113924,0.5427392732783012,1.0,21/126,9.93%,UTRN;EDNRA;CALD1;VCL;GJC1;SMTN;SNTB1;MYL12B;ITGA1;MYL6;TPM4;ITGB5;PXN;ALDOA;ACTA2;TPM2;MYH11;MYL9;TMOD3;TPM3;CHRNB1
prerank,bone development (GO:0060348),0.38057022651275985,1.1957395571998681,0.2126126126126126,0.8735857308828396,1.0,3/39,2.49%,RANBP3L;DYM;CYP26B1
prerank,regulation of DNA metabolic process (GO:0051052),-0.34528216353184327,-1.1957047286377633,0.1662921348314607,0.5428233467493042,1.0,23/44,34.14%,KAT7;UBE2V2;XRCC5;PARG;TERF2IP;YLPM1;WRNIP1;KPNA2;NBN;SIRT7;NUCKS1;TOM1L1;USP1;HNRNPD;TERF2;WDR18;KPNA1;STOX1;HELB;MYC;PIF1;TICRR;IL7R
prerank,arachidonic acid secretion (GO:0050482),0.5194975557302868,1.1955635324720444,0.26666666666666666,0.8697681740023134,1.0,3/10,8.72%,BDKRB2;PNPLA8;DRD3
prerank,arachidonate transport (GO:1903963),0.5194975557302868,1.1955635324720444,0.26666666666666666,0.8697681740023134,1.0,3/10,8.72%,BDKRB2;PNPLA8;DRD3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.24432779950664751,-1.1955434904211752,0.012345679012345678,0.5426017145460241,1.0,100/497,14.83%,MECOM;LEF1;FOXP1;LIMS1;ATP8B1;BMPR2;DAB2IP;ZBTB16;ELK3;ZEB1;FOXP2;MDFIC;ACVRL1;PPARD;WWP1;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;WAPL;GAS6;RUNX2;LIMD1;CTCF;ZHX3;ID1;BMP4;PRDM16;CRY1;L3MBTL3;PTPRK;DACH1;GLI3;JUN;KAT6A;CBFA2T3;BHLHE40;CREB3L1;CCDC85B;KCTD1;NIPBL;PSPC1;WNT5A;RACK1;HES1;XRCC5;TWIST2;SP3;DAP;HEYL;FOXN3;NACC2;PRDM5;MYBBP1A;CD38;RPS3;HDAC9;SPEN;YWHAQ;CDKN1C;HEY2;NAB1;ZFPM2;CDK5;EIF2AK3;HMBOX1;AHR;CIR1;KLF4;S100A11;GCLC;PER1;TLE5;SOX7;TWIST1;ATXN1;PDCD4;PHB2;HHEX;SOX18;SYNCRIP;BMP2;POU2F1;SAP18;USP47;TBX2;NACC1;HDAC6;NFIL3;ENPP1;SUV39H1;RBFOX2;MTERF3;ZNF318;YAF2;TIMELESS;MT3;SPINDOC;ARID5A
prerank,regulation of protein binding (GO:0043393),-0.2927232916811531,-1.1954237175250237,0.12894736842105264,0.5422317095328577,1.0,38/114,21.74%,ACTB;CAV1;RAPGEF2;CLDN5;B2M;PKD1;STK3;DISC1;BMP4;APP;BTBD1;RALB;CARD16;CSNK1E;RACK1;PRKCD;SPPL3;TIAM1;PPP1CA;GTF2F1;PRMT7;TLE5;NMD3;BMP2;HIP1R;LRP1;VTN;PRKACA;EPB41;LDLRAP1;PEX14;MARK3;PSME3IP1;PPP2CA;EFHB;ROCK1;RIPK2;DTX3L
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.41005020380884316,1.1953022656962573,0.22401433691756273,0.8684739904821325,1.0,9/27,16.09%,PLAAT5;LPIN1;ETNK2;PNPLA8;PCYT2;CHKB;PLA2G15;NAAA;PLAAT3
prerank,protein localization to cell surface (GO:0034394),-0.3979996993285645,-1.195105725985887,0.20995670995670995,0.5423749787391952,1.0,9/26,16.41%,VCL;SMURF1;PTPRK;FLNA;EMP2;FGF7;JAM3;UNC50;PIGK
prerank,regulation of transmembrane transport (GO:0034762),-0.3744216310737048,-1.1950277691486475,0.18737270875763748,0.541925210402358,1.0,10/31,16.03%,ACTB;SLC2A1;NEDD4L;KCNJ2;OCLN;KCNJ12;ACE2;KCNJ8;KCNJ15;CTTNBP2NL
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.46554925873955944,-1.1950186052395022,0.24543610547667344,0.5413207735227651,1.0,5/14,18.05%,ENTPD1;ENTPD6;ENTPD2;ADPRM;NUDT16
prerank,carbohydrate biosynthetic process (GO:0016051),-0.4156193461774588,-1.1943724540059302,0.21458333333333332,0.5422569486050983,1.0,5/21,8.21%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.49411642076429974,-1.1941477718509337,0.25708502024291496,0.5422148567989821,1.0,2/11,4.43%,CDH13;PLCG2
prerank,positive regulation of blood coagulation (GO:0030194),-0.44709871019080843,-1.1940788948607444,0.23160173160173161,0.5417307637163579,1.0,5/17,11.56%,ST3GAL4;THBS1;F3;SERPINE1;ENPP4
prerank,negative regulation of neuron differentiation (GO:0045665),0.42242185618134037,1.193740678722556,0.24208566108007448,0.8720099612200354,1.0,4/22,11.97%,BMP7;DTX1;MED1;SOX9
prerank,polarized epithelial cell differentiation (GO:0030859),-0.474119919120195,-1.1936947446730446,0.26720647773279355,0.541993518327527,1.0,5/13,21.28%,RHOA;RAP2A;ZDHHC7;CDC42;MSN
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.48637809813154836,1.1933482650379756,0.2644135188866799,0.8712658036706316,1.0,3/13,5.83%,BMP7;METRNL;HNRNPU
prerank,regulation of nervous system process (GO:0031644),0.4484235636529281,1.193223229339721,0.2403846153846154,0.8695546184282048,1.0,3/18,4.08%,SLC8A3;ROCK2;NPTX1
prerank,relaxation of muscle (GO:0090075),0.4878714359385875,1.1931442244154957,0.24313725490196078,0.8676556423806951,1.0,1/13,0.03%,ATP1A2
prerank,autophagy of mitochondrion (GO:0000422),-0.3541645248363049,-1.1930822771769931,0.20714285714285716,0.5429158175355413,1.0,18/38,30.21%,ATG3;WIPI1;GABARAPL2;CISD2;MAP1LC3B;RB1CC1;SQSTM1;PHB2;GABARAP;ATG12;ATG5;WDR45B;ULK2;ULK1;FUNDC2;ATG14;WIPI2;USP30
prerank,regulation of autophagy (GO:0010506),0.28501864010289224,1.192760610188257,0.11367127496159754,0.8668756244363867,1.0,45/216,15.99%,PRKAG2;RNF152;SNX6;LEPR;NUPR1;CTSA;PRKAA2;RRAGC;PRKAG3;ATP6V0A2;PLEKHF1;ITPR1;OPTN;PIK3CB;TRIM5;ATP6V0B;ATP6V1H;CASP3;ZKSCAN3;HTRA2;KAT5;MTMR4;RMC1;LRRK2;GOLGA2;ATP6V1B2;SLC38A9;ATP6V1E1;BCL2;CSNK2A2;FZD5;IL10RA;ATG13;KDM4A;LAMTOR2;TBC1D14;ATP6V0E2;ATP6V1C1;VDAC1;ATP6V0D2;NPRL2;LAMTOR3;ABL1;HGF;ATM
prerank,neuron apoptotic process (GO:0051402),-0.43385397529965397,-1.1925666006860423,0.24509803921568626,0.5434829482122214,1.0,8/19,19.46%,APP;FAS;CIT;TNFRSF21;CDK5;DIABLO;GAPDH;LIG4
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3424944068912294,-1.1922271833554121,0.1724137931034483,0.5436946835914561,1.0,15/50,16.53%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;TNFAIP8L3;PIK3CA;PIK3CD;EXOC1;PIK3C3;IRS1;CSF1R;PI4KB
prerank,rRNA transcription (GO:0009303),-0.4340598236805102,-1.191356339772718,0.21560574948665298,0.5452609651151931,1.0,8/17,24.15%,GTF3C5;SPIN1;POLR1G;CAVIN1;GTF3A;SIRT7;GTF3C3;POLR1E
prerank,cellular response to increased oxygen levels (GO:0036295),-0.492298856060897,-1.191054398421591,0.25882352941176473,0.5453829371413916,1.0,4/11,8.36%,CAV1;FOXO1;FAS;ATP6V0D1
prerank,mitochondrial membrane organization (GO:0007006),0.3943234756953546,1.1909833273588046,0.22287968441814596,0.8712981273493599,1.0,11/32,17.15%,SLC25A5;PPIF;CHCHD3;MTX2;APOO;BCL2;MICOS10;MFN2;TMEM11;APOOL;HSPA9
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.2665284453137278,-1.1909201084349872,0.07848837209302326,0.5450951329569002,1.0,49/199,17.52%,PTPRG;MEF2C;BMP5;BMPR2;DAB2IP;NOS3;ATP2B1;PLCL1;RPS6KA5;NOTCH1;GAS6;EGFR;SDHAF2;CORO1C;ID1;BMP4;ADAMTS5;TBX18;IL17RD;KLF7;RAB11FIP5;SPRED2;ARHGDIB;NPTN;TLE3;NOVA2;RAB11FIP1;MDK;SPRY2;HDAC9;HEY2;VASN;IL15;MYOCD;ADM;PTCH1;BMP2;ABHD6;LNPEP;SPRY1;ACVR1C;MAD2L2;NR1H4;BRCA2;ATF4;HEY1;N4BP1;PTEN;RAB11FIP3
prerank,B cell proliferation (GO:0042100),-0.4337304015105383,-1.1905982424540993,0.24793388429752067,0.5452373213954588,1.0,4/17,13.63%,MEF2C;CTPS1;CD40;PTPRC
prerank,negative regulation of hormone secretion (GO:0046888),-0.5017352637800043,-1.1904253612535285,0.2661596958174905,0.5450025012359722,1.0,3/10,17.52%,RAB11FIP5;RAB11FIP1;RAB11FIP3
prerank,import into cell (GO:0098657),0.36953178308719475,1.1897309599025212,0.1974169741697417,0.8736200644482496,1.0,5/41,3.99%,ATP1A2;SLC6A13;SLC5A3;SLC29A2;SLC38A1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.36213093840258787,-1.189347496147759,0.19863013698630136,0.5469953309921618,1.0,7/36,6.52%,CAV1;STIM2;ATP2B1;TRPC3;CACNB2;TRPC6;CXCL12
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2945667650571352,-1.188817148158426,0.14102564102564102,0.5475974008183987,1.0,51/110,31.13%,DAB2IP;HJURP;GSN;ABCA1;ICE1;FNIP2;RALB;TFRC;RACK1;IAPP;ANKRA2;RPS3;SRC;APOE;TAL1;AIDA;CDC42EP2;GFAP;HDAC6;VEGFA;SAR1A;BAK1;NCLN;TRAF3IP1;SLF2;LATS1;ATF7IP;HCK;CDC42;LCMT1;SPIDR;AJUBA;SYK;FAF1;BIK;SVIP;PTPN11;ULK1;BBS10;SELP;MPP7;VCP;FARP2;HRK;PARK7;CD36;MMP3;FBLIM1;SH3GLB1;HSPA5;BMF
prerank,synaptic vesicle exocytosis (GO:0016079),0.3720507263155846,1.187898002822588,0.2167577413479053,0.8779922370155485,1.0,11/40,16.46%,UNC13C;SYT1;SNAP29;SNAPIN;SNAP47;RIMS1;SNAP25;SYT10;CPLX1;STX4;CPLX2
prerank,bicellular tight junction assembly (GO:0070830),-0.34304707519239785,-1.1874458604516676,0.20353982300884957,0.5501573354822606,1.0,11/46,7.76%,PECAM1;CLDN5;ESAM;PARD3;RAMP2;F11R;TBCD;PAK2;CLDN14;OCLN;APC
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3794447927433375,1.187385269555112,0.22826086956521738,0.8776897566926833,1.0,8/41,9.07%,PTGS1;ACSL1;DAGLA;PLA2G4C;PNPLA8;GSTM2;PTGR1;ABCD1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.45439812314348227,1.1873388147272022,0.255278310940499,0.8756819967209186,1.0,7/17,19.71%,BMP6;TRIM5;CACTIN;SASH1;PRKCA;CX3CL1;NFKBIL1
prerank,visual system development (GO:0150063),0.3827756479967267,1.1872982102651144,0.23161764705882354,0.8736707756988654,1.0,16/37,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;FOXC1;ADAMTS18;ITGAM;RBP4;HIPK2;C1QA;SOX2;MEIS3
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.46764635190077497,-1.1871158661168193,0.25614754098360654,0.5503333063626207,1.0,3/13,3.22%,TBX3;NOTCH1;BMP4
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3767745671013154,-1.186909132322478,0.25,0.5502178928581639,1.0,10/30,11.83%,BCL2L1;CD44;CXCL12;TPT1;RPS3;ACKR3;FBXO5;TWIST1;DYRK1A;CD74
prerank,cellular component assembly (GO:0022607),-0.25797010975727996,-1.1868195674987072,0.07692307692307693,0.5498034585297535,1.0,48/253,14.65%,SPTBN1;ACTB;LIMS1;SLC2A1;RHOJ;LIMS2;MYO1B;CALD1;PARD3;RHOA;GSN;PARVB;ACTG1;GAS6;PLS3;DARS1;FAS;FLNA;WIPF1;VAMP3;WNT5A;EPS8;HES1;CLDN14;ABCA3;OCLN;APC;IL1RAP;RBBP4;CAPZA2;NEDD9;CD2AP;YWHAZ;PARVA;FAM107A;CAPG;LIMA1;TEAD1;CD74;RANBP9;PTK2B;STX7;RAD21;CD40;FZD1;SHROOM1;HAS1;ZW10
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.30098671734129673,1.1866699088040957,0.15857605177993528,0.8737585898473108,1.0,18/142,9.59%,ATP1A2;ADCY5;CCR9;ACKR2;SMAD3;PDGFRA;TAC1;C5AR2;BDKRB1;LPAR2;BDKRB2;ADCY8;FZD9;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4921386360916262,-1.1865767546859947,0.26908396946564883,0.5498038895338849,1.0,3/10,9.64%,TMEM30A;ABCA3;APOE
prerank,catecholamine biosynthetic process (GO:0042423),0.5044101050266679,1.186412448326109,0.2587268993839836,0.8724921365127394,1.0,1/11,0.23%,MOXD1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4495064515425897,-1.1855801758618627,0.24691358024691357,0.5515413854344124,1.0,8/15,13.82%,TJP1;BMPER;ITGA5;SMAD1;FGF2;KLF4;JAK1;VEGFA
prerank,positive regulation of cytokine production (GO:0001819),-0.2552861787162595,-1.1851311905013846,0.06622516556291391,0.5520273870371869,1.0,80/292,23.27%,SPTBN1;FOXP1;PDE4D;IL6ST;IL1R1;RFTN1;LRRFIP1;CD200;F3;CYP1B1;CD34;POLR3F;AFAP1L2;RUNX1;STAT3;SLC7A5;APP;PTGS2;NOD1;PLA2R1;TMED10;PLCG2;DHX33;ARHGEF2;GBP5;WNT5A;S100A13;XRCC5;IL6R;ANXA1;MDK;RPS3;CCBE1;G3BP1;SOD1;FLT4;EIF2AK3;SERPINE1;IL15;MALT1;PIK3CD;TWIST1;ISG15;POLR3H;PIBF1;CD74;AGPAT1;CD40;PTPRC;CD86;IFIH1;NR1H4;CSF1R;ATF4;NFKB2;CD46;POLR3B;GAPDH;NOD2;IL33;C3;IRF5;RIPK1;POLR3A;HMGB1;MYD88;ZBP1;POLR3D;CADM1;TICAM1;SYK;RIPK2;PAEP;GLMN;HPSE;MAPK11;CD276;ZFPM1;BCL10;POLR2F
prerank,regulation of cell differentiation (GO:0045595),-0.2797207729573758,-1.18490300421012,0.12073490813648294,0.5519293259645676,1.0,42/148,21.29%,SLC6A6;LTBP4;SPOCK2;ZFHX3;TRPS1;PHLDB1;RUNX2;NGF;RUNX1;SIX1;RPS6KA3;TBX1;PHLDB2;AR;CBFB;MDK;APC;EMP2;HEY2;TIAM1;VHL;IGF2;NOTCH4;KLF4;CEBPD;EDN3;SUZ12;CD24;ALK;ID2;PA2G4;ATF4;PRKACA;BCL6B;HEY1;GREM1;CDK6;PTHLH;MOSMO;MCRIP1;PPP2CA;ROCK1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4678107897382423,1.1848535530427315,0.251953125,0.8758638636385296,1.0,4/13,8.19%,PRKCZ;ECHDC3;GKAP1;SORBS1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4677661054698286,1.1836307172622689,0.2647058823529412,0.8781746324719246,1.0,5/16,6.95%,TGFBR3;IGF1;BMPR1A;RBPJ;FGFR2
prerank,organelle organization (GO:0006996),-0.246026294517629,-1.1831138238873427,0.057971014492753624,0.555758782549603,1.0,70/388,12.97%,FMNL2;ARHGAP10;SYNE1;CAV1;ATP8B1;FGD5;SEMA6A;PLCE1;MICAL2;MARK1;NOS3;FGD6;DST;RAB14;ATL3;TMEM135;LIMD1;VPS13C;ARAP3;PALLD;FAF2;LMAN2L;RAB31;TMED10;USP6NL;FAM161A;TNIK;CHMP2B;SIPA1L3;MAST4;ATXN7;PRKD1;PPIA;NRF1;FBXW8;CHMP4B;CHMP4A;CSNK1A1;COG3;SEC16B;MDK;ABCA3;CCL13;CNN2;ABCD2;CXADR;PEX7;BRWD1;ZFYVE16;ATP5F1B;EIF2AK3;APOE;NEDD9;SORT1;GOLPH3;CAV2;CFL1;SIRT5;BAG5;SEC31A;PHB2;FNBP1L;RANBP9;NECTIN2;UBXN2A;VPS13D;SIPA1;SEC61A1;STX7;ODF2
prerank,ventricular septum development (GO:0003281),-0.3599160600889173,-1.1831101214912176,0.23841059602649006,0.5551408168619703,1.0,12/37,8.57%,BMPR2;SLIT2;ACVR1;TGFB2;NOTCH1;TGFBR2;HES1;PDE2A;HEYL;STRA6;HEY2;ZFPM2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.5062722860076497,-1.182778110945304,0.2766798418972332,0.5552850917410985,1.0,7/11,38.75%,ANXA1;SOCS5;ZC3H12A;JAK3;SMAD7;RC3H2;IL4
prerank,relaxation of cardiac muscle (GO:0055119),0.4808576250686719,1.1825928100336165,0.2629558541266795,0.8796775865719834,1.0,1/13,0.03%,ATP1A2
prerank,protein localization to chromosome (GO:0034502),-0.36520105106452627,-1.1821509482765655,0.21868365180467092,0.5561904491794694,1.0,10/34,18.16%,RPA1;WAPL;CTCF;ESR1;TNKS;XRCC5;TERF2IP;RAD21;SLF2;RPA2
prerank,dopamine metabolic process (GO:0042417),0.44656083449177086,1.1814202089558026,0.28087649402390436,0.8818830989357324,1.0,4/18,11.40%,MOXD1;SNCAIP;DRD3;COMT
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.36505528537569654,-1.1810086385099932,0.21304347826086956,0.5583670419637256,1.0,9/32,20.14%,CAV1;TRPC3;PLCG1;TRPC1;CEMIP;APLNR;GPER1;GRIN1;NPSR1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.27980267388245955,1.1806499632378247,0.1253731343283582,0.8824042691549945,1.0,81/241,24.68%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2;U2SURP
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.4016460934604852,-1.180232387431665,0.23194748358862144,0.5596495746132991,1.0,4/23,5.66%,SLC12A7;SLC12A2;ATP6V0A4;SLC12A6
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.37984107884241813,-1.1802085103642932,0.21855670103092784,0.5590932327752256,1.0,9/25,15.39%,SLIT2;LIMK2;KANK1;PRKCD;EVI5L;ABI3;TBC1D7;CCP110;RAP1GAP
prerank,negative regulation of secretion by cell (GO:1903531),-0.3536345550324199,-1.1801913209884765,0.2094017094017094,0.558492720365945,1.0,11/38,14.79%,STXBP6;NOTCH1;TNFRSF1B;SLC30A1;VAMP3;GRM7;ANXA1;SYT4;APOE;RSAD2;HTR1B
prerank,regulation of T cell mediated immunity (GO:0002709),-0.4955250091040191,-1.1798984730283781,0.25925925925925924,0.5586492706021251,1.0,4/10,24.12%,TNFRSF1B;ZBTB1;HMGB1;CCR2
prerank,actomyosin structure organization (GO:0031032),-0.3110103060373941,-1.1793913529715547,0.17391304347826086,0.5592869968374593,1.0,14/75,8.89%,FRMD5;PGM5;TJP1;RHOA;MYH9;WDR1;F11R;ITGB1;CIT;CDC42BPA;ITGB5;CSRP2;SRC;TMOD3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.34454997514732605,1.1793355291990297,0.22319859402460457,0.8851546482229843,1.0,10/61,12.11%,EYA1;DNMT3L;EYA4;EYA2;SMOC2;OTUD4;ABRAXAS1;MRE11;RTEL1;PML
prerank,canonical glycolysis (GO:0061621),0.42188818982538095,1.1787124538722193,0.23689320388349513,0.8832254376546084,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.42188818982538095,1.1787124538722193,0.23689320388349513,0.8832254376546084,1.0,9/24,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.33003052611360306,-1.1782540667782495,0.19444444444444445,0.5614101106637343,1.0,11/52,11.52%,SPTBN1;PRKCH;PIK3R1;EGFR;NKD2;ITGB1;STX3;ZDHHC8;STAC;EPHB2;SQSTM1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.31381313436383645,-1.1781824582341696,0.18028846153846154,0.5609736115098974,1.0,18/68,14.92%,LEF1;CAV1;LRP6;FZD6;LRP5;SFRP4;CSNK1E;WNT5A;CSNK1A1;APC;PPP1CA;AMER1;FZD4;WNT9A;RARG;FZD1;NR4A2;PLPP3
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.38262996437288077,-1.177665660752242,0.22573839662447256,0.5616447084126082,1.0,6/27,9.60%,BMPR2;ACVRL1;DACH1;TNKS;FGF2;HMBOX1
prerank,regulation of histone modification (GO:0031056),-0.46822899647686234,-1.1774064141048275,0.2736842105263158,0.5616488199123838,1.0,5/13,11.27%,NNMT;HPF1;IGF2;PARG;MYOCD
prerank,RNA processing (GO:0006396),0.2908716680058012,1.1770845528855565,0.14786585365853658,0.8870497354547162,1.0,55/176,23.03%,CELF2;PABPN1;RRAGC;NOVA1;SRSF5;TFIP11;CCAR2;CPSF6;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;TENT4A;DDX17;PRMT9;SON;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;SRRM4;BICD1;LSM4;TUT4;MPHOSPH10;USP39;SRSF11;DICER1;RBM5;USB1;RNPS1;AKAP8L;DHX8;PRPF6;NOL3;PRPF3;DDX39B;THOC1;DDX47;ADAR;FASTKD5;SF3B2;SF3B1;SUPT4H1;SNRPB;HNRNPH1;CDK12;SCNM1;SF3B3;TSEN34;SRPK1;SNRPN;CELF1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3598069232284019,-1.1768887754946744,0.21710526315789475,0.5622838647578207,1.0,10/38,13.94%,CAV1;INSR;PTGIS;CD34;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,muscle cell differentiation (GO:0042692),0.3867046282579405,1.176816396618724,0.25364963503649635,0.8859172569820255,1.0,6/32,4.75%,RORA;NEBL;DUSP29;SPEG;WNT5B;SGCZ
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.36818459888126087,-1.1760198655907008,0.2111111111111111,0.5637179536407323,1.0,14/34,26.87%,PTPRB;PTPN12;PTPRJ;UBASH3B;PTPN1;DUSP3;PTPRZ1;DUSP6;PTPN6;PTPRF;DUSP1;PTPN11;DUSP7;DUSP18
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.4017923543941119,-1.1759736760063808,0.24416135881104034,0.5632040279559929,1.0,9/22,15.72%,RPS15;RPS20;PLA2R1;SPRED2;UBB;RPS7;RPL23;EEF1E1;RPL37
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.33683279200410937,1.1747698781111255,0.20913884007029876,0.8914867713276883,1.0,6/61,6.99%,PRKAG2;NQO1;PPARA;PSMD3;PDK2;PANK2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.34058386889729875,-1.1747544194194903,0.2025862068965517,0.565553296332028,1.0,10/43,13.74%,PID1;PIP4K2A;GRB14;KANK1;PRKCD;NCK1;PTPN1;IGF2;IRS1;ENPP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.40550198279750727,-1.1747169963318376,0.261758691206544,0.565037071340213,1.0,10/21,24.73%,NGF;AIM2;GRIN2B;BIRC3;MT3;USP50;GRIN1;BEX3;FYN;EPHA7
prerank,response to lipopolysaccharide (GO:0032496),-0.277259247547773,-1.1741857379473304,0.12435233160621761,0.5657754740580108,1.0,35/138,23.21%,FOXP1;MEF2C;DAB2IP;NOS3;RHOA;SCARB1;IRAK3;TNFRSF1B;RPS6KA3;DEFA6;TNFRSF11A;GCH1;CARD16;WNT5A;SRR;SERPINE1;MAPKAPK2;PAF1;PDCD4;LIAS;CD86;GIT1;IFNAR1;NOD2;ERBIN;ZC3H12A;HMGB1;GGT7;MYD88;TICAM1;SBNO2;CASP1;GGT1;SMAD6;BCL10
prerank,ERAD pathway (GO:0036503),0.32382621056210065,1.174053713226378,0.17598684210526316,0.8919135162526979,1.0,20/83,15.61%,DERL1;DNAJC18;JKAMP;DNAJB14;UBE4B;TMUB1;ECPAS;DNAJC10;USP19;FBXO6;SGTB;TMEM67;RNF121;CCDC47;UBXN6;FBXO17;BAG6;RNF5;UBXN4;DNAJB2
prerank,positive regulation of cell growth (GO:0030307),-0.29325625364055025,-1.1736335172705075,0.15647921760391198,0.5665681989447815,1.0,26/96,16.33%,NEDD4L;NTN1;SEMA7A;TGFB2;EGFR;NGF;SMURF1;MACF1;H3-3A;ITSN2;RPS6KA3;ADAM10;SYT4;CDKN2AIP;RPTOR;EDN1;PABIR1;MFSD2A;USP47;CSNK2A1;SHTN1;LIMK1;NCBP1;KLHL22;DDX49;RNF157
prerank,negative regulation of cellular protein localization (GO:1903828),0.37928821123963263,1.173596602925865,0.24202626641651032,0.8914353548406093,1.0,5/34,4.82%,LEPROT;ROCK2;ACTN2;PICALM;TTBK2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3005632400090007,1.1733802288668918,0.17845659163987138,0.890099176277004,1.0,16/141,8.34%,ATP1A2;RORA;ADCY5;SLC5A5;ROCK2;IL18;TRPV1;TFPI;ADCY1;RUVBL2;ADCY8;CASP3;KAT5;LRRK2;IMPACT;MED1
prerank,negative regulation of signal transduction (GO:0009968),-0.25571865140833416,-1.1725974394620027,0.07692307692307693,0.5684100402268933,1.0,63/249,17.39%,BMP5;SEMA6A;PID1;DCN;DAB2IP;NTN1;PTPN12;ACVR1;NOTCH3;PIP4K2A;THBS1;EGFR;GRB14;PTPRJ;NFATC1;KANK1;SFRP4;IRAK3;CRY1;GLI3;YWHAB;NKD2;CARD16;CREB3L1;UBASH3B;XDH;RACK1;HHIP;LYN;PRKCD;NCK1;APOD;EPN2;SPRY2;GATA2;PTPN1;FGF2;SOCS5;HGS;HERC4;PTCH1;HHEX;BMP2;TCIM;TAX1BP3;CSNK2A1;PTPRC;FBXW7;IRS1;ENPP1;LRP1;SPRY1;PTCH2;TMBIM1;NR4A2;GPC1;DDIT4;CILP;RNF157;ADAMTS12;HEY1;SIGIRR;PTEN
prerank,regulation of protein secretion (GO:0050708),0.3077554012442405,1.1725813736040025,0.19095477386934673,0.8909112878361111,1.0,35/119,18.74%,BMP6;CACNA1D;IGF1;FRMD4A;GCK;ITPR1;CACNA2D2;ADRA2A;LLGL2;STXBP5L;SERGEF;DRD3;SNAP25;KCNC2;LLGL1;CLOCK;MYO18A;ITPR2;IER3IP1;RAPGEF3;ENSA;CYP51A1;KCNS3;PER2;EIPR1;IL6;GIPR;PRKCA;IL1A;PICK1;APBB1;IL12A;DPP4;HMGCR;RHBDF1
prerank,response to chemokine (GO:1990868),-0.4548149825887186,-1.1723620378046389,0.2817796610169492,0.5684038352383893,1.0,5/13,9.84%,LRCH1;SLC12A2;RHOA;CXCL12;DOCK8
prerank,neuron projection morphogenesis (GO:0048812),0.2959299186948832,1.1718804171909314,0.16586151368760063,0.8913408464262581,1.0,28/137,12.64%,ALCAM;BMP7;MAP2;DCDC2;BAIAP2;CPNE1;FLRT3;WNT7A;ATL1;GAS7;AFG3L2;FGFR2;SHANK1;CNTNAP2;FLRT1;LRRK2;IMPACT;LRP4;KLK8;GPM6A;LLGL1;DLG4;SLITRK4;DOCK7;DTNBP1;WASL;BDNF;NYAP2
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3565132194122026,-1.1717070207527691,0.2328767123287671,0.5694071519995527,1.0,12/39,8.66%,ACTB;VCL;ACTG1;MYH9;FN1;ACTN1;FLNA;TJP2;UBASH3B;PPIA;CLIC1;MYL9
prerank,ameboidal-type cell migration (GO:0001667),-0.32971817397850356,-1.17113289096598,0.1830065359477124,0.5702564377413324,1.0,19/51,22.00%,SEMA6A;SEMA3C;SEMA7A;CORO1C;CCN3;TBX1;SEMA5B;SEMA3E;ITGA4;SEMA3G;FAT2;AMOT;PKN3;SEMA5A;SEMA6D;AMOTL1;SOX8;SEMA3F;SEMA4C
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.29397022180031596,-1.17109726227412,0.18244803695150116,0.569720924908208,1.0,30/86,26.29%,APP;WDR1;CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;SYNPO2;APOE;GPX1;EDN1;CDC42EP2;PTK2B;PFN1;TRPV4;CLIP1;LIMK1;KATNB1;NCKAP1L;SEMA5A;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,organophosphate ester transport (GO:0015748),-0.38978880974814445,-1.171038574425019,0.23236514522821577,0.569218555667297,1.0,7/24,7.63%,PITPNC1;SCARB1;PLTP;TNFAIP8L3;NPC2;MTTP;ABCA3
prerank,embryonic digestive tract development (GO:0048566),-0.42510248005620055,-1.170929629964783,0.28210526315789475,0.5688713833225503,1.0,6/18,7.63%,RARB;PCSK5;TGFB2;GLI3;NIPBL;STRA6
prerank,myotube differentiation (GO:0014902),0.44831004898375393,1.1707342609572968,0.27474747474747474,0.8935370144791951,1.0,4/17,5.03%,IGF1;ADAM12;ADAMTS15;ADGRB3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.44061525484186065,1.170668461518781,0.2807017543859649,0.891693145481793,1.0,3/16,6.63%,FGF1;NPNT;CITED1
prerank,cellular copper ion homeostasis (GO:0006878),-0.4516181525486683,-1.170492019127068,0.266,0.5693361858093807,1.0,8/14,29.00%,APP;SLC31A1;ATOX1;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,organelle fusion (GO:0048284),0.4201932534459259,1.1702522888956988,0.23137254901960785,0.8911241370301137,1.0,8/22,20.76%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2;STX4;MIGA1;BAX
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.45031857588740826,-1.1702390816225083,0.2545090180360721,0.5692916124269017,1.0,5/14,20.25%,ADAM10;ADAM19;DYRK1A;PSEN2;PSENEN
prerank,cellular response to organic substance (GO:0071310),-0.28521873639977724,-1.1697511797327043,0.14507772020725387,0.5698836138997208,1.0,16/116,6.03%,LEF1;GHR;PID1;BMPR2;SLIT2;RHOA;PTPN12;ACVR1;ACVRL1;RAMP2;CYP1B1;SOCS2;STAT3;TGFBR2;CPNE3;RACK1
prerank,glial cell development (GO:0021782),-0.3850744413664102,-1.16960681625389,0.24312896405919662,0.5695952836175023,1.0,15/25,34.79%,APP;MDK;EIF2B2;MT3;NRROS;EIF2B1;CDK6;MYRF;DLL1;SOX11;MXRA8;NSUN5;PRDM8;S100A9;TLR2
prerank,digestive tract development (GO:0048565),-0.366402377422812,-1.169557900549065,0.23076923076923078,0.5691060139959127,1.0,9/32,13.91%,RARB;PCSK5;TGFB2;PKD1;GLI3;NIPBL;STRA6;SMO;RARRES2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.46057038322757426,-1.1694735494759727,0.28487229862475444,0.5686771155177449,1.0,5/13,14.66%,ENTPD1;ENTPD6;ENTPD2;ENPP1;SMPDL3A
prerank,eye morphogenesis (GO:0048592),-0.41477621059760095,-1.1692109677420908,0.23647294589178355,0.5686734554579131,1.0,10/19,18.80%,MFAP5;STAT3;COL5A2;FBN1;NIPBL;RARG;VEGFA;AGTPBP1;ALDH1A3;EFEMP1
prerank,respiratory tube development (GO:0030323),0.39921020229632026,1.1689888143733935,0.24593128390596744,0.8935881162925157,1.0,6/28,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2742692501778372,1.168473875383414,0.1286549707602339,0.8934332158995982,1.0,87/264,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;STRAP;SRSF5;TFIP11;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;DDX17;SRSF10;CPSF7;HNRNPL;PTBP1;LSM5;ZMAT5;ELAVL1;CACTIN;IK;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;USP39;SNUPN;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;PRPF40A;GCFC2;SNRPB;DCPS;PPIL1;HNRNPH1;DDX39A;PRMT5;SCNM1;SART3;PRPF38A;PPIL3;SF3B3;SRPK1;SNRPN;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,lipid oxidation (GO:0034440),-0.46248336953186553,-1.1684231629694477,0.26692456479690524,0.5699344406299316,1.0,2/12,5.09%,ADIPOR2;ACOX1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.38201433513502775,-1.1682825163493071,0.232662192393736,0.5696613714317472,1.0,10/27,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;XYLT1;CHSY3;BGN;B3GAT1;B3GAT3;NCAN
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2881292543857629,-1.1672183432114644,0.16019417475728157,0.5716627611834608,1.0,40/109,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,regulation of chromosome organization (GO:0033044),-0.3920307389431862,-1.166888705590319,0.24236252545824846,0.5718286951566713,1.0,12/22,34.31%,WAPL;XRCC5;TERF2IP;YLPM1;SHCBP1L;LIG4;HNRNPD;TERF2;MAPT;MYC;PIF1;BUB1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4194624297873776,1.1665836898402282,0.2846299810246679,0.8984184755116631,1.0,7/20,12.76%,ROCK2;DLG1;LLGL2;RHOQ;LLGL1;FHOD1;RAB13
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.42816242480112554,-1.1664474522632564,0.2606177606177606,0.5722696639033303,1.0,7/16,25.86%,RBM3;PRDX6;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3880751305595046,1.1663996404095474,0.25048923679060664,0.8969626419637216,1.0,7/31,11.04%,TGFBR3;BMPR1A;RBPJ;NRG1;FGFR2;TGFBR1;RYR2
prerank,sarcomere organization (GO:0045214),0.39630307877680654,1.166323885091549,0.2601626016260163,0.8951634271874517,1.0,4/27,8.50%,ACTN2;CAPN3;CSRP3;CSRP1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.45943188376113603,1.1663153807596238,0.26522593320235754,0.8931199522981179,1.0,8/17,19.13%,EMC2;EMC4;BAG6;MMGT1;GET1;UBL4A;EMC10;EMC1
prerank,regulation of cytokine production (GO:0001817),-0.27839414155789666,-1.1662813790427142,0.14745308310991956,0.572078733578616,1.0,55/126,30.42%,FOXP1;ATP2B1;RPS6KA5;AFAP1L2;TNFRSF1B;PLA2R1;S100A13;NPTN;LYN;TRIM56;ANXA1;HDAC9;SOD1;MAPKAPK2;IL15;PER1;PIK3CD;TRIL;ISG15;CCN4;ACE2;AGPAT1;PTPRC;IFIH1;BCL6B;MAST2;N4BP1;GAPDH;PPP1R11;IL33;POLA1;PLD3;ZBP1;CADM1;GLMN;ASB1;FCGR2B;CD276;ACKR1;CCR2;RGCC;CASP8;PIK3CG;PLD4;SNAI2;HILPDA;TREM2;NFAM1;AGT;MIF;IGF2BP2;PTGER4;IGF2BP1;IRF3;LGALS9
prerank,icosanoid biosynthetic process (GO:0046456),-0.49241576604430914,-1.1662694432311405,0.286,0.5714862730882001,1.0,1/10,0.90%,PLA2G4A
prerank,cellular response to lipid (GO:0071396),0.2863916512330143,1.1661771007060269,0.1580547112462006,0.8915523961400534,1.0,28/191,12.34%,ATP1A2;RORA;ADCY5;ROCK2;TFPI;PABPN1;CTR9;WNT5B;PTK7;ADCY1;RUVBL2;TNIP3;ADCY8;WNT6;HTRA2;KAT5;NLRP3;MED1;TNIP2;CACTIN;NR1H3;FZD7;LCOR;MAPK14;CDC73;SOX9;KCNK4;SPHK2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2974346640195569,-1.1656960632170958,0.17114914425427874,0.5722525773780169,1.0,26/84,24.17%,CDC27;UBC;ANAPC5;RPS27A;UBB;PSMA6;PSMB7;CDC16;FBXO31;PSMB6;PSMB5;FBXO5;FZR1;PSMB8;PTTG1;PSMC4;PSMD11;ECRG4;PSMB4;PSMD14;CDC26;PSMD10;PSME1;PSMB3;CDC23;CUL3
prerank,mRNA export from nucleus (GO:0006406),0.30775270043584624,1.165516546065062,0.19516407599309155,0.8918447687719057,1.0,27/102,19.96%,MCM3AP;PABPN1;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;PCID2;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;POLR2D;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,cellular response to interleukin-1 (GO:0071347),-0.27806462182109165,-1.165435407371319,0.13520408163265307,0.5722641863661047,1.0,39/143,23.25%,DAB2IP;IL1R1;RPS6KA5;PTGIS;NFKBIA;IRAK3;UBC;NOD1;RPS27A;UBB;PSMA6;PSMB7;CCL13;IL1RAP;PSMB6;PSMB5;SQSTM1;CD40;PSMB8;IRAK2;TAB1;PSMC4;PSMD11;ADAMTS12;MAP3K8;PSMB4;PSMD14;NOD2;CCL25;USP10;MAPK3;ZC3H12A;PSMD10;MYD88;PSME1;RIPK2;HAS2;MAPK11;PSMB3
prerank,cellular glucose homeostasis (GO:0001678),-0.3466310870405287,-1.1652628692018836,0.21603563474387527,0.5720468321730442,1.0,8/41,6.87%,LRRC8D;FOXO1;GAS6;PIK3R1;UNC13B;ERN1;RACK1;LRRC8A
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3021813942804261,-1.1644291917627454,0.18205128205128204,0.5734403137060662,1.0,26/75,18.34%,HEG1;DAB2IP;LRP6;LRP5;BMP4;PTPRJ;RASIP1;IRAK3;LYN;PRKCD;APC;SPRY2;CDKN1C;IPO7;PTPN1;APOE;MYOCD;IPO5;HHEX;STK38;SPRY1;PAQR3;PRKAR2B;PTEN;LATS1;UCHL1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.32476665972762725,-1.1642548891697255,0.20930232558139536,0.5732167214104856,1.0,22/52,31.09%,PDIA5;WIPI1;PDIA6;ERN1;TATDN2;ATP6V0D1;SEC31A;KDELR3;ACADVL;VAPB;SRPRA;EXTL3;PPP2R5B;DCTN1;YIF1A;DNAJB11;WFS1;GOSR2;EDEM1;PLA2G4B;ADD1;HSPA5
prerank,negative regulation of cell junction assembly (GO:1901889),-0.38375868411492664,-1.1642316342157364,0.2540322580645161,0.572656745576827,1.0,7/25,10.47%,ACVRL1;THBS1;CORO1C;PHLDB2;APOD;SRC;FAM107A
prerank,negative regulation of phosphatase activity (GO:0010923),0.3983591500449726,1.164038698954734,0.25045372050816694,0.8951797730981184,1.0,3/25,5.02%,SH3RF2;SH2D4A;PPP4R4
prerank,negative regulation of programmed cell death (GO:0043069),-0.2458045567604204,-1.1640341072615448,0.07142857142857142,0.5725321709974283,1.0,81/355,16.33%,MECOM;LEF1;ARHGAP10;TEK;IL6ST;TJP1;PTMA;FOXO1;TBX3;THBS1;GAS6;PIK3R1;EGFR;BCL2L1;NGF;NFKBIA;SOCS2;CD44;BMP4;KDR;UBC;RPS6KA3;RPL10;CARD14;NAA16;DNAJA1;FAS;FLNA;TFRC;RNF144B;RPS27A;UBB;PAK2;WNT5A;MET;ADAM10;ANXA1;TPT1;PLK2;SPRY2;CD38;SRC;XIAP;FLT4;VHL;MAP4K4;CAT;GCLC;GOLPH3;YWHAZ;BABAM2;CFL1;MALT1;TNFAIP8;HSPB1;SQSTM1;GRK5;CD74;PHB2;SERPINB9;COMP;BIRC3;PTK2B;USP47;TCIM;AKT2;NME2;ARHGDIA;VEGFA;HIGD2A;MT3;CBL;RHBDD1;PLAUR;NR1H4;PA2G4;BAG1;NCKAP1L;STIL;SIX4;RNF157
prerank,pentose-phosphate shunt (GO:0006098),-0.4831185303108354,-1.1638930517726984,0.3094736842105263,0.5722492812716811,1.0,5/11,25.90%,PGM2;RPE;DERA;RBKS;H6PD
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.41701864070444933,1.1637383644603987,0.2630480167014614,0.8943087465466996,1.0,4/21,8.02%,CACNA1D;ANK2;SNTA1;KCNH2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4395025911358302,1.1634308377439233,0.2631578947368421,0.89337441141402,1.0,3/17,2.36%,ROBO1;EFNB2;PIK3R3
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3821619568701543,1.1631664880887944,0.2587800369685767,0.8922658880606956,1.0,8/36,9.08%,AFDN;VAMP5;OPTN;RILPL2;RILPL1;GGA2;NSF;AMN
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.45055454773550524,1.1631362509433816,0.2727272727272727,0.890337400021936,1.0,5/16,11.46%,IGF1;IGFBP3;CDH3;PHIP;MYORG
prerank,cellular protein localization (GO:0034613),-0.25164169056711355,-1.163024977405052,0.09480122324159021,0.5738137917417618,1.0,73/285,16.84%,TBC1D4;RABGAP1L;VCL;ESAM;RAB14;TBC1D8;EGFR;SMURF1;ID1;SCFD2;WIPI1;PTPRK;TBC1D12;RAB6A;STX1A;HERC2;SNX13;RAB31;TMED10;USP6NL;TBC1D5;FLNA;RAP2A;STX3;TBC1D2B;ARHGEF2;NIPBL;WNT5A;SH3PXD2B;AXIN2;SNX1;TBC1D1;COG3;OCLN;EVI5L;EMP2;HEY2;VPS26A;RAB22A;TBC1D13;FGF7;DNAJC27;CPE;HGS;WDR11;SEC31A;JAM3;CD74;HHEX;RRAGA;STX7;HDAC6;ARL5A;AMOT;TBC1D10A;CNTLN;AP2A1;STX8;SAR1A;RAB5C;RAB1B;FERMT2;TBC1D25;BICD2;NPHP1;RAB3GAP2;SEC13;UNC50;ARF5;PIGK;COPA;COPB2;IFT27
prerank,negative regulation of neurogenesis (GO:0050768),-0.359637096304134,-1.162984905055752,0.232409381663113,0.5732934467915951,1.0,5/34,2.27%,RAPGEF2;PTN;RHOA;B2M;NOTCH1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.48477456622596854,-1.1628654409550574,0.2570281124497992,0.5729539063393397,1.0,3/10,4.34%,LRP5;TGFBR2;TBX1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.37178852281393393,-1.1617841229975432,0.2543103448275862,0.5750349423243016,1.0,8/31,15.55%,TFRC;VAMP3;SHLD1;EPHB2;PHB2;PTPRC;CD86;MAD2L2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.35943447963080427,1.1615850805692645,0.23183391003460208,0.8937434631625834,1.0,8/43,6.45%,BMP7;BMP6;WNT4;IGF1;BMPR1A;LRP3;WWTR1;NPNT
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.39339666808984053,1.1614711154454642,0.2630597014925373,0.8921029026592336,1.0,5/30,6.34%,TGFBR3;SMAD3;TWSG1;DKK3;NREP
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.28215314478724907,-1.160823676694797,0.16752577319587628,0.5767434818460251,1.0,35/124,20.24%,LEF1;RHOA;FZD6;PRICKLE2;SMURF1;NFATC1;SFRP4;AGO1;AP2B1;WNT5A;GNB1;PSMA6;GNG2;PSMB7;PPP3CA;TIAM1;AGO2;PSMB6;PSMB5;FZD4;DAAM1;ROR2;PFN1;FZD1;AP2A1;PSMB8;PSMC4;PSMD11;PSMB4;AGO4;PSMD14;CELSR2;ARRB2;CDC42;PSMD10
prerank,folic acid metabolic process (GO:0046655),0.43687165963293056,1.1603481486884326,0.2644135188866799,0.8941974045711999,1.0,7/18,17.34%,ALDH1L1;SLC19A1;MTHFS;MTHFD1;MTHFR;FPGS;MTHFD2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.45979295854286273,-1.160204362599643,0.26804123711340205,0.577622829678972,1.0,6/13,28.87%,UBE2J1;BCAP31;OS9;SVIP;EDEM2;EDEM1
prerank,stem cell differentiation (GO:0048863),0.3678362212715386,1.1601619849392397,0.24259259259259258,0.8928584579713178,1.0,10/39,10.98%,OSR1;DNMT3L;KIT;LMBR1L;WNT7A;FGFR2;JARID2;HOXB4;GPM6A;BATF
prerank,negative regulation of ossification (GO:0030279),-0.3868909845620749,-1.1597316714559267,0.26180257510729615,0.5782097192329723,1.0,6/23,13.74%,MEF2C;NOTCH1;MDK;PTK2B;ECM1;ENPP1
prerank,negative regulation of endocytosis (GO:0045806),0.40022948577651263,1.1597233268658598,0.24169741697416974,0.8925295109052884,1.0,6/24,12.52%,SYT11;PICALM;NR1H3;SCAMP5;CD300A;MTMR2
prerank,regulation of telomerase activity (GO:0051972),-0.32803845488121447,-1.1595721180678968,0.22532188841201717,0.5780226389459808,1.0,15/45,22.79%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;SRC;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;MAP3K4;DKC1
prerank,sulfate transport (GO:0008272),0.4742607555082121,1.1595163909040804,0.2965235173824131,0.8912159818706885,1.0,3/14,6.01%,SLC13A4;SLC26A1;SLC25A11
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2806371447002893,-1.158814026818315,0.14745308310991956,0.5792911517980205,1.0,28/108,13.83%,RSPO3;MDFIC;DAAM2;DISC1;RUNX1;MACF1;NFATC1;KANK1;SFRP4;APP;CDK14;ESR1;NKD2;RACK1;CCNY;CBFB;SPIN1;ATP6AP2;TIAM1;PPP1CA;AMER1;SOX7;HHEX;BMP2;GSKIP;TAX1BP3;CSNK2A1;LRP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4485678491508342,1.1579281198554618,0.29310344827586204,0.8949438478704892,1.0,8/16,22.08%,HNRNPA2B1;TNKS2;SMG5;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,response to glucagon (GO:0033762),0.42616053782115554,1.1579020010388603,0.2660377358490566,0.8930456144999341,1.0,4/19,6.20%,ADCY5;GCGR;ADCY1;ADCY8
prerank,negative regulation of TOR signaling (GO:0032007),0.3722815087900857,1.1576655318392326,0.25,0.8918675598076607,1.0,14/36,22.75%,RNF152;PRKAA2;NPRL3;DEPTOR;SESN1;TSC1;NPRL2;SIRT1;ATM;FNIP1;CASTOR2;PDCD6;TMEM127;EPM2A
prerank,amide biosynthetic process (GO:0043604),-0.3275978562410479,-1.157607846394133,0.21379310344827587,0.5816163619516743,1.0,23/47,32.14%,SGMS1;SGMS2;PCSK5;DEGS2;AGK;CERS5;CERS6;SAMD8;ASMT;ASS1;SPTSSA;ASAH2;DMD;CERS4;SMPD1;TLCD3B;NANP;CERS3;SPTLC3;SPTSSB;NMRAL1;ALOXE3;AANAT
prerank,regulation of bone mineralization (GO:0030500),-0.31804901732726376,-1.1570555563712543,0.21475054229934923,0.5824269278724084,1.0,18/55,13.74%,MEF2C;BMPR2;PTN;SGMS2;ATP2B1;ACVR1;BMP4;S1PR1;CCN1;NBR1;TMEM119;TGFB3;TWIST1;ISG15;BMP2;PTK2B;ECM1;ENPP1
prerank,mitochondrial fusion (GO:0008053),0.4264970281507675,1.1569217257799451,0.2734375,0.8925510596699668,1.0,5/18,11.63%,MIGA2;AFG3L2;CHCHD3;MIEF2;MFN2
prerank,positive regulation of phagocytosis (GO:0050766),-0.3253900842395023,-1.156293492091354,0.21100917431192662,0.5836733530490029,1.0,20/47,30.30%,MERTK;GAS6;PTPRJ;RAB31;C4B;DOCK2;GATA2;IL15;RAB27A;PTPRC;NCKAP1L;C3;FCGR2B;ANO6;CD300LF;TREM2;LYAR;IL2RG;AHSG;PLA2G5
prerank,cellular response to glucose stimulus (GO:0071333),-0.3611053532549561,-1.156083551340394,0.2558139534883721,0.5836071297132451,1.0,15/30,29.41%,GAS6;UNC13B;RAB11FIP5;ERN1;RACK1;RAB11B;KCNB1;PRKACA;GPER1;RAB11FIP2;IGF1R;TRA2B;SELENOT;SLC39A14;PDK3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40576388443796807,-1.1560365488394433,0.2567849686847599,0.5831150768715865,1.0,7/19,21.23%,GAS6;MDK;ZBTB1;NCKAP1L;BTK;ZMIZ1;SYK
prerank,regulation of multicellular organism growth (GO:0040014),-0.4316578126682229,-1.1558245279071169,0.2753623188405797,0.5830269071056627,1.0,5/15,12.19%,GHR;APP;SOD1;PTCH1;MFSD2A
prerank,positive regulation of type 2 immune response (GO:0002830),0.46693752080725653,1.1555921055484157,0.29774127310061604,0.8952573995251721,1.0,5/14,16.36%,IL18;PRKCZ;NLRP3;IL6;RARA
prerank,positive regulation of T cell differentiation (GO:0045582),-0.34909735646562207,-1.155217612576652,0.21603563474387527,0.5838676816024164,1.0,21/36,42.93%,LEF1;GLI3;MDK;ZBTB1;SOX12;NCKAP1L;CD46;ZMIZ1;SOCS1;IL4I1;VNN1;VSIR;ZAP70;GATA3;TESPA1;BCL6;IL4;TNFSF9;XBP1;IL23A;SOX4
prerank,autophagosome organization (GO:1905037),-0.32039765268740905,-1.1550735022651508,0.2340909090909091,0.5835992051419354,1.0,15/50,21.01%,ATG3;WIPI1;GABARAPL2;MAP1LC3B;RB1CC1;ATG16L1;PIK3C3;UBXN2A;GABARAP;RAB1B;ATG12;ATG5;WDR45B;EMC6;ULK2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4149397425519703,1.1548315991594502,0.2720156555772994,0.895952659385242,1.0,6/22,13.27%,ROCK2;PICALM;CASP3;CLU;EPHA4;ABCA2
prerank,nuclear export (GO:0051168),0.3199590156224455,1.1548307463034149,0.21441124780316345,0.8939738875378729,1.0,16/80,18.53%,RANBP3L;SRSF5;POM121;NUP155;NUP62CL;STRADB;NEMF;RITA1;UPF3B;SRSF11;DESI1;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2977092181981478,-1.154583017547104,0.175,0.5841876211184348,1.0,14/79,10.87%,ST3GAL4;GCNT2;BMPR2;ST8SIA4;CSGALNACT1;ST3GAL6;B3GNT2;CHST8;COG3;ST8SIA6;XYLT1;GOLPH3;B4GALT5;GCNT1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.45131683948247386,1.1541283619912837,0.27755102040816326,0.8943323620367675,1.0,5/17,13.30%,CTR9;CPSF6;CPSF7;RNF20;ZC3H3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2820118922765825,-1.1538531683261157,0.15485564304461943,0.5853858163468433,1.0,24/108,11.28%,HIP1;ACER2;GSN;TNFSF10;MAP3K5;APAF1;F3;NGF;NOD1;FAS;CRADD;XDH;RACK1;HSPE1;DAP;CASP8AP2;RPS3;BCAP31;CTSD;ATP2A3;EIF2AK3;IFT57;MALT1;SOX7
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.3340926730533816,-1.1533539710839618,0.22197802197802197,0.5860759415509917,1.0,11/45,10.02%,B2M;VCAM1;CD44;MID1;ICAM1;IRF9;CAMK2D;PRKCD;TRIM25;IRF2;JAK1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3367663530625952,-1.1531056978500447,0.23883928571428573,0.5860263081194687,1.0,14/40,22.20%,SMURF1;RPL5;RPS7;RPL23;RAD23B;FOXF2;PTK2B;CSNK2A1;FBXW7;GNA12;PTEN;LATS1;GLMN;CCDC22
prerank,cartilage development (GO:0051216),-0.33069188120599663,-1.1531023790046515,0.23205741626794257,0.5854180007921986,1.0,13/49,13.24%,MEF2C;ZBTB16;PKD1;RUNX2;RUNX1;CD44;BMP4;CCN3;SNX19;FGF2;BMP2;ITGB8;TRPV4
prerank,regulation of AMPA receptor activity (GO:2000311),0.40368762315905327,1.1528592404610634,0.2822878228782288,0.8969427495807925,1.0,13/25,23.77%,CACNG7;NLGN2;NLGN3;SHISA7;SHANK1;GSG1L;CNIH3;SHISA8;MINK1;MAPK8IP2;CACNG4;CACNG5;CACNG8
prerank,atrial septum development (GO:0003283),0.46434023506884164,1.152852291264239,0.2926829268292683,0.8950003614876093,1.0,2/13,1.72%,NOTCH2;ANK2
prerank,mitotic chromosome condensation (GO:0007076),0.4013586078301887,1.1526716887524184,0.26120857699805067,0.8936706716287067,1.0,6/26,10.44%,KMT5A;NCAPD2;PHF8;PLK1;TENT4A;CSNK2A2
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4379059330048684,1.1519696136806001,0.28651685393258425,0.8943196333623942,1.0,6/16,20.52%,CTR9;KMT2A;AUTS2;PIH1D1;KDM1A;SMAD4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.39728118742177615,-1.1516730238774706,0.25165562913907286,0.58837440513076,1.0,6/21,12.65%,DCN;CSGALNACT1;CSPG4;VCAN;CHSY3;BGN
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.4011429849132855,-1.151579617751228,0.2651821862348178,0.5879974698304848,1.0,7/20,14.97%,THBS1;CREB3L1;NPTN;SPRY2;FGF2;SPRY1;GPC1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.4914416259756662,-1.1515532303473133,0.3203125,0.5874523677777859,1.0,4/10,24.54%,MAP4K4;FGF7;MAPRE2;EPB41L4B
prerank,Ras protein signal transduction (GO:0007265),-0.27160093485374975,-1.1513336182846345,0.1554959785522788,0.5873554049463806,1.0,42/137,16.70%,PLCE1;RAPGEF2;RHOA;NTN1;ARHGEF3;RASGRP3;RAP1A;CDH13;CDC42EP5;JUN;CDC42EP3;RALB;RAP2A;PRKD1;EPS8;AGTR1;GNB1;ARHGDIB;PLK2;RAPGEF6;SHOC2;G3BP1;TIAM1;FGF2;EPS8L2;RIPOR1;CFL1;GRAP;ADGRG1;CDC42EP2;KRAS;NRAS;ARHGAP1;TAX1BP3;RERG;SHTN1;ARHGDIA;GNA12;LIMK1;RAP2B;USP50;RREB1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.34758054115607573,-1.1512441959803312,0.24536082474226803,0.5869556867548807,1.0,9/37,11.70%,MFHAS1;YWHAB;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF;PPP1R2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.34441815136739584,-1.1512121833709532,0.24282560706401765,0.5864304820899136,1.0,9/41,10.02%,PODXL;GCNT2;TJP1;PIEZO1;CD44;DENND6A;MDK;ADAM19;JAK1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.33729293112174813,1.1511834936146796,0.26714801444043323,0.8951144566441309,1.0,10/56,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;INHA;GDF9;TGFBR1
prerank,bile acid metabolic process (GO:0008206),-0.3745261132193105,-1.1507241812871432,0.2521186440677966,0.5870446970701199,1.0,4/27,6.51%,CYP7B1;OSBPL3;CYP39A1;OSBP
prerank,extracellular matrix assembly (GO:0085029),-0.3948015255256988,-1.1502215750005398,0.2701525054466231,0.5876405635221666,1.0,7/23,8.19%,RAMP2;GAS6;TNXB;NTN4;MFAP4;LAMB2;MYH11
prerank,regulation of hemopoiesis (GO:1903706),-0.48510927305247137,-1.1497739817163382,0.29714285714285715,0.5881827219339292,1.0,3/10,7.25%,PTN;RUNX1;CBFB
prerank,epidermis development (GO:0008544),0.33998262607860225,1.1497720369337656,0.2332155477031802,0.8982173769674731,1.0,7/56,6.95%,OVOL2;LAMB3;CRABP2;CCN2;SPRR1A;FLOT2;FGFR2
prerank,regulation of organelle organization (GO:0033043),-0.2949490469879257,-1.1495347423297655,0.19672131147540983,0.5881511232511676,1.0,35/80,30.91%,TJP1;CLIC4;F11R;MFF;USP6NL;SCARB2;CAPN2;PAK2;PDE2A;ARMH3;MAPK1;GOLPH3;SQSTM1;SAR1A;SURF4;TBC1D25;CLEC16A;PRMT6;TAOK1;MAPK3;ARHGEF5;SIRT7;MSN;STX5;RHOT2;MUL1;AKAP9;ARL6IP1;CAMSAP2;MAPT;STOX1;LMAN1;CAMSAP3;VPS35;CLN3
prerank,negative regulation of developmental process (GO:0051093),-0.30382823264570985,-1.1493255050802276,0.20047169811320756,0.5879729810748244,1.0,21/69,19.85%,NOS3;NOTCH1;GAS6;BMP4;KANK1;TBX1;KLF7;TFRC;ARHGEF15;CST3;VAT1;HEY2;NOTCH4;BMP2;TBX2;SUZ12;HEY1;FGFR3;GREM1;CDK6;SPI1
prerank,regulation of neuron projection arborization (GO:0150011),-0.42630482136072734,-1.1492976908949195,0.2845849802371542,0.5874539106987781,1.0,4/15,12.19%,MACF1;WNT5A;FZD4;MFSD2A
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.41872441692351353,-1.1491511761722735,0.2809224318658281,0.5871932559488804,1.0,8/16,29.65%,SMC1A;NIPBL;RAD21;MAU2;REC8;SGO1;DSCC1;NAA50
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2852773227292599,1.1491240558114062,0.1672077922077922,0.8986015484263046,1.0,17/159,5.82%,SDK1;ROBO1;ALCAM;CLDN20;OBSL1;IL1RAPL1;SDK2;TENM1;CDH15;CDH3;PCDHB11;CDH17;FLRT3;MPZL2;GRID2;CDH10;IGSF9
prerank,protein oxidation (GO:0018158),0.4872151111862236,1.1487751767919532,0.296078431372549,0.8978593075026068,1.0,3/11,7.13%,LOXL3;SUMF1;LOXL1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4869949882374014,-1.148288368367023,0.30330882352941174,0.5887444085967796,1.0,3/10,11.79%,DNAJA1;AIDA;PDCD4
prerank,regulation of insulin secretion (GO:0050796),0.3084094586837793,1.148207820519947,0.22016806722689075,0.8979025473868587,1.0,27/101,18.38%,CACNA1D;ADCY5;NNAT;GCK;NLGN2;ITPR1;CACNA2D2;ADRA2A;BMP8A;SNAP25;KCNC2;CLOCK;ITPR2;STXBP4;CHGA;RAPGEF3;ENSA;KCNS3;PER2;EIPR1;IL6;GIPR;RBP4;PRKCA;PICK1;TCF7L2;DPP4
prerank,kinetochore organization (GO:0051383),0.46986212543055267,1.1475046851001514,0.3012295081967213,0.8985974751182858,1.0,6/13,21.79%,NDC80;CENPC;POGZ;NUF2;CENPA;CENPH
prerank,mesenchyme development (GO:0060485),0.4427258824216303,1.147124875548434,0.2937853107344633,0.8979901358900214,1.0,4/15,10.07%,BMP7;FGFR2;CRELD1;TGFBR1
prerank,chordate embryonic development (GO:0043009),-0.3144666225140216,-1.1469911767574197,0.2222222222222222,0.5912622349730887,1.0,18/55,16.19%,MBNL1;BMP5;PCSK5;PKD1;FUT8;KIAA1217;TBX1;WNT5A;ADAM10;IGF2;TGFB3;XYLT1;PTCH1;COL1A1;BMP2;VEGFA;STIL;SIX4
prerank,sulfur compound transport (GO:0072348),0.4009700323495599,1.146765516878252,0.2734225621414914,0.8973105160811815,1.0,4/27,6.01%,SLC6A13;SLC13A4;SLC26A1;SLC25A11
prerank,cellular response to metal ion (GO:0071248),0.2934202223519806,1.1463367922705356,0.20454545454545456,0.8969892056450449,1.0,24/123,12.42%,BMP6;SYT11;SYT12;SLC41A1;PRKAA2;CYP11B1;CPNE1;CAPN3;SYT9;ADCY1;CHUK;GLRA1;CPNE4;PPIF;SYT1;ADCY8;SYT13;LRRK2;ADGRV1;DLG4;SYT10;TRPM2;CPNE6;MAPK9
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3993444975098759,1.1462128946078924,0.28735632183908044,0.8954926900011047,1.0,4/25,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4088567902609943,-1.1458246176271911,0.23943661971830985,0.5935508767459875,1.0,5/19,9.75%,ACOX1;MAOB;SOD1;CAT;GPX1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2810747069421897,-1.1455856469961374,0.18439716312056736,0.5935204764768325,1.0,22/109,12.35%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;PIK3R1;PLCG1;PIK3C2A;PLCG2;BMX;PLEKHA8;PIK3R6;PLEKHA4;INPP5D;PIK3CA;FGF2;MTMR11;PIK3CD;MTMR7;FIG4;PIK3C3;MTMR12
prerank,positive regulation of inflammatory response (GO:0050729),-0.2900023459811619,-1.1445555855794776,0.2033096926713948,0.5954628901116096,1.0,15/86,11.84%,IL6ST;OSMR;ETS1;NFKBIA;ABCC1;APP;WNT5A;AGTR1;PDE2A;MDK;IFI35;SERPINE1;IL15;PDCD4;CCN4
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4716594981703571,1.1445428961815922,0.30831643002028397,0.8993652457127173,1.0,4/11,13.13%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4204210581189596,-1.1444859204717786,0.3022774327122153,0.595015149896342,1.0,8/17,26.33%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.48653466884903945,-1.1444138623131688,0.318359375,0.5945592517007114,1.0,5/10,8.77%,DCN;KDR;RACK1;MYOC;SRC
prerank,negative regulation of microtubule polymerization (GO:0031115),0.4676454768929685,1.1443836833537633,0.3106212424849699,0.8979773014619298,1.0,5/12,15.52%,MAP2;CLIP3;EML2;TUBB4A;MAPRE1
prerank,central nervous system development (GO:0007417),-0.25206231726125466,-1.1443445930462257,0.11708860759493671,0.5941302010382594,1.0,63/250,20.92%,ADGRL2;SLC2A1;ZBTB16;PBX1;ZFHX3;COL4A1;SHROOM4;VIT;GSN;WWP1;TBX3;PKD1;PBX3;STAT3;LSR;TGFBR2;EML1;RPS6KA3;BPTF;CHST8;NIPBL;ADGRA2;DCLK1;APOD;UFC1;EIF2B2;GRIN2B;CDK5;PDGFC;ATP6AP2;VCAN;CAPG;BTD;DSCAML1;ADGRG1;PTPRZ1;ATXN1;PTCH1;MFSD2A;SH3GL2;SMO;SNTG2;MARCKS;NCOA6;SOX12;CDH2;NR4A2;ALDH5A1;DDIT4;PTEN;NCAN;ECRG4;GRIN1;UGP2;C3;HAPLN3;LIG4;SOX8;CHD8;POU3F3;ADGRL3;NKX2-2;BCAN
prerank,chondrocyte differentiation (GO:0002062),-0.35277473668556725,-1.1432344466628135,0.2810304449648712,0.5962814529383356,1.0,8/32,9.16%,MEF2C;BMPR2;RUNX2;RUNX1;BMP4;CCN3;SNX19;EIF2AK3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.48716887009063364,1.142993316578485,0.3096646942800789,0.9010887777800536,1.0,4/11,13.38%,ARR3;ARRB1;DRD3;GRK3
prerank,dephosphorylation (GO:0016311),-0.2717552821062455,-1.1425794910373968,0.16991643454038996,0.5973241471198849,1.0,50/147,25.75%,PTPRM;PTPRB;PTPRG;PTPN12;SDHAF2;PTPRJ;ALPL;PPP1R12A;SSH2;PTPRK;PPP3CA;PPP2R5C;PPM1H;PLPP1;PTPN1;PPP1CA;DUSP3;MTMR7;ILKAP;PTPRZ1;DUSP23;PPP2R3A;PTPRC;PPP1CC;PPP4R2;PLPP3;THNSL2;TAB1;NT5C;CTTNBP2NL;PTEN;DUSP6;PTPN6;SGPP1;CTDNEP1;PPM1L;PPP2R5B;PPP2CA;PTPRF;DUSP1;ACP3;PLPP2;TIMM50;CTDSP1;SSH1;PDP1;PLPP6;DUSP7;PLPP5;PPP2R2A
prerank,mesonephric tubule development (GO:0072164),0.454560359318696,1.1425687175796895,0.3096153846153846,0.9005969050924816,1.0,4/15,6.95%,BMP7;OSR1;NPNT;FGFR2
prerank,mRNA processing (GO:0006397),0.2657185961063129,1.1422017846667436,0.15918958031837915,0.9000054612815376,1.0,92/287,24.43%,DDX5;PABPN1;ESS2;SRRM2;DDX46;NOVA1;CPSF3;SRSF5;TFIP11;CPSF6;SF3B5;HNRNPH3;HNRNPA2B1;CCAR1;PQBP1;HNRNPU;HNRNPA3;SRSF10;PRMT9;SON;CPSF7;HNRNPL;PTBP1;LSM5;PPARGC1A;ZMAT5;ELAVL1;CACTIN;IK;SRRM4;RNMT;WBP11;YTHDC1;PRPF19;LSM4;CHERP;RBMX2;UPF3B;XAB2;ZMAT2;RPRD2;USP39;PRCC;SRSF11;RBM5;LSM8;POLR2D;SNIP1;ELAVL2;RNPS1;AKAP8L;ALYREF;DHX8;SNU13;PRPF6;PRPF3;HNRNPH2;SRRT;DDX39B;MTREX;THOC1;SNRPB2;SRSF6;SUGP1;CWF19L1;PUF60;POLR2A;SF3B2;SF3B1;SARNP;SUPT4H1;PRPF40A;GCFC2;SNRPB;PPIL1;HNRNPH1;DDX39A;SART3;PRPF38A;PPIL3;SF3B3;SNRPN;CELF1;EFTUD2;POLR2B;HNRNPC;SNRPC;DDX41;WDR83;RBM15B;CSTF2;SRSF2
prerank,regulation of hippo signaling (GO:0035330),-0.4250777581628358,-1.141813392547771,0.29978586723768735,0.5986566065338654,1.0,7/17,22.64%,LIMD1;MOB3B;CIT;SCHIP1;MARK3;AJUBA;SOX11
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.36226365589051046,-1.141479942048642,0.2565217391304348,0.5988405804264945,1.0,5/30,9.41%,BMPR2;ACVRL1;DACH1;SRC;TENT4B
prerank,neural crest cell differentiation (GO:0014033),-0.41343722136592687,-1.1412892614866155,0.2717842323651452,0.5986916285890794,1.0,7/18,26.11%,MEF2C;LRP6;CDH2;SOX8;SOX11;TAPT1;SNAI2
prerank,protein complex oligomerization (GO:0051259),0.3153827181347263,1.1412684283178332,0.24319727891156462,0.9013389777403392,1.0,30/85,23.72%,UPB1;WDCP;TMEM120B;VSTM5;ATL1;CPSF6;GSDMD;ADCY8;KCNC3;CPSF7;ELAVL1;RNF135;KCNC2;CUTC;BEND3;MICU1;RNF213;NOL3;ALAD;TRMT61B;OXA1L;NLRC4;HGSNAT;PYCARD;DNM1L;MAT2A;IKZF4;ALS2;MPP2;SPAST
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.41423745904541986,-1.1412518062734114,0.3115079365079365,0.5981785792369616,1.0,10/17,21.83%,CACNA1G;STX1A;SYT4;RAB3A;RAB27A;CACNA1I;KCNB1;CACNA1H;RAB3D;SLC4A8
prerank,regulation of lipase activity (GO:0060191),-0.4464539261502798,-1.1412020904093816,0.29713114754098363,0.597712883565138,1.0,2/13,1.78%,RHOA;PCSK5
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.39400712315627995,1.1411086424107215,0.29366602687140114,0.9000039600424918,1.0,5/26,4.43%,GCHFR;SPHK1;NQO1;PM20D1;ARG2
prerank,regulation of protein import into nucleus (GO:0042306),-0.34292718685151535,-1.1410435279843678,0.24301075268817204,0.5974742990536813,1.0,9/36,12.56%,MDFIC;PIK3R1;CDH1;BMP4;FLNA;PRKCD;APOD;IPO5;TPR
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.2787086817811487,-1.1409828750381181,0.1650943396226415,0.5970256718376885,1.0,21/110,11.60%,ADGRL4;ADGRL2;CALCRL;RAPGEF2;ADGRG6;ADRA1B;RAMP2;ABCA1;ADCY4;ADGRE5;S1PR1;GNB1;ADCY7;GNG2;IAPP;ADGRD1;ADCY2;S1PR3;ADGRG1;ADGRG2;ADM
prerank,positive regulation of ossification (GO:0045778),-0.339380960446345,-1.1409097512413804,0.23178807947019867,0.5965984749216671,1.0,14/39,12.38%,MEF2C;BMPR2;ZBTB16;PTN;ATP2B1;ACVR1;TGFB2;BMP4;WNT5A;CCN1;TMEM119;TGFB3;ISG15;BMP2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.2850156308074237,-1.1402734340621843,0.20765027322404372,0.5976697531456221,1.0,28/101,15.76%,RAPGEF2;DAB2IP;RHOA;PKD1;EGFR;RALB;CAB39;PIK3R6;WNT5A;CCNY;IL34;CALM3;FLT1;SRC;PDGFC;FGF2;RPTOR;EDN1;EDN3;CEMIP;INCENP;PDGFD;TCIM;CD40;CD24;VEGFA;FERMT2;CSF1R
prerank,actin filament-based transport (GO:0099515),-0.39207114047677616,-1.1400960757676992,0.2775423728813559,0.5975204866226599,1.0,6/21,12.00%,MYO1D;ACTN4;MYO1B;MYO19;MYO1F;FNBP1L
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.419276021370105,1.1397809018843512,0.30228136882129275,0.9027786359340532,1.0,2/19,0.40%,AFDN;BMP6
prerank,peptidyl-amino acid modification (GO:0018193),0.4955323521237822,1.1397184680089292,0.3155818540433925,0.9011112833341837,1.0,4/10,23.24%,METAP2;ATP7A;TTLL4;METAP1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.43981770996125624,-1.1390178504507442,0.2923728813559322,0.5995897298142447,1.0,3/14,2.88%,TMSB4X;PKD1;NFKBIA
prerank,negative regulation of autophagy (GO:0010507),0.334317015398105,1.138943936832864,0.26936619718309857,0.901871565636855,1.0,12/54,13.71%,LEPR;NUPR1;CTSA;QSOX1;ZKSCAN3;LRRK2;GOLGA2;BCL2;IL10RA;KDM4A;TBC1D14;TSC1
prerank,cellular response to sterol (GO:0036315),0.45589745139520677,1.138935835601903,0.2966601178781925,0.900004233295034,1.0,3/13,5.58%,RORA;INSIG2;GRAMD1B
prerank,C21-steroid hormone metabolic process (GO:0008207),0.41575968650000733,1.1386401527155259,0.2990990990990991,0.8991463953597928,1.0,6/20,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.42308135600558816,-1.1385760639039497,0.2799188640973631,0.6000902000624925,1.0,6/16,12.38%,BMPR2;TGFB2;ENG;NOTCH1;HEY2;BMP2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.4429190252079493,1.1383132020864177,0.2994011976047904,0.8984436856359435,1.0,4/17,16.09%,LPGAT1;PLA2G4C;LCLAT1;PLAAT3
prerank,fatty acid metabolic process (GO:0006631),0.29711112684155705,1.1379672278537625,0.23575949367088608,0.8977471156289797,1.0,25/115,17.36%,ACSL1;CEL;PON1;ACSM2A;ACSM2B;PPARA;LPIN1;AASDH;PNPLA8;ACADSB;ECHDC3;PPARGC1A;CPT1C;SLC27A6;FA2H;PLA2G15;CROT;SLC27A4;NAAA;PER2;GGT5;ACACA;ACOT1;MSMO1;ACOT6
prerank,cobalamin metabolic process (GO:0009235),-0.42767578193981526,-1.137698272089503,0.2817796610169492,0.60164484421644,1.0,4/17,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,regulation of RNA metabolic process (GO:0051252),0.3298091368931583,1.1372906208855824,0.2637931034482759,0.8983170317036457,1.0,24/59,19.61%,OAS2;NOVA1;HNRNPH3;PQBP1;FASTK;PTBP2;SON;HNRNPL;PTBP1;MED1;OAS3;SRRM4;CLK3;AFF2;GRSF1;PCBP4;MBNL3;CLK2;FAM50A;METTL18;HNRNPH2;PTBP3;MITF;CLK1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4530408421313613,-1.1372632291419569,0.3037974683544304,0.6021486006973469,1.0,4/12,15.78%,NOTCH1;HES1;BMP2;ID2
prerank,synaptic vesicle endocytosis (GO:0048488),0.3719723606427905,1.1371945737256095,0.26003824091778205,0.8968208753781637,1.0,8/33,11.75%,DNAJC6;CEL;NLGN2;PICALM;SYT1;NLGN3;SYNJ2;CANX
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.40069339963861755,-1.137180880626218,0.2898550724637681,0.6017676389794173,1.0,4/20,6.54%,ST3GAL4;ST3GAL6;FUT8;ST6GALNAC5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4465575752937484,1.136732596540525,0.30515463917525776,0.896514125108847,1.0,3/14,8.03%,IL18;PRKCZ;NLRP3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.44352363576206333,-1.1365952363068392,0.29878048780487804,0.602669683360316,1.0,4/13,12.38%,BMP5;SOD1;APOE;BMP2
prerank,negative regulation of receptor binding (GO:1900121),-0.4870617895893674,-1.1363063724193603,0.3163841807909605,0.6027464451644575,1.0,4/10,21.70%,B2M;ATP2A3;ADAM15;PTPRF
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3583487061189865,1.1357753660886896,0.24561403508771928,0.8980548114604304,1.0,5/38,3.16%,CACNA1D;DSC2;KCND3;ANK2;KCNJ5
prerank,Golgi ribbon formation (GO:0090161),0.4630130594747996,1.135735607850366,0.3221343873517787,0.8963343517145786,1.0,4/13,10.19%,OPTN;STX16;GOLGA2;MYO18A
prerank,protein processing (GO:0016485),0.2981454513349851,1.1356431746046087,0.21052631578947367,0.8948402534498897,1.0,11/102,8.52%,AEBP1;METAP2;ADAMTS13;PCSK4;CPN1;FURIN;PITRM1;AFG3L2;HTRA2;SPRTN;LONP2
prerank,regulation of cellular respiration (GO:0043457),-0.41236494224423137,-1.1355687614425733,0.3002028397565923,0.6040151149512984,1.0,9/17,38.75%,PRDM16;CBFA2T3;IFNAR1;SHMT2;VCP;IFNLR1;NOS2;PRELID1;IL4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3041319019682519,-1.135183194665567,0.2048780487804878,0.6043858669670708,1.0,20/73,21.46%,KITLG;TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;SPI1;METTL3;PSMD10;PSME1
prerank,regulation of cell morphogenesis (GO:0022604),-0.3633443710485674,-1.1348209951307828,0.25625,0.6046747895179932,1.0,7/30,12.19%,FMNL2;SPARC;MACF1;CD44;EFNA5;CFL1;MFSD2A
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2675298589986211,-1.1348166100416632,0.17754569190600522,0.6040746236561209,1.0,27/150,10.62%,HIP1;KITLG;TEK;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;MET;IAPP;MYOC;SPRY2;PIK3CA;SRC;IGF2;FGF2;FGF7;PIK3CD
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3601554462302132,-1.1347843551034593,0.2925764192139738,0.6035603762610031,1.0,17/29,32.89%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3417039927057709,-1.134751795358999,0.2648870636550308,0.6030509478347833,1.0,8/39,10.59%,UTRN;NEDD4L;FXYD5;HECW2;CAMK2D;SLMAP;FXYD6;FGF13
prerank,regulation of protein localization to nucleus (GO:1900180),-0.332173714025217,-1.1345766895449942,0.26666666666666666,0.602875675917621,1.0,9/43,9.16%,KAT7;LIMK2;BMP4;MFHAS1;CTNNA1;TFRC;OTUD7B;ORMDL3;EIF2AK3
prerank,regulation of cell adhesion (GO:0030155),-0.26926889754447103,-1.1344474486557314,0.17980295566502463,0.6025910798694022,1.0,50/129,25.85%,FRMD5;PODXL;ZFHX3;ACVRL1;CDH13;PTPRJ;PPP1R12A;NUAK1;STX3;ARHGDIB;ADAM10;LYN;CXCL12;PPP3CA;MDK;PRKX;TGM2;TGFBI;EFNA5;SRC;EPHB2;ADGRG1;PLXNC1;RET;PTK2B;SIPA1;ARHGDIA;VEGFA;ZDHHC2;SEMA5A;PLXNA4;CELSR2;GPR4;PLXND1;PPP2CA;ROCK1;DUSP1;RASA1;DLL1;TESC;LPXN;ATXN3;FES;EPB41L4B;CXCR4;EPHA7;PTPN11;PIK3CG;RND1;KIF14
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2861249617048266,1.1341250279937078,0.21337579617834396,0.8983714768430661,1.0,32/148,18.35%,PRKAG2;KMT5A;PRKAA2;PRKAG3;RICTOR;CHD4;TTC5;MEAF6;MAP2K6;PDPK1;KAT5;CHD3;TAF10;RFC5;MRE11;BRD7;CSNK2A2;MAPK14;TAF1;PML;CHEK2;SMYD2;NOC2L;RPA3;BANP;ATM;CHD5;MDM2;CDK5R1;RAD17;HIPK2;AKT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.41505072037234225,-1.133646739507017,0.2845691382765531,0.604013493232102,1.0,2/17,1.51%,RAPGEF2;ADRA1B
prerank,nervous system development (GO:0007399),0.2561421048772535,1.133618962718663,0.135752688172043,0.8982625173166582,1.0,88/429,16.70%,SDK1;ROBO1;ALDH1A2;NOTCH2;TRAK1;NR2E1;ESS2;OBSL1;INTU;SDK2;RAPGEF5;VXN;ARNT2;TENM1;NLGN2;ADAM22;LRCH4;CELSR1;PCDHB11;DAGLA;FLRT3;NPTX1;IL1RAPL2;GFRAL;CHRM2;CRMP1;NRTN;ADGRB2;PAX6;MAB21L2;MARCKSL1;TRIM71;WWTR1;FGF12;FZD9;IGSF8;DPF1;ATN1;NRG1;NLGN3;JARID2;SCRG1;WDR62;LSAMP;LPAR1;CLN8;ADGRV1;TMOD2;WDPCP;ZIC2;GPM6A;DLG4;SRRM4;APC2;TGFBR1;LDB2;LDB1;NES;RITA1;CHRM1;FZD5;FKTN;PCDHB3;CHERP;CPNE6;DPYSL2;ARHGAP26;BDNF;ZIC5;HDAC4;L1CAM;CLN5;TYRO3;FUT10;CYP51A1;GFRA4;CSPG5;SCN8A;DPF3;NRSN2;EPHB1;GBA2;KALRN;HPCAL4;AXL;TRIM3;NAV3;NRSN1
prerank,acyl-CoA metabolic process (GO:0006637),0.3675300895035391,1.1333321543680572,0.26895306859205775,0.8975064600806545,1.0,10/35,22.40%,ACSM2A;ACSM2B;SUCLA2;GLYAT;ACACA;ACOT1;ACOT6;ACOT13;SUCLG2;ACOT9
prerank,secondary palate development (GO:0062009),-0.4309539950284481,-1.1332888154597953,0.3032128514056225,0.6042831570843517,1.0,5/14,9.46%,LEF1;TGFB2;TGFBR2;WNT5A;TGFB3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.34316019078944704,1.1331288212187907,0.2671353251318102,0.8963153113709821,1.0,15/47,19.50%,BMP7;TMEM64;LMO3;METRNL;HNRNPU;CREBL2;AAMDC;ADIG;CDS1;TFE3;CREB1;AKT1;FNDC5;PIM1;ASXL2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.47533167913856855,-1.1330809427765944,0.29838709677419356,0.604225500777513,1.0,4/10,7.11%,CACNB2;CACNA2D1;NOS1AP;CALM3
prerank,response to peptide (GO:1901652),-0.35793038448264997,-1.1330253486598556,0.28450106157112526,0.6037423084328049,1.0,12/33,22.08%,KAT7;STAT3;ANXA1;EIF2B2;CACNA1B;IRS1;MMP2;EIF2B1;NOD2;ERBIN;IRF5;FYN
prerank,eye development (GO:0001654),0.3398468275227978,1.1329036194957787,0.28222996515679444,0.8953114671148368,1.0,16/54,15.93%,SMOC1;COL5A1;PBX2;RAB3GAP1;MEIS1;PAX6;MAB21L2;PBX4;CEP290;ZDHHC16;CPAMD8;SHROOM2;FOXC1;TSKU;ADAMTS18;RBP4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.43827148529677573,1.1327822468800859,0.3142857142857143,0.8939428014074109,1.0,4/16,15.49%,RORA;PDK2;PDK1;SIRT1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4162940908439391,1.1327183378229027,0.29300567107750475,0.8923478225172081,1.0,9/19,16.66%,HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,neuron projection extension (GO:1990138),0.37391048174635444,1.131262402757025,0.28431372549019607,0.8957809884009206,1.0,8/32,8.15%,ALCAM;CPNE1;FLRT3;AUTS2;NLGN3;LLPH;FLRT1;IMPACT
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.33880306410707667,-1.1312247135694025,0.25757575757575757,0.607523642585941,1.0,10/39,15.55%,PODXL;JAG1;FXYD5;NOTCH1;CDH1;NOTCH4;KLF4;BMP2;VEGFA;MAD2L2
prerank,positive regulation of metabolic process (GO:0009893),0.30153400317539825,1.1303516993058238,0.23190789473684212,0.8971079934886422,1.0,7/103,1.08%,EPAS1;PPARGC1B;LEPR;ACSL1;IL18;PTH2R;APPL2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.43725343238562586,-1.1301780934901269,0.3333333333333333,0.6096145355420606,1.0,3/13,6.06%,PDE8A;RACK1;MET
prerank,regulation of signal transduction (GO:0009966),-0.2568085871187272,-1.1299058626607028,0.1792717086834734,0.6097032952445114,1.0,49/190,16.63%,PLCE1;RSPO3;RGS3;LIFR;RGS12;ACVR1;MDFIC;RGS5;TMEM204;SOCS2;RUNX1;PLSCR1;APP;ESR1;IGFBP6;MGLL;UBASH3B;PRKD1;HHIP;PPIA;NCK1;PXN;CBFB;RGS6;CD55;SRC;PTPN1;SOCS5;CDKN2AIP;WDR11;MFNG;SREBF2;GRK5;PTCH1;UGCG;CDC42SE2;GSKIP;TSPAN12;ZDHHC7;CD24;RGS4;IRAK2;GIT1;GIT2;LFNG;SEMA5A;SP100;CD46;NCLN
prerank,epidermal cell differentiation (GO:0009913),-0.33420404436289164,-1.1296760729946627,0.27056277056277056,0.6096930792898192,1.0,9/41,12.95%,JAG1;CLIC4;BCR;WNT5A;ANXA1;TXNIP;SCEL;UGCG;ERCC2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.46708850387353174,-1.1293510987282807,0.30985915492957744,0.6098977788399402,1.0,3/12,4.22%,ACTB;ACTG1;LAMA3
prerank,amino acid transport (GO:0006865),-0.32113712990890814,-1.1288687649230964,0.24,0.6105127165513965,1.0,11/49,9.02%,SLC6A6;SLC38A11;SH3BP4;SLC1A5;SLC7A5;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC7A14;SLC43A1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2815760438520215,-1.1288184964805323,0.21899736147757257,0.6100179253285415,1.0,25/103,13.40%,ARHGAP31;PLCE1;RAPGEF2;NTN1;RASGRP3;BCR;JUN;TIAM2;RALB;PRKD1;ARHGAP32;GNB1;PLK2;RAPGEF6;SHOC2;G3BP1;ABR;TIAM1;FGF2;GRAP;KRAS;NRAS;ARHGAP1;RERG;SHTN1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.492842640408344,1.128352518206768,0.313953488372093,0.9021792206621144,1.0,3/10,6.35%,DNMT3L;DNMT3A;PCGF5
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.45199320825278566,-1.1283174327986638,0.319755600814664,0.6107187287175148,1.0,3/12,11.83%,FOXP1;KLF4;CD74
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.26605919001908107,-1.1281312834259367,0.16758241758241757,0.6105955600923488,1.0,39/136,20.24%,DAB2IP;TMSB4X;CD200;FZD6;PKD1;GAS6;CYP1B1;PTGIS;NFKBIA;ID1;SFRP4;IRAK3;ESR1;FLNA;BHLHE40;TRIM37;AIM2;HES1;NLRC5;DAP;HEYL;USP7;KLF4;PHB2;PTCH1;MTURN;IRAK2;MAD2L2;ID2;SP100;SIGIRR;PEX14;HDAC2;ERBIN;LRRC14;ZC3H12A;SPI1;ARRB2;PSMD10
prerank,L-amino acid transport (GO:0015807),-0.36178022617760813,-1.12801002455525,0.29148936170212764,0.6102998242906549,1.0,8/28,17.44%,SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3237360323668642,-1.127887537922272,0.2733050847457627,0.6099997025946878,1.0,16/43,17.35%,FOXP1;THBS1;CDH13;BMP4;JUN;ERN1;IL6R;ADAMTS1;FGF2;EDN1;CCN4;P2RY6;HTR1B;ID2;LDLRAP1;MMP2
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.439849776907123,-1.127870293730326,0.31759656652360513,0.609430919333686,1.0,4/13,10.46%,NOTCH1;TGFBR2;HEY2;CPE
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.4710442884886978,1.1274669570024016,0.3132780082987552,0.9034134565381442,1.0,4/11,12.05%,ENPP3;NT5C3A;DCK;THTPA
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4643682776810448,1.127269976068024,0.3346693386773547,0.9023009074954684,1.0,6/11,20.96%,NECAB1;SOAT1;ABCA2;BACE2;NECAB3;ITM2C
prerank,response to organonitrogen compound (GO:0010243),0.35812637975079137,1.1272519378793455,0.2843866171003718,0.9005597648398287,1.0,10/38,15.60%,TRPV1;RRAGC;DERL1;GLRA1;DRD3;TRPM2;CCDC47;UBXN6;RNF5;IL6
prerank,protein modification process (GO:0036211),-0.2998472335155394,-1.126794484863319,0.2222222222222222,0.6115357723459629,1.0,20/76,16.26%,ST8SIA4;ST3GAL6;PLOD2;ATG3;ST3GAL1;UBE2D3;LOX;CSNK1G3;YES1;CPE;UBE2L3;FBXW2;STK38;AKT2;UBL5;PPP4R2;ST8SIA2;ICMT;PHKA2;PHEX
prerank,regulation of monocyte differentiation (GO:0045655),-0.43375460339365135,-1.1266838243423187,0.3097713097713098,0.6112192226926175,1.0,3/14,11.83%,FOXP1;IL34;CD74
prerank,establishment of vesicle localization (GO:0051650),0.43125530609256235,1.1266457448383722,0.2925430210325048,0.9008197740783902,1.0,4/18,6.54%,SYT11;KIF5C;IKBKG;SNAPIN
prerank,acylglycerol biosynthetic process (GO:0046463),0.3915116078745335,1.126207465728085,0.27756653992395436,0.9005083487995342,1.0,6/23,12.75%,LPGAT1;GK;LPIN1;MOGAT1;PLA2G15;DGAT2
prerank,regulation of cell cycle (GO:0051726),-0.2429585728721255,-1.1261226005165208,0.16065573770491803,0.6120241445600495,1.0,84/271,23.40%,APBB2;MECOM;TTC28;DAB2IP;NEK7;LRP6;FAP;PLAGL1;TGFB2;TBX3;THBS1;NOTCH1;DCUN1D3;PKD1;IQGAP1;AFAP1L2;STAT3;BMP4;ADARB1;PTPRK;JUN;MAP3K20;ERN1;RACK1;ADAM10;APC;MYBBP1A;RPS6KA2;CDC123;RBBP4;CDK5;XIAP;WHAMM;RPL23;FBXO5;GRK5;PDCD4;BMP2;BIRC3;LIN54;SIPA1;CSNK2A1;AKT2;GAS2L1;PTPRC;MADD;PUM1;JMY;FOXO4;ID2;PRKACA;RPS15A;TBRG4;ING4;GPER1;JUNB;NBN;BARD1;MASTL;CCND1;MAPK12;KIF20B;CDC26;CDK6;ASAH2;PCLAF;CCPG1;METTL3;RHOB;L3MBTL1;CHEK1;JUND;THAP1;TTLL12;DUSP1;RPRD1B;FBXL6;CCNB2;CDKN1B;RNF40;CDK11B;CYLD;PRDM11;NANOS3
prerank,amino acid transmembrane transport (GO:0003333),-0.32675316209632244,-1.1260132787064623,0.2599118942731278,0.6116805461859162,1.0,10/45,8.49%,SLC47A1;SLC6A6;LRRC8D;SLC38A11;SLC7A5;SFXN1;SLC38A5;SLC7A7;SLC7A1;SLC16A2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.30678421484341784,-1.126011515538948,0.2330316742081448,0.6110882065372325,1.0,22/59,18.12%,PTPRM;HMCN1;PECAM1;BSG;PKD1;CDH13;CDH1;PALLD;ITGB1;NECTIN3;NPTN;ROBO4;CEACAM1;DSCAML1;NECTIN2;FAT2;EMB;CDH2;KIRREL3;PVR;DSG2;CELSR2
prerank,histone H2A monoubiquitination (GO:0035518),0.43729606643652863,1.1256216008217754,0.31781376518218624,0.9007720420820815,1.0,5/17,12.26%,DDB2;PCGF2;PCGF5;PCGF6;RING1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.45620445770866336,1.1255485625421051,0.31956521739130433,0.8992565795325845,1.0,4/12,16.23%,LPIN1;PLK1;PRKCB;PRKCA
prerank,negative regulation of nuclear division (GO:0051784),0.48058213155176344,1.125319815562807,0.317907444668008,0.8982727525183565,1.0,2/11,6.64%,BMP7;TOM1L2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3351164224034434,-1.12527372230003,0.2652582159624413,0.6122498486382973,1.0,11/39,14.93%,DAB2IP;PTPN12;EGFR;PTPRJ;ITGA1;SPRY2;DUSP3;HGS;SH3GL2;SPRY1;CBL
prerank,postsynaptic membrane organization (GO:0001941),0.4228739517179578,1.124695371173641,0.29080675422138835,0.898641772466865,1.0,6/17,9.52%,CEL;NLGN2;NLGN3;SHISA7;LRP4;DLG4
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3917357312191402,-1.1246543623546919,0.29375,0.6131849415571197,1.0,7/19,11.67%,PLCE1;NFATC1;PPP3CA;NFAT5;EDN1;NFATC2;EDN3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.30183062517714665,-1.1245564513308692,0.23623853211009174,0.6128107738857607,1.0,17/65,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;PABIR1;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;CHEK1;PSME1;PSMB3
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2942320576005908,-1.1236517733352067,0.2619047619047619,0.6145294081627283,1.0,34/73,30.26%,ACTB;CTCF;H3-3A;MYBBP1A;RBBP4;IGF2;GPX1;PRMT7;MTA1;DNMT3B;HDAC6;SUZ12;POLR1F;POLR1G;TASOR;ZFP57;TDG;EPC1;POLR1A;SPI1;AEBP2;DNMT1;GLMN;POLR1H;MYO1C;POLR2F;POLR1E;BMI1;POLR2H;PHF19;DDX21;POLR1C;POLR2E;SMARCA5
prerank,positive regulation of T cell migration (GO:2000406),-0.39170656537207454,-1.123138707377676,0.31446540880503143,0.6152039782695767,1.0,6/20,9.84%,RHOA;APP;WNT5A;ADAM10;CXCL12;DOCK8
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3841831653633223,-1.1231190656614123,0.29473684210526313,0.6146595414639003,1.0,6/22,9.34%,NTRK3;PLCG1;ESR1;AGTR1;FLT1;FGF2
prerank,regulation of chromatin organization (GO:1902275),-0.4356875278175932,-1.1228211596945112,0.31827956989247314,0.614755076458708,1.0,4/14,10.36%,MLLT3;HPF1;IGF2;PARG
prerank,cholesterol biosynthetic process (GO:0006695),0.3730695613228518,1.1226915549688263,0.312621359223301,0.9038831784387535,1.0,10/31,20.27%,ACAT2;INSIG2;DHCR24;SC5D;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4026184720715848,1.1225741539226437,0.2965931863727455,0.9025395760511598,1.0,4/21,10.53%,DCDC2;EVC;ARMC9;TEDC2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.33218774523103994,-1.122522046940176,0.26948775055679286,0.6148945306687339,1.0,15/40,21.10%,CRY1;UBE2V2;PRKCD;FEM1B;IER3;WDR76;PARG;FBXO5;WRNIP1;FMR1;FXR1;RPA2;MCL1;SIRT7;NSMCE4A
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.42721945038463727,1.1223543703111212,0.31176470588235294,0.9015251018377314,1.0,4/17,11.47%,IGF1;RTN1;NTRK2;CLU
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3588792197654117,-1.1222375974730556,0.28600823045267487,0.6149712932727677,1.0,9/29,17.48%,SLC4A10;APP;APOE;EPHB2;NSMF;RAB3A;ZDHHC2;MCTP1;SYNGR1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4585993192278065,1.1220220038410318,0.33268101761252444,0.9009061043551384,1.0,4/12,13.27%,ROCK2;PICALM;FLOT2;ABCA2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.24587428751078588,-1.1217726034497517,0.1831831831831832,0.6155419008704734,1.0,53/248,13.10%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;DAAM2;STK3;EGFR;LIMD1;SDHAF2;KANK1;SFRP4;CDK14;GLI3;TLE4;NKD2;SOX17;IGFBP6;CSNK1E;CSNK1G1;ADGRA2;WNT5A;TNKS;AXIN2;CCNY;PLEKHA4;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;CSNK1G3;INVS;APC;XIAP;ATP6AP2;PPP1CA;APOE;PSMB6;AMER1;PSMB5;TLE5;SOX7;SCEL;FZD4;DKK2;HHEX;COL1A1;BMP2;GSKIP;USP47;ANKRD6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.26067898591037547,-1.1217428184938139,0.22281167108753316,0.6150193173292376,1.0,50/145,28.00%,FBXL7;YWHAE;RAD51B;FHL1;DYNC1I2;BRD4;CSNK1E;PSMA6;PSMB7;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;USP47;ODF2;DYNLL1;PSMB8;CCP110;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;PRKACA;PSMB4;DYNC1H1;PSMD14;CCND1;RAB11A;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDK5RAP2;CEP152;DTL;HMMR;KIF14;AKAP9;ACTR1A;CUL1;CDK2;CNTRL;AVEN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4191121276975644,-1.1215353574672173,0.31020408163265306,0.6149163389504196,1.0,8/15,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;ARPC5
prerank,calcineurin-mediated signaling (GO:0097720),-0.4745286412524612,-1.121416190018833,0.33194154488517746,0.6140410589252598,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4745286412524612,-1.121416190018833,0.33194154488517746,0.6140410589252598,1.0,6/10,23.05%,NFATC1;PPP3CA;NFAT5;NFATC2;NFATC3;NFATC4
prerank,cellular response to light stimulus (GO:0071482),-0.3014667370127014,-1.1213439179127718,0.23684210526315788,0.6136229379056706,1.0,28/66,34.02%,PTPRK;GNB1;PRKCD;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;N4BP1;RHNO1;GPR88;METTL3;NEDD4;NSMCE3;TRIAP1;SMPD1;GPR52;PARP1;SDE2;BMF;MYC;AQP1;RRH;OPN1MW3;OPN1MW;TP53
prerank,regulation of translational initiation (GO:0006446),-0.29770862671810655,-1.1213097534081957,0.2409090909090909,0.6131387596264438,1.0,16/63,15.85%,EIF3E;ALKBH1;EIF3H;NCK1;CDC123;EIF2B2;EIF2AK3;AGO2;HSPB1;NCBP2;TPR;EIF1B;NCBP1;EIF4G3;FMR1;ATF4
prerank,cell-cell junction organization (GO:0045216),0.3116602471930497,1.1208811775331333,0.24655172413793103,0.9030716038253124,1.0,12/79,8.04%,SDK1;AFDN;SMAD3;SDK2;NLGN2;CDH15;CDH3;CDH17;PKP4;CDH10;CDH18;PRKCI
prerank,receptor signaling pathway via STAT (GO:0097696),-0.37196245263943295,-1.1208421491327827,0.317351598173516,0.6137412931738676,1.0,4/25,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,response to steroid hormone (GO:0048545),0.38028851084109205,1.120691450750848,0.29213483146067415,0.9020061088773907,1.0,7/31,14.78%,ATP1A2;TFPI;MED1;NR1H3;PAQR7;ABCA2;WBP2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4100156970021779,1.1202716543494697,0.3076923076923077,0.9016779289253329,1.0,5/20,10.40%,PRKAA2;RUVBL2;ARRB1;PPARGC1A;BRD7
prerank,regulation of protein localization (GO:0032880),0.3282609294050669,1.1198764016070046,0.2711864406779661,0.9013088683870154,1.0,9/58,10.46%,AFDN;MAP2;PICALM;TRIM5;CAMK1;DLG1;CEP290;WDPCP;VIP
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.33913862492030056,-1.119513414642624,0.3004201680672269,0.6164478319983272,1.0,10/32,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3421200037217788,1.1190099894551269,0.2987910189982729,0.9025686687415548,1.0,10/48,11.48%,ROBO1;NLRP2B;OTUD4;USP18;PELI3;CACTIN;NR1H3;OAS3;PARP14;STAT2
prerank,renal filtration (GO:0097205),-0.47809031433272886,-1.1184973248980277,0.3365019011406844,0.6184509521251129,1.0,7/10,41.01%,CD34;MCAM;MYO1E;JCHAIN;SULF1;SULF2;ITGA3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3723077410798856,-1.1184278383168849,0.30833333333333335,0.6180039628146224,1.0,6/25,10.52%,B2M;SLC7A5;PLCG2;WNT5A;CD55;MALT1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4493387001163239,-1.1184228077227385,0.34782608695652173,0.6174223261919969,1.0,3/12,8.65%,NOTCH1;CCN3;TMEM119
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.36594127267659454,-1.118256225725914,0.304635761589404,0.6172128753763046,1.0,8/27,17.44%,SLC47A1;SLC7A5;SLC1A3;SLC38A5;SLC7A1;SLC1A1;SLC36A4;SLC7A8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.44345155110456624,1.118072157795349,0.3497942386831276,0.9039390700606406,1.0,6/14,18.53%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,response to interleukin-1 (GO:0070555),-0.29697471767355615,-1.117922832622477,0.2570194384449244,0.6174916738049271,1.0,20/73,23.57%,DAB2IP;IL1R1;PTGIS;IRAK3;APP;TNFRSF11A;ANXA1;CCL13;SRC;TLE5;CD40;IRAK2;ADAMTS12;CCL25;USP10;ZC3H12A;MYD88;HAS2;MAPK11;TAF9
prerank,mitotic nuclear division (GO:0140014),-0.2885719052771129,-1.1174087627265568,0.23877068557919623,0.6182476700169632,1.0,31/71,27.77%,RHOA;SMC4;FLNA;SMC1A;PPP2R2D;EPS8;CHMP4B;STAG1;NCAPG2;MAP9;PIBF1;MZT1;ZW10;KLHL22;STAG2;TOGARAM1;NUSAP1;ARHGEF10;RAB11A;TPX2;KNSTRN;AAAS;KIFC1;NUP62;NSL1;NDEL1;CENPK;MIS12;CDCA8;SGO1;TUBG2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.29592481753748373,-1.1174010259824452,0.26588235294117646,0.6176800751228481,1.0,10/70,7.46%,DAB2IP;HIPK1;TGFB2;BCL2L1;NGF;TNFRSF1B;FAS;CRADD;IL6R;CASP8AP2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.4808360113256587,-1.1172555024705824,0.33121019108280253,0.6174699737053292,1.0,4/10,24.43%,UBE2J1;INSIG1;OS9;SVIP
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.31868760816384534,-1.1169762475015657,0.2692307692307692,0.6175477757471853,1.0,12/54,7.09%,CAV1;NEDD4L;YWHAE;KCNJ2;NOS1AP;FHL1;FLNA;CAB39;GNB1;KCNMB2;GNG2;KCNQ1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.2848743473814186,-1.1169375558078287,0.25485436893203883,0.6170521732451022,1.0,34/83,27.23%,ACVR1;CDK17;CDK14;CACUL1;BRD4;PLK2;KLF11;CDK5;EIF4E;FBXO5;NASP;ORC1;DHFR;LATS1;CCND1;CDK16;CDC45;CDK6;POLA1;CCNH;CDKN1B;CDK18;CUL3;LATS2;PLK3;CDC34;PIM2;CDKN3;TYMS;CUL4A;NPAT;TFDP1;CUL1;CDK2
prerank,regulation of MAP kinase activity (GO:0043405),0.3010672547484635,1.116904229039052,0.25170068027210885,0.9062576890211427,1.0,11/92,8.22%,ROBO1;BMP7;FGF1;TENM1;KIT;ADRA2A;PIK3CB;PPEF2;SNF8;LRRK2;KSR1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.27097336386941007,-1.1167666587983718,0.1905940594059406,0.61689969961379,1.0,26/104,14.89%,ST3GAL4;DCN;CSGALNACT1;SLC26A2;ST3GAL6;SLC10A7;B3GNT2;CSPG4;B4GALT4;PAPSS2;GSS;ST3GAL1;LUM;AKR1A1;GGTA1;VCAN;GCLC;SLC35B3;B4GALT5;CHSY3;LIAS;BGN;GCLM;CHST1;ESD;GSTT1
prerank,regulation of metal ion transport (GO:0010959),0.43128440812856433,1.1167329424753933,0.33653846153846156,0.9050669129381198,1.0,5/16,15.47%,ANK2;DLG1;SLC30A10;BCL2;ORAI1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.43801801420826264,1.1161938338171944,0.3231083844580777,0.9051526524386292,1.0,1/14,0.12%,PPP2R2B
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.39000595792542836,-1.1159465855143933,0.31157894736842107,0.6182565000655788,1.0,8/19,15.99%,VCAM1;PTPRJ;KDR;STIMATE;BCAP31;PTPRC;PTGFR;PRKACA
prerank,neuron development (GO:0048666),-0.26252418242669784,-1.1155433161487287,0.19047619047619047,0.6187059531186888,1.0,25/141,12.27%,PTPRM;FRY;MEF2C;RAPGEF2;PBX1;TGFB2;PBX3;RUNX1;APP;STMN1;TBCD;STX3;VSX1;MAP4;ETV1;LYN;LGI4;MYOC;CDK5;APOE;B4GALT5;FRYL;MICALL2;UGCG;SH3GL2
prerank,protein transport (GO:0015031),-0.23934358236184122,-1.115521016592234,0.14285714285714285,0.6181835962300529,1.0,76/332,16.89%,SPTBN1;TBC1D4;CALCRL;RABGAP1L;STEAP3;RAB14;RAMP2;SLC10A7;MYH9;TBC1D8;MACF1;SCFD2;ABCA1;ATP6V0A4;TBC1D12;LMAN2L;RAB6A;STX1A;HERC2;SNX13;RAB31;MIA2;TMED10;USP6NL;TBC1D5;CHMP2B;STX3;TBC1D2B;TFRC;MON1A;ARHGEF2;SNX1;TBC1D1;MTTP;CMTM6;EVI5L;ATP6V0D1;ATP6V0A1;VPS26A;RAB22A;TXNIP;TBC1D13;APOE;GOLPH3;DNAJC27;WDR11;SEC31A;VLDLR;CD74;RAB3A;SCAMP1;PDIA4;ARHGAP1;ATP6V1D;STX7;HDAC6;ARL5A;SYS1;TBC1D10A;LRP1;AP2A1;STX8;SAR1A;RAB11B;RAB5C;RAB1B;HIKESHI;TBC1D25;RAB3GAP2;SEC13;ARF5;COPA;COPB2;TCIRG1;IFT27;LRP1B
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.27177812622100894,-1.1155154369597649,0.22249388753056235,0.6176096012103679,1.0,23/107,16.14%,DAB2IP;NIBAN1;MAP3K5;THBS1;PIK3R1;RASGRF2;JUN;CREB3L1;ERN1;NCK1;UFC1;BCAP31;ATP2A3;EIF2AK3;TMCO1;PDIA4;BBC3;RHBDD1;ATF6B;BAK1;ATF4;OS9;CFTR
prerank,BMP signaling pathway (GO:0030509),0.3190361977842642,1.1154234250556787,0.257679180887372,0.9061265499329104,1.0,7/62,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3560360138113379,-1.1151755163601216,0.29713114754098363,0.6178636103971523,1.0,7/32,10.57%,ITGA1;PPIA;PPP1R16B;PRKCD;CALM3;SPPL3;NSMF
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4330729744098934,1.1148120626594333,0.32612966601178783,0.9064683856418231,1.0,4/15,12.98%,NLGN2;ZDHHC12;SYN3;ZDHHC3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.369364601788835,1.1148057021171212,0.325,0.9047496467924068,1.0,10/29,18.41%,LPGAT1;PPARA;SORBS1;SLC45A3;NR1H3;CREBL2;CREB1;AKT1;MID1IP1;MLXIPL
prerank,macroautophagy (GO:0016236),0.2894049905477703,1.1146958763399073,0.26791277258566976,0.903385214141255,1.0,21/118,12.89%,PRKAG2;PRKAA2;PRKAG3;CHMP6;STAM;SNX14;VAMP7;VTA1;TOMM40;SNAP29;SNF8;AMBRA1;VPS16;TOMM22;CSNK2A2;LAMP2;LIX1L;MFN2;ATG13;UBXN6;VPS39
prerank,DNA modification (GO:0006304),-0.385928216399098,-1.1142026033402936,0.3181818181818182,0.6198064174288228,1.0,17/22,41.10%,TERF2IP;TDG;NEIL3;MUTYH;EXOSC4;SMUG1;EXOSC5;PARP3;TINF2;TERF2;EXOSC3;PARP1;OGG1;UNG;PARP2;NTHL1;TERF1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4174431315846934,1.1138676390933662,0.3135245901639344,0.9045012627325852,1.0,6/18,14.80%,RAB3GAP1;SNAPIN;RIMS1;LRRK2;DTNBP1;SYN1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3551300737978297,-1.1137899271248244,0.28778467908902694,0.6202212710548717,1.0,11/29,18.18%,TEK;DGKZ;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2818843528676951,1.1135153449750859,0.24958402662229617,0.9040711716572474,1.0,24/152,10.46%,CACNA1D;ADCY5;LGR4;GCGR;PTH2R;ADGRG4;ADCY1;CRHR1;ADRA2A;LPAR2;CHRM2;ADGRB2;ADGRB3;ADCY8;GPR12;GPR26;LPAR1;PTGER1;GABBR1;ADGRL1;GPR37;HTR1F;ADGRG3;VIP
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2534004294860791,-1.1132748603813614,0.17150395778364116,0.6208986807602076,1.0,37/172,14.60%,PLA2G4A;PIP5K1B;PIP4K2A;RAB14;INPP4A;DGKH;PIK3R1;CEPT1;DGKZ;PLSCR1;AGK;PIK3C2A;PLCG2;BMX;PLEKHA8;CPNE3;PIK3R6;SLC44A2;PLEKHA4;INPP5D;PIK3CA;FGF2;PIK3CD;MTMR7;FIG4;PIK3C3;MFSD2A;MTMR12;SLC44A1;AGPAT1;LPIN3;CSNK2A1;ABHD4;ABHD8;ETNK1;PIK3R4;AGPAT5
prerank,heart trabecula morphogenesis (GO:0061384),-0.40342670743815817,-1.1128847758290181,0.30184804928131415,0.6212783883939187,1.0,7/18,5.58%,TEK;BMP5;ADGRG6;TGFB2;ENG;NOTCH1;S1PR1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.44593112652844535,-1.1126119290486693,0.3264033264033264,0.6213422063457081,1.0,6/12,32.25%,CHMP4B;CHMP4A;SEC61A1;SEC62;HSPA5;GET3
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4197073938026475,1.112568930019047,0.32945736434108525,0.905621584714882,1.0,6/18,23.59%,KMT2A;SETD4;SETD7;SMYD2;SETD1B;SETD2
prerank,regulation of phosphatase activity (GO:0010921),0.39506313125879766,1.1116510281862748,0.30710172744721687,0.9070016434061364,1.0,4/24,13.71%,SH3RF2;SH2D4A;HTT;TSC1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.45933604674989914,-1.1115267650527023,0.3508771929824561,0.623512610503774,1.0,9/11,41.45%,LYN;JAK1;PLAUR;SYK;CCL5;ANK3;RDX;TNFSF11;BLK
prerank,Fc receptor signaling pathway (GO:0038093),-0.2738879494285726,-1.1108841312955462,0.24757281553398058,0.6245215106840486,1.0,40/110,27.53%,PIK3R1;PLCG1;NFATC1;JUN;PLCG2;PAK2;TEC;LYN;PSMA6;PSMB7;MAPK1;PPP3CA;PIK3CA;VAV2;PSMB6;MALT1;PSMB5;NFATC2;PSMB8;TAB1;PSMC4;PSMD11;LAT2;PSMB4;PSMD14;MAPK3;BTK;NFATC3;PSMD10;MAP2K7;SYK;PSME1;BCL10;PSMB3;GRAP2;VAV3;GRB2;CUL1;FBXW11;CALM1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.31304694443319614,-1.1103156700470267,0.26495726495726496,0.6253174096062498,1.0,15/51,20.10%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;SYNPO2;TGFB3;PFN1;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.3349444402753996,-1.110233985444306,0.3053097345132743,0.6249494577977491,1.0,11/40,14.23%,NTRK3;EDNRA;EGFR;PLCG1;ESR1;FLT1;FGF2;PHB2;HTR2A;CD86;P2RY6
prerank,vasculature development (GO:0001944),-0.41808198137401964,-1.1101556625814075,0.3293172690763052,0.6245750937878783,1.0,9/16,16.62%,BMPR2;ACVRL1;STRA6;PIK3CA;FLT4;NOTCH4;SOX18;FBXW7;APLNR
prerank,positive regulation of immune response (GO:0050778),-0.2990014601332963,-1.1100741014845716,0.2523364485981308,0.6241765958905182,1.0,16/64,22.51%,IL6ST;TGFB2;POLR3F;PLSCR1;GBP5;IFI35;IL15;CD74;RSAD2;PTPRC;CD46;POLR3B;NOD2;POLR3D;NMI;FCGR2B
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.4299567094281714,-1.1096555603826537,0.32475247524752476,0.6246957195209395,1.0,5/15,18.32%,ENTPD1;ENTPD6;ENTPD2;NME2;AK4
prerank,tetrapyrrole metabolic process (GO:0033013),-0.40522261286393735,-1.1090008094805601,0.3305084745762712,0.6257356242020379,1.0,4/18,8.59%,ABCC1;LMBRD1;MMADHC;CUBN
prerank,axonal transport of mitochondrion (GO:0019896),0.4683051728261342,1.1086275890669228,0.3418467583497053,0.9156170568084099,1.0,5/11,26.43%,TRAK1;ACTR10;NEFL;SPAST;HAP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3803611852082692,1.1085976264853206,0.31273408239700373,0.9140017835115875,1.0,4/27,6.49%,IGF1;PDGFRA;SPHK1;E2F1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.39126227733525576,1.1083040685974315,0.30754716981132074,0.9132526480352522,1.0,9/25,20.39%,GCK;ENO1;ALDOB;PGK1;HK1;ALDOC;PFKP;GPI;TPI1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.30649845322898694,-1.1081486830507261,0.2654462242562929,0.6273715063682551,1.0,12/56,11.93%,RAD51B;CDC27;KMT2E;EGFR;ANAPC5;BRD4;ANXA1;ADAMTS1;CDC16;RPTOR;FBXO5;PHB2
prerank,pre-replicative complex assembly (GO:0036388),-0.29602737103685195,-1.107287131579651,0.2772727272727273,0.6289324615950208,1.0,19/64,23.25%,UBC;RPS27A;UBB;PSMA6;PSMB7;PSMB6;PSMB5;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;ORC5;PSMD10;PSME1;MCM3;PSMB3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.43364461816835576,-1.1071990289184641,0.33131313131313134,0.6285870828383814,1.0,2/13,0.78%,NRP1;NRP2
prerank,cell junction organization (GO:0034330),0.31333460434453897,1.1068261857293276,0.2804878048780488,0.9165900364374588,1.0,7/71,2.86%,SDK1;SLC6A1;SLC8A3;SMAD3;SDK2;FLNC;NLGN2
prerank,oligosaccharide metabolic process (GO:0009311),-0.3164492459290648,-1.1066372667596371,0.3004484304932735,0.629440727026405,1.0,7/46,8.21%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;FUT8;ST6GALNAC5;ST8SIA6
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4007575199979893,1.1064483030368562,0.3333333333333333,0.9161210609279374,1.0,6/22,10.27%,APPL2;TAFA3;TRIM71;FZD9;LRRK2;NES
prerank,protein-containing complex disassembly (GO:0032984),-0.3059823550176212,-1.106396103856791,0.29357798165137616,0.629465624137219,1.0,11/54,13.72%,CAV1;LRP6;GABARAPL2;CSNK1A1;MAP1LC3B;APC;PPP1CA;AMER1;RPL23;GABARAP;FZD1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.4692472118319576,-1.106309945616134,0.32815533980582523,0.6290854978664778,1.0,3/10,13.60%,PRKCH;TRIM16;NME2
prerank,long-term synaptic potentiation (GO:0060291),0.40371164635154927,1.1062246393797597,0.30739299610894943,0.9151151697515593,1.0,3/21,5.02%,SLC8A3;PRKCZ;GRIN2D
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.29017406377160926,-1.1059673503057437,0.2759433962264151,0.6293100472940182,1.0,33/73,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;CD86;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;BCL10;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,response to hydrogen peroxide (GO:0042542),-0.3213929593157825,-1.1058592463529244,0.296127562642369,0.6289975563779846,1.0,10/45,9.75%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3;STK24;SOD1;CAT;GPX1
prerank,metal ion transport (GO:0030001),0.3047133076669719,1.1056049680028972,0.294017094017094,0.9155057620475752,1.0,15/86,11.47%,CACNA1D;SLC8A3;SLC41A1;CACNG7;CACNB3;NDFIP1;GRIN3A;ITPR1;TUSC3;NMUR1;CHRNB2;KCNN4;MAGT1;RYR2;TRPM2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.304759376060904,1.1056036611572841,0.27917981072555204,0.9138017689613854,1.0,11/85,7.28%,FGF1;TGFBR3;BMP6;IGF1;NUPR1;OSR1;FGF9;MCC;FUT2;FGFR2;NLRC3
prerank,regulation of TORC1 signaling (GO:1903432),0.3568722779941204,1.1054303461187382,0.29764065335753176,0.9126657834255608,1.0,9/33,18.67%,RNF152;RRAGC;GPR137C;SESN1;PIH1D1;ATM;TELO2;RRAGB;CASTOR2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3111191459225325,-1.1053352520862398,0.28859060402684567,0.6297368259010496,1.0,14/49,17.34%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36560548669122156,1.1051079902106506,0.31417624521072796,0.9120081638127578,1.0,9/32,16.46%,SYT11;SNCAIP;SNAPIN;RIMS1;LRRK2;DTNBP1;CPLX1;SYN1;CPLX2
prerank,membrane organization (GO:0061024),-0.24395121559620395,-1.1050661456329203,0.1752873563218391,0.6298326724125969,1.0,51/227,16.63%,HIP1;SPTBN1;ACTB;DNM3;STON2;ACTG1;CERT1;EGFR;CORO1C;UBC;AP2B1;PIK3C2A;SCARB2;PLEKHA8;CHMP2B;FCHO2;TFRC;SGIP1;RPS27A;VAMP3;UBB;WNT5A;CLTB;FNBP1;CHMP4B;CHMP4A;EPN2;NEMP1;GAPVD1;CHRNB1;RABIF;HGS;DYSF;SUN1;LEMD3;FZD4;FNBP1L;SH3GL2;HIP1R;UBXN2A;AP2A1;REEP3;SAR1A;CBL;ARPC2;VAPB;TLCD1;CFTR;SYNGR2;SNAP23;LDLRAP1
prerank,cellular response to virus (GO:0098586),0.37158840349581984,1.1049343259478739,0.31636363636363635,0.9108969966458305,1.0,11/30,20.76%,CHUK;GSDME;VWCE;MAPK14;IL6;GBF1;IL12A;HSP90AA1;POU2F2;DDX3X;BAX
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3451570862969023,1.1046660698564292,0.3044280442804428,0.910137414346506,1.0,12/44,20.27%,PRKAG2;INSIG2;SC5D;CYP27A1;AMACR;OSBPL9;SQLE;PER2;MSMO1;HMGCR;HSD17B4;LBR
prerank,regulation of type I interferon production (GO:0032479),-0.28686538690475594,-1.1039555921653528,0.27423167848699764,0.6319847466911304,1.0,26/84,23.79%,LRRFIP1;POLR3F;DHX33;RNF125;XRCC5;NLRC5;TRIM56;TRIM25;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;TRAF3IP1;PCBP2;GAPDH;IRF5;POLA1;POLR3A;MYD88;ZBP1;POLR3D;POLR2F;CYLD;TAX1BP1
prerank,monocyte chemotaxis (GO:0002548),-0.34606432633791373,-1.1039330915542718,0.2838709677419355,0.6314689894950494,1.0,5/32,8.06%,TNFRSF11A;IL6R;ANXA1;FLT1;CCL13
prerank,regulation of platelet activation (GO:0010543),-0.3770886662166419,-1.1038381237881199,0.32231404958677684,0.6311291234924314,1.0,5/21,9.64%,PLA2G4A;NOS3;TEC;LYN;APOE
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4542589480536582,1.1038020992092796,0.3339920948616601,0.9113698348628136,1.0,1/12,0.26%,BMP7
prerank,action potential (GO:0001508),-0.32247281926897786,-1.1037323639967564,0.2830188679245283,0.6308178493394117,1.0,14/44,21.60%,KCNJ2;CACNA1G;GNA11;KCNMB2;KCNQ1;CACNA1I;KCNB1;KCNE4;SCN3A;GPER1;CACNA1H;GNA14;DMD;SCN7A
prerank,protein monoubiquitination (GO:0006513),0.35659022219815006,1.1036912900888867,0.3267857142857143,0.9100471451927589,1.0,9/36,14.73%,CTR9;RNF126;LEO1;TOPORS;RNF20;UBE2W;OBI1;CDC73;UBE2R2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.4750943183492119,1.1034103079790312,0.350104821802935,0.9093218921223922,1.0,3/10,15.49%,KLF15;NOC2L;SIRT1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4018624430987651,1.1032494456746806,0.32954545454545453,0.9082287542223147,1.0,6/22,15.46%,KRI1;EXOSC8;NOP9;PES1;EXOSC2;WDR12
prerank,leukocyte tethering or rolling (GO:0050901),-0.4033734961726072,-1.1022368241090672,0.33397312859884837,0.6338993386301425,1.0,5/17,12.40%,VCAM1;ITGB1;GOLPH3;GCNT1;ITGA4
prerank,fat cell differentiation (GO:0045444),0.31943461986333,1.1017273588106982,0.2893835616438356,0.9116393061456466,1.0,20/57,22.09%,OSBPL8;WNT5B;TMEM120B;METRNL;CLIP3;CEBPA;C1QTNF3;MED1;PPARGC1A;ADIG;CTBP2;FAM120B;PER2;SIRT1;TCF7L2;OSBPL11;INHBB;TRIM32;NR4A3;BBS2
prerank,regulation of phospholipase C activity (GO:1900274),-0.42649592373133566,-1.1015360315902618,0.3333333333333333,0.6350549890361633,1.0,5/15,9.34%,NTRK3;PLCG1;ESR1;FLT1;FGF2
prerank,embryonic skeletal system development (GO:0048706),0.34756790211193345,1.1012121669267323,0.3339449541284404,0.9117117358556122,1.0,8/35,11.20%,PDGFRA;OSR1;HOXB9;HOXB3;HOXA3;HOXB4;MEGF8;UCMA
prerank,microtubule nucleation (GO:0007020),0.4112031830407338,1.1012022050528523,0.3306930693069307,0.9100830383053803,1.0,5/19,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3650459731205379,-1.1007735294786485,0.325678496868476,0.6363444601140047,1.0,12/23,29.41%,GAS6;UNC13B;ERN1;RACK1;SLC26A6;KCNB1;PRKACA;GPER1;IGF1R;TRA2B;SLC39A14;PDK3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.38108984969431875,-1.1006416044874021,0.32210526315789473,0.6360388205887314,1.0,7/19,7.98%,SEMA6A;DCN;DAB2IP;JCAD;XDH;SPRY2;CCBE1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.3557881526395651,-1.0997318306543515,0.2924731182795699,0.6377495114765108,1.0,12/25,29.59%,CSGALNACT1;EXT1;B3GNT2;HAS1;HAS2;B3GNT3;B3GALT5;B3GNT8;EXT2;B3GALT1;CSGALNACT2;B3GNT6
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.337296953750832,-1.0996312991967045,0.31533477321814257,0.6374234442027547,1.0,13/34,18.18%,TEK;DAB2IP;PIK3R1;TNFAIP8L3;PIK3IP1;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2
prerank,nuclear membrane disassembly (GO:0051081),0.4371779651364282,1.0994769099836197,0.3354978354978355,0.914221335967956,1.0,5/14,16.67%,LPIN1;PLK1;PRKCB;PRKCA;AKAP8L
prerank,positive regulation of cellular respiration (GO:1901857),0.4679690745667697,1.0992375660407516,0.3445378151260504,0.9133156433495684,1.0,1/11,0.90%,NUPR1
prerank,cellular response to hypoxia (GO:0071456),0.2820462678475585,1.098625167378619,0.2599337748344371,0.9136917933523704,1.0,21/126,16.70%,BMP7;RORA;EPAS1;CPEB2;SLC8A3;OPRD1;PSMD3;LMNA;PGK1;KCND2;HIF3A;NDRG1;ANGPT4;TERT;PSMD1;ARNT;PSMC5;PSMA1;SIRT1;PSMD12;MDM2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.357782743737009,-1.098487935962492,0.31759656652360513,0.6398116069133238,1.0,12/28,24.88%,NOTCH3;EGFR;GATA2;TCIM;FBXW7;LFNG;HEY1;METTL3;DLL4;DLL1;EGF;ZBTB7A
prerank,negative regulation of interleukin-6 production (GO:0032715),0.380259104898812,1.0981747064501644,0.3273092369477912,0.9134981165485598,1.0,5/27,7.55%,SYT11;C5AR2;C1QTNF3;NLRC3;ARRB1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3535432632028765,1.0981556227670342,0.3187855787476281,0.9119160694733521,1.0,11/33,18.35%,IGF1;HSPA1A;SLC25A5;PPIF;FZD9;ADCK1;CLU;TMEM14A;HGF;NOL3;AKT1
prerank,positive regulation of dendrite development (GO:1900006),-0.4661145102006276,-1.098139132881994,0.3597560975609756,0.6400741293853869,1.0,3/10,1.04%,BMP5;DAB2IP;PTN
prerank,glycoprotein metabolic process (GO:0009100),-0.3079029912667259,-1.098077902967168,0.2889908256880734,0.6396266496016529,1.0,14/53,14.69%,ST3GAL4;ST6GALNAC3;ST8SIA4;FUT8;ST8SIA6;STT3B;MGAT4A;AGA;GOLPH3;B4GALT5;GCNT1;FBXO44;MGAT4B;ST8SIA2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3196329510504613,1.0969311438722065,0.30111524163568776,0.9144952190232002,1.0,7/61,8.53%,ROBO1;NOTCH2;IGF1;PIK3CB;AUTS2;ARRB1;LPAR1
prerank,phagosome acidification (GO:0090383),0.37200301414184717,1.0967641560799863,0.3382899628252788,0.9133691107692286,1.0,8/26,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4390932649506279,1.0960191206346266,0.3435700575815739,0.9142139274540564,1.0,5/14,11.92%,ANGEL2;ELAVL4;ELAVL1;MAPK14;BOLL
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2555940846061026,-1.0954032158960256,0.235,0.6460066366412823,1.0,46/163,23.25%,PDE4D;MEF2C;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;BMX;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;CD38;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;NFATC2;SH2B2;PTPRC;PSMB8;PSMC4;PSMD11;NCKAP1L;DENND1B;LAT2;EIF2B1;PSMB4;PSMD14;ZC3H12A;BTK;PSMD10;SYK;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,response to interleukin-4 (GO:0070670),-0.46981622462806155,-1.0952960061142152,0.3487903225806452,0.6456756654335682,1.0,1/10,0.18%,LEF1
prerank,retinol metabolic process (GO:0042572),0.4297669943844296,1.0951576801672291,0.34523809523809523,0.9155228238674328,1.0,2/14,1.22%,ADH7;ADH4
prerank,protein alkylation (GO:0008213),0.39012576215452516,1.095150019648792,0.32571428571428573,0.913898470362267,1.0,8/22,21.67%,EEF2KMT;PRMT2;FAM98B;PCMT1;PRMT3;ETF1;SNRPB;VCPKMT
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.4528635569708918,-1.0951173257874656,0.3674698795180723,0.6455285313626271,1.0,4/11,15.84%,H3-3A;RBBP4;NASP;UBN1
prerank,DNA replication initiation (GO:0006270),-0.3299564275277637,-1.094895262077759,0.31601731601731603,0.6455094661860963,1.0,16/37,27.23%,RPA1;ORC1;ORC2;RPA2;CDC45;ORC5;POLA1;POLA2;MCM3;PURA;CDC34;PRIM2;POLE3;MCM5;MCM6;CDK2
prerank,regulation of postsynapse organization (GO:0099175),-0.35052577895427584,-1.0946102207610602,0.31004366812227074,0.6456273221133526,1.0,7/28,13.56%,SHANK3;PDLIM5;WNT5A;CDK5;ABI3;CFL1;ABHD17C
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38083429415888775,-1.0943454976153904,0.33530571992110453,0.6456369331351443,1.0,11/20,32.10%,ACVR1;ACVRL1;AIDA;DSCAML1;PTCH1;GREM1;LMX1B;LHX1;BMPR1B;TBX20;NOG
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.380004159637526,1.094272854280464,0.30994152046783624,0.9151712772674915,1.0,6/25,8.07%,GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,lymphocyte mediated immunity (GO:0002449),-0.4395962870918376,-1.0941078369951394,0.3453815261044177,0.6457188640257885,1.0,4/12,17.01%,JAG1;CD55;CD46;GNL1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3945005859012226,1.0939550583433053,0.3235867446393762,0.9145713630437234,1.0,3/22,7.55%,BMP7;CDKN2A;INHA
prerank,regulation of chromosome segregation (GO:0051983),-0.40648481251939933,-1.0938876470126506,0.3470715835140998,0.6456916649699115,1.0,10/16,37.60%,PUM2;SMC5;CSNK2A1;PUM1;MKI67;CDC6;BUB1;SMC6;IHO1;KIF2C
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.23335765950816045,-1.0936876166723706,0.19732441471571907,0.6455865787341689,1.0,54/308,13.83%,LEF1;PRKCH;GHR;CAV1;GCNT2;BMPR2;ZBTB16;PTN;ADRA1B;ACVR1;TGFB2;GAS6;EBF2;ABCA1;BMP4;PRDM16;SIX1;TGFBR2;GATM;PLA2R1;ADIPOR2;TFRC;WNT5A;S100A13;AXIN2;MDK;APC;SHLD1;TMEM119;PDGFC;SOD1;TIAM1;TRIM16;FGF2;SERPINE1;TGFB3;AGO2;IL15;APOE;B4GALT5;ELOVL6;IL4R;CFL1;PIK3CD;FBXO5;HADH;TWIST1;COL1A1;BMP2;SMO;AGPAT1;NME2;VEGFA;LRP1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3013675592447848,-1.0933347333794345,0.29571106094808125,0.6459019298708752,1.0,15/55,23.25%,FBXL7;FHL1;PSMA6;PSMB7;PSMB6;PSMB5;USP47;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3
prerank,regulation of gene expression (GO:0010468),0.23352103839953087,1.0928118365636095,0.17343173431734318,0.9167632065760715,1.0,127/903,12.42%,PRDM6;ROBO1;DENND4A;NOTCH2;BMP7;AFDN;RORA;FGF1;BMP6;WNT4;PPARGC1B;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;PABPN1;OVOL2;CTR9;ANK2;PRKAA2;SUFU;NDFIP1;ZBTB38;SCRT1;MYBL2;PIK3R3;NOVA1;CRABP2;CPNE1;ARNT2;ZNF431;OPRD1;NFYB;CDH3;ESRRA;POU1F1;TULP3;BMPR1A;PICALM;FGF9;CCAR2;HNRNPH3;TNRC6A;PIK3CB;TRIM5;LRP3;ASCC2;PEG3;CCAR1;PQBP1;PAX6;RBPJ;ACTR8;MZF1;TRIM71;WWTR1;ZNF462;PDCD5;RNF14;NFYC;E2F1;CIAO3;WNT6;CEBPA;CITED1;FASTK;PTBP2;FLOT2;SRSF10;SON;CHD3;AFF3;NTRK2;FAM98B;SNF8;KDM6B;RIMS1;HNRNPL;PTBP1;PHF1;HES6;MED1;CRNN;MAFA;PPARGC1A;HINFP;CACTIN;ZNF711;FZD7;PARP14;NKAP;SSBP2;CLOCK;CREBL2;SRRM4;PRDM2;GON4L;MEGF8;NSD1;TGFBR1;LDB1;HRG;RNF20;RNF6;CLK3;MAPK14;YTHDC1;ZFPL1;FUBP1;MAGED1;TAF1;CTSH;DTNBP1;CLU;ATRAID;DMTF1;KDM4A;SOX9;RLIM;PML;CHEK2;RBAK;MAPK9
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.46157038669096273,-1.092582465523147,0.35912698412698413,0.6472166072343568,1.0,4/10,21.28%,RHOA;RAP2A;CDC42;MSN
prerank,positive regulation of macroautophagy (GO:0016239),0.33286625531040975,1.0923826328432806,0.336283185840708,0.9165868509248238,1.0,10/48,10.33%,PRKAA2;OPTN;RAB3GAP1;FYCO1;SLC25A5;IKBKG;GPSM1;SESN1;HTT;PAFAH1B2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.38431273350245365,1.0923047879190269,0.35315315315315315,0.9152013139244181,1.0,7/24,12.68%,LEPR;COQ10A;NDUFS1;PPARGC1A;CYCS;MRAP2;COX10
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2742386387549088,-1.0922903018553762,0.2635294117647059,0.6473984642486985,1.0,26/87,18.34%,CAV1;SEMA6A;DAB2IP;FOXO1;BMP4;PTPRJ;IRAK3;SPRED2;PPIA;LYN;PRKCD;SPRY2;PTPN1;APOE;DUSP3;EPHB2;RANBP9;STK38;PEBP1;PTPRC;SPRY1;PAQR3;PTEN;GPER1;DUSP6;UCHL1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3822201731928331,1.0922345041166621,0.33268101761252444,0.9138124454664991,1.0,7/26,13.78%,SLC5A3;PPARA;SLC30A10;ABCD1;SPHK2;TRAP1;CYBA
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4258118270922828,1.0921453734876791,0.35067437379576105,0.9124876180404908,1.0,10/17,26.15%,CORO1B;WASF1;CYFIP1;WASF3;PICK1;CTNNA2;BRK1;ARF1;GMFB;ARFIP1
prerank,protein localization to cell periphery (GO:1990778),-0.2596837838707471,-1.092117662829739,0.27461139896373055,0.6472328309751825,1.0,23/133,7.96%,SPTBN1;CAV1;RAPGEF2;BSG;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;EFR3B;RAPGEF6;SLMAP;EMP2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33546329690251314,-1.0919864245394255,0.30603448275862066,0.6469670940691876,1.0,10/35,18.38%,HIP1;B2M;MKLN1;SGIP1;SERPINE1;HIP1R;CBL;VTN;LDLRAP1;C3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.36317339663805487,1.091901072406758,0.3409090909090909,0.9117163482913169,1.0,4/30,4.40%,HSPA1A;DNAJC18;DNAJB4;DNAJB14
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3250847146614285,1.091389142939374,0.30526315789473685,0.911824429939153,1.0,12/54,14.93%,HSPA1A;SPHK1;CPNE1;CHUK;CLIP3;NLRP2B;IKBKG;PELI3;CFLAR;RNF31;HSPA1B;RBCK1
prerank,regulation of nervous system development (GO:0051960),-0.331183849868701,-1.0910959196860648,0.3103448275862069,0.6485895352213427,1.0,8/37,11.68%,PTN;TNFRSF1B;BHLHE40;HES1;LGI4;HEYL;HEY2;PTPRZ1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3735957539427778,1.0906275414282813,0.3405940594059406,0.9128482211313934,1.0,8/28,16.04%,MAP2;PRUNE1;CLASP1;ARL2;SKA2;ABL1;MAPRE1;GBA2
prerank,response to organophosphorus (GO:0046683),-0.4046335648995213,-1.0905814697271028,0.34375,0.6492478284842161,1.0,3/16,9.27%,TRPC3;ABCC9;TRIM16
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4590350357656811,1.09056761979449,0.3645621181262729,0.9114429929249551,1.0,6/12,22.71%,PLK1;GOLGA2;CDC14B;RAB1A;UBE2S;BTRC
prerank,actin filament capping (GO:0051693),-0.38831585949811087,-1.0903379954898584,0.3422131147540984,0.6487498811016527,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,barbed-end actin filament capping (GO:0051016),-0.38831585949811087,-1.0903379954898584,0.3422131147540984,0.6487498811016527,1.0,7/18,13.75%,SVIL;GSN;EPS8;CAPZA2;CAPG;VILL;AVIL
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3240443555330466,1.0901769797578502,0.31985940246045697,0.9111449640774307,1.0,11/53,15.99%,EYA1;DDX5;EYA4;EYA2;CCAR2;ABRAXAS1;SPRED3;FXR2;MSX1;SIRT1;ATM
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3420787217935106,-1.0901765075517542,0.328125,0.6485646171683725,1.0,4/29,3.15%,GHR;PKD1;SOCS2;STAT3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.26852462115154246,1.0901737640690434,0.27009646302250806,0.909551815376281,1.0,17/182,4.65%,ROBO1;NOTCH2;WNT4;IGF1;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;CPNE1;OPRD1;BMPR1A;PICALM;OPTN;TNRC6A;LRP3;TET1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.45940062597639264,-1.0899000535450045,0.34782608695652173,0.6481349982651089,1.0,2/10,4.43%,FTO;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.45940062597639264,-1.0899000535450045,0.34782608695652173,0.6481349982651089,1.0,2/10,4.43%,FTO;ALKBH1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4533452874359726,-1.089867350011232,0.35330578512396693,0.6476290838125348,1.0,4/11,8.77%,CORO1C;CD44;KANK1;SRC
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4119144137434416,1.0897205245462682,0.3436293436293436,0.9094563751157321,1.0,3/16,7.14%,PPARGC1B;DDX5;DDX17
prerank,monocarboxylic acid transport (GO:0015718),0.328181793831382,1.0896401727108687,0.30809859154929575,0.9081536720560937,1.0,5/51,3.04%,SLC16A6;SLC6A13;SLC6A12;SLC16A11;SLC16A12
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.34972974282873637,1.089559113455481,0.3179297597042514,0.906821699943027,1.0,7/34,8.07%,GABRG1;GLRA1;RAB3GAP1;GRID2;GRIN2D;NLGN3;LRRK2
prerank,negative regulation of cholesterol transport (GO:0032375),0.48141462122099266,1.0887468076102516,0.3920792079207921,0.9079132965062487,1.0,4/10,23.75%,ABCG5;ABCA2;NFKB1;SHH
prerank,cellular response to peptide (GO:1901653),-0.30084109968705897,-1.0881988138998604,0.3099273607748184,0.6512617016989102,1.0,22/56,23.54%,CAV1;CACNA2D1;VCAM1;ABCC1;APP;NOD1;ICAM1;ARHGEF2;CDK5;SRC;RPL23;ITGA4;LRP1;TIMELESS;GPER1;GRIN1;NOD2;CASP4;RIPK2;FYN;FCGR2B;IGF1R
prerank,ganglioside metabolic process (GO:0001573),-0.38537680796878887,-1.0880572117856426,0.31982942430703626,0.6509811671923611,1.0,6/20,14.69%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6;HEXA;ST8SIA2
prerank,regulation of immune response (GO:0050776),-0.25692293617910283,-1.0877506977017357,0.2512690355329949,0.6512185417459617,1.0,28/135,17.42%,FOXP1;CLEC2D;CD200;B2M;TGFB2;CD34;VCAM1;PLSCR1;ITGB1;ICAM1;LYN;ADCY7;CXADR;XIAP;IL15;AHR;NECTIN2;COL1A1;ITGA4;BIRC3;CD40;RSAD2;ICAM2;IFITM1;ULBP1;PVR;N4BP1;DENND1B
prerank,carnitine metabolic process (GO:0009437),0.4520195514940333,1.087404545417703,0.37450980392156863,0.9107888614442259,1.0,5/12,19.14%,BBOX1;CPT1C;CROT;ALDH9A1;CPT2
prerank,coenzyme A biosynthetic process (GO:0015937),0.45445484818656734,1.0869302645294427,0.3798449612403101,0.9077272511587858,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.45445484818656734,1.0869302645294427,0.3798449612403101,0.9077272511587858,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.45445484818656734,1.0869302645294427,0.3798449612403101,0.9077272511587858,1.0,3/11,6.99%,PANK1;ACAT1;PANK2
prerank,membrane assembly (GO:0071709),0.35577819769320707,1.0869053345442239,0.34,0.9062558684091224,1.0,8/34,8.56%,CEL;IL1RAPL1;NLGN2;PICALM;FLOT2;NLGN3;LRP4;PTPRD
prerank,pancreas development (GO:0031016),-0.43815863036441216,-1.0865529116804369,0.3506224066390041,0.6537083740841523,1.0,9/12,43.05%,MET;NKX6-1;FOXF1;ZIC3;SELENOT;NPHP3;CCDC40;ISL1;DNAAF1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4135905070192038,-1.086454852596603,0.342911877394636,0.6533914468114738,1.0,6/15,27.62%,APP;IAPP;APOE;PFDN6;TREM2;LDLR
prerank,negative regulation of synaptic transmission (GO:0050805),0.3802574678638985,1.0861072405953773,0.344294003868472,0.9073932676044982,1.0,5/23,12.52%,SYT11;ATAD1;LRRK2;DRD3;MTMR2
prerank,intracellular pH reduction (GO:0051452),0.35129579407971523,1.0850797671295707,0.35018050541516244,0.9092472650459099,1.0,9/33,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;CLCN3;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,negative regulation of JNK cascade (GO:0046329),-0.3448437060343868,-1.0848369292608133,0.35892116182572614,0.6569486218990546,1.0,6/31,11.79%,MECOM;DNAJA1;AIDA;DUSP3;PER1;PDCD4
prerank,cellular response to chemokine (GO:1990869),-0.31654034667491826,-1.0847126891662,0.3157894736842105,0.6566811507538134,1.0,8/46,12.51%,LRCH1;SLC12A2;RHOA;CXCL12;CCL13;DOCK8;ACKR3;PTK2B
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.24647083200448974,-1.0844727940515295,0.2549019607843137,0.6567391873809886,1.0,43/186,15.64%,CAV1;DAB2IP;MLLT3;LRP6;FZD6;STK3;LIMD1;SDHAF2;NFATC1;SFRP4;GLI3;TLE4;NKD2;SOX17;IGFBP6;WNT5A;AXIN2;RACK1;PSMA6;TLE3;CSNK1A1;ZNRF3;PSMB7;MDK;INVS;APC;APOE;PSMB6;AMER1;PSMB5;TLE5;FZD4;DKK2;BMP2;ANKRD6;TAX1BP3;LRP1;PSMB8;RBMS3;AMER2;PSMC4;MAD2L2;PSMD11
prerank,copper ion homeostasis (GO:0055070),-0.3931895435998325,-1.0842251945359738,0.3562753036437247,0.6567510500454306,1.0,9/17,29.00%,APP;SLC31A1;ATOX1;XIAP;MT2A;CCDC22;SLC31A2;ABCB6;ATP7B
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.38946319987033595,1.0841800875138154,0.33852140077821014,0.909114555236843,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),0.38946319987033595,1.0841800875138154,0.33852140077821014,0.909114555236843,1.0,2/20,1.77%,IGF1;PRKAA2
prerank,cytosolic calcium ion transport (GO:0060401),-0.34672055120653444,-1.0841358498510143,0.34934497816593885,0.65639690003158,1.0,10/28,14.31%,ATP2B1;MICU3;CACNA2D1;SLC35G1;ATP2A3;MCUB;JPH2;MICU2;ITPR3;SMDT1
prerank,positive regulation of growth (GO:0045927),-0.2930875864933676,-1.0831780405756426,0.28604118993135014,0.6582384987603993,1.0,16/64,15.62%,RFTN1;TGFB2;INSR;EGFR;H3-3A;RPS6KA3;ADAM10;CDKN2AIP;RPTOR;PABIR1;MFSD2A;USP47;CSNK2A1;NCBP1;KLHL22;DDX49
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3567792636567868,-1.0831583992521487,0.3758099352051836,0.657705468754508,1.0,10/24,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,chloride transmembrane transport (GO:1902476),-0.31096449636533613,-1.0827355922224273,0.32062780269058294,0.6582538807447348,1.0,14/48,16.14%,SLC12A7;SLC12A2;ANO1;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,cellular response to dsRNA (GO:0071359),0.42442310990871485,1.0824070795929457,0.3705103969754253,0.913429063595595,1.0,3/15,7.53%,COLEC12;PQBP1;IFIT1
prerank,regulation of chemokine production (GO:0032642),-0.32578697414052366,-1.0823821215197431,0.30324074074074076,0.6585619201960664,1.0,14/36,27.07%,FOXP1;APP;WNT5A;IL6R;CD74;CSF1R;SIGIRR;IL33;ACKR1;TLR4;AIF1;SNAI2;HMOX1;TREM2
prerank,positive regulation of ATPase activity (GO:0032781),0.3411214337249207,1.0822526656651847,0.34501845018450183,0.9123751585073738,1.0,16/41,25.45%,ATP1B3;ATP1B2;ALDOB;HNRNPU;MSH6;DNAJC10;SSBP1;RYR2;MSH3;DNAJB2;ATP2A1;FGF10;DNAJB1;VMP1;TOR1AIP1;DNAJC9
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4524908661509065,1.0821092983873513,0.3881856540084388,0.9112666492378527,1.0,4/12,13.99%,CCDC115;TMEM199;LRRK2;CLN5
prerank,iron ion homeostasis (GO:0055072),0.3144537408180005,1.0818042990852055,0.3249551166965889,0.9107113074912274,1.0,10/58,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;PICALM;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.44144675988720716,1.0816537525019656,0.3724279835390947,0.909617319895775,1.0,4/13,8.19%,IGF1;GCK;PHKG2;SORBS1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4288094893226876,1.0813559954046637,0.3577075098814229,0.9075193234091236,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4288094893226876,1.0813559954046637,0.3577075098814229,0.9075193234091236,1.0,4/15,13.56%,AP3S2;SNAPIN;DTNBP1;AP3B2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.38104970008909905,-1.0812167104127568,0.3452631578947368,0.6610109301254118,1.0,7/18,22.15%,PLCG2;DOCK2;IFI35;DYSF;SYK;NMI;SBNO2
prerank,cellular response to BMP stimulus (GO:0071773),0.3066537336078974,1.080817106141482,0.32642487046632124,0.9076810945128703,1.0,7/66,5.24%,BMP7;TGFBR3;BMP6;DDX5;SMAD3;BMPR1A;BMP8A
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.31285077059852623,-1.0807230723309766,0.32018561484918795,0.6616923165964751,1.0,10/47,10.45%,FOXO3;NFKBIA;RBM3;APP;RPL10;AGTR1;EIF4E;APOE;KLF4;EDN1
prerank,regulation of steroid metabolic process (GO:0019218),0.3947666108985077,1.0806854693208392,0.35551330798479086,0.9065603546293366,1.0,5/23,15.67%,RORA;PANK2;ABCA2;EPHX2;STAR
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3367705772152489,-1.080580923190556,0.3662551440329218,0.6614330576370614,1.0,11/29,24.36%,LEF1;TLE4;AXIN2;TLE3;RUVBL1;SMARCA4;BCL9;TRRAP;BCL9L;ASH2L;TCF7
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2134499646037176,-1.0805488334820452,0.11235955056179775,0.6609267845766367,1.0,140/834,13.94%,LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MICAL2;RARB;LRP6;ACVR1;NOTCH3;ETS1;ACVRL1;PLAGL1;TCF12;TGFB2;MEOX2;PPARD;ENG;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;NFKBIA;ASXL3;LMO2;RUNX1;STAT3;BMP4;NFATC1;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;GNL3;TFEB;BRD4;SOX17;ARHGEF2;SMAD5;SMAD1;RPS27A;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;NFAT5;HEY2;ZFPM2;GATA2;IGF2;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;NOTCH4;IRF2;KLF4;TAL1;SS18;GTF2F1;RFXAP;EDN1;PER1;TCF20;TMF1;MYOCD;SREBF2;SQSTM1;TWIST1;TEAD1;ATAD2;HHEX;SOX18;FOXF2;FOSL2;BMP2;POU2F1;RARG;LPIN3;CD40;NME2;NCOA6;MAFF;SOX12;VEGFA;KMT2C;KLF2
prerank,lipid droplet organization (GO:0034389),0.38072856050334414,1.080496735200487,0.3422562141491396,0.9056747843351656,1.0,5/22,14.04%,FITM2;RAB3GAP1;PLA2G4C;CDS1;SQLE
prerank,negative regulation of transposition (GO:0010529),0.42099265245343626,1.0803696420518654,0.3682008368200837,0.9045846984976935,1.0,4/16,14.13%,TDRD9;SPOCD1;TUT4;MYBL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.3195649867035919,-1.0799365127770184,0.31877729257641924,0.6619015863375384,1.0,16/42,22.57%,RPA1;UBC;RPS27A;UBB;TRIM25;ZBTB1;ISG15;WRNIP1;USP43;RPA2;PRIMPOL;USP10;PCLAF;POLA1;RFC4;POLD4
prerank,positive regulation of B cell activation (GO:0050871),-0.30827765187396533,-1.0798382144166738,0.29605263157894735,0.6615560323812386,1.0,14/50,21.23%,MEF2C;TFRC;CD38;SHLD1;EPHB2;NFATC2;CD74;CD40;PTPRC;MAD2L2;NCKAP1L;NOD2;BTK;SYK
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4500809979929606,1.079665071962337,0.35984095427435386,0.9054121678701229,1.0,5/12,15.92%,BICD1;PCM1;KIF3A;CCDC120;NINL
prerank,organophosphate catabolic process (GO:0046434),0.46423608003620254,1.0793133980611556,0.3771760154738878,0.9050909751321758,1.0,4/11,26.58%,PON1;PLBD2;ABHD12;ANGPTL3
prerank,regulation of cellular component size (GO:0032535),-0.33919453085497386,-1.0791441540830702,0.34051724137931033,0.6627620385548121,1.0,12/30,27.40%,EPS8;RAB22A;VAV2;PPP1CA;RPTOR;RARG;PTEN;MSN;RAB3B;AP2M1;VAV3;NEB
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3702995431966763,-1.078954192117463,0.32793522267206476,0.6626684903742076,1.0,4/21,12.38%,MEF2C;ITGA1;CALM3;BMP2
prerank,regulation of microtubule-based process (GO:0032886),-0.33165838991748076,-1.0788202365709134,0.3354978354978355,0.6624252787064615,1.0,14/36,23.36%,PHLDB1;MACF1;PHLDB2;APC;EFNA5;FAM107A;HDAC6;BICD2;MEMO1;TRAF3IP1;TAOK1;ROCK1;CYLD;MAP6D1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3439110450486578,1.0787760623206133,0.3339622641509434,0.9052850570445807,1.0,6/37,9.82%,ALCAM;IL1RAPL1;TENM1;GRID2;PTPRD;ADGRL1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4189684432911369,-1.0785720644908046,0.36633663366336633,0.6624552745472467,1.0,5/13,16.11%,SHANK3;APP;EPHB2;SQSTM1;ZDHHC2
prerank,transcription by RNA polymerase II (GO:0006366),0.24881969516944594,1.0784507197172772,0.25892857142857145,0.9048290415539451,1.0,39/305,11.83%,MAF;NOTCH2;RORA;DDX5;NR2E1;PABPN1;SOX5;CTR9;THRB;DTX1;NR6A1;CCN2;PPARA;CPSF3;ESRRA;GLIS3;GTF2I;CCNT2;TCEA1;PCID2;LEO1;RBPJ;WWTR1;INTS4;ZC3H8;CPSF7;MED1;PPARGC1A;TAF10;EAF2;NR1H3;RXRA;RNMT;MBD1;TSC22D1;TAF1;SLBP;MLLT1;CDC73
prerank,positive regulation of exosomal secretion (GO:1903543),0.4237239366480381,1.0783192813961682,0.3653483992467043,0.9037365430912162,1.0,3/15,7.85%,STAM;SMPD3;SNF8
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.300173177843881,1.0780219808490576,0.32013769363166955,0.9032006570709746,1.0,26/84,20.57%,CELF2;DDX5;NOVA1;RBM11;HNRNPU;DDX17;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;C1QBP;YTHDC1;NUP98;FXR2;RBM5;PCBP4;MBNL3;RNPS1;SRSF6;CELF6;RBFOX1;PUF60;REST;LARP7
prerank,RNA interference (GO:0016246),-0.39694973336180417,-1.0774639407400979,0.3630573248407643,0.6647508497803607,1.0,7/17,23.33%,AGO1;AGO2;DROSHA;CLP1;AGO4;MRPL44;TARBP2
prerank,phagolysosome assembly (GO:0001845),-0.43751895853727446,-1.0772813501149558,0.371900826446281,0.6646027532657892,1.0,7/12,32.71%,RAB14;ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34
prerank,regulation of axonogenesis (GO:0050770),0.32201846929453987,1.076961338348713,0.3310225303292894,0.9051326937740324,1.0,11/51,11.82%,ROBO1;PLXNA2;RUFY3;PLXNA1;NTRK2;KIF13B;LRP4;PLXNA3;SIPA1L1;LRRC4C;EPHA4
prerank,regulation of protein localization to cell surface (GO:2000008),0.35446296451143144,1.0769283825207625,0.3696060037523452,0.9037296632935041,1.0,11/33,18.46%,LEPROT;ACTN2;PICALM;BDNF;ABCA2;STX4;GBF1;SNX33;HFE;GPM6B;GPD1L
prerank,signal transduction in response to DNA damage (GO:0042770),0.32528253114887273,1.0765054942543353,0.3421516754850088,0.9036039738865566,1.0,19/49,22.83%,DOT1L;E2F1;HINFP;CLOCK;NDRG1;FBXO6;MAPK14;BATF;PRPF19;CHEK2;ABL1;GADD45A;ATM;CLSPN;RAD17;MYO6;CASP9;ATRX;MDM4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4513390684218769,1.0764147515988263,0.388,0.9023570068796012,1.0,4/12,17.22%,UCKL1;DCK;UPP2;UMPS
prerank,lipid modification (GO:0030258),-0.3251652881383199,-1.0763341966083673,0.3485838779956427,0.6665219304974376,1.0,14/37,27.98%,DGKH;MBOAT1;DGKZ;PLPP1;PLPP3;SGPP1;DGKB;PLPP2;LPCAT3;PLA2G7;PLPP6;DGKG;PLPP5;DGKA
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4672937803865132,1.0762925293920975,0.3934740882917466,0.9012525469756792,1.0,2/10,4.13%,OXSR1;STK39
prerank,keratan sulfate catabolic process (GO:0042340),0.4577739831527793,1.075789436084486,0.3889980353634578,0.9013451950560082,1.0,3/11,6.65%,OGN;OMD;GALNS
prerank,alpha-amino acid metabolic process (GO:1901605),0.33280453464253873,1.0756926027419214,0.33098591549295775,0.9002077383963357,1.0,14/45,16.57%,ASPG;RIMKLA;MMUT;ASPA;KMO;SLC25A12;GLS2;GOT1;KYAT3;MTHFD1;MTHFR;GOT2;GLUL;ATP7A
prerank,Golgi inheritance (GO:0048313),0.45968558601002923,1.0755797458643752,0.3691983122362869,0.8991122779128341,1.0,4/11,16.60%,PLK5;GOLGA2;STK25;GBF1
prerank,response to sterol (GO:0036314),0.457945858163299,1.0755120201046546,0.33665338645418325,0.8978524048508056,1.0,3/11,13.27%,RORA;TGFBR1;ABCA2
prerank,protein localization to membrane (GO:0072657),-0.24699676170882606,-1.0752404101640711,0.28106508875739644,0.6687173061198329,1.0,44/187,15.35%,SPTBN1;CAV1;SHANK3;RAPGEF2;PTN;BSG;RFTN1;LRP6;RAMP2;GAS6;RAP1A;TTC7A;PACS1;CACNB2;SMURF1;CDH1;F11R;TNIK;FLNA;NKD2;FCHO2;RAP2A;SH3PXD2B;EFR3B;RAPGEF6;SLMAP;EMP2;CPE;EHD2;FGF13;HGS;RAB3A;PTCH1;EHD4;ITGA4;LIN7C;ARL5A;KCNB2;RAB11B;PPIL2;AGRN;S100A10;FERMT2;KCNB1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.27536484008795503,1.0751914443440478,0.2935323383084577,0.8973540416240797,1.0,18/132,9.07%,RNF152;IGF1;PRKAA2;GTPBP1;SH3D19;PPARA;FURIN;PLEKHF1;PHKG2;OPTN;ADRA2A;PIK3CB;TRIM5;ABHD5;SUPV3L1;KAT5;LRRK2;ABCD1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.291844095656405,-1.0750838289119098,0.31220657276995306,0.6685274876950134,1.0,13/54,11.60%,CAV1;DCUN1D3;RPL5;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;SQSTM1;ISG15
prerank,response to leucine (GO:0043201),-0.4552393363863446,-1.074995285341369,0.3739669421487603,0.6676077227692597,1.0,5/10,20.23%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,cellular response to leucine (GO:0071233),-0.4552393363863446,-1.074995285341369,0.3739669421487603,0.6676077227692597,1.0,5/10,20.23%,RPTOR;SESN3;KLHL22;UBR1;RRAGD
prerank,regulation of protein acetylation (GO:1901983),0.4448248758623571,1.0745810908599134,0.37181996086105673,0.8978494167856308,1.0,5/12,15.49%,MAGEA2;CAMK1;KAT5;RAPGEF3;SIRT1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4307454106021513,-1.074507535758503,0.36327345309381237,0.6682441093516414,1.0,4/11,6.75%,RSPO3;MLLT3;CSNK1E;PLEKHA4
prerank,regulation of cell projection organization (GO:0031344),-0.4182677951602004,-1.0744583722963033,0.3800383877159309,0.6677869260786848,1.0,3/13,12.19%,MACF1;SPRY2;MFSD2A
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.45228730933496164,-1.0743064791539336,0.3822937625754527,0.6675899512007253,1.0,3/11,4.88%,CAV1;NEDD4L;CAB39
prerank,regulation of cellular component movement (GO:0051270),-0.30230124336851594,-1.0741245065205967,0.3486682808716707,0.6675042420663908,1.0,19/49,24.52%,ACTN4;RHOA;ETS1;CD9;EGFR;ACTN1;ARAP1;LYN;HDAC6;VEGFA;MEMO1;SP100;PRAG1;CDK6;ROCK1;NRG2;EGF;RPS19;FES
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2980466654594009,-1.0738082408169434,0.31565656565656564,0.667727020859239,1.0,19/55,24.12%,IL6ST;VCAM1;TFRC;ANXA1;NCK1;SLC7A1;RPS3;IGF2;IL15;PTPRC;CD24;CD86;NCKAP1L;CD46;JAK3;HMGB1;SYK;CD276;CCR2
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3326238263488327,-1.0736231380912726,0.350104821802935,0.6675920063569895,1.0,14/34,24.19%,INSR;LRP5;CDC27;ANAPC5;CDC16;IGF2;EDN1;EDN3;NUSAP1;EGF;CDC23;NUP62;CUL3;RGCC
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4698242058119696,1.0735514506030477,0.3784355179704017,0.8983977832071924,1.0,2/10,2.89%,NUPR1;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),0.4698242058119696,1.0735514506030477,0.3784355179704017,0.8983977832071924,1.0,2/10,2.89%,NUPR1;PPARA
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.44240456796137767,-1.0734219673234038,0.3907815631262525,0.6675393802292817,1.0,7/11,15.93%,RAPGEF2;TJP1;F11R;TJP2;RAPGEF6;RAB1B;RAP2B
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2986840912914653,-1.0733086902324385,0.34216335540838855,0.6672471638388944,1.0,10/55,7.91%,CAV1;DAB2IP;TNFSF10;BCL2L1;FAS;CRADD;PAK2;RACK1;RPS3;BCAP31
prerank,regulation of dephosphorylation (GO:0035303),0.4121247905878973,1.0732566145857203,0.35876288659793815,0.8979005197885631,1.0,5/15,15.53%,PPP1R16A;MTMR4;SMG5;MTMR2;SMG6
prerank,synaptic vesicle recycling (GO:0036465),0.34992324029210187,1.0728759242310604,0.3397312859884837,0.8976380521052278,1.0,7/31,11.75%,CEL;NLGN2;WNT7A;SYT1;NLGN3;SYNJ2;CANX
prerank,positive regulation of DNA repair (GO:0045739),0.3353348092695461,1.0726949061028228,0.33457943925233646,0.8967938167026892,1.0,5/46,6.74%,EYA1;EYA4;EYA2;XRCC1;ABRAXAS1
prerank,histone ubiquitination (GO:0016574),0.3877449309855411,1.0725579934967369,0.3657587548638132,0.895760105595869,1.0,10/21,28.22%,CTR9;LEO1;RNF20;CDC73;PHC1;UBR2;RNF8;UBE2B;UBE2N;UHRF1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.20863118202433217,-1.072526377094427,0.07547169811320754,0.6686886322241208,1.0,256/1082,20.67%,MECOM;LEF1;MEF2C;MAML2;ERG;BMP5;MRTFB;PID1;DCN;BMPR2;DAB2IP;ZBTB16;PBX1;ZFHX3;ELK3;JAG1;ITGA6;MLLT3;RARB;LRP6;ACVR1;MDFIC;ETS1;ACVRL1;PLAGL1;TCF12;MEOX2;PPARD;ENG;FLI1;MAP3K5;KAT7;FOXO1;TBX3;RPS6KA5;NOTCH1;LRP5;PKD1;KMT2E;PIK3R1;CDH13;EGFR;RUNX2;FOXO3;CTCF;NFKBIA;AFAP1L2;ASXL3;LMO2;RUNX1;CDH1;STAT3;BMP4;ICE1;NFATC1;PRDM16;AGO1;PLSCR1;PPP1R12A;SIX1;RNF111;APP;NFIA;UBC;REL;DCAF6;RPS6KA3;GLI3;JUN;GLYR1;NAA16;ESR1;LMO7;TBX1;NFIX;KLF7;BPTF;KAT6A;DHX33;ARID1B;TFEB;BRD4;SOX17;SMARCC1;ZXDC;ARHGEF2;SMAD5;SMAD1;RPS27A;XPC;NFYA;UBB;PRKD1;SLC30A9;WNT5A;TNKS;MET;HES1;ETV1;NLRC5;NRF1;TRIM56;SP3;NCK1;ETV5;AR;ELF4;CCN1;PPP3CA;HEYL;NRIP1;CD38;NFAT5;ACTA2;CDKN1C;HEY2;SPIN1;ZFPM2;ARID1A;GATA2;VHL;EIF2AK3;IGF2;TRIM16;FGF2;SERPINE1;ELK1;PELP1;TGFB3;AGO2;AHR;APOE;NOTCH4;RPTOR;IRF2;FGF7;KLF4;TAL1;SS18;GTF2F1;RFXAP;ETS2;EDN1;PER1;TCF20;PITHD1;SERTAD1;TMF1;MYOCD;GTF2H1;NFATC2;SREBF2;SQSTM1;TWIST1;DYRK1A;TEAD1;ATAD2;CD74;FZD4;HHEX;SOX18;FOXF2;COL1A1;RET;BLM;FOSL2;BMP2;POU2F1;RARG;NFIL3;LPIN3;CD40;HNRNPAB;NME2;FZD1;NCOA6;MAFF;SOX12;CD86;VEGFA;KMT2C;KLF2;ZNF318;TFCP2;YAF2;NR4A2;AGRN;MRPL12;MT3;E2F5;ATF6B;CRTC3;FOXO4;MAD2L2;NR1H4;ENY2;BRCA2;ID2;RGMA;ATF4;SIX4;NFKB2;SP100;RREB1;DNAJC2;CSRNP2;FOXD2;HEY1;ZBTB48;IER2;ZNF496;ELL;SP7;MED14;HDAC2;GPER1;JUNB;GRIN1;NOD2;NR2F1;IL33;ATF7IP;EPC1;HIVEP1;PCBP1;NKX6-1;GREM1;FOXE1;MAPK3;ZC3H12A;ZMIZ2;NUFIP1;UBTF;IRF5;RYBP;SOX8;PAX3;SSBP4;RIPK1;TGFB1I1;SPI1;SIRT7;SMARCA4;FOXL2;CDCA4;NFATC3;ZMIZ1;HMGB1;LMX1B;CHD8;ATF3;POU3F3;NUP85;MAP2K7;MED13;MAML3
prerank,neuron projection organization (GO:0106027),-0.4084618907536603,-1.071485601626856,0.3708086785009862,0.6706924483427943,1.0,3/15,8.27%,INSR;APP;ABCD2
prerank,acute-phase response (GO:0006953),-0.43381581200203506,-1.0714066481667883,0.3699788583509514,0.6702956527021579,1.0,5/12,29.29%,PLSCR1;IL6R;SIGIRR;CEBPB;AHSG
prerank,peptide cross-linking (GO:0018149),-0.3548397501472525,-1.0712049769980652,0.35064935064935066,0.6702550957100544,1.0,5/25,7.66%,NDNF;THBS1;FN1;ANXA1;TGM2
prerank,DNA-dependent DNA replication (GO:0006261),-0.2577755899582907,-1.0711671890273973,0.30952380952380953,0.6697656479363763,1.0,47/128,27.75%,RPA1;UBC;RPS27A;UBB;REV3L;PSMA6;PSMB7;RPAIN;PSMB6;PSMB5;BLM;WRNIP1;ORC1;PSMB8;DDX23;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;PRIMPOL;CDC45;ORC5;SIRT7;POLA1;PSMD10;RFC4;POLA2;MCMBP;PSME1;MCM3;WDHD1;PURA;POLD4;PSMB3;POLB;POLG2;CDC34;PRIM2;POLE3;GINS3;MCM5;MCM6;RFC2;CDK2;RECQL5
prerank,plasma membrane organization (GO:0007009),0.3097833853476023,1.0710907146176976,0.34192439862542956,0.8989905422721193,1.0,10/61,10.09%,COL5A1;SYT11;ANXA6;ANK2;MICALL1;PLSCR2;MYOF;NSF;ABCD1;FA2H
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.421304443130771,-1.0710455833498578,0.38551859099804303,0.6695002427252739,1.0,5/14,25.25%,THBS1;IRAK3;PIBF1;JAK3;CMKLR1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3723822792328719,-1.070808774622736,0.3649484536082474,0.6694963747741005,1.0,9/20,28.90%,PKD1;EGFR;CCNY;CCND1;PSMD10;CCND2;RGCC;MAPRE3;STOX1
prerank,cellular response to starvation (GO:0009267),0.26941182281384846,1.0707857371675704,0.3160453808752026,0.8985038563796249,1.0,19/147,9.50%,PRKAG2;RNF152;GCGR;PRKAA2;NPRL3;RRAGC;PRKAG3;PPARA;ATP6V0B;NIM1K;ATP6V1H;CPEB4;LRRK2;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1
prerank,negative regulation of cyclase activity (GO:0031280),0.4190227829513749,1.0705834422236857,0.37333333333333335,0.8976786804982209,1.0,4/14,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,negative regulation of cytokine production (GO:0001818),-0.24900080910906036,-1.0697232240616807,0.2853333333333333,0.6716565213474318,1.0,51/163,24.19%,LEF1;TMSB4X;ATP2B1;CD200;RPS6KA5;THBS1;GAS6;CD34;IRAK3;FN1;RNF125;NPTN;NLRC5;ANXA1;ADCY7;APOD;TNFRSF21;TRIM25;OTUD7B;CEACAM1;HDAC7;HDAC9;ABCD2;CHID1;KLF4;ISG15;PIBF1;PDCD4;PTPRC;IFIH1;NR1H4;NCKAP1L;TRAF3IP1;PCBP2;SIGIRR;N4BP1;PPP1R11;PTPN6;ZC3H12A;JAK3;CUEDC2;HMGB1;TRIB2;BCL3;ASB1;FCGR2B;DLL1;ZFPM1;CYLD;TAX1BP1;RGCC
prerank,protein localization to nucleus (GO:0034504),0.2870677441588212,1.0696908731085766,0.3282312925170068,0.8990917163249619,1.0,23/102,17.12%,BMP7;APPL2;IPO13;FAM53A;POM121;NUP155;LMNA;PLK1;NUP62CL;HNRNPU;ARL2;TNPO3;TOR1B;TOPORS;NXT1;PML;IPO8;MSX1;TNPO2;BANP;IPO4;MDM2;NUP88
prerank,respiratory system development (GO:0060541),0.3621920303045933,1.069386223449167,0.35315985130111527,0.8986234192924649,1.0,6/32,6.95%,FGF1;FGF9;LOXL3;CEBPA;PDPN;FGFR2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4285432248513868,1.0693714437668047,0.37375745526838966,0.8972359202913701,1.0,4/13,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,chromosome condensation (GO:0030261),0.3447292026366468,1.0687642830746047,0.3371868978805395,0.8976876087036081,1.0,10/36,16.67%,KMT5A;NCAPD2;AIFM1;PHF8;PLK1;TENT4A;CSNK2A2;ACIN1;CHMP1A;AKAP8L
prerank,muscle cell development (GO:0055001),0.35424209331556655,1.0681696528873026,0.36242884250474383,0.89812668749003,1.0,5/30,6.61%,IGF1;NEBL;ANK2;SGCZ;MYOF
prerank,leukotriene biosynthetic process (GO:0019370),-0.4123094774852772,-1.0674217253904472,0.3436293436293436,0.6769882957882633,1.0,6/14,30.47%,PLA2G4A;GGTA1;GGT7;GGT1;PLA2G5;ALOX5AP
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3334082381110985,1.0672168547386882,0.3593220338983051,0.899733247983892,1.0,6/43,4.47%,ERRFI1;SNX6;CHMP6;GPRC5A;STAM;RNF126
prerank,anterior/posterior pattern specification (GO:0009952),-0.2937929477121334,-1.0671364659607285,0.3355855855855856,0.6770962670639427,1.0,12/53,12.38%,BMPR2;PCSK5;LRP5;TBX1;BHLHE40;HES1;HEYL;HEY2;ATP6AP2;HOXA6;HHEX;BMP2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.45095992093938453,-1.067052767159981,0.41683778234086244,0.6767465652880231,1.0,4/10,20.33%,ESR1;PSMC4;ATF7IP;HMGB1
prerank,Notch signaling involved in heart development (GO:0061314),0.4494353300345226,1.06670746754993,0.38803088803088803,0.8998870275317369,1.0,3/11,5.34%,NOTCH2;GALNT11;RBPJ
prerank,cardiac muscle cell development (GO:0055013),-0.37167341386032565,-1.0666449820020143,0.346,0.6771990045745614,1.0,5/20,8.50%,SORBS2;PDLIM5;MYH11;CXADR;HEY2
prerank,protein glycosylation (GO:0006486),-0.2546990766620526,-1.0660641180035124,0.31117021276595747,0.6781484955272177,1.0,32/125,19.41%,ST3GAL4;GCNT2;ST8SIA4;ST3GAL6;B3GNT2;FUT8;PLOD2;EOGT;MGAT5;SLC39A8;AQP11;ST3GAL1;COG3;PLOD3;ST8SIA6;STT3B;MGAT4A;B4GALT5;GFPT2;PMM1;MGAT4B;GALNT10;ST8SIA2;GALNT6;ALG10B;ST6GALNAC2;KRTCAP2;ST3GAL2;ALG6;TMEM258;POMT2;GALNT9
prerank,positive regulation of DNA recombination (GO:0045911),-0.3431890675416146,-1.065812540262356,0.3347022587268994,0.6782421268668247,1.0,7/27,15.55%,TFRC;SHLD1;FUS;ERCC2;FANCB;TIMELESS;MAD2L2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3400194938213053,1.0655208413664772,0.3487544483985765,0.9021793200003688,1.0,10/36,17.82%,DOT1L;E2F1;HINFP;CLOCK;FBXO6;PRPF19;CHEK2;ATM;CLSPN;RAD17
prerank,regulation of actomyosin structure organization (GO:0110020),0.4214706844034839,1.0652933854786653,0.3932135728542914,0.9015030654772894,1.0,4/13,15.08%,ROCK2;FHOD1;TSC1;WAS
prerank,embryonic organ morphogenesis (GO:0048562),-0.3059832504236434,-1.0652186358402753,0.32563025210084034,0.6791534463205742,1.0,15/42,19.86%,MFAP5;ACVR1;SIX1;TBX1;FBN1;SOX17;NIPBL;HES1;DSCAML1;RARG;ID2;ALDH1A3;EFEMP1;FOXE1;HOXA4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3761007828754195,1.0648664167204003,0.3645418326693227,0.9014712055977203,1.0,6/24,11.96%,ANXA6;ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,positive regulation of dendrite extension (GO:1903861),-0.39321046734780046,-1.0647715768820867,0.35269709543568467,0.6797231777260169,1.0,6/17,17.69%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,inorganic anion transmembrane transport (GO:0098661),-0.28401733990958056,-1.0647542574326057,0.3486238532110092,0.6791885947168391,1.0,17/63,16.14%,SLC12A7;SLC12A2;ANO1;SLC26A2;SLC5A6;SLC1A3;SLC12A6;LRRC8A;GABRA3;GLRB;SLC37A3;SLC1A1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.35518267118193686,1.0647440991288386,0.36397748592870544,0.9004211030142859,1.0,8/31,13.42%,MAGEA2;PLK1;ARRDC3;DCUN1D4;GOLGA2;TOPORS;CDC14B;RAB1A
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.45658542969475924,1.0646805485163426,0.38193018480492813,0.8992013988567956,1.0,3/10,8.72%,CRHR1;GNB5;DRD3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.37596872291547834,-1.064246629176431,0.3821656050955414,0.6798855590081012,1.0,6/20,12.86%,PLOD2;PLSCR1;GATM;GSS;GCLC;GCLM
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.35732492156896994,-1.0641355427624875,0.40286298568507156,0.6795800087758324,1.0,17/26,38.21%,CDC27;HECW2;ANAPC5;CDC16;FBXO5;LCMT1;DUSP1;CDC23;CDK5RAP2;CUL3;ANAPC11;NSMCE2;CDC6;ESPL1;UBE2C;CENPE;CCNB1
prerank,COPII-coated vesicle budding (GO:0090114),0.3033252394413703,1.0639738606545843,0.3623931623931624,0.9001247786539968,1.0,21/68,17.94%,F5;BET1;SEC23B;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;MIA3;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC31B;SEC22B;TFG;F8
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.36122615254034496,-1.0637934331423495,0.38412017167381973,0.6798881717377807,1.0,4/22,7.99%,DAB2IP;MFHAS1;LYN;IFI35
prerank,regulation of tissue remodeling (GO:0034103),0.3999618047370118,1.0636980914347836,0.38058252427184464,0.8996184918760564,1.0,2/18,0.87%,LEPR;IL18
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.44001339023184977,1.063483216080935,0.39436619718309857,0.8988977471429429,1.0,4/12,11.38%,THRB;BRD8;MED1;CTSH
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.42536677349247165,-1.0633800530302453,0.39183673469387753,0.6804032576026241,1.0,8/13,29.05%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,regulation of dendrite extension (GO:1903859),-0.38747338917017676,-1.062797107487087,0.37130801687763715,0.6813255657192451,1.0,6/18,17.69%,NEDD4L;SMURF1;ITSN2;SYT4;RNF157;UNC13A
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.24285841233365332,1.0626818481045712,0.3081232492997199,0.8999976144299531,1.0,39/348,9.01%,ROBO1;BMP7;AFDN;FGF1;BMP6;IGF1;HSPA1A;SLC24A3;GCGR;ROCK2;SMAD3;OSR1;FGF4;OVOL2;MAGI2;ANK2;PIK3R3;CDH3;FGF9;TNRC6A;PIK3CB;LRP3;PAX6;RBPJ;PDCD5;E2F1;WNT6;CITED1;ATAD1;ARRB1;NTRK2;FAM98B;SNF8;PPHLN1;RIMS1;MED1;PPARGC1A;HINFP;NSF
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3861756639951672,-1.0626082598511497,0.36809815950920244,0.6812108298853157,1.0,4/17,7.77%,PARD3;SPRED2;CALM3;SPRY2
prerank,lymphocyte differentiation (GO:0030098),-0.2816535754460264,-1.062400744149414,0.323943661971831,0.6811509671261745,1.0,15/68,13.63%,PBX1;KAT7;VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;JAG2;RELB;HDAC9;PIK3CD;HHEX;ITGA4;NFIL3;PTPRC
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.2810922373489938,1.0622783469212844,0.34206219312602293,0.8999258838643024,1.0,32/102,21.43%,CPEB2;ADCY5;GCGR;GCK;CYP11B1;ADCY1;CRHR1;INSIG2;LPIN1;SLC30A10;ADCY8;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;PRKDC;GOT1;RELA;AKT1;ADCY6;NFKB1;INHBB;RAB15;INPP5K;MYO5A;PRKAR1A;DENND4C;CAPN10;NR4A3
prerank,cellular protein catabolic process (GO:0044257),-0.2814649182278282,-1.0621101330113905,0.3378076062639821,0.6813386554461487,1.0,19/59,20.39%,DAB2IP;FAP;AP2B1;CAPN2;PSMA6;CTSO;MALT1;CTSB;VLDLR;RNF123;AP2A1;CTSF;TCIRG1;ADAMTS12;CTSS;UBE2G1;RSPRY1;RIPK1;MYLIP
prerank,B cell homeostasis (GO:0001782),-0.44465358482317463,-1.0616460770411391,0.3869047619047619,0.681987325172642,1.0,3/10,6.40%,MEF2C;DOCK10;LYN
prerank,GTP metabolic process (GO:0046039),0.414305238550804,1.0614368972404624,0.3941176470588235,0.9011628273123924,1.0,5/15,18.26%,GTPBP1;LRRK2;RHOQ;RAB23;AK3
prerank,response to interferon-gamma (GO:0034341),-0.2826887013542259,-1.0612606245514826,0.3372093023255814,0.6823322569266467,1.0,21/67,25.81%,IFITM3;GBP4;GCH1;GBP5;WNT5A;CCL13;CD74;SYNCRIP;SLC26A6;CD40;SP100;IFITM1;GAPDH;CCL25;KYNU;IFITM2;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,regulation of T cell chemotaxis (GO:0010819),0.4564568660745109,1.061126166357309,0.4128787878787879,0.9007692640050902,1.0,2/11,4.13%,OXSR1;STK39
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3392590858553707,-1.0610747820563204,0.3752711496746204,0.6822534830567597,1.0,9/30,21.23%,CD34;STAT3;PLCG2;ISG15;PIBF1;CD46;NOD2;HMGB1;SYK
prerank,regulation of cell communication (GO:0010646),-0.32871723739305814,-1.0609751931386344,0.3516483516483517,0.6819122166541881,1.0,10/35,12.26%,SOCS2;TBX18;MGLL;CAMK2D;ANXA1;CXADR;PTPN1;GRK5;UGCG;CDC42SE2
prerank,activation of protein kinase activity (GO:0032147),0.27999218620172694,1.060770361836539,0.3425324675324675,0.900430220858745,1.0,13/106,7.86%,FGF1;OSBPL8;ADCY5;IGF1;IL18;RICTOR;ADCY1;ADRA2A;ADCY8;STRADB;PDPK1;NRG1;PRLR
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.30881187423159334,-1.0604692790451422,0.350210970464135,0.6827619445410501,1.0,13/44,20.10%,NRP1;RHOA;LIMCH1;ARHGEF15;PXN;MYOC;TGFB3;LIMK1;S100A10;FERMT2;ARHGEF10;ARHGEF5;CDC42
prerank,regulation of microtubule polymerization (GO:0031113),0.33553993862625237,1.0603414972545873,0.3664825046040516,0.9003630994877548,1.0,13/40,17.57%,MAP2;CLIP3;EML2;PRUNE1;CLASP1;ARL2;DRG1;TUBB4A;ABL1;MAPRE1;GBA2;NAV3;CDK5R1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3966197000652944,1.0600410885088203,0.3666026871401152,0.8999243329515262,1.0,7/19,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,positive regulation of cation channel activity (GO:2001259),0.33135805860862466,1.0598431612213055,0.36330935251798563,0.8991457938983086,1.0,8/40,11.59%,ACTN2;ANK2;LRRC38;ANTKMT;GSTM2;NLGN3;HTT;GSTO1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.4321554543831916,1.0597033966007356,0.3983903420523139,0.8982035844815948,1.0,4/13,18.67%,RNF152;SESN1;ATM;CASTOR2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3514132751267369,-1.0594457392652634,0.37731958762886597,0.6848017805579066,1.0,4/27,7.53%,MARK1;MBOAT1;DISC1;NCS1
prerank,mitochondrion morphogenesis (GO:0070584),-0.42999276596566915,-1.059301589092043,0.39960629921259844,0.6845944676596203,1.0,3/11,8.00%,PID1;MFF;NUBPL
prerank,microtubule anchoring at centrosome (GO:0034454),0.4623800026608053,1.0591421169811015,0.4074074074074074,0.8985344937926927,1.0,4/10,15.92%,PCM1;KIF3A;CCDC120;NINL
prerank,sulfur amino acid metabolic process (GO:0000096),0.37153046856595434,1.0587456294457964,0.37832699619771865,0.8983412499065128,1.0,7/24,16.78%,ADI1;MMUT;CDO1;MTHFD1;MTHFR;AHCY;CTH
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3714738110037069,-1.0586196339621674,0.3706140350877193,0.6858057950584872,1.0,8/20,18.68%,AGO1;ZC3H7A;PUM2;AGO2;DROSHA;PUM1;AGO4;MRPL44
prerank,neuron projection fasciculation (GO:0106030),-0.4422728113089771,-1.0582553479012025,0.40556660039761433,0.6861763053080072,1.0,4/10,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3452493656485359,1.0581999961926585,0.37318840579710144,0.8987715515700537,1.0,5/34,6.49%,RORA;SMAD3;LRP3;WWTR1;E2F1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.30749202281082805,-1.058024637841939,0.36199095022624433,0.6861967303717451,1.0,19/45,30.42%,STAT3;APP;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;USP50;NOD2;MYD88;RIPK2;CASP1;CASP8;TLR4;TMEM106A;CD36;TLR6;LGALS9
prerank,RNA polyadenylation (GO:0043631),-0.3459921705359872,-1.0575857640747752,0.36637931034482757,0.6861484032771484,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,mRNA polyadenylation (GO:0006378),-0.3459921705359872,-1.0575857640747752,0.36637931034482757,0.6861484032771484,1.0,8/26,13.42%,APP;TENT2;PABPC1;PAPOLA;TENT4B;WDR33;PAF1;CLP1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2589550029129324,1.0575223278893189,0.321656050955414,0.8995222804283884,1.0,31/170,15.44%,PRDM6;IGF1;ROCK2;NOVA1;TRIM5;PEG3;ZNF462;CIAO3;KIF16B;MTMR4;AFF3;KDM6B;CRNN;HINFP;CACTIN;ZNF711;NKAP;RSPO1;PRDM2;MEGF8;HRG;FUBP1;ATRAID;MTMR2;AFF2;ZFP64;ZNF507;TSKU;PCBP4;TAPBP;TBC1D16
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.41653396109449736,-1.0572331576527187,0.4,0.686455929494848,1.0,6/13,8.59%,ABHD2;BMP4;ESR1;NR3C2;AR;PLPP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3463122642990114,-1.0571268014845332,0.4041237113402062,0.6861319972058451,1.0,9/26,13.98%,ITSN2;AP2B1;FCHO2;SGIP1;LMBRD1;CLTB;GPR107;FNBP1L;AP2A1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.25020179869441667,-1.0563139939130322,0.3279569892473118,0.6877918723990403,1.0,19/128,9.58%,PTN;ETS1;THBS1;NFKBIA;POLR3F;ABCC1;PLSCR1;SCARF1;APP;STX3;GBP5;WNT5A;AGTR1;PDE2A;PUM2;MDK;IFI35;SERPINE1;IL15
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.3854452892253336,-1.0559767696253637,0.386,0.6880613164229819,1.0,7/17,15.87%,NRP1;ADAMTS1;MDK;S100A11;CCN4;VTN;DOCK4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4226199401095561,1.0557329055275135,0.3954802259887006,0.9038320294171759,1.0,3/14,5.75%,CTR9;KMT2A;AUTS2
prerank,protein-DNA complex assembly (GO:0065004),-0.2540167625110134,-1.0556395289275873,0.3435897435897436,0.6883788841490817,1.0,31/116,22.03%,RPA1;H3-3A;UBC;RPS27A;XPC;UBB;PSMA6;PSMB7;CHD1L;GTF2H5;PSMB6;PSMB5;GTF2H1;RAD23B;DMC1;ERCC2;ORC1;PSMB8;PSMC4;PSMD11;ORC2;PSMB4;PSMD14;RPA2;CHAF1A;ORC5;PSMD10;XPA;PSME1;CCNH;MCM3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3138939832305012,-1.055574680728942,0.34754797441364604,0.6879478635530822,1.0,15/40,20.03%,HIP1;B2M;INSR;SFRP4;TBC1D5;SGIP1;SERPINE1;VEGFA;CBL;VTN;FMR1;LDLRAP1;C3;GREM1;ARRB2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3663036565033619,1.0554758936591522,0.37732342007434944,0.9033062784012778,1.0,10/25,21.98%,CCAR2;CCNT2;EAF2;LDB1;ALYREF;DDX39B;THOC1;SUPT4H1;HTATSF1;WDR43
prerank,regulation of telomere capping (GO:1904353),-0.3488966081753605,-1.0554197217051884,0.3942505133470226,0.6877695184518543,1.0,10/23,26.19%,NEK7;TNKS;MAPK1;USP7;NBN;MAPK3;MAP2K7;MAP3K4;HNRNPD;TERF2
prerank,regulation of protein kinase B signaling (GO:0051896),-0.24185248598577602,-1.0552992460523538,0.3352272727272727,0.687487191773519,1.0,30/193,9.88%,HIP1;KITLG;TEK;NTRK3;GCNT2;GAB1;ENG;INSR;THBS1;GAS6;PIK3R1;F3;EGFR;PTPRJ;MFHAS1;ESR1;ITGB1;TNFAIP8L3;XDH;RACK1;MET;IAPP;MYOC;SPRY2;PPP2R5C;PIK3CA;SRC;IGF2;FGF2;FGF7
prerank,chemical homeostasis (GO:0048878),0.3090398191739193,1.0551583422117872,0.34429065743944637,0.9028821557634673,1.0,17/61,17.29%,WNK3;RBP1;FITM2;SLC4A9;ABHD5;PNPLA8;CEBPA;WNK4;ADCK1;CLN8;NR1H3;USF1;SLC4A3;SLC66A1;ABCB4;TM6SF2;TLCD3A
prerank,cellular macromolecule catabolic process (GO:0044265),0.31304490334539353,1.0544895377986592,0.36713286713286714,0.9036279014287287,1.0,11/49,15.07%,MAGEA2;RNASEH2A;SIAH2;SUPV3L1;HTRA2;FBXO6;CHEK2;FBXO17;RNF5;SND1;ADAMTS9
prerank,embryonic heart tube development (GO:0035050),-0.40970239485964477,-1.054231014481384,0.3932135728542914,0.6896396480520568,1.0,5/14,12.91%,ACVR1;SOX17;HES1;SOX18;TBX2
prerank,synaptic vesicle cycle (GO:0099504),0.3501616436543895,1.0539120597041076,0.38589981447124305,0.9041375301427476,1.0,10/30,22.60%,WNT7A;SNAPIN;RIMS1;SNAP25;SYT10;CPLX1;CPLX2;SYNDIG1;SLC32A1;SYT7
prerank,myeloid cell differentiation (GO:0030099),-0.3027661030908636,-1.0538281675946597,0.3735763097949886,0.6901249317841816,1.0,9/47,9.95%,SNRK;ZBTB16;KMT2E;RUNX1;MFHAS1;KAT6A;LYN;PRKX;TAL1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22690890521083978,-1.053719147633699,0.2672672672672673,0.6898581602494286,1.0,58/291,15.58%,PDE3A;ACTB;MEF2C;PID1;RAPGEF2;DAB2IP;SLIT2;RHOA;FOXO1;GUCY1B1;RAP1A;SH3BP4;EGFR;TNFRSF1B;PTPRK;JUN;ESR1;TBX1;DEFA6;CARD16;CAPN2;PRKD1;WNT5A;GNB1;PDE2A;LYN;PRKCD;PXN;GNG2;MAPK1;KCNQ1;TGM2;NRIP1;RPS3;SPAAR;SERPINE1;AHR;INSIG1;RPTOR;NSMF;IPO5;PAF1;PDCD4;FZD4;WNT9A;RET;PTK2B;SLC26A6;RRAGA;IRS1;CD86;P2RY6;ROMO1;MT3;GLRA2;ZFAND1;GIT1;NR1H4
prerank,AMP metabolic process (GO:0046033),-0.4184710291719753,-1.053415087500377,0.3801980198019802,0.6901251417484155,1.0,6/13,19.90%,XDH;NT5C1A;NT5E;ADSS1;AK4;AMPD2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.28060436056468435,-1.052784710173651,0.35523114355231145,0.6912297892398722,1.0,31/69,33.08%,THBS1;STAT3;PTPRJ;APP;PLCG2;ARHGEF2;WNT5A;EPHB2;HSPB1;TWIST1;PTPRC;IFIH1;NOD2;IL33;RIPK1;HMGB1;SYK;FRMD8;CCR2;PTPN11;TLR4;DDT;MIF;RASGRP1;TMEM106A;FADD;LGALS9;TLR1;CD14;TLR3;TYROBP
prerank,spliceosomal complex assembly (GO:0000245),0.32148576558270386,1.0526587791157118,0.39344262295081966,0.9067598761684791,1.0,18/46,23.03%,CELF2;SRSF5;SRSF10;YTHDC1;PRPF19;USP39;RBM5;PRPF6;NOL3;DDX39B;SRSF6;CELF6;PUF60;SF3B1;GCFC2;LUC7L;SRPK1;CELF1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.41424440179442523,-1.052422429239248,0.38323353293413176,0.6915643611218018,1.0,5/13,18.64%,PTGIS;PTGS2;NNMT;NUDT12;NAXE
prerank,positive regulation of nervous system process (GO:0031646),-0.3689913295938555,-1.0518501351312939,0.38284518828451886,0.6924743418266887,1.0,3/18,3.68%,PARD3;TNFRSF1B;UNC13B
prerank,regulation of Rac protein signal transduction (GO:0035020),0.40232357698312116,1.0517017659511656,0.3900990099009901,0.90835299643028,1.0,3/16,8.77%,PIK3CB;AUTS2;ARHGAP24
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.33758260082289376,-1.0516120055388294,0.37656903765690375,0.6925394640666729,1.0,10/28,23.39%,ESAM;WDR1;CXCL12;ARHGAP35;PLEKHG2;PFN1;LATS1;FCHSD1;RASA1;HCLS1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.417219390187662,1.0513904659672693,0.41392649903288203,0.9079421291786806,1.0,5/15,19.53%,IDO1;HAAO;KMO;GSTZ1;KYAT1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.42977983285306776,-1.0511720935219417,0.4011627906976744,0.693115714345702,1.0,4/11,16.30%,WDR1;TRPV4;KATNB1;SEMA5A
prerank,positive regulation of cell division (GO:0051781),0.3364611760013423,1.0510934079851957,0.3638095238095238,0.9075030217286407,1.0,5/38,8.72%,FGF1;TAS1R2;PKP4;FGFR2;DRD3
prerank,apoptotic process (GO:0006915),-0.23628998117329947,-1.0502003856296207,0.32044198895027626,0.6949884122463057,1.0,69/203,25.20%,HIP1;SEMA6A;MAGI3;ZBTB16;FAP;PLAGL1;PPARD;FOXO1;APAF1;STK3;BCL2L1;NFKBIA;PLSCR1;TGFBR2;APP;TBX1;FAS;CIT;PPIA;PRKCD;DAP;IAPP;TNFRSF21;CASP7;FEM1B;EFNA5;PIK3CA;RFK;CDK5;IER3;AHR;IFT57;PDCD4;PTK2B;TNFRSF19;ERCC2;ADAM15;BBC3;BAK1;DDIT4;RTN4;ING4;DIABLO;FXR1;ATCAY;GAPDH;LIG4;PAX3;RIPK1;RHOB;MYD88;PPP2CA;CHEK1;CASP4;PAEP;BIK;CASP1;CDK11B;EGLN3;TRAIP;BOK;DAPK1;PLK3;MRPS30;CXCR4;CASP8;BNIP2;JADE1;PRKCE
prerank,regulation of tube diameter (GO:0035296),-0.41448227430785206,-1.050182429804564,0.41188524590163933,0.6938761718761616,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,vascular process in circulatory system (GO:0003018),-0.41448227430785206,-1.050182429804564,0.41188524590163933,0.6938761718761616,1.0,5/13,12.86%,NOS3;AGTR1;GCLC;ACE2;GCLM
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.2930069524526944,-1.050104260642789,0.3660287081339713,0.6935001356266667,1.0,12/50,11.60%,CAV1;CRY1;SPOPL;DNAJA1;SPRY2;RPS3;PRKCG;UBXN1;BAG5;FBXO5;SQSTM1;ISG15
prerank,keratan sulfate metabolic process (GO:0042339),-0.3316128651771705,-1.0500252117012223,0.4039301310043668,0.6931268022175937,1.0,9/31,10.33%,ST3GAL4;ST3GAL6;B3GNT2;GNS;B4GALT4;ST3GAL1;LUM;B4GALT5;HEXA
prerank,proteolysis (GO:0006508),0.24883242482038587,1.0496858737546262,0.34627831715210355,0.9106508336587483,1.0,48/252,17.78%,AEBP1;METAP2;ADAMTS13;PCSK4;CTSA;SUFU;CPQ;CPNE1;CPN1;PGPEP1;FURIN;PITRM1;CAPN3;AFG3L2;DPP8;CASP3;PLAT;HTRA2;SPRTN;NAPSA;PLG;CTRL;LONP2;ATG4D;ADGRV1;CPA2;FBXO6;CTSH;ENDOU;NEDD8;APH1A;DESI2;DESI1;ATG4C;CNDP2;VASH1;ADAMTS9;TRHDE;GGT5;HGF;BACE2;PAPPA2;MDM2;CAPN7;SRGN;ADAMTS7;TRABD2B;ST14
prerank,negative regulation of protein processing (GO:0010955),-0.4393617714999773,-1.0493799674422635,0.41141732283464566,0.6942219489957023,1.0,3/12,9.35%,THBS1;TMEM59;SERPINE1
prerank,epithelial cell differentiation (GO:0030855),0.2841127755642233,1.0493557847608266,0.3768844221105528,0.9103159719525622,1.0,12/88,11.20%,MAF;DAB2;OVOL2;HNRNPH3;PGK1;CITED1;FGFR2;KDM6B;E2F8;FZD7;E2F4;PIH1D1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4303914570533997,1.0488449566006737,0.4154786150712831,0.9106115744887967,1.0,4/13,6.95%,TGFBR3;BMPR1A;RBPJ;FGFR2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.26257121866109223,-1.0487689734227656,0.348780487804878,0.6952570827127359,1.0,21/98,15.35%,SPTBN1;PRKCH;YWHAE;PIK3R1;EGFR;MFF;YWHAB;NKD2;ITGB1;STX3;ZDHHC8;YWHAQ;YWHAZ;STAC;EPHB2;SQSTM1;CEMIP;AKT2;LRP1;BBC3;KCNB1
prerank,regulation of response to external stimulus (GO:0032101),-0.25522531623746914,-1.0485261718415222,0.3316953316953317,0.6952893131770933,1.0,43/121,25.72%,FOXP1;CAV1;IL1R1;TMSB4X;SEMA7A;PTGS2;BRD4;MGLL;ADGRA2;WNT5A;AGTR1;ANXA1;PSMA6;STK24;CD55;SPAAR;XIAP;SPATA2;EPHB2;IL1RL2;BIRC3;ACE2;ADAMTS12;BCL6B;N4BP1;NOD2;HCK;MYD88;ZBP1;CASP4;SBNO2;CASP1;FCGR2B;GGT1;CYLD;ERAP1;GUCA1B;CCR2;CXCR4;AREL1;CASP8;LRP8;F2R
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3822249354830676,1.0484934889718143,0.4046692607003891,0.9103258621193647,1.0,3/21,4.58%,ERRFI1;ROCK2;MAFG
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4354529156317642,1.0482240536786462,0.41865079365079366,0.9097869528060826,1.0,2/11,8.49%,COLEC12;TNIP2
prerank,lipoprotein catabolic process (GO:0042159),-0.4365617340536783,-1.0476874641379545,0.3803680981595092,0.6969019601418471,1.0,5/11,28.34%,CTSD;APOE;ABHD17C;ABHD17B;LYPLAL1
prerank,mRNA transport (GO:0051028),0.27877040410860765,1.047604538861138,0.347008547008547,0.9103602419768986,1.0,38/101,27.33%,MCM3AP;CPSF3;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP;DDX39A;RAE1;RBM15B;SRSF2;ZFP36;U2AF2;NUP160;ZC3H11A;ZFP36L1;NUP133;THOC2;FIP1L1;POLDIP3
prerank,positive regulation of endocytosis (GO:0045807),-0.3023253297009316,-1.0475228796100222,0.3785557986870897,0.6967814013250971,1.0,15/45,18.38%,HIP1;NEDD4L;B2M;ANKFY1;RAB31;SGIP1;SERPINE1;APOE;LRP1;CBL;VTN;NCKAP1L;LDLRAP1;CD151;C3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.4314246245632601,-1.0474769103094679,0.4,0.6963523034064231,1.0,6/11,30.20%,LANCL1;STK26;FYN;UBQLN1;PARK7;MMP3
prerank,cellular iron ion homeostasis (GO:0006879),0.3060769910981537,1.047263339308263,0.3683274021352313,0.9100983794131637,1.0,9/55,8.00%,BMP6;NDFIP1;HEPHL1;ATP6V0A2;FLVCR1;ACO1;CCDC115;TMEM199;CP
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.43705253263749994,1.0466586177207378,0.41825095057034223,0.910712596303826,1.0,6/12,23.22%,CYP11B1;FDX1;STAR;FDX2;FDXR;TSPOAP1
prerank,post-translational protein modification (GO:0043687),-0.22250117259724395,-1.0457382872658914,0.29310344827586204,0.7002468233293415,1.0,91/332,22.20%,FBXL7;ZBTB16;LTBP1;PTP4A2;DCUN1D3;GAS6;SOCS2;BMP4;APP;FN1;BTBD1;DCAF6;LMO7;FBN1;PDIA6;MSLN;COP1;CST3;ADAM10;DCAF10;FBXW8;KLHL2;PSMA6;PSMB7;CCN1;FBXO31;FEM1B;FBXO30;LAMB2;KTN1;MFGE8;STT3B;MGAT4A;VCAN;VHL;FBXO4;CAND1;SOCS5;APOE;PSMB6;FBXO32;UBE2F;PSMB5;RAB3A;PNPLA2;DCAF13;DCAF5;FBXW2;FBXO44;EVA1A;FBXW7;FBXL18;TNC;RAB11B;CDH2;PSMB8;RAB1B;RHBDD1;GOLM1;PSMC4;ICMT;KLHL22;KBTBD7;PSMD11;KLHL3;ASB13;GPS1;ATG5;CISH;CHRDL1;SOCS3;IGFBP4;PSMB4;PSMD14;KCTD6;CCNF;C3;FBXL4;RAB11A;CKAP4;MATN3;FBXW5;PSMD10;COPS6;CALU;KLHL11;PSME1;KLHL25;CHM;ASB1;CCDC22
prerank,engulfment of apoptotic cell (GO:0043652),-0.39466721434662233,-1.0457089508044788,0.40307101727447214,0.6997566314157477,1.0,2/15,2.26%,RHOBTB1;THBS1
prerank,regulation of protein catabolic process (GO:0042176),-0.25914799659518495,-1.0456879756543196,0.3285024154589372,0.6992176351627664,1.0,30/99,23.30%,DAB2IP;NEDD4L;WWP1;FOXO1;EGFR;SMURF1;EEF1A1;HECW2;IRAK3;FLNA;WNT5A;PLK2;APC;PRKCG;HGS;GFAP;CSNK2A1;FZR1;MAD2L2;ZDHHC2;BARD1;HACE1;NEDD4;AGAP2;FAF1;AZIN1;CDKN1B;ODC1;STX5;OAZ1
prerank,glycine transport (GO:0015816),0.4510301302522323,1.0453065597562476,0.3924050632911392,0.9135931100953667,1.0,1/10,2.09%,SLC6A9
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3240061338159391,1.045260892212743,0.3888888888888889,0.9123700847047767,1.0,10/41,10.67%,ACTN2;ANK2;KCNJ5;KCNJ10;KCNH2;GABBR1;KCNN4;PDZK1;KCNJ16;GABBR2
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3992446250918951,-1.0452310027688574,0.3825242718446602,0.6998247178858711,1.0,6/14,30.53%,RHOA;RAP2A;CDC42;MSN;FOXJ1;CAMSAP3
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.35662933249683587,-1.044964626842706,0.37782340862423,0.6999200694042899,1.0,8/23,19.05%,GNB1;GNG2;MAPK1;KCNQ1;TGM2;ATF4;PRKACA;MAPK3
prerank,positive regulation of exocytosis (GO:0045921),0.3352314154043302,1.0447125225820155,0.36971830985915494,0.9127692866784063,1.0,7/35,13.80%,UNC13D;STAM;CLASP1;SMPD3;SNF8;RAB2B;CADPS2
prerank,aorta development (GO:0035904),0.41878606582504807,1.0446391246796607,0.4202020202020202,0.9116449965293759,1.0,1/14,0.08%,ROBO1
prerank,cellular response to interferon-gamma (GO:0071346),-0.2664177712556216,-1.0446354479743847,0.3566265060240964,0.7002668173673522,1.0,29/88,25.81%,B2M;VCAM1;CD44;MID1;GBP4;ICAM1;IRF9;CAMK2D;GBP5;WNT5A;PRKCD;TRIM25;CCL13;IRF2;JAK1;SYNCRIP;SLC26A6;SP100;GAPDH;CCL25;MT2A;IRF5;HCK;FCGR1A;CASP1;RPL13A;DAPK1;TLR4;AIF1
prerank,mammary gland epithelium development (GO:0061180),0.42280554072674387,1.0444939454511337,0.4146341463414634,0.9107600525484895,1.0,1/14,0.43%,WNT4
prerank,myoblast fusion (GO:0007520),0.4311410344418323,1.0443494796004174,0.4057971014492754,0.9098361679246513,1.0,3/12,5.03%,ADAM12;ADAMTS15;ADGRB3
prerank,positive regulation of cellular component organization (GO:0051130),-0.25664104323835146,-1.0442094378787325,0.36829268292682926,0.7007829674011916,1.0,18/107,9.95%,ATP10A;SHANK3;DAB2IP;NEDD4L;TGFB2;INSR;RUNX1;ICE1;FNIP2;TMEM30A;TFRC;RACK1;AR;RPS3;TGFB3;APOE;GPX1;TAL1
prerank,regulation of protein processing (GO:0070613),-0.3629444939108178,-1.0441935171337025,0.4065040650406504,0.7002360687663698,1.0,4/21,7.98%,RUNX1;NKD2;TMEM59;CCBE1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3491230403680075,1.0440532886163159,0.4119922630560928,0.9094767143953246,1.0,2/29,0.69%,NOTCH2;IGF1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.4299043893207094,-1.0439820466226843,0.42574257425742573,0.7002320447987312,1.0,7/12,42.33%,ABCC9;KCNJ8;CACNA1H;ABCC8;P2RX3;KCNJ11;RHAG
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2820822889907823,-1.0438119872996148,0.38095238095238093,0.7000831366750799,1.0,17/69,17.39%,PLCB4;PLCE1;RHOA;PLCL1;PIK3R1;NGF;PIK3C2A;PIK3CA;EDN1;PIK3CD;EXOC1;PIK3C3;HTR2A;IRS1;CSF1R;PI4KB;PTEN
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3163681667674264,1.043687974949819,0.375,0.9092519192004841,1.0,12/46,15.40%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,cellular response to heat (GO:0034605),0.3379508050607498,1.043342218554877,0.37351778656126483,0.9089633968554298,1.0,3/35,1.13%,FGF1;HSPA1A;TRPV1
prerank,amino acid import (GO:0043090),0.38110716097156827,1.0428229641417248,0.3942307692307692,0.9092946147679338,1.0,2/21,0.21%,SLC6A13;SLC6A1
prerank,camera-type eye morphogenesis (GO:0048593),-0.4476612194682238,-1.042521938771265,0.4254032258064516,0.7028894791448401,1.0,5/10,22.99%,LRP6;TBX2;VEGFA;SKI;KDM2B
prerank,mitochondrial translation (GO:0032543),-0.25595471142121184,-1.0418243694602516,0.3496143958868895,0.7041174928781292,1.0,29/104,20.20%,GATB;DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MTIF3;GFM1;LARS2;MRPL23;MRPS31;NDUFA7;EARS2;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,eye photoreceptor cell development (GO:0042462),0.40146855469152687,1.041677840969428,0.39539347408829173,0.91141454863363,1.0,3/15,10.22%,USH1C;CEP290;TOPORS
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4395828093185037,1.0415269237844729,0.42884990253411304,0.910535674740318,1.0,3/12,7.53%,COLEC12;PQBP1;IFIT1
prerank,glucose metabolic process (GO:0006006),0.3041474030829574,1.0413644113574587,0.39372822299651566,0.9097005495420223,1.0,21/58,21.46%,SORD;ENO1;PGM1;ALDOB;PGK1;SLC25A11;PPARGC1A;SLC25A12;BRAT1;G6PC3;HECTD4;GOT1;PER2;GOT2;RBP4;ALDOC;GPI;CRTC2;TPI1;OMA1;SLC25A13
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.38242057157916914,1.0409431738020274,0.39889705882352944,0.9097399433428747,1.0,5/21,13.20%,SLC8A3;ANXA6;AFG3L2;SLC25A23;MICU1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4434895698582505,1.0408737316769743,0.4336099585062241,0.9086155334460252,1.0,2/11,3.93%,STX18;ATL1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2634761601957679,-1.0407635482417597,0.36255924170616116,0.7062537908466641,1.0,21/88,14.26%,STXBP6;MYO1B;CLINT1;RAB14;VPS13C;EXOC6;APP;EXOC4;SORT1;RABIF;FTL;RP2;EXOC1;HGS;STEAP2;SCAMP1;SH3GL2;VPS13A;SYS1;AP2A1;PUM1
prerank,nucleoside salvage (GO:0043174),0.4559492541257375,1.040586246408044,0.4318181818181818,0.9081818289916265,1.0,3/10,11.30%,UCKL1;DCK;UPP2
prerank,O-glycan processing (GO:0016266),0.3168669383095844,1.0403002157963295,0.4010600706713781,0.9077459890487506,1.0,6/54,4.00%,GXYLT2;CHST4;MUC19;ST3GAL3;GALNT11;GALNT14
prerank,pinocytosis (GO:0006907),-0.43956440909414485,-1.0401921277030608,0.4369747899159664,0.7071124446646717,1.0,7/10,32.71%,DOCK2;MAPKAPK2;SNX5;CARMIL1;AHSG;MAPKAPK3;RAB34
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.24892140852870903,-1.0400052728525981,0.34545454545454546,0.7070322468930732,1.0,35/144,16.87%,YWHAE;GAS6;PIK3R1;PRR5L;CDH1;ICE1;MFF;YWHAB;FLNA;TMEM30A;UBE2D3;SAE1;ABLIM3;PRKCD;SEC16B;ARIH2;YWHAQ;YWHAZ;RIPOR1;SREBF2;IPO5;MICALL2;CEMIP;TPR;UBE2L3;AKT2;FBXW7;UBL5;SAR1A;BBC3;ZFAND1;UBE2J2;KCNB1;ZDHHC2;B3GAT3
prerank,negative regulation of cell growth (GO:0030308),-0.24955936733949166,-1.0398108325715174,0.3676092544987147,0.7069296819614472,1.0,23/121,14.78%,APBB2;BMPR2;SLIT2;ACVRL1;TGFB2;DCUN1D3;SH3BP4;BTG1;PTPRJ;FHL1;CCN3;SOX17;CCDC85B;RACK1;CDKN2AIP;FGF13;NME6;SEMA3G;SIPA1;RERG;ENPP1;ADAM15;MT3
prerank,response to thyroid hormone (GO:0097066),0.4209987786308278,1.03908992345333,0.424,0.9102208987362025,1.0,4/13,11.38%,THRB;BRD8;MED1;CTSH
prerank,camera-type eye development (GO:0043010),-0.3366794892280417,-1.038750306576962,0.4148936170212766,0.7090567836700974,1.0,9/25,21.97%,LAMA1;CYP1B1;FBN1;STRA6;VEGFA;ALDH1A3;EFEMP1;FOXL2;SKI
prerank,protein homooligomerization (GO:0051260),0.2708169499777691,1.0387430546508405,0.3511705685618729,0.9099759728225599,1.0,26/114,19.12%,ALDH1A2;UPB1;APPL2;TRPV1;VSTM5;ATL1;GSDMD;CLYBL;ADCY8;GOLGA2;ELAVL1;RNF135;KCNC2;SSBP1;TRPM2;BEND3;MICU1;ACACA;RNF213;CTH;ALAD;TRMT61B;NLRC4;ALDH9A1;ACOT13;USP16
prerank,regulation of coagulation (GO:0050818),-0.4306318742423942,-1.0387184012785726,0.40332640332640335,0.7085515162869482,1.0,2/11,10.32%,CAV1;EPHB2
prerank,positive regulation of gene expression (GO:0010628),-0.2128338729171579,-1.038363629127381,0.31521739130434784,0.7089264069026817,1.0,77/442,12.95%,LEF1;ACTB;LIMS1;MEF2C;NTRK3;PID1;CLDN5;NOS3;NIBAN1;GSN;ETS1;RAMP2;THBS1;NOTCH1;ACTG1;GAS6;PIK3R1;F3;EGFR;CD34;CTCF;NGF;RBM3;STAT3;BMP4;SFRP4;AGO1;PLSCR1;RPL5;APP;FN1;NOS1AP;PLA2R1;EIF3E;PLCG2;TFRC;SMAD1;WNT5A;S100A13;ERN1;EEF2;PDE2A;AR;MAPK1;SEC16B;RPS7;OCLN;SPRY2;MYBBP1A;ADAM19;RPS3;ACTA2;HEY2;TMEM119;GATA2;SOD1;EIF2AK3;FGF2;TENT4B;AGO2;IL15;FGF7;KLF4;EPHB2;PIK3CD;HGS;RPL23;TWIST1;DYRK1A;CD74;KRAS;DNMT3B;SERPINB9;BMP2;SMO;RAB27A;AGPAT1
prerank,presynaptic endocytosis (GO:0140238),0.35850742347164233,1.0382922138373405,0.3996138996138996,0.910063269515173,1.0,7/24,15.03%,CEL;NLGN2;SYT1;NLGN3;SYNJ2;CANX;AMPH
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3401536875559,1.038138929586831,0.40784313725490196,0.9092363277072963,1.0,10/30,18.92%,DAB2;DDX5;PRMT2;RNF14;RNF6;SAFB2;SIRT1;NCOR2;KDM1A;NCOR1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.31155225784135204,-1.0374199217433113,0.40176600441501104,0.7107582812299501,1.0,14/37,23.57%,RPL5;EIF3H;RPS7;UBXN1;USP7;RPL23;BAG5;CSNK2A1;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.33529287725982415,-1.0368831174933189,0.3683083511777302,0.7109663880316232,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,CENP-A containing chromatin organization (GO:0061641),-0.33529287725982415,-1.0368831174933189,0.3683083511777302,0.7109663880316232,1.0,12/29,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,protein localization to plasma membrane (GO:0072659),0.2684142444097142,1.0362253979742204,0.3827751196172249,0.913865142046027,1.0,16/129,6.93%,AFDN;ROCK2;ANK1;KCNIP3;ACTN2;ATP1B3;TSPAN5;FYB1;ANK2;CACNB3;WNK3;PLEKHF1;DLG1;FYB2;RAB3C;FLOT2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.2764305994022291,-1.0361214386445043,0.38588235294117645,0.7123071626238686,1.0,30/68,30.12%,PAPOLA;GTF2H5;CPSF4;WDR33;GTF2H1;NCBP2;ERCC2;CLP1;POLR1F;POLR1G;SNRPE;CAVIN1;NCBP1;CSTF1;SMN1;POLR1A;UBTF;MED18;CCNH;POLR1H;POLR2F;SSU72;POLR1E;POLR2H;PCF11;SCAF8;SETX;POLR1C;CSTF3;POLR2E
prerank,ether lipid biosynthetic process (GO:0008611),-0.4319523330924198,-1.035754327642124,0.4156378600823045,0.7126927603058486,1.0,3/10,8.56%,PLA2G4A;DHRS7B;PEX7
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3430251985715703,-1.0355172949182465,0.3878787878787879,0.7127498301798662,1.0,8/25,10.59%,CAV1;TBX18;NOS1AP;CAMK2D;CALM3;CXADR;CTNNA3;FGF13
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35478844852812086,1.035337174607196,0.3723608445297505,0.9152272049068388,1.0,5/27,7.33%,BRD8;ATAT1;SGF29;RUVBL2;KAT5
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.35006338764488243,-1.0347555483725206,0.39019189765458423,0.7141569441509793,1.0,12/24,26.60%,ZBTB16;TRPS1;ACVRL1;MDK;WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2;BMPR1B
prerank,positive regulation of actin nucleation (GO:0051127),-0.43216336862300375,-1.034742277395324,0.4195519348268839,0.7136167716709589,1.0,3/11,10.16%,GSN;WASF2;WHAMM
prerank,RNA export from nucleus (GO:0006405),0.27474748777292746,1.034614718166406,0.3778162911611785,0.9161736156364889,1.0,25/100,19.96%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;NUP62CL;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,DNA geometric change (GO:0032392),0.3654331181365728,1.0344226125847373,0.40576923076923077,0.9154717754579867,1.0,5/24,11.77%,RECQL4;HNRNPA2B1;SUPV3L1;MRE11;RTEL1
prerank,regulation of membrane depolarization (GO:0003254),-0.3799298271410153,-1.0340339624330126,0.4383838383838384,0.7147910372673305,1.0,3/18,5.59%,NEDD4L;FHL1;CAMK2D
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.26773466643361965,-1.0333487052306365,0.4009546539379475,0.7159492524051295,1.0,28/76,26.03%,CAV1;DCUN1D3;CRY1;GNL3;UBB;SAE1;XIAP;FBXO4;FAM107A;AMER1;MALT1;DCUN1D5;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23;ZC3H12A;PSMD10;CENPX;RIPK2;NSMCE3;BCL10;CUL3;PIAS3;MUL1;UBQLN1;WFS1
prerank,positive regulation of reproductive process (GO:2000243),-0.320570183325305,-1.0330791155374557,0.4008438818565401,0.7160954967164371,1.0,5/31,13.82%,PDE3A;LHFPL2;AGO2;PGAM4;VEGFA
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4280913984831093,1.0325907026002294,0.4173076923076923,0.919860591125446,1.0,2/11,6.77%,GCK;C1QTNF3
prerank,early endosome to Golgi transport (GO:0034498),-0.4215920585183401,-1.0322962930835649,0.4386694386694387,0.7175246085378263,1.0,7/11,33.21%,RAB6A;SNX1;SURF4;SNX2;STX5;LMAN1;RBSN
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3158050432612417,-1.0322910218235024,0.4029535864978903,0.7169616934394029,1.0,6/33,11.79%,PRKG1;MEF2C;APOD;TAFA5;TGFB3;PDCD4
prerank,regulation of protein kinase activity (GO:0045859),-0.25620805732218455,-1.0322395980535584,0.33080808080808083,0.7165146702078597,1.0,32/106,23.67%,PLCE1;RAPGEF2;LRP6;GAS6;RASSF2;RAP1A;IQGAP1;CACUL1;UBASH3B;PAK2;XRCC5;PPIA;CCN1;CEACAM1;SOD1;HSPB1;GSKIP;PTK2B;DBNDD2;PTPRC;TAB1;RAP2B;AKT1S1;AGAP2;TRIB2;TRAF4;MMD2;MMD;PRKRIP1;TRIB3;TARBP2;CAMKK2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3826465997427164,-1.0322360691047021,0.42436974789915966,0.7159524530994368,1.0,4/16,8.21%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,adipose tissue development (GO:0060612),-0.42441621571956484,-1.0319952261949148,0.4268292682926829,0.7160376858185459,1.0,6/11,30.57%,LRP5;SH3PXD2B;PGRMC2;SOX8;RORC;NAMPT
prerank,response to cholesterol (GO:0070723),-0.3753812125620232,-1.0317557085106832,0.4247422680412371,0.716087562523256,1.0,5/17,12.66%,LRP6;TGFBR2;GRAMD1A;PTCH1;SMO
prerank,positive regulation of MAP kinase activity (GO:0043406),0.29565559657761425,1.031738332769151,0.40252707581227437,0.9212419316265877,1.0,8/66,10.29%,ROBO1;FGF1;TENM1;KIT;ADRA2A;LRRK2;MAP3K10;SASH1
prerank,central nervous system neuron differentiation (GO:0021953),0.3367261848162477,1.0316541077303332,0.4116575591985428,0.9201533372234046,1.0,11/33,20.12%,MAP2;GRID2;NTRK2;MDGA2;GBA2;CHD5;ATP7A;FAIM2;SIN3A;SPOCK1;KNDC1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2776755896511254,1.031610298051964,0.3989983305509182,0.9189796630309242,1.0,15/95,10.07%,TGFBR3;DAB2;SNX6;HSPA1A;SMAD3;PPARA;STRAP;DKK3;NREP;CITED1;PDPK1;MTMR4;SPRED3;VEPH1;TGFBR1
prerank,mitotic spindle organization (GO:0007052),-0.23731875667066443,-1.0311765157775903,0.3858267716535433,0.7170081106993823,1.0,57/153,28.45%,RHOA;STMN1;EML1;DYNC1I2;FLNA;SMC1A;MAP4;TNKS;PLK2;STAG1;NUP107;MAP9;DYNC1I1;PIBF1;KIF23;RPS27;RMDN1;MZT1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;STAG2;CENPQ;CENPL;TOGARAM1;DYNC1H1;TAOK1;ARHGEF10;RAB11A;PRC1;NUP85;B9D2;GPSM2;TPX2;AAAS;KIFC1;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2;VCP;BIRC5
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3454893299182987,1.031053207702788,0.41005802707930367,0.9193850335198673,1.0,9/30,20.27%,ACAT2;INSIG2;DHCR24;SQLE;CYP51A1;MSMO1;GGPS1;HMGCR;LBR
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.34281615949171246,-1.0305253159904078,0.4088050314465409,0.7181180832882729,1.0,7/25,13.94%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2
prerank,protein localization to mitochondrion (GO:0070585),0.4404998990553708,1.0305132519287348,0.422680412371134,0.9197213131247852,1.0,6/11,20.60%,COX18;LRRK2;HK1;MTCH2;AKT1;MAIP1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3613506979016661,-1.0301796579053044,0.4300202839756592,0.7183498970939188,1.0,10/21,19.19%,PDE4D;PDE9A;XDH;PDE2A;HPRT1;NT5C1A;NT5E;HINT1;NUDT16;MLYCD
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2782591965477016,-1.0300914574111242,0.4116279069767442,0.7179955388052799,1.0,22/59,25.75%,DAB2IP;NFKBIA;UBC;REL;RPS27A;UBB;RELB;NKIRAS1;TBKBP1;BIRC3;IRAK2;TAB1;RIPK1;TICAM1;ROCK1;RIPK2;BCL3;IRAK1BP1;BCL10;AZI2;TLR4;MAP3K14
prerank,regulation of centrosome duplication (GO:0010824),-0.33014168657636295,-1.0298416711761795,0.38675213675213677,0.7181368754566059,1.0,11/29,24.56%,CHMP2B;PLK2;CHMP4B;CEP76;STIL;CEP295;CCNF;CHMP1B;FBXW5;CEP131;XRCC3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.3543043038430383,1.029825790343407,0.41254752851711024,0.9205247422291344,1.0,2/23,1.77%,IGF1;PRKAA2
prerank,regulation of sodium ion transport (GO:0002028),0.32738257878920035,1.0297007115614296,0.4058252427184466,0.9195982099253025,1.0,5/34,6.71%,WNK3;SNTA1;DLG1;FGF12;WNK4
prerank,positive regulation of protein catabolic process (GO:0045732),-0.261358889613929,-1.029625742215595,0.38349514563106796,0.7181447887869385,1.0,25/84,24.87%,DAB2IP;NEDD4L;WWP1;FOXO1;SMURF1;HECW2;TNFRSF1B;WNT5A;PLK2;APC;APOE;AMER1;CSNK2A1;FZR1;BARD1;HACE1;NEDD4;MSN;FAF1;CDKN1B;STX5;OAZ1;PLK3;AREL1;DTL
prerank,hexose transmembrane transport (GO:0008645),0.3751915220681077,1.0295910854555148,0.424408014571949,0.9186288745912877,1.0,3/21,2.69%,SLC2A12;SLC5A3;SLC5A10
prerank,negative regulation of cell death (GO:0060548),-0.2596394555383072,-1.029394810888083,0.4023809523809524,0.7182167344854694,1.0,14/88,9.34%,MECOM;PDE8A;CD200;CD34;BMP4;TNFRSF1B;CCN3;PRKD1;NCK1;CHMP4B;CHMP4A;CCN1;CDK5;FGF2
prerank,DNA replication (GO:0006260),-0.25480707480948056,-1.0293932498361709,0.3805970149253731,0.7176526240977879,1.0,48/105,32.48%,RPA1;KAT7;REV3L;TIPIN;RPAIN;BLM;WRNIP1;KIN;ORC1;TIMELESS;ING4;ORC2;RHNO1;NBN;BARD1;RPA2;RMI1;CDC45;ORC5;PCLAF;POLA1;DUT;SET;RFC4;CHEK1;POLA2;MCMBP;TOP1;MCM3;WDHD1;POLD4;POLB;POLG2;RBMS1;POLE3;MCM5;MCM6;RFC2;CDK2;RECQL5;FAM111A;HELB;GRWD1;ORC3;CDK1;CDC6;PIF1;FEN1
prerank,steroid metabolic process (GO:0008202),0.29093629542103194,1.0293462850055033,0.36936936936936937,0.9180520266972795,1.0,19/72,21.56%,LIPA;CYP26B1;CYP11B1;DHCR24;PRLR;DHRS11;CYP27A1;AMACR;FDX1;PIAS4;CYP51A1;STAR;GBA2;FDX2;MSMO1;HSD17B4;NPC1;FDXR;HSD11B1
prerank,positive regulation of protein acetylation (GO:1901985),0.4220288480540866,1.02921828564197,0.4032258064516129,0.9171164142929266,1.0,4/12,12.39%,PRKAA2;CAMK1;KAT5;RAPGEF3
prerank,cellular response to ATP (GO:0071318),0.4139724702901962,1.0282714015363479,0.4288659793814433,0.9187535440235604,1.0,2/14,11.18%,TRPV1;TAF1
prerank,leukotriene metabolic process (GO:0006691),-0.37077752282050425,-1.0280135979764076,0.42857142857142855,0.720664248402262,1.0,4/19,14.97%,PLA2G4A;ABCC1;MAPKAPK2;ABCC10
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4469430965696586,1.0279404852344063,0.42677824267782427,0.9184567911515265,1.0,5/10,24.96%,PRKAA2;KLF15;SIRT1;DIP2A;SETD5
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.27828995938696754,-1.0277808510724686,0.39359267734553777,0.7206731321668286,1.0,19/57,23.95%,GHR;IL6ST;STAT3;HES1;LYN;IL6R;IL15;PIBF1;ARL2BP;CD40;VEGFA;CSF1R;SOCS3;FGFR3;CRLF1;PPP2CA;CTF1;HCLS1;SOCS1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.42679706308738125,1.0277592382267347,0.43418467583497056,0.917665503459437,1.0,3/12,15.93%,STRAP;SOX9;RBP4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32692964519077694,1.0274155004214716,0.40370370370370373,0.9174788684576507,1.0,10/38,16.68%,RORA;TNIP3;NLRC3;NLRX1;CACTIN;STAT1;MAPKBP1;OTUD7A;SIRT1;PPM1B
prerank,stress fiber assembly (GO:0043149),-0.38926412017917034,-1.027396252774918,0.42661448140900193,0.7205024719105547,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,contractile actin filament bundle assembly (GO:0030038),-0.38926412017917034,-1.027396252774918,0.42661448140900193,0.7205024719105547,1.0,4/15,8.77%,RHOA;ITGB1;ITGB5;SRC
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4432781282881541,-1.0273866293075666,0.43570057581573896,0.7199606948184772,1.0,8/10,47.66%,MALT1;ZC3H12A;SMAD7;NFKBID;RC3H2;IL4;FOXP3;TBX21
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.24751580231596068,-1.027298557224421,0.40616966580976865,0.7195979090335445,1.0,47/122,29.47%,NIBAN1;BCAR3;TGFB2;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;KDR;RPL5;EIF3E;EEF2;NLRC5;AR;IGF2;FGF2;KLF4;NMD3;AKT2;IRS1;FMR1;BRPF3;PRR16;FXR1;NOD2;IL33;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;EGF;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;METTL14;RPS4X;SLC25A37;NSUN5;PCIF1;TMEM106A;GLI1
prerank,regulation of protein sumoylation (GO:0033233),0.3990751830493274,1.027264327823397,0.42722117202268434,0.9166637696923668,1.0,5/17,13.52%,MAGEA2;CAPN3;GNL3L;PIAS4;HDAC4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.3806110304742105,1.0272559337306217,0.4,0.9153883985397309,1.0,4/20,4.37%,ACTN2;OSR1;STK39;ADRA2A
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3056372963310701,-1.0268587568043848,0.4025974025974026,0.7202211387351253,1.0,12/42,20.47%,ACTB;ARID1B;SMARCC1;GATAD2B;RBBP4;ARID1A;PBRM1;NASP;ACTR6;HDAC2;SMARCA4;CHD8
prerank,negative regulation of phosphorylation (GO:0042326),-0.26354993518657177,-1.0266341834544868,0.36683417085427134,0.7202680866247599,1.0,25/85,17.39%,NTRK3;PID1;DAB2IP;SLIT2;NIBAN1;LRP6;PRR5L;CORO1C;BMP4;CBFA2T3;XDH;PPIA;LYN;OCLN;CDKN1C;EPHB2;TERF2IP;SH3GL2;DYNLL1;PAQR3;PLPP3;GIT1;FKBP8;TRAF3IP1;PTEN
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2793750323192076,1.026629642466411,0.39398998330550916,0.9160628591426233,1.0,12/86,10.07%,BMP7;BMP6;DAB2;TWSG1;BMPR1A;BMP3;BMP8A;RBPJ;CITED1;INHA;GDF9;TGFBR1
prerank,response to interferon-alpha (GO:0035455),-0.38085079185173226,-1.0260111360947322,0.4219409282700422,0.7212353126749593,1.0,6/16,21.58%,GAS6;IFITM3;TPR;IFITM1;IFNAR1;IFITM2
prerank,regulation of filopodium assembly (GO:0051489),-0.31050730257819303,-1.0258387056698972,0.4153846153846154,0.7211246458578144,1.0,11/38,17.17%,NRP1;MYO10;PIK3R1;ARAP1;PPP1R16B;PRKCD;TGFB3;FNBP1L;AGRN;FMR1;FXR1
prerank,negative regulation of binding (GO:0051100),-0.26471680084586446,-1.0255958332857407,0.39097744360902253,0.7211975376166218,1.0,12/81,6.70%,LEF1;ACTB;CAV1;WAPL;DISC1;NFKBIA;JUN;RALB;CARD16;CSNK1E;RACK1;PRKCD
prerank,peptidyl-threonine modification (GO:0018210),0.29501508119335096,1.0255894608358485,0.39473684210526316,0.9180285140057693,1.0,22/66,18.35%,ROCK2;OXSR1;WNK3;GALNT11;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;GALNT3;GALNT2;MAP3K12;GALNT1;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,DNA duplex unwinding (GO:0032508),-0.2874827474016195,-1.0255060271733545,0.39429928741092635,0.7208770901706634,1.0,12/50,12.95%,RPA1;UBC;RPS27A;XPC;UBB;ANXA1;CHD1L;GTF2H5;GTF2H1;RAD23B;BLM;ERCC2
prerank,establishment of spindle orientation (GO:0051294),0.3453170587792436,1.0254897745547198,0.4160714285714286,0.917045868944465,1.0,7/28,9.52%,PLK1;CLASP1;LLGL2;HTT;NDC80;MAD2L1;LLGL1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.41338733746422107,1.0254088290030283,0.4204322200392927,0.9159777027887369,1.0,3/12,8.19%,PRKCZ;GKAP1;SORBS1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.37169917982219824,-1.0253986048788124,0.4410058027079304,0.7206026722204055,1.0,10/18,25.41%,IL6ST;STAT3;IL6R;SRC;JAK1;CBL;SOCS3;SPI1;PTPN11;YAP1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4024471154090499,1.025272800737304,0.42505133470225875,0.9150954019210004,1.0,8/16,21.77%,BMP7;METRNL;HNRNPU;TFE3;SIRT1;FNDC5;PIM1;NAPEPLD
prerank,regulation of cholesterol esterification (GO:0010872),-0.42789192918504715,-1.0252059740385358,0.45222929936305734,0.7205502065321043,1.0,5/10,27.83%,AGTR1;APOE;STARD4;APOC1;AGT
prerank,MAPK cascade (GO:0000165),-0.2212363190131168,-1.0251363715458488,0.336734693877551,0.7201707408289825,1.0,73/295,20.32%,SPTBN1;KITLG;TEK;MEF2C;SHANK3;RAPGEF2;DAB2IP;RASAL2;MAP3K5;RASGRP3;YWHAE;PIK3R1;EGFR;BCL2L1;RASGRF2;KDR;IL17RD;UBC;YWHAB;TNIK;MAP3K20;RPS27A;UBB;MET;PSMA6;PSMB7;MAPK1;SPTAN1;SHOC2;GRIN2B;PIK3CA;PDE6D;MAP4K4;FGF2;MAPKAPK2;FGF7;PSMB6;JAK1;FGF13;PSMB5;KRAS;NRAS;RANBP9;PRKG2;RET;RASA3;PEBP1;ABHD17C;IRS1;PPP1CC;PSMB8;MT3;PAQR3;PSMC4;ICMT;KBTBD7;PSMD11;TAOK3;FGFR3;MRAS;MAP3K8;DUSP6;PSMB4;GRIN1;PSMD14;TAOK1;MAPK12;MAPK3;MARK3;JAK3;GOLGA7;PSMD10;ABHD17B
prerank,negative regulation of RNA splicing (GO:0033119),0.3804224410582259,1.0249064833340586,0.4354166666666667,0.9149155605621072,1.0,8/19,18.53%,PTBP2;SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;PTBP3;SRSF6
prerank,negative regulation of neuron death (GO:1901215),-0.25961304980343075,-1.0248259534669084,0.3939393939393939,0.7204346601778975,1.0,23/93,16.19%,MEF2C;CD200;NDNF;CD34;NGF;SIX1;TNFRSF1B;CHMP4B;CHMP4A;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;NENF;ATF4;SIX4
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40133676957055353,-1.0246142614022917,0.4442231075697211,0.720404154520968,1.0,2/13,7.91%,CAV1;BCAP31
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4532354993596187,1.0245154499488687,0.43259557344064387,0.9148067748482157,1.0,5/10,19.13%,EMC2;EMC4;MMGT1;EMC10;EMC1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3254455319812995,1.0241701781546684,0.3985102420856611,0.9145844861816229,1.0,8/41,11.96%,SLC8A3;TRPV1;ITPR1;GRIN2D;ITPR2;RYR2;TRPM2;CHERP
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3057655325884072,-1.0241152913561167,0.3925619834710744,0.721153502053791,1.0,6/39,6.32%,UTRN;NEDD4L;FXYD5;YWHAE;FHL1;TRPC6
prerank,histone modification (GO:0016570),0.26865255850664366,1.0237552727529398,0.3989983305509182,0.9145792926405887,1.0,27/109,20.32%,EYA1;EYA4;EYA2;BRD8;SGF29;RUVBL2;PRMT2;RCOR3;KAT5;MIER3;TAF10;NSD1;KDM4A;RCOR2;MAP3K12;HDAC4;TBL1XR1;NTMT1;SIRT1;NSD3;USP21;USP16;SIN3A;KAT6B;BRMS1L;KAT8;PHC1
prerank,histone lysine methylation (GO:0034968),0.3409434690191227,1.0233567259236542,0.411231884057971,0.9145968115618637,1.0,7/33,13.72%,DOT1L;KMT2A;N6AMT1;DYDC2;SMYD3;SMYD2;MEN1
prerank,actin filament bundle organization (GO:0061572),0.3322587483138161,1.0233326068585629,0.4169811320754717,0.9133870634612469,1.0,6/33,6.79%,USH1C;RFLNA;BAIAP2;PAWR;ADD2;CORO1B
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.2793075020264308,-1.0232084418821257,0.3835294117647059,0.7229044891510157,1.0,25/57,25.52%,RPS15;RPL38;RPL5;RPS24;RPL7;RPS17;RPS16;RPL35A;RPS7;RPS28;SURF6;RPS25;RPL14;GTF3A;URB2;MRPL36;LTV1;MRTO4;EBNA1BP2;SDAD1;RRS1;NOP16;RPS19;CUL4A;RIOK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2586197506086766,1.0231666670236654,0.4155629139072848,0.912579487513092,1.0,17/140,9.59%,ADCY5;CCR9;ACKR2;PDGFRA;TAC1;CACNB3;C5AR2;BDKRB1;JPH1;LPAR2;BDKRB2;ADCY8;LPAR1;DRD3;PTGER1;DLG4;C3AR1
prerank,neural crest cell development (GO:0014032),-0.2972932115844113,-1.022921756592889,0.4233409610983982,0.72309950387917,1.0,19/44,27.06%,SEMA6A;SEMA3C;SEMA7A;CORO1C;TBX1;SEMA5B;SEMA3E;SEMA3G;CDH2;SEMA5A;SEMA6D;SOX8;SEMA3F;SEMA4C;SOX11;TAPT1;SNAI2;SEMA4D;SEMA4F
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.41662568303803293,-1.0221779704163199,0.430327868852459,0.7244715149992831,1.0,5/11,15.67%,NOS3;GCH1;QDPR;PRKG2;DHFR
prerank,embryonic hemopoiesis (GO:0035162),-0.40443420599474145,-1.0219346372303473,0.40764331210191085,0.7245765556546448,1.0,4/12,9.95%,KITLG;TGFBR2;KDR;TAL1
prerank,DNA strand elongation (GO:0022616),0.3923440772400071,1.0212132996512722,0.4258188824662813,0.9172269226529551,1.0,6/18,16.77%,GINS1;POLD2;MRE11;TERT;MCM7;MCMDC2
prerank,positive regulation of lipid transport (GO:0032370),-0.41042137907751375,-1.0205110302884777,0.4188911704312115,0.7276687124417782,1.0,3/12,13.83%,ABCA3;APOE;LRP1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3706108440087208,1.0204884828349343,0.43378119001919385,0.9182359783237521,1.0,3/20,6.12%,PPIL6;PPIF;NKTR
prerank,response to reactive oxygen species (GO:0000302),-0.2858426722374779,-1.0204408232389697,0.3882863340563991,0.7272588920762332,1.0,12/54,9.75%,EGFR;PTPRK;JUN;PXN;APOD;MAPK1;RPS3;STK24;SOD1;CAT;APOE;GPX1
prerank,cholesterol homeostasis (GO:0042632),-0.2710788321305858,-1.020201004835209,0.38694638694638694,0.7273105368330347,1.0,13/64,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.40302159583787944,1.0199249789367242,0.41967871485943775,0.9187087752866667,1.0,2/15,0.78%,IGF1;ROCK2
prerank,metanephros development (GO:0001656),0.3495700754027572,1.019804988299468,0.44665461121157324,0.9178082653333067,1.0,3/26,6.63%,BMP7;OSR1;CITED1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.23675051024102772,-1.0197038447541664,0.38095238095238093,0.728046928762043,1.0,27/158,13.32%,ROR1;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;MID2;FLNA;BRD4;CARD16;TFRC;PRKD1;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;MALT1;TERF2IP;EDA2R;CD74;BIRC3;TNFRSF19;ECM1;CD40
prerank,regulation of axon regeneration (GO:0048679),-0.4107435486678752,-1.0196763170658785,0.4511930585683297,0.7275447671749188,1.0,3/12,8.17%,PTN;SCARF1;STK24
prerank,negative regulation of mRNA processing (GO:0050686),0.39596256525030826,1.0193194601593358,0.44536082474226807,0.9180737606737228,1.0,6/15,18.53%,SRSF10;PTBP1;C1QBP;PCBP4;RNPS1;SRSF6
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.28923221404132526,1.0192804124273753,0.40545454545454546,0.9169211454741988,1.0,13/72,11.39%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3
prerank,regulation of chromatin binding (GO:0035561),-0.43182669620347947,-1.019156903197456,0.4442307692307692,0.7283062473845849,1.0,2/10,9.60%,WAPL;HMBOX1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.21950284839512424,1.0190717952093946,0.40601503759398494,0.9163129007151063,1.0,122/807,12.63%,PRDM6;AEBP1;BMP7;WWOX;BMP6;WNT4;DAB2;SNX6;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;DNMT3L;SCML4;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;ZBTB38;CDKN2A;SCRT1;ARID4A;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;CAPN3;TFDP2;CCAR2;DKK3;ENO1;ZHX1;LOXL3;IFI27;DLG1;PEG3;PRMT2;PAX6;IKZF1;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;RCOR3;ZKSCAN3;E2F1;CEBPA;CITED1;DPF1;ATN1;PBXIP1;NRG1;MOSPD1;FGFR2;LBH;JARID2;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;PRDX5;CHD3;MIER3;IMPACT;MED1;KDM2A;HINFP;MAP3K10;MAX;DMAP1;NR1H3;E2F8;ZIC2;MED25;NKAP;RXRA;CLOCK;CBX6;ZFP90;PRDM2;C1QBP;MPHOSPH8;COMMD7;NSD1;FOXP4;LDB2;LDB1;PLCB1;BRD7;RITA1;LCOR;STAT1;FST;MBD1;TAF1;MXI1;KDM5C;QARS1;GATAD2A;PCGF6;CDC73;KDM4A;SOX9;CIPC;RLIM;BEND3;PML;RCOR2;RING1;RBAK;BHLHE41;PIAS4
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.42782235560517157,-1.0187558402345476,0.43378119001919385,0.7287997046832977,1.0,2/11,2.27%,FOXO1;NOTCH1
prerank,receptor clustering (GO:0043113),0.33992578960142733,1.0186284265199252,0.42661448140900193,0.9163277904390159,1.0,8/27,17.81%,MAGI2;DLG1;LRP4;DLG4;ITGB7;LRRC7;DNAJA3;PICK1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.30696050806164354,-1.018325468801672,0.40700218818380746,0.7293422093680481,1.0,15/38,30.67%,HJURP;H3-3A;RBBP4;NASP;UBN1;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ASF1B
prerank,activation of protein kinase A activity (GO:0034199),0.3968318647278718,1.0179323579063877,0.4280078895463511,0.9171686919343485,1.0,3/16,6.20%,ADCY5;ADCY1;ADCY8
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2966639460726811,-1.0177517014526802,0.4214876033057851,0.7303464685017884,1.0,18/42,31.31%,SHLD1;TERF2IP;FUS;SMCHD1;FANCB;PPP4R2;TIMELESS;MAD2L2;RPA2;SPIDR;CHEK1;SIRT6;SHLD3;RAD51AP1;PARP1;CGAS;HELB;MRNIP
prerank,renal system development (GO:0072001),-0.28998483222545507,-1.0177144033620684,0.42596810933940776,0.7298766511764274,1.0,10/52,7.63%,PCSK5;TGFB2;PKD1;BMP4;TBX18;SIX1;ITGA8;SOX17;AGTR1;STRA6
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3854066866846305,-1.0175037018111075,0.43775933609958506,0.7298255893101274,1.0,4/14,14.56%,ARHGDIB;AGO2;VEGFA;ACVR1C
prerank,regulation of histone acetylation (GO:0035065),0.33332351141789773,1.0165080824936563,0.4225621414913958,0.9202747448477044,1.0,8/33,13.55%,KMT2A;CAMK1;RUVBL2;ARRB1;PPARGC1A;BRD7;RAPGEF3;NOC2L
prerank,cochlea morphogenesis (GO:0090103),-0.4273706169143304,-1.016363973500454,0.4489795918367347,0.7321630352695521,1.0,2/10,4.34%,TBX18;TBX1
prerank,fatty acid catabolic process (GO:0009062),0.2900857811078706,1.0158002613603847,0.3955094991364421,0.9211047403979604,1.0,14/67,12.22%,CEL;ACAT2;LPIN1;ACAT1;PCCA;ACAD10;ECHS1;MMUT;ABCD1;ACAD11;ECHDC2;PLA2G15;ABHD3;CROT
prerank,fibrinolysis (GO:0042730),0.40892105712154836,1.0157055187422461,0.4467680608365019,0.920134487810404,1.0,3/13,10.36%,PLAT;PLG;HRG
prerank,protein destabilization (GO:0031648),0.33644981612314706,1.0154635999173867,0.4148550724637681,0.9195850668495531,1.0,10/32,19.07%,DERL1;CAPN3;PLK1;HTT;CTSH;CDC73;SIRT1;MDM2;RNF139;PRNP
prerank,negative regulation of macrophage activation (GO:0043031),0.3916601790489435,1.0154095093708244,0.4326923076923077,0.9184852731020899,1.0,3/16,9.09%,SYT11;TAFA3;NR1H3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.36509101887449247,-1.0153077439293716,0.4111776447105788,0.734344127455517,1.0,7/18,23.96%,PIK3R1;ERN1;NCK1;BAK1;FCGR2B;ATXN3;BOK
prerank,carbohydrate transport (GO:0008643),0.430117168450006,1.015004402587383,0.4332688588007737,0.9185033916836653,1.0,2/11,2.73%,SLC23A2;SLC23A1
prerank,vacuolar acidification (GO:0007035),0.3657202268808353,1.0149509196339963,0.41106719367588934,0.917404905274212,1.0,7/21,14.53%,ATP6V0A2;ATP6V1H;CCDC115;TMEM199;ATP6V0E2;CLN5;ATP6V0D2
prerank,positive regulation of integrin activation (GO:0033625),-0.4186486497516833,-1.0148365073495504,0.45576923076923076,0.7349245730195015,1.0,4/11,15.34%,PIEZO1;RASIP1;SRC;FERMT2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3772798022542526,-1.0147983893445136,0.43870967741935485,0.7344394397522327,1.0,8/17,29.05%,CD44;TWIST1;DYRK1A;CD74;PSMD10;SNAI2;MIF;PTTG1IP
prerank,negative regulation of blood coagulation (GO:0030195),0.3275935004006713,1.0146231380051203,0.4232209737827715,0.9171454220885151,1.0,7/38,10.36%,PDGFRA;TFPI;F10;PLAT;PLG;THBD;HRG
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.34450876830727567,-1.014266573008783,0.4388646288209607,0.7352247033365068,1.0,10/23,25.52%,UBC;RPS27A;XPC;UBB;RAD23B;GPS1;XPA;COPS6;COPS4;CUL4A
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4210173247615896,1.0142209688675896,0.42338709677419356,0.9158767272138301,1.0,1/12,1.69%,FHL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4210173247615896,1.0142209688675896,0.42338709677419356,0.9158767272138301,1.0,1/12,1.69%,FHL2
prerank,cellular response to osmotic stress (GO:0071470),0.3720882981464101,1.0140225766325761,0.4380952380952381,0.9152481043278067,1.0,4/21,4.13%,OXSR1;WNK3;CAPN3;STK39
prerank,T cell differentiation in thymus (GO:0033077),-0.3883580433140617,-1.013963219915669,0.4563106796116505,0.7354006106939123,1.0,6/14,33.14%,GLI3;PTPRC;LIG4;ZFP36L2;FADD;RABL3
prerank,positive regulation of transmembrane transport (GO:0034764),0.40614016060805846,1.0138092263846925,0.4409937888198758,0.9146976294464357,1.0,3/13,11.53%,ACSL1;CLIP3;AZIN2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.23843967917019054,-1.013381053470169,0.43010752688172044,0.7362982941993422,1.0,31/133,15.99%,CAV1;STIM2;ATP2B1;TRPC3;YWHAE;SLC10A7;MICU3;SLC30A1;CAMK2D;NPTN;TRPC6;CXCL12;SLC35G1;TPT1;TRPC4;CCL13;ATP2A3;MCUB;TRPC1;TMCO1;EDN1;CAV2;EDN3;HTR2A;TRPV4;CD40;MICU2;SMDT1;VAPB;BAK1;PRKACA
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3080862855138812,-1.0131871361656528,0.43231441048034935,0.7362358383626538,1.0,7/35,10.78%,GHR;CAV1;NOTCH1;CYP1B1;HES1;VHL;HGS
prerank,coenzyme A metabolic process (GO:0015936),0.3998665389200964,1.0129604850409244,0.4405458089668616,0.9159798385779858,1.0,4/14,12.22%,PANK1;ACAT1;PANK2;CROT
prerank,negative regulation of lyase activity (GO:0051350),0.38587972750325156,1.012772649487079,0.4274952919020716,0.9152961801818379,1.0,4/16,10.67%,DRD3;ADGRV1;LTB4R2;GABBR2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4421214209080643,1.0127362393613761,0.40707964601769914,0.9141815272561771,1.0,2/10,3.24%,CDH3;FURIN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.27935543608768715,-1.0124909873102415,0.4182692307692308,0.7375292305792202,1.0,26/57,25.72%,TNFSF10;MAP3K5;NOD1;AIM2;PERP;BCAP31;CTSD;GRIN2B;MALT1;SOX7;TBC1D10A;ACVR1C;BAK1;USP50;GPER1;GRIN1;FOXL2;HMGB1;SYK;RIPK2;FYN;CASP1;BCL10;DAPK1;CASP8;F2R
prerank,mRNA catabolic process (GO:0006402),0.3134651893080735,1.01196233370044,0.4368231046931408,0.9153342645335291,1.0,8/44,14.28%,HSPA1A;DDX5;DHX34;SUPV3L1;LSM5;TUT4;AGO3;HSPA1B
prerank,calcium ion import (GO:0070509),-0.3246964544213829,-1.0116313196084492,0.4230769230769231,0.7391861521161255,1.0,10/28,15.31%,MICU3;CACNB2;CACNA1G;TRPC4;MCUB;CACNA1B;TRPV4;MICU2;SMDT1;CACNA1I
prerank,response to light stimulus (GO:0009416),0.3008448757363399,1.0114845111583761,0.4295774647887324,0.9154614084041891,1.0,9/55,10.96%,DDB2;CCAR2;UBE4B;SPRTN;MSH6;REV1;CLOCK;MAPK10;USF1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3358846286130846,-1.0113925512759305,0.4418604651162791,0.7392134195481853,1.0,4/24,9.04%,DCN;KDR;MFF;MYO19
prerank,base conversion or substitution editing (GO:0016553),-0.41702058997744307,-1.0112024195055962,0.4609375,0.7391643721726581,1.0,3/11,20.15%,ADARB1;NUDT16;METTL3
prerank,regulation of interferon-alpha production (GO:0032647),0.35868928235673997,1.0111370541464506,0.4416058394160584,0.9153046236106227,1.0,8/23,23.59%,CHUK;NLRC3;STAT1;HAVCR2;TLR8;DDX3X;PTPRS;SETD2
prerank,positive regulation of cell communication (GO:0010647),0.3451205807536543,1.0109960855761735,0.42696629213483145,0.9144967788653424,1.0,5/28,9.52%,WLS;SYT1;GRIK2;RIMS1;DLG4
prerank,exit from mitosis (GO:0010458),-0.40497060400625595,-1.010708410253946,0.45824847250509165,0.7399064898068105,1.0,3/12,6.91%,PPP2R2D;EPS8;CHMP4B
prerank,retinal metabolic process (GO:0042574),0.42743722634070547,1.0101428459566844,0.43664717348927873,0.9158045375355801,1.0,2/12,2.38%,ALDH8A1;ABCA4
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.27071993972011554,1.010121318712382,0.4205933682373473,0.9146505537537546,1.0,24/96,19.96%,MCM3AP;CPSF3;SRSF5;POM121;NUP155;HNRNPA2B1;SMG5;DDX19B;NXT1;YTHDC1;SLBP;NUP98;UPF3B;SRSF11;SMG6;NUP37;RNPS1;ALYREF;NUP88;DDX39B;THOC1;SRSF6;NDC1;SARNP
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.36505226428708615,-1.0100809270660271,0.44510978043912175,0.7409453517068281,1.0,6/18,20.25%,ADAM10;ADAM19;APOE;LDLRAP1;PSEN2;PSENEN
prerank,negative regulation of DNA binding (GO:0043392),-0.32135076701524806,-1.0095076784666783,0.4328018223234624,0.7418583655955754,1.0,9/28,17.19%,LEF1;NFKBIA;JUN;TNKS;HEY2;SMO;MAD2L2;SP100;HEY1
prerank,protein palmitoylation (GO:0018345),0.33958483460523803,1.0095015838307693,0.4527938342967245,0.9153253756626603,1.0,10/30,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3652099754817741,-1.0093579813551758,0.4385593220338983,0.7416957961590961,1.0,9/18,27.87%,FLNA;DHX33;EIF2AK3;MAF1;ATF4;UBTF;SIRT7;RASL11A;LYAR
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.31099291751679503,-1.0085344397066163,0.44565217391304346,0.7431771952309117,1.0,17/37,27.91%,PHLDB1;STMN1;PHLDB2;EFNA5;FAM107A;GAS2L1;BICD2;TRAF3IP1;TAOK1;STMN4;MAPRE2;ROCK1;CYLD;MAP6D1;MAPRE3;SKA3;MAPT
prerank,fatty acid oxidation (GO:0019395),0.29741565914490053,1.0083013292067706,0.4328097731239092,0.9177288209770694,1.0,11/57,12.22%,ADH7;ADH4;ACAT2;ACAT1;ACAD10;ECHS1;PPARGC1A;ABCD1;ACAD11;ECHDC2;CROT
prerank,establishment of protein localization to organelle (GO:0072594),0.28319888414393674,1.0082387847991412,0.44947735191637633,0.9166892072569076,1.0,17/72,18.35%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;LAMP2;NXT1;RYR2;IL10RA;IPO8;TNPO2;HK1;IPO4;NUP88;AKT1
prerank,epithelium development (GO:0060429),0.26639408190614555,1.0081700269795217,0.4215686274509804,0.9156616204744124,1.0,10/107,6.95%,ALDH1A2;WNT4;ERRFI1;OSR1;HNRNPH3;LOXL3;TRIM71;PGK1;NDRG4;FGFR2
prerank,steroid catabolic process (GO:0006706),0.44272892738341796,1.008128726439046,0.4256198347107438,0.9145781815257739,1.0,10/10,55.75%,HSD17B11;HSD11B1;SPP1;HSD17B14;HSD17B6;CYP19A1;FGF23;YWHAH;CYP24A1;CYP27B1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.38159752324139035,1.0077973380672909,0.46716697936210133,0.9143238541004758,1.0,3/18,7.03%,CACNG7;NLGN2;NLGN3
prerank,actin nucleation (GO:0045010),-0.34908081060455654,-1.0076102668960356,0.42795698924731185,0.745032116202905,1.0,10/21,34.03%,WHAMM;JMY;ARPC2;ARPC3;ACTR3;ARPC1B;ARPC1A;SPIRE2;SCIN;ARPC5
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3831489809134568,1.007448419545593,0.45348837209302323,0.914153227234137,1.0,1/17,0.29%,FGF1
prerank,positive regulation of cell aging (GO:0090343),0.42314730266915423,1.0071303365796376,0.45161290322580644,0.9138571407311663,1.0,3/11,4.43%,CDKN2A;LMNA;ARG2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3802228811424645,1.0070005619270368,0.4358490566037736,0.9129893402891867,1.0,1/17,0.50%,LPGAT1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3350063159383371,-1.0069392857092117,0.4291845493562232,0.7461994923652275,1.0,13/26,30.38%,INSR;NOS1AP;PTGS2;KLF4;EDN1;DDAH1;KLF2;ASS1;DDAH2;TLR4;TMEM106A;CD36;TLR6
prerank,mammary gland development (GO:0030879),-0.33959702362195127,-1.0067737682175053,0.4625,0.7460897734866627,1.0,6/21,13.82%,CAV1;TBX3;ARHGAP35;TGFB3;NOTCH4;VEGFA
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.269738014606439,-1.006749069058956,0.4340909090909091,0.7455909163930425,1.0,11/63,8.77%,CAV1;ITGA6;ACVR1;TNFSF10;THBS1;BMP4;FAS;PAK2;AR;FEM1B;SRC
prerank,error-free translesion synthesis (GO:0070987),-0.3418331392393993,-1.0067154905198425,0.45435684647302904,0.7451206032481906,1.0,4/22,5.64%,RPA1;UBC;RPS27A;UBB
prerank,alanine transport (GO:0032328),-0.4198717138532932,-1.0067104440832635,0.4629981024667932,0.7445696227265255,1.0,1/10,0.35%,SLC6A6
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3799419736827277,-1.0066972549571518,0.4376321353065539,0.7440338281311202,1.0,3/14,9.96%,GAS6;CARD16;CCDC3
prerank,acylglycerol catabolic process (GO:0046464),-0.31692086569003514,-1.0065817242137025,0.4391304347826087,0.7437990210309479,1.0,4/30,12.54%,ABHD2;MGLL;PNPLA2;ABHD6
prerank,odontogenesis (GO:0042476),-0.2985422649771154,-1.0065557631956399,0.46924829157175396,0.7432923232237539,1.0,7/35,12.38%,LRP6;TGFB2;BMP4;TBX1;AXIN2;TGFB3;BMP2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.326714917923324,-1.0063994804850107,0.42943548387096775,0.7431548395038973,1.0,5/26,10.47%,FOXP1;CRY1;STRN3;HEYL;PER1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.2940961794485052,1.0063672753454824,0.4525939177101968,0.9112845256948087,1.0,20/61,20.28%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,vesicle coating (GO:0006901),0.2940961794485052,1.0063672753454824,0.4525939177101968,0.9112845256948087,1.0,20/61,20.28%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,COPII vesicle coating (GO:0048208),0.2940961794485052,1.0063672753454824,0.4525939177101968,0.9112845256948087,1.0,20/61,20.28%,F5;BET1;NAPA;GOLGA2;NSF;SEC23IP;CNIH3;TRAPPC1;USO1;RAB1A;PPP6C;TRAPPC4;TRAPPC3;TMED2;MCFD2;SEC22B;TFG;F8;PEF1;PDCD6
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4148117187005133,-1.0063200099247023,0.4516765285996055,0.7427876964275008,1.0,3/11,13.36%,P4HA1;CRTAP;P4HA2
prerank,cellular response to amino acid starvation (GO:0034198),0.2849755766608457,1.006067469155242,0.4337568058076225,0.9109727984534973,1.0,17/71,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.31920199416054107,-1.0059353543926874,0.4431818181818182,0.7432760255358645,1.0,5/31,10.52%,SHANK3;PDLIM5;CDK5;ABI3;CFL1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.35983055131103947,1.0057644412349238,0.4367588932806324,0.9094927039720333,1.0,8/22,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.35983055131103947,1.0057644412349238,0.4367588932806324,0.9094927039720333,1.0,8/22,17.44%,ZDHHC12;CLIP3;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;ZDHHC23
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3771751129394271,-1.0057145527196438,0.44375,0.7432960058020271,1.0,10/16,39.92%,SHLD1;SMCHD1;FANCB;MAD2L2;SHLD3;CGAS;HELB;RADX;POLQ;SHLD2
prerank,negative regulation of GTPase activity (GO:0034260),-0.34311073397418235,-1.0056903644029347,0.44742268041237115,0.7427973078549707,1.0,4/22,3.89%,LRCH1;DAB2IP;SH3BP4;F11R
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.28289052532431697,-1.0052373633832727,0.42857142857142855,0.7434157541733025,1.0,15/52,15.19%,YWHAE;YWHAB;UBE2D3;SAE1;ABLIM3;ARIH2;YWHAQ;YWHAZ;SREBF2;MICALL2;UBE2L3;FBXW7;UBL5;BBC3;UBE2J2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.334240587156138,-1.0052262804783627,0.4357298474945534,0.7428787583050315,1.0,7/24,12.34%,BMPR2;ACVRL1;DACH1;XRCC5;RPS3;TERF2IP;BLM
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.324945947306869,-1.0051117426685907,0.453781512605042,0.7426245719555472,1.0,11/27,20.35%,TEK;TNFAIP8L3;PRKD1;FLT1;FGF2;PTK2B;IRS1;PIK3R4;FGFR3;NOD2;AGAP2
prerank,brain development (GO:0007420),-0.23801548541896997,-1.0040061729217615,0.4411764705882353,0.7449600041503228,1.0,20/136,12.19%,ADGRL2;SHANK3;RAPGEF2;PBX1;ZFHX3;COL4A1;SHROOM4;PBX3;TGFBR2;EML1;BPTF;NIPBL;APOD;UFC1;GRIN2B;DSCAML1;ADGRG1;ATXN1;PTCH1;MFSD2A
prerank,cellular response to acid chemical (GO:0071229),-0.32092281318973565,-1.003815427159381,0.445859872611465,0.7448923545145932,1.0,10/27,14.92%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;VEGFA;KLF2;GLRA2
prerank,retrograde axonal transport (GO:0008090),-0.3699023409984745,-1.0032448323275265,0.45222929936305734,0.7457949042682128,1.0,5/16,17.93%,DST;SOD1;KIF1C;PAFAH1B1;DYNC1H1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.34339975677264395,-1.0031275688337675,0.4537987679671458,0.7455260399058158,1.0,6/22,19.47%,SLC7A5;TNFRSF1B;WNT5A;TRIL;NOD2;BTK
prerank,actin filament network formation (GO:0051639),-0.41343803023811204,-1.0029838434882878,0.44285714285714284,0.7453493348973989,1.0,2/11,4.45%,PLS3;ACTN1
prerank,hexose metabolic process (GO:0019318),0.3197433887526482,1.002788950128212,0.43470149253731344,0.9172040545442841,1.0,11/39,17.05%,CHST15;SORD;PGM1;ALDOB;GALT;FUCA1;BRAT1;PMM2;HECTD4;HK1;ALDOC
prerank,translational elongation (GO:0006414),-0.24830050130691794,-1.0027729374774548,0.4508816120906801,0.7452730892334894,1.0,28/101,20.20%,EEF2K;EEF1A1;DAP3;MRPS10;MRPL20;RACK1;EEF2;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;EEF1G;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,response to nitric oxide (GO:0071731),-0.3916443078126607,-1.0025709742551494,0.47398843930635837,0.7452498510949668,1.0,2/13,2.33%,FOXO1;GUCY1B1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.2787256798552364,1.0025306560613492,0.4685430463576159,0.9167375106083275,1.0,22/74,18.35%,EYA1;IGF1;HSPA1A;EYA4;EYA2;SIAH2;PELI3;HTT;PHIP;TGFBR1;CFLAR;BCL2;FAIM;TERT;SCG2;HSPA1B;NOL3;FAIM2;RELA;IL1A;TCF7L2;AKT1
prerank,protein ubiquitination (GO:0016567),0.22407208635842119,1.002236884872438,0.4380952380952381,0.9164368642107349,1.0,113/471,21.24%,RNF220;RNF152;EPAS1;RNF43;UBE2E2;DDB2;SH3RF2;CTR9;ASB2;PDZRN3;DTX1;DERL1;FBXL19;TRIM62;PSMD3;SIAH2;RNF41;RNF126;TRIM5;FBXL12;LEO1;PLK1;DZIP3;TRIM71;KLHL13;SHPRH;RNF14;TNKS2;UBE4B;UBA1;FBXO11;TRIM35;ARRB1;DTX2;PELI3;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;SASH1;BCL2;FBXO6;RNF10;RNF20;RNF6;CAND2;PRPF19;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;CDC73;RLIM;RNF31;NEDD8;FBXO17;FBXO41;PSMD1;SPSB2;PSMC5;RNF138;RNF7;PRKDC;PSMA1;UBE2R2;RBCK1;UCHL3;EIPR1;SIRT1;PSMD12;RNF213;KLHL20;TRIM3;FBXL16;MDM2;RBBP6;UBE2S;ANKIB1;ANAPC7;USP9X;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;FBXO22;PSMD7;TRIM2;TRIM13;BFAR;FBXL5;KLHL7;SPSB1;KLHL42;TRIM41;PHC1;NFX1;RNF146;MYCBP2;RMND5A;UBOX5;KLHL21;HECW1;FBXL15;ZSWIM8;PSME2;TRIM32;RNF103-CHMP3
prerank,ubiquinone metabolic process (GO:0006743),0.3889349173533984,1.002160551560901,0.4547244094488189,0.9154942777473593,1.0,6/15,20.55%,COQ10A;COQ8B;AIFM2;COQ7;COQ3;FDXR
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3820204557857491,-1.0018414675849037,0.4524793388429752,0.7466338807800855,1.0,4/14,14.71%,FOXO3;FASTKD1;EARS2;MRPL12
prerank,connective tissue development (GO:0061448),-0.3092262817692544,-1.0018093999531208,0.4481236203090508,0.7461654541721722,1.0,5/35,5.93%,ZBTB16;LRP5;PKD1;CD44;SH3PXD2B
prerank,purine nucleotide metabolic process (GO:0006163),-0.3381370439959792,-1.0017785212825383,0.43661971830985913,0.7456920727792988,1.0,13/24,37.84%,XDH;HPRT1;GPX1;NT5C1A;NT5E;NT5C;GDA;FHIT;PRPSAP1;GART;PRPS2;NUDT15;PPAT
prerank,endodermal cell fate commitment (GO:0001711),0.43440964439651586,1.0016531232263524,0.4866412213740458,0.9157885442817113,1.0,3/10,11.83%,CTR9;LEO1;CDC73
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3817491545837334,1.0016335900872804,0.4327485380116959,0.9146449609117724,1.0,4/17,5.34%,NOTCH2;GALNT11;BMPR1A;RBPJ
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.32253905462367255,-1.001596044287724,0.4634146341463415,0.7455894880923619,1.0,10/31,23.25%,GPHN;GCH1;LIAS;NFS1;MOCS1;LSS;NOXRED1;SRD5A1;PYCR3;SCP2
prerank,microtubule anchoring (GO:0034453),0.4193934173837629,1.0015609726218029,0.44045368620037806,0.9136490757778045,1.0,3/12,11.11%,CLASP1;BICD1;PCM1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.20780849004557764,1.001538459556239,0.4616252821670429,0.9125333163551579,1.0,271/1668,15.61%,PRDM6;AEBP1;ZKSCAN2;MAF;RORA;FGF1;WWOX;EPAS1;HLF;BMP6;DAB2;CREB5;PPARGC1B;IGF1;DDX5;CBX7;IL18;SMAD3;KCNIP3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;MAGEA2;HMX2;MSX2;CXXC5;SOX5;BEX1;OVOL2;CTR9;FHL2;THRB;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;NR6A1;ARNT2;DOT1L;PBX2;KIT;ZNF431;PCGF2;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;HOXB9;BMPR1A;TFDP2;BRD8;SIM1;WNT7A;CSRP3;CHUK;CCNT2;ENO1;ZHX1;SMARCD3;TNRC6A;KMT2A;HOXB3;MAFG;LPIN1;TET1;MEIS1;IFI27;CAMK1;DLG1;TIAL1;PEG3;RUVBL2;TCEA1;MLXIP;PAX6;IKZF1;PHF8;RBPJ;PLK1;IKZF2;MZF1;DNMT3A;AUTS2;ARID3A;HNRNPU;ZFHX2;TNIP3;WWTR1;ZBTB26;HOXA7;ZNF462;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;IKBKG;PCGF5;E2F1;CEBPA;CITED1;DPF1;ATN1;MOSPD1;FGFR2;HOXB6;DDX17;BCL11B;KAT5;NR2F2;TEF;ARRB1;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KDM6B;NLRP3;ZNF467;MIER3;PHF2;IMPACT;NFATC2IP;HES6;MED1;MAFA;TNIP2;PPARGC1A;ZFX;KDM2A;HINFP;HIF3A;MAX;DMAP1;EAF2;NR1H3;RHOQ;PHIP;E2F8;ZBTB22;HDX;ZIC2;MED25;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CBX6;ZFP90;PRDM2;PSIP1;C1QBP;NSD1;SALL3;FOXP4;LDB2;LDB1;PRKCB;CSRNP3;BRD7;ZNF260;PPM1D;RNF10;RITA1;LCOR;BCLAF3;E2F4;CSRNP1;MAPK14;STAT1;USF1;BATF;FST;TAF1;MXI1;STAT2;WASL;FZD5;GATAD2A;PCGF6;ZBTB49;CDC73;DMTF1;SOX9;SRA1;MED12L;BEND3;RCOR2;RBAK;FHOD1;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;JAZF1;GABPA;ZIC5;AGO3;YEATS4;SMYD2;ABCA2;ABHD14B;EN2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;DICER1;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;ZFP64;CREB3L4;PRKDC;ZNF507;GABPB1;MLLT10;WBP2;SAFB2;TBL1XR1;BCL11A;PER2;WAS;MED15;HEXIM2;PTOV1;ZBTB43;ERF;ABL1;TADA1;MUC1;PPP3R1;MSX1;HNF4G;GADD45A;TFE3;HIC2;SIRT1;DPF3;IL6;HGF
prerank,cellular response to alkaloid (GO:0071312),0.37898279070291485,1.0014187700218458,0.4556213017751479,0.9117121607476957,1.0,4/17,11.04%,TRPV1;CASP3;GSTM2;RYR2
prerank,purine-containing compound catabolic process (GO:0072523),-0.39745336886865,-1.0013561581526886,0.4624505928853755,0.7456658469760125,1.0,6/13,21.88%,XDH;GPX1;NT5C1A;NT5E;NT5C;GDA
prerank,regulation of programmed cell death (GO:0043067),-0.23090956445666677,-1.0011721683872923,0.46070460704607047,0.7455982258821363,1.0,58/161,30.16%,HIP1;MECOM;ACTN4;STEAP3;ACER2;APAF1;ACTN1;FAS;CRADD;PERP;TPT1;TGM2;RPS3;CDK5;BCAR1;IFT57;MALT1;CTSB;PHLPP1;BIRC3;RARG;NME2;MADD;ALK;RTN4;RBM25;TMEM219;OSGIN1;PTPN6;STK26;TIGAR;RIPK1;JAK3;AKT1S1;ACER3;LCMT1;BCL3;SLK;CHM;CASP1;NUP62;FANK1;TRIAP1;DAPK1;ZBTB7A;LRP8;WFS1;RTKN;DAPK2;DDX42;AGT;VCP;BIRC5;FBXO10;MARK4;FLT3;PMAIP1;IRF3
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4053874551413182,-1.0010029836553758,0.4572564612326044,0.7454461413392854,1.0,4/11,30.30%,AGTR1;PLA2G7;AGT;PLA2G5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.37049045568516165,-1.0008538575284882,0.458,0.7452623604255372,1.0,6/17,17.01%,JAG1;STAT3;CD55;BACH2;CD46;GNL1
prerank,membrane lipid metabolic process (GO:0006643),-0.3423713244114222,-1.0006949684294806,0.47435897435897434,0.7451032461088369,1.0,4/22,4.01%,ST3GAL6;CYP1B1;AGK;B4GALT4
prerank,striated muscle cell differentiation (GO:0051146),-0.3696578767514346,-1.0004977136422515,0.4817073170731707,0.7450306189042365,1.0,11/16,37.17%,MEF2C;SORT1;MYOCD;BMP2;PLD3;SKI;CBY1;SIK1;POPDC3;POPDC2;MYEF2
prerank,determination of bilateral symmetry (GO:0009855),-0.3367111864885012,-1.000417900464185,0.4752688172043011,0.7446704984147188,1.0,14/24,35.59%,NOTCH1;TBX1;DNAH11;STIL;CFAP53;DLL1;ODAD2;ODAD3;ZIC3;FOXJ1;NPHP3;LEFTY1;DNAAF4;BBS7
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3735857732298904,-0.9999502872787016,0.45219123505976094,0.7453209819354852,1.0,5/16,17.64%,CAV1;TRIM14;TRIM25;NECTIN2;EXOC7
prerank,regulation of secretion by cell (GO:1903530),0.2958819658499011,0.9998145135991687,0.4595070422535211,0.9153312462490327,1.0,19/54,20.07%,SNCAIP;RAB21;SYT1;RAB3C;LLGL2;STXBP5L;RIMS1;NSF;LLGL1;CPLANE2;RAB13;CPLX1;SYN1;STX4;HTR1A;CPLX2;RHBDF1;SCG5;RAB15
prerank,JNK cascade (GO:0007254),-0.2943012264848084,-0.9997592310326618,0.4683257918552036,0.7452464839938165,1.0,13/40,22.59%,MAP3K5;UBC;NOD1;RPS27A;UBB;TNFRSF19;IRAK2;TAB1;GPS1;NOD2;MAP2K7;RIPK2;MAP4K3
prerank,blood vessel endothelial cell migration (GO:0043534),0.3571172003951469,0.9993778186366397,0.46534653465346537,0.9153964739019846,1.0,3/22,2.36%,ROBO1;EFNB2;PIK3R3
prerank,mitotic cytokinetic process (GO:1902410),-0.3487288522842977,-0.9992478006971369,0.4340770791075051,0.7460236351432595,1.0,4/20,6.92%,RHOA;CHMP2B;CHMP4B;CHMP4A
prerank,T cell receptor signaling pathway (GO:0050852),-0.23868236335909776,-0.9991624587996522,0.45707070707070707,0.7456937350735776,1.0,37/138,23.25%,PDE4D;RFTN1;PIK3R1;PLCG1;PTPRJ;PLCG2;PAK2;TEC;NCK1;PSMA6;INPP5D;PSMB7;TNFRSF21;SPPL3;EIF2B2;PIK3CA;BCAR1;PSMB6;MALT1;PIK3CD;PSMB5;PTPRC;PSMB8;PSMC4;PSMD11;DENND1B;EIF2B1;PSMB4;PSMD14;ZC3H12A;PSMD10;PSME1;RIPK2;FYN;CD276;BCL10;PSMB3
prerank,regulation of extracellular matrix organization (GO:1903053),0.4010587036126099,0.9989339185838303,0.43434343434343436,0.9155763688403854,1.0,1/15,0.06%,AEBP1
prerank,neuron differentiation (GO:0030182),0.24961737092239614,0.9984749964631571,0.4351851851851852,0.9157528082807986,1.0,21/165,10.11%,WNT4;HS6ST1;IL1RAPL1;VXN;WNT5B;TENM1;PBX2;DTNB;WNT7A;PAX6;FZD8;PBX4;CASP3;FZD3;WNT6;NTRK2;PTPRD;FZD7;TDP2;TGFBR1;LDB1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4388264404434617,0.9980348809786636,0.4538152610441767,0.9158710255516638,1.0,3/10,11.76%,RENBP;GNPDA1;NPL
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.39862177199710547,-0.997933399492768,0.46942800788954636,0.7483930338020923,1.0,6/13,18.75%,CACNA1G;STX1A;SYT4;CACNA1I;KCNB1;CACNA1H
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3955130816646304,-0.9979047850667552,0.4518201284796574,0.7479191736358896,1.0,5/13,18.85%,NOS3;GLS;DDAH1;GLUD1;PRODH
prerank,protein kinase B signaling (GO:0043491),0.35152875458538185,0.997774942938807,0.44701348747591524,0.9154418429028561,1.0,2/23,2.36%,IGF1;PIK3R3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3340536075641249,-0.9974929171981601,0.4790794979079498,0.7484143284500171,1.0,7/24,15.85%,NOTCH1;CREB3L1;VEGFA;KLF2;MT3;ATF6B;ATF4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3453641570097662,-0.9973840727096218,0.45474613686534215,0.7481339270515296,1.0,4/20,6.06%,CRY1;STMN1;YWHAB;MET
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3498729131999307,-0.9973751974121098,0.445859872611465,0.7476017483339186,1.0,6/19,13.71%,PRKCD;ABCD2;TWIST1;PNPLA2;AKT2;IRS1
prerank,regulation of presynapse assembly (GO:1905606),0.36723626177155466,0.9973312684359299,0.47368421052631576,0.9144458909453814,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,regulation of presynapse organization (GO:0099174),0.36723626177155466,0.9973312684359299,0.47368421052631576,0.9144458909453814,1.0,4/18,8.56%,IL1RAPL1;WNT7A;IL1RAPL2;PTPRD
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.28786266917541153,-0.9968273780916266,0.4666666666666667,0.7484410382350113,1.0,20/46,31.73%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.36515240873036237,-0.9966604577876984,0.46220302375809935,0.74834243512697,1.0,8/17,28.06%,FAF2;HM13;RHBDD1;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,kidney development (GO:0001822),0.2870204092356244,0.9963501478491655,0.45323741007194246,0.9161387238904284,1.0,13/65,14.87%,BMP7;WNT4;GREB1L;OSR1;CITED1;LRP4;VANGL2;CEP290;TGFBR1;CTSH;BAG6;FOXC1;ARL3
prerank,protein deacetylation (GO:0006476),-0.28973896736787985,-0.9963044600069815,0.4677754677754678,0.748711960988404,1.0,14/41,23.63%,MIER1;FLNA;PRDM5;HDAC7;HDAC9;SIRT5;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6
prerank,atrial septum morphogenesis (GO:0060413),-0.42338567622546164,-0.9961670270978813,0.47347740667976423,0.7485028887354809,1.0,4/10,8.50%,BMPR2;ACVR1;TGFB2;HEY2
prerank,regulation of vacuole organization (GO:0044088),0.36557009545347957,0.9958626506392848,0.4217557251908397,0.9164318462857933,1.0,11/20,26.50%,NPRL3;ENO1;ENO4;TBC1D14;NPRL2;ANXA2;ADPRH;PIKFYVE;IFT20;MTM1;ENO3
prerank,protein-containing complex assembly (GO:0065003),0.2346019987703156,0.9957428089893812,0.46050670640834573,0.9155945152778786,1.0,69/259,20.28%,AFDN;F5;USH1C;CD247;WDCP;BET1;WDR19;CAPN3;PLEKHA7;PICALM;RSPH4A;KMT2A;DNAJB14;AFG3L2;ADD2;LEO1;GSDMD;ADCY8;IKBKG;KAT5;SHANK1;NAPA;RIMS1;LRRK2;GOLGA2;WASF1;PPARGC1A;NSF;TUBGCP4;LLGL1;DLG4;SEC23IP;CAND2;WASL;EPRS1;CDC73;SOX9;PML;CNIH3;TRAPPC1;USO1;WASF3;TERT;RAB1A;MEN1;PPP6C;TRAPPC4;TRAPPC3;WAS;TAPBP;TMED2;MDM2;MCFD2;HFE;NOL3;SEC22B;SKAP2;TFG;TCF7L2;F8;CX3CL1;MITF;SNX9;TFAP4;HGSNAT;PYGO1;PEF1;DNM1L;PDCD6
prerank,positive regulation of ruffle assembly (GO:1900029),-0.39548150061442355,-0.995586547920134,0.4472168905950096,0.7493705737810011,1.0,3/13,13.07%,EPS8;EPS8L2;PFN1
prerank,histone H3 acetylation (GO:0043966),-0.29272932624613796,-0.995453368012675,0.430406852248394,0.7491696634202437,1.0,10/40,16.90%,LEF1;KAT7;KAT6A;TRIM16;PER1;JADE2;TAF5L;BRCA2;BRPF3;ING4
prerank,sterol homeostasis (GO:0055092),-0.26350304885091813,-0.99536903650366,0.4423529411764706,0.7488162884872878,1.0,13/65,11.15%,CYP7B1;CAV1;SCARB1;LRP5;ABCA1;CYP39A1;NPC2;TTC39B;MTTP;HDAC9;APOE;INSIG1;LIMA1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.30951479626292105,-0.9952888495585075,0.4597457627118644,0.7484486295287643,1.0,20/34,34.99%,PDE4D;KCNQ1;CALM3;PRKACA;PLN;ZC3H12A;GJA5;PIK3CG;SLC8A1;STC1;RGS2;CALM1;HCN4;SMAD7;RNF207;NOS1;ADRA1A;ATP1B1;TNNI3K;CALM2
prerank,maturation of LSU-rRNA (GO:0000470),0.34333870568957897,0.9948981307693325,0.45604395604395603,0.916988208786199,1.0,1/26,0.08%,NSA2
prerank,response to amino acid starvation (GO:1990928),0.2810875131446448,0.9948722507776483,0.45863309352517984,0.9159058398836524,1.0,17/72,15.20%,RNF152;NPRL3;RRAGC;ATP6V0B;ATP6V1H;IMPACT;SESN1;ATP6V1B2;EIF2AK2;SLC38A9;ATP6V1E1;LAMTOR2;ATP6V0E2;ATP6V1C1;ATP6V0D2;NPRL2;LAMTOR3
prerank,female gonad development (GO:0008585),0.37621605449514284,0.9946874979823678,0.47534516765285995,0.9152948926336697,1.0,5/19,10.52%,KIT;NR2F2;INHA;EIF2B4;COL9A3
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3082599822518507,-0.9945217608661083,0.43951612903225806,0.7493500191414258,1.0,11/31,26.39%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3082599822518507,-0.9945217608661083,0.43951612903225806,0.7493500191414258,1.0,11/31,26.39%,GTF2H5;GTF2F1;GTF2H1;NCBP2;ERCC2;NCBP1;POLR2I;CCNH;CMTR2;POLR2F;POLR2H
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3102907778391259,-0.9944240238264475,0.45726495726495725,0.7490298549770352,1.0,7/34,13.79%,SLC7A5;VAMP3;WNT5A;EPHB2;PHB2;PTPRC;CD86
prerank,regulation of dendritic spine development (GO:0060998),-0.3468191769350765,-0.994395281416722,0.46693386773547096,0.7485561129804866,1.0,2/19,0.56%,MEF2C;SHANK3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3611364644258039,-0.9942000569775244,0.44933920704845814,0.7485522372896538,1.0,10/17,38.15%,CXCL12;SERPINE1;HMGB1;PLA2G7;CCR2;ANO6;AIF1;CXCL17;CCL5;CCR1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.302124199221474,0.9941313330188882,0.4763636363636364,0.915759310266698,1.0,9/48,8.98%,ADCY5;ADCY1;SLC26A1;PANK1;ACAT1;ADCY8;PANK2;AK5;AMPD3
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.28992730070309325,-0.9937608475489148,0.46170212765957447,0.7491139128176298,1.0,11/44,20.01%,GSN;CDC42EP5;CDC42EP3;NCK1;WHAMM;CDC42EP2;PTK2B;PFN1;NCKAP1L;FCHSD1;HCK
prerank,cytosolic transport (GO:0016482),-0.2431872777145398,-0.9937255672774035,0.46534653465346537,0.7486540319142952,1.0,42/108,27.30%,MYO1D;RAB14;VPS53;VPS13C;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;EMP2;VPS26A;SORT1;TMEM87B;PIK3C3;GOSR1;VPS13A;SYS1;TBC1D10A;AP2A1;STX8;SNX2;ANKRD27;STX6;RHOBTB3;DCTN1;PREPL;EPS15;SNX5;RIC1;VPS26B;VPS52;STX5;GAK;EVI5;DOP1B;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.28824774683251575,-0.9936932738755816,0.4789356984478936,0.7481856239784127,1.0,9/46,12.56%,YWHAE;GAS6;PIK3R1;CDH1;FLNA;PRKCD;IPO5;NCBP2;TPR
prerank,dendrite morphogenesis (GO:0048813),-0.29973842824562263,-0.9936798635675843,0.4837310195227766,0.747673782927929,1.0,7/35,10.32%,SHANK3;FARP1;DOCK10;PTN;KLF7;BTBD3;EPHB2
prerank,glycolipid metabolic process (GO:0006664),-0.2879716402340128,-0.9936171300500263,0.4637002341920375,0.7472958552790498,1.0,10/47,13.30%,ST3GAL4;ST6GALNAC3;ESYT2;ST3GAL6;ST8SIA6;ESYT3;HEXA;PSAP;UGCG;ARSA
prerank,neuronal action potential (GO:0019228),-0.33776324848936945,-0.9931697867511526,0.46771037181996084,0.7478508956754575,1.0,7/22,21.60%,CACNA1G;KCNMB2;CACNA1I;SCN3A;GPER1;CACNA1H;SCN7A
prerank,apoptotic mitochondrial changes (GO:0008637),0.3228996298387852,0.9930709962418542,0.44204322200392926,0.917776226129288,1.0,10/32,20.76%,IFIT2;CCAR2;FZD9;NDUFS1;BCL2;CLU;AIFM2;ATP2A1;DNM1L;BAX
prerank,hyaluronan catabolic process (GO:0030214),-0.36760763446573,-0.9930322479727456,0.4881422924901186,0.747640294931349,1.0,5/18,15.20%,CD44;FGF2;HEXA;CEMIP;CEMIP2
prerank,regulation of cellular pH (GO:0030641),-0.3217478849024881,-0.9928932296050164,0.4714587737843552,0.7474446624967742,1.0,6/29,14.88%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2
prerank,regulation of cation channel activity (GO:2001257),0.2721887943547621,0.9928873113080485,0.4706927175843694,0.9171348248839961,1.0,19/89,15.09%,CACNG7;ACTN2;CACNB1;ANK2;CACNB3;NLGN2;JPH1;DLG1;FGF12;SHISA7;SHANK1;GSG1L;DLG4;CNIH3;FGF14;OPRM1;SHISA8;LRRC7;GRIA2
prerank,lysine catabolic process (GO:0006554),0.4171336874627415,0.9926973778704969,0.46808510638297873,0.9153677016776959,1.0,2/12,11.65%,ALDH7A1;GCDH
prerank,lysine metabolic process (GO:0006553),0.4171336874627415,0.9926973778704969,0.46808510638297873,0.9153677016776959,1.0,2/12,11.65%,ALDH7A1;GCDH
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.39358580289264844,0.9926472641045035,0.48440748440748443,0.9143526420479992,1.0,2/14,4.92%,IL18;EBI3
prerank,sensory perception of light stimulus (GO:0050953),0.2705936464339186,0.9923742415630855,0.4438687392055268,0.9140135165020752,1.0,23/87,22.59%,USH1C;GPR143;EYA4;WHRN;EML2;ARR3;PAX6;PCDH15;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA;CLRN1
prerank,intracellular protein transport (GO:0006886),0.23132794685772493,0.9923609705905968,0.468562874251497,0.9129013529894633,1.0,68/304,18.93%,RANBP3L;SNX6;TRAK1;APPL2;CTSA;WLS;IPO13;FAM53A;POM121;RAB21;STAM;NAPB;NUP155;CLIP3;COX18;SGSM3;NUP62CL;VPS26C;ARFGAP3;STX16;GGA2;STRADB;TNPO3;RUNDC1;TBC1D9B;KIF13B;NAPA;SNF8;RAB6B;ARL5B;NSF;SEC23IP;LAMP2;NXT1;TMED9;TMED4;SGSM2;IPO8;USO1;SNX8;RAB1A;TBC1D14;AP4M1;TBC1D10B;DESI1;FUT10;GGA1;VPS45;TBC1D16;AKAP6;RAB23;TNPO2;STX4;RAB19;TMED2;RPGR;IPO4;SEC31B;NUP88;SYNDIG1;PICK1;OXA1L;AKT1;HPS4;VPS29;GRTP1;SNX9;RAB38
prerank,nitric oxide metabolic process (GO:0046209),0.39807343370674475,0.9913078138101515,0.44969199178644764,0.9147551670175836,1.0,3/14,4.43%,GCHFR;NQO1;ARG2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3873056991556326,-0.9909799457317107,0.4726166328600406,0.751752906638569,1.0,4/14,15.55%,TFRC;SHLD1;NECTIN2;MAD2L2
prerank,phospholipid catabolic process (GO:0009395),-0.3289022195471187,-0.9908595567257679,0.49324324324324326,0.7515069918477635,1.0,4/24,14.66%,PLA2G4A;GPCPD1;PRDX6;SMPDL3A
prerank,positive regulation of mRNA processing (GO:0050685),-0.3387882268523164,-0.9907936591435333,0.49190283400809715,0.7511663348720112,1.0,9/21,25.86%,RBM3;PRDX6;PAF1;NCBP2;NCBP1;NCL;SNW1;TRA2B;DAZAP1
prerank,glial cell differentiation (GO:0010001),-0.311829366066496,-0.9903979323659952,0.4663677130044843,0.751608338948776,1.0,10/28,22.64%,ADGRG6;STAT3;CDK5;PTPRZ1;CDH2;GPC1;SOX8;MYRF;METRN;SOX11
prerank,cellular response to purine-containing compound (GO:0071415),0.431246692573129,0.9903156565938961,0.4878048780487805,0.9165071005849289,1.0,3/10,11.47%,GSTM2;RYR2;TRPM2
prerank,regulation of exit from mitosis (GO:0007096),-0.2950302000939269,-0.9897464111591466,0.4883720930232558,0.7527372572307932,1.0,6/38,7.05%,CDC27;UBC;ANAPC5;RPS27A;UBB;CDC16
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.30310003249773265,-0.988990983822058,0.45951859956236324,0.7541610813721463,1.0,13/33,22.53%,SLC39A8;GLS;GCLC;DDAH1;GCLM;ALDH18A1;GLUD1;ALDH5A1;CAD;PRODH;PYCR3;DDAH2;GGT1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.36969971206727026,-0.988610973316543,0.4777327935222672,0.7545352280811272,1.0,7/15,17.41%,DCN;CSGALNACT1;CSPG4;VCAN;BGN;B3GAT3;NCAN
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.26313868370601246,-0.9885778846100471,0.47115384615384615,0.7540861036780754,1.0,27/68,33.08%,STAT3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;TWIST1;CD74;IFIH1;NOD2;IL33;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;TYROBP
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.31159255743126607,-0.988396723739729,0.47921225382932164,0.7540045391036221,1.0,17/30,32.89%,UBC;RPS27A;UBB;UBE2D3;BIRC3;CD40;RIPK1;TICAM1;CASP8;TLR4;CD300LF;FADD;IRF3;TLR6;CD14;IKBKB;TLR3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.35125400286964176,-0.9883952962432776,0.4699792960662526,0.7534636458924,1.0,3/18,5.64%,UBC;RPS27A;UBB
prerank,regulation of stem cell differentiation (GO:2000736),-0.25223504644950007,-0.9878131442502991,0.45588235294117646,0.7544217932738383,1.0,25/89,23.25%,PTN;JAG1;TCF12;NOTCH1;LMO2;RUNX1;HES1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;SP7;PSMB4;PSMD14;METTL3;PSMD10;PSME1;RBM24;PSMB3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2577219263501825,-0.9878080359371576,0.4781491002570694,0.7538959142404363,1.0,13/76,9.91%,DAB2IP;TMSB4X;CD200;CYP1B1;PTGIS;NFKBIA;IRAK3;TRIM37;AIM2;NLRC5;DAP;USP7;KLF4
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2975752208139479,-0.9878080149384335,0.47285067873303166,0.7533535430791123,1.0,11/36,17.95%,ENG;RASSF2;RAP2A;CALM3;PPP2R5C;PDGFC;PDGFD;ENPP1;VEGFA;TNKS1BP1;NBN
prerank,pre-miRNA processing (GO:0031054),-0.38864569198458,-0.987738472267479,0.47674418604651164,0.7529897586980786,1.0,6/14,23.33%,AGO1;AGO2;DROSHA;AGO4;MRPL44;TARBP2
prerank,regulation of immunoglobulin production (GO:0002637),-0.3403681226643887,-0.9873463466568482,0.4589473684210526,0.7534813515924464,1.0,5/23,13.79%,VAMP3;EPHB2;PHB2;PTPRC;CD86
prerank,cGMP biosynthetic process (GO:0006182),-0.41181407636806977,-0.9873273127458831,0.45790554414784396,0.7529884575191211,1.0,3/10,18.89%,GUCY1B1;GUCY1A1;NPPC
prerank,dicarboxylic acid metabolic process (GO:0043648),0.29432573499633113,0.9871018515541423,0.466789667896679,0.9247827145882282,1.0,13/52,17.34%,ADHFE1;ALDH1L1;ME2;HAAO;SLC19A1;MTHFS;GOT1;MTHFD1;IDH2;MTHFR;GOT2;FPGS;MTHFD2
prerank,miRNA metabolic process (GO:0010586),0.370543010086758,0.9870665011865659,0.45064377682403434,0.923747002298989,1.0,6/20,15.04%,TRIM71;DDX17;BCDIN3D;TUT4;DICER1;SND1
prerank,protein localization to cilium (GO:0061512),0.3259643516761296,0.9857701727858492,0.46835443037974683,0.9263518538141631,1.0,7/32,14.87%,TTC21B;TULP3;WDR19;WDR35;IFT122;TCTN2;ARL3
prerank,epithelial cell morphogenesis (GO:0003382),0.375537648673725,0.9848239647364704,0.4784394250513347,0.9279286555134368,1.0,4/17,9.77%,COL22A1;RILPL2;RILPL1;DACT2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3930938080408516,0.9848024890199322,0.4766536964980545,0.9268397561151417,1.0,5/15,12.34%,SPHK1;SMPD3;ORMDL2;SMPD2;SPHK2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.31057598339764664,-0.9842555686485934,0.4623217922606925,0.7602812142246627,1.0,11/30,24.43%,EIF3H;UBXN1;USP7;BAG5;N4BP1;RYBP;UCHL5;FHIT;GIPC1;TAF9;SVIP
prerank,protein autophosphorylation (GO:0046777),-0.22686662982228104,-0.9841488835808526,0.5083798882681564,0.7600084874753373,1.0,40/157,20.01%,TEK;INSR;PEAK1;EGFR;EEF2K;KDR;BMX;TNIK;CAMK2D;PAK2;TEC;PRKD1;ERN1;LYN;FLT1;PRKX;STK24;SRC;FLT4;EIF2AK3;STK33;MAPKAPK2;GRK5;STK10;DYRK1A;PTK2B;STK16;ALK;CSF1R;MKNK2;TAOK3;CAD;FGFR3;TAOK1;STK26;MAPK3;MARK3;STK17B;RIPK1;HCK
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3019298277546507,-0.9838430774554956,0.4531914893617021,0.7602369281823951,1.0,14/35,23.61%,DAB2IP;MFHAS1;XDH;PER1;PHLPP1;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;DUSP1;CYLD;PRMT1
prerank,cellular response to ketone (GO:1901655),0.3127993326672696,0.9837680196236644,0.4896810506566604,0.9286648349308099,1.0,6/35,12.34%,ADCY5;ROCK2;ADCY1;ADCY8;NDOR1;SPHK2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3697403272300287,0.9836085241779221,0.46942800788954636,0.927979615061088,1.0,4/17,11.04%,ANK2;SNTA1;KCNH2;RYR2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.42667754914104206,0.9835249772073726,0.4812623274161736,0.9270593118103789,1.0,2/10,7.90%,BMP6;PLG
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3424080563067007,-0.9834601486965612,0.48023715415019763,0.760685442668885,1.0,15/21,45.71%,DUSP3;PIBF1;JAK3;FCGR2B;SOX11;FOXJ1;SAMSN1;IL4I1;LAPTM5;GPNMB;VTCN1;TNFAIP3;FGL1;TNFAIP8L2;BANK1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.30905254683048344,-0.9833286760124589,0.482837528604119,0.7605050808884577,1.0,10/31,20.10%,MEF2C;BOC;CTNNA1;HDAC9;IGF2;MYOCD;CDH2;ID2;MAPK12;CDC42
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4153902772323543,-0.9831908370770667,0.5164609053497943,0.7603385068130013,1.0,5/10,31.09%,EIF2AK3;ATF4;QRICH1;HERPUD1;HSPA5
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.34135630035198417,-0.9829160232895681,0.47128712871287126,0.7605128796629923,1.0,7/20,15.59%,NRP1;SLIT2;SERPINE1;S100A11;CCN4;LRP1;VTN
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.33089141012924556,-0.9818986948807685,0.46203904555314534,0.7624685943229381,1.0,8/23,16.95%,ELOVL7;FAR2;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,endomembrane system organization (GO:0010256),-0.2261099169745019,-0.9815175455170772,0.5058823529411764,0.7629238181510368,1.0,37/178,16.55%,SPTBN1;SYNE1;ATP8B1;ATL3;LMAN2L;TMED10;WASHC4;USP6NL;CHMP2B;PRKD1;FBXW8;CSNK1A1;COG3;SEC16B;ALS2CL;RAB22A;EIF2AK3;GOLPH3;CAV2;BAG5;DYSF;SUN1;SEC31A;SQSTM1;LEMD3;SNX10;UBXN2A;SEC61A1;REEP3;SURF4;REEP5;ZW10;VAPB;TLCD1;LYSMD3;SYNGR2;USP50
prerank,cellular response to reactive oxygen species (GO:0034614),-0.27092246356391536,-0.9813872717474781,0.49676025917926564,0.7627245153388885,1.0,11/59,7.89%,NET1;MAP3K5;EGFR;CYP1B1;PTPRK;JUN;ANXA1;PRKCD;PXN;MAPK1;RPS3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.28167111106558596,-0.9809139686652347,0.4988558352402746,0.7633901213729646,1.0,10/49,15.24%,SGMS1;CAV1;BCL2L1;RACK1;BCAP31;SRC;EIF2AK3;PTPMT1;BBC3;PLAUR
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.36880656325749545,-0.9808977604409886,0.4699792960662526,0.7628782180670891,1.0,5/15,14.71%,CDC27;HECW2;CDC16;TPR;PTTG1
prerank,peripheral nervous system development (GO:0007422),-0.330762187959711,-0.9808732208202856,0.4863731656184486,0.7623957629319758,1.0,6/23,19.58%,ADGRG6;NGF;GPC1;PMP22;NFASC;SOX8
prerank,response to calcium ion (GO:0051592),0.2574511763691,0.9806587512570168,0.4896907216494845,0.9343291705036951,1.0,18/102,12.06%,SYT11;SYT12;PRKAA2;CPNE1;CAPN3;SYT9;ADCY1;CPNE4;PPIF;SYT1;ADCY8;SYT13;ADGRV1;SLC25A12;SYT10;RYR2;TRPM2;CPNE6
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3531849214371874,0.9803705088739337,0.4530938123752495,0.9340264194621128,1.0,6/20,13.17%,DAB2;PICALM;PKDCC;RHOQ;MRAP2;MRAP
prerank,cell part morphogenesis (GO:0032990),-0.38220085133875564,-0.9803114023183268,0.4672131147540984,0.7633588385145237,1.0,3/13,8.00%,PID1;MFF;NUBPL
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.34142352564941264,0.9803027992871095,0.49806201550387597,0.9330617675540165,1.0,9/25,17.41%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;STAT5B
prerank,endosome organization (GO:0007032),-0.2895570325777087,-0.9801309886364892,0.5043478260869565,0.7632818211142963,1.0,8/41,12.78%,CORO1C;WASHC4;CHMP2B;ALS2CL;RAB22A;SQSTM1;SNX10;RAB27A
prerank,negative regulation of nervous system development (GO:0051961),0.3690642557524465,0.9800916084507584,0.4865424430641822,0.9325151831125837,1.0,5/17,15.60%,APPL2;WNT7A;PAX6;PCM1;IL6
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3272734694697206,-0.9795608235221535,0.5029940119760479,0.7641649845546373,1.0,8/24,17.39%,NUBPL;NFU1;HSCB;NFS1;GLRX3;BOLA2;ISCA2;NUBP1
prerank,proteasome assembly (GO:0043248),-0.3993973163740787,-0.9795297008563002,0.49317738791423,0.7636999896109644,1.0,4/11,21.90%,PSMD11;ADRM1;PSMD10;PSMG1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.32491522731105665,-0.9793897640943109,0.48008849557522126,0.7634699655191698,1.0,8/27,13.83%,CAV1;NFKBIA;PLTP;ZDHHC8;ABCA3;APOE;PTCH1;LRP1
prerank,cellular response to fatty acid (GO:0071398),-0.39474786682920665,-0.9790771013915335,0.49306930693069306,0.7637764790165555,1.0,4/12,19.09%,PID1;IRS1;NR1H4;ZC3H12A
prerank,early endosome to late endosome transport (GO:0045022),0.3641034127234015,0.9788634817146116,0.4781783681214421,0.9348560225249026,1.0,6/20,17.36%,WDR91;SNX16;KIF16B;SNF8;HOOK1;PTPN23
prerank,dendritic spine organization (GO:0097061),-0.3218761650431421,-0.9788306793877626,0.4805194805194805,0.76387358407246,1.0,3/26,2.11%,SHANK3;DOCK10;INSR
prerank,negative regulation of cell communication (GO:0010648),-0.33881236091757994,-0.9787691771360877,0.4927835051546392,0.7634850740822102,1.0,5/21,9.53%,ACVR1;UBASH3B;HHIP;PTPN1;SOCS5
prerank,ureteric bud morphogenesis (GO:0060675),-0.3703807192989251,-0.9785801312367086,0.49478079331941544,0.7634119156405827,1.0,4/16,12.38%,BMP4;SIX1;FGF2;BMP2
prerank,phospholipid biosynthetic process (GO:0008654),-0.2951773592014045,-0.9783803716954553,0.47415730337078654,0.7633682688680293,1.0,5/36,4.99%,SGMS1;SGMS2;MBOAT1;AGK;CPNE3
prerank,regulation of cytoskeleton organization (GO:0051493),-0.24055887372396734,-0.9782842025057498,0.5121359223300971,0.763069100772453,1.0,30/108,23.36%,RHOBTB1;TJP1;RHOA;CLIC4;PHLDB1;IQGAP1;F11R;PHLDB2;CAPN2;PAK2;PRKCD;ARHGAP35;MAPK1;EFNA5;FAM107A;HIP1R;RND3;LRP1;BICD2;TRAF3IP1;TAOK1;RHOBTB3;MAPK3;ARHGEF5;RHOB;RAC3;ROCK1;RND2;CYLD;MAP6D1
prerank,establishment of protein localization to membrane (GO:0090150),0.2827354419204689,0.9780731457036876,0.4783362218370884,0.9360197341590238,1.0,9/66,9.20%,AFDN;SYNE3;MICALL1;ZDHHC12;RAB3GAP1;COX18;PRKCI;ZDHHC24;ZDHHC1
prerank,positive regulation of viral genome replication (GO:0045070),0.3314520552047835,0.9780096271853728,0.5053003533568905,0.9350611992197123,1.0,4/29,7.53%,HACD3;TOP2B;PPARA;IFIT1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4016512207170419,-0.9776485848254008,0.48412698412698413,0.7640687257788817,1.0,9/11,45.87%,IL34;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1
prerank,regulation of spindle assembly (GO:0090169),0.3399553770303816,0.9775997961240636,0.4758364312267658,0.9351019355829828,1.0,8/25,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;SPAG5;CHMP1A
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3181970635700009,-0.9775768599795641,0.48847926267281105,0.7637045684450429,1.0,6/26,20.33%,CAV1;MFHAS1;IFI35;RSAD2;RTN4;HMGB1
prerank,polyol biosynthetic process (GO:0046173),0.3679193833365772,0.9773512345701068,0.4887640449438202,0.9347370636504645,1.0,4/16,17.52%,ISYNA1;CYP27A1;IPPK;IP6K2
prerank,smooth muscle contraction (GO:0006939),-0.3766785321919486,-0.977099221468814,0.509090909090909,0.7642971129593822,1.0,5/14,8.19%,EDNRA;SMTN;PIK3C2A;ACTA2;MYH11
prerank,nitric oxide biosynthetic process (GO:0006809),0.4021256938691918,0.9766625030360643,0.4686192468619247,0.9355386801275041,1.0,3/13,4.43%,GCHFR;NQO1;ARG2
prerank,regulation of phagocytosis (GO:0050764),-0.273893011968141,-0.9763703964998854,0.47334754797441364,0.7655663873831137,1.0,12/53,13.63%,SCARB1;MERTK;GAS6;PLSCR1;RACK1;TGM2;DOCK2;GATA2;IL15;DYSF;RAB27A;PTPRC
prerank,positive regulation of telomere capping (GO:1904355),-0.3518541811476896,-0.9763686323352422,0.5040650406504065,0.7650324514041037,1.0,7/17,25.92%,NEK7;TNKS;MAPK1;MAPK3;MAP2K7;MAP3K4;HNRNPD
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3731240051370363,-0.9761597384619006,0.4908350305498982,0.7650552756471216,1.0,2/15,2.44%,YWHAE;GAS6
prerank,fatty acid elongation (GO:0030497),0.3984818933296568,0.9757868320921457,0.4962121212121212,0.936948897148617,1.0,4/13,9.07%,HACD3;HACD4;HACD1;ABCD1
prerank,double-strand break repair (GO:0006302),0.24379943010983152,0.9756374346797849,0.5113636363636364,0.9362369382135268,1.0,33/158,18.13%,EYA1;PAXX;POLM;ERCC1;RECQL4;XRCC1;ACTR8;AUNIP;TENT4A;ABRAXAS1;MEIOB;EME2;KAT5;KDM2A;ZFYVE26;TDP2;MDC1;MRE11;PRPF19;KDM4A;CHEK2;PIAS4;RAD51D;RNF138;PRKDC;RPA3;ATM;AP5Z1;RAD52;POLN;XRCC2;APBB1;NHEJ1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.31193316697507256,-0.9755480373559674,0.4977973568281938,0.7660652447588306,1.0,4/27,5.95%,PRKCH;NFKBIA;ABCA1;AGTR1
prerank,vesicle transport along microtubule (GO:0047496),0.3469450977833172,0.9754421819933258,0.4731800766283525,0.9356669131359359,1.0,8/23,19.57%,TRAK1;FYCO1;HTT;KIF3A;RAB1A;KIF3B;KIF1A;NDE1
prerank,negative regulation of dephosphorylation (GO:0035305),0.36361468186141616,0.9754022820318871,0.49304174950298213,0.9346451101762948,1.0,2/18,2.54%,SH3RF2;SH2D4A
prerank,regulation of mRNA processing (GO:0050684),0.3246416446847781,0.9752605161588033,0.5113207547169811,0.9339121142235439,1.0,13/32,26.13%,PABPN1;SLTM;SRSF10;SON;TIA1;YTHDC1;SAFB2;SAFB;LARP7;SRPK1;AHCYL1;JMJD6;ZFP36L1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3919062109027548,0.9752541250304005,0.4700193423597679,0.9327873535754764,1.0,4/14,10.51%,LPIN1;ETNK2;PCYT2;CHKB
prerank,regulation of sensory perception of pain (GO:0051930),-0.40140490788931604,-0.9751091816659969,0.5020491803278688,0.7666398850208015,1.0,6/11,25.72%,CCN3;MGLL;TMEM100;ATPSCKMT;ACP3;F2R
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21921739811261373,-0.9749522657918301,0.5498575498575499,0.7665164083844871,1.0,40/198,15.94%,PTPRB;PLCB4;PLCE1;PLA2G4A;PIP4K2A;INPP4A;LIMD1;LIMK2;PLCG1;STAT3;ALPL;AGK;PLCG2;PANK3;TNFAIP8L3;PAK2;INPP5D;PPP3CA;ALDOA;PRKCG;PIK3CA;PLPP1;CDK5;PPP1CA;PFKL;DUSP3;BCKDK;EPHB2;PIK3CD;GFPT2;DUSP23;AGPAT1;PTPRC;ENPP1;ALK;PLPP3;THNSL2;IPMK;NT5C;ACYP1
prerank,regulation of mitotic nuclear division (GO:0007088),0.2888837271134296,0.974592285689897,0.49909584086799275,0.9336306985688482,1.0,7/55,9.15%,BMP7;IGF1;OBSL1;CDC25C;TOM1L2;DRD3;PHIP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2584278159044196,-0.9741023659406742,0.501123595505618,0.7681466563451945,1.0,20/70,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;LNPEP;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3834657556219512,-0.9740064207704253,0.49572649572649574,0.7678384934990287,1.0,6/13,21.54%,RPS15;ABCE1;NMD3;LTV1;SDAD1;RRS1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2704803068823177,-0.9735469170853432,0.4859154929577465,0.7685109525751929,1.0,21/56,26.98%,SPTBN1;RHOA;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;DCTN3;INCENP;IST1;NUSAP1;RHOB;RAB35;ROCK1;RASA1;ALKBH4;KIF4A;JTB;CEP55;RTKN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3448547558847377,0.97349348360307,0.47947761194029853,0.9356563667757473,1.0,12/22,27.51%,ANK2;GSTM2;HTT;RYR2;GSTO1;AKAP6;ATP2A1;STAC3;VMP1;SLC9A1;HAP1;STAC2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.35613624269028377,-0.9732453818235068,0.4919678714859438,0.7687050726806132,1.0,4/17,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.28194299521976773,-0.9732083144001967,0.48951048951048953,0.7682631289435846,1.0,19/48,27.53%,PDE4D;PLCG1;UBASH3B;CAMK2D;CALM3;TRPC1;JPH2;CEMIP;PTK2B;PRKACA;APLNR;GPER1;DMD;NPSR1;JPH3;F2R;SELENON;CASQ1;CALM1
prerank,endoplasmic reticulum organization (GO:0007029),-0.25546807702250784,-0.9728692389651524,0.4877450980392157,0.7686060745771013,1.0,26/72,25.25%,ATL3;APP;LMAN2L;STX1A;SEC16B;EIF2AK3;CAV2;SEC31A;SEC61A1;SHTN1;REEP3;REEP5;VAPB;UBE2J2;RTN4;TOR1AIP2;RTN3;WDR83OS;REEP1;STX5;GAK;LPCAT3;DOP1B;TLE6;REEP2;VAPA
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3012791574412318,-0.9724807470207965,0.4869215291750503,0.7690683017702972,1.0,6/32,6.49%,RAPGEF2;NEDD4L;HECW2;TNIK;RAP2A;FBXW8
prerank,negative regulation of kinase activity (GO:0033673),0.28213035397865693,0.9724574316487746,0.48939929328621906,0.937591542242124,1.0,5/62,6.70%,PRKAG2;DEPTOR;HNRNPU;WWTR1;PDPK1
prerank,negative regulation of inflammatory response (GO:0050728),-0.2206118803919097,-0.9724221756000541,0.5601092896174863,0.7686921475001744,1.0,30/182,11.80%,TEK;CALCRL;CD200;PPARD;RAMP2;MYH9;PTGIS;PLCG1;TNFRSF1B;MFHAS1;CCN3;PLCG2;ADCY4;GNB1;PTGDR;LYN;PRKCD;ADCY7;GNG2;PLK2;IAPP;MDK;SRC;ADCY2;APOE;KLF4;YES1;ADM;CYSLTR2;CYSLTR1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.38656356137884595,0.9724036939238271,0.4729458917835671,0.9365992628085985,1.0,3/15,3.58%,FGF1;FGF4;SMOC2
prerank,sodium ion import across plasma membrane (GO:0098719),0.3725381675666887,0.9723025359314746,0.4785992217898833,0.9357707336963658,1.0,1/17,0.21%,SLC6A1
prerank,cognition (GO:0050890),-0.2881610947393444,-0.9720205151910802,0.4875283446712018,0.7691747751907921,1.0,8/42,12.19%,ST3GAL4;SHROOM4;APP;CHMP2B;NIPBL;STRA6;FAM107A;MFSD2A
prerank,spinal cord development (GO:0021510),-0.38844606241286683,-0.971816555685094,0.4894957983193277,0.7691365106789372,1.0,5/12,22.64%,VIT;PKD1;SOX12;DLL1;SOX11
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3218371550242093,0.9716380957525552,0.4944237918215613,0.9365997403626057,1.0,6/30,9.68%,ACSL1;HACD3;HACD4;HACD1;ABCD1;SLC27A6
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2997692136137149,-0.971626614633628,0.4817987152034261,0.7690666864366434,1.0,6/36,10.47%,MECOM;FOXO1;PPIA;AIDA;DUSP3;PER1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.31105453285293866,-0.9706344398127141,0.4666666666666667,0.771005620552701,1.0,6/28,12.56%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.26353810773189745,-0.9704820113438569,0.5234741784037559,0.7708942562315222,1.0,25/66,30.42%,FOXP1;STAT3;APP;CARD16;GBP5;WNT5A;AIM2;TRIM16;MALT1;HSPB1;GIT1;USP50;NOD2;ZC3H12A;MYD88;RIPK2;CASP1;CASP8;TLR4;F2R;CPTP;TMEM106A;CD36;TLR6;LGALS9
prerank,somite development (GO:0061053),-0.39262857351304015,-0.9703238638299342,0.5136268343815513,0.7707602625474544,1.0,4/11,13.20%,MEOX2;PTCH1;SMO;PPP2R3A
prerank,axon extension (GO:0048675),-0.330321664507943,-0.9698953584694727,0.5010060362173038,0.7713007445559384,1.0,11/23,21.38%,NRP1;NRP2;SLIT2;CDK5;SEMA5B;MAP1B;SEMA5A;ULK2;SLIT1;SLIT3;SEMA3F
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21416027521521935,0.9698828085590872,0.5613333333333334,0.9405803294442675,1.0,120/572,19.24%,PRDM6;AEBP1;WWOX;BMP6;DAB2;HSPA1A;DDX5;CBX7;SMAD3;KCNIP3;KMT5A;OSR1;NR2E1;MAGEA2;MSX2;CXXC5;CTR9;FHL2;THRB;SUFU;SCRT1;NR6A1;ZNF431;PCGF2;PPARA;GLIS3;ENO1;ZHX1;IFI27;DLG1;PEG3;PAX6;RBPJ;PLK1;MZF1;DNMT3A;HNRNPU;HOXA7;ZKSCAN3;E2F1;ATN1;MOSPD1;FGFR2;KAT5;NR2F2;CHD3;MIER3;IMPACT;MED1;MAX;DMAP1;NR1H3;E2F8;MED25;NKAP;RXRA;CBX6;ZFP90;PRDM2;C1QBP;NSD1;FOXP4;LDB2;LDB1;RITA1;LCOR;STAT1;FST;TAF1;MXI1;GATAD2A;CDC73;SOX9;BEND3;BHLHE41;JAZF1;SMYD2;HDAC4;NOC2L;CTBP2;FOXC1;MEN1;DICER1;TBL1XR1;BCL11A;PER2;HEXIM2;ERF;GADD45A;SIRT1;TENM2;RARA;NCOR2;MDM2;MDFI;DNAJA3;CITED2;IRF8;RELA;MTF2;KDM1A;USP9X;TCF7L2;TCF25;FNIP1;HDGF;APBB1;ARID5B;PCGF1;MLX;MITF;IRF2BP2;NFKB1;POU6F1;NCOR1;MEF2A;SOX2;LIN37;CPEB3;SIN3A
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2231532814384719,0.9697574707819896,0.5299145299145299,0.9398004654272162,1.0,50/327,12.40%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;DMTF1;PML;CHEK2;RBAK
prerank,regulation of fibrinolysis (GO:0051917),-0.3833683861518812,-0.9692463630048161,0.4832347140039448,0.7724276647766307,1.0,3/13,9.35%,FAP;THBS1;SERPINE1
prerank,plasma membrane tubulation (GO:0097320),-0.3855105456032166,-0.968762386461057,0.5030674846625767,0.7731157794785722,1.0,5/13,12.00%,CAVIN2;CHMP4A;WHAMM;EHD2;FNBP1L
prerank,neuromuscular synaptic transmission (GO:0007274),0.36267326788213117,0.9687421993971782,0.48859315589353614,0.9415439337692468,1.0,2/18,8.71%,DTNA;CHRNB2
prerank,cellular response to amyloid-beta (GO:1904646),0.3053934104475355,0.9682363931898071,0.5114638447971781,0.9418957894471242,1.0,3/35,1.71%,SNX6;IGF1;CACNB1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.2993433068416856,0.9680967277287854,0.48849557522123893,0.9411609279148464,1.0,16/46,18.53%,IGF1;IL18;OGN;IGFBP3;NOX1;NDRG4;VIP;STAT1;MFN2;PRKDC;IL6;RBPMS2;TCF7L2;AKT1;IL12A;CX3CL1
prerank,nuclear body organization (GO:0030575),-0.38918164686601325,-0.9680324045707123,0.5126705653021443,0.7744522351500059,1.0,4/12,16.55%,ETS1;SERBP1;USPL1;USP50
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.25903440771701325,-0.9676907666258142,0.5241545893719807,0.7748070244316712,1.0,18/70,21.46%,TCF12;LMO2;RUNX1;PSMA6;PSMB7;CBFB;GATA2;TAL1;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;METTL3;PSMD10;PSME1
prerank,primary miRNA processing (GO:0031053),0.4233310997824373,0.9676021539784555,0.49105367793240556,0.9415114679705018,1.0,2/10,4.90%,SMAD3;HNRNPA2B1
prerank,regulation of Golgi organization (GO:1903358),-0.36034989627786435,-0.9674243140227831,0.482897384305835,0.7749108658662882,1.0,9/17,33.21%,USP6NL;ARMH3;MAPK1;MAPK3;STX5;AKAP9;CAMSAP2;CAMSAP3;RBSN
prerank,epithelial cell-cell adhesion (GO:0090136),-0.40078940150103093,-0.9672204912376814,0.501984126984127,0.774858463274544,1.0,7/11,24.27%,VCL;CCN3;ITGB5;SERPINB8;DSP;JUP;THBS4
prerank,negative regulation of potassium ion transport (GO:0043267),-0.382201986427269,-0.9666030954280681,0.5150300601202404,0.775840565071654,1.0,3/13,4.88%,CAV1;NEDD4L;CAB39
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.24234343399753577,0.9661864710442264,0.5089430894308943,0.9443779418257148,1.0,15/138,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3468158920780219,0.9660881380198393,0.5124760076775432,0.9435258285148161,1.0,5/22,8.72%,CACNB1;CACNB3;CRHR1;GNB5;DRD3
prerank,axonemal dynein complex assembly (GO:0070286),0.33431669791545415,0.9657916217942463,0.5069306930693069,0.943251309545088,1.0,9/27,26.85%,DNAH1;DNAL1;DRC1;DNAAF2;DNAAF5;DNAAF3;DNAH5;DNAH17;ODAD4
prerank,regulation of blood circulation (GO:1903522),-0.2965571690100028,-0.9656331205974521,0.5151515151515151,0.7776695349373871,1.0,10/34,18.75%,ECE1;CAMK2D;AGTR1;KCNMB2;KCNQ1;KCNJ12;ACE2;TBX2;PLN;CACNA1H
prerank,regulation of RNA splicing (GO:0043484),0.2738384867996904,0.9654228855619772,0.519327731092437,0.9431403719902974,1.0,27/69,23.03%,HSPA1A;HNRNPH3;PQBP1;FASTK;PTBP2;SRSF10;SON;HNRNPL;PTBP1;TIA1;SRRM4;CLK3;YTHDC1;AFF2;GRSF1;MBNL3;CLK2;ZPR1;FAM50A;HNRNPH2;PTBP3;CLK1;POLR2A;LARP7;HNRNPH1;SRPK1;CELF1
prerank,regulation of transferase activity (GO:0051338),0.36441724465710734,0.9654172093771877,0.4887640449438202,0.9420255813408868,1.0,9/17,21.55%,PPP1R3F;LDB2;LDB1;PARP4;FEM1A;SMG6;ATM;PINX1;JMJD8
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.26096586911850267,-0.9652474971036333,0.5061425061425061,0.7780922437553253,1.0,20/66,23.39%,KAT7;PIK3R1;LIMK2;CDH1;FLNA;TFRC;PRKCD;ORMDL3;EIF2AK3;IPO5;NMD3;TPR;CCT2;FERMT2;ZC3H12A;MEPCE;JUP;DTX3L;DKC1;HCLS1
prerank,protein localization to cell junction (GO:1902414),-0.3236013093017697,-0.9650417198966285,0.4957983193277311,0.7780482290705643,1.0,6/22,11.47%,HEG1;TJP1;TJP2;PAK2;JAK1;JAM3
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3840104554160057,-0.9646577845302664,0.48443579766536965,0.7784700948363197,1.0,4/13,17.10%,NFU1;GLRX3;BOLA2;ISCA2
prerank,apical protein localization (GO:0045176),-0.41056911794302786,-0.96465404762501,0.5187265917602997,0.7779438805491017,1.0,2/10,0.62%,ACTB;ATP8B1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31760967587858074,-0.9646519044767131,0.5149572649572649,0.7774149185922754,1.0,6/25,13.25%,RPL5;GABARAPL2;RPS7;PRKCG;RPL23;CSNK2A1
prerank,protein hydroxylation (GO:0018126),-0.3627898907701342,-0.9645776791928835,0.5,0.7770566696203116,1.0,9/15,38.07%,PLOD2;PLOD3;JMJD4;EGLN3;JMJD7;P3H1;VIPAS39;PLOD1;P3H2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3041130800599737,-0.9645592197362083,0.5043478260869565,0.7765559106657351,1.0,9/29,16.95%,ELOVL7;ELOVL5;ACSL5;FASN;ELOVL6;ACSL3;SCD;ELOVL1;ACSL4
prerank,negative regulation of gene expression (GO:0010629),0.22397362633073775,0.9644006578256095,0.5419734904270986,0.9438418667140668,1.0,46/302,14.43%,ROBO1;NOTCH2;WNT4;LGR4;SYT11;IGF1;HSPA1A;SLC24A3;ROCK2;OVOL2;PRKAA2;NDFIP1;TWSG1;CPNE1;OPRD1;BMPR1A;PICALM;TNRC6A;LRP3;TRIM71;DNMT3A;PTBP2;FLOT2;JARID2;PPHLN1;PTBP1;PHF1;LSM5;HINFP;EIF2AK2;PARP14;PAIP2B;MPHOSPH8;PPM1D;PAIP2;TAF1;EPRS1;KDM4A;EIF4E2;AGO3;TERT;TSC1;DICER1;HSPA1B;HAVCR2;FXR2
prerank,response to UV (GO:0009411),-0.24036717147446662,-0.9640466104315767,0.5382585751978892,0.7773263849855109,1.0,33/95,25.03%,DCUN1D3;EGFR;PTPRK;PRKCD;MFAP4;ZBTB1;CAT;GPX1;USP47;ERCC2;COPS9;SCARA3;RHBDD1;BAK1;FMR1;ATF4;UBE2A;N4BP1;RHNO1;PRIMPOL;CCND1;PCLAF;METTL3;NEDD4;XPA;MAP2K7;NSMCE3;BCL3;MAP3K4;MAP4K3;TRIAP1;DTL;USP1
prerank,regulation of DNA binding (GO:0051101),-0.27986292266673957,-0.9636107509297007,0.5079365079365079,0.7778889502005615,1.0,6/44,6.07%,LEF1;HJURP;NGF;NFKBIA;JUN;HES1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.26611208006952475,-0.9635211591805888,0.5136986301369864,0.7775884417202571,1.0,26/54,26.01%,RPL5;RPL10;RPL7;MRPL20;RPLP0;RPL35A;RPF1;RPL7A;SURF6;RPL6;RPL24;RPL10A;RPL14;RRP15;GTF3A;MRPL1;MRTO4;EBNA1BP2;RPL3;SDAD1;NHP2;RRS1;NOP16;RPL23A;PPAN;MDN1
prerank,icosanoid secretion (GO:0032309),-0.39135310040908655,-0.9634668876334747,0.5335968379446641,0.7771846283162628,1.0,2/12,6.64%,ABCC4;ANXA1
prerank,regulation of TOR signaling (GO:0032006),0.27737410439791366,0.9628900044468609,0.5208711433756806,0.9471554869025339,1.0,25/67,24.50%,PRKAA2;NPRL3;RRAGC;RICTOR;DEPTOR;SLC38A9;PIH1D1;FBXO9;LAMTOR2;TSC1;NPRL2;LAMTOR3;SIRT1;TELO2;RRAGB;FNIP1;PDCD6;MLST8;LAMTOR1;TMEM127;EPM2A;ARAF;TTI1;GPAT3;UBR2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.33689327983864537,0.96260304435423,0.515625,0.9468239242392531,1.0,4/24,8.34%,ERRFI1;ROCK2;HOXA7;MED1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3189928139164422,0.9625434696317018,0.5087412587412588,0.945865570438816,1.0,8/30,12.73%,LEPROT;PDCD5;HTRA2;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2971003102339906,0.9625334448378882,0.5217391304347826,0.9447743835695921,1.0,13/45,19.71%,HSPA1A;DDX5;RIOK2;SUPV3L1;ZC3H18;WDR75;GRSF1;IL6;ZPR1;UTP15;RELA;NFKB1;POLR2A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.2758859843365766,-0.9625252852581901,0.5153508771929824,0.7789898824619075,1.0,14/46,17.73%,SEMA6A;DAB2IP;SPRED2;LYN;SPRY2;PTPN1;DUSP3;EPHB2;RANBP9;PTPRC;SPRY1;PTEN;GPER1;DUSP6
prerank,cardiolipin metabolic process (GO:0032048),-0.37617560194510247,-0.9622131433421885,0.4936708860759494,0.7792373203547472,1.0,4/13,17.92%,PLA2G4A;PTPMT1;PLA2G6;TAMM41
prerank,protein O-linked glycosylation (GO:0006493),0.2635192537205666,0.9621612292134859,0.5082236842105263,0.944768132954763,1.0,20/96,15.98%,GXYLT2;TRAK1;CHST4;MUC19;ST3GAL3;TMTC4;GALNT11;GALNT14;TET1;LARGE1;GALNT12;GALNT3;FKTN;GALNT2;B3GLCT;DPM1;GALNT1;CRPPA;MUC1;TET2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3271652367122588,0.962125760237916,0.5027624309392266,0.943742266687157,1.0,10/27,18.21%,DDX5;KMT5A;SPRED3;SMYD2;MSX1;SIRT1;ATM;MDM2;KDM1A;SPRED1
prerank,regulation of gluconeogenesis (GO:0006111),0.33073350071483043,0.9617409407301104,0.5160075329566854,0.9437830447438929,1.0,6/27,16.17%,GCK;C1QTNF3;PDK2;PPARGC1A;SIRT1;CLK2
prerank,negative regulation of cellular component movement (GO:0051271),0.38000218613761044,0.9613631176290068,0.5,0.9437185282880495,1.0,2/15,2.23%,TGFBR3;FBLN1
prerank,regulation of protein modification process (GO:0031399),-0.26838124283042664,-0.961272286659892,0.5103926096997691,0.7810473288750553,1.0,10/50,11.50%,CORO1C;FN1;FNIP2;SPRED2;LYN;PPP1R16B;HPF1;IGF2;PARG;HSPB1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.26339615381019443,0.9610865502857161,0.5340909090909091,0.9433937636144466,1.0,7/87,3.11%,NOTCH2;ROCK2;PDGFRA;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2158374322716519,-0.9610114721298866,0.5714285714285714,0.7811654557644516,1.0,61/184,27.86%,YWHAE;CDC27;PKD1;HECW2;UBC;DYNC1I2;ANAPC5;CSNK1E;RPS27A;XPC;UBB;PSMA6;PSMB7;CDC16;TUBA1A;PSMB6;CEP76;PSMB5;FBXO5;DCTN3;ERCC2;ODF2;DYNLL1;FZR1;PSMB8;CCP110;ZW10;PSMC4;PRKAR2B;PSMD11;PAFAH1B1;ID2;PRKACA;PSMB4;DYNC1H1;PSMD14;PTPN6;CDC26;PSMD10;CSNK1D;DCTN1;PSME1;CEP41;TPX2;TUBA4A;CEP131;PSMB3;CDC23;CDK5RAP2;CUL3;RGCC;CEP152;HMMR;KIF14;ZFP36L2;AKAP9;ACTR1A;CUL1;CDK2;ANAPC1;CNTRL
prerank,RNA splicing (GO:0008380),0.2580254447234513,0.9608134205877681,0.5383304940374787,0.943036910981655,1.0,31/95,24.43%,RRAGC;NOVA1;CCAR2;HNRNPH3;SRSF10;PTBP1;PPARGC1A;ZMAT5;LSM4;MPHOSPH10;USP39;SRSF11;USB1;RNPS1;DHX8;PRPF6;NOL3;PRPF3;DDX39B;DDX47;SF3B2;SF3B1;SNRPB;CDK12;SCNM1;SF3B3;SRPK1;SNRPN;HNRNPC;WDR83;SRSF2
prerank,regulation of interleukin-13 production (GO:0032656),0.39631719978056024,0.9605759555657546,0.49173553719008267,0.942629853098901,1.0,2/13,1.59%,IL18;PRKCZ
prerank,response to peptide hormone (GO:0043434),0.29348293263251185,0.9605081207031402,0.47927927927927927,0.9417148050786376,1.0,14/43,19.02%,TGFBR3;ROCK2;CYP11B1;CITED1;EIF2B4;STAT1;STAT2;TSC1;SIRT1;CREB1;STAT5B;AKT1;STAT6;KHK
prerank,negative regulation of viral process (GO:0048525),0.2832117978694999,0.9603525690459945,0.519327731092437,0.9410583559923726,1.0,27/57,28.71%,OAS2;TRIM62;UBP1;TRIM5;TRIM35;IFIT1;EIF2AK2;OAS3;STAT1;PML;TRIM13;ILF3;LARP7;TRIM32;CHMP3;PARP10;BST2;SLPI;SRPK1;BTBD17;ZFP36;RNASEL;TRIM28;MAVS;TRIM8;MBL2;TRIM11
prerank,regulation of urine volume (GO:0035809),0.4200480383721576,0.9603280807430491,0.516597510373444,0.9400319432835788,1.0,3/10,20.59%,NPR3;ADCY6;INPP5K
prerank,cellular response to lectin (GO:1990858),-0.2390576612861666,-0.9601998328330794,0.5417721518987342,0.7820545485533081,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2390576612861666,-0.9601998328330794,0.5417721518987342,0.7820545485533081,1.0,28/104,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3436072485575917,-0.9599239830062265,0.4978902953586498,0.7822087350586837,1.0,7/18,16.95%,ELOVL7;ELOVL5;ACSL5;ELOVL6;ACSL3;ELOVL1;ACSL4
prerank,dendritic spine morphogenesis (GO:0060997),-0.36037957690982747,-0.9598873655096334,0.48760330578512395,0.7817549780349744,1.0,2/15,0.82%,SHANK3;DOCK10
prerank,regulation of synapse assembly (GO:0051963),-0.27432677170087727,-0.9597890077257295,0.5565610859728507,0.7814667686238749,1.0,9/46,14.47%,GPC6;MEF2C;PDLIM5;APP;CLSTN2;IL1RAP;EPHB2;LHFPL4;SRPX2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.24564367925226,-0.9597724306733365,0.5341463414634147,0.7809703540104543,1.0,18/88,13.63%,PTPRB;CAV1;DAB2IP;LRP6;LRP5;CORO1C;ADARB1;UBASH3B;PAK2;PPIA;CEACAM1;CDKN1C;PTPN1;DUSP3;HSPB1;GSKIP;DBNDD2;PTPRC
prerank,ear morphogenesis (GO:0042471),0.35568780000358186,0.959695241154327,0.49053030303030304,0.9406600563641406,1.0,3/20,6.95%,OSR1;USH1C;FGFR2
prerank,negative regulation of histone methylation (GO:0031061),0.42281681094807544,0.9595722759024642,0.5100806451612904,0.9399083729073463,1.0,4/10,17.54%,JARID2;PHF1;MTF2;KDM1A
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3420718286947939,-0.9595189977788817,0.5276073619631901,0.7810545152777132,1.0,2/19,1.66%,PARD3;CLIC4
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.244319348578102,-0.9593216927600614,0.548926014319809,0.7810305475786948,1.0,28/87,27.02%,FBXL7;DCUN1D3;FHL1;PSMA6;PSMB7;APC;KLF4;PSMB6;FAM107A;PSMB5;FBXO5;USP47;PSMB8;PSMC4;PSMD11;PTEN;PSMB4;PSMD14;CDK6;PSMD10;PSME1;PSMB3;E2F7;RGCC;JADE1;ZFP36L2;CDKN2B;CUL1
prerank,glutathione derivative metabolic process (GO:1901685),0.34893141528657595,0.9592719273446857,0.508637236084453,0.938544982672069,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.34893141528657595,0.9592719273446857,0.508637236084453,0.938544982672069,1.0,7/20,18.30%,GSTM2;GSTO2;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,mitochondrial protein processing (GO:0034982),0.4090958919743003,0.9590863373082982,0.5030927835051546,0.9379455915730076,1.0,2/11,5.63%,AFG3L2;IMMP1L
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2706116572970845,0.9587850119351958,0.5456110154905336,0.9377101904989521,1.0,16/68,19.11%,GTPBP1;ACSM2A;ACSM2B;ACAT1;GLYAT;LRRK2;AMPD3;RHOQ;CROT;ABHD14B;RAB23;ACOT1;ACOT6;TPST1;AK3;ACOT13
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2590140868248742,0.958521049565279,0.5264026402640264,0.9373717314512289,1.0,26/95,17.06%,HS3ST3A1;UST;HS3ST3B1;OGN;CHST15;ST3GAL3;HS6ST1;OMD;NDST1;PXYLP1;B4GALT2;B4GALT1;B3GALT6;B4GALT3;HS3ST6;HS3ST5;HS6ST2;HYAL1;FMOD;CSPG5;ABCC5;DSE;NDST2;HS2ST1;CHST9;CHST3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.34910420848170276,0.9584153246672718,0.533457249070632,0.9365481272139754,1.0,2/22,6.93%,BMP7;FLOT2
prerank,regulation of translation (GO:0006417),-0.21995573198480992,-0.958317533230433,0.5694822888283378,0.7829743992188434,1.0,60/173,29.77%,NIBAN1;THBS1;FOXO3;RBM3;RPL5;APP;RPS6KA3;RPL10;EIF3E;ALKBH1;EIF3H;RACK1;EEF2;RPS3;MTRF1;EIF2B2;EIF2AK3;EIF4E;HSPB1;NCBP2;SYNCRIP;EIF1B;NCBP1;EIF4G3;DHFR;FMR1;PRR16;DDX25;FXR1;GAPDH;RIDA;METTL3;NCL;PIWIL2;MTG1;EIF4H;BCL3;CAPRIN1;KLHL25;EIF4A3;NANOS3;EIF3B;RPL13A;DAPK1;BTG2;SHMT2;TYMS;HNRNPD;MTIF2;LTN1;METTL14;RPS6KA1;RPS4X;GEMIN5;SHMT1;NSUN5;IGF2BP2;PCIF1;IGF2BP1;CNOT1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3878424953793588,0.9580408381322826,0.4930139720558882,0.9365488650902739,1.0,4/13,11.47%,NUPR1;NR1H3;USP19;CLU
prerank,protein polyglutamylation (GO:0018095),0.4022661397375835,0.9579905451229632,0.5,0.9356015384358969,1.0,4/11,21.52%,TTLL6;CFAP20;TTLL11;TTLL4
prerank,body fluid secretion (GO:0007589),0.3781700480151097,0.9576015194647439,0.4942528735632184,0.9355997844747409,1.0,3/15,12.82%,PRLR;VIP;SLC22A2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3008122804489918,0.9575645103069729,0.5204991087344029,0.9346154422943218,1.0,9/38,12.73%,LEPROT;HTRA2;LRRK2;BAG4;RHOU;CSNK2A2;FZD5;ATG13;RNF31
prerank,pseudouridine synthesis (GO:0001522),-0.3740743087311048,-0.9573032455321111,0.5250501002004008,0.7848933548518806,1.0,6/13,27.20%,PUS3;PUS7L;NHP2;DKC1;PUSL1;NOP10
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2600957877259139,0.9571170005687347,0.5268456375838926,0.9348107657817928,1.0,26/88,22.19%,BMP7;SMAD3;STX18;ERCC1;STAM;SMPD3;NRG1;SNF8;GNL3L;PIH1D1;CHGA;CLU;HYAL1;PRKCA;TRABD2B;SLF1;FNIP1;CX3CL1;BRK1;TIRAP;BAX;EMILIN1;ATP13A2;SDCBP;SLX4;PLEK
prerank,regulation of transposition (GO:0010528),0.3891137137526469,0.9570199663372436,0.4936440677966102,0.9339993996044026,1.0,3/13,14.13%,TDRD9;SPOCD1;MYBL1
prerank,ion transport (GO:0006811),0.2521256812339327,0.9569846715190655,0.5605815831987075,0.9330087054204981,1.0,13/111,11.52%,TRPM3;SLC8A3;SLC5A5;SLC24A3;SLC26A1;GLRA1;WNK4;SLC15A2;CHRNB2;KCNN4;SLC12A5;SLC12A1;PLP2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.40818083916250125,-0.9568413942456303,0.5191919191919192,0.7854973480630967,1.0,4/10,16.87%,CSGALNACT1;XYLT1;B3GAT1;B3GAT3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4000611689400802,0.9567845126595151,0.5137795275590551,0.9324883738940256,1.0,4/12,12.04%,HNRNPU;PCGF5;YTHDC1;RLIM
prerank,negative regulation of metabolic process (GO:0009892),0.27993585773628815,0.9565560157069926,0.5017006802721088,0.9320591859509373,1.0,12/54,15.40%,LGR4;NPR3;NOVA1;RBPJ;ARRDC3;MAP2K6;ALDH1A1;NR1H3;DOCK7;NRDC;LAMA4;TFE3
prerank,smoothened signaling pathway (GO:0007224),-0.30069789110342265,-0.9565003455447323,0.5201793721973094,0.7858218138275014,1.0,12/32,20.93%,HIPK1;GLI3;ARL13B;TCTN3;PTCH1;SMO;PTCH2;EVC2;STIL;IFT27;DISP3;DYRK2
prerank,gastrulation (GO:0007369),-0.3618660032681731,-0.9560951973610885,0.4834710743801653,0.7863269638832209,1.0,3/15,14.11%,LRP5;LMBRD1;TASOR
prerank,Golgi to plasma membrane transport (GO:0006893),-0.27578859801273614,-0.9555294857755744,0.5424528301886793,0.7872019703732798,1.0,6/47,4.37%,SPTBN1;STXBP6;MACF1;EXOC6;RAB31;EXOC4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.35179531686030274,0.9554890593487841,0.5203883495145631,0.9341332360521002,1.0,5/21,17.21%,OSBPL8;PLA1A;OSBPL5;PLAAT3;OSBPL10
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.3885693687373931,0.9554424080095004,0.52,0.9331664851155049,1.0,1/12,0.87%,IL18
prerank,ncRNA metabolic process (GO:0034660),0.30787958511597596,0.9554210906636501,0.49427480916030536,0.9321549144724315,1.0,7/37,13.90%,DTD1;TDRD9;TRIM71;DDX17;BCDIN3D;TUT4;DICER1
prerank,mesenchymal cell development (GO:0014031),-0.34327442902070726,-0.9552885599796953,0.5239085239085239,0.7872754905980609,1.0,11/18,34.67%,NOTCH1;HEYL;HEY2;CDH2;SOX8;SOX11;TAPT1;SNAI2;TBX20;KBTBD8;NOLC1
prerank,response to ionizing radiation (GO:0010212),0.26697928210471644,0.955056037814987,0.5368782161234992,0.9320915295166844,1.0,17/70,19.36%,EYA1;FANCD2;ABRAXAS1;KAT5;CLOCK;INIP;MAPK14;BRAT1;AEN;MEN1;GADD45A;SIRT1;ATM;CLK2;NHEJ1;FIGNL1;TRIM13
prerank,regulation of cell motility (GO:2000145),-0.2296762081105019,-0.9549766609079285,0.565,0.7875364889780593,1.0,34/121,20.50%,FRMD5;SPOCK2;DOCK10;RHOA;TMSB4X;NTN1;EGFR;MACF1;SPATA13;FLNA;ROBO4;PRKX;CEACAM1;FGF2;ABI3;FGF7;TMSB10;PLXNC1;TWIST1;CCDC25;SST;AKT2;AMOT;CAVIN1;CSF1R;MEMO1;PLXNA4;OSGIN1;PRAG1;CDK6;AMOTL1;HACE1;RHOB;PLXND1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4185845798950639,0.9549719610525479,0.5212981744421906,0.9312526264990588,1.0,3/10,11.20%,RUVBL2;PIH1D2;PIH1D1
prerank,cellular response to pH (GO:0071467),0.3689963391496963,0.9545847346687352,0.504725897920605,0.9312638268112237,1.0,4/17,13.35%,TRPV1;IMPACT;KCNK4;HYAL1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3383710272455637,0.9545160775769221,0.5145631067961165,0.9303730107720617,1.0,7/20,17.57%,CHRM2;CHRNB2;LY6G6D;PLCB1;CHRM1;RGS8;CDK5R1
prerank,negative regulation of lipid storage (GO:0010888),0.35855520786691564,0.9542858979403824,0.49245283018867925,0.9299933890591215,1.0,4/19,9.09%,OSBPL8;PPARA;ABHD5;NR1H3
prerank,androgen receptor signaling pathway (GO:0030521),0.4149585477470364,0.9540802792955219,0.5089108910891089,0.9295132680772715,1.0,3/11,7.14%,DDX5;RNF14;DDX17
prerank,protein autoprocessing (GO:0016540),0.3659455197618536,0.9537492308629382,0.5039525691699605,0.9293309422137972,1.0,3/17,7.31%,AFG3L2;HTRA2;SPRTN
prerank,hyaluronan metabolic process (GO:0030212),-0.3266041786610484,-0.953423826840823,0.5269461077844312,0.7908551399132,1.0,6/23,15.20%,CD44;FGF2;HEXA;CEMIP;HAS1;CEMIP2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.3652017066507963,-0.953104244620074,0.5363825363825364,0.7911133706507725,1.0,8/14,23.53%,SEC24D;SEC23A;SEC31A;SEC24B;SAR1A;SEC13;SEC24A;TBC1D20
prerank,nucleotide biosynthetic process (GO:0009165),-0.3445427886612729,-0.9530866734419106,0.5149700598802395,0.7906258645292928,1.0,10/18,38.99%,ME1;HPRT1;RRM2B;NMNAT1;PRPSAP1;RRM1;GART;PRPS2;PPAT;RRM2
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.30973989094783133,-0.9529326349448138,0.5150214592274678,0.7904859487791782,1.0,6/26,6.44%,ST3GAL4;ST3GAL6;B3GNT2;B4GALT4;ST3GAL1;LUM
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.23753785314243794,-0.9526271175411546,0.5721649484536082,0.7906878226722187,1.0,28/105,23.25%,RPS6KA5;PLCG2;PAK2;LYN;PRKCD;PSMA6;PSMB7;RELB;SRC;PSMB6;MALT1;PSMB5;KRAS;NRAS;ICAM2;PSMB8;TAB1;PSMC4;PSMD11;PRKACA;PSMB4;PSMD14;PSMD10;SYK;PSME1;FYN;BCL10;PSMB3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.39908987514838595,-0.9520710727630589,0.5379746835443038,0.7909558267019385,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.39908987514838595,-0.9520710727630589,0.5379746835443038,0.7909558267019385,1.0,6/11,28.42%,JAK1;PTK2B;JAK3;SYK;IL2RA;IL2RG
prerank,regulation of cell cycle phase transition (GO:1901987),-0.24075076631821837,-0.9520438269391988,0.5672371638141809,0.7904853293206392,1.0,24/91,23.32%,CDC27;ANAPC5;XPC;PSMA6;PSMB7;CDC16;PSMB6;PSMB5;FBXO5;ERCC2;TCIM;FBXW7;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;CDC26;PSMD10;PSME1;CDKN1B;PSMB3;CDC23
prerank,regulation of protein polymerization (GO:0032271),0.30180641732143143,0.9519593273104883,0.5130597014925373,0.9331732701007597,1.0,11/35,23.15%,MAP2;ARHGAP28;PRUNE1;ARL2;ABL1;GBA2;HSP90AA1;ABITRAM;TTBK1;DBNL;PAK3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3828799604974362,0.9519509892670796,0.5454545454545454,0.9321377670575743,1.0,5/13,18.21%,DDX5;SPRED3;MSX1;ATM;SPRED1
prerank,response to growth factor (GO:0070848),-0.28392959826845243,-0.9518661348533852,0.5581896551724138,0.7904027583737864,1.0,10/41,14.56%,BMPR2;ACVR1;ACVRL1;TGFBR2;CPNE3;RACK1;KLF4;HDAC6;TBC1D7;ACVR1C
prerank,regulation of DNA replication (GO:0006275),-0.2698273697537639,-0.9518232581877011,0.535377358490566,0.789984077882329,1.0,15/49,24.66%,BCAR3;ACVRL1;KAT7;WAPL;EGFR;S100A11;FBXO5;BLM;BRPF3;ORC5;PPP2CA;FAF1;NUCKS1;EGF;CTC1
prerank,protein import (GO:0017038),0.26359077470688114,0.951776319507266,0.5428082191780822,0.9315468362008272,1.0,20/84,19.04%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3;ATAD1;TOMM22;ABCD1;LAMP2;NXT1;CLU;IPO8;TNPO2;IPO4;SNX33;NUP88;AKT1;HSP90AA1
prerank,positive regulation of autophagy (GO:0010508),0.26376710849475565,0.9517601196124643,0.5357766143106457,0.9305374313962224,1.0,13/81,10.33%,RNF152;PRKAA2;PLEKHF1;OPTN;PIK3CB;TRIM5;IKBKG;KAT5;GPSM1;LRRK2;SESN1;HTT;PAFAH1B2
prerank,positive regulation of lyase activity (GO:0051349),0.37399014939840985,0.9515653569886551,0.5146198830409356,0.9300091779898204,1.0,1/14,0.44%,CACNA1D
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3850624427334294,0.9514858133154828,0.5059055118110236,0.9291804315915838,1.0,2/14,4.13%,OXSR1;STK39
prerank,regulation of superoxide anion generation (GO:0032928),-0.36599944411929075,-0.9513508299659739,0.5059760956175299,0.7906120286974618,1.0,7/14,36.32%,PRKCD;SOD1;SYK;AATF;MAPT;TYROBP;CRP
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.3580260667802302,0.9512945707132948,0.5269461077844312,0.9286767389202805,1.0,5/19,10.07%,TGFBR3;BMPR1A;RBPJ;FGFR2;TGFBR1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3950878865897461,0.9509357922349836,0.5159474671669794,0.9286714971306577,1.0,3/12,9.89%,TET1;PPHLN1;MPHOSPH8
prerank,negative regulation of interferon-beta production (GO:0032688),0.4108927514246324,0.9509210461703435,0.5436507936507936,0.9276666564050585,1.0,6/10,20.22%,NLRC3;CACTIN;PPM1B;SIRPA;PYCARD;PTPRS
prerank,lymphocyte proliferation (GO:0046651),-0.3257431184035446,-0.9505270693377244,0.5262054507337526,0.7921348054927079,1.0,5/22,13.63%,MEF2C;ELF4;CTPS1;CD40;PTPRC
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.36466174114821476,0.9503971936566148,0.500945179584121,0.9280281809649533,1.0,3/16,11.97%,APPL2;WDTC1;SOX9
prerank,regulation of myotube differentiation (GO:0010830),-0.31737622931105175,-0.9501635863104914,0.5317796610169492,0.792482403454893,1.0,5/24,8.65%,NOTCH1;PIEZO1;CCN3;HDAC9;TMEM119
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.4018479835673727,0.950158153483455,0.5147058823529411,0.9276758688477367,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3434598713217045,0.950135738983242,0.5456273764258555,0.9266998486964376,1.0,3/21,4.59%,CEL;CYP26B1;LPIN1
prerank,regulation of mitochondrion organization (GO:0010821),-0.27367746405947746,-0.950098126338937,0.5439814814814815,0.792108217598198,1.0,21/47,31.00%,PID1;MFF;PDE2A;IAPP;MYO19;GOLPH3;SREBF2;SQSTM1;HDAC6;FBXW7;PRMT6;SIRT7;SREBF1;RHOT2;MUL1;TREM2;MAPT;STOX1;FLCN;VPS35;USP36
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3720194308839869,0.9500738553134697,0.514792899408284,0.9258327307641175,1.0,6/15,18.35%,IGF1;PPIF;CLU;HGF;NOL3;AKT1
prerank,maintenance of protein localization in organelle (GO:0072595),0.3532978918439417,0.9500657564606845,0.4942528735632184,0.924823695847238,1.0,6/19,18.35%,HNRNPU;ARL2;TOPORS;PML;HK1;AKT1
prerank,phospholipid metabolic process (GO:0006644),0.2719067951418528,0.949902334898303,0.5296167247386759,0.9242506095384392,1.0,16/71,17.39%,FITM2;AGPAT4;PLA2G4C;SMPD3;PCYT2;PLCD1;CLN8;PLPPR3;SMPD2;ACP6;PLA2G15;GDE1;ABCA2;PLBD2;PLAAT3;AGPAT2
prerank,cellular response to insulin stimulus (GO:0032869),0.24444666036574905,0.9496432537256614,0.5616,0.923917456655659,1.0,27/124,14.88%,CPEB2;GCK;BAIAP2;PIK3R3;ATP6V0A2;INSIG2;LPIN1;ATP6V0B;ATP6V1H;SOS1;PDPK1;PDK2;PRKCI;SORBS1;ATP6V1B2;RHOQ;PHIP;ATP6V1E1;USF1;EPRS1;RAB13;ATP6V0E2;ATP6V1C1;SLC27A4;PRKDC;ATP6V0D2;GOT1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.23697879764071003,-0.9494645464506736,0.5558194774346793,0.7930951735918303,1.0,35/96,26.03%,MEF2C;TGFB2;NDNF;FOXO3;NGF;SIX1;MDK;PRKCG;FOXQ1;CDK5;SOD1;TGFB3;APOE;NSMF;UNC5B;PTPRZ1;PTK2B;LANCL1;MT3;KCNB1;ATF4;SIX4;CRLF1;LIG4;AKT1S1;AGAP2;SET;RASA1;KDM2B;NFATC4;EGLN3;EPHA7;F2R;KIF14;WFS1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.38624339001278873,-0.9492584269412155,0.5366876310272537,0.7931048736292612,1.0,3/12,10.53%,SERINC5;SRR;SERINC3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.37380565657054216,0.9491316220950532,0.5239005736137667,0.9242552933298406,1.0,6/15,16.23%,KIT;WHRN;ADGRV1;KCNK4;PDZD7;LHFPL5
prerank,cellular response to topologically incorrect protein (GO:0035967),0.31490880404698907,0.9477916073760482,0.5381818181818182,0.9269080140141831,1.0,4/31,4.40%,HSPA1A;DNAJC18;OPTN;DNAJB14
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.32184492637695905,-0.9463711001327391,0.538961038961039,0.7996566380913617,1.0,5/23,15.44%,MYO10;DYNC1I2;TUBA1A;DYNC1I1;KIF1C
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2480211777295371,-0.9458380175429272,0.5879518072289157,0.8003931307559987,1.0,28/78,26.95%,ACTB;PKD1;EGFR;CCNY;APC;CDKN1C;IPO7;SERTAD1;MYOCD;GTF2H1;IPO5;HHEX;BLM;PTEN;LATS1;CCNF;CCND1;PSMD10;CCND2;CCNH;CCNB2;CDKN1B;RGCC;LATS2;CDKN3;MAPRE3;CDKN2B;CCNT1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3225958496199892,0.9457523816954714,0.5251396648044693,0.9313758001219097,1.0,8/28,17.57%,HSPA1A;CLASP1;ARL2;DRG1;HSPA1B;MAPRE1;NAV3;CDK5R1
prerank,DNA catabolic process (GO:0006308),-0.38402801231894623,-0.9456180960579216,0.5280665280665281,0.8003903664687513,1.0,5/11,36.14%,REXO4;DFFB;XRN2;ISG20;MUS81
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.347623443112071,0.9453675391567222,0.5329341317365269,0.9314175545359925,1.0,5/20,11.83%,CTR9;MEIS1;LEO1;LDB1;CDC73
prerank,neurotrophin signaling pathway (GO:0038179),-0.3253553995123475,-0.9449657766213717,0.5448851774530271,0.8014618906699124,1.0,5/21,9.86%,RAPGEF2;RAP1A;NGF;BCAR1;SORT1
prerank,dendritic cell differentiation (GO:0097028),-0.3178176095306391,-0.9448577652455503,0.5461689587426326,0.8011759440996049,1.0,3/22,6.40%,GAS6;TGFBR2;LYN
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.29839557423756213,-0.9448118242719121,0.5116279069767442,0.8007601571238211,1.0,6/33,7.89%,NET1;MAP3K5;CYP1B1;ANXA1;PRKCD;RPS3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2942671871568666,-0.9447387078621772,0.5735294117647058,0.8004162875152238,1.0,9/32,23.86%,DEFA6;RPL39;RPL30;CCL13;ROMO1;GAPDH;HMGN2;RPS19;PGLYRP1
prerank,peroxisome organization (GO:0007031),-0.31700813035919745,-0.9445101310554983,0.5442477876106194,0.8004613411218012,1.0,5/25,8.56%,TMEM135;MFF;SEC16B;ABCD2;PEX7
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3321283936954205,0.9444857182575976,0.5452830188679245,0.9328221262921805,1.0,3/23,8.03%,IGF1;NLRP2B;NLRP3
prerank,triglyceride metabolic process (GO:0006641),0.2860100231810291,0.9443588026433017,0.5439252336448598,0.9321131994385139,1.0,7/48,16.09%,LPGAT1;GK;LPIN1;MOGAT1;DGAT2;SIRT1;PLAAT3
prerank,protein polymerization (GO:0051258),-0.2667851580639426,-0.9441358291412937,0.542528735632184,0.8008408811245469,1.0,12/55,13.24%,GSN;MSRB2;CHMP4B;CHMP4A;MAP7D3;TPPP3;WASHC3;FAM107A;FGF13;MICALL2;PSTPIP2;TRPV4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.3817660684017067,-0.9438599496876642,0.5207920792079208,0.8009224607877056,1.0,2/11,6.40%,MFHAS1;LYN
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3444994594319652,-0.9438041584601045,0.5641547861507128,0.8005350167048684,1.0,4/17,9.91%,TMSB4X;ANXA1;OTUD7B;KLF4
prerank,response to exogenous dsRNA (GO:0043330),-0.34134474576480955,-0.9434710799798164,0.5280172413793104,0.8008719131082088,1.0,4/18,4.57%,CAV1;RFTN1;IRAK3;RALB
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3199630462678063,-0.9432858821184941,0.5446985446985447,0.8008236929349601,1.0,9/23,30.62%,PLA2G4A;MBOAT1;ABHD4;PLA2G6;LPCAT3;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.32541444522251245,0.9432229756444384,0.5055762081784386,0.9341144671399676,1.0,5/27,4.37%,CACNB1;ANK2;CACNB3;JPH1;ADRA2A
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3626633849742519,-0.9430314410538081,0.5303326810176126,0.800895875335886,1.0,3/13,7.09%,GJC1;CACNB2;KCNQ1
prerank,N-glycan processing (GO:0006491),-0.3346242379065261,-0.9427627604406902,0.5526315789473685,0.8010030377547736,1.0,6/18,14.69%,ST8SIA4;FUT8;ST8SIA6;MGAT4A;MGAT4B;ST8SIA2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27656771180958933,0.9426975067486725,0.5551601423487544,0.9345352362061213,1.0,12/58,15.99%,PAXX;POLM;ERCC1;ABRAXAS1;KAT5;KDM2A;MDC1;MRE11;PRPF19;PIAS4;PRKDC;ATM
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.24042505457587704,-0.9424785621247042,0.5641025641025641,0.8011851706295624,1.0,27/88,27.22%,FBXL7;PSMA6;PSMB7;FBXO31;FBXO4;PSMB6;PSMB5;FBXO44;FBXW7;FBXL18;PSMB8;PSMC4;PSMD11;PSMB4;AMN1;PSMD14;CCNF;FBXL4;FBXW5;PSMD10;PSME1;FBXL6;PSMB3;CUL4A;KIF14;CUL1;FBXW11
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.40625253724052,-0.9423134746033034,0.5585412667946257,0.8010701486185563,1.0,7/10,30.38%,MYD88;TICAM1;CD68;TLR4;TREM2;CD36;TLR6
prerank,cellular response to interleukin-12 (GO:0071349),-0.2683335863681289,-0.9415368347273704,0.5714285714285714,0.802463872960061,1.0,21/48,33.01%,MTAP;PAK2;PPIA;RPLP0;CNN2;SOD1;JAK1;CFL1;PDCD4;BOLA2;CDC42;CAPZA1;MSN;HNRNPF;IL12RB2;STAT4;AIP;MIF;LMNB1;RAP1B;CD47
prerank,cellular protein-containing complex assembly (GO:0034622),-0.21916860581756586,-0.9407155373910215,0.6178010471204188,0.8039881928617428,1.0,29/159,16.90%,HIP1;STXBP6;RPL38;PIK3C2A;TBCD;FCHO2;SGIP1;SMAD1;VAMP3;CLTB;NCK1;PXN;CHMP4B;CHMP4A;PTGES3;SRP19;SRC;NUP107;TIAM1;BBS12;IMMP2L;HIP1R;TPR;HIGD2A;CCT2;PSMD11;RTN4;DNAI4;ADRM1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.24205175649161034,0.9406439052307235,0.5853658536585366,0.9392123374723261,1.0,15/129,9.83%,RNF220;LGR4;LRRK1;WLS;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2;LRRK2;RSPO1;LYPD6
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3881480165486637,0.9406102566858224,0.5273833671399595,0.9382711634167262,1.0,3/12,8.19%,IGF1;GCK;SORBS1
prerank,cell proliferation in forebrain (GO:0021846),0.4086701953968972,0.9405829518253626,0.5252525252525253,0.9373201084091288,1.0,3/10,11.14%,WNT7A;PCM1;DOCK7
prerank,icosanoid metabolic process (GO:0006690),0.29863795945976224,0.9404728871639716,0.5446584938704028,0.9365895809758863,1.0,6/40,7.80%,PTGS1;PON1;DAGLA;PLA2G4C;PNPLA8;PTGR1
prerank,inner dynein arm assembly (GO:0036159),0.4068516653767969,0.9398662359257448,0.5138339920948617,0.9371740633613136,1.0,1/10,2.77%,DNAH1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3430222126850419,0.9398041793136179,0.5483271375464684,0.9363158962003032,1.0,7/21,23.65%,GCK;HKDC1;G6PC3;HK1;GPI;PGLS;SHPK
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.34219975407053627,-0.9398030838215602,0.5571142284569138,0.8055954043431817,1.0,4/17,13.63%,PPP1R12A;ITGA1;CALM3;PTPRC
prerank,regulation of lymphocyte activation (GO:0051249),-0.37614415564998516,-0.9396407730987129,0.5265306122448979,0.8054653009733336,1.0,7/12,38.09%,DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,C-terminal protein amino acid modification (GO:0018410),-0.39634022491158594,-0.9396079447776422,0.5264227642276422,0.8050120005835617,1.0,5/11,20.30%,ICMT;ATG12;ATG5;AGTPBP1;LCMT1
prerank,macromolecule catabolic process (GO:0009057),0.32693728726327137,0.9393743909074661,0.5501930501930502,0.9364503672067848,1.0,6/26,14.98%,CAPN3;KIF16B;CTRL;CLN8;CLN5;UCHL3
prerank,myelin maintenance (GO:0043217),-0.39525463357002383,-0.9391119389807802,0.5294117647058824,0.8057015563750594,1.0,6/10,24.61%,ABCD2;SOD1;PRX;PTEN;MYRF;CXCR4
prerank,negative regulation of telomere maintenance (GO:0032205),0.3664450905144075,0.9390833884959556,0.5486381322957199,0.9362243560734329,1.0,7/15,22.08%,ERCC1;TNKS2;RTEL1;SMG6;ATM;PINX1;SLX4
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.25323101325603947,-0.9387901679849031,0.5698198198198198,0.805975111091097,1.0,19/67,23.25%,B2M;VAMP3;ITGB5;TAP2;PSMA6;PSMB7;PSMB6;NCF2;PSMB5;PSMB8;PSMC4;PSMD11;SNAP23;PSMB4;PSMD14;PSMD10;PSME1;FCGR1A;PSMB3
prerank,generation of neurons (GO:0048699),-0.2120550344704143,-0.9387524097320626,0.6468842729970327,0.805526517812622,1.0,35/190,17.26%,NRP1;MEF2C;RAPGEF2;MARK1;TGFB2;NDNF;DISC1;RUNX2;RUNX1;SIX1;EML1;CEP85L;BHLHE40;LHX6;WNT5A;CIT;MET;HES1;HEYL;HEY2;CDK5;FGF13;ACSL3;FZD4;WNT9A;NGRN;FZD1;NR4A2;MAP1B;PAFAH1B1;SIX4;DDIT4;ACSL4;HEY1;IER2
prerank,regulation of fibroblast proliferation (GO:0048145),0.289417129903129,0.9386866821302972,0.5346358792184724,0.9363017786386546,1.0,8/45,11.83%,IGF1;PDGFRA;SPHK1;E2F1;NLRC3;MED25;CD300A;CDC73
prerank,positive regulation of histone acetylation (GO:0035066),0.3293293186802691,0.938431292726881,0.5400763358778626,0.9359399558609373,1.0,8/23,15.28%,RUVBL2;ARRB1;PPARGC1A;BRD7;PIH1D1;SPHK2;WBP2;MUC1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3405370886698208,0.9383789715708852,0.5456273764258555,0.9350573519653166,1.0,2/22,1.35%,IL18;SPHK1
prerank,regulation of mRNA stability (GO:0043488),-0.22239749175137324,-0.9383531127474253,0.6279683377308707,0.8060087604135354,1.0,42/145,23.25%,FTO;UBC;YWHAB;SERBP1;RPS27A;FASTKD1;PABPC1;UBB;EXOSC1;AXIN2;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;FUS;PUM1;PSMB8;PSMC4;PSMD11;FMR1;TENT5C;TBRG4;FXR1;CARHSP1;PSMB4;PSMD14;RIDA;TENT5A;METTL3;PSMD10;SET;ROCK1;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.282004881138123,-0.9383259511142981,0.5421412300683371,0.8055400203268391,1.0,8/39,12.00%,MYO1D;ACTN4;MYO1B;SYT4;MYO19;MYO1F;DYNC1I1;FNBP1L
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3121044692559125,0.9379674455499595,0.525328330206379,0.9351129599374868,1.0,7/33,11.83%,PLK5;APPL2;E2F1;CRNN;STXBP4;TAF1;CDC73
prerank,development of primary male sexual characteristics (GO:0046546),-0.2823070296197674,-0.9375898144896521,0.5440180586907449,0.8067684849251181,1.0,5/34,6.86%,KITLG;TGFB2;LHFPL2;WNT5A;AR
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3348417004698751,0.9375611320807903,0.5355731225296443,0.9352132240995893,1.0,2/22,5.02%,ROCK2;PPP4R4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.26871246230730955,-0.9375506990611071,0.5892857142857143,0.8063420621453197,1.0,20/50,32.32%,ACTB;CDKN1C;SERTAD1;GTF2H1;BLM;CCNF;CCND1;CCND2;CCNH;CCNB2;CDKN1B;CDKN3;CDKN2B;CCNT1;CCNJ;STOX1;CDK5R2;CAMK2N1;CCNE1;CDC6
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2836325749702787,-0.9366789358858834,0.564935064935065,0.8079165258480865,1.0,17/31,41.45%,LYN;TNFRSF21;CD86;GLMN;FCGR2B;SOX11;CEBPB;IL4I1;GPNMB;TYROBP;SDC4;VTCN1;ARG1;PDCD1LG2;CD80;CTLA4;BLK
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.33274551773794536,0.9358883928403591,0.51171875,0.9386383897767077,1.0,2/23,2.77%,PLK5;ZWINT
prerank,fatty acid beta-oxidation (GO:0006635),0.2808485543024147,0.9358663934503407,0.5691489361702128,0.9376782913367038,1.0,11/51,12.22%,ACAT2;IVD;ACAT1;ACAD10;ECHS1;ABCD1;AMACR;ACAD11;ECHDC2;GCDH;CROT
prerank,regulation of tau-protein kinase activity (GO:1902947),0.40036402435197405,0.9358044111703141,0.5168986083499006,0.9368154399195886,1.0,10/10,59.99%,CLU;HSP90AA1;SORL1;RB1;HSP90AB1;IFNG;DKK1;NAB2;C5AR1;EGR1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.3678461466799077,-0.9353254325432457,0.5508130081300813,0.8107243682127466,1.0,6/13,19.30%,MDFIC;APOD;TPR;SP100;BARD1;CABP1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22754677747651655,-0.9353217299295183,0.618421052631579,0.8102012220067278,1.0,34/121,23.25%,PRR5L;UBC;YWHAB;SERBP1;RPS27A;PABPC1;UBB;EXOSC1;PRKCD;PSMA6;PSMB7;PUM2;MAPKAPK2;PSMB6;YWHAZ;PSMB5;HSPB1;PUM1;PSMB8;PSMC4;PSMD11;FMR1;FXR1;CARHSP1;PSMB4;PSMD14;ZC3H12A;PSMD10;SET;PSME1;RBM24;EXOSC4;EXOSC5;PSMB3
prerank,diacylglycerol metabolic process (GO:0046339),-0.31688798921204775,-0.9337152320045492,0.5714285714285714,0.8135271381048237,1.0,3/23,3.37%,PLCE1;DGKH;DGKZ
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.36607557326314855,0.9333183493694662,0.5588235294117647,0.9424282406498384,1.0,4/16,9.07%,APPL2;PPARA;NLRC3;ABCD1
prerank,response to interferon-beta (GO:0035456),-0.3173301067349053,-0.933157860164107,0.5665914221218962,0.814371123149928,1.0,4/22,7.87%,PLSCR1;IFITM3;AIM2;XAF1
prerank,cilium organization (GO:0044782),0.22684582664142008,0.9331002954139354,0.6122112211221122,0.9419898049512998,1.0,53/209,20.22%,CFAP44;DCDC2;INTU;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;CEP78;RILPL1;SNAP29;CFAP61;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;IFT122;B9D1;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;CDC14B;RAB1A;CFAP20;TCTN2;ARL3;RAB23;FUZ;RPGR;GBF1;PTPN23;OCRL;KIF3B;ARMC2;DYNC2H1;TTC36;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,regulation of protein metabolic process (GO:0051246),-0.27325506480407435,-0.9330442480516549,0.55863539445629,0.814109547168226,1.0,11/44,16.11%,LTBP4;NEDD4L;APP;SPOPL;APOE;KLF4;HGS;GSAP;KLF2;PLAUR;ZDHHC2
prerank,renal water homeostasis (GO:0003091),0.33583763096705366,0.9328406945039918,0.5420560747663551,0.9416807427625657,1.0,3/23,6.20%,ADCY5;ADCY1;ADCY8
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.24119351550287524,-0.9328229223334111,0.5904761904761905,0.8141143628457251,1.0,15/78,11.06%,CAV1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;BCAP31;ARIH2;SOCS5;ARIH1;PABIR1
prerank,protein dephosphorylation (GO:0006470),0.23986049687245523,0.9327386373656886,0.6042003231017771,0.9409195856044772,1.0,24/135,13.75%,PPP2R2B;EYA1;DUSP29;EYA4;PTPN9;EYA2;PPM1M;PTPN4;PTPN13;DUSP11;PPEF2;PPM1G;TNS2;MTMR4;PTPRD;PTPN21;PPM1D;PPP1CB;MTMR2;CDC14B;PTPN14;PTPRO;PTPRU;PPP6C
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3899424615960848,-0.9326298865779743,0.5691699604743083,0.8140706065407829,1.0,6/11,30.94%,SCARB1;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.21292965183987297,0.932561810345461,0.6322489391796322,0.9403401482889922,1.0,90/366,20.71%,DENND4A;RORA;PPARGC1B;CTR9;SUFU;ZBTB38;SCRT1;MYBL2;CRABP2;ARNT2;ZNF431;NFYB;ESRRA;POU1F1;TULP3;CCAR2;ASCC2;CCAR1;PQBP1;ACTR8;MZF1;WWTR1;RNF14;NFYC;E2F1;CEBPA;SRSF10;CHD3;PHF1;EIF2B4;HES6;MAFA;PPARGC1A;HINFP;FZD7;SSBP2;CLOCK;CREBL2;PRDM2;GON4L;NSD1;TGFBR1;LDB1;RNF20;RNF6;ZFPL1;MAGED1;OBI1;DMTF1;CYFIP1;PML;CHEK2;RBAK;TGFBRAP1;FOXC1;TSC1;MYBL1;SMC3;ABL1;ANKRD17;ELAVL2;METTL18;RBBP6;SOX6;RELA;MYCBP;MYT1;MTF2;SRRT;APBB1;NSD3;NLK;PCGF1;MLXIPL;MLX;MITF;SOX2;KAT6B;DDIT3;POLR2A;PUM3;REST;SUPT4H1;EIF2A;SPTY2D1;MLLT6;NFX1;GCFC2;HOXB7;TGIF2
prerank,negative regulation of immune effector process (GO:0002698),0.37069157673256636,0.9325492381602056,0.5150905432595574,0.9393545200323843,1.0,3/13,14.32%,ENPP3;CD300A;HAVCR2
prerank,positive regulation of secretion by cell (GO:1903532),-0.2439886471484262,-0.9322555440341951,0.6108597285067874,0.8144431483753473,1.0,22/70,20.35%,SLC12A2;TGFB2;UNC13B;STX1A;TMED10;PPIA;TGFB3;GOLPH3;CD2AP;EDN1;EXOC1;EDN3;RAB3A;BMP2;RAB27A;APBB3;KCNB1;CFTR;GPER1;EXPH5;MYOM1;RAB27B
prerank,sterol transport (GO:0015918),-0.3298592826799139,-0.9322050570683238,0.5614406779661016,0.8140375219119282,1.0,3/19,6.51%,CAV1;NPC2;OSBP
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2968332435854477,0.9311817009654039,0.5522388059701493,0.9420348902695418,1.0,3/39,2.86%,NNAT;GCK;NLGN2
prerank,positive regulation of cell cycle process (GO:0090068),-0.23479284654222823,-0.9311558389042873,0.5796766743648961,0.8160329627388846,1.0,31/91,25.85%,RHOA;SVIL;INSR;LRP5;PLSCR1;MAP3K20;CIT;IGF2;EDN1;EDN3;KIF23;TPR;RAD21;NUSAP1;CEP295;RHNO1;DYNC1H1;RANBP1;NUDT16;KIF20B;CDC42;GPSM2;EGF;GIPC1;E2F7;NUP62;CUL3;RGCC;XRCC3;PRKCE;KIF14
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.30574977809465514,0.9309719583661754,0.5350194552529183,0.9415955424929401,1.0,6/30,11.04%,CACNA1D;ANK2;SNTA1;FGF12;KCNH2;RYR2
prerank,sensory organ development (GO:0007423),0.28312340471065783,0.9306778501412085,0.5701754385964912,0.9414056543794211,1.0,15/51,19.53%,SMOC1;PBX2;MEIS1;PAX6;MAB21L2;PBX4;ZDHHC16;CPAMD8;SHROOM2;FOXC1;ADAMTS18;RBP4;HIPK2;SOX2;MEIS3
prerank,cAMP metabolic process (GO:0046058),0.3718787965524201,0.9301154751586358,0.5438931297709924,0.9419175929589646,1.0,3/13,6.20%,ADCY5;ADCY1;ADCY8
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.24351261528181553,-0.930111099561425,0.607981220657277,0.8179716206805412,1.0,14/75,13.40%,ACTB;MEF2C;FARP1;PARD3;APP;KLF7;TBCD;BTBD3;CDK5;S100A6;DSCAML1;RAB3A;MFSD2A;SHTN1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3375668297150338,-0.9300892584403512,0.5496828752642706,0.8174939306885847,1.0,5/18,18.87%,RAD51B;BRD4;FBXO5;CCND1;RAB11A
prerank,regulation of programmed necrotic cell death (GO:0062098),0.33471975353581096,0.9300540478731995,0.542649727767695,0.9410637174910049,1.0,3/20,10.07%,NUPR1;FLOT2;CFLAR
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.2122475843077973,-0.9297426648440598,0.6430594900849859,0.8178622178653407,1.0,54/190,20.85%,PDE3A;PDE4D;CAV1;DAB2IP;SLIT2;TMSB4X;THBS1;SH3BP4;LIMD1;BCL2L1;PTPRJ;CCN3;ESR1;PDE10A;PIK3IP1;XDH;CIT;RACK1;PDE2A;LYN;OTUD7B;PPP2R5C;IFI35;HDAC7;SRC;DUSP3;CD2AP;PER1;PHLPP1;TWIST1;TNFAIP8L1;PEBP1;TBC1D7;PLAUR;NR1H4;DDIT4;RNF157;APLNR;PHLPP2;PTEN;GPER1;UBR1;CARD19;USP10;ZC3H12A;MCL1;MARK3;RIPK1;SPI1;ARRB2;AKT1S1;PSMD10;PPP2R5B;AJUBA
prerank,regulation of fat cell differentiation (GO:0045598),0.2609367440466719,0.9294107342776476,0.5609756097560976,0.9417627857096869,1.0,11/74,12.33%,RORA;TMEM64;SMAD3;LMO3;LRP3;WWTR1;E2F1;CREBL2;AAMDC;ADIG;CDS1
prerank,telomere maintenance (GO:0000723),-0.26117187965299166,-0.9289063436546311,0.5794392523364486,0.8193083648774785,1.0,18/50,26.19%,RPA1;XRCC5;PTGES3;SMC5;TERF2IP;BLM;TEP1;SP100;ZBTB48;NBN;RPA2;POLD4;TEN1;PARP3;XRCC3;CTC1;TINF2;TERF2
prerank,positive regulation of proteolysis (GO:0045862),0.2775647910176748,0.9287622362686787,0.5809352517985612,0.9424254788121672,1.0,18/55,23.50%,SH3D19;FURIN;CAPN3;ADRA2A;CYFIP2;PLK1;CTSH;NRDC;NDUFA13;SNX33;ASPH;NLRC4;SNX9;ATP5IF1;TRIM32;RCN3;BTRC;PACSIN3
prerank,tRNA methylation (GO:0030488),-0.2866163419487358,-0.9286525133825503,0.5575620767494357,0.819411319157785,1.0,10/34,19.64%,METTL2A;METTL2B;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;METTL6;TRMT112;LCMT2
prerank,protein sumoylation (GO:0016925),0.28128933087679986,0.9284830495468155,0.583941605839416,0.9421569194729932,1.0,10/49,17.12%,EYA1;POM121;NUP155;TOPORS;NUP98;PIAS4;BCL11A;NUP37;RANGAP1;NUP88
prerank,regulation of protein transport (GO:0051223),-0.29601251316661265,-0.9283872708206438,0.5720250521920668,0.8195035014444716,1.0,5/27,8.94%,DISP1;DNAJC1;DNAJA1;GAPVD1;PTPN1
prerank,regulation of intracellular protein transport (GO:0033157),-0.2908139479704092,-0.9275525069945688,0.5696465696465697,0.8209506799444004,1.0,14/32,24.55%,PRR5L;BMP4;ICE1;PTPN1;RIPOR1;TPR;ZFAND1;B3GAT3;KIF20B;SIRT7;CEP131;OAZ1;PLK3;NDEL1
prerank,Golgi organization (GO:0007030),0.24534241420262348,0.927465527016615,0.5886402753872634,0.9437722938171156,1.0,22/112,13.42%,PLK5;OBSL1;DYM;TANGO2;BET1;OPTN;CLASP1;FAM174B;STX16;LRRK2;GOLGA2;TRAPPC11;HTT;SEC23IP;MYO18A;VPS51;TMED9;GOLGA8B;GOLGA5;TMED4;STK25;RAB1A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2258254628058004,-0.9274223958986828,0.625,0.8207401683791314,1.0,34/116,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;FCGR2B;GGT1;PRKAR1B
prerank,protein K48-linked ubiquitination (GO:0070936),0.27381522957981635,0.9270379871092674,0.588135593220339,0.9438993330462253,1.0,4/54,4.67%,RNF152;UBE2E2;RNF126;IFI27
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2970252308783668,-0.9268669698087958,0.5392561983471075,0.8215002331621175,1.0,12/26,27.91%,MET;OCLN;RPS3;TRPV4;CLIP1;KATNB1;TOGARAM1;DCTN1;CDK5RAP2;FES;AKAP9;MAPT
prerank,cellular response to chemical stress (GO:0062197),-0.23238260262508081,-0.9266638356876781,0.601965601965602,0.8214569647432848,1.0,21/96,16.08%,CAV1;LRRC8D;FOXO1;FOXO3;PRR5L;FAS;PRKD1;PPIA;ETV5;PIK3CA;SOD1;CAT;GPX1;NCF2;PRDX6;TRPV4;MT3;VKORC1L1;ZFAND1;ATF4;SRXN1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.19237337702408494,0.9263582322254196,0.8113207547169812,0.9446801058668115,1.0,241/1646,14.25%,DENND4A;ZKSCAN2;MAF;BMP7;RORA;EPAS1;HLF;WNT4;CREB5;PPARGC1B;SNX6;IGF1;DDX5;SMAD3;TRAK1;KDM7A;KMT5A;VGLL3;NPAS3;OSR1;NR2E1;DNMT3L;HMX2;SCML4;MSX2;SOX5;OVOL2;CTR9;SUFU;ZSCAN29;ZBTB38;CDKN2A;TTC21B;SCRT1;CHD4;MYBL2;FBXL19;ARID4A;CREBRF;CRABP2;NR6A1;ARNT2;TENM1;PBX2;KIT;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;SLTM;UBP1;TULP3;HOXB9;CAPN3;TFDP2;SIM1;WNT7A;PICALM;MSANTD1;CCAR2;CHUK;CCNT2;DKK3;ENO1;ZHX1;SMARCD3;LOXL3;KMT2A;HOXB3;MAFG;MEIS1;ASCC2;TIAL1;PEG3;CCAR1;RUVBL2;PCID2;PQBP1;PRMT2;MLXIP;PAX6;IKZF1;PHF8;RBPJ;ACTR8;IKZF2;MZF1;ARID3A;BICRAL;ZFHX2;WWTR1;ZBTB26;HOXA7;PBX4;RFX8;RNF14;NFYC;DRGX;RCOR3;ZKSCAN3;PCGF5;E2F1;CEBPA;CITED1;DPF1;PBXIP1;NRG1;LBH;HOXB6;DDX17;BCL11B;JARID2;SRSF10;BEND5;KAT5;NR2F2;ZC3H8;BCL7A;TEF;ARRB1;ARHGEF11;KLF15;CHD3;ZSCAN22;SNF8;HOXA3;ZNF569;KDM5B;KCNH2;ZNF467;PHF1;PHF2;HES6;MED1;MAFA;CEP290;PPARGC1A;ZFX;KDM2A;HINFP;MAP3K10;HIF3A;MAX;DMAP1;ZNF711;NR1H3;PHIP;E2F8;ZBTB22;HDX;ZIC2;FZD7;MLLT11;HOXB4;NKAP;SSBP2;RXRA;CLOCK;CREBL2;ZFP90;PRDM2;PSIP1;MPHOSPH8;COMMD7;GON4L;NSD1;SALL3;TGFBR1;FOXP4;LDB1;PLCB1;PRKCB;CSRNP3;BRD7;ZNF260;RNF10;RNF20;RNF6;LCOR;E2F4;CSRNP1;CAND2;MAPK14;STAT1;USF1;BATF;ZFPL1;MBD1;MAGED1;MXI1;STAT2;KDM5C;QARS1;GATAD2A;PCGF6;ZBTB49;DMTF1;KDM4A;SOX9;SRA1;CIPC;MED12L;RLIM;PML;RCOR2;RING1;CHEK2;RBAK;BHLHE41;PURB;PIAS4;BRD2;ZNF367;HBP1;CBFA2T2;GABPA;ZIC5;YEATS4;TGFBRAP1;ABCA2;MAP3K12;NIF3L1;EN2;HDAC4;CTBP2;FOXC1;MEN1;ZSCAN20;ARNT;ZNF483;PLAGL2;PSMC5;ZKSCAN4;MYBL1;POLR3C;CREB3L4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.34086587847575983,-0.9262847537314183,0.5454545454545454,0.8218525978704834,1.0,8/16,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3023548821515449,-0.9259802944194384,0.594017094017094,0.8220194719025917,1.0,8/26,20.75%,ST3GAL4;ST8SIA6;GOLPH3;B4GALT5;GCNT1;ST3GAL2;ALG6;RRM2B
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.39591966189493444,-0.925842527394102,0.5480769230769231,0.8218309452709034,1.0,3/10,2.27%,BMP5;LRP6;NOTCH1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.276200688613376,-0.9257337486378296,0.591304347826087,0.821559621722149,1.0,15/39,31.31%,SHLD1;FUS;SMCHD1;FANCB;TIMELESS;MAD2L2;SLF2;SPIDR;DTX3L;PARP3;SHLD3;RAD51AP1;PARP1;SPIRE2;MRNIP
prerank,neuron remodeling (GO:0016322),-0.39668747656466175,-0.9253031991573774,0.5633528265107213,0.8221323455235172,1.0,3/10,3.64%,ANKS1A;SCARF1;APP
prerank,chromatin remodeling at centromere (GO:0031055),-0.29207371009277633,-0.9248118042608539,0.5829787234042553,0.8227840121644007,1.0,12/31,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5
prerank,positive regulation of viral transcription (GO:0050434),-0.29982305624295624,-0.9245910278028243,0.5524625267665952,0.8227831771051171,1.0,12/25,37.01%,MDFIC;GTF2F1;POLR2I;POLR2F;POLR2H;NELFCD;CCNT1;RSF1;POLR2E;POLR2J;NELFE;DHX9
prerank,positive regulation of vacuole organization (GO:0044090),-0.393034518306377,-0.9235791709392942,0.560081466395112,0.8247523129546346,1.0,2/10,4.57%,PIP4K2A;RALB
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.1949690404991289,-0.9235611976465451,0.7292418772563177,0.824267369706811,1.0,102/341,26.21%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;NTAN1;HECW2;RNF111;SPOPL;ANAPC5;RNF144A;RNF166;UBR4;COP1;RNF144B;RNF125;UBE2D3;KCTD10;PSMA6;ZNRF3;PSMB7;CDC16;TRIM25;OTUD7B;FEM1B;PPP2R5C;ARIH2;UBXN1;ARIH1;MVB12B;PSMB6;PSMB5;SQSTM1;MTA1;RAD23B;UBXN2A;UBE2L3;FBXW7;FZR1;PSMB8;PTTG1;VPS37A;RNF149;CBL;PSMC4;KLHL22;KBTBD7;PSMD11;KLHL3;KCTD5;OS9;UBE2A;RNF19A;UBA6;ADRM1;PCBP2;UBE2G1;PSMB4;RNF128;PSMD14;KCTD6;PPP1R11;ATE1;UCHL1;RMND5B;FBXL4;CDC26;HACE1;FBXW5;TGFB1I1;TRPC4AP;ARRB2;NEDD4;PSMD10;MYLIP;PSME1;FAF1;DTX3L;KLHL25;AGAP3;RNF150;RNF40;PSMB3;CDC23;FBXO45;ATXN3;TOM1L1;TSG101;KCTD17;CUL3;CDC34;AREL1;NHLRC3;DTL;UFD1;CUL4A;KIF14;UBQLN1;SPSB3;RNF168
prerank,calcium-mediated signaling (GO:0019722),0.24951529752277538,0.9233792511808534,0.6010362694300518,0.95176432736562,1.0,14/93,11.47%,CCR9;ACKR2;SPHK1;ANK2;GPR143;DMPK;PDPK1;NUDT4;LRRK2;NMUR1;ADGRL1;RYR2;KSR2;TRPM2
prerank,activation of phospholipase C activity (GO:0007202),-0.2955707279332801,-0.9232217574243857,0.604989604989605,0.8245453710797802,1.0,7/29,14.23%,EDNRA;EGFR;PLCG1;PHB2;HTR2A;CD86;P2RY6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3917201625556823,-0.9227802930018683,0.5693877551020409,0.8250385975134762,1.0,3/10,15.59%,ITGA5;MT3;VTN
prerank,protein modification by small protein conjugation (GO:0032446),0.21127335920379364,0.9227007127520264,0.6918604651162791,0.9525251500303354,1.0,80/361,21.24%,RNF220;EYA1;RNF152;EPAS1;RNF43;CTR9;ASB2;PDZRN3;DTX1;DERL1;TRIM62;POM121;RNF41;NUP155;TRIM5;LEO1;PLK1;KLHL13;SHPRH;RNF14;UBA1;FBXO11;TRIM35;ARRB1;DCUN1D4;DTX2;DTX3;HIF3A;RNF135;TRAF7;BRAP;TOPORS;RNF20;RNF6;CAND2;HLTF;UBE2W;FBXO9;CDC73;NUP98;RLIM;PIAS4;NEDD8;SPSB2;RNF138;RNF7;PRKDC;UBE2R2;BCL11A;UCHL3;EIPR1;SIRT1;RNF213;KLHL20;NUP37;MDM2;RANGAP1;NUP88;UBE2S;ANAPC7;USP9X;RNF139;KCTD13;TRIM63;RNF26;TRIM13;NDC1;FBXL5;KLHL7;SPSB1;TRIM41;NFX1;MYCBP2;KLHL21;HECW1;FBXL15;ZSWIM8;TRIM32;URM1;RNF103-CHMP3
prerank,peptidyl-lysine modification (GO:0018205),0.24521846128655791,0.9220620101369608,0.6120689655172413,0.9532513855461499,1.0,19/99,17.12%,EYA1;NNAT;SENP3;POM121;NUP155;LOXL3;LOXL1;KAT5;TOPORS;NUP98;PIAS4;HDAC4;BCL11A;SIRT1;NUP37;ATP7A;CTH;RANGAP1;NUP88
prerank,endocrine system development (GO:0035270),0.33451942123077094,0.9219945791256015,0.5317460317460317,0.9524291147951638,1.0,3/21,10.07%,WNT4;DKK3;TGFBR1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.36346765340123866,-0.9219376190952341,0.5703125,0.8264893486948134,1.0,6/12,29.74%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,protein polyubiquitination (GO:0000209),-0.1965330557416593,-0.9218132003216851,0.7435897435897436,0.8262538367051622,1.0,68/297,20.39%,FBXL7;NEDD4L;TRAF5;WWP1;ZNRF1;CDC27;SMURF1;HECW2;UBC;ANAPC5;LMO7;RNF144A;RNF166;UBE2V2;RNF144B;RPS27A;RNF125;UBB;UBE2D3;TNKS;FBXW8;TRIM14;TRIM56;UBE2J1;PSMA6;ZNRF2;PSMB7;CDC16;CBFB;FBXO31;FBXO30;ARIH2;FBXO4;ARIH1;PSMB6;FBXO32;PSMB5;UBE2L3;UBE2Q1;FBXW2;FBXO44;LNPEP;FBXW7;FBXL18;TPP2;FBXO28;FZR1;PPIL2;PSMB8;UBE2J2;PSMC4;KBTBD7;PSMD11;KLHL3;UBE2A;RNF19A;UBE2G1;PSMB4;PSMD14;BARD1;CCNF;FBXL4;CDC26;HACE1;FBXW5;NEDD4;PSMD10;MYLIP
prerank,negative regulation of cilium assembly (GO:1902018),-0.3695152536478702,-0.9215321629822092,0.5693877551020409,0.8264012366711819,1.0,6/12,19.78%,LIMK2;MAP4;EVI5L;TBC1D7;CCP110;CEP97
prerank,protein heterooligomerization (GO:0051291),0.34983059204325057,0.9215002168492187,0.5638095238095238,0.9527764205025574,1.0,4/17,9.39%,TMEM120B;CPSF6;CPSF7;KCNC2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.40206699744004504,0.9214987462447274,0.5833333333333334,0.9517674451905181,1.0,4/11,19.22%,DERL1;BAG6;RNF5;UGGT2
prerank,response to insulin (GO:0032868),0.2538644441341507,0.9214583143002275,0.6003460207612457,0.9508623729345105,1.0,26/80,22.04%,CPEB2;GCK;INSIG2;LPIN1;CITED1;PDPK1;PRKCI;SORBS1;RHOQ;USF1;EPRS1;RAB13;TSC1;PRKDC;GOT1;SIRT1;AKT1;KHK;INHBB;RAB15;EIF6;INPP5K;MYO5A;DENND4C;CAPN10;SLC27A1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.38613137445369544,-0.9213551374670894,0.5813492063492064,0.8262622803871708,1.0,3/11,10.02%,IL6ST;STAT3;JAK1
prerank,regulation of mast cell degranulation (GO:0043304),0.35447911249354286,0.921157911875049,0.5289256198347108,0.9506355540672288,1.0,3/14,12.34%,UNC13D;CD300A;SPHK2
prerank,membrane lipid catabolic process (GO:0046466),0.39240219596659304,0.9211068650169745,0.5498084291187739,0.9497458790794152,1.0,4/10,18.30%,NAGA;FUCA1;SMPD2;MGST2
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.39096202362846444,0.9210894391710294,0.5297741273100616,0.9477923810243173,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.39096202362846444,0.9210894391710294,0.5297741273100616,0.9477923810243173,1.0,4/12,15.54%,IGF1;PTBP1;CHERP;AKAP6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3057251733455772,0.9210099367879521,0.5828571428571429,0.9470236248090803,1.0,10/32,18.38%,MAP2;CLIP3;TTBK2;EML2;CLASP1;APC2;TUBB4A;MAPRE1;NAV3;MID1IP1
prerank,defense response to virus (GO:0051607),0.24787642774553928,0.9209278154104829,0.6122112211221122,0.9462581196969041,1.0,17/100,11.48%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;ZDHHC1;RNF135;BCL2;STAT1;STAT2
prerank,negative regulation of T cell activation (GO:0050868),-0.28250501740592443,-0.9208899490784208,0.5754310344827587,0.8268376546367302,1.0,17/35,39.54%,TNFRSF21;CEACAM1;DUSP3;CD86;NCKAP1L;JAK3;GLMN;FCGR2B;CEBPB;IL4I1;LAPTM5;GPNMB;SDC4;VTCN1;ARG1;PDCD1LG2;CD80
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.29849825395570817,-0.9208642361862084,0.5752808988764045,0.8263821164950608,1.0,7/27,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,ceramide transport (GO:0035627),-0.378424853622506,-0.9207373247105722,0.5841784989858012,0.8261522669749908,1.0,8/12,28.24%,CERT1;PLTP;PLEKHA8;PSAP;SGPP1;GLTP;PLEKHA3;CPTP
prerank,peptide hormone secretion (GO:0030072),-0.30535009829046794,-0.9204632088894212,0.5854166666666667,0.8262645893134783,1.0,5/26,11.67%,LTBP4;SNX19;ANXA1;EDN1;EDN3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.39475512305728355,-0.9204266742075163,0.5545112781954887,0.8258280174238939,1.0,3/10,16.03%,THBS1;AKT2;CTTNBP2NL
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3778136440813238,-0.9197795329455228,0.5570342205323194,0.8267730702937648,1.0,4/10,18.16%,CRY1;FEM1B;WDR76;RPA2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.34479704176646586,0.9197496926029846,0.5915789473684211,0.9483160814759996,1.0,4/18,13.45%,C5AR2;SPG21;C3AR1;BAG6
prerank,cellular response to nutrient levels (GO:0031669),-0.24620491484281273,-0.9196997998895567,0.6206896551724138,0.8264123796906248,1.0,18/62,18.43%,BMPR2;FOXO1;WIPI1;RALB;TFEB;MAP1LC3B;STK24;RPTOR;RIPOR1;FAM107A;SREBF2;MFSD2A;RRAGA;GAS2L1;KCNB1;CLEC16A;WDR45B;STK26
prerank,positive regulation of organelle assembly (GO:1902117),-0.2643547980183185,-0.9195292919846363,0.6095890410958904,0.8262644736849426,1.0,14/44,23.98%,PIP4K2A;RALB;CNOT6L;ARHGAP35;G3BP1;CAPG;CCP110;RAB3GAP2;DYNC1H1;GPSM2;ENTR1;TAPT1;NUP62;KCTD17
prerank,protein localization to organelle (GO:0033365),0.2364245778459375,0.9193477791404192,0.6185897435897436,0.9483296019965407,1.0,28/133,17.00%,BMP7;ANK2;MICALL1;OBSL1;TTC21B;TULP3;CSRP3;LMNA;OPTN;WDR35;LRRK2;TIA1;TOR1B;BICD1;SCG3;TOPORS;IFT122;LAMP2;CCDC47;CYB5A;ARL3;FAM83H;MSX1;BANP;GET1;GBF1;MDM2;MTCH2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2653529088549022,-0.9192484234217122,0.5995370370370371,0.8264382554693902,1.0,8/42,14.67%,DEFA6;RPL30;IL6R;SERPINE1;DROSHA;MPEG1;RARRES2;ROMO1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.39002352323936396,-0.9192432467410959,0.5693877551020409,0.8259250485344891,1.0,2/10,10.72%,PFKL;GFPT2
prerank,positive regulation of axonogenesis (GO:0050772),-0.26816246101652463,-0.9189536604129926,0.6094808126410836,0.8260651106558579,1.0,7/43,4.42%,SLIT2;RHOA;NTN1;SEMA7A;NGF;MACF1;TIAM2
prerank,regulation of viral release from host cell (GO:1902186),0.3355607700798923,0.9188101767114629,0.5440313111545988,0.9487519888291867,1.0,7/21,21.25%,TRIM62;TRIM5;TRIM35;PML;TRIM13;TRIM32;CHMP3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3842203595435878,0.9185547310291551,0.5528455284552846,0.9484369517505401,1.0,4/12,17.22%,DPYD;CRMP1;DPYSL2;UMPS
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.30663275647377164,-0.918508804521877,0.578021978021978,0.8266093113271683,1.0,11/23,29.59%,FAF2;SURF4;AUP1;OS9;SEC13;UFD1;HERPUD1;VCP;TECPR2;RANGRF;LMAN1
prerank,ion homeostasis (GO:0050801),-0.2955935800311795,-0.9180285621636781,0.6352201257861635,0.8273067480388432,1.0,4/30,5.59%,SLC4A10;NEDD4L;FHL1;CAMK2D
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3633099950108481,-0.9173379398665065,0.5805168986083499,0.8284535717489682,1.0,3/13,13.74%,BPNT2;TPST2;ENPP1
prerank,negative regulation of neuron projection development (GO:0010977),0.266204681306837,0.9172085471531639,0.5992844364937389,0.9510648256123084,1.0,12/56,15.22%,EFNB2;PTPN9;CRMP1;RUFY3;NGEF;LRP4;LPAR1;EPHA4;CBFA2T2;PTPRO;BCL11A;TSKU
prerank,pyruvate metabolic process (GO:0006090),0.2745583339165747,0.9171216473711049,0.5914742451154529,0.9502958465409005,1.0,8/52,7.66%,GCK;ME2;ENO1;PGM1;ALDOB;ENO4;PGK1;HKDC1
prerank,regulation of neurogenesis (GO:0050767),-0.2519987579456655,-0.9170592158642271,0.6047008547008547,0.8285692547123455,1.0,10/55,8.50%,B2M;NOTCH1;SERPINF1;BHLHE40;NUMB;HES1;HEYL;TGM2;SPEN;HEY2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.206198367194955,-0.9169343169858012,0.7361111111111112,0.8283287105282912,1.0,34/208,12.61%,ROR1;DAB2IP;RHOA;TRAF5;TNFSF10;ALPK1;MIER1;REL;NOD1;ESR1;MID2;PLCG2;FLNA;BRD4;CARD16;TFRC;PRKD1;WNT5A;S100A13;SLC44A2;TRIM14;PLK2;TRIM25;OTUD7B;PER1;MALT1;TERF2IP;EDA2R;HSPB1;SQSTM1;CD74;BIRC3;TNFRSF19;ECM1
prerank,glutamate receptor signaling pathway (GO:0007215),0.2920275170987273,0.9168161301038922,0.5669144981412639,0.9501339901830632,1.0,9/37,17.57%,DAGLA;GRIN3A;GRID2;GRIK2;CPEB4;PLCB1;GRIA2;GRM8;CDK5R1
prerank,axon development (GO:0061564),-0.23704175863245008,-0.9167056835150451,0.6336405529953917,0.8283123798431676,1.0,17/78,16.66%,ACTB;PARD3;APP;KLF7;GRM7;ARHGAP35;CDK5;S100A6;EPHB2;DSCAML1;RAB3A;SHTN1;MAP1B;DHFR;SEMA5A;RTN4;RTN4RL1
prerank,cellular response to type I interferon (GO:0071357),0.2809299196780282,0.9166544502712644,0.5804701627486437,0.9485446283949533,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,type I interferon signaling pathway (GO:0060337),0.2809299196780282,0.9166544502712644,0.5804701627486437,0.9485446283949533,1.0,12/41,18.86%,IFIT2;OAS2;IFI27;IFIT3;IFIT1;OAS3;STAT1;STAT2;TYK2;IRF8;IP6K2;ADAR
prerank,membrane repolarization during action potential (GO:0086011),-0.3669725153604262,-0.9166365167464955,0.5767716535433071,0.8279436370972348,1.0,5/13,15.86%,YWHAE;KCNJ2;KCNQ1;ATP1A1;KCNE4
prerank,negative regulation of peptidase activity (GO:0010466),-0.2612882832704678,-0.9159960577292784,0.6036446469248291,0.8289586426965965,1.0,21/47,31.99%,SPOCK2;SERPINF1;CST3;UBXN1;SERPINE1;SERPINB8;SERPINB9;ECM1;LRP1;VTN;GAPDH;SERPINH1;SERPINI1;TIMP1;AGT;AHSG;PARK7;SERPINE2;SERPINC1;TIMP2;CRB2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2681621645568201,0.915870797487401,0.612280701754386,0.9495721695288786,1.0,18/59,18.35%,ROCK2;OXSR1;WNK3;STK39;PDPK1;LRRK2;MAP3K10;TGFBR1;CSNK2A2;TAF1;MAP3K12;PRKDC;DYRK4;PRKCA;CDK5R1;NLK;HIPK2;AKT1
prerank,cell chemotaxis (GO:0060326),-0.2469300846585666,-0.9157503266845581,0.6031390134529148,0.8289882376234708,1.0,10/60,10.56%,NRP1;LEF1;ABCC1;CCN3;AGTR1;CXCL12;PRKCD;BCAR1;PARVA;ACKR3
prerank,regulation of catabolic process (GO:0009894),-0.32520625306969597,-0.9155461151478124,0.5717299578059072,0.8289563759521065,1.0,7/18,16.11%,NEDD4L;FAP;ITGB1;HGS;ZDHHC7;RARRES2;ZDHHC2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3984711110102499,0.9154493559884975,0.5923694779116466,0.949751931510046,1.0,2/10,8.15%,HSPA1A;IMPACT
prerank,negative regulation of protein secretion (GO:0050709),-0.27307944122546335,-0.9148743289568759,0.5910112359550562,0.8300262128639608,1.0,11/38,17.52%,CD200;CCN3;RAB11FIP5;MIDN;RAB11FIP1;APOE;RSAD2;IRS1;KCNB1;DPH3;RAB11FIP3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.33179483308814,0.9146503101661436,0.5914396887159533,0.9508276169879861,1.0,3/21,3.86%,IGF1;BMPR1A;FGF9
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3676958843396605,0.9143586471658449,0.5466101694915254,0.950608296108549,1.0,3/13,9.32%,PCID2;NDC80;MAD2L1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3364039715776344,0.9143456888416979,0.5727788279773157,0.9496629524923769,1.0,7/20,19.29%,FITM2;ACSM2A;GCDH;DGAT2;ACACA;FAR1;HSD17B4
prerank,positive regulation of chromosome organization (GO:2001252),-0.3470355974503948,-0.9141349556736427,0.5936842105263158,0.8312771305850091,1.0,7/15,23.82%,GNL3;RAD21;SHCBP1L;NBN;LIG4;SIRT6;PPP1R10
prerank,regulation of lipid catabolic process (GO:0050994),0.33964459993095725,0.9141055794604354,0.5669291338582677,0.949324875884904,1.0,3/19,9.07%,ADRA2A;LONP2;ABCD1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2879168579857612,-0.9134003748817984,0.5925925925925926,0.8324317289647679,1.0,7/31,15.37%,YWHAE;YWHAB;YWHAQ;YWHAZ;HIP1R;BBC3;BAK1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.35016358206683135,0.9133559326345426,0.528,0.950267429416288,1.0,3/17,5.44%,NUPR1;PPARA;PPIF
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.30916375665646545,-0.9132337451826498,0.5885947046843177,0.8322895694302614,1.0,6/24,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.24950041014397809,-0.9132268862226433,0.6280193236714976,0.8317770544373587,1.0,19/60,24.19%,NEK7;TNKS;XRCC5;MAPK1;PTGES3;FBXO4;FGF2;HMBOX1;KLF4;CCT2;PARM1;GREM1;MAPK3;MAP2K7;RFC4;MAP3K4;DKC1;POLG2;RGCC
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.34481450274608594,0.9129697802100473,0.5586690017513135,0.9502546860430767,1.0,4/19,11.54%,RENBP;GNPNAT1;GNPDA1;PMM2
prerank,lipoxygenase pathway (GO:0019372),-0.3566853900437206,-0.912831652709964,0.5886075949367089,0.8321877595758543,1.0,3/14,9.75%,PTGS2;PON2;GPX1
prerank,protein deubiquitination (GO:0016579),-0.20039970209158595,-0.9128064689473415,0.7305555555555555,0.8317307492450222,1.0,64/242,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;MINDY1;USP7;USP35;EIF3F;PSMB6;SPATA2;BABAM2;HGS;PSMB5;MINDY2;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;ENY2;CFTR;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3633208900280782,0.91214939771448,0.5683168316831683,0.9513543890266016,1.0,5/15,12.49%,SOS1;CASP3;NTRK2;FRS2;BDNF
prerank,"transcription, DNA-templated (GO:0006351)",0.22194947093389872,0.9120703779780007,0.6855439642324889,0.950569055329508,1.0,24/207,11.83%,MAF;DDX5;SOX5;CTR9;THRB;RRAGC;DTX1;GLIS3;CCNT2;POLRMT;TCEA1;LEO1;E2F1;TAF10;EAF2;CREBL2;DRG1;TOPORS;RNMT;MBD1;TSC22D1;TAF1;MLLT1;CDC73
prerank,membrane protein proteolysis (GO:0033619),-0.27242521542887377,-0.9120137998216377,0.6282608695652174,0.8330107945757101,1.0,12/37,26.39%,MYH9;ADAM10;ADAM19;SPPL3;RET;HM13;RHBDD1;PSEN2;PSENEN;ERAP1;MBTPS2;PRTN3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3170036836903246,0.9118635054113147,0.5826923076923077,0.9500912256314796,1.0,5/25,12.21%,LEPROT;CHMP6;VTA1;UBXN6;DENND10
prerank,ether lipid metabolic process (GO:0046485),-0.34578572822352194,-0.9118540655874061,0.5714285714285714,0.832833819698669,1.0,4/14,15.75%,DHRS7B;PEX7;PLA2G6;PAFAH1B1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.2737457078747977,-0.9118325365431531,0.5741935483870968,0.832371716262024,1.0,10/35,21.79%,NEK7;TNKS;XRCC5;MAPK1;FBXO4;HMBOX1;CCT2;MAPK3;MAP2K7;MAP3K4
prerank,calcium ion homeostasis (GO:0055074),0.24476580142536403,0.9118136934577873,0.6140939597315436,0.9492601459626023,1.0,8/95,4.15%,SLC8A3;SLC24A3;ATP13A5;ANK2;DMPK;FAM20A;CSRP3;ATP13A3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2608404908106928,0.9115623952228468,0.6194398682042833,0.9488794921029269,1.0,20/66,21.13%,UBE2E2;PLK5;APPL2;CDKN2A;DLG1;PRMT2;E2F1;PLCB1;BRD7;CDC73;LSM11;HYAL1;ANKRD17;AKT1;WEE1;FGF10;CDK2AP2;DDX3X;PSME2;KANK2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.22057791264151574,-0.9114177549939649,0.6893203883495146,0.8328433383692172,1.0,39/124,25.56%,PTPRM;FRY;RAPGEF2;APP;STMN1;FAM161A;STX3;MAP4;LYN;MYOC;CDK5;APOE;LIMA1;FRYL;MICALL2;SH3GL2;ODF2;CSF1R;ATCAY;MANF;STMN4;CDK16;RAB11A;FAM161B;MNS1;NEDD4;HMGB1;TTC17;RAB35;ROCK1;IQCG;RYK;NPY;PRMT1;BTG2;KIFAP3;ULK1;VAPA;CARMIL1
prerank,B cell differentiation (GO:0030183),-0.2619828775686934,-0.9106647650454058,0.6386363636363637,0.8341305566109466,1.0,9/46,13.63%,VCAM1;PTPRJ;PLCG2;ITGB1;TPD52;HDAC9;HHEX;ITGA4;PTPRC
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3384946559498222,-0.9104291709149028,0.5964566929133859,0.8341843394586532,1.0,9/17,40.30%,NOS1AP;KCNE4;KCNAB1;KCNS2;RNF207;ANK3;VAMP2;KCNG1;KCNE5
prerank,lipid phosphorylation (GO:0046834),-0.38618408309252905,-0.910401922042061,0.5870445344129555,0.8337193853664956,1.0,2/10,3.37%,DGKH;DGKZ
prerank,neuron projection development (GO:0031175),-0.20964084164106878,-0.9101477541982727,0.7473404255319149,0.8337828402405665,1.0,42/168,21.29%,PTPRM;FRY;SHANK3;DOCK10;RAPGEF2;DAB2IP;NGF;APP;STMN1;TNIK;STX3;UBB;MAP4;LYN;GRM7;DCLK1;MYOC;CDK5;MAP4K4;APOE;EPHB2;FRYL;MICALL2;SH3GL2;SHTN1;ANKRD27;NCKAP1L;TAOK3;PTEN;ATCAY;TAOK1;MANF;STMN4;KIF20B;CDK16;RAB11A;CDC42;TRIO;NEDD4;HMGB1;RAB35;ROCK1
prerank,synaptic membrane adhesion (GO:0099560),-0.34850250902191926,-0.9094250347466546,0.5696465696465697,0.8349359537216785,1.0,1/14,0.21%,GPC6
prerank,iron ion transport (GO:0006826),-0.2584016100959027,-0.9091275682304714,0.6136363636363636,0.8351248358185724,1.0,10/47,14.34%,SCARA5;STEAP3;ATP6V0A4;SLC40A1;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.22696425847399004,0.9089672537478665,0.6891679748822606,0.9546501535250317,1.0,14/152,6.95%,RNF220;LGR4;LRRK1;RSPO2;WLS;WNT5B;CDH3;PTK7;PSMD3;CCAR2;GPRC5B;FZD9;TNKS2;FGFR2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.22429418151850275,-0.9088185340768585,0.705,0.8352977082497671,1.0,33/100,23.57%,EIF3H;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;UBXN1;USP7;SOCS5;ARIH1;BAG5;PABIR1;RAD23B;FOXF2;GABARAP;GNA12;RNF19A;N4BP1;RYBP;PSMD10;TRIB2;CSNK1D;UCHL5;GLMN;FHIT;TRIB3;GIPC1;TAF9
prerank,phospholipid homeostasis (GO:0055091),-0.3794240327355406,-0.9088154264265279,0.5694980694980695,0.8347814905652412,1.0,3/11,25.93%,ABCA1;TLCD1;FABP3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29014062334916435,-0.9084573801076474,0.5854166666666667,0.8351095371253363,1.0,4/29,5.72%,CAV1;TNFSF10;THBS1;PAK2
prerank,negative regulation of cell projection organization (GO:0031345),-0.26032691285487985,-0.9076305371218149,0.6205357142857143,0.8366242752366466,1.0,17/48,22.98%,RAPGEF2;KANK1;SPRY2;GRIN2B;APOE;BAG5;TRPV4;MT3;PAQR3;RTN4RL1;PTEN;HDAC2;PRAG1;MYLIP;RTN4R;FYN;GAK
prerank,carboxylic acid metabolic process (GO:0019752),-0.2809984895444032,-0.9070714185389475,0.6073752711496746,0.8373889621290109,1.0,6/33,6.34%,SLC2A1;PLA2G4A;CSGALNACT1;PTGIS;ST3GAL1;SLC2A3
prerank,positive regulation of cell cycle (GO:0045787),-0.24757873309608827,-0.9065368080761095,0.6403712296983759,0.8380945157707798,1.0,10/62,10.10%,LRP6;TGFB2;TBX3;PKD1;EGFR;APP;CCNY;EIF4E;TAL1;DUSP3
prerank,regulation of protein neddylation (GO:2000434),0.4001705326754227,0.9063532353886677,0.589098532494759,0.96037316184203,1.0,2/10,7.62%,EPAS1;DCUN1D4
prerank,nuclear transport (GO:0051169),0.3536463230428313,0.9063449048019228,0.5817490494296578,0.9594070161981266,1.0,4/16,11.89%,CITED1;PSIP1;NXT1;NUP98
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.31992103302820774,-0.9062569718900083,0.6037344398340249,0.8381768912905688,1.0,5/20,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3559955509557787,-0.9061463075594498,0.5714285714285714,0.8379215099211738,1.0,4/12,23.06%,DDC;MAOA;ODC1;HNMT
prerank,negative regulation of protein binding (GO:0032091),0.2565278087096267,0.9060957021982655,0.6459074733096085,0.9590992717133081,1.0,10/71,8.46%,IFIT2;DAB2;MAP2;TFIP11;CAMK1;TTBK2;IFIT1;LRRK2;GNL3L;GOLGA2
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.24167799522858951,-0.9057877221462226,0.6509433962264151,0.838233038854091,1.0,11/64,11.23%,PLA2G4A;CYP1B1;PTGS2;ACOX1;MGLL;ELOVL5;ACSL5;GPX1;ELOVL6;ACSL3;HACL1
prerank,cellular response to cAMP (GO:0071320),-0.2906692991899653,-0.9052500566327407,0.6176470588235294,0.8389457250808583,1.0,7/30,16.14%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6;CFTR
prerank,positive regulation of protein import (GO:1904591),-0.2851861953441359,-0.904751650612767,0.5882352941176471,0.839601877636361,1.0,10/30,23.39%,PIK3R1;CDH1;FLNA;PRKCD;IPO5;TPR;ZC3H12A;ARHGEF5;JUP;HCLS1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2876406599196262,0.9043071436956899,0.6074766355140186,0.962752804855607,1.0,11/35,17.41%,HSPA1A;ABCB10;MED1;LDB1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC;HSPA9;STAT5B
prerank,regulation of lipid storage (GO:0010883),-0.30877739901906326,-0.9039204355976638,0.610752688172043,0.8409864613979038,1.0,6/22,19.90%,FTO;NFKBIA;FBXW7;C3;ZC3H12A;MEST
prerank,response to retinoic acid (GO:0032526),0.2638676694800364,0.9039196255858405,0.6021314387211367,0.9627725759719934,1.0,15/59,18.15%,HSD17B2;WNT5B;PTK7;WNT6;HTRA2;FZD7;RXRA;CTSH;SOX9;NDUFA13;RBP4;ATM;RARA;CREB1;FZD10
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3684463232167147,0.9038685904670629,0.5826771653543307,0.9619084236575594,1.0,2/15,3.93%,TMEM33;ATL1
prerank,TOR signaling (GO:0031929),0.3097900941813716,0.9038645267969037,0.5888030888030888,0.9609385297365558,1.0,2/26,2.19%,NPRL3;RICTOR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.2809491933035237,-0.9035786766987766,0.5917525773195876,0.8412334742105599,1.0,4/31,5.07%,PARD3;RHOA;WDR1;RAP2A
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.38140854724735096,-0.9033408861742043,0.6072874493927125,0.8412650422536321,1.0,3/10,5.59%,NEDD4L;HECW2;CAMK2D
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2201435786185143,-0.9032269166075142,0.702020202020202,0.8410057277853756,1.0,16/105,10.10%,TEK;PPARD;PTGIS;IRAK3;MFHAS1;CD109;CCN3;CASK;CARD16;AJAP1;PRKCD;FGF2;SERPINE1;APOE;KLF4;DUSP3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.34400204651264404,-0.9032212802095652,0.5954825462012321,0.8405060777348882,1.0,7/14,34.79%,PUM2;PUM1;ZCCHC3;USP15;OASL;TLR3;TLR2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.3920891329201995,-0.9031416811616724,0.6045548654244306,0.8401764947358448,1.0,2/10,1.92%,ZBTB16;ACVRL1
prerank,nucleotide-excision repair (GO:0006289),-0.222856764920432,-0.9029738236822709,0.7263681592039801,0.8400627060712218,1.0,30/101,24.20%,RPA1;RNF111;UBC;RPS27A;XPC;UBB;SLC30A9;USP7;CHD1L;GTF2H5;GTF2H1;RAD23B;ERCC2;AQR;BRCA2;PPIE;GPS1;RPA2;LIG4;POLA1;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;ATXN3;POLB;COPS4
prerank,myeloid cell development (GO:0061515),-0.32737500975382716,-0.9029371391590416,0.6073619631901841,0.8396199384744724,1.0,5/18,16.13%,FOXP1;APP;SRC;NCKAP1L;NRROS
prerank,peptidyl-proline modification (GO:0018208),0.31430304047446594,0.9015833857931991,0.6133828996282528,0.9658324536660389,1.0,3/25,6.12%,PPIL6;PPIF;NKTR
prerank,tRNA wobble uridine modification (GO:0002098),0.3616732537115836,0.9014716708052423,0.6075697211155379,0.9651429564431534,1.0,5/14,23.53%,TRMT9B;GTPBP3;KTI12;URM1;ELP1
prerank,glutathione biosynthetic process (GO:0006750),-0.37047547267878145,-0.901386571872246,0.6083499005964215,0.8426516039760854,1.0,6/11,29.74%,GSS;GCLC;GCLM;GGT1;HAGH;CHAC2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.31528628785970403,-0.9011734155723927,0.6281512605042017,0.8426260764454565,1.0,7/20,21.75%,SYNE1;SUN1;MORC3;ARL2BP;SP100;BARD1;BCL3
prerank,granulocyte differentiation (GO:0030851),-0.3240416606210531,-0.9011401913730707,0.5831578947368421,0.8421669777145252,1.0,3/18,9.95%,LEF1;CBFA2T3;TAL1
prerank,negative regulation of cartilage development (GO:0061037),-0.3593821011661069,-0.9011353973613346,0.6127744510978044,0.8416516524663852,1.0,7/13,26.11%,WNT9A;ADAMTS12;EFEMP1;GREM1;PTHLH;PTPN11;SNAI2
prerank,regulation of neuron differentiation (GO:0045664),0.24855671492218392,0.9010995613730827,0.6173044925124792,0.9650892659464867,1.0,10/76,8.34%,BMP7;DTX1;CPNE1;GPRC5B;BEND6;ZFHX2;NREP;LRRK2;IMPACT;MED1
prerank,axonal fasciculation (GO:0007413),-0.35383415331806733,-0.9009890825391106,0.5964566929133859,0.8414619579020535,1.0,4/12,16.45%,ARHGAP35;EPHB2;SEMA5A;RTN4
prerank,positive regulation of organelle organization (GO:0010638),0.29418212654276193,0.9009541208288946,0.6091743119266055,0.9644932516085262,1.0,6/32,11.52%,STX18;RAB3GAP1;FYCO1;HTRA2;PPARGC1A;TMED9
prerank,negative regulation of hemostasis (GO:1900047),-0.36305675867436926,-0.9005590393546518,0.5910852713178295,0.8419469527522894,1.0,5/12,15.59%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,positive regulation of protein polymerization (GO:0032273),-0.2426362290656376,-0.9005108723470394,0.6534883720930232,0.8415367712560888,1.0,21/65,26.29%,CDC42EP5;CDC42EP3;MET;NCK1;OCLN;RPS3;TPPP3;CDC42EP2;PTK2B;PFN1;CLIP1;NCKAP1L;TOGARAM1;FCHSD1;HCK;DCTN1;CDK5RAP2;FES;PRKCE;CARMIL1;AKAP9
prerank,negative regulation of bone remodeling (GO:0046851),-0.37247429006496113,-0.9003424889946279,0.6067864271457086,0.8414111348336356,1.0,3/11,18.96%,UBASH3B;TMEM119;GREM1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3609620921882498,0.9002830568798111,0.592156862745098,0.9653046674122338,1.0,2/14,8.07%,HSPA1A;LRRK2
prerank,mitotic cytokinesis (GO:0000281),-0.25863916532307013,-0.8999018737001474,0.6428571428571429,0.8418836327956258,1.0,17/47,26.98%,SPTBN1;STMN1;SNX18;CIT;CHMP4B;APC;KIF23;INCENP;NUSAP1;RHOB;RAB35;ROCK1;RASA1;KIF4A;JTB;CEP55;RTKN
prerank,regulation of interleukin-4 production (GO:0032673),-0.30914147013147253,-0.8997744596094231,0.6127744510978044,0.8416455461763676,1.0,2/21,3.21%,LEF1;SLC7A5
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.21773164307833795,-0.8995724960376408,0.6896551724137931,0.8415626794358602,1.0,33/117,23.06%,CALCRL;RAMP2;MYH9;PLCG1;PLCG2;ADCY4;GNB1;PTGDR;LYN;ADCY7;GNG2;PLK2;IAPP;SRC;ADCY2;YES1;ADM;CYSLTR2;CYSLTR1;PRKAR2B;PRKACA;PTH1R;ADCYAP1R1;GPR176;GPR27;HCK;NPSR1;PTHLH;SYK;FCGR1A;FYN;GGT1;PRKAR1B
prerank,regulation of aerobic respiration (GO:1903715),0.3501147132435213,0.8993603535888006,0.5806451612903226,0.9666832660706924,1.0,4/15,16.57%,COX7A1;COX7A2L;ABCD1;ATP7A
prerank,negative regulation of protein catabolic process (GO:0042177),-0.26605759738097523,-0.8993556544720119,0.6335540838852097,0.8415387507303189,1.0,6/40,7.90%,DAB2IP;EGFR;IRAK3;FLNA;CST3;PRKCG
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24838586442940783,0.8989825873949701,0.6357388316151202,0.9666839577217448,1.0,22/84,20.88%,IGF1;SPHK1;RTN1;TRIM71;NTRK2;ORMDL2;EIF2AK2;PAIP2B;PAIP2;CLU;EPRS1;EIF4E2;TSC1;FXR2;RNF139;GIGYF2;PRNP;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31478741118358133,0.8988447381465476,0.5980392156862745,0.9660871749756812,1.0,9/25,21.98%,LEO1;HNRNPU;EAF2;LDB1;CDC73;SUPT4H1;LARP7;CDK12;WDR43
prerank,protein methylation (GO:0006479),0.2873716378348174,0.8987810903814916,0.6261343012704175,0.9652738452027435,1.0,13/40,21.97%,EEF2KMT;PRMT2;N6AMT1;FAM98B;NSD1;PCMT1;PRMT3;ETF1;NTMT1;NSD3;SNRPB;VCPKMT;PRMT5
prerank,membrane raft organization (GO:0031579),-0.3395153453356184,-0.8987122562343567,0.5646551724137931,0.8424695822972859,1.0,5/15,19.29%,RFTN1;EMP2;S100A10;NAXE;YJEFN3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3113863097621015,0.898497998902387,0.5962264150943396,0.965059207440306,1.0,4/25,8.94%,GPR143;ITPR1;LRRK2;HTT
prerank,regulation of cytoplasmic transport (GO:1903649),-0.3742840467494633,-0.897980863844397,0.5716945996275605,0.8436157730246763,1.0,3/11,8.77%,MAPK1;USP7;SRC
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.35525665094124065,-0.8978789465311067,0.6185567010309279,0.8433495360264854,1.0,5/13,18.15%,NOS3;GCH1;QDPR;PRKG2;MTHFD1L
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.28879864321683724,-0.8977525189167029,0.6400862068965517,0.8431245550756916,1.0,12/27,29.83%,ERN1;TRIR;NUDT16;ZC3H12A;TOE1;NYNRIN;NHP2;RNASE4;PCF11;POP7;XRN1;CSTF3
prerank,defense response to symbiont (GO:0140546),0.24290795993538508,0.8975444143651459,0.6451612903225806,0.9665678905426444,1.0,15/92,11.48%,IFIT2;OAS2;TRIM5;IFI27;PQBP1;NT5C3A;IFIT3;NCBP3;AGBL4;IFIT1;EIF2AK2;OAS3;BCL2;STAT1;STAT2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2450507287104458,0.8973113042596026,0.6511226252158895,0.9661548072775042,1.0,16/87,13.35%,FGF1;FGF4;FLRT3;FGF9;TIAL1;TRIM71;KIF16B;FGFR2;FLRT1;PTBP1;TIA1;FRS2;GALNT3;DSTYK;FGFBP1;HYAL1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.25877601914830517,-0.8970578729362292,0.6659090909090909,0.8441686805334035,1.0,11/47,15.64%,AGK;TIMM22;ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;GHITM;ROMO1;ATP5F1D;TIMM29
prerank,RNA metabolic process (GO:0016070),0.22931292975437093,0.8969248442576484,0.6834645669291338,0.9661739705305653,1.0,29/127,18.86%,CELF2;RNASEH2A;PABPN1;NOVA1;TFIP11;HNRNPH3;ELAVL4;HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;SUPV3L1;DDX17;HNRNPL;PTBP1;BICD1;MPHOSPH10;AGO3;DICER1;RBM5;SND1;LSM8;POLR2D;DHX8;HNRNPH2;DDX39B;MTREX;THOC1;ADAR
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.19002576332034335,-0.8968070215054537,0.8547854785478548,0.8442003246057086,1.0,106/336,26.91%,FOXP1;ACER2;RPA1;RAD51B;FOXO1;BCL2L1;TNFRSF1B;CRY1;HERC2;FNIP2;ALKBH1;SMC1A;CSNK1E;CRIP1;XPC;NIPBL;XRCC5;LYN;REXO4;FBXO31;APC;RPS3;ZBTB1;HPF1;CHD1L;SMC5;XIAP;RPAIN;STK33;MAPKAPK2;CDKN2AIP;WDR76;RNF169;BABAM2;OARD1;GTF2H1;NFATC2;SUSD6;DCUN1D5;BLM;KIN;USP47;NCOA6;SUV39H1;TIMELESS;BAK1;FMR1;UBE2A;TAOK3;UBA6;FANCG;GNL1;SLF2;TOP2A;NBN;BOD1L1;BARD1;MASTL;TAOK1;CCND1;MAPK12;USP10;MAPK3;ZC3H12A;MCL1;TIGAR;PCLAF;SIRT7;POLA1;METTL3;XPA;SPIDR;DYRK2;RFC4;CHEK1;NSMCE4A;MUTYH;NSMCE3;DTX3L;BCL3;WDHD1;TRRAP;RBM24;FBXO45;TAF9;POLB;PARP3;TRAIP;BOK;AATF;ZBTB40;ASH2L;PLK3;BTG2;XRCC3;DTL;POLE3;YAP1;CUL4A;NUDT1;VAV3;RNF168;OTUB1;FANCL;GRB2;RFC2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.328044947402892,-0.8966900957991328,0.592079207920792,0.843933610216782,1.0,4/17,11.50%,PPIA;SOD1;BAG5;HSPB1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.2665315304467535,-0.8966470857040273,0.6268343815513627,0.8435216193657309,1.0,9/38,15.93%,CAV1;GAS6;APP;IL34;PTPN1;NEDD9;PTPRC;CSF1R;RAP2B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30024227413367566,-0.8966158267536595,0.5806451612903226,0.8430831843445054,1.0,6/24,11.83%,BCL2L1;CD44;CXCL12;TPT1;ACKR3;CD74
prerank,response to amyloid-beta (GO:1904645),0.27293941258127175,0.8963993962447209,0.6247723132969034,0.9665321114018828,1.0,3/44,1.71%,SNX6;IGF1;CACNB1
prerank,regulation of endocytosis (GO:0030100),0.2598578543223731,0.8963350052758156,0.6265486725663717,0.965735700459133,1.0,6/61,4.69%,DAB2;SYT11;SPHK1;PICALM;CLIP3;RUFY2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.2682037764361762,0.8962407434772968,0.6179159049360147,0.9650147795462027,1.0,11/51,13.90%,BMP7;GAS7;CNTNAP2;LRRK2;WASF1;KLK8;GPM6A;DTNBP1;BDNF;NYAP2;DICER1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.202636550954716,-0.8962325388350553,0.7523510971786834,0.8434362704803339,1.0,59/193,25.21%,FBXL7;NEDD4L;CDC27;SMURF1;NTAN1;RNF111;UBC;ANAPC5;RNF144A;RNF166;UBR4;RNF144B;RPS27A;RNF125;UBB;KCTD10;ZNRF3;CDC16;TRIM25;ARIH2;ARIH1;SQSTM1;ISG15;UBE2L3;FZR1;PTTG1;RNF149;CBL;PSMD11;KLHL3;OS9;UBE2A;RNF19A;UBA6;ADRM1;UBE2G1;RNF128;PSMD14;KCTD6;PPP1R11;PCYOX1L;FBXL4;CDC26;HACE1;TRPC4AP;NEDD4;MYLIP;DTX3L;KLHL25;RNF150;RNF40;CDC23;FBXO45;ATXN3;CUL3;CDC34;AREL1;DTL;UFD1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.37775116310453816,-0.8961005717676495,0.6239495798319328,0.8432468001689565,1.0,4/10,23.33%,AGO2;DROSHA;MRPL44;TARBP2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.32021105734677524,-0.8957412272603439,0.6391752577319587,0.8435386447050599,1.0,4/18,12.38%,NOTCH1;CCN3;TMEM119;BMP2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.323496440939413,-0.8956129184297751,0.604887983706721,0.8433201573119059,1.0,8/17,25.72%,RUNX1;BMP4;CREB3L1;TGFB3;HDAC2;RGCC;AMELX;F2R
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.34670540622571117,0.8954268371397242,0.5748031496062992,0.9660855146986836,1.0,2/16,0.78%,IGF1;ROCK2
prerank,cellular response to ionizing radiation (GO:0071479),-0.2606241868474223,-0.8950726284580239,0.6812933025404158,0.844028392683708,1.0,15/47,28.05%,NET1;MAP3K20;NIPBL;XRCC5;BLM;TNKS1BP1;RHNO1;LIG4;SPIDR;RHOB;TMEM109;NUCKS1;YAP1;GRB2;RAD51AP1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3730671722406392,-0.8950086407966446,0.5995762711864406,0.8436671919824742,1.0,8/11,37.12%,FGF2;IPMK;PPIP5K1;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3
prerank,neuron projection regeneration (GO:0031102),-0.3790929199305513,-0.8950040078859125,0.6175908221797323,0.8431646022580626,1.0,3/10,16.66%,PTN;DHFR;RTN4RL1
prerank,cellular response to UV (GO:0034644),-0.23582533793514046,-0.8947932694248351,0.6811594202898551,0.8431284553311967,1.0,21/76,21.67%,PTPRK;CARD16;CRIP1;XPC;PRKCD;MFAP4;ZBTB1;USP47;COPS9;RHBDD1;BAK1;FMR1;ATF4;MMP2;N4BP1;RHNO1;METTL3;NEDD4;XPA;CHEK1;NSMCE3
prerank,regulation of cellular response to heat (GO:1900034),-0.23652982304711628,-0.8947837959204353,0.6792035398230089,0.842641350881044,1.0,25/77,24.74%,RPA1;YWHAE;CD34;CAMK2D;MAPK1;PTGES3;NUP107;MAPKAPK2;RPTOR;BAG5;TPR;HSBP1;HIKESHI;BAG1;SEC13;DNAJC2;RPA2;MAPK3;NUP50;AKT1S1;NUP85;AAAS;NUP62;NUP214;IER5
prerank,glycine metabolic process (GO:0006544),0.3696758510470448,0.8947585386786706,0.5863453815261044,0.9668265367385208,1.0,3/12,16.00%,GLDC;GLYAT;GCAT
prerank,megakaryocyte differentiation (GO:0030219),0.3808794145988187,0.8946494726063919,0.5828460038986355,0.9661454620538664,1.0,2/11,8.34%,KIT;MED1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.37070345670484256,-0.8941744202150642,0.6153846153846154,0.8434802374005539,1.0,3/11,3.58%,ACVR1;TGFB2;TGFBR2
prerank,regulation of innate immune response (GO:0045088),-0.24431458795297842,-0.8941734469299581,0.6528384279475983,0.8429720963719383,1.0,22/57,27.87%,POLR3F;PLSCR1;IRAK3;GBP5;IFI35;XIAP;PTPN1;ABCE1;BIRC3;POLR3B;N4BP1;PTPN6;POLR3D;NMI;FCGR2B;ERAP1;MUL1;CASP8;PTPN11;LRP8;TREM2;LYAR
prerank,insulin secretion (GO:0030073),-0.3178820735586361,-0.8940626334609433,0.5817805383022774,0.8426915726302932,1.0,4/19,14.34%,RAB11FIP5;SNX19;ANXA1;RAB11B
prerank,positive regulation of cyclase activity (GO:0031281),0.3558471114301438,0.8936688022988545,0.6096153846153847,0.9677184820937028,1.0,1/14,0.44%,CACNA1D
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.3474386946729441,-0.8935459345670181,0.6051587301587301,0.8428224120854722,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,cellular response to interleukin-15 (GO:0071350),-0.3474386946729441,-0.8935459345670181,0.6051587301587301,0.8428224120854722,1.0,6/13,28.42%,STAT3;IL15;JAK1;JAK3;GRB2;IL2RG
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.3426771971491218,-0.8935377535516716,0.6123260437375746,0.8423334450263202,1.0,6/14,14.99%,ABCD2;TWIST1;MFSD2A;AKT2;IRS1;TYSND1
prerank,response to amino acid (GO:0043200),-0.2759442193822358,-0.8934879933362068,0.6132478632478633,0.8419281779092574,1.0,11/31,20.23%,SH3BP4;CAPN2;GLRB;SPAAR;RPTOR;NSMF;IPO5;RRAGA;GLRA2;GRIN1;RRAGD
prerank,sister chromatid segregation (GO:0000819),0.29163937189743144,0.8932801714672599,0.5992779783393501,0.9677568234549778,1.0,6/31,9.75%,TOP2B;ZWINT;PLK1;DSN1;NDC80;TUBG1
prerank,negative regulation of cell activation (GO:0050866),-0.33410125203552876,-0.8932146410104925,0.5987261146496815,0.8420484236732865,1.0,3/14,9.64%,NOS3;CD200;APOE
prerank,positive regulation of nervous system development (GO:0051962),0.27984736143961186,0.8928632956816407,0.6307129798903108,0.9678584839737235,1.0,11/42,17.49%,IL1RAPL1;NLGN2;WNT7A;GRID2;NLGN3;PTPRD;FAIM;BDNF;OPRM1;EPHB1;SYNDIG1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3517374392838134,0.8927737623084004,0.592436974789916,0.9671180828107402,1.0,3/15,8.02%,KCND3;KCNJ5;KCNH2
prerank,centromere complex assembly (GO:0034508),-0.27167520630950875,-0.8926400618430821,0.6131078224101479,0.8427914705696568,1.0,13/36,30.26%,HJURP;RBBP4;NASP;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;MIS12;RSF1;SMARCA5
prerank,regulation of intracellular pH (GO:0051453),-0.2760197217318521,-0.8925034255992799,0.6099137931034483,0.8425708439574168,1.0,7/34,16.14%,SLC4A10;SLC9A2;ATP5F1B;SLC26A6;SLC9B1;CA2;CFTR
prerank,phasic smooth muscle contraction (GO:0014821),-0.3915108196828551,-0.8918324437726102,0.6176470588235294,0.8435690124610825,1.0,6/10,38.90%,EDN1;EDN3;PTGER3;DRD2;TIFAB;HTR1D
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.22132379852062828,-0.8918107730921612,0.7390180878552972,0.8431102495186391,1.0,15/104,12.38%,ACTB;DAB2IP;RHOA;LRP6;LRP5;RALB;CAB39;CALM3;SRC;RPTOR;HGS;SERTAD1;GTF2H1;BLM;INCENP
prerank,protein-containing complex subunit organization (GO:0043933),0.2354477235954118,0.8912459736551791,0.6740237691001698,0.9699824247350756,1.0,30/109,19.51%,CD247;WDR19;CAPN3;PICALM;KMT2A;AFG3L2;ADD2;IKBKG;SHANK1;RIMS1;WASF1;PPARGC1A;TUBGCP4;LLGL1;DLG4;WASL;EPRS1;NUP98;SOX9;PML;WASF3;WAS;TAPBP;MDM2;HFE;SKAP2;MITF;SNX9;TFAP4;NDC1
prerank,mitochondrial translational termination (GO:0070126),-0.22623596177331962,-0.8909395716699021,0.7058823529411765,0.8446326135126263,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,spindle assembly checkpoint signaling (GO:0071173),0.32192289993108514,0.8904785673448631,0.6170212765957447,0.9689930231415803,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.32192289993108514,0.8904785673448631,0.6170212765957447,0.9689930231415803,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.32192289993108514,0.8904785673448631,0.6170212765957447,0.9689930231415803,1.0,4/20,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2149808980790641,-0.8904782875173597,0.7116402116402116,0.8451532041408644,1.0,20/110,14.94%,DAB2IP;NEDD4L;WWP1;FOXO1;NFKBIA;SMURF1;HECW2;APP;WNT5A;AGTR1;PLK2;APC;APOE;KLF4;RANBP9;CSNK2A1;CD86;KLF2;FZR1;RAB1B
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2996216020746677,-0.890435416506659,0.625,0.8447261857979935,1.0,9/24,27.53%,PDE4D;CAMK2D;CALM3;JPH2;PRKACA;DMD;JPH3;SELENON;CALM1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.23484177805362758,-0.8896444031838763,0.7019230769230769,0.8459612132321538,1.0,20/74,23.51%,NOTCH1;LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;PSMB3;EGLN3
prerank,positive regulation of insulin secretion (GO:0032024),0.2907746502129882,0.8894731734227658,0.6133828996282528,0.9704784785468549,1.0,4/36,6.20%,NNAT;GCK;NLGN2;ADCY8
prerank,respiratory chain complex IV assembly (GO:0008535),0.32267397331177106,0.888977035086676,0.6185770750988142,0.9707640640804375,1.0,9/21,25.75%,COX18;COX10;COX14;TIMM21;COX20;OXA1L;COA6;COX19;FASTKD3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.320494374544303,0.8889136855461138,0.5887850467289719,0.9699683956369719,1.0,3/21,6.20%,ADCY5;ADCY1;ADCY8
prerank,calcium ion transport into cytosol (GO:0060402),0.32752834934170666,0.888896648014822,0.6072144288577155,0.9690555371418925,1.0,5/21,11.47%,CACNB3;JPH1;GRIN2D;RYR2;TRPM2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.39001386279260675,0.8888924966510372,0.5975855130784709,0.9681054454276664,1.0,3/10,14.46%,GABRG1;GABRG3;GABRB2
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2337813955132737,-0.8879013156041202,0.6681614349775785,0.849353982673429,1.0,25/69,26.03%,MEF2C;NDNF;NGF;SIX1;MDK;PRKCG;FOXQ1;SOD1;TGFB3;APOE;UNC5B;PTPRZ1;PTK2B;MT3;SIX4;CRLF1;LIG4;AGAP2;SET;RASA1;KDM2B;NFATC4;F2R;KIF14;WFS1
prerank,calcium import into the mitochondrion (GO:0036444),-0.3765333563407809,-0.8877729035595638,0.6127049180327869,0.849148654825837,1.0,4/10,14.31%,MICU3;MCUB;MICU2;SMDT1
prerank,quinone biosynthetic process (GO:1901663),0.35137061948709347,0.8875302051371138,0.591715976331361,0.9705602157850785,1.0,5/14,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3154111847399862,0.8870179070166485,0.621268656716418,0.9708939684729179,1.0,4/23,10.91%,IGF1;EFNB2;NRG1;MAPK14
prerank,signal peptide processing (GO:0006465),-0.37050561104097235,-0.8869917499160451,0.611328125,0.8503962172358419,1.0,3/11,14.21%,PCSK5;SPPL3;HM13
prerank,ovarian follicle development (GO:0001541),0.3622059424783483,0.8868882319700746,0.5936883629191322,0.9702623688629219,1.0,3/13,8.19%,KIT;INHA;EIF2B4
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3239235877250995,0.8865720369511211,0.6011560693641619,0.9700803375340075,1.0,5/21,12.71%,HS3ST3B1;HS6ST1;HS6ST3;HS3ST5;HS6ST2
prerank,cilium assembly (GO:0060271),0.20562527775987824,0.8863397079739698,0.7739520958083832,0.9697181404711264,1.0,70/296,20.22%,CFAP44;DCDC2;INTU;TTC21B;CC2D2A;DYNLT2B;TEKT2;WDR19;GALNT11;RSPH4A;ATAT1;RILPL2;IFT74;TTBK2;TEKT5;WDR35;DYNC2LI1;PLK1;CEP78;RILPL1;CLASP1;KIF3C;SNAP29;BBOF1;VANGL2;CEP290;DYNC2I2;TMEM138;BBS5;WDPCP;ARMC9;TUBG1;IFT122;B9D1;E2F4;TTC8;TMEM67;PCM1;KIF3A;CPLANE2;IFT80;ASAP1;SFI1;CDC14B;RAB1A;TUBB4A;CFAP20;TCTN2;ARL3;MAPRE1;RAB23;NINL;NEDD1;FUZ;CETN2;RPGR;GBF1;PTPN23;C2CD3;OCRL;KIF3B;DYNC2H1;HSP90AA1;TTC36;NDE1;RFX2;PTPDC1;CNGB1;CFAP54;TXNDC15
prerank,regulation of cellular catabolic process (GO:0031329),0.2516953188704039,0.8862627927723469,0.6387900355871886,0.9689563928710327,1.0,9/62,9.07%,NUPR1;RRAGC;WDR91;ITPR1;MTMR4;RMC1;LRRK2;LONP2;ABCD1
prerank,organelle assembly (GO:0070925),-0.1850367064044391,-0.8862610235617142,0.8964401294498382,0.8515545267740345,1.0,66/384,15.14%,ABCC4;PGM5;ABLIM1;NEK7;GSN;NOTCH1;PKD1;DISC1;CD34;LIMD1;STARD9;ATG3;WIPI1;EXOC6;RPS23;EXOC4;FAM161A;FLNA;CHMP2B;GABARAPL2;IFT140;TNKS;SH3PXD2B;ABLIM3;CHMP4B;CHMP4A;ARL13B;MAP1LC3B;RB1CC1;ABCA3;BBS9;RPS3;G3BP1;VPS36;ATP6V0D1;TMOD3;PDE6D;ATG16L1;RP2;PARVA;EHD2;EXOC1;HGS;WDR11;TCTN3;PIK3C3;PIBF1;SNX10;FNBP1L;EHD4;UBXN2A;ATP6V1D;STX7;HDAC6;GABARAP;IST1;DYNLL1;AVIL;CYS1;UBAP2L;DZIP1L;VPS37A;BBIP1;RAB1B;TMEM216;CFAP43
prerank,positive regulation of intracellular transport (GO:0032388),0.2760783513314033,0.8857407628826481,0.651031894934334,0.9692893215581725,1.0,9/38,17.80%,ACTN2;STX18;TENM1;RUFY3;CEP290;PCM1;EIPR1;SPAG5;ATP2A1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.26645888240044674,-0.8854183738309759,0.64,0.852906514995781,1.0,9/35,18.14%,PPP1R12A;ITGA1;NUAK1;CALM3;PPP1R2;PPP6R1;BOD1L1;PPP1R11;MASTL
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3613333290330975,-0.8852865615999268,0.6024340770791075,0.8526836836710018,1.0,4/11,13.71%,GHR;PIK3R1;EIF2AK3;IRS1
prerank,transferrin transport (GO:0033572),-0.272110715991001,-0.8852019256541347,0.6359649122807017,0.8523569059226854,1.0,9/33,16.78%,STEAP3;ATP6V0A4;TFRC;ATP6V0D1;ATP6V0A1;ARHGAP1;ATP6V1D;RAB11B;TCIRG1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.2812199310968612,-0.8851459407952894,0.6273291925465838,0.8519671229181569,1.0,8/30,17.32%,MLLT3;BMP4;KDR;FLT1;FLT4;PTPRC;CSF1R;SP7
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.3012249986570072,-0.8846684508016124,0.6204690831556503,0.8525357222057521,1.0,11/21,38.65%,RAD51B;BRD4;FBXO5;CCND1;RAB11A;DTL;STOX1;CDK1;DYRK3;CCNB1;VPS4B
prerank,ceramide catabolic process (GO:0046514),-0.3474282508600108,-0.8846447412063325,0.6292372881355932,0.8520709166475214,1.0,4/14,20.23%,ACER2;HEXA;ASAH2;ACER3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2904625284284117,-0.8843333799320817,0.6129032258064516,0.8522673664902831,1.0,9/24,25.13%,MEF2C;BOC;CTNNA1;MYOCD;CDH2;MAPK12;CDC42;MAPK11;BNIP2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3730471106522112,0.8840881672332729,0.6115537848605578,0.9724278103771611,1.0,5/11,24.24%,PARP14;PARP4;PARP16;PARP10;TIPARP
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.30747380660739976,-0.8840081874414133,0.6299376299376299,0.852487675176597,1.0,6/20,24.78%,ADAM10;HM13;RHBDD1;PSEN2;PSENEN;MBTPS2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.38106134749027054,0.8839645335240938,0.61328125,0.9717733846040064,1.0,3/10,11.65%,IVD;ACAD11;GCDH
prerank,innate immune response (GO:0045087),-0.19780348296326092,-0.8839523125606165,0.8148148148148148,0.8520869368858602,1.0,50/217,21.58%,B2M;ALPK1;APP;MFHAS1;REL;SERINC5;MID2;DEFA6;PLCG2;IFITM3;GCH1;RPL39;LYN;NLRC5;TRIM14;TRIM56;TRIM25;RELB;MFAP4;SRC;CAPZA2;NCF2;YES1;MALT1;SERINC3;PIK3CD;ISG15;CD74;PHB2;PTK2B;CD40;RARRES2;ADAM15;IFIH1;NRROS;SP100;IFITM1;NOD2;C3;IRF5;BTK;KYNU;HCK;POLR3A;CAPZA1;HMGB1;MYD88;SYK;RIPK2;IFITM2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.29567004269048147,-0.8834028747687123,0.6289308176100629,0.8527755972980586,1.0,6/26,9.16%,IL6ST;CYP1B1;PTGS2;CCBE1;FLT4;EIF2AK3
prerank,protein-DNA complex disassembly (GO:0032986),-0.3309785861065171,-0.8833522714339244,0.6361788617886179,0.8523616366271122,1.0,5/16,20.48%,SMARCC1;ARID1A;RPL23;SMARCA4;SET
prerank,gene silencing by miRNA (GO:0035195),-0.27547945571373683,-0.8832449654128405,0.6568421052631579,0.85208487297983,1.0,11/32,23.33%,LIMD1;AGO1;ZC3H7A;PUM2;AGO2;NOTCH4;PUM1;AGO4;XPO5;AJUBA;TARBP2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2860045767764891,-0.8831332442950867,0.6417582417582418,0.8518076879418569,1.0,11/29,25.18%,WNT5A;NLRC5;PTPN1;ISG15;ABCE1;PTPN6;METTL3;ZBP1;TTLL12;MUL1;PTPN11
prerank,regulation of NMDA receptor activity (GO:2000310),0.2956600585722948,0.8825698542877893,0.6030534351145038,0.9742650778673517,1.0,9/32,19.03%,ACTN2;SLC6A9;DLG1;DLG4;OPRM1;LRRC7;GRIA2;NEFL;MAPK8IP2
prerank,renal absorption (GO:0070293),-0.37003724041306574,-0.8825610185199718,0.6127744510978044,0.8525188839835288,1.0,4/10,22.49%,GSN;KCNQ1;KLHL3;HAS2
prerank,female gamete generation (GO:0007292),-0.28248890503508506,-0.8822411553874029,0.6611570247933884,0.852681143387721,1.0,17/29,46.82%,PTN;MDK;DMC1;METTL3;PIWIL2;NANOS3;TRIP13;NANOS1;BMP15;IHO1;FSHR;MARF1;NANOS2;M1AP;BCL2L10;FMN2;HORMAD1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.282395619060176,0.8821158745877459,0.6420664206642066,0.9744340046223156,1.0,9/35,16.95%,PPARGC1B;DDX5;RNF14;DDX17;MED1;PMEPA1;WBP2;SAFB;TADA3
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3758159860361047,-0.8820627378222122,0.6059479553903345,0.8525344828644452,1.0,4/10,16.59%,ABCA3;PHB2;MFSD2A;MTMR1
prerank,regulation of biosynthetic process (GO:0009889),0.3696334421290484,0.8819714887552742,0.5974304068522484,0.9738113095968998,1.0,11/11,63.06%,SPHK2;MID1IP1;ALOX5;PIKFYVE;SNCA;PCK1;UCP1;SLC25A33;CCN6;GSTP1;THRSP
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3504583888858826,-0.881687437706694,0.6363636363636364,0.852850812418094,1.0,3/12,16.14%,ANO1;PLA2G6;CFTR
prerank,regulation of endocytic recycling (GO:2001135),0.3697755028573543,0.8816663453234365,0.5900383141762452,0.9735729980958636,1.0,1/11,0.97%,ACTN2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.35684823010482103,0.8815328068210532,0.6298568507157464,0.9729561331753389,1.0,6/13,26.06%,SRSF10;PRPF19;PRPF6;PRPF3;SART3;PRPF8
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2665119366682761,-0.8812401893254767,0.6862302483069977,0.8532820278780372,1.0,15/38,26.63%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;RHNO1;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;CDKN2B;TFDP1
prerank,phosphatidylserine metabolic process (GO:0006658),0.2910892116886907,0.8812183493278563,0.6277372262773723,0.9727485366789076,1.0,5/32,11.37%,OSBPL8;PLA1A;PTDSS2;OSBPL5;PLA2G15
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.36511920789569735,0.8810854210253837,0.6130346232179226,0.9721366900251862,1.0,3/12,11.04%,DSC2;DLG1;RYR2
prerank,regulation of cholesterol transport (GO:0032374),0.32627952904017565,0.8810749702971093,0.6163873370577281,0.9712098521016987,1.0,8/20,22.03%,ABCA13;NR1H3;ABCA2;ABCB4;ABCA5;NUS1;NFKB1;LAMTOR1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3115091188491307,0.8810476429860918,0.6273764258555133,0.9703434779940027,1.0,3/24,11.37%,LPGAT1;PNPLA8;PLA2G15
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3784652268409935,-0.8810038614282785,0.6133603238866396,0.8533230213225642,1.0,2/10,2.04%,CAV1;ENG
prerank,negative regulation of defense response (GO:0031348),0.24574800623399745,0.8808990108522612,0.6773109243697479,0.9697470187009163,1.0,10/77,9.85%,RORA;ENPP3;PPARA;METRNL;C1QTNF3;NLRC3;NLRP3;CACTIN;NR1H3;C1QBP
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3348241679163133,0.8808904350075288,0.5843373493975904,0.9688251955059396,1.0,4/17,16.36%,PRKCZ;NLRP3;HAVCR2;RARA
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3885942079319315,0.8808541076744286,0.6060606060606061,0.9679808982385775,1.0,2/10,11.77%,TFIP11;RTEL1
prerank,regulation of gastrulation (GO:0010470),-0.33480217451191835,-0.8807083725261988,0.6273291925465838,0.8534454504798582,1.0,3/14,6.03%,PHLDB1;PHLDB2;RACK1
prerank,response to glucose (GO:0009749),-0.25217913484481047,-0.8797651538394681,0.6963123644251626,0.8549782965163536,1.0,12/46,18.95%,THBS1;GAS6;UNC13B;ERN1;RACK1;EIF2B2;PFKL;KCNB1;PRKACA;EIF2B1;GPER1;NKX6-1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29366867332784624,-0.8796774798720541,0.6365503080082136,0.8546657816823049,1.0,9/24,23.59%,RPA1;UBC;RPS27A;UBB;RPA2;LIG4;RFC4;POLD4;POLB
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2399651800637297,0.8790903954653396,0.7111486486486487,0.9713777863361104,1.0,19/85,18.66%,DAB2;HSPA1A;NUPR1;SH3RF2;PLK1;RNF14;CEBPA;LRRK2;TAF1;RNFT1;CLU;BAG6;PSMC5;HSPA1B;DNAJB2;MDM2;ANKIB1;RNF180;FBXO22
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2685857294966029,0.8790506176365775,0.6648841354723708,0.9705356472626101,1.0,8/49,13.88%,PRKCZ;OPRD1;TFIP11;NLRP2B;NLRC3;IMPACT;CLU;PMEPA1
prerank,male gonad development (GO:0008584),0.2835148723699374,0.8788122281250046,0.6298932384341637,0.970146759550675,1.0,3/34,3.86%,WNT4;KIT;FGF9
prerank,regulation of phosphorylation (GO:0042325),0.22744146244546126,0.8786893425634275,0.7444253859348199,0.9695031485254184,1.0,15/120,12.11%,PRKAG2;BMP7;GCK;CDKN2A;POM121;NUP155;INHA;PHIP;ROPN1L;FZD7;LDB2;LDB1;STAT2;NUP98;PML
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.2957851197890008,0.8782999582345028,0.6184971098265896,0.969544371121697,1.0,3/30,8.53%,ROBO1;ARRB1;LPAR1
prerank,homocysteine metabolic process (GO:0050667),0.37495608662574853,0.8782170985263364,0.626746506986028,0.9688160954690451,1.0,5/11,26.01%,MMUT;MTHFR;CTH;BLMH;DPEP1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3706360804202393,0.8782143372995737,0.6211538461538462,0.9678925830636336,1.0,6/12,21.10%,CHRNB2;EPHA4;TSKU;EPHB1;MYCBP2;GLI2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3535490026031061,-0.8772346611135675,0.6330645161290323,0.8594735615448051,1.0,6/12,24.00%,PROM1;STAT3;VEGFA;AGTPBP1;MYO7A;RORB
prerank,oligodendrocyte development (GO:0014003),-0.3313719227159463,-0.8772203411035537,0.6233766233766234,0.8589864807054137,1.0,7/15,32.35%,EIF2B2;B4GALT5;EIF2B1;MYRF;NSUN5;B4GALT6;PRDM8
prerank,cellular response to UV-A (GO:0071492),-0.36632378594397197,-0.877024245515269,0.635036496350365,0.8588778699665058,1.0,9/11,49.01%,MMP2;TIMP1;MMP3;MME;OPN5;MMP9;CERS1;PPID;OPN1SW
prerank,positive regulation of lipid metabolic process (GO:0045834),0.312116989765863,0.8768722655101616,0.6055555555555555,0.9702650973289667,1.0,6/22,18.41%,PPARA;SORBS1;CREBL2;CREB1;AKT1;MLXIPL
prerank,positive regulation of neurogenesis (GO:0050769),0.2517385166071041,0.8767144676248185,0.653169014084507,0.9697374626051544,1.0,10/68,9.03%,ROBO1;OBSL1;IL1RAPL1;PLXNA2;SMARCD3;FZD3;PLXNA1;NTRK2;PTPRD;PLXNA3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32882007570507166,-0.8766301499848671,0.6086065573770492,0.8592371937202254,1.0,6/16,25.89%,SHLD1;SMCHD1;MAD2L2;DTX3L;PARP3;SHLD3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3784943271102194,0.8765621809675536,0.590818363273453,0.9691893023496903,1.0,1/11,0.43%,WNT4
prerank,hematopoietic stem cell differentiation (GO:0060218),0.37665078170459887,0.8763044464381956,0.6071428571428571,0.9688877908329376,1.0,3/10,10.98%,LMBR1L;HOXB4;BATF
prerank,regulation of interleukin-6 production (GO:0032675),-0.2209936034018943,-0.8760939250707342,0.766109785202864,0.8598797384504093,1.0,38/96,33.08%,CD200;GAS6;AFAP1L2;STAT3;IRAK3;APP;PLCG2;ARHGEF2;WNT5A;IL6R;MAPKAPK2;TWIST1;CD74;IFIH1;NCKAP1L;NOD2;IL33;PTPN6;ZC3H12A;HMGB1;MYD88;SYK;BCL10;PTPN11;TLR4;F2R;AIF1;TREM2;FOXJ1;TMEM106A;TLR6;LGALS9;TLR1;NOS2;TSLP;TLR3;CD47;TYROBP
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2641214212528319,-0.8759841516573466,0.7,0.8596294263056566,1.0,12/37,22.57%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,regulation of protein ubiquitination (GO:0031396),-0.21283221438369357,-0.875695779240108,0.7605263157894737,0.8597266692232963,1.0,23/108,14.29%,CAV1;CRY1;SPOPL;DNAJA1;UBB;SPRY2;RPS3;PRKCG;UBXN1;XIAP;FBXO4;FAM107A;AMER1;MALT1;BAG5;SQSTM1;ISG15;FOXF2;BIRC3;UBE2L3;TBC1D7;FBXW7;PHF23
prerank,RNA biosynthetic process (GO:0032774),-0.2755536580797674,-0.8754619457103103,0.6344827586206897,0.8596930015084437,1.0,13/31,30.26%,NCOA6;SMN1;POLA1;TBPL1;POLA2;NAT14;PRIM2;BRF2;SETX;RSF1;HELB;TAF7;SMARCA5
prerank,regulation of necroptotic process (GO:0060544),-0.29130009893112757,-0.8753381260609775,0.6581986143187067,0.8594840909828312,1.0,10/23,27.08%,ARHGEF2;YBX3;SPATA2;BIRC3;MLKL;RIPK1;ZBP1;CYLD;CASP8;PELI1
prerank,mitochondrial translational elongation (GO:0070125),-0.22193206624038614,-0.8751294082690655,0.7443609022556391,0.8593852844618618,1.0,23/88,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;GFM1;MRPL23;MRPS31;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;MRPL33;MRPL35
prerank,glycerophospholipid catabolic process (GO:0046475),-0.27795284120167607,-0.8745924462248623,0.6453089244851259,0.8600336359976811,1.0,2/27,1.61%,PLA2G4A;GPCPD1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.3641763371599842,-0.8743722708117753,0.6459143968871596,0.8600235922696466,1.0,2/11,9.75%,CAT;GPX1
prerank,urogenital system development (GO:0001655),0.3738427294721337,0.8743657801845893,0.6402321083172147,0.9725460122614954,1.0,2/11,11.97%,OSR1;SOX9
prerank,protein localization to chromatin (GO:0071168),0.3237410753815202,0.8736003858605828,0.6452905811623246,0.9734578761366232,1.0,5/18,11.20%,SGF29;RUVBL2;PLK1;PPHLN1;PIH1D1
prerank,actin filament bundle assembly (GO:0051017),0.2812585462099804,0.8735452429268675,0.6396226415094339,0.9726737200916236,1.0,5/33,6.79%,USH1C;BAIAP2;PAWR;ADD2;CORO1B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.35438908647044187,0.8732964990183415,0.6276150627615062,0.9723530319827213,1.0,5/13,27.46%,SPHK2;ITGAM;STX4;LAMP1;AP1G1
prerank,necroptotic process (GO:0070266),-0.32206266266432276,-0.8729753324559877,0.6086956521739131,0.8625173240311443,1.0,8/16,32.89%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.33623535028079876,-0.8724868694944625,0.6323529411764706,0.863084198507646,1.0,6/14,26.19%,TNKS;XRCC5;TERF2IP;BRCA2;TINF2;TERF2
prerank,regulation of DNA repair (GO:0006282),0.2732177749609946,0.8723900638755647,0.6418181818181818,0.9737299064906307,1.0,3/44,2.60%,EYA1;EYA4;EYA2
prerank,regulation of cellular response to stress (GO:0080135),0.2280180690433553,0.8722778506625884,0.7266553480475382,0.9730893803195343,1.0,21/115,16.21%,HSPA1A;ROCK2;NUPR1;POM121;CCAR2;NUP155;ADCY8;ARMT1;ABCD1;USP19;BAG4;NUP98;OPRM1;HSPA1B;AIFM2;RPA3;VASH1;ABL1;SIRT1;ATM;NUP37
prerank,regulation of ion transmembrane transport (GO:0034765),0.2867662513781007,0.8722675270734983,0.6305609284332688,0.9721862138144591,1.0,6/33,9.74%,KCNJ13;WNK3;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,response to UV-A (GO:0070141),-0.34765973948083195,-0.8718515269860779,0.6402321083172147,0.8639294289451307,1.0,5/14,30.20%,EGFR;MMP2;CCND1;TIMP1;MMP3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.35467410184464515,-0.8715520345890208,0.6509803921568628,0.8640576633769722,1.0,5/12,27.62%,IAPP;APOE;PFDN6;TREM2;LDLR
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.22872250325869267,-0.8711226569735607,0.7051886792452831,0.8644348719105811,1.0,18/75,18.38%,PLCE1;RGS3;RGS12;RGS5;CRY1;YWHAB;MGLL;RGS6;EDN1;GRK5;ZDHHC7;RGS4;GIT1;GIT2;RNF157;GPER1;PDE6H;C3
prerank,regulation of primary metabolic process (GO:0080090),0.22343195324912007,0.8710946561371156,0.7223168654173765,0.9740453005375932,1.0,28/126,19.41%,ROCK2;NQO1;PPARA;NFYB;PSMD3;SMARCD3;NFYC;CHD9;MED1;SC5D;RXRA;PSMD1;PSMC5;SQLE;CYP51A1;PSMA1;TBL1XR1;RUBCNL;ACACA;PSMD12;TM6SF2;NCOR2;GGPS1;HMGCR;PSMD7;NCOR1;SIN3A;OPA3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3445898018831326,0.8707668854316801,0.6262425447316103,0.9739013861787175,1.0,7/16,21.97%,MRAP2;GRP;CHGA;MRAP;PRKCA;KLK6;PRMT5
prerank,striated muscle cell development (GO:0055002),-0.3377624802363382,-0.8705820456976426,0.6115537848605578,0.8650894307722435,1.0,2/14,8.89%,PGM5;TMOD3
prerank,aminoglycan biosynthetic process (GO:0006023),0.25973072457193164,0.8702780877347015,0.6772983114446529,0.9741788659812733,1.0,9/49,12.71%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;HS3ST6;HS3ST5;HS6ST2
prerank,glycerolipid metabolic process (GO:0046486),-0.3621019493826214,-0.8701855117913742,0.6348884381338742,0.8654146461796659,1.0,8/11,43.94%,DGKZ;DGKB;DGKG;DGKA;PIP5K1A;DGKQ;PDXP;PNPLA3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.32990602138725356,-0.8699485983238532,0.6207584830339321,0.865426592762283,1.0,4/14,11.83%,SEMA7A;PLCG2;WNT5A;CD74
prerank,signal transduction by p53 class mediator (GO:0072331),0.2898383797460557,0.8699287277936117,0.6326923076923077,0.9740997113716849,1.0,5/30,10.98%,DDX5;MAGEA2;PDK2;NDRG1;BATF
prerank,endoderm development (GO:0007492),-0.3438404720722295,-0.8694829376190835,0.618,0.8658920959844484,1.0,8/13,38.98%,SOX17;SOX7;DUSP1;LHX1;TBX20;DUSP5;DUSP2;GATA4
prerank,nuclear envelope organization (GO:0006998),0.3247413495627863,0.8694378301752963,0.6349206349206349,0.974315592751173,1.0,3/20,8.40%,DMPK;NUP155;TOR1B
prerank,phagosome-lysosome fusion (GO:0090385),-0.3697927766628102,-0.869309266009322,0.6300813008130082,0.8657592815787292,1.0,8/10,44.10%,ARL8B;RAB20;RAB39A;PLA2G5;CLN3;RAB34;RAB7A;RAB7B
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21906686273830822,-0.8692562756251064,0.7129840546697038,0.86536658404837,1.0,15/91,14.91%,HIP1;NRP1;STON2;SCARB1;CDH13;MAPK1;USP7;SRC;PTPN1;ZFYVE16;RAB3A;HIP1R;PTPRC;RAB11B;RAB5C
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.28591804024958334,-0.8685833374059658,0.6541666666666667,0.8663054346852499,1.0,14/27,29.16%,PDE4D;CAV1;CAMK2D;CTNNA3;FGF13;DSG2;PLN;DSP;JUP;GJA5;STC1;AKAP9;HCN4;RANGRF
prerank,negative regulation of DNA replication (GO:0008156),0.35028391806393233,0.8685217452746575,0.597979797979798,0.9755768457105713,1.0,2/13,4.97%,GMNC;TSPYL2
prerank,neuromuscular process (GO:0050905),-0.32434855411065544,-0.8683655881879495,0.6350515463917525,0.8662594351716426,1.0,5/16,21.28%,GCH1;STRA6;PAFAH1B1;AGTPBP1;DCTN1
prerank,negative regulation of insulin secretion (GO:0046676),-0.30705777308155024,-0.8680011832009867,0.6430107526881721,0.8665480800024774,1.0,5/17,15.35%,CCN3;KLF7;MIDN;IRS1;KCNB1
prerank,neuron maturation (GO:0042551),-0.3087822536219413,-0.8675620238043021,0.6492985971943888,0.8669326652243401,1.0,5/18,10.32%,ANKS1A;SCARF1;APP;LGI4;B4GALT5
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3279267338251767,0.8671633634805908,0.606,0.9778695208671474,1.0,5/16,12.34%,PPARA;ENO1;ANTKMT;PPARGC1A;SPHK2
prerank,negative regulation of transport (GO:0051051),0.2595557605331385,0.8669205637193846,0.7124773960216998,0.977543598644338,1.0,9/51,16.72%,SYT11;NDFIP1;NRG1;NR1H3;SCAMP5;MTMR2;SNX3;NDFIP2;SNX33
prerank,negative regulation of reproductive process (GO:2000242),0.32365258549822246,0.8666118173602091,0.6429942418426103,0.977309638997399,1.0,1/17,0.69%,IGF1
prerank,response to organic cyclic compound (GO:0014070),0.26132208791837225,0.8663891620244847,0.6761565836298933,0.9768884884327067,1.0,11/52,15.34%,IL18;TRPV1;GLDC;LRRK2;CHRNB2;DRD3;PAQR7;TRPM2;ABCA2;ABCB4;GGT5
prerank,positive regulation of cell death (GO:0010942),-0.2385923366346283,-0.8660441416912631,0.7024390243902439,0.8696606183228509,1.0,20/59,22.51%,SLC6A6;ACER2;MAP3K5;BMP4;WNT5A;AXIN2;APC;GRIN2B;RARG;LRP1;MT3;DDIT4;PRODH;ZC3H12A;RIPK1;RIPK2;FAF1;FYN;CDKN1B;FCGR2B
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.32176704380531834,0.8657920774181876,0.6592741935483871,0.9773514337585298,1.0,5/19,22.27%,NQO1;CHRNB2;RAPSN;ACHE;RIC3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3735881112516974,0.8655149583129877,0.6285140562248996,0.9770724071022052,1.0,3/10,16.38%,NDFIP1;SNX3;NDFIP2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.30115816746496754,-0.8653141951633462,0.6469387755102041,0.8706904047675247,1.0,6/20,13.65%,BMP5;ASXL3;CEACAM1;BMP2;ACADVL;FBXW7
prerank,protein targeting (GO:0006605),0.225677349521441,0.8652800462993507,0.7482876712328768,0.9767349352776293,1.0,22/118,15.85%,TRAK1;MICALL1;ZDHHC12;PITRM1;TOMM40;ZFAND6;TIMM17A;KIF13B;PRKCI;LONP2;TOMM22;ZDHHC24;ZDHHC1;PEX1;LAMP2;MFN2;ZDHHC6;ZDHHC3;AP4M1;FUT10;AKAP6;ZDHHC21
prerank,muscle cell migration (GO:0014812),-0.36674205487155864,-0.8652626844430614,0.6231578947368421,0.8703045086877657,1.0,2/10,4.28%,SIX1;CCN3
prerank,proteoglycan biosynthetic process (GO:0030166),0.2873071824603401,0.8647819154826949,0.6804308797127468,0.9770097926570853,1.0,5/31,7.91%,IGF1;HS3ST3B1;CHST10;PXYLP1;B3GALT6
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.34087140857478465,-0.8646664176158917,0.650197628458498,0.8710211024491723,1.0,9/13,47.49%,PRKCD;SOD1;SYK;MAPT;TYROBP;CRP;GSTP1;F2RL1;CD177
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.2865366510085406,-0.8643096618540339,0.6471774193548387,0.8712407569749099,1.0,5/24,9.55%,PID1;BCL2L1;NUMB;TMEM59;ABI3
prerank,stress-activated MAPK cascade (GO:0051403),-0.2368033368255158,-0.8642318000612571,0.7156177156177156,0.8708793818136406,1.0,18/61,22.62%,MAP3K5;UBC;NOD1;MAP3K20;RPS27A;UBB;MAPK1;TNFRSF19;IRAK2;TAB1;GPS1;MAP3K8;NOD2;MAPK3;MAP2K7;RIPK2;MAP4K3;MAPK11
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2222007406480944,-0.8641912146004438,0.7463054187192119,0.8704584058266933,1.0,35/88,31.20%,DAB2IP;DNAJC1;CST3;RACK1;RPS3;CDK5;EIF2AK3;APOE;EDN1;SYNCRIP;HDAC6;DHFR;FMR1;FXR1;GAPDH;RIDA;NCL;CAPRIN1;EIF4A3;RIC1;NANOS3;RPL13A;DAPK1;BTG2;TYMS;SHMT1;IGF2BP2;PCIF1;IGF2BP1;CNOT1;SERPINE2;PATL2;CLN3;CAMK2N1;CNOT10
prerank,determination of left/right symmetry (GO:0007368),-0.2642523260338981,-0.8641232086211598,0.6718061674008811,0.8700957086053265,1.0,17/36,35.59%,NOTCH1;TBX1;SMO;DNAH11;STIL;CFAP53;DLL1;ODAD2;ENKUR;ODAD3;ZIC3;FOXJ1;NPHP3;CCDC40;LEFTY1;DNAAF4;BBS7
prerank,protein secretion (GO:0009306),-0.24283781313905023,-0.8637303662894493,0.7168141592920354,0.8703994671612251,1.0,11/56,12.39%,STEAP3;PCSK5;ABCA1;MIA2;MON1A;SNX19;ANXA1;MTTP;GOLPH3;RAB3A;PDIA4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32840233294004895,0.8635983567402563,0.6471774193548387,0.978879151103358,1.0,5/18,15.07%,NAGA;FUCA1;FBXO6;FBXO17;ADAMTS9
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3542435565860601,0.8635889705755451,0.6269230769230769,0.9779812053530186,1.0,3/13,6.42%,HACD3;HACD4;HACD1
prerank,protein acylation (GO:0043543),0.2794180789274694,0.8635150344495903,0.6794625719769674,0.9772350792598983,1.0,10/38,17.44%,SPHK1;ZDHHC12;ZDHHC1;CLOCK;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,mRNA 3'-end processing (GO:0031124),0.24204695931616585,0.8635108467704937,0.7056672760511883,0.9763316590311861,1.0,20/78,18.53%,PABPN1;CPSF3;SRSF5;CPSF6;LEO1;CPSF7;SLBP;CDC73;UPF3B;LSM11;RPRD2;SRSF11;PAPOLB;GRSF1;POLR2D;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,cellular defense response (GO:0006968),0.2731281177523206,0.863115479648057,0.6466165413533834,0.976339198042501,1.0,2/40,1.32%,CCR9;DCDC2
prerank,histone H3 deacetylation (GO:0070932),-0.3298742489227302,-0.862897521474431,0.6512096774193549,0.8715774983767804,1.0,6/15,24.89%,HDAC9;PER1;HDAC2;SIRT7;SIRT6;ELK4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3093998686194165,-0.8628508232674676,0.657258064516129,0.8711614744139433,1.0,3/18,4.28%,EGFR;BMP4;ESR1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3234493771110437,-0.8626835302509526,0.6346938775510204,0.8710006441636917,1.0,2/16,6.84%,CLDN5;CLDN14
prerank,myelin assembly (GO:0032288),-0.360050996788535,-0.8625810607967799,0.626,0.8706948465933826,1.0,3/10,18.39%,CD9;GPC1;PMP22
prerank,muscle tissue morphogenesis (GO:0060415),-0.3215572133200999,-0.8624094860315661,0.6597938144329897,0.870527910810436,1.0,5/16,12.38%,NOTCH1;BMP4;TBX1;HEY2;BMP2
prerank,protein targeting to membrane (GO:0006612),-0.21864974346105048,-0.8620349247115591,0.7678571428571429,0.8708143389826407,1.0,24/83,23.68%,PARD3;ATG3;ZDHHC20;AQP11;CHMP4B;CHMP4A;ABCD2;SRP19;SEC61A1;ZDHHC7;VPS37A;SRP14;ICMT;ZDHHC2;ACBD5;PEX14;SRPRA;PEX2;GDAP1;GOLGA7;CHM;MYO1C;SEC62;PEX12
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3184276377677509,0.8616914753457826,0.61328125,0.9787566376984419,1.0,5/20,19.36%,HSPA1A;PTGES3L;CLU;HSP90AA1;LONP1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3093240286567202,0.8603506675508032,0.6204081632653061,0.9809578445904578,1.0,4/20,11.57%,IL18;PRKCZ;NLRP3;FZD5
prerank,regulation of peptidase activity (GO:0052547),-0.3045568989332087,-0.8601500230117889,0.6645569620253164,0.8741899797311969,1.0,5/19,18.62%,CAV1;CST3;ECM1;PSMB8;MAPK12
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.30841128039188237,-0.8601402299597486,0.6731182795698925,0.8736982046827857,1.0,5/18,15.25%,CD200;RPS6KA5;PRKD1;VEGFA;CRTC3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3215033849587279,0.8600378188396764,0.626746506986028,0.9807848999298776,1.0,3/17,8.02%,ANK2;SNTA1;KCNH2
prerank,primary neural tube formation (GO:0014020),0.28693484081674325,0.8595816817683053,0.6942307692307692,0.9809620797801235,1.0,8/30,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,glycosaminoglycan metabolic process (GO:0030203),0.25147221308238904,0.8594646164009033,0.7038391224862889,0.9803376558390524,1.0,16/54,19.43%,HS3ST3A1;HS3ST3B1;HS6ST1;NDST1;PXYLP1;B3GALT6;FUCA1;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1;CHST9;B3GAT2;IDUA;HGSNAT
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3030278104196018,-0.8593293174429705,0.6681222707423581,0.874859447718026,1.0,5/19,10.10%,POLR3F;ICE1;AR;RPTOR;MAF1
prerank,myeloid dendritic cell activation (GO:0001773),-0.34324251080278534,-0.8588167938088419,0.6680080482897385,0.8754727299002495,1.0,2/12,7.73%,TGFBR2;DOCK2
prerank,ncRNA 3'-end processing (GO:0043628),-0.3308441210404292,-0.8584257665749968,0.6403162055335968,0.8757685633521788,1.0,6/14,35.07%,ELAC2;TOE1;INTS6L;ERI1;PTCD1;INTS12
prerank,phosphate ion homeostasis (GO:0055062),-0.36021252026608896,-0.8583761462237436,0.6632653061224489,0.875349617429887,1.0,2/10,13.74%,SFRP4;ENPP1
prerank,nucleocytoplasmic transport (GO:0006913),-0.2539381968859368,-0.8583549155830489,0.6550925925925926,0.8748905175853731,1.0,10/40,15.22%,SNRPD1;BACH2;MALT1;RSRC1;ATXN1;SNRPD2;NCBP2;GEMIN8;SNRPE;NCBP1
prerank,positive regulation of cell killing (GO:0031343),0.3468937780000712,0.8579428066760818,0.6533066132264529,0.9829237065197945,1.0,3/13,13.78%,NOX1;FZD7;CYBA
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.28158103563030734,0.8579158912281212,0.6580406654343808,0.9820749394104346,1.0,6/33,11.83%,PLK5;CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,regulation of organelle assembly (GO:1902115),0.243131704642759,0.857892171107419,0.7106598984771574,0.9812284670331137,1.0,10/72,8.17%,DCDC2;NPRL3;STX18;DYNLT2B;STAM;SGSM3;DYNC2LI1;ATXN2L;TBC1D9B;RABEP2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2533149206443922,-0.8578893361819684,0.695067264573991,0.8753595034729392,1.0,12/39,22.57%,RPA1;UBC;RPS27A;UBB;CHD1L;GTF2H5;GTF2H1;ERCC2;RPA2;XPA;RFC4;POLD4
prerank,chromosome organization (GO:0051276),0.22854444291772694,0.8576405500069472,0.7380952380952381,0.9808961430476483,1.0,26/99,20.72%,DDB2;TOP2B;DOT1L;HMGN3;NUP155;PHF1;MSH6;NDC80;LDB1;SETD7;MSH3;ABL1;MTHFR;BAHD1;SIRT1;CETN2;FAM50A;SAFB;MTF2;TCF7L2;CENPV;SOX2;ACTL6B;COPS7A;SUPT4H1;NUF2
prerank,positive regulation of transport (GO:0051050),-0.2167204034748473,-0.8575790621083191,0.7785388127853882,0.8755206333976236,1.0,18/85,17.98%,ACTB;NEDD4L;MERTK;GAS6;ANXA1;DOCK2;GATA2;IL15;APOE;ACSL3;HIP1R;RAB27A;AKT2;LRP1;BAK1;FMR1;DYNC1H1;CD151
prerank,gonad development (GO:0008406),0.2684388608253541,0.8569774261956754,0.6761061946902654,0.981484642346851,1.0,6/41,11.97%,WNT4;KIT;FGF9;NR2F2;COL9A3;SOX9
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3122800383861739,0.8562665374634968,0.6504854368932039,0.982231129671018,1.0,1/20,0.87%,IL18
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22430159547946116,-0.8562337127637928,0.7505938242280285,0.8777410152893502,1.0,17/72,21.46%,REL;CARD14;PSMA6;PSMB7;RELB;PSMB6;MALT1;PSMB5;BIRC3;PSMB8;PSMC4;PSMD11;NFKB2;PSMB4;PSMD14;PSMD10;PSME1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3526615778102645,0.85613307991094,0.6220472440944882,0.9816260410102453,1.0,2/12,8.17%,SOAT2;SOAT1
prerank,activin receptor signaling pathway (GO:0032924),0.33356591658817,0.8560434331545187,0.6326129666011788,0.9809219368883935,1.0,2/15,10.07%,SMAD3;TGFBR1
prerank,regulation of axon extension (GO:0030516),-0.2591726790109512,-0.8558402820526906,0.7192224622030238,0.8780171536596901,1.0,9/37,16.45%,NTN1;SEMA7A;MACF1;APOE;SEMA3G;SHTN1;MT3;LIMK1;RTN4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.32190333364327683,-0.8557131163677346,0.6687898089171974,0.8777560953665869,1.0,4/15,17.64%,LRP6;TBX1;BMP2;HDAC2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.28509575114581737,-0.8555863999982686,0.6701030927835051,0.8775003982837472,1.0,5/24,8.25%,BCL2L1;CREB3L1;AQP11;RACK1;UBXN1
prerank,positive regulation of signaling (GO:0023056),0.27432225867000626,0.8553770412114111,0.6885553470919324,0.9815132408545149,1.0,6/37,9.52%,WLS;SYT1;GRIK2;RIMS1;NSF;DLG4
prerank,diterpenoid metabolic process (GO:0016101),0.2524514551988354,0.8551836373952753,0.7003424657534246,0.9810754051919371,1.0,4/55,2.46%,ADH7;ADH4;ABCA4;RBP1
prerank,sphingoid biosynthetic process (GO:0046520),0.3679955064413488,0.8550687505894214,0.6209016393442623,0.9795301635918644,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),0.3679955064413488,0.8550687505894214,0.6209016393442623,0.9795301635918644,1.0,3/11,13.27%,SPHK1;SPHK2;ABCA2
prerank,regulation of cell development (GO:0060284),0.27492835786636116,0.8548270606589059,0.6892655367231638,0.9791829308025863,1.0,10/36,18.66%,NOTCH2;PRUNE1;HES6;CLOCK;DOCK7;BHLHE41;PER2;AKT1;CX3CL1;FBXO22
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.37265499517159484,0.8545809740797031,0.627254509018036,0.9787993488146355,1.0,4/10,18.87%,KAT5;MUC1;HIPK2;TFAP4
prerank,histone methylation (GO:0016571),0.2952104886634834,0.8543896038294349,0.6816479400749064,0.9782871339395445,1.0,7/26,18.08%,PRMT2;N6AMT1;NSD1;SMYD3;SMYD2;NTMT1;NSD3
prerank,diol biosynthetic process (GO:0034312),-0.32459115192719223,-0.8542910822753944,0.6450304259634888,0.8796610775489708,1.0,6/15,20.23%,ACER2;GCH1;QDPR;DHFR;ASAH2;ACER3
prerank,RNA transport (GO:0050658),0.24135943373180396,0.8542603483702091,0.7132867132867133,0.9776899497755525,1.0,25/71,26.52%,SIDT1;SRSF5;KIF5C;POM121;NUP155;HNRNPA2B1;NUP62CL;SLBP;UPF3B;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6;RBFOX1;SARNP;DDX39A;RAE1;SRSF2;ZFP36;U2AF2;ZC3H11A;ZFP36L1;THOC2
prerank,regulation of isotype switching (GO:0045191),-0.3380665166496643,-0.8541732520056512,0.6557377049180327,0.8793980819238113,1.0,5/14,25.89%,TFRC;SHLD1;MAD2L2;PARP3;SHLD3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3018000810508681,-0.8541360425618609,0.6878850102669405,0.8789700716050952,1.0,6/20,20.85%,LIMD1;AGO1;AGO2;HELZ;AGO4;AJUBA
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.21141591675580912,0.8536925952848913,0.8282988871224165,0.9781103475296129,1.0,16/166,9.58%,NOTCH2;RORA;NR2E1;THRB;NR6A1;CCN2;PPARA;ESRRA;POLRMT;RBPJ;WWTR1;MED1;PPARGC1A;TAF10;NR1H3;RXRA
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24286160631907666,0.8534044276911623,0.7164429530201343,0.9778737260887453,1.0,11/63,13.52%,LEPR;NUPR1;TIMP3;ZKSCAN3;GOLGA2;BCL2;ATRAID;IL10RA;KDM4A;MTMR2;TBC1D14
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3267536364062027,-0.8531297447688264,0.6634241245136187,0.8805381905365304,1.0,4/14,14.83%,AR;PELP1;SERPINB9;ARID5A
prerank,response to purine-containing compound (GO:0014074),-0.3117410607766994,-0.8527033754586906,0.6390041493775933,0.8808988763050156,1.0,2/17,2.31%,TRPC3;ABCC9
prerank,snRNA metabolic process (GO:0016073),-0.3098279923391912,-0.8523726669582755,0.6707317073170732,0.8810638497839145,1.0,5/17,20.00%,INTS11;RBM7;INTS10;INTS9;MEPCE
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2720860110692569,-0.852216536992488,0.6855895196506551,0.8808893952926461,1.0,20/29,41.81%,RPS16;RPS8;BMS1;DCAF13;PWP2;RRS1;RPS21;RPS19;WDR46;HELB;DHX37;TSR1;NOP14;RPP40;HEATR1;UTP4;NOL10;UTP20;UTP6;MRPS11
prerank,regulation of complement activation (GO:0030449),0.2683559016230602,0.8522141462775542,0.6966731898238747,0.979715647019637,1.0,7/40,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,chromatin remodeling (GO:0006338),-0.21338928650311814,-0.8520504782662258,0.8053333333333333,0.8807468129354432,1.0,12/100,8.61%,ACTB;ESR1;BPTF;ARID1B;SMARCC1;BAZ2B;EZH1;ZBTB1;GATAD2B;RBBP4;CHD1L;ARID1A
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19650277559884735,-0.8516869751538211,0.8455056179775281,0.8809885702472265,1.0,43/171,23.32%,TTC28;NEK7;CDC27;IQGAP1;AFAP1L2;BTG1;APP;ANAPC5;XPC;PSMA6;PSMB7;CDC16;CDKN1C;EIF4E;TAL1;PSMB6;DUSP3;CAV2;BTG3;PSMB5;FBXO5;ERCC2;FZR1;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;KIF20B;CDC26;ASAH2;PSMD10;L3MBTL1;THAP1;PSME1;TTLL12;CDKN1B;RNF40;CDK11B;MKI67;PSMB3;CYLD;CDC23
prerank,positive regulation of hormone secretion (GO:0046887),0.32436061696590057,0.851262741436976,0.6653543307086615,0.9809253248094975,1.0,4/17,16.92%,VAMP7;C1QTNF3;GRP;HFE
prerank,peptidyl-methionine modification (GO:0018206),0.3545020971516979,0.8510923784546152,0.6396917148362236,0.9804372978389118,1.0,1/12,0.84%,METAP2
prerank,regulation of microtubule depolymerization (GO:0031114),-0.28014021367658565,-0.8510469827923615,0.6974789915966386,0.8817197065914092,1.0,13/25,32.41%,ARHGEF2;ATXN7;APC;FGF13;TRPV4;KATNB1;MAP1B;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3021369687684502,0.8506469227821883,0.6771653543307087,0.9805567064912747,1.0,7/26,20.75%,IGF1;FHL2;PTBP1;CHERP;AKAP6;PRNP;RCAN1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3455651113931058,-0.8502112620725356,0.6881091617933723,0.8829264508586916,1.0,6/11,23.95%,CAV1;VHL;HGS;SOCS3;BCL3;SOCS1
prerank,tube closure (GO:0060606),0.281622063603258,0.8500987497016992,0.6921606118546845,0.9808945907687329,1.0,8/31,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38521185820268633,0.8497207470366387,0.6493775933609959,0.9808420942191596,1.0,1/10,0.97%,ACTN2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.27370629010015396,-0.8495160562210715,0.7089715536105032,0.8838387941086734,1.0,10/28,24.80%,UBC;NOD1;RPS27A;UBB;IRAK2;TAB1;NOD2;RIPK2;CYLD;CASP8
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.32887848275566184,0.8493327769527682,0.6621880998080614,0.9808080018460802,1.0,4/15,17.73%,CAMK1;MAPK14;RAPGEF3;RIPOR2
prerank,response to glucocorticoid (GO:0051384),-0.2791331778860154,-0.8492291235126043,0.7008547008547008,0.8838779775078749,1.0,4/26,12.71%,SLIT2;ANXA1;FAM107A;UBE2L3
prerank,excitatory postsynaptic potential (GO:0060079),0.3146720601206494,0.8491308207381459,0.6446601941747573,0.9803729545984902,1.0,4/19,8.07%,RAB3GAP1;GRID2;GRIN2D;LRRK2
prerank,T cell differentiation (GO:0030217),0.27030269170761856,0.8490920778013302,0.6885553470919324,0.9795633493731769,1.0,3/40,3.31%,LEPR;KIT;LMBR1L
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.35786708324010974,-0.8485494214046836,0.6434108527131783,0.8846969168357038,1.0,1/10,0.88%,RAPGEF2
prerank,lysosome localization (GO:0032418),-0.2526054615800893,-0.8483376128943063,0.7149122807017544,0.8846308890381581,1.0,17/37,32.71%,MYH9;TFEB;S100A13;PIK3CD;RAB3A;HDAC6;ARL8B;NDEL1;MILR1;BORCS6;PIK3CG;HPS6;TMEM106B;PLEKHM1;FLCN;SYTL4;RAB34
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.31257098863059724,-0.8480791572775993,0.678714859437751,0.884623695215278,1.0,8/16,23.95%,CAV1;VHL;HGS;PIBF1;SOCS3;PPP2CA;BCL3;SOCS1
prerank,DNA metabolic process (GO:0006259),-0.18253896845634737,-0.8479162708010614,0.9272727272727272,0.884440332644539,1.0,85/270,28.22%,RPA1;RAD51B;UBC;ALKBH1;SMC1A;UBE2V2;CSNK1E;RPS27A;XPC;UBB;AXIN2;XRCC5;REXO4;ZBTB1;PTGES3;USP7;CHD1L;RPAIN;PARG;TERF2IP;GTF2H1;DMC1;BLM;ORC1;RAD21;TIMELESS;ZNF445;DDX23;KPNA2;NT5E;UBE2A;SP100;DFFB;FANCG;TOP2A;TDG;ORC2;NEIL3;NBN;BARD1;RPA2;PRIMPOL;CDC45;ORC5;LIG4;SIRT7;POLA1;XPA;HMGB1;RFC4;CHEK1;NSMCE4A;POLA2;DNMT1;MUTYH;TOP1;NSMCE3;MCM3;WDHD1;TRRAP;PURA;POLD4;SMUG1;POLB;PARP3;BTG2;XRCC3;CDC34;CTC1;TINF2;PRIM2;POLE3;TYMS;UHRF2;NUDT1;MCM5;TERF2;FANCL;MCM6;RFC2;CDK2;RECQL5;RAD51AP1;VCP;CBS
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3039847867210489,0.847886333428268,0.6548323471400395,0.9814055484354941,1.0,2/22,0.78%,IGF1;ROCK2
prerank,regulation of cytokinesis (GO:0032465),-0.2192919736345212,-0.8476335373199281,0.7885985748218527,0.8844976734774729,1.0,37/78,33.14%,RHOA;SVIL;BCL2L1;CIT;PLK2;CALM3;MYO19;MAP9;PIK3C3;KIF23;PIK3R4;CCP110;GIT1;RAB11FIP3;KIF20B;RAB11A;KIF13A;PRC1;CDC42;ENTR1;FSD1;GIPC1;E2F7;CUL3;PLK3;PRKCE;KIF14;CALM1;DRD2;FLCN;CSPP1;SH3GLB1;KIF20A;AURKA;CDC6;OPN1MW;BIRC6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.25645131100872154,-0.8476225813893442,0.7207207207207207,0.884012710712499,1.0,8/33,11.93%,KMT2E;EGFR;PLCG2;ANXA1;ADAMTS1;RPTOR;PAF1;PHB2
prerank,regulation of cell cycle process (GO:0010564),-0.2082175654334456,-0.847268620232469,0.8219895287958116,0.8842360970247484,1.0,31/104,23.14%,DCUN1D3;BCL2L1;PLK2;CALM3;APC;TIPIN;MYO19;CAV2;MAP9;FBXO5;PIK3C3;CSNK2A1;PIK3R4;CCP110;GIT1;RAB11FIP3;GPER1;DYNC1H1;NUDT16;KIF20B;RAB11A;KIF13A;PRC1;CDC42;L3MBTL1;CHEK1;RPRD1B;KNSTRN;ENTR1;FSD1;MKI67
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3389714751235617,-0.8470838665212124,0.6531007751937985,0.8841105327847977,1.0,6/12,24.64%,BMP4;TPR;SIRT7;NEDD4;AAAS;NUP214
prerank,regulation of pH (GO:0006885),0.3633684357276491,0.8470830163724037,0.6626506024096386,0.982297213634843,1.0,3/11,13.33%,LACC1;PDK2;CLCN3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.28939491395717987,-0.8468167024262317,0.7033195020746889,0.8841422214246718,1.0,7/21,17.39%,RPL5;RPS7;RPL23;FBXO5;FZR1;MAD2L2;PTEN
prerank,myotube cell development (GO:0014904),0.3702898175380073,0.846515539120964,0.6432865731462926,0.9826215651335815,1.0,1/10,0.69%,IGF1
prerank,inositol phosphate metabolic process (GO:0043647),-0.24221078710719593,-0.8464855810204247,0.7384259259259259,0.8842652324110608,1.0,7/46,9.34%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D;FGF2
prerank,zinc ion transmembrane transport (GO:0071577),-0.2964795053582533,-0.8463834425037159,0.6791208791208792,0.8839729448565342,1.0,5/22,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,regulation of feeding behavior (GO:0060259),0.3685930419018353,0.8459059504215954,0.6559356136820925,0.9830980069434632,1.0,1/11,0.68%,LEPR
prerank,regulation of interleukin-17 production (GO:0032660),0.27901386820643526,0.8451949553268192,0.6990990990990991,0.9838345833846361,1.0,2/31,1.35%,IL18;SPHK1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.32181600135354294,-0.845191842765632,0.6872427983539094,0.8858254792196202,1.0,4/15,5.55%,SIX1;TGFBR2;TBX1;NIPBL
prerank,positive regulation of biosynthetic process (GO:0009891),0.26855519409953377,0.8451012010492971,0.71875,0.9831422881011859,1.0,9/40,18.41%,WNT4;SLC5A3;PPARA;SORBS1;CREBL2;CYBA;CREB1;AKT1;MLXIPL
prerank,synaptic vesicle localization (GO:0097479),0.3533213340953524,0.8449459199493523,0.615678776290631,0.9825769650056994,1.0,6/13,25.65%,KIF5C;SNAPIN;SPG11;SYNDIG1;SYNJ1;KIF5A
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.25463200895323845,0.8448064972488224,0.7017857142857142,0.9819980070231612,1.0,3/47,1.72%,WNT4;ROCK2;GCK
prerank,translational termination (GO:0006415),-0.21200237814904696,-0.844759012629368,0.8214285714285714,0.8861732023849485,1.0,25/95,20.20%,DAP3;MRPS10;MRPL20;MRPL52;MRPL21;MTRF1;MRPL23;MRPS31;ABCE1;MRPL10;MRPL12;GFM2;PTCD3;MRPS12;MRPL1;MRPL55;MRPL43;MRPL45;MRPS22;MRPL44;MRPL36;CHCHD1;TRMT112;MRPL33;MRPL35
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.21957493886566437,-0.8445769146389913,0.7892156862745098,0.886015636642766,1.0,16/76,13.65%,SMURF1;CBFA2T3;RNF144A;NKD2;COP1;RNF144B;CSNK1E;RACK1;ZYG11B;CSNK1A1;ARIH2;SOCS5;ARIH1;PABIR1;GABARAP;FBXW7
prerank,photoperiodism (GO:0009648),-0.27105323066835824,-0.8445061633776532,0.695364238410596,0.8856596778964017,1.0,7/28,15.78%,CRY1;BHLHE40;PPP1CA;PER1;MTA1;PPP1CC;ID2
prerank,negative regulation of macroautophagy (GO:0016242),0.2919219564187455,0.8443761253857542,0.6680244399185336,0.9820531499612976,1.0,10/26,26.27%,NUPR1;QSOX1;LRRK2;TSC1;SEC22B;AKT1;NRBP2;LZTS1;FEZ1;MTM1
prerank,zymogen activation (GO:0031638),0.2708424838884643,0.8442264717324097,0.7182320441988951,0.9814868508500507,1.0,11/39,23.29%,FURIN;CYFIP2;PGK1;PLAT;CTSH;KLK1;ASPH;NLRC4;OMA1;C1RL;LGMN
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2605228750729363,-0.8438386795085296,0.7046413502109705,0.8864322769858978,1.0,5/33,7.25%,RUNX1;H3-3A;ESR1;AR;CBFB
prerank,potassium ion export across plasma membrane (GO:0097623),-0.33945868308139276,-0.8437391733534823,0.6824196597353497,0.8861077651235807,1.0,3/13,8.97%,KCNT2;KCNQ1;KCNK5
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.359197684505218,0.843670725886709,0.6446601941747573,0.9818374354767416,1.0,1/11,0.82%,DDX5
prerank,regulation of receptor internalization (GO:0002090),-0.25728919256953664,-0.8433612100955861,0.7064017660044151,0.886389692995588,1.0,12/35,24.06%,INSR;SFRP4;MKLN1;TBC1D5;ANKRD13A;VEGFA;FMR1;ANKRD13B;GREM1;ARRB2;EGF;ANKRD13D
prerank,negative regulation of hippo signaling (GO:0035331),-0.3443410867901855,-0.8429211158936145,0.6563786008230452,0.8867259828781839,1.0,4/12,20.85%,LIMD1;CIT;MARK3;AJUBA
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.30070731649102067,0.8428665243938191,0.6911764705882353,0.9826949743958019,1.0,6/24,10.43%,DNMT3A;JARID2;PPHLN1;PHF1;MPHOSPH8;PPM1D
prerank,protein stabilization (GO:0050821),-0.1959066256167566,-0.8427106585270181,0.8864265927977839,0.8866381906728353,1.0,35/168,18.40%,HIP1;RASSF2;STK3;PIK3R1;RPL5;NAA16;FLNA;SOX17;PRKCD;COG3;RPS7;PTGES3;USP7;VHL;CRTAP;PARVA;MFSD1;RPL23;BAG5;MORC3;PHB2;HIP1R;PFN1;FBXW7;CCT2;MT3;PLPP3;BAG1;RTN4;NCLN;PTEN;SUGT1;GAPDH;ATF7IP;DNLZ
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.24399513416904778,-0.8426900116212243,0.7482678983833718,0.886183777340735,1.0,3/48,3.21%,PDE4D;IL1R1;SLC7A5
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.35884166345830715,0.8425222755531476,0.6312741312741312,0.9826318899382801,1.0,2/11,6.37%,NUPR1;FZD9
prerank,positive regulation of viral life cycle (GO:1903902),-0.29644313160101965,-0.842408281494228,0.6926229508196722,0.8862424267699212,1.0,4/22,15.68%,CHMP2B;CD74;KPNA2;FMR1
prerank,nucleus organization (GO:0006997),-0.24085313113843762,-0.8424063044198119,0.734065934065934,0.885747651426527,1.0,12/47,18.79%,SYNE1;CHMP2B;ATXN7;CHMP4B;CHMP4A;SUN1;LEMD3;TPR;REEP3;PITPNB;CTDNEP1;CHMP1B
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.23573359299691984,0.8423896001703146,0.75,0.9820226826265732,1.0,12/76,10.95%,ACTN2;C5AR2;OPRD1;ADRA2A;CHRM2;LPAR1;NMUR1;DRD3;C3AR1;VIP;GRPR;CHRM1
prerank,regulation of phospholipase activity (GO:0010517),0.3719165770811055,0.8423706497512258,0.6573705179282868,0.9811850345448466,1.0,2/10,6.95%,PDPK1;FGFR2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2701694890360842,-0.8414670389312193,0.7075892857142857,0.8870839436449711,1.0,14/29,38.75%,GAS6;CXCL12;SERPINE1;HMGB1;PLA2G7;JAM2;CCR2;ANO6;AIF1;LGALS9;CXCL17;CCL5;CCR1;IL4
prerank,heart process (GO:0003015),-0.3254823808064441,-0.8401552116630647,0.6829745596868885,0.8891116059564184,1.0,3/14,9.75%,SGCD;SOD1;GPX1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.34349212758305403,0.8397802431224372,0.6522593320235757,0.9860210933859702,1.0,3/12,9.07%,PPARA;PPARGC1A;ABCD1
prerank,multivesicular body organization (GO:0036257),-0.26266505258151235,-0.8394221912097345,0.704225352112676,0.8899918202776903,1.0,10/31,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;RAB27A;IST1;VPS37A;CHMP1B;RAB11A
prerank,protein modification by small protein removal (GO:0070646),-0.1845976148391384,-0.8393480658871543,0.9369627507163324,0.8896218882094195,1.0,64/252,23.59%,ACTB;RHOA;USP24;NFKBIA;UBC;ESR1;SMAD1;RPS27A;UBB;ATXN7;PSMA6;AR;PSMB7;USP46;OTUD7B;APC;USP7;USP35;USPL1;EIF3F;SENP6;PSMB6;BABAM2;HGS;PSMB5;RAD23B;BIRC3;USP47;RNF123;PSMB8;CCP110;IFIH1;TAB1;PSMC4;FOXO4;PSMD11;CFTR;GPS1;USP50;ADRM1;JOSD1;PTEN;RUVBL1;PSMB4;RNF128;PSMD14;BARD1;IL33;UCHL1;USP10;ZC3H12A;RIPK1;ARRB2;PSMD10;COPS6;RCE1;UCHL5;PSME1;TRRAP;USP15;PSMB3;CYLD;ATXN3;POLB
prerank,protein deneddylation (GO:0000338),-0.3517703096704782,-0.838999885552179,0.6647286821705426,0.8897815707905127,1.0,3/10,24.20%,GPS1;COPS6;COPS4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23390861867421917,-0.8389720059214878,0.7622377622377622,0.8893260204446725,1.0,8/51,9.60%,NEK7;TNKS;XRCC5;MAPK1;SRC;FBXO4;TENT4B;HMBOX1
prerank,nuclear pore complex assembly (GO:0051292),-0.3478506955022513,-0.8387919165037055,0.6979591836734694,0.8891772761451164,1.0,3/10,16.45%,NUP107;TPR;RTN4
prerank,embryonic digit morphogenesis (GO:0042733),-0.309840209223184,-0.8379499309399708,0.6720647773279352,0.8902807081706922,1.0,6/18,12.91%,ECE1;TBX3;GLI3;MAP3K20;TWIST1;TBX2
prerank,response to acidic pH (GO:0010447),0.34014608156902315,0.8376090035723878,0.6673427991886409,0.9898807896194043,1.0,2/13,8.15%,TRPV1;IMPACT
prerank,positive regulation of protein transport (GO:0051222),0.24086661496438425,0.8375766397649583,0.7513513513513513,0.9890452807326056,1.0,9/67,11.11%,BMP6;IGF1;FRMD4A;TENM1;RUFY3;CEP290;MYO18A;IER3IP1;PCM1
prerank,homologous chromosome segregation (GO:0045143),0.30562641141792984,0.8375270187563975,0.6530214424951267,0.988263086963498,1.0,3/20,14.10%,FANCD2;MEIOB;CENPC
prerank,positive regulation of cellular protein localization (GO:1903829),0.23627414484363957,0.8373013452280395,0.7228915662650602,0.9878937425531001,1.0,9/69,9.94%,SYT11;PRKAA2;SLC5A3;PLK1;WWTR1;GNL3L;NDC80;PDZK1;BICD1
prerank,positive regulation of receptor internalization (GO:0002092),-0.2893949500118876,-0.8372246762700158,0.7249466950959488,0.8911862224354018,1.0,8/22,23.11%,INSR;SFRP4;TBC1D5;VEGFA;FMR1;GREM1;ARRB2;EGF
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.32973076338714,-0.837191281448076,0.6965648854961832,0.8907464057694922,1.0,4/13,20.46%,PIK3C3;PIK3R4;IRAK2;MYD88
prerank,response to nutrient levels (GO:0031667),-0.30927001735214404,-0.8369521906966878,0.6901408450704225,0.8907091649934987,1.0,10/17,35.02%,RPTOR;FAM107A;KCNB1;ATF4;CD68;ULK1;MEAK7;EIF4G1;PRKAA1;RPS6KB1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2624976380710914,0.8369517648775645,0.7103321033210332,0.9877802615991076,1.0,10/42,16.04%,CTSA;ST3GAL5;SUMF1;LARGE1;SMPD3;SMPD2;ST6GALNAC6;ABCA2;CERK;GBA2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.318710690719668,-0.8368814767959728,0.6666666666666666,0.8903714499100939,1.0,5/14,27.01%,RAPGEF2;PRKAR2B;PRKAR1B;PKIA;PRKAR2A
prerank,histone H4 acetylation (GO:0043967),0.2578546219856603,0.8368480503241855,0.7256317689530686,0.9871211923545012,1.0,17/47,21.29%,BRD8;KANSL2;KMT2A;RUVBL2;MEAF6;DMAP1;EP400;BEND3;YEATS4;CHD5;MCRS1;TADA3;APBB1;MSL1;ACTL6B;KAT8;ACTL6A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.2861990166559974,-0.8367931724848343,0.6883408071748879,0.8900305943612125,1.0,9/23,20.71%,GLI3;RACK1;HHIP;HERC4;PTCH1;ENPP1;PTCH2;KCTD6;MOSMO
prerank,cardiocyte differentiation (GO:0035051),-0.3554782812034991,-0.8363652508755383,0.6529774127310062,0.8903621866202954,1.0,3/10,12.38%,TGFB2;MYOCD;BMP2
prerank,cell differentiation in hindbrain (GO:0021533),0.3503304648142636,0.8361256928710016,0.6475247524752475,0.9878155416100399,1.0,4/11,20.12%,GRID2;ATP7A;FAIM2;KNDC1
prerank,vitamin transport (GO:0051180),-0.2706130170324564,-0.8361157684902024,0.7109704641350211,0.8903364844539863,1.0,3/29,8.59%,ABCG2;SLC5A6;CUBN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.212789458371315,-0.8360633440632477,0.765807962529274,0.8899323156012072,1.0,32/80,29.59%,VPS53;ANKFY1;RAB6A;TBC1D5;VAMP3;SNX1;VPS26A;TMEM87B;GOSR1;TBC1D10A;SURF4;SNX2;STX6;RHOBTB3;DCTN1;PREPL;SNX5;RIC1;VPS26B;VPS52;STX5;EVI5;RAB9B;VPS50;BET1L;PHETA1;YKT6;PHETA2;VTI1B;GOSR2;HEATR5A;LMAN1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.31100750339857763,-0.8360291520962896,0.6633266533066132,0.8894942067987287,1.0,4/15,13.42%,ERN1;TSEN2;CPSF4;CLP1
prerank,regulation of cellular metabolic process (GO:0031323),0.25753535243355424,0.8359888848868754,0.7204301075268817,0.9872456644173808,1.0,17/45,24.49%,PPARA;RNF41;KIF16B;PDK2;PANK2;MPV17;RSPO1;ABCA2;TBC1D16;ACACA;NCOR2;COQ7;EIF6;LAMTOR1;PDK4;ARF1;BCO2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23186909697783353,0.8358309078072974,0.729636048526863,0.986685734252092,1.0,11/80,10.22%,MAGEA2;SPHK1;NDFIP1;DERL1;PLK1;ARRDC3;SPRTN;DCUN1D4;LRRK2;FANCI;TOPORS
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.304548620184296,-0.8358297108067794,0.6998087954110899,0.8894094078327479,1.0,2/16,1.96%,PTN;TGFB2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.33558303616387186,0.8356775005350343,0.6633064516129032,0.9861563251377177,1.0,4/14,18.26%,ENPP3;AK5;AK1;AK3
prerank,regulation of double-strand break repair (GO:2000779),-0.25282298838624895,-0.8354017826764408,0.7280701754385965,0.8897278052553869,1.0,16/39,31.31%,RNF169;TERF2IP;TWIST1;PPP4R2;TIMELESS;SLF2;RPA2;SIRT7;SPIDR;CHEK1;SIRT6;OTUB2;OTUB1;RAD51AP1;SPIRE2;MRNIP
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.30629952185888076,0.8353512492822344,0.688588007736944,0.9859461933221841,1.0,4/20,13.20%,SLC8A3;AFG3L2;SLC25A23;MICU1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.34706967474652783,0.8353174382930145,0.6733870967741935,0.9851297954995234,1.0,1/12,0.98%,PLK5
prerank,receptor recycling (GO:0001881),-0.3494548034255688,-0.8351930395919827,0.6861924686192469,0.8896219510134974,1.0,5/10,30.32%,RAB11B;PHETA1;PHETA2;NSG1;LMTK2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.1934977786015766,-0.835182483367878,0.9132791327913279,0.8891450715962366,1.0,55/166,27.62%,NIBAN1;BCAR3;SCARB1;INSR;KAT7;THBS1;EGFR;RBM3;EPM2AIP1;RPL5;NOS1AP;PTGS2;EIF3E;ELOVL5;EEF2;NNMT;IGF2;FGF2;KLF4;EDN1;STARD4;DDAH1;NMD3;MFSD2A;AKT2;IRS1;KLF2;FMR1;BRPF3;PRR16;FXR1;PTH1R;ASS1;CTDNEP1;METTL3;PIWIL2;DYRK2;FAF1;BCL3;EIF4A3;DDAH2;SREBF1;EGF;GIPC1;PRMT1;RGCC;CTC1;PPP1R3E;TLR4;HNRNPD;FABP3;METTL14;RPS4X;SLC25A37;LDLR
prerank,positive regulation of filopodium assembly (GO:0051491),0.29752833121127864,0.8347887698228593,0.6977687626774848,0.9854133586183887,1.0,8/24,17.73%,DOCK11;TENM1;RHOQ;GPM6A;WASL;MIEN1;TENM2;RIPOR2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.31120323085972296,0.8347122189680275,0.6692456479690522,0.9847131461410973,1.0,7/19,21.64%,HTRA2;HTT;CSNK2A2;FZD5;VDAC1;DNM1L;ATP13A2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.27594775857886894,0.8344513529542982,0.705765407554672,0.9843785564206395,1.0,2/29,6.95%,TGFBR3;FGFR2
prerank,diol metabolic process (GO:0034311),-0.2941393630350172,-0.8342504293781988,0.6864406779661016,0.8904653151254603,1.0,8/19,19.49%,NOS3;DEGS2;GCH1;PLPP1;PRKG2;PLPP3;SGPP1;ASAH2
prerank,cellular response to leucine starvation (GO:1990253),0.3643607368181516,0.8338815683716804,0.6810699588477366,0.9847542431008423,1.0,3/10,16.73%,IMPACT;SESN1;RRAGB
prerank,positive regulation of catalytic activity (GO:0043085),0.2638512713961155,0.8333913818895656,0.6746323529411765,0.984990730938573,1.0,13/37,18.38%,SLC5A3;PHACTR4;MSH6;SSBP1;MAPK14;AZIN2;APH1A;MSH3;ABL1;STX4;ATP7A;NHEJ1;MID1IP1
prerank,RNA catabolic process (GO:0006401),0.25602749634161104,0.8333607724498182,0.7234848484848485,0.9841904001857933,1.0,9/46,18.14%,HSPA1A;RNASEH2A;SUPV3L1;LSM5;AGO3;HSPA1B;SND1;ZPR1;MTREX
prerank,synaptic vesicle transport (GO:0048489),0.3588856018879525,0.8331106683919564,0.6537717601547389,0.9838554050324793,1.0,3/11,13.82%,KIF5C;SNAPIN;SPG11
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3493348798722835,0.8326651780390171,0.6607495069033531,0.9839640983612921,1.0,4/12,19.29%,ACSL1;ABCD1;FADS2;HSD17B4
prerank,regulation of humoral immune response (GO:0002920),0.25631254526759073,0.8318215994663832,0.7441860465116279,0.9848913758788035,1.0,7/44,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,regulation of chemotaxis (GO:0050920),0.28071512058099246,0.8313558246093805,0.6854990583804144,0.9850519658126191,1.0,2/30,1.53%,PDGFRA;EFNB2
prerank,DNA conformation change (GO:0071103),-0.29978587146390323,-0.8312963894244194,0.7170212765957447,0.8955333764821475,1.0,6/17,21.39%,KAT6A;HHEX;NAA10;TOP2A;HMGB1;TOP1
prerank,protein neddylation (GO:0045116),-0.32387362555562527,-0.830898575824974,0.6847389558232931,0.8957978626615481,1.0,3/13,11.76%,DCUN1D3;UBE2F;DCUN1D5
prerank,cortical cytoskeleton organization (GO:0030865),-0.24247930787915078,-0.8308623020879191,0.7404063205417607,0.8953696262201434,1.0,3/41,1.39%,FMNL2;RHOBTB1;RHOA
prerank,negative regulation of viral transcription (GO:0032897),-0.3298563345809317,-0.8308013225615017,0.68,0.8949991269379383,1.0,3/13,6.52%,MID2;IFITM3;TRIM14
prerank,regulation of neuroblast proliferation (GO:1902692),0.33291486151312644,0.8304832979615344,0.6890756302521008,0.9860492995069243,1.0,4/15,8.07%,TAFA3;SMARCD3;FZD3;LRRK2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3211766680262001,-0.8301363172027213,0.6951219512195121,0.8957638965073577,1.0,2/13,3.22%,PPARD;BMP4
prerank,ubiquinone biosynthetic process (GO:0006744),0.32259246527441543,0.8299641453857057,0.6803921568627451,0.9862845579959295,1.0,5/15,20.55%,COQ10A;COQ8B;COQ7;COQ3;FDXR
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3523125683208428,-0.8297712676565826,0.686,0.8959537291325055,1.0,2/10,6.04%,GNL3;SAE1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24460954822464898,0.8296506086549803,0.7456445993031359,0.9860409737518824,1.0,18/62,21.19%,HSPA1A;CCAR2;ENO1;PPIF;DDIAS;HTRA2;LRRK2;BCL2;CLU;NOC2L;NDUFA13;SIRT1;MDM2;NOL3;AKT1;DDX3X;HYOU1;TRIM32
prerank,regulation of autophagosome maturation (GO:1901096),-0.332525717877247,-0.8293655694514382,0.7116182572614108,0.8962339846254763,1.0,4/13,16.38%,PHF23;TBC1D25;CLEC16A;TMEM39A
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.21574246029492297,-0.8290886088953798,0.8085106382978723,0.8962554218616069,1.0,23/72,26.91%,RPA1;UBC;RPS27A;UBB;USP7;GTF2H5;GTF2H1;ERCC2;AQR;PPIE;GPS1;RPA2;XPA;POLR2I;COPS6;RFC4;CCNH;POLD4;POLR2F;COPS4;CUL4A;POLR2H;RFC2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3377287578709519,-0.8281998781541818,0.7247899159663865,0.8974098856406438,1.0,2/12,3.15%,NFKBIA;ABCA1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.22857771720762715,-0.8280986555548573,0.804147465437788,0.8971167454187834,1.0,13/59,18.58%,LEF1;RUNX2;AGO1;JUN;CBFB;MED27;TWIST1;MED31;CSF1R;MED14;PTEN;AGO4;CCND1
prerank,response to axon injury (GO:0048678),0.3114544499409939,0.8280061000943225,0.6921529175050302,0.9886002127198529,1.0,5/18,14.34%,FLRT3;NREP;GAP43;SARM1;MORN4
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.3129824919805583,-0.8279859349023282,0.7056530214424951,0.8968301891251805,1.0,4/16,9.64%,SCARB1;NOS1AP;GCH1;APOE
prerank,endocytic recycling (GO:0032456),-0.23639742011187523,-0.827447087319887,0.7615740740740741,0.8973539188874715,1.0,18/50,22.82%,RAB14;VPS53;CMTM6;VPS26A;EHD2;MICALL2;EHD4;RAB11B;ANKRD27;STX6;DENND1B;RAB11FIP3;RAB35;EPS15;CCDC22;DENND1A;ENTR1;VPS52
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.22920162836258973,0.8272134358947636,0.797274275979557,0.9894022199264699,1.0,28/80,22.42%,STX18;ARFGAP3;ARFGAP2;KIF3C;NAPA;RAB6B;HTT;NSF;RINT1;KIF3A;COPG1;TMED9;COPG2;RAB1A;RER1;TAPBP;COPE;TMED2;GBF1;COPB1;SEC22B;PICK1;KIF3B;KLC1;KLC2;UVRAG;ATP9B;LMAN2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3631329668219715,0.8271992422441227,0.6533613445378151,0.9885705558260852,1.0,2/10,10.26%,APPL2;PRKCB
prerank,isotype switching (GO:0045190),0.34986139584957326,0.8269647033281343,0.6620278330019881,0.9882069744740081,1.0,2/10,10.98%,MSH6;BATF
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3299058085701656,0.8266964308966254,0.6612903225806451,0.9879263416917159,1.0,4/15,11.48%,USP18;CACTIN;OAS3;STAT2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.34966985867244776,-0.8264228828186155,0.6848249027237354,0.8987762344373724,1.0,5/11,26.86%,TENT4B;EXOSC4;DKC1;EXOSC5;EXOSC3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.31954717688786,-0.8262561607118823,0.6844181459566075,0.8985941056736777,1.0,3/14,15.37%,DAB2IP;PTPN1;BAK1
prerank,DNA repair (GO:0006281),0.19455117641263694,0.8261513736507935,0.8998548621190131,0.9882495371090009,1.0,53/284,18.00%,EYA1;DDB2;RNASEH2A;DOT1L;ERCC1;RECQL4;PMS2;FANCD2;XRCC1;ASCC2;ACTR8;TENT4A;POLD2;ABRAXAS1;EME2;SPRTN;KAT5;MBD4;MSH6;EXO5;HINFP;RFC5;TDP2;MDC1;FANCI;KMT5C;PARP4;MRE11;INIP;MLH3;FBXO6;KDM4A;CHEK2;PIAS4;MSH3;MEN1;RAD51D;POLI;POLE;PRKDC;RPA3;NEIL1;ABL1;GADD45A;FAAP100;SIRT1;ATM;CETN2;RAD52;POLN;XRCC2;RAD17;APBB1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3361319862503965,0.8259710242423268,0.6547368421052632,0.9877598862524773,1.0,2/13,8.07%,NUPR1;LRRK2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.21681900987986696,-0.8259284304165635,0.7925925925925926,0.8987120311440313,1.0,31/72,36.96%,RPA1;UBC;DCP1B;RPS27A;UBB;REXO4;CHD1L;GTF2H5;GTF2H1;ERCC2;ENPP1;RPA2;ZC3H12A;XPA;RFC4;POLD4;RNASE4;PNRC2;CUL4A;RFC2;XRN2;PARP1;ISG20;OGG1;FEN1;EDC3;GTF2H2;DDX1;MUS81;ANKLE1;IHO1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.29091997763050537,0.8253004123358553,0.7260536398467433,0.9883040647951498,1.0,6/24,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,cellular response to oxidative stress (GO:0034599),0.21404100635885118,0.8250873932512864,0.8072916666666666,0.9878757302469457,1.0,28/118,20.59%,CPEB2;HSPA1A;PDGFRA;PRKAA2;RBM11;CHUK;PDK2;HTRA2;PRDX5;LRRK2;PPARGC1A;MPV17;CYCS;ALDH3B1;MAPK9;CYBA;ARNT;HSPA1B;ABL1;STX4;RAD52;ERO1A;AKT1;NCF1;LONP1;EIF2S1;PYROXD1;ERCC6L2
prerank,response to ATP (GO:0033198),-0.3015394056375369,-0.8250497872772339,0.7128309572301426,0.8998086723644082,1.0,2/18,2.31%,TRPC3;ABCC9
prerank,positive regulation of sodium ion transport (GO:0010765),0.33830351052932817,0.8249410010579046,0.6774847870182555,0.9873144548340212,1.0,1/12,2.29%,WNK3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3134250383526813,-0.8247577508352543,0.7244444444444444,0.8998529998416378,1.0,2/15,5.95%,PRKCH;AGTR1
prerank,regulation of immune effector process (GO:0002697),0.25877321933169084,0.8243985642880745,0.7377690802348337,0.9876226842268829,1.0,7/41,11.47%,C5AR2;CPN1;CFP;C3AR1;CR2;C1QBP;CLU
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.32645348993300277,-0.824244267634271,0.6852589641434262,0.9002825658860008,1.0,6/12,32.70%,CEACAM1;PIBF1;ACADVL;TRIB3;APOC1;ERLIN1
prerank,RNA 3'-end processing (GO:0031123),0.23708218354780794,0.8242275564789832,0.8014705882352942,0.9871216151478581,1.0,15/69,18.53%,PABPN1;CPSF3;SRSF5;TENT4A;SUPV3L1;CPSF7;TUT4;UPF3B;RPRD2;SRSF11;RNPS1;ALYREF;DDX39B;THOC1;SRSF6
prerank,brain morphogenesis (GO:0048854),-0.33148399072753354,-0.8241951196704572,0.6949891067538126,0.8998833319043585,1.0,5/12,27.22%,SHANK3;PAFAH1B1;PTEN;SPEF2;FBXW11
prerank,response to UV-B (GO:0010224),-0.3393107322814924,-0.824085968015822,0.6901960784313725,0.8995883662852495,1.0,2/12,7.72%,CRIP1;MFAP4
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.33220431360384245,0.8237408523854298,0.693359375,0.9872512480550951,1.0,1/13,1.86%,GTPBP1
prerank,I-kappaB phosphorylation (GO:0007252),-0.35342197027378436,-0.8232856189277659,0.7123287671232876,0.9005735965360786,1.0,1/10,0.94%,DAB2IP
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.30560899495789356,-0.823223220542739,0.7295597484276729,0.9001990598957585,1.0,9/16,43.29%,NAA16;NAA10;NAA15;NAA50;AANAT;NAA60;NAA40;NAA35;NAA11
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.22707969872459147,0.8231780447264753,0.7823834196891192,0.98754065688528,1.0,23/80,20.34%,ROCK2;PICALM;PASK;CASP3;SMPD3;ELAVL1;SMPD2;CLU;EPHA4;SPHK2;UPF3B;ABCA2;FXR2;PRKDC;METTL5;IL6;PYM1;UPF3A;RELA;CPEB3;LARP4B;DDX3X;EIF6
prerank,mitochondrion localization (GO:0051646),0.30423550013266276,0.8230089777216995,0.7046413502109705,0.987028249243612,1.0,6/19,18.95%,TRAK1;LRRK2;BRAT1;MFN2;ATP2A1;MEF2A
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3372700389825605,-0.8228359310660021,0.7033195020746889,0.9004717705043724,1.0,5/12,21.03%,ARHGAP35;B4GALT5;EPHB2;PTEN;EPHB6
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.354751373746553,0.8221203689409241,0.6918367346938775,0.9879288459256494,1.0,3/10,11.82%,FURIN;ATRAID;EPHA4
prerank,regulation of RNA export from nucleus (GO:0046831),0.3410667370397594,0.8209983168667382,0.67,0.9892752636362152,1.0,3/11,16.67%,CPSF6;NSUN2;AKAP8L
prerank,cellular response to radiation (GO:0071478),-0.24148970242287346,-0.8208899912244426,0.7717391304347826,0.9035559691272133,1.0,16/40,34.02%,NET1;BLM;TNKS1BP1;RHNO1;LIG4;GPR88;SPIDR;RHOB;NSMCE3;GRB2;RAD51AP1;GPR52;RRH;OPN1MW3;OPN1MW;TP53
prerank,regulation of cellular senescence (GO:2000772),-0.26623404670669065,-0.8208294441509077,0.7666666666666667,0.9031666094761739,1.0,9/28,18.98%,B2M;AKT3;NUAK1;ABI3;FBXO5;TWIST1;EEF1E1;YPEL3;CDK6
prerank,negative regulation of cell cycle process (GO:0010948),0.2399418199928395,0.8203884756107556,0.7704347826086957,0.9896506604060523,1.0,9/61,12.26%,BMP7;PCGF2;TFDP2;E2F1;TOM1L2;MAX;E2F8;PCGF6;RING1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.29490612681733414,0.8203409870236277,0.7251461988304093,0.9889095659485653,1.0,4/21,9.48%,ZWINT;PLK1;MAD2L1;IK
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2746699052163622,-0.8201483966024141,0.7479838709677419,0.9034414271896448,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2746699052163622,-0.8201483966024141,0.7479838709677419,0.9034414271896448,1.0,5/23,14.59%,YWHAE;YWHAB;YWHAQ;YWHAZ;BBC3
prerank,lung epithelium development (GO:0060428),0.3597239253708908,0.8201127868494545,0.6824457593688363,0.9885420411309779,1.0,1/10,0.50%,ERRFI1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.23303899940121275,0.8198059823495031,0.7968476357267951,0.9883122264081451,1.0,18/68,17.34%,ALDH1L1;SLC23A2;SLC23A1;PCCA;PANK2;GSTO2;SLC19A1;MMUT;AMN;MTHFS;GSTO1;CYB5A;THTPA;MTHFD1;MTHFR;FPGS;AASDHPPT;MTHFD2
prerank,spermatid development (GO:0007286),0.27665690892563577,0.8195511494813064,0.7337057728119181,0.9879990347212727,1.0,2/32,4.95%,CCDC42;TDRD5
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2832009039337917,0.8194455929412413,0.7300970873786408,0.9873575595586115,1.0,10/29,18.86%,SMAD3;HNRNPA2B1;TRIM71;TUT4;ZC3H7B;AGO3;DICER1;SNIP1;SRRT;ADAR
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.31378286573138675,0.8191906382813533,0.7087378640776699,0.9870384229627888,1.0,5/18,16.77%,GINS1;POLD2;POLE;MCM7;MCMDC2
prerank,protein deacylation (GO:0035601),-0.2710534544218415,-0.8190991553719384,0.7239263803680982,0.9048177530789061,1.0,7/23,23.63%,HDAC7;SIRT5;HDAC6;ABHD17C;SIRT7;ABHD17B;SIRT6
prerank,regulation of actin filament-based movement (GO:1903115),0.3583419689555887,0.8189767440867466,0.6866267465069861,0.9866435714326584,1.0,2/10,6.78%,ANK2;PDPN
prerank,cellular response to amino acid stimulus (GO:0071230),-0.25303752905390464,-0.8186453987005464,0.758695652173913,0.9051194230981849,1.0,13/33,22.08%,SH3BP4;CAPN2;SPAAR;RPTOR;NSMF;IPO5;RRAGA;SESN3;GLRA2;KLHL22;UBR1;RRAGD;FYN
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2995850435479117,-0.8185682899328263,0.7184265010351967,0.9047626286088789,1.0,11/17,41.10%,TERF2IP;TDG;NEIL3;MUTYH;SMUG1;TINF2;TERF2;OGG1;UNG;NTHL1;TERF1
prerank,mRNA stabilization (GO:0048255),0.26100844984479593,0.8183278034394595,0.7378815080789947,0.9870769570984879,1.0,8/40,11.92%,ANGEL2;ELAVL4;HNRNPU;E2F1;ELAVL1;VIP;MAPK14;BOLL
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.24674201025309755,-0.8180545641010104,0.7564102564102564,0.9051809683349683,1.0,14/37,28.37%,ENTPD1;ENTPD6;SIDT2;ENTPD2;ADPRM;NCBP1;DFFB;NUDT16;PPP1R8;NUDT1;HNRNPD;RNASEH2B;XRN2;PABPC4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33260708674043216,-0.8177285846456018,0.713472485768501,0.9052653293543143,1.0,2/11,7.25%,RUNX1;CBFB
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.2968390037035564,-0.8177152729011594,0.7164461247637051,0.9047928844861405,1.0,6/17,23.96%,BCL2L1;MFF;BBC3;BAK1;TIMM50;BOK
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.34052893234466897,-0.8170843865609443,0.6889312977099237,0.9054282804368353,1.0,5/11,18.13%,PAPOLA;PAF1;NCBP2;NCBP1;BARD1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.20237366036511387,-0.8169758985096536,0.8805970149253731,0.9051402572939301,1.0,11/112,5.85%,FOXP1;THBS1;GAS6;CD34;STAT3;PTPRJ;IRAK3;APP;PLCG2;ARHGEF2;WNT5A
prerank,NAD biosynthetic process (GO:0009435),-0.2888552896980117,-0.8166894150941928,0.7215189873417721,0.9051757381766155,1.0,7/20,23.73%,PTGIS;PTGS2;NNMT;NUDT12;NAXE;KYNU;NMNAT1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.26664517236724117,0.816506502435834,0.7518656716417911,0.9898074454251065,1.0,5/30,11.35%,SH3BP5L;PRKCZ;SH3BP5;PARP14;CD300A
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3151499681086661,-0.8162925412652946,0.733201581027668,0.9053805748444387,1.0,9/15,30.94%,SCARB1;MFSD2A;FBXW7;C3;CTDNEP1;SREBF1;LDLR;SIK1;NR1H2
prerank,regulation of synapse organization (GO:0050807),-0.26944774617784933,-0.8161500974373673,0.7372881355932204,0.9051396565131387,1.0,5/26,13.56%,MEF2C;PDLIM5;WNT5A;YWHAZ;ABHD17C
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.17410823094551645,-0.8154117992150912,0.9725085910652921,0.9059642718862646,1.0,98/314,28.92%,FBXL7;NEDD4L;WWP1;ZNRF1;CDC27;PCNP;SMURF1;HECW2;UBC;FAF2;SPOPL;ANAPC5;COP1;RPS27A;UBB;UBE2D3;KCTD10;UBE2J1;PSMA6;PSMB7;CDC16;TRIM25;FBXO31;FEM1B;PPP2R5C;UBXN1;STT3B;FBXO4;PSMB6;PSMB5;FBXO5;MTA1;RAD23B;UBXN2A;FBXO44;FBXW7;FBXL18;FZR1;PSMB8;PTTG1;UBE2J2;PSMC4;KLHL22;KBTBD7;AUP1;PSMD11;KCTD5;OS9;UBE2A;PCBP2;UBE2G1;ECRG4;PSMB4;AMN1;PSMD14;UCHL1;CCNF;RMND5B;UBR1;FBXL4;CDC26;HACE1;FBXW5;ARRB2;NEDD4;PSMD10;PSME1;FAF1;AGAP3;FBXL6;PSMB3;CDC23;FBXO45;ATXN3;KCTD17;CUL3;CDC34;AREL1;NHLRC3;UFD1;CUL4A;KIF14;UBQLN1;WFS1;SPSB3;LTN1;CUL1;PELI1;FBXW11;CDK2;ANAPC1;ZFAND2B;HERPUD1;VCP;EDEM1;ZFAND2A;ARMC8;FBXO2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.21338700942226974,-0.8153076333974523,0.8451776649746193,0.9056431894688068,1.0,14/75,15.76%,PLA2G4A;GPCPD1;DGKH;PLCG1;AGK;SERINC5;CPNE3;ABCA3;PIGC;PRDX6;ABHD6;PLA2G6;PAFAH1B1;CSF1R
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3379123030080643,-0.8147822973083683,0.6927835051546392,0.9061614309296112,1.0,6/11,24.10%,TPR;TASOR;ATF7IP;DNMT1;SIRT6;SETDB2
prerank,sulfur compound catabolic process (GO:0044273),0.25897327267811127,0.8144383039692048,0.7461832061068703,0.9931285679327787,1.0,10/38,16.78%,OGN;OMD;FITM2;ACAT1;GALNS;HYAL1;FMOD;CSPG5;GGT5;CTH
prerank,defense response to tumor cell (GO:0002357),0.35084318832714756,0.8142851346246663,0.6853002070393375,0.992604957767096,1.0,1/10,0.98%,PLK5
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3576884679217814,0.8142005417825022,0.7048192771084337,0.9919283871412703,1.0,3/10,18.78%,ADRA2A;HBEGF;NCF1
prerank,transcription by RNA polymerase III (GO:0006383),-0.2609009298223371,-0.8140389221842663,0.7463312368972747,0.9069766282235805,1.0,11/27,35.73%,ICE1;GTF3C5;POLR3H;GTF3A;ELL;GTF3C3;SNAPC5;GTF3C6;SNAPC4;GTF3C2;SNAPC3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.2786663574877551,0.8135874294910399,0.7524557956777996,0.992320453088464,1.0,3/26,6.20%,ADCY5;ADRA2A;ADCY8
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.35011054634261424,0.8134219324152275,0.7121848739495799,0.9918054612083125,1.0,2/10,11.35%,APPL2;CD300A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2949018198443483,0.8131066596174652,0.7282608695652174,0.9915989268900213,1.0,8/20,20.23%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,cholesterol transport (GO:0030301),0.24999743073625688,0.8125050094942068,0.7586206896551724,0.9919132784464891,1.0,13/45,21.58%,CEL;ABCG5;SOAT2;STARD5;SOAT1;OSBPL5;CLU;TSKU;STAR;ABCA5;RELCH;NPC1;SERAC1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.2244069744229086,-0.8123703412375476,0.8493150684931506,0.9093857298611416,1.0,13/60,18.58%,LEF1;RUNX2;AGO1;CBFB;HEY2;MED27;MED31;CSF1R;MED14;PTEN;AGO4;ATF7IP;CCND1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.20356134055206737,-0.8112878532370089,0.8660049627791563,0.9108288996532984,1.0,29/95,28.71%,RPA1;RAD51B;HELQ;NIPBL;REV3L;MMS22L;SMC5;RAD54B;BLM;RAD21;FANCB;PALB2;BRCA2;NBN;PSMD14;RPA2;RMI1;CDC45;RAD51AP2;SPIDR;MCM3;NUCKS1;XRCC3;REC8;MCM5;MCM6;RECQL5;RAD51AP1;PARP1
prerank,RNA methylation (GO:0001510),-0.21869651917241323,-0.8111021722425384,0.8423529411764706,0.9106398898837744,1.0,15/60,20.15%,METTL2A;METTL2B;THUMPD2;TRMT10A;FTSJ1;TRMT44;TYW3;WTAP;METTL6;DIMT1;TRMT112;LCMT2;NSUN4;MEPCE;METTL3
prerank,neural tube closure (GO:0001843),0.26575893637002207,0.8109715161400256,0.7596153846153846,0.9940102696874019,1.0,8/34,16.18%,CELSR1;LMO4;PHACTR4;VANGL2;IFT122;MTHFD1;MTHFR;FUZ
prerank,regulation of viral life cycle (GO:1903900),0.29422486080757343,0.8106704882960797,0.7140077821011673,0.9937550889828601,1.0,5/21,16.29%,TRIM62;TRIM5;HS3ST5;TYRO3;AXL
prerank,regulation of establishment of cell polarity (GO:2000114),-0.30869697619167014,-0.810280597008567,0.7419354838709677,0.9115252906509234,1.0,7/16,21.29%,GSN;KANK1;RACK1;PTK2B;SHTN1;KIF20B;ROCK1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24442251538681814,0.8102609076114647,0.7793103448275862,0.993749772054864,1.0,17/48,20.76%,E2F1;HTRA2;MSH6;IKBKE;TOPORS;BCL2;PML;CHEK2;BAG6;AEN;PRKDC;ABL1;SIRT1;ATM;HIPK2;PYCARD;BAX
prerank,negative regulation of coagulation (GO:0050819),-0.3192247575050918,-0.810058713703189,0.7305389221556886,0.911417960791718,1.0,5/14,15.59%,CD34;SERPINE1;APOE;EDN1;VTN
prerank,protein import into nucleus (GO:0006606),0.2337386483252357,0.8098155875133751,0.8,0.9937483991836302,1.0,7/66,6.97%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,histone exchange (GO:0043486),-0.24545983040416483,-0.8096620736465892,0.7604166666666666,0.9116161626237229,1.0,14/37,31.29%,HJURP;RBBP4;NASP;ACTR6;CENPQ;CENPL;RUVBL1;CENPX;MIS18A;CENPN;CENPK;RSF1;SMARCA5;ANP32E
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3418243896262557,-0.8093458068131192,0.7109207708779444,0.9116676572804558,1.0,1/10,0.90%,PLA2G4A
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.32781758519690696,-0.8083831681536425,0.7361111111111112,0.9128372913093415,1.0,7/12,37.84%,HPRT1;AMPD2;ADA;PRPSAP1;GART;PRPS2;PPAT
prerank,snRNA processing (GO:0016180),-0.2996366153663024,-0.8083690269423528,0.7495145631067961,0.9123701135614457,1.0,5/16,22.48%,INTS11;INTS10;INTS9;TOE1;INTS6L
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.21845044621374327,-0.8079381215420315,0.8352668213457076,0.9126000272652143,1.0,20/62,24.64%,LIMD1;STAT3;H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;FXR1;NUP50;NUP85;POLR2I;AJUBA;AAAS;POLR2F;NUP62;NUP214
prerank,regulation of calcium ion transport (GO:0051924),0.24289197964566583,0.8075370955355954,0.7957371225577264,0.9973294745200176,1.0,4/54,4.37%,CACNA1D;ANK2;WNK3;ADRA2A
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.31010558676819566,0.8072687503654344,0.6822810590631364,0.9970258633355213,1.0,5/16,16.60%,ANK2;LRRK2;RYR2;MIA3;GBF1
prerank,positive regulation of RNA splicing (GO:0033120),-0.254064433761696,-0.8071355029530821,0.7725409836065574,0.9135136675471626,1.0,12/29,30.49%,PIK3R1;RBM3;ERN1;PRDX6;DYRK1A;NCBP1;NCL;SNW1;TRA2B;DAZAP1;SETX;HABP4
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.29398498580439836,-0.8071119508668463,0.7091633466135459,0.9130591118174886,1.0,4/16,22.64%,TNFRSF1B;AHR;TNFSF8;SOX11
prerank,negative regulation of organelle assembly (GO:1902116),0.2640570186404267,0.8070090800884294,0.7451737451737451,0.9967024859334137,1.0,4/35,8.07%,NUPR1;ODF2L;TCHP;LRRK2
prerank,aerobic electron transport chain (GO:0019646),-0.21524069214547578,-0.806881681767065,0.8671328671328671,0.9129364769780303,1.0,18/68,19.54%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.30558454726121176,0.8068496761964551,0.732421875,0.9961593830986333,1.0,5/18,18.04%,COX18;COX14;TIMM21;COX20;OXA1L
prerank,DNA recombination (GO:0006310),-0.23520582438398777,-0.8067775418582707,0.8127853881278538,0.9126171227229032,1.0,10/37,20.33%,RPA1;RAD51B;RPAIN;RAD54B;DMC1;BLM;RAD21;RHNO1;LIG4;HMGB1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.17989882286343184,-0.8066253085380319,0.9548022598870056,0.9123991983497107,1.0,63/203,27.44%,FBXL7;ACVR1;YWHAE;CDC27;PPP1R12A;CDK14;DYNC1I2;CACUL1;PPP2R2D;CSNK1E;EPS8;CCNY;PLK2;CHMP4B;CDC16;TUBA1A;EIF4E;CEP76;DCTN3;NASP;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;CCNF;CCND1;CDK6;LCMT1;AJUBA;CSNK1D;CCND2;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CDKN1B;CEP131;CDC23;CDK5RAP2;CUL3;LATS2;CEP152;PLK3;CDC34;PIM2;KDM8;CDKN3;CUL4A;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;ANAPC1
prerank,zinc ion transport (GO:0006829),0.2929129370140723,0.8065710286890069,0.7349177330895795,0.995840548056,1.0,4/21,11.47%,SLC30A6;SLC30A10;SLC39A13;TRPM2
prerank,cholesterol efflux (GO:0033344),0.2908189431597771,0.8062445535700473,0.7403100775193798,0.9956775511336368,1.0,3/20,8.17%,ABCG5;SOAT2;SOAT1
prerank,polyol metabolic process (GO:0019751),-0.2307350702103102,-0.8062300055122494,0.8066825775656324,0.9125903833433234,1.0,6/46,6.96%,PLCB4;PLCE1;INPP4A;PLCG1;PLCG2;INPP5D
prerank,tRNA modification (GO:0006400),-0.21869663406679934,-0.806134067040414,0.8245614035087719,0.9122764734231714,1.0,15/62,19.64%,ALKBH1;METTL2A;METTL2B;THUMPD2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRIT1;TRMT44;CDKAL1;TYW3;METTL6;TRMT112;LCMT2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3144640120676486,-0.8057107811775852,0.7525354969574036,0.912535930421405,1.0,6/14,31.31%,FUS;FANCB;TIMELESS;RAD51AP1;PARP1;MRNIP
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.2758650883959302,-0.805380249593538,0.7484662576687117,0.9126285727010928,1.0,8/20,27.84%,CAMK2D;TGM2;BCAP31;TMCO1;BAK1;KCTD17;WFS1;HERPUD1
prerank,snRNA transcription (GO:0009301),-0.21320831695210546,-0.8049948855998753,0.8289156626506025,0.9127955431687302,1.0,20/70,26.95%,ICE1;INTS11;USPL1;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.28546110209149894,0.8044565446794497,0.728515625,0.9982935386221574,1.0,8/22,21.80%,CCNT2;LEO1;CDC73;ALYREF;DDX39B;THOC1;SUPT4H1;CDK12
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.26340617788146037,-0.8043947586278775,0.7757936507936508,0.9133782292647156,1.0,10/27,25.58%,DTYMK;CTPS1;NME2;AK4;CTPS2;DUT;RRM2B;AK2;TYMS;DCTD
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.24096144453335744,-0.8042757423831632,0.8065934065934066,0.9131019119429685,1.0,14/37,20.96%,STAT3;GBP5;ADCY7;APOD;ABCD2;CHID1;PER1;PDCD4;NOD2;ZC3H12A;PLD3;CUEDC2;MYD88;TICAM1
prerank,autophagosome maturation (GO:0097352),0.26598135211323515,0.8040550409881302,0.7404580152671756,0.9982557790565147,1.0,6/32,11.53%,SNX14;VAMP7;SNAP29;VPS16;LAMP2;LIX1L
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2836288700554552,-0.8037440752324017,0.7368421052631579,0.9135466781217424,1.0,4/19,9.46%,RUNX1;BMP4;CREB3L1;TGFB3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3126347961761474,-0.8037211040489255,0.7663366336633664,0.9130956983916554,1.0,4/14,15.22%,ERN1;CPSF4;NCBP2;NCBP1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2451587318172302,0.8033766523208989,0.7737881508078994,0.9987426894841602,1.0,9/46,15.83%,PITRM1;AIFM1;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;TIMM21;HK1
prerank,regulation of centrosome cycle (GO:0046605),-0.27478176190993486,-0.8033505168263135,0.7259713701431493,0.913232281201505,1.0,12/21,40.95%,CHMP2B;CHMP4B;CHMP1B;FBXW5;CEP131;XRCC3;MARK4;AURKA;PKHD1;ATF5;VPS4B;PDCD6IP
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2000591942921804,-0.8030615382313859,0.8817480719794345,0.9132122469636019,1.0,36/101,30.94%,NIBAN1;THBS1;NFKBIA;RBM3;RPL5;EIF3E;AGTR1;PERP;EEF2;KLF4;AMER1;IST1;TBC1D10A;BAK1;FMR1;PRR16;FXR1;HDAC2;METTL3;PIWIL2;MSN;FAF1;BCL3;EIF4A3;CASP8;HNRNPD;METTL14;FBXW11;RPS4X;AGT;NSUN5;PTTG1IP;PCIF1;FADD;VPS35;NR1H2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.32433269358782263,0.8020366919472118,0.7020408163265306,1.0,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,regulation of cilium assembly (GO:1902017),0.23419857870280164,0.8016181281301343,0.8127090301003345,1.0,1.0,9/62,8.94%,DCDC2;ODF2L;DYNLT2B;SGSM3;DYNC2LI1;TCHP;TBC1D9B;RABEP2;HTT
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.23679642682680574,0.8014387527574187,0.8095238095238095,0.9998777952086977,1.0,3/59,2.70%,ALDH1A2;ACSM2A;ACSM2B
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.34110984522038745,-0.8012794119933819,0.6924686192468619,0.9156930853699274,1.0,4/10,22.36%,ATP5MC3;ATP5F1D;ATP5MG;ATP5PD
prerank,lipoprotein localization (GO:0044872),0.33748111820164783,0.8011280972987823,0.7154150197628458,0.9996170125191798,1.0,5/11,26.09%,PRKCB;ZDHHC3;MIA3;VMP1;PPARG
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.24742464885418508,-0.8011205445798488,0.7539503386004515,0.9154763787352813,1.0,13/31,34.79%,PLCG2;MDK;CD40;IRF5;HMGB1;SYK;RIPK2;MAPK11;TLR4;LGALS9;LAPTM5;TLR3;TLR2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3251293987433093,-0.8010531435897411,0.7196078431372549,0.9151158033777833,1.0,2/12,4.28%,STAT3;ESR1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.32316209548066754,-0.8005594974222897,0.7323651452282157,0.9154642872759636,1.0,4/12,16.30%,WDR1;PIK3CA;LIMA1;SEMA5A
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.23840488730889955,0.8005464353466862,0.7975567190226877,0.9999309283583421,1.0,14/54,17.42%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,mesenchymal to epithelial transition (GO:0060231),0.3494258490383216,0.7999323799397563,0.7081632653061225,1.0,1.0,2/10,9.38%,CITED1;FZD7
prerank,androgen metabolic process (GO:0008209),0.30231858417780477,0.7999318789064467,0.7151051625239006,0.9994487593579711,1.0,4/18,23.75%,MED1;HSD17B11;HSD17B4;SHH
prerank,non-motile cilium assembly (GO:1905515),-0.253649043851345,-0.7997299996854562,0.7920997920997921,0.9163774228111583,1.0,10/30,21.28%,DISC1;ARL13B;IFT57;PIBF1;GORAB;TMEM216;TOGARAM1;TMEM107;CSNK1D;DCTN1
prerank,replicative senescence (GO:0090399),0.3263445051786974,0.7995087588603105,0.733201581027668,0.9993896297550388,1.0,4/12,15.99%,CDKN2A;CHEK2;TERT;ATM
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.22211780658478114,-0.7993344964206134,0.8280542986425339,0.9160351452568316,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.22211780658478114,-0.7993344964206134,0.8280542986425339,0.9160351452568316,1.0,13/56,19.94%,TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;NDUFA7;NDUFA5;NDUFAF6;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.26071760157160956,0.7992274245684153,0.7644927536231884,0.9990437807264687,1.0,8/33,14.47%,HSPA1A;ABCB10;MED1;MAPK14;STAT1;ARNT;HSPA1B;PRKDC
prerank,organophosphate biosynthetic process (GO:0090407),0.2543372951969165,0.7990557724770718,0.7730496453900709,0.9985326284501463,1.0,4/37,6.92%,GK;FITM2;AGPAT4;PCYT2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2834975163340918,0.7985616181168378,0.7623762376237624,0.9986169352581217,1.0,4/21,13.13%,PPARA;SLC30A10;ABCD1;TRAP1
prerank,motile cilium assembly (GO:0044458),0.33663202908401,0.7980089748697362,0.7157676348547718,0.9988087119925313,1.0,3/12,10.81%,BBOF1;BBS5;E2F4
prerank,mitotic sister chromatid segregation (GO:0000070),0.21623140927990683,0.7980020022975697,0.870242214532872,0.9979880577188233,1.0,12/98,10.44%,KMT5A;NCAPD2;EML4;CHMP6;ZWINT;PHF8;PLK1;TENT4A;DSN1;NDC80;TUBG1;CSNK2A2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.32938968547982767,-0.7974631927190209,0.7333333333333333,0.9185945584071756,1.0,2/11,7.08%,LYN;TNFRSF21
prerank,central nervous system neuron development (GO:0021954),-0.30334911314816515,-0.7973869526480909,0.7514677103718199,0.918218037260534,1.0,4/15,10.32%,RAPGEF2;LHX6;ARHGAP35;B4GALT5
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.1900248197604691,-0.7971124503664356,0.943089430894309,0.9181706371744701,1.0,24/132,15.22%,RPS15;RPL38;RPL5;RPL10;MRPL20;COIL;SNRNP200;XRCC5;RPLP0;RPS5;SNRPD1;RPS28;PTGES3;RPL6;PRMT7;RPL24;RPS27;SNRPD2;RRP7A;CLP1;GEMIN8;SNRPE;DDX23;NCBP1
prerank,negative regulation of signaling (GO:0023057),0.2763045483544744,0.7970854765577092,0.7385496183206107,0.9989507140578413,1.0,5/25,13.54%,IGFBP3;GLRA1;OPTN;BRAP;OPRM1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.280978599742735,0.7966661246857597,0.7206477732793523,0.9988685594894555,1.0,12/23,27.60%,MTMR4;INPP5J;SYNJ2;MTMR2;MTMR10;OCRL;INPP5K;PIP4P2;SYNJ1;MTM1;TPTE;PIP4P1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.22527642215996524,-0.7965441053282886,0.8262806236080178,0.9186261640729153,1.0,16/53,23.30%,PSMA6;PSMB7;PSMB6;BCKDK;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30220238276366385,-0.7963217061503725,0.7389558232931727,0.9185035412296457,1.0,2/14,10.52%,CARD14;MALT1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2559972496397567,0.79630131878734,0.7614503816793893,0.9987537873340068,1.0,15/39,21.69%,TANGO2;ARFGAP3;RAB3C;COPG1;CANX;TVP23B;RAB13;COPG2;SCG2;MIA3;NECAB3;TANGO6;LTBP2;RAB15;RCN3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.3406244370535555,-0.7962188713362172,0.7193675889328063,0.918182120821066,1.0,5/10,33.38%,APC;NUP62;MARK4;PARD6A;CEP250
prerank,cellular response to retinoic acid (GO:0071300),0.2503570497813886,0.7961822425898027,0.7769652650822669,0.9981489454549138,1.0,10/42,18.15%,WNT5B;PTK7;WNT6;HTRA2;FZD7;SOX9;NDUFA13;ATM;CREB1;FZD10
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2153121747898833,0.7960673897879468,0.8547008547008547,0.9975316412293642,1.0,29/94,20.76%,DDX5;ITPR1;AIFM1;E2F1;PDK2;HTRA2;TMEM117;MSH6;DNAJC10;IKBKE;MLLT11;C1QBP;TOPORS;BCL2;PML;CHEK2;PDK1;BAG6;PRKDC;ABL1;ATM;ERO1A;ATP2A1;HIPK2;RRP8;DDIT3;PYCARD;DDX3X;BAX
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3350731925283885,-0.7955986180902362,0.7344961240310077,0.9186697189677464,1.0,2/10,5.61%,SEC14L1;RNF125
prerank,histone acetylation (GO:0016573),0.22664640114886042,0.7953807723849712,0.8105065666041276,0.9979845859019096,1.0,20/69,19.95%,BRD8;SGF29;RUVBL2;MEAF6;KAT5;TAF10;DMAP1;EP400;KAT14;BEND3;YEATS4;TADA1;CHD5;TADA3;APBB1;KAT6B;DR1;MAP3K7;ACTL6B;KAT8
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.34212250761937935,-0.7947678510184377,0.7325102880658436,0.9195308158124915,1.0,1/10,6.03%,GNB1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.26692470928285444,0.7945541870514924,0.7617260787992496,0.9986256135404443,1.0,7/29,15.25%,MAGEA2;PLK1;ARRDC3;DCUN1D4;TOPORS;FEM1A;ABL1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.22653564891810898,-0.7943625541077072,0.8151447661469933,0.9197249493823366,1.0,15/50,23.30%,PSMA6;PSMB7;PSMB6;PSMB5;PSMB8;PSMC4;PSMD11;PSMB4;PSMD14;PSMD10;PSME1;AZIN1;ODC1;PSMB3;OAZ1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24994927911341114,-0.7936927894738837,0.7949260042283298,0.9203299256620825,1.0,12/33,27.23%,RPA1;PTGES3;TERF2IP;TNKS1BP1;ZBTB48;NHP2;DKC1;CTC1;TINF2;TERF2;NOP10;CDK2
prerank,second-messenger-mediated signaling (GO:0019932),0.2176724310398974,0.7936642966736721,0.865979381443299,0.999445943279405,1.0,11/82,11.28%,CCR9;ACKR2;SPHK1;GPR62;PDPK1;NUDT4;LRRK2;MAFA;NMUR1;RYR2;KSR2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2106867884133701,-0.7933224025462084,0.888631090487239,0.9204312442433786,1.0,18/69,19.54%,SDHAF2;COX6C;NDUFA10;NDUFA8;NDUFS6;COX7C;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;UQCRB;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2357657931206296,0.7932340492517678,0.8266423357664233,0.9985756929343828,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.2357657931206296,0.7932340492517678,0.8266423357664233,0.9985756929343828,1.0,20/51,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,peptide catabolic process (GO:0043171),0.2813774607985776,0.7930041735022164,0.7556390977443609,0.9981792858282879,1.0,5/23,15.34%,ADAMTS13;CPQ;CTSH;TRHDE;GGT5
prerank,axonal transport (GO:0098930),0.25966764464868836,0.7926854026697491,0.761384335154827,0.9979276006731984,1.0,11/36,20.74%,RAB21;AP3S2;SNAPIN;KIF3A;DTNBP1;AP3B2;NEFL;KIF1B;KIF3B;KIF1A;AP3S1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.25938928729778066,-0.7922899589368594,0.7866108786610879,0.921618745011477,1.0,8/28,22.20%,DAB2IP;SMURF1;ECSCR;FBXW7;FMR1;PTEN;TMTC3;CCDC22
prerank,tRNA aminoacylation (GO:0043039),-0.23451195358816765,-0.7922551361598782,0.8183856502242153,0.9211834241699088,1.0,7/37,13.40%,GATB;WARS2;DARS1;LARS2;YARS2;EEF1E1;GARS1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.255500768987319,-0.7921725105841356,0.7852631578947369,0.9208219289080282,1.0,11/29,27.23%,RPA1;PPIA;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,regulation of telomere maintenance (GO:0032204),-0.2594928582738425,-0.7918196257535947,0.7912087912087912,0.9209147742203723,1.0,11/26,26.19%,GNL3;XRCC5;USP7;TERF2IP;YLPM1;NBN;SIRT6;PPP1R10;TINF2;HNRNPD;TERF2
prerank,regulation of neuron death (GO:1901214),0.2185690316086911,0.7915856231539454,0.8506944444444444,0.9990814377693751,1.0,23/82,20.10%,EFNB2;PM20D1;PICALM;GRID2;DHCR24;RILPL1;IKBKG;HTRA2;LRRK2;PPARGC1A;CHGA;CLU;TSC1;SARM1;ITGAM;EPHB1;FAIM2;AKT1;C1QA;TRIM2;PRNP;REST;EIF2S1
prerank,response to muscle stretch (GO:0035994),-0.30017024477985266,-0.7909775048654248,0.7525562372188139,0.9217384021119622,1.0,8/15,34.60%,GSN;PIK3CA;CDH2;DMD;SLC8A1;TTN;CTNNB1;TCAP
prerank,positive regulation of bone resorption (GO:0045780),-0.3194716215246466,-0.7907561738060692,0.7640232108317214,0.9215829501150573,1.0,5/11,34.42%,TNFRSF11A;SYK;PLEKHM1;MC4R;ATP6AP1
prerank,regulation of hormone secretion (GO:0046883),0.31104182594745095,0.7904405758568601,0.7321063394683026,1.0,1.0,1/15,0.66%,SNX6
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.24245546285650987,-0.7904107731822332,0.8236607142857143,0.9216499561927491,1.0,13/36,26.63%,DAB2IP;APAF1;RBBP4;SUZ12;YAF2;FOXO4;EPC1;RYBP;MGA;CHEK1;BMI1;PHC3;TFDP1
prerank,triglyceride catabolic process (GO:0019433),-0.2857171114873827,-0.7902210397695749,0.7515400410677618,0.9214441594865134,1.0,10/19,52.93%,PNPLA2;FABP5;FABP3;FABP4;LPL;FABP12;PNPLA3;FABP7;LIPG;CPS1
prerank,negative regulation of histone modification (GO:0031057),0.315087555921072,0.7899034515260125,0.7338877338877339,1.0,1.0,3/14,13.55%,JARID2;SPHK2;NOC2L
prerank,regulation of macrophage activation (GO:0043030),-0.2504947255814655,-0.7897536157629053,0.8060046189376443,0.9216880181462762,1.0,4/30,5.85%,CD200;THBS1;MFHAS1;WNT5A
prerank,positive regulation of cellular senescence (GO:2000774),0.33773159453536494,0.7891273215488049,0.6986301369863014,1.0,1.0,2/10,4.43%,CDKN2A;ARG2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.27278657550237084,-0.7887475827282785,0.795131845841785,0.9228612551432475,1.0,4/21,9.16%,BCL2L1;CREB3L1;NCK1;EIF2AK3
prerank,cellular response to nitrogen compound (GO:1901699),0.29190224734740533,0.7882287553833616,0.7538759689922481,1.0,1.0,1/20,0.78%,ROCK2
prerank,erythrocyte development (GO:0048821),0.3422247084229113,0.7881457565752155,0.7238658777120316,1.0,1.0,2/10,8.34%,ABCB10;MED1
prerank,defense response to bacterium (GO:0042742),0.20860637553539954,0.7879948426341619,0.884430176565008,1.0,1.0,19/105,20.02%,COLEC12;OAS2;PGLYRP3;CFP;OPTN;GSDMD;OAS3;CHGA;GBP6;RAB1A;TNFRSF14;IL6;ANKRD17;STAB2;IL12A;NLRC4;TIRAP;SHC1;PYCARD
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.22305645886541245,0.787526782631262,0.8415672913117547,1.0,1.0,24/72,22.83%,TFDP2;ARID3A;CDC25C;E2F1;KAT5;E2F8;NDRG1;E2F4;BATF;PML;CHEK2;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3;HIPK2;TFAP4;BAX;CNOT8;MYO6;ATRX;MDM4
prerank,positive regulation of isotype switching (GO:0045830),-0.2964402705880117,-0.7872334206602168,0.7436893203883496,0.9248129692824725,1.0,4/15,15.55%,TFRC;SHLD1;CD40;MAD2L2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2563315028857096,-0.7871861407353902,0.8032786885245902,0.9244014911346249,1.0,7/28,15.85%,DAB2IP;MAP3K5;ERN1;ATP2A3;BBC3;BAK1;ATF4
prerank,histone mRNA catabolic process (GO:0071044),-0.3037217487385846,-0.7871229981640274,0.7806841046277666,0.9240176471840386,1.0,6/15,28.74%,TENT2;TENT4B;MTPAP;EXOSC4;ERI1;XRN1
prerank,tRNA metabolic process (GO:0006399),0.2978040288219465,0.7863392140743618,0.763671875,1.0,1.0,3/17,11.67%,DTD1;TRPT1;DARS2
prerank,defense response to fungus (GO:0050832),-0.28286807445574935,-0.7849355716494163,0.7589098532494759,0.9269205452077173,1.0,4/17,23.21%,PLCG2;RARRES2;GAPDH;BCL10
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.2926517684391108,-0.7847084824958833,0.7740585774058577,0.9267916047559093,1.0,3/15,13.83%,FAP;CST3;LRP1
prerank,positive regulation of nuclear division (GO:0051785),-0.2628211251750438,-0.7845944118817914,0.7791932059447984,0.9264872618598242,1.0,9/25,24.19%,INSR;LRP5;IGF2;EDN1;EDN3;NUSAP1;EGF;NUP62;RGCC
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.19371218170232515,0.7842964975500544,0.9177215189873418,1.0,1.0,40/173,17.94%,F5;ANK1;ANK2;BET1;PROZ;F10;VAMP7;ARFGAP3;ARFGAP2;NAPA;GOLGA2;TRAPPC11;NSF;IER3IP1;COPG1;TMED9;CNIH3;TMED4;TRAPPC1;SPTBN2;COPG2;USO1;RAB1A;MIA3;ACTR10;SPTA1;TRAPPC4;CAPZB;TRAPPC3;GOLT1A;CNIH4;DYNC1LI2;COPE;TMED2;GBF1;COPB1;MCFD2;SEC22B;TFG;F8
prerank,phosphatidylcholine metabolic process (GO:0046470),0.22126402799110464,0.7839850250783122,0.839344262295082,1.0,1.0,11/70,11.80%,PON1;STARD7;PLA2G4C;LPIN1;PNPLA8;NR1H3;CHPT1;CSNK2A2;CHKB;PLA2G15;ABHD3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.33312573601805673,-0.7839036764118119,0.763302752293578,0.9270651013180795,1.0,3/10,22.21%,APC;CDC42;KNSTRN
prerank,glutamate metabolic process (GO:0006536),-0.27816865739206753,-0.7836484906263627,0.7936170212765957,0.9270130465142042,1.0,8/19,22.53%,GLS;GCLC;GCLM;ALDH18A1;GLUD1;ALDH5A1;PRODH;GGT1
prerank,establishment of mitotic spindle localization (GO:0040001),0.2654355902819058,0.7832829081041499,0.7541589648798521,1.0,1.0,5/28,9.32%,PLK1;CLASP1;HTT;NDC80;MAD2L1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2781160008616671,0.7831453680984215,0.7458256029684601,1.0,1.0,2/21,3.27%,DDB2;ERCC1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2781160008616671,0.7831453680984215,0.7458256029684601,1.0,1.0,2/21,3.27%,DDB2;ERCC1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.25654339432248274,0.7826303322220055,0.7915129151291513,1.0,1.0,7/34,14.18%,LGR4;NLRP2B;OTUD4;CACTIN;CD300A;SARM1;TYRO3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.29126971819771796,-0.7824849210765895,0.7911646586345381,0.928334702061813,1.0,6/15,25.70%,STAT3;GBP5;NOD2;MYD88;TICAM1;TLR4
prerank,receptor catabolic process (GO:0032801),-0.259017221231074,-0.7820629063661665,0.7848360655737705,0.9285233086255328,1.0,9/24,23.19%,SMURF1;AP2B1;ZNRF3;VLDLR;AP2A1;PIK3R4;NEDD4;MYLIP;AP2M1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.23172307514976648,-0.7819087742403424,0.848421052631579,0.9282703882656868,1.0,15/42,27.66%,PEX7;SEC61A1;AKT2;ROMO1;GRPEL1;TIMM23;PEX14;DNLZ;PEX2;TOMM40L;TIMM50;SEC62;PEX12;RTN2;ZFAND2B
prerank,cell-cell junction maintenance (GO:0045217),-0.32652644332739206,-0.7816714976243876,0.7582644628099173,0.9281398931147746,1.0,5/11,26.39%,TJP1;FERMT2;CSF1R;F2R;PRTN3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.27825880433503747,0.7811006321975096,0.7518656716417911,1.0,1.0,8/22,20.23%,CDKN2A;PLK1;CEBPA;NR2F2;MEN1;HEXIM2;TFAP4;CDK5RAP1
prerank,recombinational repair (GO:0000725),-0.20421457066076876,-0.7810918536579339,0.8826291079812206,0.928532239986309,1.0,17/77,20.42%,RPA1;RAD51B;HELQ;REV3L;MMS22L;SMC5;RAD54B;BLM;PALB2;BRCA2;RHNO1;NBN;PSMD14;RPA2;RMI1;RAD51AP2;SPIDR
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2799007853584255,-0.7807665634076768,0.7908366533864541,0.9285224579049429,1.0,12/18,39.25%,EGFR;ESR1;NRIP1;GPER1;NCOA3;CCDC62;SSTR2;POU4F1;RAMP3;CRHBP;FAM210B;SSTR1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.2919811685231829,-0.7803441508937746,0.7794117647058824,0.9286742126054419,1.0,6/17,19.54%,COX6C;COX7C;NDUFA4;COX8A;COX4I1;COX15
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.26397208277312467,-0.780198772726491,0.7995824634655533,0.9284073769593308,1.0,11/21,32.41%,ARHGEF2;ATXN7;APC;FGF13;KATNB1;TAOK1;TPX2;CAMSAP2;CIB1;CAMSAP3;CAMSAP1
prerank,peptidyl-lysine acetylation (GO:0018394),0.33644242103029365,0.7795308883848914,0.7346938775510204,1.0,1.0,3/10,15.49%,KAT5;BAG6;SIRT1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.22759082830410862,0.7794158475881171,0.8589511754068716,1.0,1.0,13/57,17.82%,FANCD2;PLK1;ABRAXAS1;EME2;RINT1;MDC1;MRE11;CHEK2;CDC14B;PRKDC;ATM;CLSPN;RAD17
prerank,protein insertion into ER membrane (GO:0045048),0.2547002571556649,0.7792469081205979,0.7871198568872988,1.0,1.0,12/37,19.13%,EMC2;EMC4;CCDC47;CYB5A;BAG6;MMGT1;GET1;UBL4A;EMC10;TRAM1;PRNP;EMC1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.29206320549597287,0.7792202672555285,0.773469387755102,1.0,1.0,4/18,9.52%,ROCK2;RUFY3;LLGL2;LLGL1
prerank,cellular response to unfolded protein (GO:0034620),0.27176799709328003,0.7787008967848389,0.8022181146025879,1.0,1.0,3/26,5.52%,HSPA1A;OPTN;ABCB10
prerank,tRNA processing (GO:0008033),-0.21461069219791068,-0.7786994693869213,0.8872901678657075,0.9301752472522085,1.0,29/61,36.22%,TSEN2;PUS3;THUMPD1;TRMT10A;FTSJ1;TRMT10B;CPSF4;TRIT1;ELAC2;CLP1;CDKAL1;RPP21;ADAT1;LCMT2;RTCB;WDR4;AARS2;RTRAF;ADAT2;POP7;CTU2;TRMT61A;CTU1;PTCD1;RPP40;THG1L;DDX1;KARS1;DTWD1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.30367801529931254,-0.7785263457988193,0.7431372549019608,0.9299460860814895,1.0,9/14,37.84%,RFK;ADSS1;IMPDH1;ADSS2;ADK;PAICS;IMPDH2;GART;PPAT
prerank,histone deacetylation (GO:0016575),-0.22544268781262414,-0.7784536522083834,0.8684759916492694,0.9295704483503077,1.0,14/43,26.26%,MIER1;PRDM5;HDAC9;PER1;MTA1;HDAC6;HDAC2;MIER2;MTA3;SIRT7;MSL3;SIRT6;ELK4;RCOR1
prerank,negative regulation of locomotion (GO:0040013),-0.315227407481667,-0.778428962005596,0.7643564356435644,0.929125499238491,1.0,2/12,10.10%,FRMD5;DUSP3
prerank,cellular respiration (GO:0045333),0.2431058625755753,0.7782256061528543,0.8257042253521126,1.0,1.0,13/41,21.46%,COQ10A;NDUFS1;PPARGC1A;UQCRH;CYCS;SDHC;COX10;LYRM7;OXA1L;SDHB;ETFDH;NR4A3;SLC25A13
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.29263190208475154,-0.7780321001630331,0.757201646090535,0.9292455757271619,1.0,6/15,28.06%,FAF2;AUP1;OS9;UFD1;HERPUD1;VCP
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.32477524354167703,-0.7780165819205095,0.779559118236473,0.9287828660685219,1.0,6/10,30.75%,PIBF1;SOCS3;PPP2CA;SOCS1;INPP5F;PPP2R1A
prerank,inner ear morphogenesis (GO:0042472),0.28039936905859497,0.77777468689616,0.764378478664193,1.0,1.0,4/22,11.97%,USH1C;FGFR2;MYO3A;SOX9
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2966532718603254,-0.7773709636006986,0.806841046277666,0.9292457138757807,1.0,7/16,33.22%,TIPIN;ORC1;TIMELESS;CDC45;HUS1B;CDC6;TICRR
prerank,DNA packaging (GO:0006323),-0.29102389953760477,-0.7770992518856626,0.7569721115537849,0.929169334788307,1.0,9/16,39.20%,KAT6A;RBBP4;NAA10;CHAF1A;BANF2;BANF1;TP53;H1-0;CHAF1B
prerank,regulation of mRNA metabolic process (GO:1903311),0.3206560377718976,0.7770968100958878,0.7565922920892495,1.0,1.0,4/11,22.91%,SLTM;SAFB2;SAFB;SRPK1
prerank,nucleosome disassembly (GO:0006337),-0.3010645794824377,-0.7769732350558567,0.7753036437246964,0.9283803001949873,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,chromatin disassembly (GO:0031498),-0.3010645794824377,-0.7769732350558567,0.7753036437246964,0.9283803001949873,1.0,4/14,20.48%,SMARCC1;ARID1A;SMARCA4;SET
prerank,protein import into peroxisome matrix (GO:0016558),-0.31248812040519536,-0.7766211173673675,0.7596741344195519,0.9284099740895418,1.0,4/12,23.68%,PEX7;PEX14;PEX2;PEX12
prerank,cristae formation (GO:0042407),-0.25359299845721783,-0.7761505249268934,0.8230277185501066,0.9286138057809353,1.0,9/27,25.63%,ATP5MF;ATP5F1E;ATP5F1B;DNAJC11;ATP5MC3;ATP5F1D;ATP5MG;ATP5PD;LETM1
prerank,negative regulation of biosynthetic process (GO:0009890),0.3008427103703175,0.775905057867412,0.7678207739307535,1.0,1.0,7/16,21.84%,PPARA;SLC30A10;ABCD1;TRAP1;IL6;EMILIN1;CIITA
prerank,negative regulation of protein metabolic process (GO:0051248),-0.22133950664494187,-0.7754869457987202,0.8540772532188842,0.9291381333277597,1.0,12/48,21.87%,EGFR;IRAK3;FLNA;IAPP;PRKCG;APOE;EDN1;MAD2L2;PFDN6;AGAP2;ROCK1;AZIN1
prerank,chromatin assembly (GO:0031497),-0.23631439532438892,-0.7754707250676085,0.8105022831050228,0.9286813233217612,1.0,6/38,12.68%,CTCF;H3-3A;EZH1;RBBP4;PAF1;LIN54
prerank,response to cAMP (GO:0051591),-0.23538110240425977,-0.7754640522573508,0.8244444444444444,0.9282079872063379,1.0,6/37,12.76%,RAPGEF2;RAP1A;PDE2A;KCNQ1;AHR;SLC26A6
prerank,regulation of interferon-gamma production (GO:0032649),-0.2034884798620076,-0.7752433554523765,0.9166666666666666,0.9280331318021071,1.0,4/71,3.21%,PDE4D;IL1R1;GAS6;SLC7A5
prerank,regulation of interferon-beta production (GO:0032648),0.2399821876337147,0.7750365816389188,0.8403669724770643,1.0,1.0,14/46,20.22%,OAS2;NLRC3;CACTIN;OAS3;RNF135;POLR3C;TLR8;PPM1B;SIRPA;TIRAP;HSP90AA1;PYCARD;DDX3X;PTPRS
prerank,DNA double-strand break processing (GO:0000729),0.28851799067145617,0.7747665679641679,0.7505070993914807,1.0,1.0,6/18,22.08%,KAT5;MRE11;RNF138;ATM;RAD52;SLX4
prerank,positive regulation of type I interferon production (GO:0032481),-0.20016964454776479,-0.7747430096824539,0.9011764705882352,0.9282993333942607,1.0,29/73,32.89%,LRRFIP1;POLR3F;DHX33;XRCC5;TRIM56;G3BP1;ISG15;POLR3H;IFIH1;NFKB2;POLR3B;GAPDH;IRF5;POLR3A;MYD88;ZBP1;POLR3D;RIPK2;POLR2F;PTPN11;TLR4;POLR2H;CGAS;POLR1C;POLR2E;IRF3;CD14;CTNNB1;TLR3
prerank,GPI anchor metabolic process (GO:0006505),0.26728085782412114,0.774362781779326,0.7716535433070866,1.0,1.0,11/26,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGB;MPPE1;PGAP3;PIGW
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2694277852374052,-0.7741655358348695,0.7706611570247934,0.9286788487964815,1.0,4/22,10.10%,PTPRJ;DGKZ;CEACAM1;DUSP3
prerank,nucleotide metabolic process (GO:0009117),0.2725339786254001,0.7741427696867788,0.7680311890838206,1.0,1.0,5/23,15.11%,ENPP3;AK5;DCK;AK1;GUK1
prerank,peptidyl-arginine modification (GO:0018195),-0.29835482414735204,-0.7740749462938333,0.7704590818363274,0.928335030350704,1.0,10/15,47.03%,ART3;PRMT7;KRTCAP2;PRMT1;PARK7;ART1;PADI1;PADI4;PRMT8;ART5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.29687180586765594,-0.7739441864719886,0.7775551102204409,0.9280404775459387,1.0,9/15,30.38%,DHX33;GBP5;USP50;MYD88;TLR4;TREM2;CPTP;CD36;TLR6
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26441823231749817,-0.7737873559288155,0.7808764940239044,0.9278088018434708,1.0,7/22,22.29%,NUBPL;NFU1;HSCB;NFS1;ISCA2;NUBP1;FXN
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.26007752084704966,-0.7736302578444415,0.7945492662473794,0.9275428377795959,1.0,6/23,16.03%,SLIT2;MPP1;MDK;JAM3;CD74;NCKAP1L
prerank,inflammatory response (GO:0006954),0.18979562860763388,0.7732917690616026,0.94,1.0,1.0,36/195,18.84%,IL18;TAC1;C5AR2;KIT;IL17D;ADCY1;CHUK;LOXL3;PLA2G4C;BDKRB2;NOX1;ADCY8;IKBKG;PRDX5;NLRP3;KLRG1;LTB4R2;PTGER1;C3AR1;PARP4;HYAL1;HDAC4;CDO1;SCG2;CYBA;TLR5;GGT5;IL6;TAC4;HRH1;RELA;IL1A;TPST1;CX3CL1;NLRC4;NFKB1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2195750708500374,-0.7732731098851208,0.8536036036036037,0.9275896893763602,1.0,22/49,32.89%,F3;AFAP1L2;STAT3;NOD1;SERPINE1;CD74;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,embryonic axis specification (GO:0000578),0.30668954645780755,0.7730654668762791,0.7674418604651163,1.0,1.0,2/15,3.68%,CXXC4;WNT7A
prerank,negative regulation of leukocyte activation (GO:0002695),-0.2893900839540452,-0.7728813853229778,0.7919191919191919,0.9276924607311352,1.0,8/15,33.12%,CD200;GPER1;ZC3H12A;FCGR2B;MILR1;CD300LF;GRN;CD84
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3239591939952837,-0.7723095916836067,0.7568627450980392,0.9280871809740796,1.0,5/10,29.94%,PDE8A;STK26;RIPK1;PARK7;PYCR1
prerank,regulation of B cell activation (GO:0050864),-0.25473147119513556,-0.7722919291245279,0.8234086242299795,0.9276337365901449,1.0,10/25,34.01%,AHR;NOD2;FCGR2B;ZFP36L2;FOXJ1;SAMSN1;IL4I1;LAPTM5;IKZF3;THEMIS2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2518978628342235,-0.7713997158001152,0.8333333333333334,0.9284705850514923,1.0,8/27,18.80%,CDC27;ANAPC5;UBE2D3;CDC16;UBE2L3;FZR1;UBE2A;CDC26
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2669875404353904,-0.7712694598804972,0.80083857442348,0.9281700312854448,1.0,9/22,23.61%,MFHAS1;XDH;BMP2;VEGFA;RELL1;ZC3H12A;SPI1;MAP3K4;PRMT1
prerank,histone deubiquitination (GO:0016578),-0.28028103866291953,-0.7711293980273437,0.7922606924643585,0.927903540857842,1.0,8/18,34.84%,ATXN7;USP7;ENY2;TRRAP;USP15;USP36;BRCC3;ATXN7L3
prerank,regulation of protein kinase C signaling (GO:0090036),-0.30100129659069996,-0.7709837759770835,0.7453027139874739,0.9276438122972404,1.0,4/14,13.82%,WNT5A;FLT4;CD40;VEGFA
prerank,protein targeting to mitochondrion (GO:0006626),0.2302552571620218,0.7709720354907481,0.8194945848375451,1.0,1.0,10/52,15.15%,PITRM1;AIFM1;IMMP1L;TOMM40;TIMM17A;TOMM22;MFN2;PAM16;NDUFA13;TIMM21
prerank,regulation of endopeptidase activity (GO:0052548),0.2251499499627467,0.7707734009775146,0.8511796733212341,1.0,1.0,10/59,14.45%,TIMP3;SERPINA10;FURIN;PICALM;SERPIND1;HRG;APH1A;NRDC;SERPINA9;SERPINE3
prerank,phagosome maturation (GO:0090382),0.24761162333991074,0.770075458822004,0.8108108108108109,1.0,1.0,8/35,14.53%,ATP6V0A2;ATP6V0B;ATP6V1H;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,regulation of autophagosome assembly (GO:2000785),0.2552326390633187,0.7695976579175361,0.8155339805825242,1.0,1.0,4/33,8.07%,NUPR1;NPRL3;RAB3GAP1;LRRK2
prerank,positive regulation of histone modification (GO:0031058),-0.237421855081411,-0.7686239654824575,0.8586723768736617,0.9305157190631415,1.0,8/33,19.05%,RPS6KA5;GLYR1;NIPBL;SAP30BP;PAF1;FMR1;APLNR;MAPK3
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3193170231033286,0.7685132701805002,0.7495069033530573,1.0,1.0,1/12,0.36%,UST
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3285234487756898,0.7683996875572104,0.7509803921568627,1.0,1.0,4/10,22.81%,JARID2;SIRT1;KDM1A;ATRX
prerank,establishment of melanosome localization (GO:0032401),0.2827947408085912,0.7680611684589439,0.7704280155642024,1.0,1.0,3/19,13.11%,GPR143;BBS5;SHROOM2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3139116241202916,0.7678581624415758,0.7434869739478958,1.0,1.0,5/13,16.06%,OAS2;EBI3;STAT1;CANX;TYK2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.266481538611395,0.7671533977522175,0.7721280602636534,1.0,1.0,10/26,22.21%,NLRC3;CACTIN;C1QBP;MAPKBP1;TYRO3;PPM1B;RNF26;NFKBIL1;ILRUN;DHX58
prerank,neurogenesis (GO:0022008),0.2385326325135511,0.7665232584035717,0.8415300546448088,1.0,1.0,6/43,10.61%,TRAK1;VXN;DAGLA;WDR62;LPAR1;RITA1
prerank,N-terminal protein amino acid modification (GO:0031365),0.30229694555711345,0.766500369529876,0.7742574257425743,1.0,1.0,1/14,0.84%,METAP2
prerank,fluid transport (GO:0042044),-0.30474263110811384,-0.7660684931259664,0.7842323651452282,0.9336231830367888,1.0,2/12,12.76%,AQP11;SLC26A6
prerank,long-chain fatty acid import into cell (GO:0044539),0.3339610870838495,0.7660319497474206,0.7627811860940695,1.0,1.0,1/10,0.68%,ACSL1
prerank,protein targeting to peroxisome (GO:0006625),0.25738531261624314,0.7655307028378081,0.7897623400365631,1.0,1.0,5/29,10.42%,ZFAND6;ATAD1;LONP2;ABCD1;PEX1
prerank,positive regulation of TOR signaling (GO:0032008),0.2373827319385703,0.7653288262617538,0.8289473684210527,1.0,1.0,10/40,17.90%,RRAGC;RICTOR;GPR137C;SLC38A9;PIH1D1;LAMTOR2;LAMTOR3;TELO2;RRAGB;FNIP1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.29082922076929274,-0.7652123642959366,0.7891440501043842,0.9344038520469964,1.0,4/15,17.68%,ANXA1;FAM107A;UBE2L3;GPER1
prerank,negative regulation of type I interferon production (GO:0032480),-0.22969527653101776,-0.7651868012725709,0.8401727861771058,0.9339606820677978,1.0,9/40,17.21%,REL;RNF125;NLRC5;TRIM25;RELB;ISG15;IFIH1;TRAF3IP1;PCBP2
prerank,proteasomal protein catabolic process (GO:0010498),0.18640481112091842,0.7650318025290492,0.9612518628912071,1.0,1.0,51/201,21.17%,DERL1;FBXL19;HECTD3;PSMD3;SIAH2;RNF41;RNF126;IFI27;MAEA;TRIM71;SOCS6;UBE4B;KAT5;ARRB1;CLOCK;TOPORS;PRPF19;UBE2W;CCDC47;UBXN6;PML;PSMD1;BAG6;SPSB2;PSMC5;RNF5;PSMA1;FEM1C;TBL1XR1;RBCK1;SIRT1;PSMD12;KLHL20;TRIM3;MDM2;KCTD2;RNF139;FBXL22;KCTD13;PSMD7;TRIM2;TRIM13;BFAR;DDIT3;SPSB1;KLHL42;RMND5A;HECW1;ZSWIM8;PSME2;TRIM9
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2626843886271746,0.7648168953892707,0.8038834951456311,1.0,1.0,3/26,4.38%,NPR3;CDH3;PIK3CB
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24158116263704627,-0.7646854025881387,0.8175965665236051,0.9341631457968308,1.0,12/30,29.47%,SHLD1;RNF169;TWIST1;SMCHD1;FANCB;MAD2L2;NUDT16L1;OTUB2;SHLD3;OTUB1;CGAS;HELB
prerank,negative regulation of immune response (GO:0050777),0.19248546831304553,0.7645847667810041,0.9456342668863262,1.0,1.0,29/154,18.50%,ADCY5;PTH2R;CD247;ENPP3;FURIN;ADCY1;CRHR1;GPR45;ADCY8;HTR7;HRH2;NLRC3;CACTIN;C1QBP;VIP;MAPK14;CD300A;MAPKBP1;TYRO3;HAVCR2;GGT5;IL6;GIPR;PPM1B;CREB1;COL3A1;VIPR2;ADCY6;RNF26
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.33389819870708615,0.7643750505610801,0.7430278884462151,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.33389819870708615,0.7643750505610801,0.7430278884462151,1.0,1.0,10/10,66.63%,CNGB1;CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;TULP1;CEP250
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2727443135180897,-0.7641928684819078,0.7839506172839507,0.934366048766042,1.0,4/18,18.27%,THBS1;WNT5A;NECTIN2;IL33
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2717388760964041,0.763926375223651,0.7841328413284133,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2717388760964041,0.763926375223651,0.7841328413284133,1.0,1.0,7/23,22.01%,DAB2;CITED1;MEN1;CITED2;HIPK2;SMAD4;SDCBP
prerank,covalent chromatin modification (GO:0016569),-0.2886268420034222,-0.7637586309142209,0.7749003984063745,0.93444785628977,1.0,10/14,44.75%,CHD1;MT3;SIRT7;PARK7;HDAC1;PARP2;MBD2;AURKB;HLCS;AURKC
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.27501726207543176,0.7635461412514045,0.7955801104972375,1.0,1.0,3/22,7.85%,STAM;RNF126;SNF8
prerank,cytoplasmic microtubule organization (GO:0031122),-0.21088697587924993,-0.7635338047979835,0.8909512761020881,0.9342937438662774,1.0,19/54,27.91%,RHOA;DST;LIMK2;CLIP4;CLIP2;TRPV4;CLIP1;KATNAL1;DYNC1H1;CRIPT;RAB11A;DCTN1;SLK;FSD1;PLK3;KATNA1;CAMSAP2;CIB1;MAPT
prerank,fatty acid biosynthetic process (GO:0006633),-0.20517511836969426,-0.763434888625431,0.9045346062052506,0.9339673616973921,1.0,14/63,19.49%,ABHD2;ELOVL7;PTGS2;ELOVL5;FADS3;ELOVL6;LIAS;SCD;ELOVL1;TECRL;ELOVL4;MCAT;MLYCD;ASAH2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2860741224977475,0.7634084828274008,0.7601547388781431,1.0,1.0,3/18,10.41%,SLC25A5;PPIF;BCL2
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.27731845256874665,-0.7633950409794172,0.7824267782426778,0.9335399753403121,1.0,3/17,9.86%,PCSK5;HDAC9;SORT1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.2788528583797071,-0.7630436764695664,0.7889344262295082,0.9335201064867528,1.0,7/17,22.25%,RHOA;CCN1;TMEM119;BMP2;GREM1;SOX8;HPSE
prerank,microtubule bundle formation (GO:0001578),-0.2246908131466262,-0.762790441131261,0.8473804100227791,0.9333835480799688,1.0,17/42,34.92%,NCKAP5;TPPP3;GAS2L1;NCKAP5L;CLIP1;TOGARAM1;RP1;AAAS;CDK5RAP2;CFAP46;FOXJ1;MARK4;KIF20A;PSRC1;CFAP206;NAV1;CCDC40
prerank,regulation of neurotransmitter transport (GO:0051588),-0.283480944364772,-0.7622082149862134,0.8102766798418972,0.9336718391942678,1.0,4/16,16.51%,MEF2C;MCTP2;FMR1;MCTP1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.28589417973097125,-0.7619103068347847,0.7930327868852459,0.9336332531770362,1.0,7/16,30.94%,SCARB1;PNPLA2;MFSD2A;CTDNEP1;SREBF1;LDLR;NR1H2
prerank,pyroptosis (GO:0070269),0.29986177141616066,0.7618100374822895,0.7784090909090909,1.0,1.0,2/15,5.72%,GSDME;GSDMD
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3310116728529958,0.7611631867388795,0.7304015296367112,1.0,1.0,2/10,11.40%,ALDH7A1;COMT
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.26038863245595173,0.7606189094060356,0.8062157221206582,1.0,1.0,5/29,10.46%,DHX34;HNRNPU;E2F1;ELAVL1;VIP
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.19415569501554383,-0.7604728610051685,0.9333333333333333,0.9351405157149255,1.0,27/82,27.86%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;DYNC1H1;CSNK1D;DCTN1;CEP41;TPX2;TUBA4A;CEP131;CDK5RAP2;CEP152;HMMR;KIF14;AKAP9;ACTR1A;CDK2;CNTRL
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18834090405050588,-0.7601317817815054,0.9368686868686869,0.9351269597320454,1.0,21/95,23.21%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HMGB1;MYD88;TICAM1;SBNO2;CASP1;FCGR2B;BCL10
prerank,cellular lipid catabolic process (GO:0044242),-0.24487473146210292,-0.7601049596094571,0.8299776286353467,0.9346767101536373,1.0,7/27,20.40%,PPARD;CYP1B1;ACOX1;LPIN3;MT3;ACBD5;SMPDL3B
prerank,estrogen metabolic process (GO:0008210),0.3000203724226065,0.7600372680854409,0.7607843137254902,1.0,1.0,3/15,19.29%,HSD17B2;HSD17B11;HSD17B4
prerank,regulation of cell death (GO:0010941),0.2080120772102021,0.7597890107753218,0.9028268551236749,1.0,1.0,14/94,14.28%,BMP7;HSPA1A;CCN2;OLFM4;DHCR24;RILPL1;LRRK2;IMPACT;PRR7;CLU;PARP16;TSC1;SARM1;HSPA1B
prerank,sphingosine metabolic process (GO:0006670),-0.27514753753200705,-0.7597110187971079,0.8130252100840336,0.9347752575408903,1.0,7/17,22.64%,ACER2;PLPP1;PLPP3;SGPP1;ASAH2;ACER3;PLPP2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3116043488909266,0.7595307691981577,0.7584158415841584,1.0,1.0,1/13,0.87%,IL18
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.2858959821255527,-0.7594884986923254,0.7964774951076321,0.9346115614486946,1.0,1/14,0.48%,ACTN4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.32738777513777706,0.7592958410488856,0.753968253968254,1.0,1.0,2/10,10.92%,NPTX1;NPTXR
prerank,snRNA 3'-end processing (GO:0034472),0.2817187134888892,0.7583693394405733,0.7728194726166329,1.0,1.0,4/19,15.57%,EXOSC8;EXOSC2;USB1;INTS8
prerank,oligodendrocyte differentiation (GO:0048709),0.2813543416501235,0.758309781727684,0.8007736943907157,1.0,1.0,3/19,11.97%,SLC8A3;EIF2B4;SOX9
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.2600517954733273,-0.7580968065135103,0.8,0.9360663272947628,1.0,8/21,33.69%,JUN;TWIST1;MED14;MED13;MED24;SETX;MED30;PAXIP1
prerank,telomere organization (GO:0032200),0.23907085395014385,0.7579427220738539,0.8254545454545454,1.0,1.0,10/43,15.99%,DOT1L;RECQL4;POLD2;MRE11;RTEL1;TERT;RAD51D;PRKDC;RPA3;ATM
prerank,multivesicular body assembly (GO:0036258),-0.23932087518838474,-0.7579311090243953,0.822429906542056,0.9358225511296769,1.0,9/30,18.87%,CHMP2B;CHMP4B;CHMP4A;VPS36;HGS;IST1;VPS37A;CHMP1B;RAB11A
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.2950003854132483,-0.7573339653630556,0.808,0.9361525486217652,1.0,2/13,8.86%,BMP4;SOD1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.30643651556827445,-0.757307555220227,0.7579617834394905,0.9357159746579433,1.0,5/13,23.11%,MGAT5;HES1;PTPRC;JAK3;EGF
prerank,actin filament polymerization (GO:0030041),-0.2419415353745315,-0.7570286635441347,0.8292134831460675,0.9356233537325711,1.0,9/29,20.57%,GSN;MSRB2;WASHC3;FAM107A;MICALL2;PSTPIP2;PREX1;DIAPH3;TTC17
prerank,integrated stress response signaling (GO:0140467),0.30727580214022343,0.756419591931675,0.7729941291585127,1.0,1.0,5/14,20.82%,IMPACT;EIF2AK1;DDIT3;EIF2S1;OMA1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.23873052691294203,-0.7563943433731426,0.8406708595387841,0.9360009911147043,1.0,6/33,12.21%,PTPRJ;DGKZ;RPS3;CEACAM1;DUSP3;NECTIN2
prerank,regulation of viral genome replication (GO:0045069),-0.2079384862220348,-0.7562165310350228,0.9141414141414141,0.9357444217639435,1.0,13/56,17.37%,PLSCR1;ADARB1;IFITM3;PABPC1;PPIA;ISG15;RSAD2;IFIH1;VAPB;PPIE;TMEM39A;IFITM1;N4BP1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.24837780274439442,-0.7561963263495511,0.8407079646017699,0.935296142283787,1.0,5/26,10.10%,APP;HES1;EIF4E;TAL1;DUSP3
prerank,dermatan sulfate metabolic process (GO:0030205),0.30740919156013335,0.756124477954276,0.772635814889336,1.0,1.0,1/13,0.36%,UST
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.25461330104962043,0.7558734558218289,0.8178506375227687,1.0,1.0,9/29,16.82%,NAPA;RAB6B;NSF;COPG1;GOLGA5;COPG2;TRAPPC3;COPE;COPB1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2639681363275525,0.7558408302860472,0.8197343453510436,1.0,1.0,9/25,24.34%,DERL1;UBE2W;BAG6;RNF5;UGGT2;LONP1;OMA1;NGLY1;KLHL15
prerank,positive regulation of macrophage activation (GO:0043032),0.289638632793066,0.7551854726340682,0.7796610169491526,1.0,1.0,3/17,8.49%,TAFA3;CEBPA;TNIP2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.21683610639747258,-0.7547228899337616,0.8891352549889135,0.9367427437290735,1.0,8/48,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;PLA2G6;AGPAT5
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.30239049628321324,0.7541333058371564,0.7584830339321357,1.0,1.0,4/14,17.46%,RFLNA;TGFBR1;SOX9;ADAMTS7
prerank,nuclear membrane reassembly (GO:0031468),0.2200258521838031,0.7535846924084647,0.8843416370106761,1.0,1.0,20/54,26.44%,CHMP6;POM121;NUP155;LMNA;NUP98;NUP37;RANGAP1;ANKLE2;NDC1;LBR;LEMD2;CHMP3;CHMP7;CHMP4C;SPAST;VRK1;NUP160;SUMO1;RCC1;NUP133
prerank,negative regulation of protein depolymerization (GO:1901880),-0.2455596413935531,-0.7530812748892798,0.848421052631579,0.9385234872444619,1.0,8/24,18.23%,ARHGEF2;ATXN7;APC;PIK3CA;FGF13;LIMA1;KATNB1;TAOK1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.1777722786813533,-0.7529780638278554,0.9701492537313433,0.938187572030707,1.0,40/125,27.77%,STMN1;EML1;DYNC1I2;MAP4;TNKS;PLK2;NUP107;DYNC1I1;RPS27;RMDN1;INCENP;DYNLL1;PPP1CC;ZWILCH;CLIP1;ZW10;DCTN6;PAFAH1B1;SEC13;STIL;PMF1;CENPQ;CENPL;NUSAP1;DYNC1H1;TAOK1;NUP85;B9D2;GPSM2;NSL1;CENPN;NDEL1;KIF4A;CENPK;SPC25;SPDL1;MIS12;CDCA8;SGO1;TUBG2
prerank,inositol phosphate catabolic process (GO:0071545),0.3158686339319222,0.7516456127143011,0.7837837837837838,1.0,1.0,7/12,27.75%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A;NUDT3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2515045100226894,0.7514318455241842,0.799618320610687,1.0,1.0,6/31,15.15%,AIFM1;TOMM40;TIMM17A;PEX1;PAM16;TIMM21
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.332080394071516,0.7512449669340692,0.7583333333333333,1.0,1.0,4/10,18.53%,SMARCD3;FZD3;KDM1A;CX3CL1
prerank,natural killer cell mediated immunity (GO:0002228),0.29467624097219514,0.7511172075105268,0.8027613412228797,1.0,1.0,1/15,2.98%,KLRD1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.23369012583910848,0.7506216041938627,0.8414414414414414,1.0,1.0,3/44,4.31%,ROCK2;GTPBP1;TNRC6A
prerank,negative regulation of DNA recombination (GO:0045910),-0.21927547629686905,-0.7505717822728522,0.9163090128755365,0.9408413105273968,1.0,16/43,30.12%,SHLD1;TERF2IP;BLM;SMCHD1;FANCB;MAD2L2;POLR2I;POLR2F;PARP3;TINF2;SHLD3;TERF2;POLR2H;CGAS;HELB;POLR2E
prerank,regulation of actin filament-based process (GO:0032970),0.2161295116179348,0.7505479539748778,0.9058823529411765,1.0,1.0,5/70,3.11%,ROCK2;RICTOR;BAIAP2;RHOBTB2;CELSR1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.2785895397089693,0.7498105705389949,0.8062015503875969,1.0,1.0,6/18,17.57%,CHRM2;PLCB1;CHRM1;OPRM1;RGS8;CDK5R1
prerank,regulation of cell division (GO:0051302),-0.1990722711888309,-0.749646043635021,0.9158163265306123,0.941596026287947,1.0,34/72,33.43%,MLLT3;BCL2L1;RACK1;PLK2;CALM3;MYO19;TXNIP;TAL1;PIK3C3;BLM;PIK3R4;CCP110;GIT1;RAB11FIP3;RAB11A;KIF13A;PRC1;NCOA3;ENTR1;DLL1;FSD1;TLE6;PLK3;SUSD2;CALM1;CIB1;FLCN;CSPP1;SH3GLB1;MYC;KIF20A;AURKA;BIRC6;ESRRB
prerank,establishment of spindle localization (GO:0051293),0.302841026105261,0.7490110943668584,0.795959595959596,1.0,1.0,3/14,9.52%,CLASP1;LLGL2;LLGL1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2731355463703745,-0.7489107036805918,0.7984496124031008,0.9420884153040702,1.0,9/18,38.05%,NCKAP1L;PRDM1;METTL3;CCR2;ZFP36L2;IL4I1;IKZF3;PRELID1;CRTAM
prerank,dendritic cell migration (GO:0036336),-0.27791850482814184,-0.748813071582873,0.8123711340206186,0.9417443636564027,1.0,11/16,44.94%,EPS8;HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,heterochromatin assembly (GO:0031507),0.27199872349780935,0.7483347876696048,0.7745098039215687,1.0,1.0,8/20,21.63%,CDKN2A;BEND3;BAHD1;SIRT1;CENPV;RRP8;BAZ2A;HELLS
prerank,negative regulation of proteolysis (GO:0045861),0.2475434886957434,0.74819877356084,0.8308550185873605,1.0,1.0,7/34,13.45%,TIMP3;PLAT;LRRK2;CLN8;EPHA4;GAS1;BAG6
prerank,positive regulation of lymphocyte activation (GO:0051251),0.25822075317205334,0.7477935605516807,0.8240917782026769,1.0,1.0,7/28,20.02%,TNIP2;PRKDC;IL6;IL12A;SIRPA;FGF10;PYCARD
prerank,melanosome localization (GO:0032400),0.27163096153501715,0.7477439564897201,0.80078125,1.0,1.0,3/21,13.11%,GPR143;BBS5;SHROOM2
prerank,regulation of mitotic spindle organization (GO:0060236),0.23943266457765888,0.7472891013183839,0.844731977818854,1.0,1.0,7/35,16.50%,HSPA1A;PLK1;HNRNPU;DRG1;HSPA1B;EML3;CHMP1A
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.25738778382880106,0.7471743207908067,0.8311688311688312,1.0,1.0,3/25,6.70%,ANK2;CAPN3;PDPK1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3199097691158304,0.7459713684108655,0.7840670859538784,1.0,1.0,1/11,1.96%,LRRC38
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25182169157085577,0.7458889468627586,0.8423005565862709,1.0,1.0,7/30,14.60%,VAMP5;OPTN;GGA2;NSF;AMN;GGA1;GOLGA4
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.23990081750296313,-0.7449140036254249,0.8491735537190083,0.9463079902709979,1.0,5/26,15.85%,PDE8A;PPIA;BAG5;HSPB1;ATF4
prerank,regulation of cellular protein localization (GO:1903827),-0.21763568659699742,-0.7447793250732612,0.8876889848812095,0.9459927316624761,1.0,16/45,28.71%,GPC6;RAB11FIP5;RALB;CSNK1E;PTPN1;RAB11B;GPC1;GPC4;SPIDR;EGF;NDEL1;SUMO3;TRIM67;MAPT;VCP;PARP1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.28342169134576745,0.7447518287736102,0.8015414258188824,1.0,1.0,6/16,24.20%,ACAT1;GCDH;ACACA;CBR4;ACSS1;DIP2A
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.22817426337847727,-0.7443710502806556,0.8705357142857143,0.9460521546505238,1.0,9/35,22.53%,FAR2;GGTA1;HMGCLL1;FASN;AACS;SCD;GGT7;AWAT2;GGT1
prerank,mitochondrial gene expression (GO:0140053),-0.2203817934374548,-0.7442885461522459,0.8719101123595505,0.9456781623271951,1.0,9/42,17.19%,GATB;FOXO3;LARS2;MRPL23;NDUFA7;MRPL12;GFM2;PTCD3;MRPS12
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.2399962716050819,0.7439704673575829,0.8427787934186471,1.0,1.0,5/35,11.87%,PCDHB11;CDH17;CDH10;CDH18;PCDHB3
prerank,regulation of cell aging (GO:0090342),0.310489779921572,0.7439688182749993,0.7747572815533981,1.0,1.0,3/11,20.21%,LMNA;VASH1;NEK4
prerank,positive regulation of translational initiation (GO:0045948),0.28170562899172646,0.7435620595612059,0.7729083665338645,1.0,1.0,7/18,24.44%,BOLL;POLR2D;UHMK1;DDX3X;LARP1;YTHDF3;YTHDF2
prerank,regulation of neutrophil migration (GO:1902622),-0.3190944521063933,-0.743460151769424,0.8036072144288577,0.946268133627701,1.0,3/10,16.03%,MPP1;JAM3;NCKAP1L
prerank,regulation of nuclear division (GO:0051783),0.27056643584494827,0.7427544965653575,0.7950191570881227,1.0,1.0,2/20,5.79%,OBSL1;CDC25C
prerank,T cell proliferation (GO:0042098),-0.2982052931160931,-0.7427488040505137,0.8207171314741036,0.9467030328834535,1.0,8/13,38.05%,DOCK8;CTPS1;CADM1;MSN;PIK3CG;RASGRP1;TNFRSF4;CRTAM
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.19663689835183035,-0.742713833235211,0.9249394673123487,0.9462708218665113,1.0,26/69,35.73%,ICE1;INTS11;GTF2F1;NCBP2;POU2F1;ELL2;NCBP1;INTS10;ELL;INTS9;POLR2I;RPRD1B;POLR2F;TAF9;GTF2E2;GTF2E1;RPRD1A;POLR2H;CCNT1;SNAPC5;POLR2E;SNAPC4;POLR2J;TAF5;INTS12;SNAPC3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.245502908715431,0.7422286699045819,0.8409961685823755,1.0,1.0,5/33,12.96%,PABPN1;CPSF3;CPSF7;SLBP;LSM11
prerank,rRNA 3'-end processing (GO:0031125),0.3242526106429935,0.7414544356654202,0.7806324110671937,1.0,1.0,2/10,11.29%,EXOSC8;EXOSC2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.27108358611626837,0.7411593013085004,0.8204633204633205,1.0,1.0,6/21,18.53%,SMARCD3;FZD3;FZD9;NES;KDM1A;CX3CL1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.24437851395044705,0.7409318983025416,0.8377862595419847,1.0,1.0,9/30,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,nucleosome organization (GO:0034728),-0.2056848574589123,-0.7403390721882968,0.9111617312072893,0.9488353084188472,1.0,9/55,13.28%,CTCF;H3-3A;BPTF;SMARCC1;ARID1A;PAF1;NASP;LIN54;ACTR6
prerank,regulation of secretion (GO:0051046),0.3004460552388755,0.7402518628675971,0.7806324110671937,1.0,1.0,2/13,6.82%,OAS2;NRG1
prerank,response to unfolded protein (GO:0006986),0.22502361004090315,0.7396476432519891,0.8647686832740213,1.0,1.0,4/48,4.35%,HSPA1A;DERL1;OPTN;DNAJB4
prerank,import into nucleus (GO:0051170),0.21064175965591192,0.7396448594894401,0.8900709219858156,1.0,1.0,7/73,6.97%,APPL2;IPO13;FAM53A;POM121;NUP155;NUP62CL;TNPO3
prerank,t-circle formation (GO:0090656),0.33053811806643285,0.7396345302221035,0.7875243664717348,1.0,1.0,1/10,3.27%,ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.33053811806643285,0.7396345302221035,0.7875243664717348,1.0,1.0,1/10,3.27%,ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.33053811806643285,0.7396345302221035,0.7875243664717348,1.0,1.0,1/10,3.27%,ERCC1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.1817684389052937,-0.7390276565617636,0.9766233766233766,0.9499271316209932,1.0,25/101,25.70%,MEF2C;DAB2IP;RHOA;TNFRSF1B;DEFA6;CARD16;WNT5A;LYN;SERPINE1;PAF1;PDCD4;CD86;GIT1;NOD2;ZC3H12A;HCK;HMGB1;MYD88;TICAM1;SBNO2;CASP1;BCL10;CD68;PRKCE;TLR4
prerank,positive regulation of translation (GO:0045727),-0.18805920740439908,-0.7388219130839548,0.9534313725490197,0.9496766679281475,1.0,19/94,22.20%,NIBAN1;THBS1;RBM3;RPL5;EIF3E;EEF2;YBX3;CDC123;AGO2;RPS9;NGRN;FMR1;PRR16;FXR1;METTL3;PIWIL2;BCL3;EIF4A3;JMJD4
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2425832900072893,0.7385938349825922,0.8248587570621468,1.0,1.0,9/32,20.02%,DDX5;PDK2;PML;BAG6;AEN;SIRT1;HIPK2;RRP8;PYCARD
prerank,peptidyl-asparagine modification (GO:0018196),0.2411566648192046,0.7380232339361891,0.8503787878787878,1.0,1.0,9/31,19.92%,ASGR1;TUSC3;MAGT1;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPM2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.22004848267081106,0.7379309014234094,0.8863636363636364,1.0,1.0,9/53,16.76%,OPRD1;CHRM2;HTR7;HRH2;HTR1F;CHRM1;OPRM1;HTR1A;HRH1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3179063153152606,0.7376400049801157,0.819672131147541,1.0,1.0,4/11,11.20%,HTRA2;PRR7;CAAP1;PIH1D1
prerank,regulation of T cell activation (GO:0050863),-0.2206353942450626,-0.7375933984717993,0.8942731277533039,0.9506579035755872,1.0,25/42,49.65%,TNFRSF1B;DUSP3;JAK3;METTL3;TNFSF8;CCR2;IL4I1;LAPTM5;LAT;GPNMB;CD47;CCL5;PRELID1;VTCN1;CRTAM;LCK;CCDC88B;TNFSF11;TNFSF9;FGL1;TNFAIP8L2;TBX21;LGALS3;TNFSF18;CD2
prerank,regulation of response to biotic stimulus (GO:0002831),0.24725130112624383,0.7369964082466756,0.8467432950191571,1.0,1.0,4/28,9.37%,APPL2;TKFC;TRIM5;RNF135
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.24165253480219065,-0.7368886119272448,0.8622222222222222,0.9510183024342225,1.0,5/26,9.78%,KMT2E;EGFR;ANXA1;ADAMTS1;RPTOR
prerank,negative regulation of translation (GO:0017148),0.20222947851674092,0.7365254760279376,0.9480069324090121,1.0,1.0,20/87,20.88%,CPEB2;ROCK2;TRIM71;UNK;CPEB4;EIF2AK2;PAIP2B;PAIP2;EPRS1;EIF4E2;TSC1;FXR2;EIF4EBP3;RNF139;GIGYF2;CPEB3;ILF3;DDX3X;LARP1;CNOT8
prerank,positive regulation of neuron death (GO:1901216),0.22397563134860551,0.7362094834874761,0.8905380333951762,1.0,1.0,13/46,20.76%,NUPR1;EFNB2;PICALM;CLU;SARM1;ITGAM;CDK5R1;C1QA;PRNP;DDIT3;REST;EIF2S1;BAX
prerank,"phototransduction, visible light (GO:0007603)",-0.27987528212662194,-0.736092795355977,0.8089430894308943,0.9515234055488165,1.0,2/14,6.03%,GNA11;GNB1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.241310301711661,0.7360554493855593,0.847457627118644,1.0,1.0,8/35,16.02%,XRCC1;POLD2;MBD4;RFC5;POLE;RPA3;NEIL1;POLG
prerank,synaptic vesicle membrane organization (GO:0048499),-0.26461584001747035,-0.7357595227651228,0.8326180257510729,0.9514340990399311,1.0,5/17,17.48%,STX1A;STX3;SYNGR2;SNAP23;SYNGR1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.2768896972027425,-0.7353434498729705,0.8247011952191236,0.9514638562229761,1.0,4/16,14.93%,SNRNP200;SFSWAP;NCBP2;DDX23
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2268045373366337,-0.7352950977630389,0.8731182795698925,0.9510394314623818,1.0,19/33,47.19%,FBN1;UBASH3B;TLR4;GPR137B;CEBPB;LRRC17;TLR3;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;CSF1;CCL3;IL12B
prerank,proteoglycan metabolic process (GO:0006029),-0.2435442727103178,-0.7352462550116975,0.865934065934066,0.9506312371505233,1.0,3/26,4.80%,BMPR2;CSGALNACT1;CHST8
prerank,melanosome transport (GO:0032402),0.2747269770070364,0.7351049805581414,0.8043052837573386,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,pigment granule transport (GO:0051904),0.2747269770070364,0.7351049805581414,0.8043052837573386,1.0,1.0,2/18,9.00%,GPR143;BBS5
prerank,heme biosynthetic process (GO:0006783),-0.25213849403818467,-0.734834609440542,0.8716904276985743,0.9506487138575621,1.0,7/22,24.86%,ABCG2;NFE2L1;UROS;HMBS;COX15;FXN;FECH
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.18947130917835978,-0.7345337267769141,0.9445843828715366,0.9505613317702624,1.0,23/86,23.51%,LIMD1;UBC;RPS27A;UBB;PSMA6;PSMB7;VHL;PSMB6;PSMB5;VEGFA;KLF2;PSMB8;PSMC4;PSMD11;ATF4;PSMB4;PSMD14;PSMD10;ATF3;CHEK1;PSME1;PSMB3;EGLN3
prerank,regulation of viral transcription (GO:0046782),-0.21573707005583082,-0.7338337498606172,0.8891402714932126,0.9509594746277985,1.0,5/39,10.09%,MDFIC;MID2;IFITM3;TRIM14;GTF2F1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25549551832968465,0.7337853843093615,0.8326923076923077,1.0,1.0,7/23,19.69%,INHA;C1QBP;HAVCR2;AXL;RARA;PRNP;DDIT3
prerank,placenta development (GO:0001890),0.30005980840620383,0.7330158640254753,0.801923076923077,1.0,1.0,6/12,26.09%,CITED1;E2F8;PLAC1;CUL7;PTK2;PPARG
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2552611060145767,-0.7329166236987041,0.864406779661017,0.9515919299610761,1.0,8/20,24.61%,ENTPD1;APP;TXNIP;NT5E;SUGT1;C3;CASP1;ANO6
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3064714597122986,0.7327386190871362,0.796875,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3064714597122986,0.7327386190871362,0.796875,1.0,1.0,2/11,11.59%,GSTM2;GSTO1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.3098262360839177,0.7318729122702524,0.7713097713097713,1.0,1.0,3/11,10.75%,EFNB2;FZD7;FRS2
prerank,regulation of response to stress (GO:0080134),0.31829770067627994,0.731419005158593,0.7909270216962525,1.0,1.0,2/10,13.54%,ADCY8;OPRM1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2975766189988958,0.7311913623453393,0.8011695906432749,1.0,1.0,3/12,8.74%,SNAP29;SNAP47;SNAP25
prerank,protein insertion into membrane (GO:0051205),-0.22344997032884023,-0.7304850671488549,0.8777777777777778,0.9539617617445029,1.0,3/32,4.03%,EGFR;APP;STX1A
prerank,apoptotic DNA fragmentation (GO:0006309),0.27980537057294774,0.730470625759325,0.8138195777351248,1.0,1.0,4/16,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,protein N-linked glycosylation (GO:0006487),0.20577592269539308,0.7301589303228284,0.9236111111111112,1.0,1.0,19/66,22.76%,MAN1C1;ASGR1;B4GALT1;TUSC3;MGAT4C;MAGT1;PMM2;DPM1;RPN2;MCFD2;STT3A;UGGT2;DPAGT1;DPM2;ALG2;ALG12;PGM3;DOLPP1;ST6GAL1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.29894781093196066,-0.7293086656361684,0.8278688524590164,0.9548038705132202,1.0,8/12,51.07%,ZBTB1;CCR2;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,sensory perception of chemical stimulus (GO:0007606),0.29105976896032115,0.7290892500756477,0.8307984790874525,1.0,1.0,15/15,70.92%,SYT10;SLC24A4;UBR3;GNAL;MKKS;GFY;OBP2B;OMP;BEST2;C5AR1;BBS4;ADCY3;GNAS;CD36;DRD2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2182282647572817,-0.7283322713380891,0.8997668997668997,0.9554479492085439,1.0,11/38,23.17%,POLR3F;PLSCR1;GBP5;PUM2;IFI35;PUM1;POLR3B;ZCCHC3;POLR3D;NMI;USP15
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.22752878984063596,-0.7282014920907857,0.8603603603603603,0.9551027825545789,1.0,12/32,27.53%,PLCG1;CALM3;TRPC1;JPH2;CEMIP;P2RY6;APLNR;GPER1;NPSR1;F2R;CASQ1;CALM1
prerank,glycogen catabolic process (GO:0005980),-0.2753706786103017,-0.7281020234949005,0.8353174603174603,0.9547441140862949,1.0,5/15,15.47%,RB1CC1;PYGB;GAA;PGM2;PHKA2
prerank,synaptonemal complex assembly (GO:0007130),-0.27479901255448314,-0.7280955959080633,0.8416833667334669,0.9538008735668272,1.0,7/15,35.25%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),-0.27479901255448314,-0.7280955959080633,0.8416833667334669,0.9538008735668272,1.0,7/15,35.25%,RAD21;TEX11;SYCP2;REC8;TRIP13;TEX12;STAG3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.31155203198255277,-0.727972789645032,0.788235294117647,0.9534880077642182,1.0,5/10,29.99%,AKT2;IRS1;PTH1R;PRKCE;PMAIP1
prerank,regulation of macrophage differentiation (GO:0045649),-0.2764377144269475,-0.7279374686376419,0.8168724279835391,0.9530498302256005,1.0,11/15,46.05%,IL34;C1QC;ID2;RIPK1;CASP8;FADD;LIF;PF4;HSF1;CSF1;PTPN2
prerank,regulation of interleukin-8 production (GO:0032677),-0.19139594084807596,-0.7278155502474242,0.9497716894977168,0.9527163040664615,1.0,29/69,32.89%,TMSB4X;F3;AFAP1L2;STAT3;NOD1;ANXA1;OTUD7B;SERPINE1;KLF4;CD74;PTPRC;NOD2;RIPK1;HMGB1;MYD88;SYK;BCL3;BCL10;TLR4;F2R;PARK7;FADD;LAMTOR5;TLR6;LGALS9;TLR1;NOS2;CD14;TLR3
prerank,regulation of calcium ion import (GO:0090279),-0.2528908399698144,-0.7273484597524624,0.8597938144329897,0.9528135686552255,1.0,7/21,25.77%,SLC30A1;CXCL12;PLN;PSEN2;FYN;EGF;STC1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.29260548745730675,0.7273026671898571,0.8026819923371648,1.0,1.0,4/13,14.17%,RAB3GAP1;GRIK2;SHISA7;SHISA8
prerank,membrane depolarization (GO:0051899),-0.2236223741328056,-0.7261029822206404,0.8957055214723927,0.9537768713750375,1.0,8/32,21.60%,CAV1;CACNA1G;CACNA1B;CACNB4;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,negative regulation of catabolic process (GO:0009895),0.2195095943202069,0.7259408069729005,0.8747697974217311,1.0,1.0,11/47,18.92%,NUPR1;PPARA;ADRA2A;MAD2L1;AZIN2;HDAC4;CYP51A1;SNX3;BANP;HMGCR;NCOR1
prerank,histone H2A ubiquitination (GO:0033522),0.27726294860557477,0.7249453926200556,0.828,1.0,1.0,7/17,26.88%,DDB2;RING1;PCGF1;UBR2;RNF8;BCOR;UBE2B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.28093693667265174,-0.7248322623537576,0.8333333333333334,0.9542645392067758,1.0,6/15,32.21%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.28093693667265174,-0.7248322623537576,0.8333333333333334,0.9542645392067758,1.0,6/15,32.21%,PABPC1;AGO2;NANOS3;ZFP36L2;CNOT1;NANOS1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.2724221326803715,0.7247617004661908,0.8187134502923976,1.0,1.0,6/17,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,response to tumor necrosis factor (GO:0034612),-0.18563536091983862,-0.7241705362534196,0.9675925925925926,0.9545098888315238,1.0,10/91,8.06%,PID1;DAB2IP;TNFRSF11A;GCH1;ARHGEF2;ADAM10;YBX3;TNFRSF21;RPS3;CCL13
prerank,response to gamma radiation (GO:0010332),-0.24140878099403013,-0.7240853657126729,0.8821052631578947,0.95412843407605,1.0,3/24,6.25%,DCUN1D3;MAP3K20;XRCC5
prerank,RNA modification (GO:0009451),-0.2005182429618564,-0.7236609112215098,0.9327354260089686,0.9541221067634139,1.0,21/54,31.83%,ADARB1;ALKBH1;PUS3;THUMPD1;FTSJ1;TRIT1;CDKAL1;PUS7L;LCMT2;NSUN4;MEPCE;METTL3;WDR4;AARS2;NOP10;ADAT2;NSUN5;CTU2;TRMT61A;TSR3;CTU1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2466453298397716,0.7225151608078519,0.8646616541353384,1.0,1.0,5/28,15.08%,TFIP11;AUNIP;KMT5C;PRKDC;WAS
prerank,aerobic respiration (GO:0009060),-0.2574021673601372,-0.7224977686528256,0.8556034482758621,0.9549968541211274,1.0,8/20,23.65%,ATP5F1D;UQCRB;NDUFS7;MTFR2;NDUFS8;SLC25A14;UQCR10;UQCRC1
prerank,positive regulation of neutrophil migration (GO:1902624),0.2682539666648526,0.7224519008239838,0.8188976377952756,1.0,1.0,6/18,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.209083372984893,0.7224395415387739,0.91005291005291,1.0,1.0,15/63,17.42%,TFDP2;ARID3A;CDC25C;E2F1;E2F8;E2F4;PML;CHEK2;PRKDC;MUC1;PCBP4;GADD45A;ATM;MDM2;CNOT3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2032460231098797,-0.7223834179877626,0.9336384439359268,0.9541743777081896,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2032460231098797,-0.7223834179877626,0.9336384439359268,0.9541743777081896,1.0,25/50,34.42%,H3-3A;AGO1;PUM2;NUP107;AGO2;TPR;PUM1;FMR1;SEC13;NUP50;NUP85;POLR2I;AAAS;POLR2F;NUP62;NUP214;POLR2H;NUP205;POLR2E;NUP210;NUP43;POLR2J;EIF4G1;NUP35;NUP42
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3039510650052963,-0.7221866941406525,0.8227611940298507,0.9539151636671489,1.0,4/10,22.51%,CEACAM1;PTPRC;ARRB2;FCGR2B
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.2427962782242405,-0.7215310996873998,0.8789808917197452,0.9541741904848889,1.0,7/26,21.29%,SHANK3;ACTG1;SYNPO2;PFN1;LIMK1;CDC42;ROCK1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.294004076323981,0.7214754056665318,0.8185328185328186,1.0,1.0,5/13,19.69%,MSX2;TAF1;PER2;SIN3A;DDIT3
prerank,negative regulation of axonogenesis (GO:0050771),0.2476131912486799,0.7212343283052995,0.8492647058823529,1.0,1.0,4/27,10.62%,MAP2;RUFY3;LRP4;RNF6
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.25217207403737246,-0.7201208245229298,0.8311965811965812,0.954814298069579,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.25217207403737246,-0.7201208245229298,0.8311965811965812,0.954814298069579,1.0,8/19,32.69%,TERF2IP;POLR2I;POLR2F;TINF2;TERF2;POLR2H;POLR2E;POLR2J
prerank,negative regulation by host of viral process (GO:0044793),-0.2995179225583928,-0.7200586510729884,0.814595660749507,0.9544150705966374,1.0,7/10,50.37%,ZC3H12A;VAPA;CRP;CCL8;PTX3;PSMC3;LTF
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23505124462098081,0.720019517330129,0.8586762075134168,1.0,1.0,6/32,11.80%,STARD7;LPIN1;CHPT1;CSNK2A2;CHKB;ABHD3
prerank,visual perception (GO:0007601),0.19700751395860566,0.718966282204886,0.9329805996472663,1.0,1.0,19/84,22.27%,GPR143;EYA4;EML2;ARR3;PAX6;CHRNB2;ADGRV1;ZIC2;RABGGTB;CRYBB1;RPGR;GRM8;OPA3;CABP4;CNGB1;MYO9A;RDH12;BBS2;PITPNA
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.17063682989415985,-0.7187097770503298,0.9841688654353562,0.9554157711364446,1.0,41/128,27.86%,FBXL7;YWHAE;PPP1R12A;CDK14;DYNC1I2;CSNK1E;CCNY;TUBA1A;CEP76;DCTN3;ODF2;DYNLL1;CCP110;PRKAR2B;PAFAH1B1;PRKACA;LATS1;DYNC1H1;MASTL;LCMT1;AJUBA;CSNK1D;DCTN1;CEP41;CCNH;FBXL6;TUBA4A;CCNB2;CEP131;CDK5RAP2;CEP152;PLK3;KDM8;PPP2R2A;AKAP9;CDKN2B;ACTR1A;CUL1;FBXW11;CDK2;CNTRL
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23068604665575787,-0.7183597689358185,0.9128540305010894,0.9553503213480906,1.0,13/28,39.54%,TNFRSF21;CD86;GLMN;CEBPB;IL4I1;LGALS9;GPNMB;SDC4;VTCN1;ARG1;CRTAM;PDCD1LG2;CD80
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2875279527955077,-0.7183150904872735,0.8307086614173228,0.9549259086543626,1.0,3/13,17.15%,NECTIN2;STX7;PVR
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30854810856949233,-0.7171973593070764,0.812375249500998,0.9556524748472368,1.0,5/10,31.36%,NHP2;DKC1;NOP10;RPUSD3;TSR3
prerank,sphingolipid catabolic process (GO:0030149),0.2892350732089433,0.7171051015388199,0.8458498023715415,1.0,1.0,2/15,10.24%,SPHK1;SMPD2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.21407957357657303,-0.7170884149234191,0.9080962800875274,0.955297331075686,1.0,9/38,19.44%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,mRNA destabilization (GO:0061157),0.22791450490503135,0.7169825886093905,0.8781362007168458,1.0,1.0,12/38,26.13%,ROCK2;TRIM71;TUT4;POLR2D;GIGYF2;CPEB3;DCPS;YTHDF3;CELF1;YTHDF2;ZFP36;ZFP36L1
prerank,microtubule polymerization (GO:0046785),0.24566719249105834,0.7166139061092713,0.8247619047619048,1.0,1.0,5/28,9.75%,CLASP1;TUBGCP5;GOLGA2;TUBGCP4;TUBG1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.30905145726327277,0.716522046219305,0.8258317025440313,1.0,1.0,6/11,26.81%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.30905145726327277,0.716522046219305,0.8258317025440313,1.0,1.0,6/11,26.81%,INPP5J;SYNJ2;OCRL;INPP5K;SYNJ1;INPP5A
prerank,chromatin organization (GO:0006325),-0.1717260103231264,-0.7164046044233503,0.9842931937172775,0.9555806246404341,1.0,14/132,11.05%,MECOM;PRDM16;ESR1;BPTF;SMARCC1;BAZ2B;EZH1;ZBTB1;RBBP4;CHD1L;ARID1A;BRWD1;CHD1;PBRM1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.26605643742510304,0.716348615426906,0.8508604206500956,1.0,1.0,7/19,28.31%,CHUK;STAT1;TLR8;DDX3X;SETD2;TLR7;MAVS
prerank,peptidyl-glutamic acid modification (GO:0018200),0.25081952808136526,0.715991605975221,0.838150289017341,1.0,1.0,6/24,21.52%,TTLL6;AGBL4;GGCX;CFAP20;TTLL11;TTLL4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.24725374225502122,-0.7155206895746133,0.878,0.9560809916200698,1.0,4/21,16.39%,CNOT6L;CNOT11;PAN3;TNKS1BP1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2985951597655169,0.714979900050189,0.8329896907216495,1.0,1.0,3/12,18.35%,PPARA;MIA3;AKT1
prerank,glucan catabolic process (GO:0009251),0.275124281543645,0.7145794257953072,0.8143712574850299,1.0,1.0,4/15,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,sphingoid metabolic process (GO:0046519),-0.28697788940209995,-0.7145726861049165,0.8362068965517241,0.9566094185988042,1.0,6/12,22.64%,DEGS2;PLPP1;PLPP3;SGPP1;ASAH2;PLPP2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.30323033358130475,0.7144542928223181,0.8058252427184466,1.0,1.0,4/11,18.87%,KAT5;MUC1;HIPK2;TFAP4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.29238827619641883,0.7137739775306813,0.8262626262626263,1.0,1.0,1/12,0.53%,DAB2
prerank,protein acetylation (GO:0006473),-0.22822706740300241,-0.7136356563473212,0.8891304347826087,0.9571218160887907,1.0,3/30,4.55%,FOXO1;NAA16;KAT6A
prerank,response to hexose (GO:0009746),-0.23713020965945503,-0.7128832013745209,0.8859470468431772,0.9574036562583191,1.0,3/25,9.44%,THBS1;EIF2B2;PFKL
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2625529414399411,-0.7124119079241332,0.8471074380165289,0.9574298675872844,1.0,10/18,39.99%,APOE;AMER1;RNF128;MSN;FAF1;PTTG1IP;VPS35;DACT1;EZR;RDX
prerank,interstrand cross-link repair (GO:0036297),-0.19622424717670384,-0.7122576885573885,0.9565217391304348,0.9571202938805523,1.0,18/53,28.06%,RPA1;UBC;RPS27A;UBB;FANCB;FANCG;NEIL3;RPA2;RAD51AP2;XPA;CENPX;NUCKS1;XRCC3;USP1;RNF168;FANCL;RAD51AP1;VCP
prerank,protein import into mitochondrial matrix (GO:0030150),0.2711367107011149,0.7121391876134965,0.83640081799591,1.0,1.0,4/18,15.15%,TOMM40;TIMM17A;PAM16;TIMM21
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2274751606414715,-0.7115367717779809,0.8817427385892116,0.9574116267696291,1.0,11/28,31.06%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C;DMTN;CIB1;GDI1;ITGB1BP1
prerank,fatty acid transport (GO:0015908),0.27237215402524645,0.7114045741899133,0.8279352226720648,1.0,1.0,4/17,15.79%,ACSL1;SLC27A6;SLC27A4;GOT2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.30427414799472796,0.710669996332409,0.8149606299212598,1.0,1.0,10/10,69.59%,PRNP;PRKAR1A;SCRIB;CD274;RC3H1;BTN2A2;FOXP3;PDCD1LG2;CRTAM;LGALS9
prerank,negative regulation of cellular senescence (GO:2000773),0.2844567647097962,0.7101578955827936,0.8311195445920304,1.0,1.0,4/13,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,mitotic metaphase plate congression (GO:0007080),-0.19996709733475404,-0.7100985521686087,0.9438202247191011,0.9583945755566504,1.0,19/51,26.71%,CHMP2B;CHMP4B;CHMP4A;PIBF1;RMDN1;ZW10;CHMP1B;RAB11A;RRS1;KIFC1;CDC23;NUP62;CUL3;KIF22;KIF14;SPDL1;MIS12;CDCA8;CEP55
prerank,dendritic cell chemotaxis (GO:0002407),-0.27353014775054446,-0.7092337257751496,0.8350515463917526,0.9587784024136324,1.0,10/14,44.94%,HMGB1;CCR2;CXCR4;PIK3CG;CCL5;GPR183;CCR1;CCL19;CCR6;CXCR2
prerank,epithelial structure maintenance (GO:0010669),0.30075734846076935,0.7091081059881671,0.8394308943089431,1.0,1.0,1/11,3.10%,STRAP
prerank,outer dynein arm assembly (GO:0036158),0.28032400135643004,0.7089252570121709,0.87374749498998,1.0,1.0,5/14,26.85%,DNAL1;DNAAF5;DNAH5;DNAH17;ODAD4
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3072819343768781,-0.7080903734939002,0.8303030303030303,0.9594444016431837,1.0,4/10,21.33%,LYN;CD40;CD24;BTLA
prerank,respiratory electron transport chain (GO:0022904),0.28777365047155734,0.707562086379967,0.8229376257545271,1.0,1.0,6/14,23.32%,PPARGC1A;SLC25A12;SDHB;ETFDH;SLC25A13;SLC25A18
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2751741323067113,0.707292301889826,0.8472222222222222,1.0,1.0,3/15,8.55%,PPARA;PPM1K;SLC45A3
prerank,regulation of receptor recycling (GO:0001919),-0.26142535261338334,-0.7062594463971815,0.8752436647173489,0.9608333858828615,1.0,2/16,5.49%,ECE1;VAMP3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.24978414366060422,0.7061267955666479,0.8713768115942029,1.0,1.0,8/23,23.39%,PLK1;HTT;NDC80;MAD2L1;INSC;NDE1;CENPA;MISP
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2132278202874022,-0.7060686602615793,0.9206349206349206,0.9605533208845044,1.0,9/40,20.46%,DEFA6;GBP4;RPL39;DROSHA;MPEG1;RARRES2;ROMO1;PPP1R11;MYD88
prerank,negative regulation of developmental growth (GO:0048640),-0.22613940337108626,-0.7059784897276239,0.9055793991416309,0.9601784563914688,1.0,12/30,27.89%,FGF13;PTCH1;SEMA3G;MT3;RTN4;FGFR3;PTEN;ULK2;RTN4R;CDKN1B;ULK1;DCC
prerank,cell junction maintenance (GO:0034331),0.28691817202978703,0.7055363086557461,0.8295687885010267,1.0,1.0,1/14,2.86%,NLGN2
prerank,digestive tract morphogenesis (GO:0048546),0.2873229700627604,0.7050806839841687,0.8461538461538461,1.0,1.0,2/14,6.95%,PDGFRA;FGFR2
prerank,negative regulation of translational initiation (GO:0045947),-0.2732512057013792,-0.7048524782651179,0.8580375782881002,0.9608498730144962,1.0,4/13,15.68%,EIF3E;AGO2;TPR;FMR1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.17424080776415213,-0.7045761301381372,0.9828431372549019,0.960658406877075,1.0,27/94,24.33%,YWHAE;DYNC1I2;CSNK1E;TUBA1A;CEP76;TCTN3;DCTN3;ODF2;DYNLL1;CCP110;TMEM216;PRKAR2B;PAFAH1B1;KIF24;NPHP1;PRKACA;DYNC1H1;RAB11A;CEP97;CSNK1D;DCTN1;B9D2;CEP41;TUBA4A;CEP131;CDK5RAP2;CEP152
prerank,lytic vacuole organization (GO:0080171),0.22723257629225516,0.7038911539236969,0.8911819887429644,1.0,1.0,10/32,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2350036135162371,0.7036395336649292,0.8839458413926499,1.0,1.0,9/29,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,RNA destabilization (GO:0050779),0.2640626297147084,0.7035754524968578,0.8369351669941061,1.0,1.0,1/18,0.78%,ROCK2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2572515770526441,-0.7029664425174283,0.867816091954023,0.9617789457766133,1.0,7/15,28.88%,SEC61A1;SRP14;RAB3GAP2;SRPRA;ZFAND2B;EDEM1;ZFAND2A
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2244994826229053,-0.7026881385933416,0.9008264462809917,0.9615816675757626,1.0,10/31,24.93%,OTUD7B;USP7;SPATA2;BABAM2;USP50;PSMD14;CYLD;ATXN3;OTUB2;SHMT2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.23266038602273229,-0.7019200049053692,0.8886597938144329,0.9618433932381839,1.0,9/26,22.08%,STAT3;AIM2;LYN;GRIN2B;USP50;GRIN1;PSENEN;PSME1;FYN
prerank,DNA biosynthetic process (GO:0071897),0.27405618751130134,0.7016125389691099,0.8610567514677103,1.0,1.0,4/16,15.49%,POLD2;TERT;POLE;SIRT1
prerank,cellular response to interferon-beta (GO:0035458),0.28218550575045265,0.7005118978883353,0.8666666666666667,1.0,1.0,3/14,14.97%,HTRA2;STAT1;NDUFA13
prerank,negative regulation of B cell activation (GO:0050869),-0.2415132276105944,-0.7004188508771524,0.8813905930470347,0.9628336791169047,1.0,9/21,33.08%,LYN;TNFRSF21;ID2;FCGR2B;PARP3;FOXJ1;SAMSN1;LAPTM5;TYROBP
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.25783886980091086,0.6997410159988418,0.8718446601941747,1.0,1.0,6/19,20.23%,MOSPD2;C1QBP;CAMK1D;RIPOR2;TIRAP;DNM1L
prerank,telomere capping (GO:0016233),0.27236467730928304,0.699548287164239,0.862708719851577,1.0,1.0,3/16,14.47%,TFIP11;MRE11;PRKDC
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.25057145158242045,-0.6993097119933396,0.8638297872340426,0.9634716895528386,1.0,10/18,40.86%,ANXA1;FAM107A;UBE2L3;ZFP36L2;SSTR2;AQP1;KLF9;PCK2;ISL1;BCL2L11
prerank,cellular polysaccharide catabolic process (GO:0044247),0.265075624687916,0.6990733841710739,0.8464566929133859,1.0,1.0,4/16,13.55%,PHKG2;PHKB;PYGL;PYGM
prerank,detection of calcium ion (GO:0005513),-0.2714844314689868,-0.6985757420128655,0.8461538461538461,0.9636915245661295,1.0,8/13,36.66%,KCNMB2;CALM3;STIM1;CALM1;KCNMB4;KCNIP2;CALM2;KCNMB1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.20142234717753277,-0.6985458189687821,0.9407894736842105,0.9632522361310099,1.0,7/46,14.60%,PLA2G4A;DGKH;DGKZ;AGPAT1;ABHD4;ABHD8;AGPAT5
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.23665999627919193,-0.6981081958130592,0.9087048832271762,0.9632348229240231,1.0,8/24,24.86%,ABCG2;NFE2L1;RSAD1;UROS;HMBS;COX15;FXN;FECH
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3093845661289982,0.6979542363750392,0.8372093023255814,1.0,1.0,4/10,17.34%,MTHFS;MTHFD1;MTHFR;MTHFD2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.2932931507168709,0.6970412165665243,0.814968814968815,1.0,1.0,7/11,26.59%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.2932931507168709,0.6970412165665243,0.814968814968815,1.0,1.0,7/11,26.59%,TNRC6A;TRIM71;AGO3;EIF6;TNRC6C;ZFP36;RBM4
prerank,histone H4-K16 acetylation (GO:0043984),0.2560051460238242,0.696170676202703,0.8738229755178908,1.0,1.0,3/19,6.62%,KANSL2;KMT2A;MEAF6
prerank,tRNA wobble base modification (GO:0002097),0.28371987239302565,0.6961034385767569,0.8422090729783037,1.0,1.0,2/14,5.85%,TRMT9B;GTPBP3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.28667599485851647,0.6957900503809169,0.8382066276803118,1.0,1.0,2/13,9.11%,KRI1;NOP9
prerank,mRNA methylation (GO:0080009),0.2729760162473835,0.6957312082064285,0.8599605522682445,1.0,1.0,6/15,23.41%,NSUN2;TRMT6;TRMT61B;TRMT10C;ZC3H13;METTL8
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.2856053169934015,-0.6941050103655585,0.8366533864541833,0.966433237850141,1.0,7/11,29.66%,NOVA2;ZNF445;PCBP2;PCBP1;RASA1;IGF2BP2;IGF2BP1
prerank,macrophage chemotaxis (GO:0048246),-0.2945001566757489,-0.6940188319791581,0.8478260869565217,0.9660405161954597,1.0,6/10,50.19%,TAFA4;CXCL17;CCL5;CCL3;LGALS3;CKLF
prerank,tRNA 5'-end processing (GO:0099116),0.26803812486507894,0.6929781009241626,0.8353174603174603,1.0,1.0,4/15,21.60%,POP4;RPP25L;TRMT10C;RPP30
prerank,cell cycle G1/S phase transition (GO:0044843),0.19893387903664095,0.6915666286460026,0.9439579684763573,1.0,1.0,7/61,8.86%,CDKN2A;PHF8;TRIM71;E2F1;USP26;HINFP;MAX
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2475873327653905,-0.6912043943487769,0.8877338877338877,0.9681903502407754,1.0,7/18,30.64%,DAB2IP;AMER1;MSN;FAF1;RIC1;PTTG1IP;VPS35
prerank,detection of visible light (GO:0009584),0.26721482715661504,0.6909975352844884,0.8406374501992032,1.0,1.0,1/16,2.38%,ABCA4
prerank,protein prenylation (GO:0018342),-0.29304458010595624,-0.6906623808188935,0.8495049504950495,0.9682018426101132,1.0,4/10,24.70%,PTAR1;RCE1;CHM;CHML
prerank,regulation of myoblast fusion (GO:1901739),0.29195188697779956,0.6902374219215304,0.8235294117647058,1.0,1.0,3/11,17.73%,CFLAR;MAPK14;RIPOR2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.27490013401833613,0.6899010550438333,0.8127490039840638,1.0,1.0,4/14,18.35%,SLC45A3;PPARGC1A;SIRT1;AKT1
prerank,neuropeptide signaling pathway (GO:0007218),0.2020238638331403,0.6896166608802292,0.9371816638370118,1.0,1.0,10/58,17.17%,OPRD1;GLRA1;NTS;NMUR1;LTB4R2;GPR37;GRP;OPRM1;PENK;GPR149
prerank,negative regulation of phagocytosis (GO:0050765),0.26156705096290156,0.6894989798977414,0.8802395209580839,1.0,1.0,1/17,0.56%,SYT11
prerank,midbody abscission (GO:0061952),-0.25584066625308355,-0.6892541852052287,0.8954918032786885,0.9689695968358434,1.0,3/17,6.92%,CHMP2B;CHMP4B;CHMP4A
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2459305206596662,-0.6890225602896999,0.86875,0.968721584542128,1.0,3/18,13.63%,CD34;HDAC7;PTPRC
prerank,regulation of cilium movement (GO:0003352),-0.29488269637866743,-0.6889315950945427,0.8628230616302187,0.9683348280073126,1.0,5/10,34.92%,DNAH11;CFAP43;ODAD2;CFAP206;CCDC40
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.30366888130367264,0.686530730243662,0.8256513026052105,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.30366888130367264,0.686530730243662,0.8256513026052105,1.0,1.0,3/10,12.34%,SMPD3;SMPD2;SPHK2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.2279845252109412,0.6860421969732087,0.9156862745098039,1.0,1.0,7/32,16.86%,PLK1;ABRAXAS1;RINT1;MRE11;CDC14B;ATM;CLSPN
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.22607877999134207,-0.685569913903391,0.9105058365758755,0.9708571467090682,1.0,7/24,22.73%,MFF;CEMIP;AKT2;KCNB1;MIEF1;FYN;MYO1C
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.2721115143151769,-0.6841570337126942,0.8464912280701754,0.9715909297964754,1.0,1/12,2.11%,INSR
prerank,negative regulation of histone acetylation (GO:0035067),0.2854939858530595,0.6835283949968656,0.8113207547169812,1.0,1.0,3/11,19.24%,NOC2L;SIRT1;SIN3A
prerank,water transport (GO:0006833),-0.2773959116076417,-0.6828644627802062,0.8903508771929824,0.9722506364440947,1.0,2/12,16.14%,AQP11;CFTR
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.21442565068806066,0.6828078118258006,0.9217391304347826,1.0,1.0,12/42,19.41%,HARS2;TARS2;RARS2;EPRS1;QARS1;DARS2;TARS1;PPA1;IARS2;FARSA;IARS1;YARS1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.21287399634159507,-0.6827525722357166,0.9401709401709402,0.9718616979258144,1.0,12/33,25.28%,PIK3R1;PIK3C2A;PIK3CA;EDN1;PIK3CD;HTR2A;IRS1;PTEN;NYAP1;IGF1R;PIK3C2B;PIK3CG
prerank,actin crosslink formation (GO:0051764),-0.2737980423249925,-0.6822141279401948,0.8775510204081632,0.9718530451654201,1.0,3/12,13.49%,FLNA;EPS8;GAS2L1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.1888095076614282,-0.6818749255110264,0.9551569506726457,0.9716710213128105,1.0,21/57,32.03%,DCN;TNFSF10;KDR;MFF;HIP1R;BBC3;PLAUR;BAK1;GPER1;MIEF1;BIK;CAMKK2;BOK;MUL1;TREM2;HRK;PARK7;PMAIP1;VPS35;BMF;AURKA
prerank,regulation of stem cell population maintenance (GO:2000036),-0.24152858562360502,-0.6817669624081971,0.8815261044176707,0.9712969618016623,1.0,1/18,1.04%,PTN
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.22952718611774187,-0.6815864283676397,0.8945233265720081,0.9709787648609489,1.0,6/24,19.31%,TGFB2;FOXO3;CDK5;FBXW7;ATF4;MCL1
prerank,tyrosine metabolic process (GO:0006570),-0.2856129115072401,-0.6815736591239749,0.8426294820717132,0.9705182274821017,1.0,3/11,29.98%,FAH;HGD;IL4I1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.27882332063333015,0.680766361048677,0.8524271844660194,1.0,1.0,2/12,13.62%,CYP26B1;CTBP2
prerank,organelle disassembly (GO:1903008),0.22379854775996125,0.6804519124857813,0.9101338432122371,1.0,1.0,9/33,22.86%,PLK5;RETREG1;GOLGA2;ATG2B;MRRF;GBF1;KLC1;EIF2D;DENR
prerank,regulation of protein export from nucleus (GO:0046825),0.23580918524889072,0.6802852027416799,0.9122137404580153,1.0,1.0,7/23,19.17%,IFI27;CAMK1;RAPGEF3;PTPN14;RANGAP1;TCF7L2;UHMK1
prerank,oxoacid metabolic process (GO:0043436),0.2300423282757451,0.6801116566019507,0.904296875,1.0,1.0,6/27,18.85%,DDO;ABHD14B;PPA1;MINPP1;TPST1;LIPT1
prerank,cellular senescence (GO:0090398),0.2360914867353911,0.6790697051026449,0.9064220183486239,1.0,1.0,2/27,1.98%,MAGEA2;CDKN2A
prerank,sensory perception of smell (GO:0007608),0.2909866934471505,0.6785246401870831,0.856,1.0,1.0,11/11,70.92%,SYT10;SLC24A4;UBR3;MKKS;GFY;OBP2B;OMP;BEST2;BBS4;ADCY3;DRD2
prerank,skeletal muscle contraction (GO:0003009),0.24928747004722343,0.6784431923407528,0.8843813387423936,1.0,1.0,5/19,22.87%,TNNI1;MYH14;STAC3;TNNC1;TNNI3
prerank,transition metal ion homeostasis (GO:0055076),0.2279019660008339,0.6783122500728288,0.8976234003656307,1.0,1.0,4/28,10.12%,HEPHL1;PICALM;CP;CUTC
prerank,glucan biosynthetic process (GO:0009250),0.28264741111303526,0.6781312390087529,0.873767258382643,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,glycogen biosynthetic process (GO:0005978),0.28264741111303526,0.6781312390087529,0.873767258382643,1.0,1.0,3/12,15.02%,PGM1;GYG1;PER2
prerank,protein mannosylation (GO:0035268),0.24298138271745984,0.6768998338519057,0.8984962406015038,1.0,1.0,9/22,22.13%,TMTC4;LARGE1;FKTN;DPM1;DPY19L1;CRPPA;POMT1;DPM2;FKRP
prerank,cellular response to gamma radiation (GO:0071480),-0.2482057106535438,-0.6766627415042552,0.901010101010101,0.9741917071135849,1.0,2/17,6.25%,MAP3K20;XRCC5
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.28075093063625123,-0.6761870004047895,0.8905660377358491,0.974143586761232,1.0,3/11,13.63%,CEACAM1;AHR;PTPRC
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.29082920993226474,0.6760582205198085,0.835030549898167,1.0,1.0,5/10,26.12%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.24528808248598544,0.6756279868296082,0.896421845574388,1.0,1.0,3/21,11.97%,IGF1;CTSH;SOX9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.28171555504246715,-0.675619579217512,0.8798283261802575,0.9741502980031224,1.0,5/11,23.65%,UQCR11;UQCRFS1;UQCRB;UQCR10;UQCRC1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.22908701156039335,-0.6755057519486247,0.906832298136646,0.973770040917198,1.0,8/22,34.02%,ESR1;PSMC4;MED14;MED13;MED24;MED30;PAXIP1;TP53
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.20289365055843897,-0.6751908242884996,0.9356321839080459,0.9735579962587108,1.0,9/40,23.85%,MMS22L;TIPIN;BLM;TIMELESS;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.24295867874556681,-0.6747849232177142,0.9200863930885529,0.9734203129031892,1.0,6/19,22.07%,HIPK1;DDIT4;DYRK2;TMEM109;BCL3;SNW1
prerank,superoxide anion generation (GO:0042554),0.2772215588416148,0.6747688145641323,0.8813905930470347,1.0,1.0,3/13,18.78%,NOX1;CYBA;NCF1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.21013456074545367,-0.6746956908623503,0.9464285714285714,0.9730330583453134,1.0,11/33,25.70%,POLR3F;TRIM56;ISG15;IFIH1;POLR3B;IRF5;POLR3A;POLR3D;RIPK2;PTPN11;TLR4
prerank,negative regulation of bone mineralization (GO:0030502),0.2749426909861254,0.6742378037681404,0.8721374045801527,1.0,1.0,1/13,1.65%,RFLNA
prerank,Rac protein signal transduction (GO:0016601),0.2581455266340131,0.6742325678375498,0.900952380952381,1.0,1.0,3/18,11.96%,HACD3;WASF1;CYFIP1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.23190908741672075,0.6739955818181644,0.9103585657370518,1.0,1.0,5/26,11.96%,ITPR1;ITPR2;RYR2;TRPM2;CHERP
prerank,positive regulation of telomere maintenance (GO:0032206),0.22105066064928464,0.6739944755529663,0.9228007181328546,1.0,1.0,6/31,12.11%,ERCC1;HNRNPA2B1;TNKS2;MRE11;RTEL1;PML
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.23059029763698127,-0.6738234609871949,0.925764192139738,0.9732923005142454,1.0,11/22,31.06%,MDFIC;APOD;INSIG1;SP100;BARD1;CABP1;DMTN;LMAN1;PARK7;GDI1;ITGB1BP1
prerank,transport along microtubule (GO:0010970),0.2757571113027487,0.6734337805299148,0.8725490196078431,1.0,1.0,5/13,17.64%,CLIP3;COPG1;COPG2;SPG11;BORCS5
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.19474370475005257,0.6732426606395544,0.9539823008849557,1.0,1.0,8/62,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.277108894875363,0.673200640685562,0.8716904276985743,1.0,1.0,4/12,20.72%,NDC80;CENPC;BOD1;NUF2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.17313109914872946,-0.6729583785662903,0.9859484777517564,0.973553114193904,1.0,18/87,19.94%,SDHAF2;TIMMDC1;NUBPL;NDUFA10;NDUFA8;TMEM126A;NDUFS6;IMMP2L;NDUFA7;SDHAF4;NDUFA5;NDUFAF6;SCO1;UQCRFS1;NDUFA1;NDUFS7;NDUFS8;NDUFAF8
prerank,protein O-linked mannosylation (GO:0035269),0.25407650215298483,0.6726894060108856,0.8515625,1.0,1.0,8/18,22.13%,TMTC4;LARGE1;FKTN;DPM1;CRPPA;POMT1;DPM2;FKRP
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2528164171084163,0.6720388835453769,0.8659574468085106,1.0,1.0,6/18,18.92%,PTBP2;PTBP1;TERT;NCOR2;PTBP3;NCOR1
prerank,telomere maintenance via telomerase (GO:0007004),-0.21984932703872828,-0.6719490147419435,0.9365750528541226,0.9739155985756816,1.0,10/28,27.23%,RPA1;PTGES3;TERF2IP;TNKS1BP1;NHP2;DKC1;TINF2;TERF2;NOP10;CDK2
prerank,negative regulation of catalytic activity (GO:0043086),0.2376935398042832,0.6711590043186507,0.8822393822393823,1.0,1.0,4/24,10.27%,APBA3;CCAR2;IFIT1;NES
prerank,C4-dicarboxylate transport (GO:0015740),-0.26184545131166886,-0.6699116524065261,0.9032258064516129,0.9750939274089077,1.0,1/14,0.97%,LRRC8D
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19610970370372588,-0.6697974376777959,0.9473684210526315,0.9747140721204067,1.0,7/40,15.83%,PID1;BCL2L1;UBB;SOD1;AKT2;BAK1;SLC25A36
prerank,negative regulation of defense response to virus (GO:0050687),-0.2817559917130255,-0.6694176878325981,0.8687872763419483,0.9745556991902599,1.0,5/10,24.48%,TRAF3IP1;PCBP2;TSPAN6;TARBP2;MUL1
prerank,positive regulation of rRNA processing (GO:2000234),0.2934451216886985,0.6689616951743294,0.849609375,1.0,1.0,4/10,21.98%,RIOK2;WDR75;UTP15;WDR43
prerank,organelle transport along microtubule (GO:0072384),0.22688038141550987,0.6683681222006091,0.9222011385199241,1.0,1.0,6/31,13.42%,TRAK1;HTT;BICD1;COPG1;COPG2;RAB1A
prerank,negative regulation of cell division (GO:0051782),-0.2776490226299233,-0.6666910042146791,0.8929292929292929,0.9762454980004968,1.0,5/11,31.46%,TXNIP;BLM;E2F7;SUSD2;MYC
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22144628939538652,0.6649206165476936,0.9260700389105059,1.0,1.0,9/31,23.18%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;EDC4;CNOT8;DCPS;DCP2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.25579735286634486,0.6648994739847267,0.902,1.0,1.0,4/15,18.52%,RUVBL2;CCT3;CCT5;CCT8
prerank,phosphate ion transport (GO:0006817),0.2580872834759856,0.6643290634216004,0.8919449901768173,1.0,1.0,2/16,9.13%,SLC25A11;SLC34A3
prerank,nuclear membrane organization (GO:0071763),0.24918047901330692,0.6639741680075714,0.9034749034749034,1.0,1.0,7/19,24.38%,PLK1;TOR1B;TMEM43;AKAP8L;CHMP7;SPAST;TOR1AIP1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.28263642779681813,-0.6634219942409443,0.8682634730538922,0.978288940419615,1.0,6/10,43.07%,EFHB;STIM1;CASQ1;CD84;GRAMD2A;HOMER2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.26836288538950487,-0.6633143350541147,0.8780487804878049,0.9779004177785455,1.0,6/12,34.82%,SLC37A3;SLC25A14;SLC20A1;SLC37A4;XPR1;SLC20A2
prerank,neuron fate commitment (GO:0048663),0.2651873545589235,0.6626532664186281,0.9015748031496063,1.0,1.0,2/14,10.07%,PAX6;TGFBR1
prerank,maturation of SSU-rRNA (GO:0030490),-0.204362665078308,-0.6625377515651301,0.9549356223175965,0.9780425373180356,1.0,15/34,33.66%,RPS16;RPS8;RPS28;BMS1;DCAF13;PWP2;RPS19;WDR46;RIOK1;HELB;DHX37;TSR3;TSR1;NOP14;HEATR1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.26225408484102325,-0.6624647816207334,0.8941908713692946,0.9776309351422826,1.0,6/13,29.82%,PERP;TBC1D10A;BAK1;RIPK2;CASP8;FADD
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.22554770067972482,0.6622659546172529,0.9080234833659491,1.0,1.0,4/29,15.41%,FANCD2;MEIOB;BAG6;SYCE2
prerank,protein lipidation (GO:0006497),0.1948137539375348,0.6615192160107488,0.9553072625698324,1.0,1.0,16/59,19.92%,ZDHHC12;ZDHHC1;ZDHHC16;PIGH;PIGG;ZDHHC6;ZDHHC3;DPM1;PGAP4;ZDHHC21;GLUL;PGAP2;ZDHHC23;WDR45;PIGO;DPM2
prerank,regulation of actin nucleation (GO:0051125),-0.2712742625501208,-0.6602632985692892,0.8868686868686869,0.9788470694523602,1.0,2/12,10.16%,GSN;WHAMM
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.21875867141864225,0.6602503195211978,0.9191176470588235,1.0,1.0,5/31,11.83%,CDKN2A;DLG1;PRMT2;BRD7;CDC73
prerank,positive regulation of stem cell proliferation (GO:2000648),0.25107860194725934,0.6600167179916389,0.8961538461538462,1.0,1.0,5/17,19.54%,HNRNPU;CITED1;TERT;KDM1A;LTBP3
prerank,defense response to protozoan (GO:0042832),-0.2691971786965479,-0.6596241137322649,0.8974358974358975,0.9788369850890287,1.0,7/12,39.65%,GBP4;CD40;MYD88;BATF2;LYST;PF4;GBP7
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.23028033762267922,-0.6595213261307112,0.9186991869918699,0.9784394736425057,1.0,2/20,4.59%,BCL2L1;FAS
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2525674385227992,0.6589490104016726,0.8893203883495145,1.0,1.0,6/16,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2522748251178477,-0.6579450078473918,0.8841698841698842,0.9791069823343632,1.0,5/16,19.46%,CD24;PGAM1;SRPX2;BARD1;TIGAR
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.2682831611303183,0.6569387137871251,0.8695652173913043,1.0,1.0,4/12,18.92%,ELAVL1;TERT;NCOR2;NCOR1
prerank,chromatin assembly or disassembly (GO:0006333),-0.27275512715558187,-0.6568777046474189,0.9036608863198459,0.9794211523881751,1.0,2/11,19.36%,RBBP4;CHAF1A
prerank,positive regulation of cytokinesis (GO:0032467),-0.206508430852735,-0.6559858115840077,0.9535864978902954,0.9795723151341597,1.0,14/32,32.98%,RHOA;SVIL;CIT;KIF23;KIF20B;CDC42;GIPC1;CUL3;PRKCE;KIF14;DRD2;CSPP1;CDC6;OPN1MW
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23951898420393333,0.6549312884735481,0.8903846153846153,1.0,1.0,4/19,13.37%,POLD2;DCK;AMPD3;TERT
prerank,negative regulation of secretion (GO:0051048),-0.27671241034186134,-0.654913800083666,0.8806262230919765,0.9798727118495828,1.0,4/10,23.11%,VAMP3;CD74;PTGER3;EGF
prerank,serine family amino acid catabolic process (GO:0009071),-0.27673302698913693,-0.6538691295695396,0.8819875776397516,0.9801601789946807,1.0,7/10,39.67%,THNSL2;SHMT2;CBS;DLD;SHMT1;DAO;AMT
prerank,modulation by host of viral genome replication (GO:0044827),-0.2601219740517875,-0.6528314049087713,0.911340206185567,0.9803763646091417,1.0,6/13,25.25%,FMR1;ZC3H12A;PPIB;NUCKS1;TBC1D20;VAPA
prerank,secretory granule organization (GO:0033363),-0.277888893359537,-0.652614190146505,0.8846153846153846,0.980058839829305,1.0,1/10,3.15%,ABCA1
prerank,nuclear pore organization (GO:0006999),-0.24862340880070022,-0.6524556111706755,0.9026369168356998,0.9796977311719954,1.0,3/14,16.45%,NUP107;TPR;RTN4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.22651354683002628,0.6521411696547191,0.9365079365079365,1.0,1.0,4/25,13.27%,PICALM;DLG4;MTMR2;ABCA2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.20554690840552714,0.6518175934118403,0.923217550274223,1.0,1.0,11/40,20.76%,IGF1;PPIF;PDCD5;MLLT11;CLU;HGF;NOL3;AKT1;PYCARD;DNM1L;BAX
prerank,protein K48-linked deubiquitination (GO:0071108),-0.21923232771224024,-0.6506558536438324,0.9230769230769231,0.9804209857721702,1.0,7/23,26.65%,OTUD7B;MINDY1;MINDY2;USP50;ATXN3;OTUB2;OTUB1
prerank,cell cycle G2/M phase transition (GO:0044839),0.1664407193798959,0.6504157821060318,0.9983974358974359,1.0,1.0,28/129,19.57%,USH1C;OPTN;FBXL12;PLK1;CEP78;CLASP1;CDC25C;CEP290;TUBG1;PLCB1;NES;PCM1;CHEK2;PPP1CB;SFI1;TUBB4A;ENSA;AKAP8;MAPRE1;NINL;NEDD1;CETN2;AKAP8L;PKMYT1;FBXL22;HSP90AA1;WEE1;NDE1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.18748917103054172,0.6501547200101931,0.9680284191829485,1.0,1.0,8/64,11.83%,CTR9;CCNT2;TCEA1;PCID2;LEO1;EAF2;MLLT1;CDC73
prerank,telomere maintenance via recombination (GO:0000722),0.2772572167080833,0.6494907132599681,0.879182156133829,1.0,1.0,2/11,14.01%,ERCC1;RAD51D
prerank,negative regulation of cell aging (GO:0090344),0.24548089008312646,0.6493249750697411,0.9025735294117647,1.0,1.0,4/16,15.49%,SLC30A10;ZKSCAN3;TERT;SIRT1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.27782340266447153,-0.6492971802120385,0.8856548856548857,0.9808504534081558,1.0,2/10,12.49%,SLC1A3;SLC1A1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.22165488162999736,-0.6489242025477917,0.9491869918699187,0.9806575747819302,1.0,8/22,27.87%,DHX33;EIF2AK3;ATF4;UBTF;SMARCA4;NCL;RASL11A;LYAR
prerank,protein localization to kinetochore (GO:0034501),-0.25281524505498393,-0.6481394918674814,0.9040816326530612,0.9807012955211194,1.0,9/14,43.44%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;RCC2;MTBP
prerank,T cell activation (GO:0042110),0.1869498821379735,0.6475319999012464,0.9577702702702703,1.0,1.0,5/69,7.71%,LEPR;KIT;LMBR1L;NLRC3;KIF13B
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2630957284581746,-0.6471416491680775,0.907070707070707,0.980882318652946,1.0,7/12,33.04%,IDH3B;GLUD1;ASS1;IDH3G;SIRT4;ACLY;IDH1
prerank,mitotic recombination (GO:0006312),0.25411293684338154,0.6470096956518275,0.8880597014925373,1.0,1.0,4/15,17.54%,ERCC1;MSH3;RAD51D;RAD52
prerank,positive regulation of dendritic spine development (GO:0060999),0.2398950553973853,0.6465433916606591,0.9115913555992141,1.0,1.0,7/20,22.39%,CAMK1;LLPH;SHANK1;CAPRIN2;CPEB3;DLG5;DBNL
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.24571297982959736,0.6464329109310628,0.898635477582846,1.0,1.0,5/18,18.35%,HTRA2;TRAP1;SIRT1;NOL3;AKT1
prerank,reticulophagy (GO:0061709),0.2682276969005611,0.6460978197082694,0.8728323699421965,1.0,1.0,2/12,11.80%,RETREG1;ATG2B
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2112883633095638,0.6444350539030589,0.9425087108013938,1.0,1.0,2/36,2.64%,HSPA1A;CPNE1
prerank,positive regulation of DNA binding (GO:0043388),0.2154643596245684,0.644307386186558,0.9563492063492064,1.0,1.0,1/31,0.69%,IGF1
prerank,rRNA modification (GO:0000154),-0.22267487356976284,-0.6428013027227586,0.9383983572895277,0.9831727058852124,1.0,8/21,31.36%,THUMPD1;DIMT1;TRMT112;NSUN4;NHP2;DKC1;NOP10;TSR3
prerank,glutathione metabolic process (GO:0006749),0.20042086915316107,0.6425726676124999,0.9718574108818011,1.0,1.0,9/38,18.30%,ETHE1;GSTM2;CNDP2;GGT5;GSTM1;OPLAH;GSTA3;GSTZ1;MGST2
prerank,mitochondrial transcription (GO:0006390),-0.2709706528059313,-0.642540935644113,0.9059304703476483,0.982873634236143,1.0,2/10,14.71%,FOXO3;MRPL12
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.2648952997478816,-0.6414936218181493,0.905811623246493,0.9830539675136438,1.0,2/11,15.85%,RACK1;ATF4
prerank,glycolipid biosynthetic process (GO:0009247),0.20499768070988658,0.6404986983539105,0.9498269896193772,1.0,1.0,10/38,19.92%,ST3GAL5;LARGE1;PIGH;PIGG;DPM1;SCCPDH;PGAP4;PGAP2;PIGO;DPM2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.2705180299166011,0.6393135964930977,0.8868686868686869,1.0,1.0,1/12,2.11%,SLC5A3
prerank,aminoglycan metabolic process (GO:0006022),-0.2716163871419005,-0.6391297359950039,0.9211045364891519,0.9840871591992685,1.0,3/10,16.87%,XYLT1;B3GAT1;B3GAT3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.20019820951136627,0.638784707588026,0.9464627151051626,1.0,1.0,7/41,13.10%,GPRC5B;ADRA2A;NTRK2;DLG4;EPHA4;BDNF;HBEGF
prerank,purine-containing compound salvage (GO:0043101),-0.2616763892421875,-0.6384157472802617,0.907070707070707,0.9840986143878604,1.0,6/12,29.26%,GMPR;HPRT1;DGUOK;AMPD2;ADA;ADK
prerank,Golgi to lysosome transport (GO:0090160),0.2640552592839913,0.63837236625753,0.8869731800766284,1.0,1.0,1/11,2.01%,CCDC91
prerank,GPI anchor biosynthetic process (GO:0006506),0.2100830392785322,0.6376222196465938,0.9230769230769231,1.0,1.0,12/30,28.71%,PIGH;PIGG;DPM1;PGAP4;PGAP2;PIGO;DPM2;PIGS;PIGB;MPPE1;PGAP3;PIGW
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.24837618080662155,-0.6371427720079172,0.9255533199195171,0.9844042992126458,1.0,4/14,23.73%,ME1;NME2;AK4;NMNAT1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.24831811110564767,0.6369469479528516,0.8876190476190476,1.0,1.0,1/15,3.39%,DAGLA
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2569834945076621,0.6367665731781661,0.8913480885311871,1.0,1.0,9/15,29.58%,TNRC6A;TENT4A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,negative regulation of immune system process (GO:0002683),0.24475703682398967,0.6364886039218246,0.9171483622350675,1.0,1.0,4/16,17.41%,IL17D;HOXA7;SOX9;COL3A1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.27922896764831817,0.6352125363353548,0.8864541832669323,1.0,1.0,3/10,14.31%,GALNT3;GALNT2;GALNT1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.22077270018647074,0.6347631040983667,0.9254302103250478,1.0,1.0,3/26,7.55%,TCTA;HOXA7;INHA
prerank,protein localization to condensed chromosome (GO:1903083),-0.25875204235646904,-0.6341470984861952,0.898406374501992,0.9857360594778533,1.0,8/12,43.44%,ZWILCH;ZW10;SPDL1;MIS12;CDK1;KNL1;AURKB;MTBP
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2013372552523477,0.6341355179825586,0.9464944649446494,1.0,1.0,4/38,8.72%,MAGI2;PPARA;PIK3CB;DRD3
prerank,regulation of DNA recombination (GO:0000018),0.2086108638113703,0.6339979893242811,0.9364485981308411,1.0,1.0,8/32,18.36%,MSH6;MRE11;RTEL1;MSH3;ALYREF;KDM1A;FIGNL1;THOC1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.2593741401095911,-0.6337885220122756,0.9175257731958762,0.9854682903779087,1.0,5/11,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,negative regulation of endopeptidase activity (GO:0010951),0.19554385494007395,0.6336813829268608,0.9616087751371115,1.0,1.0,7/47,14.45%,TIMP3;SERPINA10;PCID2;SERPIND1;HRG;SERPINA9;SERPINE3
prerank,lysosome organization (GO:0007040),0.20237576813123545,0.6335188338180054,0.963531669865643,1.0,1.0,10/36,22.72%,ZKSCAN3;SNAPIN;LRRK2;CLN5;HPS1;HOOK1;HPS4;GNPTAB;LAMTOR1;HOOK2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.23958402358440184,-0.6331476986186951,0.9186507936507936,0.9853942677489435,1.0,3/14,23.95%,JAK1;SOCS3;SOCS1
prerank,membrane fusion (GO:0061025),0.2059185360217507,0.6330018598967366,0.9300184162062615,1.0,1.0,5/33,9.01%,SNAP29;MYOF;NAPA;RIMS1;NSF
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.2615529125631858,-0.6327867154361879,0.9109730848861284,0.9851478057949531,1.0,7/11,49.03%,MALT1;NFKBID;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,histone H4-K5 acetylation (GO:0043981),-0.24059994085531744,-0.6325475075328196,0.9230769230769231,0.9843580000975841,1.0,6/15,26.31%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),-0.24059994085531744,-0.6325475075328196,0.9230769230769231,0.9843580000975841,1.0,6/15,26.31%,KAT7;JADE2;PHF20;ING4;JADE1;KANSL3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.246152668538212,0.6310970706900065,0.9155722326454033,1.0,1.0,4/16,16.77%,RECQL4;SSBP1;MCM7;MCMDC2
prerank,anterior/posterior axis specification (GO:0009948),0.25417265997414706,0.6300126146188315,0.9145129224652088,1.0,1.0,1/15,1.66%,WLS
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.240650985168206,0.629713374810772,0.9313725490196079,1.0,1.0,6/17,27.46%,KLRD1;SLAMF6;IL12A;LAMP1;CD226;AP1G1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.23984399212458352,-0.6295186546456222,0.9319727891156463,0.9855995772762634,1.0,3/15,11.93%,PLCG2;PAF1;PHB2
prerank,amyloid-beta metabolic process (GO:0050435),-0.23081117932414136,-0.6295032583097073,0.9005964214711729,0.9851479360009031,1.0,4/16,23.99%,DYRK1A;PSEN2;PSENEN;MGAT3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.26214689265536745,0.6285454285985707,0.902542372881356,1.0,1.0,13/13,73.81%,HNRNPU;SUPT4H1;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.24144846498889638,-0.6280483180462337,0.9274193548387096,0.9854947039961901,1.0,9/14,36.68%,ACOX1;ECI2;ACOX3;SCP2;DECR2;ACOX2;CRAT;ACOXL;ACOT8
prerank,regulation of rRNA processing (GO:2000232),0.24438240075572146,0.6278360606049276,0.9126984126984127,1.0,1.0,6/16,24.44%,RIOK2;WDR75;METTL18;UTP15;WDR43;YTHDF2
prerank,Golgi localization (GO:0051645),0.2689362838565579,0.627708524773901,0.906832298136646,1.0,1.0,3/11,12.65%,TBCCD1;COPG1;STK25
prerank,negative regulation of viral genome replication (GO:0045071),0.200717742943882,0.6261575538068561,0.9629629629629629,1.0,1.0,13/40,24.69%,OAS2;IFIT1;EIF2AK2;OAS3;MPHOSPH8;ILF3;INPP5K;PARP10;BST2;SLPI;SRPK1;SETDB1;BTBD17
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.22412757617373977,0.6258937428420479,0.9318181818181818,1.0,1.0,6/22,19.36%,MAN1C1;RNF5;MAN1A2;RNF139;UGGT2;TRIM13
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.23832001194210972,0.6253889888476346,0.9116541353383458,1.0,1.0,5/18,19.84%,ADRA2A;BMP8A;CHGA;INHBB;REST
prerank,peroxisomal membrane transport (GO:0015919),-0.19936857060323906,-0.6248438675048783,0.9503239740820735,0.9868262485082333,1.0,7/27,23.68%,ABCD2;PEX7;ACBD5;PEX14;PEX2;GDAP1;PEX12
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.18404480057934952,-0.6240241288743367,0.9783549783549783,0.9868202838722986,1.0,17/43,33.64%,FOXN3;BABAM2;PABIR1;BLM;ORC1;FZR1;TAOK3;NBN;TAOK1;CHEK1;DTL;HUS1B;MRNIP;CDK1;CDC6;TICRR;BRCC3
prerank,protein import into peroxisome membrane (GO:0045046),-0.210970716354716,-0.6236307720533008,0.9354838709677419,0.9865467243534551,1.0,11/22,38.94%,ABCD2;ACBD5;PEX14;PEX2;GDAP1;PEX12;RAB8B;SLC25A17;FIS1;PXMP4;PEX3
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.22753752066298677,-0.6235662843872359,0.9450980392156862,0.9861182873602695,1.0,8/16,30.55%,RRAGA;KLHL22;CLEC16A;RRAGD;SIK3;GPR137B;LAMTOR5;FLCN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.23364147869807245,-0.6226791904985304,0.9347826086956522,0.9861483109342359,1.0,3/17,14.65%,CTCF;ZWILCH;ZW10
prerank,mitotic DNA replication (GO:1902969),-0.2650856882735396,-0.6223707248877565,0.9180327868852459,0.9858576389919138,1.0,5/10,26.81%,CDC45;POLA1;MCM3;GINS3;MCM6
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.26308362070706387,0.622294394750724,0.9026369168356998,1.0,1.0,5/11,26.12%,CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,base-excision repair (GO:0006284),-0.17881139778138877,-0.6219310307502174,0.9956331877729258,0.9856242211927351,1.0,13/48,23.59%,RPA1;PARG;USP47;PRMT6;TDG;NEIL3;RPA2;XPA;RFC4;MUTYH;POLD4;SMUG1;POLB
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2311895090602203,0.6215318547893404,0.9083503054989817,1.0,1.0,7/18,27.53%,PPARA;MIA3;AKT1;PAG1;WNK1;PTPN22;LAX1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.234540524986303,-0.6210856465138516,0.9196787148594378,0.9855873952063917,1.0,5/15,29.74%,HOGA1;PRODH;GGT7;GGT1;CHAC2
prerank,cellular component maintenance (GO:0043954),0.2626137852213486,0.6210021784508816,0.9163179916317992,1.0,1.0,4/12,19.07%,SUPV3L1;MTMR2;PICK1;PRNP
prerank,ESCRT III complex disassembly (GO:1904903),-0.263930089976082,-0.6208703145345557,0.9137931034482759,0.9847705854638338,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),-0.263930089976082,-0.6208703145345557,0.9137931034482759,0.9847705854638338,1.0,3/10,18.79%,CHMP2B;IST1;CHMP1B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2579361605580275,0.6205861670971039,0.9002079002079002,1.0,1.0,6/12,26.12%,GNL3L;CCT3;CCT5;CCT8;WRAP53;CCT6A
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2054292622262706,-0.6205191155191496,0.9525773195876288,0.9844847972752484,1.0,14/25,37.84%,GMPR;HPRT1;DGUOK;AMPD2;ADA;SHMT2;SHMT1;ADK;PRPSAP1;PAICS;GART;PRPS2;AMPD1;PPAT
prerank,photoreceptor cell development (GO:0042461),-0.23617891075260194,-0.6202048627446061,0.9268774703557312,0.9841980929938826,1.0,6/14,26.42%,MFSD2A;VEGFA;RP1;MYO7A;RORB;CDHR1
prerank,actin-myosin filament sliding (GO:0033275),-0.18476114449475994,-0.6202034934090195,0.9745762711864406,0.9832764462916344,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,muscle filament sliding (GO:0030049),-0.18476114449475994,-0.6202034934090195,0.9745762711864406,0.9832764462916344,1.0,15/38,36.05%,MYL6;TPM4;TPM2;TPM3;MYL4;DMD;TMOD1;NEB;TTN;MYBPC1;MYBPC2;TCAP;MYL3;ACTA1;TNNT3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2560099593127301,0.62010039776995,0.9218436873747495,1.0,1.0,5/14,25.75%,C1QBP;TRMT10C;MPV17L2;RCC1L;FASTKD3
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.2410316416955708,0.6199333198298657,0.898406374501992,1.0,1.0,2/15,11.01%,MAGI2;FST
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.2531118503456882,0.6173985595471682,0.8931297709923665,1.0,1.0,8/13,29.58%,TNRC6A;CPEB3;TNRC6C;ZFP36;EIF4ENIF1;CNOT7;TNRC6B;TOB1
prerank,positive regulation of lipid storage (GO:0010884),-0.21143071522143853,-0.6169874357413586,0.9534883720930233,0.9845157354489095,1.0,5/21,19.09%,SCARB1;SREBF2;C3;PLIN2;ZC3H12A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2279274732982725,-0.6156971930599311,0.9541666666666667,0.9847148032995847,1.0,7/16,31.28%,PIGC;PIGL;PIGX;PIGQ;PIGN;PIGF;PIGV
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.26213043751176973,0.6156185938542492,0.9063829787234042,1.0,1.0,12/12,73.81%,HNRNPU;LARP7;RNF8;NELFA;EAPP;TCERG1;NELFB;HEXIM1;NELFE;RECQL5;NELFCD;RNF168
prerank,regulation of defense response to virus by host (GO:0050691),0.20466617704819323,0.6129173490186687,0.9637404580152672,1.0,1.0,6/30,19.24%,PQBP1;ZDHHC1;STAT1;IL12RB1;HSP90AA1;SIN3A
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.24919202831169146,-0.6125787230128242,0.9108910891089109,0.98585241852983,1.0,3/11,20.62%,SIRT7;SMARCA4;NCL
prerank,stem cell development (GO:0048864),0.24044674219550224,0.6125322294142146,0.9131313131313131,1.0,1.0,2/16,6.82%,WNT7A;NRG1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.22694406729699773,0.6122928050925492,0.9378757515030061,1.0,1.0,6/18,26.12%,RUVBL2;CCT3;CCT5;CCT8;DCP2;CCT6A
prerank,T cell homeostasis (GO:0043029),-0.2564563142659494,-0.6119792694638789,0.9310344827586207,0.9857011023064991,1.0,5/10,29.99%,FAS;NCKAP1L;JAK3;FADD;PMAIP1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.21093616562562345,0.6111886195176071,0.9476744186046512,1.0,1.0,10/25,28.01%,SRSF10;MPHOSPH10;PRPF6;PRPF3;SF3B1;SF3B3;WDR83;PRPF8;BCAS2;SNRNP40
prerank,regulation of ERAD pathway (GO:1904292),0.26517451286542526,0.6105926077169463,0.9042769857433809,1.0,1.0,3/11,13.45%,USP19;RNFT1;BAG6
prerank,methylguanosine-cap decapping (GO:0110156),0.26220854093502194,0.6103068245157068,0.9059304703476483,1.0,1.0,4/10,23.18%,PATL1;EDC4;DCPS;DCP2
prerank,polyamine metabolic process (GO:0006595),0.24979636833087826,0.6098108117548681,0.9200779727095516,1.0,1.0,3/13,22.30%,SAT1;DHPS;OAZ2
prerank,lipoprotein transport (GO:0042953),0.26682574655835267,0.6090947647655487,0.9176706827309237,1.0,1.0,4/10,26.09%,PRKCB;MIA3;VMP1;PPARG
prerank,positive regulation of immune effector process (GO:0002699),0.20806765654056175,0.6082687769901757,0.9543726235741445,1.0,1.0,1/27,1.08%,APPL2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20850065528906447,0.606258911631187,0.9683426443202979,1.0,1.0,5/29,16.64%,PLA2G4C;PNPLA8;NR1H3;PLAAT3;TMEM86B
prerank,ruffle organization (GO:0031529),0.2333616916343642,0.6062201518546213,0.9367816091954023,1.0,1.0,4/16,22.19%,CORO1B;CYFIP1;INPP5K;PLEK
prerank,positive regulation of peptidase activity (GO:0010952),0.22070948112043542,0.6055437480448091,0.9532163742690059,1.0,1.0,5/20,21.69%,CTSH;APH1A;NDUFA13;PSME2;RCN3
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.2335110937530759,-0.605404271029538,0.9453860640301318,0.98848330868009,1.0,3/13,16.47%,SAE1;SENP6;UBA6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.2404903483889021,-0.6053677159728497,0.9389002036659878,0.9880365231272717,1.0,5/12,28.79%,CD44;CD74;TAF9;TRIAP1;MIF
prerank,protein heterotetramerization (GO:0051290),0.2467467497151379,0.6051135604379683,0.9193857965451055,1.0,1.0,2/13,7.76%,CPSF6;CPSF7
prerank,regulation of lymphocyte migration (GO:2000401),0.2612547587819587,0.6029458466443273,0.911340206185567,1.0,1.0,4/10,23.93%,WASL;MIA3;AKT1;SLC8B1
prerank,cell cycle checkpoint signaling (GO:0000075),0.2504034470406462,0.6023180822513176,0.9207317073170732,1.0,1.0,3/12,19.49%,ZWINT;PRCC;WEE1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19130685486888396,0.6014196759902154,0.9690909090909091,1.0,1.0,2/42,4.13%,OXSR1;STK39
prerank,B cell activation involved in immune response (GO:0002312),0.24718918342841456,0.6011059215856157,0.93812375249501,0.9995616304138806,1.0,2/13,10.98%,MSH6;BATF
prerank,phospholipid dephosphorylation (GO:0046839),0.19098971080527308,0.6007620222454254,0.96,0.9990571006465616,1.0,10/37,20.97%,MTMR4;INPP5J;PLPPR3;SYNJ2;MTMR2;MTMR10;EPHX2;OCRL;INPP5K;PIP4P2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.26432789535340084,0.6005019773345925,0.9372294372294372,0.9985238165129076,1.0,3/10,19.22%,LEO1;CDC73;CPEB3
prerank,ncRNA catabolic process (GO:0034661),-0.1990072646760972,-0.5985618648854837,0.9817813765182186,0.9906216275715487,1.0,10/28,30.05%,TENT4B;RBM7;TRIR;NUDT16;NUDT16L1;EXOSC4;EXOSC5;EXOSC3;XRN1;DIS3L2
prerank,negative regulation of transferase activity (GO:0051348),-0.19330402978597497,-0.5968183313715377,0.9693654266958425,0.9908962639868988,1.0,12/28,34.02%,CDKN1C;SRC;BAG5;FBXO5;LIMK1;DTX3L;CDKN1B;MAPT;SMAD7;PARK7;PIF1;TP53
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.22718907488232942,-0.5967358770661757,0.94,0.9904743096471244,1.0,3/14,17.59%,RPL7;RPL35;ZNHIT6
prerank,macrophage migration (GO:1905517),0.24036409290646574,0.5964254997491675,0.9531568228105907,0.9998769607209254,1.0,13/13,75.98%,P2RX4;P2RY12;EDNRB;CCL2;SAA1;EDN2;CKLF;LGALS3;CCL3;CCL5;CXCL17;CCR2;TAFA4
prerank,negative regulation of innate immune response (GO:0045824),0.19645219990021712,0.5959054993218179,0.9636711281070746,0.999455207180629,1.0,6/34,14.18%,USP18;NLRC3;CACTIN;OAS3;STAT2;TYRO3
prerank,transcription preinitiation complex assembly (GO:0070897),0.24160441905718408,0.5958896495650399,0.9216494845360824,0.9988016414769838,1.0,12/12,75.86%,TAF1;DR1;GTF2A2;TAF12;GTF2B;TBP;TAF11;TAF7L;TAF1B;BDP1;TAF7;POLR1E
prerank,negative regulation of chemokine production (GO:0032682),0.24256430781828564,0.5955814764692736,0.9452332657200812,0.9982797296302633,1.0,4/14,18.75%,C1QTNF3;OAS3;IL6;SIRPA
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.24726663410052707,0.5951169283653961,0.9352226720647774,0.9978459863310952,1.0,3/12,15.19%,INSIG2;ANKRD13C;RER1
prerank,ncRNA export from nucleus (GO:0097064),0.18999967846694304,0.5945959154717021,0.9771863117870723,0.9974518997049011,1.0,12/36,26.44%,POM121;NUP155;NUP98;TSC1;NUP37;NUP88;NDC1;RAE1;PHAX;NUP160;NPM1;NUP133
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.19792589871820623,-0.5943659305988815,0.9686847599164927,0.9910290465417558,1.0,5/25,17.68%,TNFSF10;MFF;BBC3;PLAUR;GPER1
prerank,positive regulation of chemokine production (GO:0032722),-0.17146804574340815,-0.593768701599924,0.9905437352245863,0.990814010475,1.0,12/44,27.00%,APP;WNT5A;IL6R;TWIST1;CD74;CSF1R;IL33;HMGB1;SYK;TLR4;AIF1;HMOX1
prerank,regulation of lamellipodium organization (GO:1902743),-0.23179509720250885,-0.5926943698968152,0.9490835030549898,0.9908027237313817,1.0,5/14,26.41%,CD44;CDC42;CARMIL1;DMTN;TWF2
prerank,positive regulation of viral process (GO:0048524),-0.16134501708567686,-0.5921587727127943,0.9975550122249389,0.990568000946719,1.0,16/60,26.95%,MDFIC;ADARB1;PABPC1;PPIA;GTF2F1;VAPB;KPNA2;PPIE;TMEM39A;POLR2I;POLR2F;TARBP2;TBC1D20;POLR2H;NELFCD;CCNT1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.22614957873543573,-0.592002745883512,0.9330628803245437,0.9901612880023095,1.0,3/14,13.42%,TSEN2;CPSF4;CLP1
prerank,positive regulation of lipid localization (GO:1905954),-0.24581607004070918,-0.5896534569499838,0.9625,0.9906902056070108,1.0,4/11,26.12%,LRP1;C3;ZC3H12A;HILPDA
prerank,histone H4 deacetylation (GO:0070933),-0.25325268997588263,-0.5895723395196526,0.9208494208494209,0.9902714831862205,1.0,3/10,26.26%,HDAC9;HDAC2;RCOR1
prerank,cell differentiation in spinal cord (GO:0021515),0.25395853436199584,0.5879134489050464,0.9217758985200846,0.9998918301394705,1.0,2/10,17.37%,MDGA2;SOX6
prerank,protein kinase A signaling (GO:0010737),0.24507129157141017,0.5878659744289381,0.9385245901639344,0.9992488731768618,1.0,2/12,12.76%,TCP11;RAB13
prerank,regulation of protein localization to Cajal body (GO:1904869),0.24623995907412652,0.5876465710064102,0.9211538461538461,0.998014749438356,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.24623995907412652,0.5876465710064102,0.9211538461538461,0.998014749438356,1.0,4/11,20.57%,CCT3;CCT5;CCT8;LARP7
prerank,nucleic acid metabolic process (GO:0090304),0.16510384294123548,0.5865716341742485,0.9949579831932773,0.9978237854557269,1.0,17/69,23.82%,HNRNPA2B1;DUSP11;HNRNPU;HNRNPA3;HNRNPL;PTBP1;LSM8;POLR2D;POLG;HNRNPH2;POLR2A;HNRNPH1;DNASE1L2;MMS19;DDX24;POLR2B;HNRNPC
prerank,protein localization to centrosome (GO:0071539),-0.21385583840795286,-0.5849622143677736,0.9606126914660832,0.9916080508738371,1.0,11/17,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;GOLGB1;CCDC14;HOOK3;BBS4;DCTN2
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2330640402762637,-0.5848422225214581,0.9401709401709402,0.9912080638882185,1.0,8/12,40.02%,SREBF2;SREBF1;LPCAT3;MBTPS2;H6PD;RAN;DGKQ;KPNB1
prerank,regulation of B cell differentiation (GO:0045577),-0.21543723477674737,-0.5847244433251287,0.9628099173553719,0.9907984802149535,1.0,7/17,33.52%,ID2;NCKAP1L;BTK;SYK;ZFP36L2;IL4I1;IKZF3
prerank,spliceosomal snRNP assembly (GO:0000387),0.1848597600538686,0.584631147703475,0.9741824440619621,0.9980269346563719,1.0,13/38,26.33%,STRAP;SRSF10;PRPF19;LSM4;SNUPN;PRPF6;PRPF3;SNRPB;PRMT5;SART3;SNRPC;PRPF8;GEMIN7
prerank,sulfur amino acid catabolic process (GO:0000098),0.2513023285005963,0.5843443105691921,0.9338677354709419,0.9974948222966797,1.0,10/10,74.89%,CTH;BLMH;MTRR;MAT1A;GADL1;TST;TXN2;ADO;CBS;MPST
prerank,toxin transport (GO:1901998),-0.24582381577149912,-0.5841427994017553,0.9367088607594937,0.9905498699137342,1.0,1/10,6.18%,ADAM10
prerank,negative regulation by host of viral transcription (GO:0043922),-0.23420048569976787,-0.5832172203407101,0.9330543933054394,0.9904579079541798,1.0,1/12,4.20%,JUN
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.23592116811725994,0.5827933929186174,0.9316770186335404,0.9975352649204746,1.0,3/13,14.64%,MBD4;UPP2;NEIL1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.21621292422976915,0.5826124394380803,0.9487666034155597,0.9969566426011028,1.0,4/18,11.83%,NLRC3;MED25;CD300A;CDC73
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.23151737745577072,0.5824321201458073,0.9540229885057471,0.9963685677410673,1.0,5/15,17.54%,BCL2;MUC1;SIRT1;MDM2;KDM1A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.20627904551594264,0.5807090006405274,0.9628252788104089,0.9964188619387766,1.0,3/23,10.95%,NR1H3;PARP14;STAT1
prerank,vitamin D metabolic process (GO:0042359),-0.23126992264010743,-0.5801350135882387,0.9584905660377359,0.9911782051514898,1.0,8/13,46.28%,CUBN;CYP2R1;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.21626055909572564,-0.579559717306073,0.944,0.990939714586705,1.0,8/16,38.75%,APOE;MYOCD;LRP1;ROCK1;TREM2;ABCA7;HDAC1;IL4
prerank,programmed necrotic cell death (GO:0097300),-0.20625934303765386,-0.5791928937541967,0.9647302904564315,0.9906207125915769,1.0,8/18,32.89%,IPMK;MLKL;RIPK1;TICAM1;CYLD;TLR4;CD14;TLR3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2034971717244038,0.5784432674167947,0.9524680073126143,0.9966818209048905,1.0,3/24,8.29%,HNRNPU;TNKS2;GNL3L
prerank,negative regulation of receptor internalization (GO:0002091),-0.2268619232466962,-0.5784024346025234,0.958984375,0.9904821084640253,1.0,5/12,30.06%,ANKRD13A;ANKRD13B;ANKRD13D;NECAB2;WDR54
prerank,protein ADP-ribosylation (GO:0006471),-0.18181009758528316,-0.5780729460134095,0.9803921568627451,0.9901484175383327,1.0,8/28,25.10%,TNKS;ART3;HPF1;SIRT5;PARP8;SIRT6;PARP3;PARP12
prerank,replication fork processing (GO:0031297),-0.17557813792060561,-0.5776795805286565,0.9842696629213483,0.9898267197065179,1.0,8/38,23.85%,MMS22L;BLM;BRCA2;BOD1L1;PRIMPOL;CENPX;NUCKS1;TRAIP
prerank,stress granule assembly (GO:0034063),0.2138647758952064,0.5770518822017431,0.9506903353057199,0.9965870563261005,1.0,8/20,24.79%,ATXN2L;BICD1;OGFOD1;EIF2S1;DDX3X;YTHDF3;YTHDF2;CSDE1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.21698265798228342,-0.5761298825473312,0.9642857142857143,0.9899222496945425,1.0,10/15,40.98%,PIBF1;SNX10;STIL;CSNK1D;CEP131;CEP83;CCDC14;HOOK3;BBS4;DCTN2
prerank,RNA stabilization (GO:0043489),0.19107911661762447,0.576113056879611,0.9796296296296296,0.9962891360833619,1.0,6/33,15.24%,HNRNPU;E2F1;ELAVL1;VIP;NSUN2;PAIP1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.21799303418536708,-0.5744236068546803,0.9668737060041408,0.9900772252027982,1.0,10/15,48.62%,NUDT16;ZC3H12A;NYNRIN;POP7;RPP40;ZC3H12D;RNASEH1;LACTB2;ZC3H12C;SLFN14
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.21117889093760614,-0.573583210064919,0.9507186858316222,0.9899275248233288,1.0,3/16,13.63%,CEACAM1;STX7;PTPRC
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.24822695035460993,-0.572337134365503,0.9430379746835443,0.9894548476018032,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.24822695035460993,-0.572337134365503,0.9430379746835443,0.9894548476018032,1.0,10/10,75.20%,KLF4;MYADM;APOA1;IL10;IL1RN;ADIPOQ;MAPK7;MBP;MAP2K5;WNK1
prerank,regulation of leukocyte migration (GO:0002685),-0.2149659894316531,-0.5720361545673751,0.9758551307847082,0.9891029013694486,1.0,3/16,16.03%,ANXA1;VEGFA;NCKAP1L
prerank,regulation of defense response to virus (GO:0050688),0.22664749749666016,0.5710759566610728,0.9493927125506073,0.9976065986421397,1.0,4/14,21.26%,C1QBP;PPM1B;RNF26;ILRUN
prerank,B cell mediated immunity (GO:0019724),-0.2368736035343771,-0.5708973317862401,0.9557344064386318,0.9890348692626036,1.0,5/10,44.08%,CD74;FCGR2B;FCER1G;CARD9;SLA2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2338494866269616,0.568870822021128,0.9616935483870968,0.9977566569103139,1.0,5/14,25.10%,IKBKG;KCNN4;RELA;CD81;CD226
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.1669369624236225,-0.5688453622188893,0.9858585858585859,0.9892654917189186,1.0,7/37,17.90%,ANKRD13A;APOE;EDN1;SIRT5;AP1AR;MT3;ANKRD13B
prerank,piRNA metabolic process (GO:0034587),0.2079879427279578,0.5664635765190749,0.9402390438247012,0.9980026189280584,1.0,19/19,79.23%,TDRD9;MYBL1;DDX4;TDRD12;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;TEX15;FKBP6;TDRKH;PIWIL4;EXD1;PIWIL2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20212036325808264,-0.5661862407365938,0.9663366336633663,0.9896878895649728,1.0,8/19,32.52%,TRIL;NR1H4;NMI;RAB11FIP2;PRKCE;TLR4;LGALS9;CD14
prerank,P-body assembly (GO:0033962),-0.22866817415169155,-0.564757939780134,0.9624505928853755,0.9896917896488456,1.0,5/12,32.62%,LIMD1;DYNC1H1;LSM3;PATL2;EDC3
prerank,negative regulation of interleukin-17 production (GO:0032700),0.24326722486803248,0.5646249768670757,0.922,0.9980094337021898,1.0,3/10,19.69%,IL12A;PRNP;DDIT3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.22950408035153794,0.5640094505048082,0.9587426326129665,0.9975734350794757,1.0,13/13,77.07%,VDAC2;BAX;RHOT1;BLOC1S2;BAD;RTL10;MOAP1;BNIP3L;BNIP3;BCL2L11;BMF;PMAIP1;RHOT2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.20298170174877495,-0.5634847325178445,0.9813664596273292,0.9896102429791656,1.0,8/19,32.42%,SRC;TENT4B;TEN1;CTC1;TINF2;TERF2;XRN1;PIF1
prerank,axoneme assembly (GO:0035082),0.18820421152868455,0.5619555765884537,0.9796672828096118,0.9976444636043538,1.0,3/30,13.59%,RSPH4A;DRC1;DNAAF2
prerank,inhibitory synapse assembly (GO:1904862),0.24119611431942856,0.5610648822865036,0.9526627218934911,0.9972828105481457,1.0,3/11,18.56%,CBLN4;GABRB2;GABRB3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.22301589601412702,-0.5585014973600202,0.9737373737373738,0.9906093911894719,1.0,4/13,27.91%,UBB;RHOT2;SYBU;MAPT
prerank,apoptotic nuclear changes (GO:0030262),0.1944580442694431,0.5542043030655373,0.9752380952380952,0.9989442924135186,1.0,5/24,16.96%,CASP3;DFFA;ACIN1;DICER1;EXOG
prerank,microtubule-based transport (GO:0099111),-0.22655574127107703,-0.5541919571074561,0.9609375,0.9914548927989593,1.0,5/12,26.04%,DYNC1I2;DYNC1I1;CABYR;ADCY10;SPEF2
prerank,protein targeting to lysosome (GO:0006622),0.20300044852380958,0.5538633062652127,0.9767441860465116,0.9983852436874676,1.0,4/20,13.79%,SNX16;LAMP2;CLU;AP4M1
prerank,eosinophil migration (GO:0072677),-0.21373371047236728,-0.5473433030769075,0.962882096069869,0.9923794704475688,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.21373371047236728,-0.5473433030769075,0.962882096069869,0.9923794704475688,1.0,9/14,48.21%,CCL13;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,tRNA 5'-leader removal (GO:0001682),0.22065489589977738,0.5470483689728337,0.952191235059761,0.999898062147487,1.0,3/13,21.60%,POP4;RPP25L;RPP30
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.22112023578748982,-0.5453926118213627,0.9691119691119691,0.9924232964767068,1.0,7/12,37.84%,ADSS1;IMPDH1;ADSS2;PAICS;IMPDH2;GART;PPAT
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.2177824446475465,0.543834325810427,0.9678800856531049,1.0,1.0,5/15,23.97%,EBI3;NKAP;IL12A;SHH;PNP
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.1938987816309362,0.541399694691263,0.9810606060606061,1.0,1.0,6/23,20.76%,COX18;TOMM22;NDUFA13;HSP90AA1;MAIP1;BAX
prerank,V(D)J recombination (GO:0033151),-0.2243369220355011,-0.5400532766130738,0.9742063492063492,0.9933017696415891,1.0,3/11,23.02%,LIG4;HMGB1;DCAF1
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.1948751793815567,-0.5393332530929872,0.9800399201596807,0.9930293710144147,1.0,8/18,35.93%,PTP4A3;CCT2;CEP295;DKC1;TREM2;CCT7;CORO2B;CEP135
prerank,positive regulation of cilium assembly (GO:0045724),0.20385082322508496,0.5377178093384861,0.9735849056603774,1.0,1.0,2/18,8.94%,SEPTIN9;HTT
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.19034721079168504,-0.5371928934919906,0.9822485207100592,0.9930809460164727,1.0,11/20,37.84%,HPRT1;ADSS1;IMPDH1;AK4;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,extracellular transport (GO:0006858),0.2236758184662581,0.5371872612848229,0.9595959595959596,1.0,1.0,3/12,18.94%,ROPN1L;DNAAF2;SPA17
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.16124076225708656,0.5369217984589885,1.0,0.9994333284540058,1.0,14/52,23.21%,EXOSC8;PATL1;LSM5;LSM4;EXOSC2;TUT4;POLR2D;EDC4;CNOT3;CNOT8;DCPS;PNLDC1;DCP2;PAN2
prerank,mitochondrial genome maintenance (GO:0000002),-0.2221808134775135,-0.5340937646635958,0.9609856262833676,0.9933634333962568,1.0,1/11,3.36%,AKT3
prerank,tRNA export from nucleus (GO:0006409),0.1720290794281465,0.529710331314563,0.9771428571428571,1.0,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.1720290794281465,0.529710331314563,0.9771428571428571,1.0,1.0,6/32,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,negative regulation of centrosome duplication (GO:0010826),0.22359631063585514,0.5277753989698495,0.966796875,0.9998898532176185,1.0,2/11,11.10%,CENATAC;TMEM67
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.17743905793163758,-0.5271259441084744,0.9874476987447699,0.9944614608679376,1.0,8/23,30.42%,PIK3R6;NECTIN2;PVR;ARRB2;CADM1;RAET1E;RASGRP1;LGALS9
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.21939862846132097,-0.5261425230014004,0.9618473895582329,0.994202909694655,1.0,6/11,42.01%,HDAC2;TMEM106A;TAF7;PF4;IL4;XBP1
prerank,glycoprotein catabolic process (GO:0006516),-0.1915898635883843,-0.5256919638037695,0.977366255144033,0.9938457486997694,1.0,6/17,28.92%,STT3B;FBXO44;ADAMTS12;EDEM2;EDEM1;FBXO2
prerank,mRNA modification (GO:0016556),0.187796358716794,0.5248750185678428,0.9870848708487084,0.9999285843951662,1.0,8/22,25.21%,NSUN2;TRMT6;TRMT61B;TRMT10C;RPUSD2;ZC3H13;METTL8;TRUB1
prerank,protein localization to phagophore assembly site (GO:0034497),0.21879139709268286,0.5246497774508562,0.9615384615384616,0.9993311550274432,1.0,5/11,24.29%,MFN2;ATG13;WDR45;TRAPPC8;PACS2
prerank,histone mRNA metabolic process (GO:0008334),0.18028435530600057,0.5241631783153151,0.9900398406374502,0.9987872669184163,1.0,5/27,15.99%,CPSF3;TUT4;SLBP;LSM11;ATM
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.17711252029347993,-0.5234595520257201,0.9858012170385395,0.9938754537387293,1.0,8/22,28.04%,PPP1CA;DUSP6;PPP2CA;DUSP1;PDP1;DUSP7;DUSP18;PPP5C
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.19791966753590665,0.5187276178574757,0.9845261121856866,0.999398143262614,1.0,7/16,32.58%,TRIM71;CPEB3;ZFP36;ZFP36L1;UPF1;PLEKHN1;TARDBP
prerank,regulation of oxidoreductase activity (GO:0051341),0.2096002960315197,0.5165885696740108,0.9724409448818898,0.9992012113125724,1.0,4/13,19.96%,ABL1;ATP7A;OXA1L;ECSIT
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.19843014128728426,0.5160169777493577,0.9801192842942346,0.9986890594520627,1.0,18/18,80.18%,ROPN1L;DNAAF2;SPA17;ODAD4;OFD1;CCDC39;SPAG17;AQP4;NEK10;DNAAF1;RFX3;DNAAF4;CCDC40;NPHP3;SPEF2;ADCY10;CFAP53;CABYR
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.18504680268554147,-0.5114687006000683,0.9918200408997955,0.9956763908265293,1.0,6/18,32.89%,FBN1;FBXW7;TLR4;GPR137B;LRRC17;TLR3
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2187798052371061,-0.5109559455936412,0.9742063492063492,0.9953051917533011,1.0,4/10,34.45%,QDPR;KYNU;IL4I1;PCBD1
prerank,regulation of mitochondrial translation (GO:0070129),-0.17621515038168079,-0.5104300442126611,0.9916142557651991,0.9949527959355033,1.0,9/21,36.22%,ALKBH1;NGRN;MTG1;SHMT2;RPUSD3;MTG2;MRPS27;MALSU1;TRUB2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.2177971137485698,0.5063562118651854,0.9603960396039604,0.9999293541576203,1.0,1/10,6.92%,PDK2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.20585520302982077,-0.5056720351946036,0.989648033126294,0.9953314390323357,1.0,6/12,36.14%,CDC45;MCM3;MCM5;MCM6;GINS2;MUS81
prerank,negative regulation of lipid catabolic process (GO:0050995),0.18899180428172627,0.504262070698084,0.9859719438877755,0.9996703490384793,1.0,1/17,4.37%,ADRA2A
prerank,tRNA transport (GO:0051031),0.1613632714521161,0.5039307775700412,0.9961389961389961,0.9990817986792798,1.0,6/35,19.51%,POM121;NUP155;NUP98;NUP37;NUP88;NDC1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.19736346516007533,-0.5028546160095944,0.9817073170731707,0.9953419505870533,1.0,13/13,80.29%,ALG6;ALG3;ALG11;ALG13;ALG1;SRD5A3;ALG8;ALG14;ALG9;MPDU1;ALG12;ALG2;DPAGT1
prerank,serine family amino acid metabolic process (GO:0009069),0.19204889534245428,0.5012164852128312,0.9761431411530815,0.9989287295168489,1.0,4/16,16.78%,GLYAT;CDO1;MTHFD1;CTH
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.19311987699962938,0.4962327987908965,0.9860834990059643,0.9991428069976571,1.0,1/16,5.33%,VAMP7
prerank,intermediate filament organization (GO:0045109),-0.1812476017040128,-0.49576583878408403,0.9862745098039216,0.9959470942625936,1.0,3/17,21.30%,GFAP;DSP;BFSP2
prerank,central nervous system myelination (GO:0022010),-0.20096307674761515,-0.4908983647695892,0.9839679358717435,0.9961836597400996,1.0,5/11,34.49%,B4GALT5;PTEN;MYRF;B4GALT6;TENM4
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.20058438353717123,0.49060329892298754,0.9858299595141701,0.9993960770722858,1.0,5/13,23.25%,STX4;SNX33;GPD1L;RIC3;MAP1A
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.17253139308778165,0.4900991156716559,0.9887218045112782,0.9988251996314047,1.0,4/23,16.96%,CASP3;DFFA;DICER1;EXOG
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.20337629802023915,0.49007895255870415,0.9717741935483871,0.9981842055330757,1.0,4/12,23.09%,CHEK2;CLSPN;RAD17;NAE1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.19319675490628918,-0.48528340280090687,0.9882352941176471,0.9964850609289511,1.0,5/12,28.71%,TNKS;PARP8;PARP3;PARP12;PARP1
prerank,positive regulation of calcium ion import (GO:0090280),-0.1922693502545379,-0.4830817110042208,0.9980769230769231,0.9963034140757749,1.0,1/12,6.52%,CXCL12
prerank,cranial nerve development (GO:0021545),-0.20240318059309298,-0.47999091650875114,0.9757575757575757,0.9962254602955378,1.0,6/11,40.22%,TMEM126A;SALL1;POU4F1;TIFAB;ISL1;ERBB3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.17112131696797217,0.47923009942283507,0.9901768172888016,0.9991396914523099,1.0,6/23,23.04%,GSTM2;EPHX2;GSTM1;ALOX5;ACSBG1;GPX4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.18367785233720055,0.4791259416192328,0.9886792452830189,0.9985127750007486,1.0,7/17,29.24%,NUS1;DPAGT1;ALG2;ALG12;DOLPP1;MPDU1;ALG9
prerank,rRNA catabolic process (GO:0016075),0.18457929610302493,0.4761859913417278,0.9879759519038076,0.9982691294839866,1.0,2/16,11.29%,EXOSC8;EXOSC2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.15921788160542993,0.47393628900482415,0.9963369963369964,0.9979043634510543,1.0,9/29,27.46%,KLRD1;SLAMF6;ITGAM;IL12A;IL12RB1;LAMP1;CD226;CYRIB;AP1G1
prerank,nucleosome assembly (GO:0006334),0.15682772334368683,0.4719427738936545,0.9944547134935305,0.9975171877082595,1.0,11/31,26.19%,SOX9;BRD2;NAP1L2;CABIN1;IPO4;KAT6B;SPTY2D1;SART3;ATRX;NPM1;ANP32B
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.19853125784584486,0.46857250786767507,0.9920159680638723,0.9972671954612693,1.0,11/11,80.16%,ITGAM;STX4;MAVS;CAMK4;ITGB2;CD177;F2RL1;STAP1;TYROBP;TICAM1;SPI1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.17318513826157378,-0.46457175818842633,0.9941860465116279,0.9973818678373145,1.0,9/16,37.84%,ADSS1;IMPDH1;AMPD2;ADSS2;PAICS;IMPDH2;GART;AMPD1;PPAT
prerank,immunoglobulin mediated immune response (GO:0016064),-0.19375682276524284,-0.46426422692053426,0.9902152641878669,0.9969575673612521,1.0,2/10,22.51%,CD74;FCGR2B
prerank,regulation of protein kinase A signaling (GO:0010738),-0.1567958149595315,-0.4568922877282801,0.9959514170040485,0.9972004936214787,1.0,11/20,42.17%,IAPP;TCIM;PRKAR2B;PRKAR1B;PRKAR2A;MIF;RAMP3;AKAP12;FSHR;PJA2;MC1R
prerank,cytoplasmic translational initiation (GO:0002183),0.1765564350673171,0.4542952616972591,0.9923954372623575,0.998125213202703,1.0,8/17,29.83%,EIF4A2;EIF3A;EIF2D;DENR;EIF3D;RBM4;EIF2S2;DHX29
prerank,regulation of response to oxidative stress (GO:1902882),0.18880552580904736,0.44108667260313617,0.9921568627450981,0.9986609575120614,1.0,2/11,14.29%,ABCD1;AIFM2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.19034164512012502,0.4333422836286512,0.9919517102615694,0.9985838464062714,1.0,2/10,18.82%,NR1H3;TIRAP
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.14842770979049735,0.4311665249030972,1.0,0.9980804745325209,1.0,3/27,9.59%,LPAR1;DRD3;C3AR1
prerank,microglial cell activation (GO:0001774),-0.15027048520291297,-0.4298427723683602,1.0,0.9985650020144698,1.0,1/21,3.64%,APP
prerank,acetyl-CoA metabolic process (GO:0006084),-0.15950507399631297,-0.42253813018402675,0.9920159680638723,0.9984488970986973,1.0,6/15,32.57%,ACACB;MLYCD;PMVK;HMGCS2;NUDT7;ACLY
prerank,long-term memory (GO:0007616),0.15123460124586333,0.40184572008327896,0.9981060606060606,0.998874834086334,1.0,7/19,30.09%,SHANK1;PRNP;CPEB3;SGK1;RASGRF1;CAMK4;EIF2AK4
